US8338131B2	NNP	O
-	:	O
Amylases	NNS	O
and	CC	O
methods	NNS	O
for	IN	O
use	NN	O
in	IN	O
starch	NN	O
processing	NN	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
CROSS-REFERENCE	NNP	O
TO	NNP	O
RELATED	NNP	O
APPLICATIONS	NNP	O
This	DT	O
application	NN	O
is	VBZ	O
a	DT	O
continuation	NN	O
of	IN	O
U.S.	NNP	O
patent	NN	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
10/489,510	CD	O
,	,	O
filed	VBD	O
Jan.	NNP	O
12	CD	O
,	,	O
2005	CD	O
,	,	O
now	RB	O
pending	VBG	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
Continuation-in-Part	NNP	O
of	IN	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
10/105,733	CD	O
,	,	O
filed	VBN	O
Mar	NNP	O
.	.	O
22	CD	O
,	,	O
2002	CD	O
,	,	O
now	RB	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
7,323,336	CD	O
,	,	O
which	WDT	O
is	VBZ	O
a	DT	O
Continuation-in-Part	NNP	O
of	IN	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
10/081,739	CD	O
,	,	O
filed	VBD	O
Feb.	NNP	O
21	CD	O
,	,	O
2002	CD	O
,	,	O
now	RB	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
7,273,740	CD	O
,	,	O
which	WDT	O
claims	VBZ	O
the	DT	O
benefit	NN	O
of	IN	O
priority	NN	O
under	IN	O
35	CD	O
U.S.C	NNP	O
.	.	O
§119	NN	O
(	(	O
e	NN	O
)	)	O
of	IN	O
60/270,495	CD	O
,	,	O
filed	VBD	O
Feb.	NNP	O
21	CD	O
,	,	O
2001	CD	O
;	:	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
60/270,496	CD	O
,	,	O
filed	VBD	O
Feb.	NNP	O
21	CD	O
,	,	O
2001	CD	O
;	:	O
and	CC	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
60/291,122	CD	O
,	,	O
filed	VBD	O
May	NNP	O
14	CD	O
,	,	O
2001	CD	O
,	,	O
now	RB	O
pending	VBG	O
.	.	O
Each	DT	O
of	IN	O
the	DT	O
aforementioned	JJ	O
applications	NNS	O
are	VBP	O
explicitly	RB	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
in	IN	O
their	PRP$	O
entirety	NN	O
and	CC	O
for	IN	O
all	DT	O
purposes	NNS	O
.	.	O
REFERENCE	NNP	O
TO	NNP	O
SEQUENCE	NNP	O
LISTING	NNP	O
SUBMITTED	NNP	O
VIA	NNP	O
EFS-WEB	NNP	O
The	DT	O
entire	JJ	O
content	NN	O
of	IN	O
the	DT	O
following	JJ	O
electronic	JJ	O
submission	NN	O
of	IN	O
the	DT	O
sequence	NN	O
listing	NN	O
via	IN	O
the	DT	O
USPTO	NNP	O
EFS-WEB	NNP	O
server	NN	O
,	,	O
as	IN	O
authorized	JJ	O
and	CC	O
set	VBD	O
forth	NN	O
in	IN	O
MPEP	NNP	O
§1730	NNP	O
II.B.2	NNP	O
(	(	O
a	DT	O
)	)	O
(	(	O
C	NNP	O
)	)	O
,	,	O
is	VBZ	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference	NN	O
in	IN	O
its	PRP$	O
entirety	NN	O
for	IN	O
all	DT	O
purposes	NNS	O
.	.	O
The	DT	O
sequence	NN	O
listing	NN	O
is	VBZ	O
identified	VBN	O
on	IN	O
the	DT	O
electronically	RB	O
filed	VBN	O
text	NN	O
file	NN	O
as	IN	O
follows	VBZ	O
:	:	O
TECHNICAL	JJ	O
FIELD	NNP	O
This	DT	O
invention	NN	O
relates	VBZ	O
to	TO	O
molecular	VB	O
and	CC	O
cellular	JJ	O
biology	NN	O
and	CC	O
biochemistry	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
is	VBZ	O
directed	VBN	O
to	TO	O
polypeptides	VB	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
e.g.	NN	O
,	,	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
,	,	O
polynucleotides	VBZ	O
encoding	VBG	O
the	DT	O
polypeptides	NNS	O
,	,	O
and	CC	O
methods	NNS	O
for	IN	O
making	VBG	O
and	CC	O
using	VBG	O
these	DT	O
polynucleotides	NNS	O
and	CC	O
polypeptides	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
amylases	NNS	O
,	,	O
for	IN	O
example	NN	O
,	,	O
alpha	NN	O
amylases	NNS	O
,	,	O
to	TO	O
catalyze	VB	O
the	DT	O
hydrolysis	NN	O
of	IN	O
starch	NN	O
into	IN	O
sugars	NNS	O
.	.	O
BACKGROUND	NNP	O
Starch	NNP	O
is	VBZ	O
a	DT	O
complex	JJ	O
carbohydrate	NN	O
often	RB	O
found	VBN	O
in	IN	O
the	DT	O
human	JJ	O
diet	NN	O
.	.	O
The	DT	O
structure	NN	O
of	IN	O
starch	NN	O
is	VBZ	O
glucose	JJ	O
polymers	NNS	O
linked	VBN	O
by	IN	O
α-1,4	JJ	O
and	CC	O
α-1,6	JJ	O
glucosidic	JJ	O
bonds	NNS	O
.	.	O
Amylase	NNP	O
is	VBZ	O
an	DT	O
enzyme	NN	O
that	WDT	O
catalyzes	VBZ	O
the	DT	O
hydrolysis	NN	O
of	IN	O
starches	NNS	O
into	IN	O
sugars	NNS	O
.	.	O
Amylases	NNS	O
hydrolyze	VBP	O
internal	JJ	O
Amylases	NNS	O
are	VBP	O
produced	VBN	O
by	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
microorganisms	NNS	O
including	VBG	O
Bacillus	NNP	O
and	CC	O
Aspergillus	NNP	O
,	,	O
with	IN	O
most	JJS	O
commercial	JJ	O
amylases	NNS	O
being	VBG	O
produced	VBN	O
from	IN	O
bacterial	JJ	O
sources	NNS	O
such	JJ	O
as	IN	O
Bacillus	NNP	O
licheniformis	NN	O
,	,	O
Bacillus	NNP	O
amyloliquefaciens	VBZ	O
,	,	O
Bacillus	NNP	O
subtilis	NNS	O
,	,	O
or	CC	O
Bacillus	NNP	O
stearothermophilus	NN	O
.	.	O
In	IN	O
recent	JJ	O
years	NNS	O
,	,	O
the	DT	O
enzymes	NNS	O
in	IN	O
commercial	JJ	O
use	NN	O
have	VBP	O
been	VBN	O
those	DT	O
from	IN	O
Bacillus	CC	O
licheniformis	JJ	O
because	IN	O
of	IN	O
their	PRP$	O
heat	NN	O
stability	NN	O
and	CC	O
performance	NN	O
,	,	O
at	IN	O
least	JJS	O
at	IN	O
neutral	JJ	O
and	CC	O
mildly	RB	O
alkaline	JJ	O
pHs	NN	O
.	.	O
In	IN	O
general	JJ	O
,	,	O
starch	NN	O
to	TO	O
fructose	VB	O
processing	VBG	O
consists	NNS	O
of	IN	O
four	CD	O
steps	NNS	O
:	:	O
liquefaction	NN	O
of	IN	O
granular	JJ	O
starch	NN	O
,	,	O
saccharification	NN	O
of	IN	O
the	DT	O
liquefied	JJ	O
starch	NN	O
into	IN	O
dextrose	JJ	O
,	,	O
purification	NN	O
,	,	O
and	CC	O
isomerization	NN	O
to	TO	O
fructose	VB	O
.	.	O
The	DT	O
object	NN	O
of	IN	O
a	DT	O
starch	JJ	O
liquefaction	NN	O
process	NN	O
is	VBZ	O
to	TO	O
convert	VB	O
a	DT	O
concentrated	JJ	O
suspension	NN	O
of	IN	O
starch	NN	O
polymer	NN	O
granules	NNS	O
into	IN	O
a	DT	O
solution	NN	O
of	IN	O
soluble	JJ	O
shorter	NN	O
chain	NN	O
length	NN	O
dextrins	NNS	O
of	IN	O
low	JJ	O
viscosity	NN	O
.	.	O
This	DT	O
step	NN	O
is	VBZ	O
essential	JJ	O
for	IN	O
convenient	NN	O
handling	VBG	O
with	IN	O
standard	JJ	O
equipment	NN	O
and	CC	O
for	IN	O
efficient	JJ	O
conversion	NN	O
to	TO	O
glucose	VB	O
or	CC	O
other	JJ	O
sugars	NNS	O
.	.	O
To	TO	O
liquefy	VB	O
granular	JJ	O
starch	NN	O
,	,	O
it	PRP	O
is	VBZ	O
necessary	JJ	O
to	TO	O
gelatinize	VB	O
the	DT	O
granules	NNS	O
by	IN	O
raising	VBG	O
the	DT	O
temperature	NN	O
of	IN	O
the	DT	O
granular	JJ	O
starch	NN	O
to	TO	O
over	VB	O
about	IN	O
72°	CD	O
C.	NNP	O
The	DT	O
heating	NN	O
process	NN	O
instantaneously	RB	O
disrupts	VBZ	O
the	DT	O
insoluble	JJ	O
starch	NN	O
granules	NNS	O
to	TO	O
produce	VB	O
a	DT	O
water	NN	O
soluble	JJ	O
starch	NN	O
solution	NN	O
.	.	O
The	DT	O
solubilized	VBN	O
starch	NN	O
solution	NN	O
is	VBZ	O
then	RB	O
liquefied	VBN	O
by	IN	O
amylase	NN	O
.	.	O
A	DT	O
starch	NN	O
granule	NN	O
is	VBZ	O
composed	VBN	O
of	IN	O
:	:	O
69-74	JJ	O
%	NN	O
amylopectin	NN	O
,	,	O
26-31	JJ	O
%	NN	O
amylose	JJ	O
,	,	O
11-14	JJ	O
%	NN	O
water	NN	O
,	,	O
0.2-0.4	CD	O
%	NN	O
protein	NN	O
,	,	O
0.5-0.9	CD	O
%	NN	O
lipid	JJ	O
,	,	O
0.05-0.1	JJ	O
%	NN	O
ash	NN	O
,	,	O
0.02-0.03	CD	O
%	NN	O
phosphorus	NN	O
,	,	O
0.1	CD	O
%	NN	O
pentosan	NN	O
.	.	O
Approximately	RB	O
70	CD	O
%	NN	O
of	IN	O
a	DT	O
granule	NN	O
is	VBZ	O
amorphous	JJ	O
and	CC	O
30	CD	O
%	NN	O
is	VBZ	O
crystalline	JJ	O
.	.	O
A	DT	O
common	JJ	O
enzymatic	JJ	O
liquefaction	NN	O
process	NN	O
involves	VBZ	O
adjusting	VBG	O
the	DT	O
pH	NN	O
of	IN	O
a	DT	O
granular	JJ	O
starch	NN	O
slurry	NN	O
to	TO	O
between	IN	O
6.0	CD	O
and	CC	O
6.5	CD	O
,	,	O
the	DT	O
pH	NN	O
optimum	NN	O
of	IN	O
alpha-amylase	JJ	O
derived	VBN	O
from	IN	O
Bacillus	NNP	O
licheniformis	NNS	O
,	,	O
with	IN	O
the	DT	O
addition	NN	O
of	IN	O
calcium	NN	O
hydroxide	NN	O
,	,	O
sodium	NN	O
hydroxide	NN	O
or	CC	O
sodium	NN	O
carbonate	NN	O
.	.	O
The	DT	O
addition	NN	O
of	IN	O
calcium	NN	O
hydroxide	NN	O
has	VBZ	O
the	DT	O
advantage	NN	O
of	IN	O
also	RB	O
providing	VBG	O
calcium	NN	O
ions	NNS	O
which	WDT	O
are	VBP	O
known	VBN	O
to	TO	O
stabilize	VB	O
the	DT	O
alpha-amylase	NN	O
against	IN	O
inactivation	NN	O
.	.	O
Upon	IN	O
addition	NN	O
of	IN	O
alpha-amylase	NN	O
,	,	O
the	DT	O
suspension	NN	O
is	VBZ	O
pumped	VBN	O
through	IN	O
a	DT	O
steam	NN	O
jet	NN	O
to	TO	O
instantaneously	RB	O
raise	VB	O
the	DT	O
temperature	NN	O
to	TO	O
between	IN	O
80°	CD	O
C.	NNP	O
to	TO	O
115°	CD	O
C.	NNP	O
The	DT	O
starch	NN	O
is	VBZ	O
immediately	RB	O
gelatinized	VBN	O
and	CC	O
,	,	O
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
alpha-amylase	NN	O
,	,	O
depolymerized	VBN	O
through	IN	O
random	JJ	O
hydrolysis	NN	O
of	IN	O
a	DT	O
(	(	O
1-4	JJ	O
)	)	O
glycosidic	JJ	O
bonds	NNS	O
by	IN	O
alpha-amylase	NN	O
to	TO	O
a	DT	O
fluid	NN	O
mass	NN	O
which	WDT	O
is	VBZ	O
easily	RB	O
pumped	VBN	O
.	.	O
In	IN	O
a	DT	O
second	JJ	O
variation	NN	O
to	TO	O
the	DT	O
liquefaction	NN	O
process	NN	O
,	,	O
alpha-amylase	NN	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
starch	NN	O
suspension	NN	O
,	,	O
the	DT	O
suspension	NN	O
is	VBZ	O
held	VBN	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
80-100°	JJ	O
C.	NNP	O
to	TO	O
partially	RB	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
granules	NNS	O
,	,	O
and	CC	O
the	DT	O
partially	RB	O
hydrolyzed	VBN	O
starch	NN	O
suspension	NN	O
is	VBZ	O
pumped	VBN	O
through	IN	O
a	DT	O
jet	NN	O
at	IN	O
temperatures	NNS	O
in	IN	O
excess	NN	O
of	IN	O
about	IN	O
105°	CD	O
C.	NNP	O
to	TO	O
thoroughly	VB	O
gelatinize	VB	O
any	DT	O
remaining	VBG	O
granular	JJ	O
structure	NN	O
.	.	O
After	IN	O
cooling	VBG	O
the	DT	O
gelatinized	VBN	O
starch	NN	O
,	,	O
a	DT	O
second	JJ	O
addition	NN	O
of	IN	O
alpha-amylase	NN	O
can	MD	O
be	VB	O
made	VBN	O
to	TO	O
further	RBR	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
.	.	O
A	DT	O
third	JJ	O
variation	NN	O
of	IN	O
this	DT	O
process	NN	O
is	VBZ	O
called	VBN	O
the	DT	O
dry	JJ	O
milling	NN	O
process	NN	O
.	.	O
In	IN	O
dry	JJ	O
milling	NN	O
,	,	O
whole	JJ	O
grain	NN	O
is	VBZ	O
ground	NN	O
and	CC	O
combined	VBN	O
with	IN	O
water	NN	O
.	.	O
The	DT	O
germ	NN	O
is	VBZ	O
optionally	RB	O
removed	VBN	O
by	IN	O
flotation	NN	O
separation	NN	O
or	CC	O
equivalent	JJ	O
techniques	NNS	O
.	.	O
The	DT	O
resulting	JJ	O
mixture	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
starch	NN	O
,	,	O
fiber	NN	O
,	,	O
protein	NN	O
and	CC	O
other	JJ	O
components	NNS	O
of	IN	O
the	DT	O
grain	NN	O
,	,	O
is	VBZ	O
liquefied	VBN	O
using	VBG	O
alpha-amylase	NN	O
.	.	O
The	DT	O
general	JJ	O
practice	NN	O
in	IN	O
the	DT	O
art	NN	O
is	VBZ	O
to	TO	O
undertake	VB	O
enzymatic	JJ	O
liquefaction	NN	O
at	IN	O
a	DT	O
lower	JJR	O
temperature	NN	O
when	WRB	O
using	VBG	O
the	DT	O
dry	JJ	O
milling	NN	O
process	NN	O
.	.	O
Generally	RB	O
,	,	O
low	JJ	O
temperature	NN	O
liquefaction	NN	O
is	VBZ	O
believed	VBN	O
to	TO	O
be	VB	O
less	RBR	O
efficient	JJ	O
than	IN	O
high	JJ	O
temperature	NN	O
liquefaction	NN	O
in	IN	O
converting	VBG	O
starch	NN	O
to	TO	O
soluble	JJ	O
dextrins	NNS	O
.	.	O
Typically	RB	O
,	,	O
after	IN	O
gelatinization	NN	O
the	DT	O
starch	NN	O
solution	NN	O
is	VBZ	O
held	VBN	O
at	IN	O
an	DT	O
elevated	JJ	O
temperature	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
alpha-amylase	NN	O
until	IN	O
a	DT	O
DE	NNP	O
of	IN	O
10-20	JJ	O
is	VBZ	O
achieved	VBN	O
,	,	O
usually	RB	O
a	DT	O
period	NN	O
of	IN	O
1-3	JJ	O
hours	NNS	O
.	.	O
Dextrose	NNP	O
equivalent	JJ	O
(	(	O
DE	NNP	O
)	)	O
is	VBZ	O
the	DT	O
industry	NN	O
standard	NN	O
for	IN	O
measuring	VBG	O
the	DT	O
concentration	NN	O
of	IN	O
total	JJ	O
reducing	VBG	O
sugars	NNS	O
,	,	O
calculated	VBD	O
as	IN	O
D-glucose	NNP	O
on	IN	O
a	DT	O
dry	JJ	O
weight	JJ	O
basis	NN	O
.	.	O
Unhydrolyzed	VBN	O
granular	JJ	O
starch	NN	O
has	VBZ	O
a	DT	O
DE	NNP	O
of	IN	O
virtually	RB	O
zero	CD	O
,	,	O
whereas	IN	O
the	DT	O
DE	NNP	O
of	IN	O
D-glucose	NNP	O
is	VBZ	O
defined	VBN	O
as	IN	O
100	CD	O
.	.	O
Corn	NNP	O
wet	NN	O
milling	NN	O
is	VBZ	O
a	DT	O
process	NN	O
which	WDT	O
produces	VBZ	O
corn	NN	O
oil	NN	O
,	,	O
gluten	VB	O
meal	NN	O
,	,	O
gluten	VBP	O
feed	NN	O
and	CC	O
starch	NN	O
.	.	O
Alkaline-amylase	NNP	O
is	VBZ	O
used	VBN	O
in	IN	O
the	DT	O
liquefaction	NN	O
of	IN	O
starch	NN	O
and	CC	O
glucoamylase	NN	O
is	VBZ	O
used	VBN	O
in	IN	O
saccharification	NN	O
,	,	O
producing	VBG	O
glucose	NN	O
.	.	O
Corn	NNP	O
,	,	O
a	DT	O
kernel	NN	O
of	IN	O
which	WDT	O
consists	VBZ	O
of	IN	O
a	DT	O
outer	NN	O
seed	NN	O
coat	NN	O
(	(	O
fiber	NN	O
)	)	O
,	,	O
starch	NN	O
,	,	O
a	DT	O
combination	NN	O
of	IN	O
starch	NN	O
and	CC	O
glucose	NN	O
and	CC	O
the	DT	O
inner	JJ	O
germ	NN	O
,	,	O
is	VBZ	O
subjected	VBN	O
to	TO	O
a	DT	O
four	CD	O
step	NN	O
process	NN	O
,	,	O
which	WDT	O
results	NNS	O
in	IN	O
the	DT	O
production	NN	O
of	IN	O
starch	NN	O
.	.	O
The	DT	O
corn	NN	O
is	VBZ	O
steeped	VBN	O
,	,	O
de-germed	JJ	O
,	,	O
de-fibered	JJ	O
,	,	O
and	CC	O
finally	RB	O
the	DT	O
gluten	NN	O
is	VBZ	O
separated	VBN	O
.	.	O
In	IN	O
the	DT	O
steeping	NN	O
process	NN	O
,	,	O
the	DT	O
solubles	NNS	O
are	VBP	O
taken	VBN	O
out	RP	O
.	.	O
The	DT	O
product	NN	O
remaining	VBG	O
after	IN	O
removal	NN	O
of	IN	O
the	DT	O
solubles	NNS	O
is	VBZ	O
de-germed	JJ	O
,	,	O
resulting	VBG	O
in	IN	O
production	NN	O
of	IN	O
corn	NN	O
oil	NN	O
and	CC	O
production	NN	O
of	IN	O
an	DT	O
oil	NN	O
cake	NN	O
,	,	O
which	WDT	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
solubles	NNS	O
from	IN	O
the	DT	O
steeping	VBG	O
step	NN	O
.	.	O
The	DT	O
remaining	VBG	O
product	NN	O
is	VBZ	O
de-fibered	JJ	O
and	CC	O
the	DT	O
fiber	NN	O
solids	NNS	O
are	VBP	O
added	VBN	O
to	TO	O
the	DT	O
oil	NN	O
cake/solubles	VBZ	O
mixture	NN	O
.	.	O
This	DT	O
mixture	NN	O
of	IN	O
fiber	NN	O
solids	NNS	O
,	,	O
oil	NN	O
cake	NN	O
and	CC	O
solubles	NNS	O
forms	VBZ	O
a	DT	O
gluten	JJ	O
feed	NN	O
.	.	O
After	IN	O
de-fibering	NN	O
,	,	O
the	DT	O
remaining	VBG	O
product	NN	O
is	VBZ	O
subjected	VBN	O
to	TO	O
gluten	VB	O
separation	NN	O
.	.	O
This	DT	O
separation	NN	O
results	NNS	O
in	IN	O
a	DT	O
gluten	JJ	O
meal	NN	O
and	CC	O
starch	NN	O
.	.	O
The	DT	O
starch	NN	O
is	VBZ	O
then	RB	O
subjected	VBN	O
to	TO	O
liquefaction	NN	O
and	CC	O
saccharification	NN	O
to	TO	O
produce	VB	O
glucose	NN	O
.	.	O
Staling	VBG	O
of	IN	O
baked	JJ	O
products	NNS	O
(	(	O
such	JJ	O
as	IN	O
bread	NN	O
)	)	O
has	VBZ	O
been	VBN	O
recognized	VBN	O
as	IN	O
a	DT	O
problem	NN	O
which	WDT	O
becomes	VBZ	O
more	RBR	O
serious	JJ	O
as	IN	O
more	JJR	O
time	NN	O
lies	VBZ	O
between	IN	O
the	DT	O
moment	NN	O
of	IN	O
preparation	NN	O
of	IN	O
the	DT	O
bread	JJ	O
product	NN	O
and	CC	O
the	DT	O
moment	NN	O
of	IN	O
consumption	NN	O
.	.	O
The	DT	O
term	NN	O
staling	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
describe	VB	O
changes	NNS	O
undesirable	JJ	O
to	TO	O
the	DT	O
consumer	NN	O
in	IN	O
the	DT	O
properties	NNS	O
of	IN	O
the	DT	O
bread	JJ	O
product	NN	O
after	IN	O
leaving	VBG	O
the	DT	O
oven	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
increase	NN	O
of	IN	O
the	DT	O
firmness	NN	O
of	IN	O
the	DT	O
crumb	NN	O
,	,	O
a	DT	O
decrease	NN	O
of	IN	O
the	DT	O
elasticity	NN	O
of	IN	O
the	DT	O
crumb	NN	O
,	,	O
and	CC	O
changes	NNS	O
in	IN	O
the	DT	O
crust	NN	O
,	,	O
which	WDT	O
becomes	VBZ	O
tough	JJ	O
and	CC	O
leathery	NN	O
.	.	O
The	DT	O
firmness	NN	O
of	IN	O
the	DT	O
bread	NN	O
crumb	NN	O
increases	VBZ	O
further	RBR	O
during	IN	O
storage	NN	O
up	RB	O
to	TO	O
a	DT	O
level	NN	O
,	,	O
which	WDT	O
is	VBZ	O
considered	VBN	O
as	IN	O
negative	JJ	O
.	.	O
The	DT	O
increase	NN	O
in	IN	O
crumb	JJ	O
firmness	NN	O
,	,	O
which	WDT	O
is	VBZ	O
considered	VBN	O
as	IN	O
the	DT	O
most	RBS	O
important	JJ	O
aspect	NN	O
of	IN	O
staling	NN	O
,	,	O
is	VBZ	O
recognized	VBN	O
by	IN	O
the	DT	O
consumer	NN	O
a	DT	O
long	JJ	O
time	NN	O
before	IN	O
the	DT	O
bread	NN	O
product	NN	O
has	VBZ	O
otherwise	RB	O
become	VBN	O
unsuitable	JJ	O
for	IN	O
consumption	NN	O
.	.	O
There	EX	O
is	VBZ	O
a	DT	O
need	NN	O
in	IN	O
the	DT	O
industry	NN	O
for	IN	O
the	DT	O
identification	NN	O
and	CC	O
optimization	NN	O
of	IN	O
amylases	NNS	O
,	,	O
useful	JJ	O
for	IN	O
various	JJ	O
uses	NNS	O
,	,	O
including	VBG	O
commercial	JJ	O
cornstarch	NN	O
liquefaction	NN	O
processes	VBZ	O
.	.	O
These	DT	O
second	JJ	O
generation	NN	O
acid	NN	O
amylases	NNS	O
will	MD	O
offer	VB	O
improved	JJ	O
manufacturing	NN	O
and/or	NN	O
performance	NN	O
characteristics	NNS	O
over	IN	O
the	DT	O
industry	NN	O
standard	NN	O
enzymes	VBZ	O
from	IN	O
Bacillus	NNP	O
licheniformis	NNS	O
,	,	O
for	IN	O
example	NN	O
.	.	O
There	EX	O
is	VBZ	O
also	RB	O
a	DT	O
need	NN	O
for	IN	O
the	DT	O
identification	NN	O
and	CC	O
optimization	NN	O
of	IN	O
amylases	NNS	O
having	VBG	O
utility	NN	O
in	IN	O
automatic	JJ	O
dish	NN	O
wash	NN	O
(	(	O
ADW	NNP	O
)	)	O
products	NNS	O
and	CC	O
laundry	JJ	O
detergent	NN	O
.	.	O
In	IN	O
ADW	NNP	O
products	NNS	O
,	,	O
the	DT	O
amylase	NN	O
will	MD	O
function	VB	O
at	IN	O
pH	JJ	O
10-11	JJ	O
and	CC	O
at	IN	O
45-60°	JJ	O
C.	NNP	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
calcium	NN	O
chelators	NNS	O
and	CC	O
oxidative	JJ	O
conditions	NNS	O
.	.	O
For	IN	O
laundry	JJ	O
,	,	O
activity	NN	O
at	IN	O
pH	JJ	O
9-10	CD	O
and	CC	O
40°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
appropriate	JJ	O
detergent	NN	O
matrix	NN	O
will	MD	O
be	VB	O
required	VBN	O
.	.	O
Amylases	NNS	O
are	VBP	O
also	RB	O
useful	JJ	O
in	IN	O
textile	NN	O
desizing	NN	O
,	,	O
brewing	NN	O
processes	NNS	O
,	,	O
starch	NN	O
modification	NN	O
in	IN	O
the	DT	O
paper	NN	O
and	CC	O
pulp	NN	O
industry	NN	O
and	CC	O
other	JJ	O
processes	NNS	O
described	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Amylases	NNS	O
can	MD	O
be	VB	O
used	VBN	O
commercially	RB	O
in	IN	O
the	DT	O
initial	JJ	O
stages	NNS	O
(	(	O
liquefaction	NN	O
)	)	O
of	IN	O
starch	NN	O
processing	NN	O
;	:	O
in	IN	O
wet	JJ	O
corn	NN	O
milling	NN	O
;	:	O
in	IN	O
alcohol	NN	O
production	NN	O
;	:	O
as	IN	O
cleaning	NN	O
agents	NNS	O
in	IN	O
detergent	NN	O
matrices	NNS	O
;	:	O
in	IN	O
the	DT	O
textile	NN	O
industry	NN	O
for	IN	O
starch	NN	O
desizing	NN	O
;	:	O
in	IN	O
baking	VBG	O
applications	NNS	O
;	:	O
in	IN	O
the	DT	O
beverage	NN	O
industry	NN	O
;	:	O
in	IN	O
oilfields	NNS	O
in	IN	O
drilling	NN	O
processes	NNS	O
;	:	O
in	IN	O
inking	NN	O
of	IN	O
recycled	JJ	O
paper	NN	O
and	CC	O
in	IN	O
animal	JJ	O
feed	NN	O
.	.	O
Amylases	NNS	O
are	VBP	O
also	RB	O
useful	JJ	O
in	IN	O
textile	NN	O
desizing	NN	O
,	,	O
brewing	NN	O
processes	NNS	O
,	,	O
starch	NN	O
modification	NN	O
in	IN	O
the	DT	O
paper	NN	O
and	CC	O
pulp	NN	O
industry	NN	O
and	CC	O
other	JJ	O
processes	NNS	O
.	.	O
The	DT	O
publications	NNS	O
discussed	VBN	O
herein	NNS	O
are	VBP	O
provided	VBN	O
solely	RB	O
for	IN	O
their	PRP$	O
disclosure	NN	O
prior	RB	O
to	TO	O
the	DT	O
filing	NN	O
date	NN	O
of	IN	O
the	DT	O
present	JJ	O
application	NN	O
.	.	O
Nothing	NN	O
herein	NN	O
is	VBZ	O
to	TO	O
be	VB	O
construed	VBN	O
as	IN	O
an	DT	O
admission	NN	O
that	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
not	RB	O
entitled	VBN	O
to	TO	O
antedate	VB	O
such	JJ	O
disclosure	NN	O
by	IN	O
virtue	NN	O
of	IN	O
prior	JJ	O
invention	NN	O
.	.	O
SUMMARY	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
,	,	O
1550	CD	O
or	CC	O
more	JJR	O
,	,	O
residues	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	NNS	O
at	IN	O
least	JJS	O
one	CD	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection	NN	O
.	.	O
Exemplary	JJ	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
isolated	VBN	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
,	,	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
,	,	O
e.g.	NN	O
,	,	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
45	CD	O
,	,	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length	NN	O
,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
a	DT	O
gene	NN	O
or	CC	O
transcript	NN	O
.	.	O
Exemplary	JJ	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
include	VBP	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
and	CC	O
variants	NNS	O
thereof	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
has	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
with	IN	O
a	DT	O
common	JJ	O
novelty	NN	O
in	IN	O
that	DT	O
they	PRP	O
are	VBP	O
derived	VBN	O
from	IN	O
mixed	JJ	O
cultures	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
mixed	JJ	O
cultures	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
,	,	O
1550	CD	O
or	CC	O
more	JJR	O
,	,	O
residues	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	NNS	O
at	IN	O
least	JJS	O
one	CD	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
mixed	JJ	O
cultures	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
,	,	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
,	,	O
e.g.	NN	O
,	,	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
45	CD	O
,	,	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length	NN	O
,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
a	DT	O
gene	NN	O
or	CC	O
transcript	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
with	IN	O
a	DT	O
common	JJ	O
novelty	NN	O
in	IN	O
that	DT	O
they	PRP	O
are	VBP	O
derived	VBN	O
from	IN	O
environmental	JJ	O
sources	NNS	O
,	,	O
e.g.	NN	O
,	,	O
mixed	JJ	O
environmental	JJ	O
sources	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
environmental	JJ	O
sources	NNS	O
,	,	O
e.g.	NN	O
,	,	O
mixed	JJ	O
environmental	JJ	O
sources	NNS	O
,	,	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
,	,	O
1550	CD	O
or	CC	O
more	JJR	O
,	,	O
residues	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	NNS	O
at	IN	O
least	JJS	O
one	CD	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
isolated	VBN	O
from	IN	O
environmental	JJ	O
sources	NNS	O
,	,	O
e.g.	NN	O
,	,	O
mixed	JJ	O
environmental	JJ	O
sources	NNS	O
,	,	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
,	,	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
,	,	O
e.g.	NN	O
,	,	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
45	CD	O
,	,	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length	NN	O
,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
a	DT	O
gene	NN	O
or	CC	O
transcript	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
is	VBZ	O
a	DT	O
BLAST	NNP	O
version	NN	O
2.2.2	CD	O
algorithm	NN	O
where	WRB	O
a	DT	O
filtering	NN	O
setting	NN	O
is	VBZ	O
set	VBN	O
to	TO	O
blastall-p	JJ	O
blastp-d	JJ	O
“	NN	O
nr	NN	O
pataa	NN	O
”	NNP	O
-F	NNP	O
F	NNP	O
,	,	O
and	CC	O
all	DT	O
other	JJ	O
options	NNS	O
are	VBP	O
set	VBN	O
to	TO	O
default	VB	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acid	NN	O
including	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
and	CC	O
the	DT	O
sequences	NNS	O
complementary	JJ	O
thereto	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
α-amylase	JJ	O
activity	NN	O
,	,	O
including	VBG	O
the	DT	O
ability	NN	O
to	TO	O
hydrolyze	VB	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
to	TO	O
produce	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
includes	VBZ	O
hydrolyzing	VBG	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
at	IN	O
random	NN	O
.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
a	DT	O
glucoamylase	NN	O
activity	NN	O
,	,	O
a	DT	O
1,4-α-D-glucan	JJ	O
glucohydrolase	NN	O
activity	NN	O
,	,	O
an	DT	O
α-amylase	JJ	O
activity	NN	O
,	,	O
an	DT	O
exoamylase	NN	O
activity	NN	O
,	,	O
or	CC	O
a	DT	O
β-amylase	JJ	O
activity	NN	O
.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,4-glucosidic	JJ	O
bond	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,6-glucosidic	JJ	O
bond	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
in	IN	O
starch	NN	O
,	,	O
e.g.	NN	O
,	,	O
liquefied	VBN	O
starch	NN	O
.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
further	RB	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
into	IN	O
maltodextrins	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
cleaving	VBG	O
a	DT	O
maltose	NN	O
or	CC	O
a	DT	O
D-glucose	JJ	O
unit	NN	O
from	IN	O
non-reducing	JJ	O
end	NN	O
of	IN	O
the	DT	O
starch	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
which	WDT	O
is	VBZ	O
thermostable	JJ	O
.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
a	DT	O
temperature	NN	O
range	NN	O
of	IN	O
between	IN	O
about	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
;	:	O
between	IN	O
about	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.	NNP	O
,	,	O
between	IN	O
about	IN	O
70°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
,	,	O
or	CC	O
,	,	O
between	IN	O
about	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
which	WDT	O
is	VBZ	O
thermotolerant	JJ	O
.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
or	CC	O
anywhere	RB	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
retains	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
at	IN	O
pH	NN	O
4.5	CD	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
comprising	VBG	O
a	DT	O
sequence	NN	O
that	WDT	O
hybridizes	VBZ	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
.	.	O
The	DT	O
nucleic	JJ	O
acid	NN	O
can	MD	O
be	VB	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length	NN	O
or	CC	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
the	DT	O
gene	NN	O
or	CC	O
transcript	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
stringent	JJ	O
conditions	NNS	O
include	VBP	O
a	DT	O
wash	JJ	O
step	NN	O
comprising	VBG	O
a	DT	O
wash	NN	O
in	IN	O
0.2×SSC	CD	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
about	IN	O
65°	CD	O
C.	NNP	O
for	IN	O
about	RB	O
15	CD	O
minutes	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
probe	NN	O
for	IN	O
identifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
probe	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
45	CD	O
,	,	O
50	CD	O
,	,	O
55	CD	O
,	,	O
60	CD	O
,	,	O
65	CD	O
,	,	O
70	CD	O
,	,	O
75	CD	O
,	,	O
80	CD	O
,	,	O
85	CD	O
,	,	O
90	CD	O
,	,	O
95	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
or	CC	O
more	JJR	O
,	,	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof	RB	O
,	,	O
wherein	VBD	O
the	DT	O
probe	NN	O
identifies	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
by	IN	O
binding	VBG	O
or	CC	O
hybridization	NN	O
.	.	O
The	DT	O
probe	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50	CD	O
,	,	O
about	RB	O
20	CD	O
to	TO	O
60	CD	O
,	,	O
about	RB	O
30	CD	O
to	TO	O
70	CD	O
,	,	O
about	RB	O
40	CD	O
to	TO	O
80	CD	O
,	,	O
or	CC	O
about	RB	O
60	CD	O
to	TO	O
100	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
probe	NN	O
for	IN	O
identifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
probe	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
30	CD	O
,	,	O
40	CD	O
,	,	O
50	CD	O
,	,	O
60	CD	O
,	,	O
70	CD	O
,	,	O
80	CD	O
,	,	O
90	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
wherein	VBP	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
visual	JJ	O
inspection	NN	O
.	.	O
The	DT	O
probe	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50	CD	O
,	,	O
about	RB	O
20	CD	O
to	TO	O
60	CD	O
,	,	O
about	RB	O
30	CD	O
to	TO	O
70	CD	O
,	,	O
about	RB	O
40	CD	O
to	TO	O
80	CD	O
,	,	O
or	CC	O
about	RB	O
60	CD	O
to	TO	O
100	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
for	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
primer	NN	O
pair	NN	O
is	VBZ	O
capable	JJ	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof	NN	O
.	.	O
One	CD	O
or	CC	O
each	DT	O
member	NN	O
of	IN	O
the	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
the	DT	O
sequence	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
amplification	NN	O
of	IN	O
a	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
with	IN	O
an	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
capable	JJ	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
fragments	NNS	O
or	CC	O
subsequences	NNS	O
thereof	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
expression	NN	O
cassettes	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
expression	NN	O
cassette	NN	O
can	MD	O
comprise	VB	O
the	DT	O
nucleic	JJ	O
acid	NN	O
that	WDT	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter	NN	O
.	.	O
The	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
viral	JJ	O
,	,	O
bacterial	JJ	O
,	,	O
mammalian	JJ	O
or	CC	O
plant	NN	O
promoter	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
plant	NN	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
potato	NN	O
,	,	O
rice	NN	O
,	,	O
corn	NN	O
,	,	O
wheat	NN	O
,	,	O
tobacco	NN	O
or	CC	O
barley	NN	O
promoter	NN	O
.	.	O
The	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
constitutive	JJ	O
promoter	NN	O
.	.	O
The	DT	O
constitutive	JJ	O
promoter	NN	O
can	MD	O
comprise	VB	O
CaMV35S	NNP	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
promoter	NN	O
can	MD	O
be	VB	O
an	DT	O
inducible	JJ	O
promoter	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
tissue-specific	JJ	O
promoter	NN	O
or	CC	O
an	DT	O
environmentally	RB	O
regulated	VBN	O
or	CC	O
a	DT	O
developmentally	RB	O
regulated	VBN	O
promoter	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
promoter	NN	O
can	MD	O
be	VB	O
,	,	O
e.g.	VB	O
,	,	O
a	DT	O
seed-specific	JJ	O
,	,	O
a	DT	O
leaf-specific	JJ	O
,	,	O
a	DT	O
root-specific	JJ	O
,	,	O
a	DT	O
stem-specific	JJ	O
or	CC	O
an	DT	O
abscission-induced	JJ	O
promoter	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
expression	NN	O
cassette	NN	O
can	MD	O
further	RB	O
comprise	VB	O
a	DT	O
plant	NN	O
or	CC	O
plant	NN	O
virus	NN	O
expression	NN	O
vector	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
cloning	VBG	O
vehicles	NNS	O
comprising	VBG	O
an	DT	O
expression	NN	O
cassette	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
vector	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
cloning	NN	O
vehicle	NN	O
can	MD	O
be	VB	O
a	DT	O
viral	JJ	O
vector	NN	O
,	,	O
a	DT	O
plasmid	NN	O
,	,	O
a	DT	O
phage	NN	O
,	,	O
a	DT	O
phagemid	NN	O
,	,	O
a	DT	O
cosmid	NN	O
,	,	O
a	DT	O
fosmid	NN	O
,	,	O
a	DT	O
bacteriophage	NN	O
or	CC	O
an	DT	O
artificial	JJ	O
chromosome	NN	O
.	.	O
The	DT	O
viral	JJ	O
vector	NN	O
can	MD	O
comprise	VB	O
an	DT	O
adenovirus	NN	O
vector	NN	O
,	,	O
a	DT	O
retroviral	JJ	O
vector	NN	O
or	CC	O
an	DT	O
adeno-associated	JJ	O
viral	JJ	O
vector	NN	O
.	.	O
The	DT	O
cloning	NN	O
vehicle	NN	O
can	MD	O
comprise	VB	O
a	DT	O
bacterial	JJ	O
artificial	JJ	O
chromosome	NN	O
(	(	O
BAC	NNP	O
)	)	O
,	,	O
a	DT	O
plasmid	NN	O
,	,	O
a	DT	O
bacteriophage	NN	O
P1-derived	JJ	O
vector	NN	O
(	(	O
PAC	NNP	O
)	)	O
,	,	O
a	DT	O
yeast	JJ	O
artificial	JJ	O
chromosome	NN	O
(	(	O
YAC	NNP	O
)	)	O
,	,	O
or	CC	O
a	DT	O
mammalian	JJ	O
artificial	JJ	O
chromosome	NN	O
(	(	O
MAC	NNP	O
)	)	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transformed	VBN	O
cell	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
vector	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
cloning	JJ	O
vehicle	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
transformed	VBN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
bacterial	JJ	O
cell	NN	O
,	,	O
a	DT	O
mammalian	JJ	O
cell	NN	O
,	,	O
a	DT	O
fungal	NN	O
cell	NN	O
,	,	O
a	DT	O
yeast	NN	O
cell	NN	O
,	,	O
an	DT	O
insect	NN	O
cell	NN	O
or	CC	O
a	DT	O
plant	NN	O
cell	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
plant	NN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
potato	NN	O
,	,	O
wheat	NN	O
,	,	O
rice	NN	O
,	,	O
corn	NN	O
,	,	O
tobacco	NN	O
or	CC	O
barley	NN	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
non-human	JJ	O
animals	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
vector	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
animal	NN	O
is	VBZ	O
a	DT	O
mouse	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
plants	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
vector	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
transgenic	JJ	O
plant	NN	O
can	MD	O
be	VB	O
a	DT	O
corn	NN	O
plant	NN	O
,	,	O
a	DT	O
potato	NN	O
plant	NN	O
,	,	O
a	DT	O
tomato	NN	O
plant	NN	O
,	,	O
a	DT	O
wheat	NN	O
plant	NN	O
,	,	O
an	DT	O
oilseed	NN	O
plant	NN	O
,	,	O
a	DT	O
rapeseed	NN	O
plant	NN	O
,	,	O
a	DT	O
soybean	NN	O
plant	NN	O
,	,	O
a	DT	O
rice	NN	O
plant	NN	O
,	,	O
a	DT	O
barley	NN	O
plant	NN	O
or	CC	O
a	DT	O
tobacco	NN	O
plant	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
seeds	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
expression	NN	O
cassette	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
vector	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
transgenic	JJ	O
seed	NN	O
can	MD	O
be	VB	O
a	DT	O
corn	NN	O
seed	NN	O
,	,	O
a	DT	O
wheat	NN	O
kernel	NN	O
,	,	O
an	DT	O
oilseed	NN	O
,	,	O
a	DT	O
rapeseed	NN	O
,	,	O
a	DT	O
soybean	NN	O
seed	NN	O
,	,	O
a	DT	O
palm	NN	O
kernel	NN	O
,	,	O
a	DT	O
sunflower	JJR	O
seed	NN	O
,	,	O
a	DT	O
sesame	NN	O
seed	NN	O
,	,	O
a	DT	O
peanut	NN	O
or	CC	O
a	DT	O
tobacco	NN	O
plant	NN	O
seed	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
antisense	JJ	O
oligonucleotide	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
complementary	JJ	O
to	TO	O
or	CC	O
capable	JJ	O
of	IN	O
hybridizing	VBG	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
inhibiting	VBG	O
the	DT	O
translation	NN	O
of	IN	O
an	DT	O
amylase	JJ	O
message	NN	O
in	IN	O
a	DT	O
cell	NN	O
comprising	VBG	O
administering	VBG	O
to	TO	O
the	DT	O
cell	NN	O
or	CC	O
expressing	VBG	O
in	IN	O
the	DT	O
cell	NN	O
an	DT	O
antisense	JJ	O
oligonucleotide	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
complementary	JJ	O
to	TO	O
or	CC	O
capable	JJ	O
of	IN	O
hybridizing	VBG	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
comprising	VBG	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
,	,	O
1550	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
,	,	O
and	CC	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
a	DT	O
visual	JJ	O
inspection	NN	O
.	.	O
Exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
and	CC	O
variants	NNS	O
thereof	NN	O
,	,	O
e.g.	NN	O
,	,	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
45	CD	O
,	,	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
in	IN	O
length	NN	O
,	,	O
or	CC	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
an	DT	O
enzyme	NN	O
.	.	O
Exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
sequence	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Exemplary	JJ	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
polypeptides	NNS	O
or	CC	O
peptides	NNS	O
specifically	RB	O
bound	VBN	O
by	IN	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
has	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
amylase	NN	O
activity	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
or	CC	O
peptide	VB	O
including	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
polypeptide	NN	O
or	CC	O
peptide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
and	CC	O
the	DT	O
sequences	NNS	O
complementary	JJ	O
thereto	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
or	CC	O
peptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprises	VBZ	O
an	DT	O
α-amylase	JJ	O
activity	NN	O
,	,	O
including	VBG	O
the	DT	O
ability	NN	O
to	TO	O
hydrolyze	VB	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
to	TO	O
produce	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
includes	VBZ	O
hydrolyzing	VBG	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
at	IN	O
random	NN	O
.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
a	DT	O
glucoamylase	NN	O
activity	NN	O
,	,	O
a	DT	O
1,4-α-D-glucan	JJ	O
glucohydrolase	NN	O
activity	NN	O
,	,	O
an	DT	O
α-amylase	JJ	O
activity	NN	O
,	,	O
an	DT	O
exoamylase	NN	O
activity	NN	O
,	,	O
or	CC	O
a	DT	O
β-amylase	JJ	O
activity	NN	O
.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,4-glucosidic	JJ	O
bond	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
glucosidic	JJ	O
bonds	NNS	O
comprise	VBP	O
an	DT	O
α-1,6-glucosidic	JJ	O
bond	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
in	IN	O
starch	NN	O
,	,	O
e.g.	NN	O
,	,	O
liquefied	VBN	O
starch	NN	O
.	.	O
The	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
further	RB	O
comprise	VB	O
hydrolyzing	VBG	O
glucosidic	JJ	O
bonds	NNS	O
into	IN	O
maltodextrins	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
cleaving	VBG	O
a	DT	O
maltose	NN	O
or	CC	O
a	DT	O
D-glucose	JJ	O
unit	NN	O
from	IN	O
non-reducing	JJ	O
end	NN	O
of	IN	O
the	DT	O
starch	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
be	VB	O
thermostable	JJ	O
.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
a	DT	O
temperature	NN	O
range	NN	O
of	IN	O
between	IN	O
about	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
,	,	O
between	IN	O
about	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.	NNP	O
,	,	O
between	IN	O
about	IN	O
70°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
,	,	O
or	CC	O
between	IN	O
about	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
be	VB	O
thermotolerant	JJ	O
.	.	O
The	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
,	,	O
or	CC	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
85°	CD	O
C.	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
after	IN	O
exposure	NN	O
to	TO	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
90°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
at	IN	O
pH	NN	O
4.5	CD	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
can	MD	O
comprise	VB	O
the	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
that	WDT	O
lacks	VBZ	O
a	DT	O
signal	JJ	O
sequence	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
can	MD	O
comprise	VB	O
the	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprising	VBG	O
a	DT	O
heterologous	JJ	O
signal	NN	O
sequence	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
heterologous	JJ	O
amylase	NN	O
or	CC	O
non-amylase	JJ	O
signal	JJ	O
sequence	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
signal	JJ	O
sequence	NN	O
comprising	VBG	O
an	DT	O
amino	JJ	O
terminal	JJ	O
peptide	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
signal	JJ	O
sequence	NN	O
consisting	NN	O
of	IN	O
a	DT	O
peptide	NN	O
having	VBG	O
a	DT	O
subsequence	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
chimeric	JJ	O
proteins	NNS	O
comprising	VBG	O
a	DT	O
first	JJ	O
domain	NN	O
comprising	VBG	O
a	DT	O
signal	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
at	IN	O
least	JJS	O
a	DT	O
second	JJ	O
domain	NN	O
.	.	O
The	DT	O
protein	NN	O
can	MD	O
be	VB	O
a	DT	O
fusion	NN	O
protein	NN	O
.	.	O
The	DT	O
second	JJ	O
domain	NN	O
can	MD	O
comprise	VB	O
an	DT	O
enzyme	NN	O
.	.	O
The	DT	O
enzyme	NN	O
can	MD	O
be	VB	O
an	DT	O
amylase	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
,	,	O
another	DT	O
amylase	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
at	IN	O
about	RB	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
100	CD	O
to	TO	O
about	IN	O
1000	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
from	IN	O
about	RB	O
500	CD	O
to	TO	O
about	IN	O
750	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
500	CD	O
to	TO	O
about	IN	O
1200	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
comprises	VBZ	O
a	DT	O
specific	JJ	O
activity	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
750	CD	O
to	TO	O
about	IN	O
1000	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
thermotolerance	NN	O
comprises	VBZ	O
retention	NN	O
of	IN	O
at	IN	O
least	JJS	O
half	NN	O
of	IN	O
the	DT	O
specific	JJ	O
activity	NN	O
of	IN	O
the	DT	O
amylase	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
after	IN	O
being	VBG	O
heated	VBN	O
to	TO	O
the	DT	O
elevated	JJ	O
temperature	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
thermotolerance	NN	O
can	MD	O
comprise	VB	O
retention	NN	O
of	IN	O
specific	JJ	O
activity	NN	O
at	IN	O
37°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
about	IN	O
500	CD	O
to	TO	O
about	IN	O
1200	CD	O
units	NNS	O
per	IN	O
milligram	NN	O
of	IN	O
protein	NN	O
after	IN	O
being	VBG	O
heated	VBN	O
to	TO	O
the	DT	O
elevated	JJ	O
temperature	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
the	DT	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
one	CD	O
glycosylation	NN	O
site	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
glycosylation	NN	O
can	MD	O
be	VB	O
an	DT	O
N-linked	JJ	O
glycosylation	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
be	VB	O
glycosylated	VBN	O
after	IN	O
being	VBG	O
expressed	VBN	O
in	IN	O
a	DT	O
P.	NNP	O
pastoris	NN	O
or	CC	O
a	DT	O
S.	NNP	O
pombe	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
about	IN	O
pH	NN	O
6.5	CD	O
,	,	O
pH	NN	O
6	CD	O
,	,	O
pH	NN	O
5.5	CD	O
,	,	O
pH	NN	O
5	CD	O
,	,	O
pH	VBZ	O
4.5	CD	O
or	CC	O
pH	VB	O
4	CD	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
retain	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
conditions	NNS	O
comprising	VBG	O
about	IN	O
pH	NN	O
7	CD	O
,	,	O
pH	VBD	O
7.5	CD	O
pH	NN	O
8.0	CD	O
,	,	O
pH	NN	O
8.5	CD	O
,	,	O
pH	NN	O
9	CD	O
,	,	O
pH	NN	O
9.5	CD	O
,	,	O
pH	NN	O
10	CD	O
,	,	O
pH	VBZ	O
10.5	CD	O
or	CC	O
pH	VB	O
11	CD	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
protein	JJ	O
preparations	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
wherein	VBP	O
the	DT	O
protein	NN	O
preparation	NN	O
comprises	VBZ	O
a	DT	O
liquid	NN	O
,	,	O
a	DT	O
solid	JJ	O
or	CC	O
a	DT	O
gel	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
heterodimers	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
a	DT	O
second	JJ	O
domain	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
second	JJ	O
domain	NN	O
can	MD	O
be	VB	O
a	DT	O
polypeptide	NN	O
and	CC	O
the	DT	O
heterodimer	NN	O
can	MD	O
be	VB	O
a	DT	O
fusion	NN	O
protein	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
second	JJ	O
domain	NN	O
can	MD	O
be	VB	O
an	DT	O
epitope	NN	O
or	CC	O
a	DT	O
tag	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
homodimers	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
immobilized	JJ	O
polypeptides	NNS	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
a	DT	O
second	JJ	O
domain	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
be	VB	O
immobilized	VBN	O
on	IN	O
a	DT	O
cell	NN	O
,	,	O
a	DT	O
metal	NN	O
,	,	O
a	DT	O
resin	NN	O
,	,	O
a	DT	O
polymer	NN	O
,	,	O
a	DT	O
ceramic	JJ	O
,	,	O
a	DT	O
glass	NN	O
,	,	O
a	DT	O
microelectrode	NN	O
,	,	O
a	DT	O
graphitic	JJ	O
particle	NN	O
,	,	O
a	DT	O
bead	NN	O
,	,	O
a	DT	O
gel	NN	O
,	,	O
a	DT	O
plate	NN	O
,	,	O
an	DT	O
array	NN	O
or	CC	O
a	DT	O
capillary	JJ	O
tube	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
arrays	RP	O
comprising	VBG	O
an	DT	O
immobilized	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
arrays	RP	O
comprising	VBG	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
antibodies	NNS	O
that	WDT	O
specifically	RB	O
bind	VBP	O
to	TO	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
to	TO	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
antibody	NN	O
can	MD	O
be	VB	O
a	DT	O
monoclonal	JJ	O
or	CC	O
a	DT	O
polyclonal	JJ	O
antibody	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
hybridomas	RB	O
comprising	VBG	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
antibody	NN	O
that	WDT	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
to	TO	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
food	NN	O
supplements	NNS	O
for	IN	O
an	DT	O
animal	JJ	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
in	IN	O
the	DT	O
food	NN	O
supplement	NN	O
can	MD	O
be	VB	O
glycosylated	VBN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
edible	JJ	O
enzyme	JJ	O
delivery	NN	O
matrices	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
delivery	NN	O
matrix	NN	O
comprises	VBZ	O
a	DT	O
pellet	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
can	MD	O
be	VB	O
glycosylated	VBN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
thermotolerant	JJ	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
thermostable	JJ	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
method	NN	O
of	IN	O
isolating	VBG	O
or	CC	O
identifying	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
sample	JJ	O
comprising	NN	O
polypeptides	NNS	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
sample	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
with	IN	O
the	DT	O
antibody	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
antibody	NN	O
can	MD	O
specifically	RB	O
bind	VB	O
to	TO	O
the	DT	O
polypeptide	NN	O
,	,	O
thereby	RB	O
isolating	VBG	O
or	CC	O
identifying	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
an	DT	O
anti-amylase	JJ	O
antibody	NN	O
comprising	VBG	O
administering	VBG	O
to	TO	O
a	DT	O
non-human	JJ	O
animal	NN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
subsequences	NNS	O
thereof	RP	O
in	IN	O
an	DT	O
amount	NN	O
sufficient	NN	O
to	TO	O
generate	VB	O
a	DT	O
humoral	JJ	O
immune	NN	O
response	NN	O
,	,	O
thereby	RB	O
making	VBG	O
an	DT	O
anti-amylase	JJ	O
antibody	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
an	DT	O
anti-amylase	JJ	O
immune	NN	O
comprising	VBG	O
administering	VBG	O
to	TO	O
a	DT	O
non-human	JJ	O
animal	NN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
subsequences	NNS	O
thereof	RP	O
in	IN	O
an	DT	O
amount	NN	O
sufficient	NN	O
to	TO	O
generate	VB	O
an	DT	O
immune	JJ	O
response	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
producing	VBG	O
a	DT	O
recombinant	JJ	O
polypeptide	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
expressing	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
under	IN	O
conditions	NNS	O
that	WDT	O
allow	VBP	O
expression	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
,	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
recombinant	JJ	O
polypeptide	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
transforming	VBG	O
a	DT	O
host	NN	O
cell	NN	O
with	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
followed	VBN	O
by	IN	O
expressing	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
,	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
recombinant	JJ	O
polypeptide	NN	O
in	IN	O
a	DT	O
transformed	JJ	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
an	DT	O
amylase	JJ	O
substrate	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
or	CC	O
a	DT	O
fragment	NN	O
or	CC	O
variant	JJ	O
thereof	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
substrate	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product	NN	O
,	,	O
wherein	VBP	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
reaction	NN	O
product	NN	O
detects	VBZ	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
substrate	NN	O
can	MD	O
be	VB	O
a	DT	O
starch	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
liquefied	VBN	O
starch	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
an	DT	O
amylase	NN	O
substrate	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
test	NN	O
substrate	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
test	NN	O
substrate	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
reaction	NN	O
product	NN	O
,	,	O
wherein	VBP	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product	NN	O
identifies	VBZ	O
the	DT	O
test	NN	O
substrate	NN	O
as	IN	O
an	DT	O
amylase	NN	O
substrate	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
determining	VBG	O
whether	IN	O
a	DT	O
test	NN	O
compound	NN	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
expressing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
or	CC	O
a	DT	O
vector	NN	O
comprising	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
under	IN	O
conditions	NNS	O
permissive	VBP	O
for	IN	O
translation	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
a	DT	O
polypeptide	NN	O
,	,	O
wherein	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
,	,	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
test	NN	O
compound	NN	O
;	:	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
with	IN	O
the	DT	O
test	NN	O
compound	NN	O
;	:	O
and	CC	O
(	(	O
d	NN	O
)	)	O
determining	VBG	O
whether	IN	O
the	DT	O
test	NN	O
compound	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
specifically	RB	O
binds	VBZ	O
to	TO	O
the	DT	O
polypeptide	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
a	DT	O
modulator	NN	O
of	IN	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
test	NN	O
compound	NN	O
;	:	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
test	NN	O
compound	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
and	CC	O
measuring	VBG	O
an	DT	O
activity	NN	O
of	IN	O
the	DT	O
amylase	NN	O
,	,	O
wherein	VBP	O
a	DT	O
change	NN	O
in	IN	O
the	DT	O
amylase	NN	O
activity	NN	O
measured	VBN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
the	DT	O
test	NN	O
compound	NN	O
compared	VBN	O
to	TO	O
the	DT	O
activity	NN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
the	DT	O
test	NN	O
compound	NN	O
provides	VBZ	O
a	DT	O
determination	NN	O
that	IN	O
the	DT	O
test	NN	O
compound	NN	O
modulates	VBZ	O
the	DT	O
amylase	NN	O
activity	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
can	MD	O
be	VB	O
measured	VBN	O
by	IN	O
providing	VBG	O
an	DT	O
amylase	NN	O
substrate	NN	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product	NN	O
,	,	O
or	CC	O
,	,	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product	NN	O
.	.	O
A	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
reaction	NN	O
product	NN	O
with	IN	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
reaction	NN	O
product	NN	O
without	IN	O
the	DT	O
test	NN	O
compound	NN	O
identifies	VBZ	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
an	DT	O
activator	NN	O
of	IN	O
amylase	NN	O
activity	NN	O
.	.	O
An	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
reaction	NN	O
product	NN	O
with	IN	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
amount	NN	O
of	IN	O
substrate	NN	O
or	CC	O
reaction	NN	O
product	NN	O
without	IN	O
the	DT	O
test	NN	O
compound	NN	O
identifies	VBZ	O
the	DT	O
test	NN	O
compound	NN	O
as	IN	O
an	DT	O
inhibitor	NN	O
of	IN	O
amylase	NN	O
activity	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
computer	NN	O
systems	NNS	O
comprising	VBG	O
a	DT	O
processor	NN	O
and	CC	O
a	DT	O
data	NN	O
storage	NN	O
device	NN	O
wherein	NN	O
said	VBD	O
data	NNS	O
storage	NN	O
device	NN	O
has	VBZ	O
stored	VBN	O
thereon	RP	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
computer	NN	O
system	NN	O
can	MD	O
further	RB	O
comprise	VB	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
and	CC	O
a	DT	O
data	NN	O
storage	NN	O
device	NN	O
having	VBG	O
at	IN	O
least	JJS	O
one	CD	O
reference	NN	O
sequence	NN	O
stored	VBD	O
thereon	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
comprises	VBZ	O
a	DT	O
computer	NN	O
program	NN	O
that	WDT	O
indicates	VBZ	O
polymorphisms	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
computer	NN	O
system	NN	O
can	MD	O
further	RB	O
comprise	VB	O
an	DT	O
identifier	NN	O
that	WDT	O
identifies	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
said	VBD	O
sequence	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
computer	NN	O
readable	JJ	O
media	NNS	O
having	VBG	O
stored	VBN	O
thereon	IN	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
identifying	VBG	O
a	DT	O
feature	NN	O
in	IN	O
a	DT	O
sequence	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
reading	VBG	O
the	DT	O
sequence	NN	O
using	VBG	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
identifies	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
a	DT	O
sequence	NN	O
,	,	O
wherein	VBP	O
the	DT	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
identifying	VBG	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
comparing	VBG	O
a	DT	O
first	JJ	O
sequence	NN	O
to	TO	O
a	DT	O
second	JJ	O
sequence	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
reading	VBG	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
second	JJ	O
sequence	NN	O
through	IN	O
use	NN	O
of	IN	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
compares	VBZ	O
sequences	NNS	O
,	,	O
wherein	VBD	O
the	DT	O
first	JJ	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
determining	VBG	O
differences	NNS	O
between	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
second	JJ	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program	NN	O
.	.	O
The	DT	O
step	NN	O
of	IN	O
determining	VBG	O
differences	NNS	O
between	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
second	JJ	O
sequence	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
the	DT	O
step	NN	O
of	IN	O
identifying	VBG	O
polymorphisms	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RB	O
comprise	VB	O
an	DT	O
identifier	NN	O
that	WDT	O
identifies	VBZ	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
a	DT	O
sequence	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
reading	VBG	O
the	DT	O
first	JJ	O
sequence	NN	O
using	VBG	O
a	DT	O
computer	NN	O
program	NN	O
and	CC	O
identifying	VBG	O
one	CD	O
or	CC	O
more	JJR	O
features	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
an	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
for	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
primer	NN	O
pair	NN	O
is	VBZ	O
capable	JJ	O
of	IN	O
amplifying	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
isolating	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
from	IN	O
the	DT	O
environmental	JJ	O
sample	NN	O
or	CC	O
treating	VBG	O
the	DT	O
environmental	JJ	O
sample	NN	O
such	JJ	O
that	IN	O
nucleic	JJ	O
acid	NN	O
in	IN	O
the	DT	O
sample	NN	O
is	VBZ	O
accessible	JJ	O
for	IN	O
hybridization	NN	O
to	TO	O
the	DT	O
amplification	NN	O
primer	NN	O
pair	NN	O
;	:	O
and	CC	O
,	,	O
(	(	O
c	NN	O
)	)	O
combining	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
with	IN	O
the	DT	O
amplification	NN	O
primer	NN	O
pair	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
amplifying	VBG	O
nucleic	JJ	O
acid	NN	O
from	IN	O
the	DT	O
environmental	JJ	O
sample	NN	O
,	,	O
thereby	RB	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample	NN	O
.	.	O
One	CD	O
or	CC	O
each	DT	O
member	NN	O
of	IN	O
the	DT	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pair	NN	O
can	MD	O
comprise	VB	O
an	DT	O
oligonucleotide	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	RB	O
10	CD	O
to	TO	O
50	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polynucleotide	JJ	O
probe	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
isolating	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
from	IN	O
the	DT	O
environmental	JJ	O
sample	NN	O
or	CC	O
treating	VBG	O
the	DT	O
environmental	JJ	O
sample	NN	O
such	JJ	O
that	IN	O
nucleic	JJ	O
acid	NN	O
in	IN	O
the	DT	O
sample	NN	O
is	VBZ	O
accessible	JJ	O
for	IN	O
hybridization	NN	O
to	TO	O
a	DT	O
polynucleotide	JJ	O
probe	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
;	:	O
(	(	O
c	NN	O
)	)	O
combining	VBG	O
the	DT	O
isolated	JJ	O
nucleic	JJ	O
acid	NN	O
or	CC	O
the	DT	O
treated	JJ	O
environmental	JJ	O
sample	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
with	IN	O
the	DT	O
polynucleotide	JJ	O
probe	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
;	:	O
and	CC	O
(	(	O
d	NN	O
)	)	O
isolating	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
that	WDT	O
specifically	RB	O
hybridizes	VBZ	O
with	IN	O
the	DT	O
polynucleotide	JJ	O
probe	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
,	,	O
thereby	RB	O
isolating	VBG	O
or	CC	O
recovering	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
from	IN	O
an	DT	O
environmental	JJ	O
sample	NN	O
.	.	O
The	DT	O
environmental	JJ	O
sample	NN	O
can	MD	O
comprise	VB	O
a	DT	O
water	NN	O
sample	NN	O
,	,	O
a	DT	O
liquid	JJ	O
sample	NN	O
,	,	O
a	DT	O
soil	NN	O
sample	NN	O
,	,	O
an	DT	O
air	NN	O
sample	NN	O
or	CC	O
a	DT	O
biological	JJ	O
sample	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
biological	JJ	O
sample	NN	O
can	MD	O
be	VB	O
derived	VBN	O
from	IN	O
a	DT	O
bacterial	JJ	O
cell	NN	O
,	,	O
a	DT	O
protozoan	NN	O
cell	NN	O
,	,	O
an	DT	O
insect	NN	O
cell	NN	O
,	,	O
a	DT	O
yeast	NN	O
cell	NN	O
,	,	O
a	DT	O
plant	NN	O
cell	NN	O
,	,	O
a	DT	O
fungal	JJ	O
cell	NN	O
or	CC	O
a	DT	O
mammalian	JJ	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
generating	VBG	O
a	DT	O
variant	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
template	JJ	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
modifying	NN	O
,	,	O
deleting	VBG	O
or	CC	O
adding	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
in	IN	O
the	DT	O
template	NN	O
sequence	NN	O
,	,	O
or	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
,	,	O
to	TO	O
generate	VB	O
a	DT	O
variant	NN	O
of	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
expressing	VBG	O
the	DT	O
variant	JJ	O
nucleic	JJ	O
acid	NN	O
to	TO	O
generate	VB	O
a	DT	O
variant	JJ	O
amylase	NN	O
polypeptide	NN	O
.	.	O
The	DT	O
modifications	NNS	O
,	,	O
additions	NNS	O
or	CC	O
deletions	NNS	O
can	MD	O
be	VB	O
introduced	VBN	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
error-prone	JJ	O
PCR	NNP	O
,	,	O
shuffling	VBG	O
,	,	O
oligonucleotide-directed	JJ	O
mutagenesis	NN	O
,	,	O
assembly	RB	O
PCR	NNP	O
,	,	O
sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
,	,	O
in	IN	O
vivo	JJ	O
mutagenesis	NN	O
,	,	O
cassette	NN	O
mutagenesis	NN	O
,	,	O
recursive	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
exponential	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
site-specific	JJ	O
mutagenesis	NN	O
,	,	O
gene	NN	O
reassembly	RB	O
,	,	O
gene	NN	O
site	NN	O
saturated	VBN	O
mutagenesis	NN	O
(	(	O
GSSM	NNP	O
)	)	O
,	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(	(	O
SLR	NNP	O
)	)	O
or	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
modifications	NNS	O
,	,	O
additions	NNS	O
or	CC	O
deletions	NNS	O
are	VBP	O
introduced	VBN	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
recombination	NN	O
,	,	O
recursive	JJ	O
sequence	NN	O
recombination	NN	O
,	,	O
phosphothioate-modified	JJ	O
DNA	NNP	O
mutagenesis	NN	O
,	,	O
uracil-containing	JJ	O
template	NN	O
mutagenesis	NN	O
,	,	O
gapped	VBD	O
duplex	JJ	O
mutagenesis	NN	O
,	,	O
point	NN	O
mismatch	NN	O
repair	NN	O
mutagenesis	NN	O
,	,	O
repair-deficient	JJ	O
host	NN	O
strain	NN	O
mutagenesis	NN	O
,	,	O
chemical	JJ	O
mutagenesis	NN	O
,	,	O
radiogenic	JJ	O
mutagenesis	NN	O
,	,	O
deletion	NN	O
mutagenesis	NN	O
,	,	O
restriction-selection	NN	O
mutagenesis	NN	O
,	,	O
restriction-purification	NN	O
mutagenesis	NN	O
,	,	O
artificial	JJ	O
gene	NN	O
synthesis	NN	O
,	,	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
multimer	NN	O
creation	NN	O
and	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
until	IN	O
an	DT	O
amylase	NN	O
having	VBG	O
an	DT	O
altered	JJ	O
or	CC	O
different	JJ	O
activity	NN	O
or	CC	O
an	DT	O
altered	JJ	O
or	CC	O
different	JJ	O
stability	NN	O
from	IN	O
that	DT	O
of	IN	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
produced	VBN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
variant	JJ	O
amylase	NN	O
polypeptide	NN	O
is	VBZ	O
thermotolerant	JJ	O
,	,	O
and	CC	O
retains	VBZ	O
some	DT	O
activity	NN	O
after	IN	O
being	VBG	O
exposed	VBN	O
to	TO	O
an	DT	O
elevated	JJ	O
temperature	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
variant	JJ	O
amylase	NN	O
polypeptide	NN	O
has	VBZ	O
increased	VBN	O
glycosylation	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
amylase	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
variant	JJ	O
amylase	NN	O
polypeptide	NN	O
has	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
a	DT	O
high	JJ	O
temperature	NN	O
,	,	O
wherein	VBP	O
the	DT	O
amylase	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
not	RB	O
active	JJ	O
under	IN	O
the	DT	O
high	JJ	O
temperature	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
until	IN	O
an	DT	O
amylase	NN	O
coding	VBG	O
sequence	NN	O
having	VBG	O
an	DT	O
altered	JJ	O
codon	NN	O
usage	NN	O
from	IN	O
that	DT	O
of	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
produced	VBN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
until	IN	O
an	DT	O
amylase	NN	O
gene	NN	O
having	VBG	O
higher	JJR	O
or	CC	O
lower	JJR	O
level	NN	O
of	IN	O
message	NN	O
expression	NN	O
or	CC	O
stability	NN	O
from	IN	O
that	DT	O
of	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
produced	VBN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
;	:	O
and	CC	O
,	,	O
(	(	O
b	NN	O
)	)	O
identifying	VBG	O
a	DT	O
non-preferred	JJ	O
or	CC	O
a	DT	O
less	JJR	O
preferred	JJ	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
preferred	JJ	O
or	CC	O
neutrally	RB	O
used	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon	NN	O
,	,	O
wherein	VBZ	O
a	DT	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
over-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
and	CC	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
under-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
,	,	O
thereby	RB	O
modifying	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
;	:	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
and	CC	O
,	,	O
(	(	O
b	NN	O
)	)	O
identifying	VBG	O
a	DT	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
different	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon	NN	O
,	,	O
thereby	RB	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
an	DT	O
amylase	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
encoding	VBG	O
an	DT	O
amylase	NN	O
polypeptide	NN	O
;	:	O
and	CC	O
,	,	O
(	(	O
b	NN	O
)	)	O
identifying	VBG	O
a	DT	O
non-preferred	JJ	O
or	CC	O
a	DT	O
less	JJR	O
preferred	JJ	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
preferred	JJ	O
or	CC	O
neutrally	RB	O
used	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon	NN	O
,	,	O
wherein	VBZ	O
a	DT	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
over-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
and	CC	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
under-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
,	,	O
thereby	RB	O
modifying	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
a	DT	O
codon	NN	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
to	TO	O
decrease	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
identifying	NN	O
at	IN	O
least	JJS	O
one	CD	O
preferred	JJ	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
replacing	VBG	O
it	PRP	O
with	IN	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon	NN	O
,	,	O
wherein	VBZ	O
a	DT	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
over-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
and	CC	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
under-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
,	,	O
thereby	RB	O
modifying	VBG	O
the	DT	O
nucleic	JJ	O
acid	NN	O
to	TO	O
decrease	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
host	NN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
bacterial	JJ	O
cell	NN	O
,	,	O
a	DT	O
fungal	NN	O
cell	NN	O
,	,	O
an	DT	O
insect	NN	O
cell	NN	O
,	,	O
a	DT	O
yeast	NN	O
cell	NN	O
,	,	O
a	DT	O
plant	NN	O
cell	NN	O
or	CC	O
a	DT	O
mammalian	JJ	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
producing	VBG	O
a	DT	O
library	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
modified	JJ	O
amylase	NN	O
active	JJ	O
sites	NNS	O
or	CC	O
substrate	VB	O
binding	NN	O
sites	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
modified	JJ	O
active	JJ	O
sites	NNS	O
or	CC	O
substrate	VB	O
binding	NN	O
sites	NNS	O
are	VBP	O
derived	VBN	O
from	IN	O
a	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
sequence	NN	O
encoding	VBG	O
a	DT	O
first	JJ	O
active	JJ	O
site	NN	O
or	CC	O
a	DT	O
first	JJ	O
substrate	NN	O
binding	NN	O
site	NN	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
first	JJ	O
active	JJ	O
site	NN	O
or	CC	O
first	JJ	O
substrate	NN	O
binding	NN	O
site	NN	O
,	,	O
wherein	WP	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
sequence	NN	O
that	WDT	O
hybridizes	VBZ	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
and	CC	O
the	DT	O
nucleic	JJ	O
acid	NN	O
encodes	VBZ	O
an	DT	O
amylase	NN	O
active	JJ	O
site	NN	O
or	CC	O
an	DT	O
amylase	JJ	O
substrate	NN	O
binding	NN	O
site	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
set	NN	O
of	IN	O
mutagenic	JJ	O
oligonucleotides	NNS	O
that	IN	O
encode	VBP	O
naturally-occurring	JJ	O
amino	NN	O
acid	NN	O
variants	NNS	O
at	IN	O
a	DT	O
plurality	NN	O
of	IN	O
targeted	JJ	O
codons	NNS	O
in	IN	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
;	:	O
and	CC	O
,	,	O
(	(	O
c	NN	O
)	)	O
using	VBG	O
the	DT	O
set	NN	O
of	IN	O
mutagenic	JJ	O
oligonucleotides	NNS	O
to	TO	O
generate	VB	O
a	DT	O
set	NN	O
of	IN	O
active	JJ	O
site-encoding	NN	O
or	CC	O
substrate	VB	O
binding	JJ	O
site-encoding	JJ	O
variant	NN	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
range	NN	O
of	IN	O
amino	NN	O
acid	JJ	O
variations	NNS	O
at	IN	O
each	DT	O
amino	NN	O
acid	VBP	O
codon	NN	O
that	WDT	O
was	VBD	O
mutagenized	VBN	O
,	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
library	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
modified	JJ	O
amylase	NN	O
active	JJ	O
sites	NNS	O
or	CC	O
substrate	VB	O
binding	NN	O
sites	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
comprises	VBZ	O
mutagenizing	VBG	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
an	DT	O
optimized	VBN	O
directed	VBN	O
evolution	NN	O
system	NN	O
,	,	O
gene	NN	O
site-saturation	JJ	O
mutagenesis	NN	O
(	(	O
GSSM	NNP	O
)	)	O
,	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(	(	O
SLR	NNP	O
)	)	O
,	,	O
error-prone	JJ	O
PCR	NNP	O
,	,	O
shuffling	VBG	O
,	,	O
oligonucleotide-directed	JJ	O
mutagenesis	NN	O
,	,	O
assembly	RB	O
PCR	NNP	O
,	,	O
sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
,	,	O
in	IN	O
vivo	JJ	O
mutagenesis	NN	O
,	,	O
cassette	NN	O
mutagenesis	NN	O
,	,	O
recursive	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
exponential	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
site-specific	JJ	O
mutagenesis	NN	O
,	,	O
gene	NN	O
reassembly	RB	O
,	,	O
gene	NN	O
site	NN	O
saturated	VBN	O
mutagenesis	NN	O
(	(	O
GSSM	NNP	O
)	)	O
,	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(	(	O
SLR	NNP	O
)	)	O
and	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
comprises	VBZ	O
mutagenizing	VBG	O
the	DT	O
first	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
or	CC	O
variants	NNS	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
recombination	NN	O
,	,	O
recursive	JJ	O
sequence	NN	O
recombination	NN	O
,	,	O
phosphothioate-modified	JJ	O
DNA	NNP	O
mutagenesis	NN	O
,	,	O
uracil-containing	JJ	O
template	NN	O
mutagenesis	NN	O
,	,	O
gapped	VBD	O
duplex	JJ	O
mutagenesis	NN	O
,	,	O
point	NN	O
mismatch	NN	O
repair	NN	O
mutagenesis	NN	O
,	,	O
repair-deficient	JJ	O
host	NN	O
strain	NN	O
mutagenesis	NN	O
,	,	O
chemical	JJ	O
mutagenesis	NN	O
,	,	O
radiogenic	JJ	O
mutagenesis	NN	O
,	,	O
deletion	NN	O
mutagenesis	NN	O
,	,	O
restriction-selection	NN	O
mutagenesis	NN	O
,	,	O
restriction-purification	NN	O
mutagenesis	NN	O
,	,	O
artificial	JJ	O
gene	NN	O
synthesis	NN	O
,	,	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
multimer	NN	O
creation	NN	O
and	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
making	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
biosynthetic	JJ	O
enzymes	NNS	O
capable	JJ	O
of	IN	O
synthesizing	VBG	O
or	CC	O
modifying	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
,	,	O
wherein	VBP	O
one	CD	O
of	IN	O
the	DT	O
enzymes	NNS	O
comprises	VBZ	O
an	DT	O
amylase	NN	O
enzyme	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
substrate	NN	O
for	IN	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
the	DT	O
enzymes	NNS	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
reacting	VBG	O
the	DT	O
substrate	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
with	IN	O
the	DT	O
enzymes	NNS	O
under	IN	O
conditions	NNS	O
that	WDT	O
facilitate	VBP	O
a	DT	O
plurality	NN	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
to	TO	O
generate	VB	O
a	DT	O
small	JJ	O
molecule	NN	O
by	IN	O
a	DT	O
series	NN	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
an	DT	O
amylase	NN	O
enzyme	NN	O
,	,	O
wherein	VBP	O
the	DT	O
enzyme	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
,	,	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
reacting	VBG	O
the	DT	O
enzyme	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
small	JJ	O
molecule	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
that	WDT	O
facilitate	VBP	O
an	DT	O
enzymatic	JJ	O
reaction	NN	O
catalyzed	VBN	O
by	IN	O
the	DT	O
amylase	NN	O
enzyme	NN	O
,	,	O
thereby	RB	O
modifying	VBG	O
a	DT	O
small	JJ	O
molecule	NN	O
by	IN	O
an	DT	O
amylase	NN	O
enzymatic	JJ	O
reaction	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
a	DT	O
plurality	NN	O
of	IN	O
small	JJ	O
molecule	NN	O
substrates	NNS	O
for	IN	O
the	DT	O
enzyme	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
,	,	O
thereby	RB	O
generating	VBG	O
a	DT	O
library	NN	O
of	IN	O
modified	VBN	O
small	JJ	O
molecules	NNS	O
produced	VBN	O
by	IN	O
at	IN	O
least	JJS	O
one	CD	O
enzymatic	JJ	O
reaction	NN	O
catalyzed	VBN	O
by	IN	O
the	DT	O
amylase	NN	O
enzyme	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
a	DT	O
plurality	NN	O
of	IN	O
additional	JJ	O
enzymes	NNS	O
under	IN	O
conditions	NNS	O
that	WDT	O
facilitate	VBP	O
a	DT	O
plurality	NN	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
by	IN	O
the	DT	O
enzymes	NNS	O
to	TO	O
form	VB	O
a	DT	O
library	NN	O
of	IN	O
modified	VBN	O
small	JJ	O
molecules	NNS	O
produced	VBN	O
by	IN	O
the	DT	O
plurality	NN	O
of	IN	O
enzymatic	JJ	O
reactions	NNS	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
the	DT	O
step	NN	O
of	IN	O
testing	VBG	O
the	DT	O
library	NN	O
to	TO	O
determine	VB	O
if	IN	O
a	DT	O
particular	JJ	O
modified	VBN	O
small	JJ	O
molecule	NN	O
which	WDT	O
exhibits	VBZ	O
a	DT	O
desired	JJ	O
activity	NN	O
is	VBZ	O
present	JJ	O
within	IN	O
the	DT	O
library	NN	O
.	.	O
The	DT	O
step	NN	O
of	IN	O
testing	VBG	O
the	DT	O
library	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
the	DT	O
steps	NNS	O
of	IN	O
systematically	RB	O
eliminating	VBG	O
all	DT	O
but	CC	O
one	CD	O
of	IN	O
the	DT	O
biocatalytic	JJ	O
reactions	NNS	O
used	VBN	O
to	TO	O
produce	VB	O
a	DT	O
portion	NN	O
of	IN	O
the	DT	O
plurality	NN	O
of	IN	O
the	DT	O
modified	JJS	O
small	JJ	O
molecules	NNS	O
within	IN	O
the	DT	O
library	JJ	O
by	IN	O
testing	VBG	O
the	DT	O
portion	NN	O
of	IN	O
the	DT	O
modified	JJS	O
small	JJ	O
molecule	NN	O
for	IN	O
the	DT	O
presence	NN	O
or	CC	O
absence	NN	O
of	IN	O
the	DT	O
particular	JJ	O
modified	VBD	O
small	JJ	O
molecule	NN	O
with	IN	O
a	DT	O
desired	JJ	O
activity	NN	O
,	,	O
and	CC	O
identifying	VBG	O
at	IN	O
least	JJS	O
one	CD	O
specific	JJ	O
biocatalytic	JJ	O
reaction	NN	O
that	WDT	O
produces	VBZ	O
the	DT	O
particular	JJ	O
modified	VBD	O
small	JJ	O
molecule	NN	O
of	IN	O
desired	JJ	O
activity	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
determining	VBG	O
a	DT	O
functional	JJ	O
fragment	NN	O
of	IN	O
an	DT	O
amylase	NN	O
enzyme	NN	O
comprising	VBG	O
the	DT	O
steps	NNS	O
of	IN	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
an	DT	O
amylase	NN	O
enzyme	NN	O
,	,	O
wherein	VBP	O
the	DT	O
enzyme	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
subsequence	NN	O
thereof	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
deleting	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
amino	NN	O
acid	NN	O
residues	NNS	O
from	IN	O
the	DT	O
sequence	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
testing	VBG	O
the	DT	O
remaining	VBG	O
subsequence	NN	O
for	IN	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
thereby	RB	O
determining	VBG	O
a	DT	O
functional	JJ	O
fragment	NN	O
of	IN	O
an	DT	O
amylase	NN	O
enzyme	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
measured	VBN	O
by	IN	O
providing	VBG	O
an	DT	O
amylase	NN	O
substrate	NN	O
and	CC	O
detecting	VBG	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
the	DT	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
reaction	NN	O
product	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
whole	JJ	O
cell	NN	O
engineering	NN	O
of	IN	O
new	JJ	O
or	CC	O
modified	VBN	O
phenotypes	NNS	O
by	IN	O
using	VBG	O
real-time	JJ	O
metabolic	JJ	O
flux	NN	O
analysis	NN	O
,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
making	VBG	O
a	DT	O
modified	VBN	O
cell	NN	O
by	IN	O
modifying	VBG	O
the	DT	O
genetic	JJ	O
composition	NN	O
of	IN	O
a	DT	O
cell	NN	O
,	,	O
wherein	VBZ	O
the	DT	O
genetic	JJ	O
composition	NN	O
is	VBZ	O
modified	VBN	O
by	IN	O
addition	NN	O
to	TO	O
the	DT	O
cell	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
culturing	VBG	O
the	DT	O
modified	VBN	O
cell	NN	O
to	TO	O
generate	VB	O
a	DT	O
plurality	NN	O
of	IN	O
modified	JJ	O
cells	NNS	O
;	:	O
(	(	O
c	NN	O
)	)	O
measuring	NN	O
at	IN	O
least	JJS	O
one	CD	O
metabolic	JJ	O
parameter	NN	O
of	IN	O
the	DT	O
cell	NN	O
by	IN	O
monitoring	VBG	O
the	DT	O
cell	NN	O
culture	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
in	IN	O
real	JJ	O
time	NN	O
;	:	O
and	CC	O
,	,	O
(	(	O
d	NN	O
)	)	O
analyzing	VBG	O
the	DT	O
data	NN	O
of	IN	O
step	NN	O
(	(	O
c	NN	O
)	)	O
to	TO	O
determine	VB	O
if	IN	O
the	DT	O
measured	VBN	O
parameter	NN	O
differs	NNS	O
from	IN	O
a	DT	O
comparable	JJ	O
measurement	NN	O
in	IN	O
an	DT	O
unmodified	JJ	O
cell	NN	O
under	IN	O
similar	JJ	O
conditions	NNS	O
,	,	O
thereby	RB	O
identifying	VBG	O
an	DT	O
engineered	JJ	O
phenotype	NN	O
in	IN	O
the	DT	O
cell	NN	O
using	VBG	O
real-time	JJ	O
metabolic	JJ	O
flux	NN	O
analysis	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
genetic	JJ	O
composition	NN	O
of	IN	O
the	DT	O
cell	NN	O
can	MD	O
be	VB	O
modified	VBN	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
deletion	NN	O
of	IN	O
a	DT	O
sequence	NN	O
or	CC	O
modification	NN	O
of	IN	O
a	DT	O
sequence	NN	O
in	IN	O
the	DT	O
cell	NN	O
,	,	O
or	CC	O
,	,	O
knocking	VBG	O
out	RP	O
the	DT	O
expression	NN	O
of	IN	O
a	DT	O
gene	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
further	RBR	O
comprise	VB	O
selecting	VBG	O
a	DT	O
cell	NN	O
comprising	VBG	O
a	DT	O
newly	RB	O
engineered	VBN	O
phenotype	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
can	MD	O
comprise	VB	O
culturing	VBG	O
the	DT	O
selected	VBN	O
cell	NN	O
,	,	O
thereby	RB	O
generating	VBG	O
a	DT	O
new	JJ	O
cell	NN	O
strain	NN	O
comprising	VBG	O
a	DT	O
newly	RB	O
engineered	VBN	O
phenotype	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
hydrolyzing	VBG	O
a	DT	O
starch	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
starch	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
hydrolyzes	VBZ	O
the	DT	O
starch	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
composition	NN	O
comprising	VBG	O
starch	NN	O
that	WDT	O
comprises	VBZ	O
an	DT	O
α-1,4-glucosidic	JJ	O
bond	NN	O
or	CC	O
an	DT	O
α-1,6-glucosidic	JJ	O
bond	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
activity	NN	O
is	VBZ	O
an	DT	O
α-amylase	JJ	O
activity	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
hydrolyzes	VBZ	O
internal	JJ	O
bonds	NNS	O
in	IN	O
a	DT	O
starch	NN	O
or	CC	O
other	JJ	O
polysaccharide	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
liquefying	VBG	O
or	CC	O
removing	VBG	O
a	DT	O
starch	NN	O
from	IN	O
a	DT	O
composition	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
starch	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
removes	VBZ	O
or	CC	O
liquefies	VBZ	O
the	DT	O
starch	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
increasing	VBG	O
thermotolerance	NN	O
or	CC	O
thermostability	NN	O
of	IN	O
an	DT	O
amylase	NN	O
polypeptide	NN	O
,	,	O
the	DT	O
method	NN	O
comprising	VBG	O
glycosylating	VBG	O
an	DT	O
amylase	NN	O
polypeptide	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
thirty	JJ	O
contiguous	JJ	O
amino	NN	O
acids	NNS	O
of	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
thereby	RB	O
increasing	VBG	O
the	DT	O
thermotolerance	NN	O
or	CC	O
thermostability	NN	O
of	IN	O
the	DT	O
amylase	NN	O
polypeptide	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
specific	JJ	O
activity	NN	O
can	MD	O
be	VB	O
thermostable	JJ	O
or	CC	O
thermotolerant	NN	O
at	IN	O
a	DT	O
temperature	NN	O
in	IN	O
the	DT	O
range	NN	O
from	IN	O
greater	JJR	O
than	IN	O
about	RB	O
37°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
overexpressing	VBG	O
a	DT	O
recombinant	JJ	O
amylase	NN	O
polypeptide	NN	O
in	IN	O
a	DT	O
cell	NN	O
comprising	VBG	O
expressing	VBG	O
a	DT	O
vector	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
wherein	VBP	O
the	DT	O
sequence	NN	O
identities	NNS	O
are	VBP	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
visual	JJ	O
inspection	NN	O
,	,	O
wherein	JJ	O
overexpression	NN	O
is	VBZ	O
effected	VBN	O
by	IN	O
use	NN	O
of	IN	O
a	DT	O
high	JJ	O
activity	NN	O
promoter	NN	O
,	,	O
a	DT	O
dicistronic	JJ	O
vector	NN	O
or	CC	O
by	IN	O
gene	NN	O
amplification	NN	O
of	IN	O
the	DT	O
vector	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
detergent	JJ	O
compositions	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
can	MD	O
be	VB	O
a	DT	O
nonsurface-active	JJ	O
amylase	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
amylase	NN	O
can	MD	O
be	VB	O
a	DT	O
surface-active	JJ	O
amylase	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
washing	VBG	O
an	DT	O
object	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
:	:	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
an	DT	O
object	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
the	DT	O
object	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
composition	NN	O
can	MD	O
wash	VB	O
the	DT	O
object	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
hydrolyzing	VBG	O
starch	NN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
a	DT	O
feed	NN	O
or	CC	O
a	DT	O
food	NN	O
prior	RB	O
to	TO	O
consumption	NN	O
by	IN	O
an	DT	O
animal	NN	O
,	,	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
obtaining	VBG	O
a	DT	O
composition	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
feed	NN	O
material	NN	O
,	,	O
comprising	VBG	O
a	DT	O
starch	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
:	:	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
adding	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
to	TO	O
the	DT	O
composition	NN	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
feed	NN	O
or	CC	O
food	NN	O
material	NN	O
,	,	O
in	IN	O
an	DT	O
amount	NN	O
sufficient	NN	O
for	IN	O
a	DT	O
sufficient	JJ	O
time	NN	O
period	NN	O
to	TO	O
cause	VB	O
hydrolysis	NN	O
of	IN	O
the	DT	O
starch	NN	O
,	,	O
thereby	RB	O
hydrolyzing	VBG	O
the	DT	O
starch	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
food	NN	O
or	CC	O
feed	NN	O
comprises	NNS	O
rice	NN	O
,	,	O
corn	NN	O
,	,	O
barley	NN	O
,	,	O
wheat	NN	O
,	,	O
legumes	RB	O
,	,	O
or	CC	O
potato	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
textile	NN	O
desizing	VBG	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
fabric	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
the	DT	O
fabric	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
amylase	NN	O
can	MD	O
desize	VB	O
the	DT	O
fabric	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
deinking	NN	O
of	IN	O
paper	NN	O
or	CC	O
fibers	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
paper	NN	O
or	CC	O
fiber	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
deink	VB	O
the	DT	O
paper	NN	O
or	CC	O
fiber	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
treatment	NN	O
of	IN	O
lignocellulosic	JJ	O
fibers	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
lignocellulosic	JJ	O
fiber	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
the	DT	O
fiber	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
treat	VB	O
the	DT	O
fiber	NN	O
thereby	RB	O
improving	VBG	O
the	DT	O
fiber	NN	O
properties	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
producing	VBG	O
a	DT	O
high-maltose	JJ	O
or	CC	O
a	DT	O
high-glucose	JJ	O
syrup	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
comprising	VBG	O
a	DT	O
starch	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
the	DT	O
fabric	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
can	MD	O
liquefy	VB	O
the	DT	O
composition	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
thereby	RB	O
producing	VBG	O
a	DT	O
soluble	JJ	O
starch	NN	O
hydrolysate	NN	O
and	CC	O
saccharify	VB	O
the	DT	O
soluble	JJ	O
starch	NN	O
hydrolysate	NN	O
thereby	RB	O
producing	VBG	O
the	DT	O
syrup	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
starch	NN	O
can	MD	O
be	VB	O
from	IN	O
rice	NN	O
,	,	O
corn	NN	O
,	,	O
barley	NN	O
,	,	O
wheat	NN	O
,	,	O
legumes	RB	O
,	,	O
potato	NN	O
,	,	O
or	CC	O
sweet	JJ	O
potato	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
improving	VBG	O
the	DT	O
flow	NN	O
of	IN	O
the	DT	O
starch-containing	JJ	O
production	NN	O
fluids	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
production	NN	O
fluid	NN	O
;	:	O
and	CC	O
(	(	O
c	NN	O
)	)	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
and	CC	O
the	DT	O
production	NN	O
fluid	NN	O
of	IN	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
amylase	NN	O
can	MD	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
in	IN	O
the	DT	O
production	NN	O
fluid	NN	O
thereby	RB	O
improving	VBG	O
its	PRP$	O
flow	NN	O
by	IN	O
decreasing	VBG	O
its	PRP$	O
density	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
production	NN	O
fluid	NN	O
can	MD	O
be	VB	O
from	IN	O
a	DT	O
subterranean	JJ	O
formation	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
anti-staling	JJ	O
compositions	NNS	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
encoded	VBN	O
by	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
preventing	VBG	O
staling	NN	O
of	IN	O
the	DT	O
baked	JJ	O
products	NNS	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
containing	VBG	O
starch	NN	O
used	VBN	O
for	IN	O
baking	NN	O
;	:	O
(	(	O
c	NN	O
)	)	O
combining	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
the	DT	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
in	IN	O
the	DT	O
composition	NN	O
used	VBN	O
for	IN	O
baking	VBG	O
thereby	RB	O
preventing	VBG	O
staling	NN	O
of	IN	O
the	DT	O
baked	JJ	O
product	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
baked	JJ	O
product	NN	O
can	MD	O
be	VB	O
bread	VBN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
using	VBG	O
amylase	NN	O
in	IN	O
brewing	NN	O
or	CC	O
alcohol	NN	O
production	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
comprises	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
composition	NN	O
containing	VBG	O
starch	NN	O
and	CC	O
used	VBN	O
for	IN	O
brewing	NN	O
or	CC	O
in	IN	O
alcohol	JJ	O
production	NN	O
;	:	O
(	(	O
c	NN	O
)	)	O
combining	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
step	NN	O
(	(	O
a	DT	O
)	)	O
with	IN	O
the	DT	O
composition	NN	O
of	IN	O
the	DT	O
step	NN	O
(	(	O
b	NN	O
)	)	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
can	MD	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
in	IN	O
the	DT	O
composition	NN	O
used	VBN	O
for	IN	O
brewing	NN	O
or	CC	O
in	IN	O
alcohol	JJ	O
production	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
composition	NN	O
containing	VBG	O
starch	NN	O
can	MD	O
be	VB	O
beer	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
a	DT	O
transgenic	JJ	O
plant	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
introducing	VBG	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
into	IN	O
the	DT	O
cell	NN	O
,	,	O
wherein	VBZ	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
thereby	RB	O
producing	VBG	O
a	DT	O
transformed	JJ	O
plant	NN	O
cell	NN	O
;	:	O
and	CC	O
(	(	O
b	NN	O
)	)	O
producing	VBG	O
a	DT	O
transgenic	JJ	O
plant	NN	O
from	IN	O
the	DT	O
transformed	VBN	O
cell	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
step	NN	O
(	(	O
a	DT	O
)	)	O
can	MD	O
further	RB	O
comprise	VB	O
introducing	VBG	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
by	IN	O
electroporation	NN	O
or	CC	O
microinjection	NN	O
of	IN	O
plant	NN	O
cell	NN	O
protoplasts	NNS	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
step	NN	O
(	(	O
a	DT	O
)	)	O
can	MD	O
further	RB	O
comprise	VB	O
introducing	VBG	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
directly	RB	O
to	TO	O
plant	NN	O
tissue	NN	O
by	IN	O
DNA	NNP	O
particle	NN	O
bombardment	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
step	NN	O
(	(	O
a	DT	O
)	)	O
can	MD	O
further	RB	O
comprise	VB	O
introducing	VBG	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
into	IN	O
the	DT	O
plant	NN	O
cell	NN	O
DNA	NNP	O
using	VBG	O
an	DT	O
Agrobacterium	NN	O
tumefaciens	VBZ	O
host	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
plant	NN	O
cell	NN	O
can	MD	O
be	VB	O
a	DT	O
potato	NN	O
,	,	O
corn	NN	O
,	,	O
rice	NN	O
,	,	O
wheat	NN	O
,	,	O
tobacco	NN	O
,	,	O
or	CC	O
barley	NN	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
expressing	VBG	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
in	IN	O
a	DT	O
plant	NN	O
cell	NN	O
comprising	VBG	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
transforming	VBG	O
the	DT	O
plant	NN	O
cell	NN	O
with	IN	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
operably	RB	O
linked	VBD	O
to	TO	O
a	DT	O
promoter	NN	O
,	,	O
wherein	VBP	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
sequence	NN	O
comprises	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
growing	VBG	O
the	DT	O
plant	NN	O
under	IN	O
conditions	NNS	O
wherein	VBP	O
the	DT	O
heterologous	JJ	O
nucleic	JJ	O
acids	NNS	O
sequence	NN	O
is	VBZ	O
expressed	VBN	O
in	IN	O
the	DT	O
plant	NN	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
process	NN	O
for	IN	O
preparing	VBG	O
a	DT	O
dough	NN	O
or	CC	O
a	DT	O
baked	JJ	O
product	NN	O
prepared	VBN	O
from	IN	O
the	DT	O
dough	NN	O
which	WDT	O
comprises	VBZ	O
adding	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
the	DT	O
dough	NN	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
effective	JJ	O
to	TO	O
retard	VB	O
the	DT	O
staling	NN	O
of	IN	O
the	DT	O
bread	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
dough	NN	O
comprising	NN	O
said	VBD	O
amylase	NN	O
and	CC	O
a	DT	O
premix	NN	O
comprising	VBG	O
flour	PRP$	O
together	NN	O
with	IN	O
said	VBD	O
amylase	NN	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
enzymatic	JJ	O
baking	NN	O
additive	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
said	VBD	O
amylase	NN	O
.	.	O
The	DT	O
use	NN	O
of	IN	O
the	DT	O
amylase	NN	O
in	IN	O
accordance	NN	O
with	IN	O
the	DT	O
present	JJ	O
invention	NN	O
provides	VBZ	O
an	DT	O
improved	JJ	O
anti-staling	JJ	O
effect	NN	O
as	IN	O
measured	VBN	O
by	IN	O
,	,	O
e.g	NN	O
.	.	O
less	RBR	O
crumb	JJ	O
firming	NN	O
,	,	O
retained	VBD	O
crumb	JJ	O
elasticity	NN	O
,	,	O
improved	VBN	O
slice-ability	NN	O
(	(	O
e.g	NN	O
.	.	O
fewer	JJR	O
crumbs	NNS	O
,	,	O
non-gummy	JJ	O
crumb	NN	O
)	)	O
,	,	O
improved	VBN	O
palatability	NN	O
or	CC	O
flavor	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
:	:	O
1	CD	O
and	CC	O
variants	NNS	O
thereof	VBP	O
having	VBG	O
at	IN	O
least	JJS	O
50	CD	O
%	NN	O
sequence	NN	O
identity	NN	O
to	TO	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
:	:	O
1	CD	O
and	CC	O
encoding	VBG	O
polypeptides	NNS	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
.	.	O
One	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
:	:	O
1	CD	O
,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
and	CC	O
sequences	NNS	O
complementary	JJ	O
thereto	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	JJ	O
acid	NN	O
including	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
and	CC	O
the	DT	O
sequences	NNS	O
complementary	JJ	O
thereto	NN	O
.	.	O
In	IN	O
yet	RB	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
.	.	O
:	:	O
2	CD	O
and	CC	O
variants	NNS	O
thereof	VBP	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
and	CC	O
having	VBG	O
at	IN	O
least	JJS	O
50	CD	O
%	NN	O
sequence	NN	O
identity	NN	O
to	TO	O
such	JJ	O
sequences	NNS	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
or	CC	O
a	DT	O
functional	JJ	O
fragment	NN	O
thereof	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
:	:	O
2	CD	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
nucleic	NN	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
amino	NN	O
acids	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
In	IN	O
yet	RB	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
purified	JJ	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
purified	JJ	O
antibody	NN	O
that	WDT	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
isolated	JJ	O
or	CC	O
purified	JJ	O
antibody	NN	O
or	CC	O
binding	VBG	O
fragment	JJ	O
thereof	NN	O
,	,	O
which	WDT	O
specifically	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
polypeptide	NN	O
having	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
amino	NN	O
acids	NNS	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
making	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
The	DT	O
method	NN	O
includes	VBZ	O
introducing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
the	DT	O
polypeptide	NN	O
into	IN	O
a	DT	O
host	NN	O
cell	NN	O
,	,	O
wherein	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter	NN	O
,	,	O
and	CC	O
culturing	VBG	O
the	DT	O
host	NN	O
cell	NN	O
under	IN	O
conditions	NNS	O
that	WDT	O
allow	VBP	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
making	VBG	O
a	DT	O
polypeptide	NN	O
having	VBG	O
at	IN	O
least	JJS	O
10	CD	O
amino	JJ	O
acids	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
The	DT	O
method	NN	O
includes	VBZ	O
introducing	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
the	DT	O
polypeptide	NN	O
into	IN	O
a	DT	O
host	NN	O
cell	NN	O
,	,	O
wherein	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter	NN	O
,	,	O
and	CC	O
culturing	VBG	O
the	DT	O
host	NN	O
cell	NN	O
under	IN	O
conditions	NNS	O
that	WDT	O
allow	VBP	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
,	,	O
thereby	RB	O
producing	VBG	O
the	DT	O
polypeptide	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
generating	VBG	O
a	DT	O
variant	JJ	O
including	VBG	O
obtaining	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
sequences	NNS	O
complementary	VBP	O
to	TO	O
the	DT	O
sequences	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
fragments	NNS	O
comprising	VBG	O
at	IN	O
least	JJS	O
30	CD	O
consecutive	JJ	O
nucleotides	NNS	O
of	IN	O
the	DT	O
foregoing	NN	O
sequences	NNS	O
,	,	O
and	CC	O
changing	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
to	TO	O
another	DT	O
nucleotide	NN	O
,	,	O
deleting	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
,	,	O
or	CC	O
adding	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
to	TO	O
the	DT	O
sequence	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
computer	NN	O
readable	JJ	O
medium	NN	O
having	VBG	O
stored	VBN	O
thereon	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
computer	NN	O
system	NN	O
including	VBG	O
a	DT	O
processor	NN	O
and	CC	O
a	DT	O
data	NN	O
storage	NN	O
device	NN	O
wherein	IN	O
the	DT	O
data	NNS	O
storage	NN	O
device	NN	O
has	VBZ	O
stored	VBN	O
thereon	RP	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
for	IN	O
comparing	VBG	O
a	DT	O
first	JJ	O
sequence	NN	O
to	TO	O
a	DT	O
reference	NN	O
sequence	NN	O
wherein	VBD	O
the	DT	O
first	JJ	O
sequence	NN	O
is	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
code	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
The	DT	O
method	NN	O
includes	VBZ	O
reading	VBG	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
reference	NN	O
sequence	NN	O
through	IN	O
use	NN	O
of	IN	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
compares	VBZ	O
sequences	NNS	O
;	:	O
and	CC	O
determining	VBG	O
differences	NNS	O
between	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
reference	NN	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
method	NN	O
for	IN	O
identifying	VBG	O
a	DT	O
feature	NN	O
in	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
or	CC	O
a	DT	O
polypeptide	JJ	O
having	VBG	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
including	VBG	O
reading	VBG	O
the	DT	O
sequence	NN	O
through	IN	O
the	DT	O
use	NN	O
of	IN	O
a	DT	O
computer	NN	O
program	NN	O
which	WDT	O
identifies	VBZ	O
features	NNS	O
in	IN	O
sequences	NNS	O
;	:	O
and	CC	O
identifying	VBG	O
features	NNS	O
in	IN	O
the	DT	O
sequence	NN	O
with	IN	O
the	DT	O
computer	NN	O
program	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
an	DT	O
assay	NN	O
for	IN	O
identifying	VBG	O
fragments	NNS	O
or	CC	O
variants	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
:	:	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
which	WDT	O
retain	VBP	O
the	DT	O
enzymatic	JJ	O
function	NN	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
sequences	NNS	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
.	.	O
The	DT	O
assay	NN	O
includes	VBZ	O
contacting	VBG	O
the	DT	O
polypeptide	NN	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
sequences	VBZ	O
substantially	RB	O
identical	JJ	O
thereto	NN	O
,	,	O
or	CC	O
polypeptide	VB	O
fragment	NN	O
or	CC	O
variant	NN	O
with	IN	O
a	DT	O
substrate	NN	O
molecule	NN	O
under	IN	O
conditions	NNS	O
which	WDT	O
allow	VBP	O
the	DT	O
polypeptide	JJ	O
fragment	NN	O
or	CC	O
variant	NN	O
to	TO	O
function	NN	O
,	,	O
and	CC	O
detecting	VBG	O
either	CC	O
a	DT	O
decrease	NN	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
substrate	NN	O
or	CC	O
an	DT	O
increase	NN	O
in	IN	O
the	DT	O
level	NN	O
of	IN	O
the	DT	O
specific	JJ	O
reaction	NN	O
product	NN	O
of	IN	O
the	DT	O
reaction	NN	O
between	IN	O
the	DT	O
polypeptide	NN	O
and	CC	O
substrate	VB	O
thereby	RB	O
identifying	VBG	O
a	DT	O
fragment	NN	O
or	CC	O
variant	NN	O
of	IN	O
such	JJ	O
sequences	NNS	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
process	NN	O
for	IN	O
preparing	VBG	O
a	DT	O
dough	NN	O
or	CC	O
a	DT	O
baked	JJ	O
product	NN	O
prepared	VBN	O
from	IN	O
the	DT	O
dough	NN	O
which	WDT	O
comprises	VBZ	O
adding	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
the	DT	O
dough	NN	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
effective	JJ	O
to	TO	O
retard	VB	O
the	DT	O
staling	NN	O
of	IN	O
the	DT	O
bread	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
dough	NN	O
comprising	NN	O
said	VBD	O
amylase	NN	O
and	CC	O
a	DT	O
premix	NN	O
comprising	VBG	O
flour	PRP$	O
together	NN	O
with	IN	O
said	VBD	O
amylase	NN	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
enzymatic	JJ	O
baking	NN	O
additive	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
said	VBD	O
amylase	NN	O
.	.	O
The	DT	O
use	NN	O
of	IN	O
the	DT	O
amylase	NN	O
in	IN	O
accordance	NN	O
with	IN	O
the	DT	O
present	JJ	O
invention	NN	O
provides	VBZ	O
an	DT	O
improved	JJ	O
anti-staling	JJ	O
effect	NN	O
as	IN	O
measured	VBN	O
by	IN	O
,	,	O
e.g	NN	O
.	.	O
less	RBR	O
crumb	JJ	O
firming	NN	O
,	,	O
retained	VBD	O
crumb	JJ	O
elasticity	NN	O
,	,	O
improved	VBN	O
slice-ability	NN	O
(	(	O
e.g	NN	O
.	.	O
fewer	JJR	O
crumbs	NNS	O
,	,	O
non-gummy	JJ	O
crumb	NN	O
)	)	O
,	,	O
improved	VBN	O
palatability	NN	O
or	CC	O
flavor	NN	O
.	.	O
The	DT	O
details	NNS	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
embodiments	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
set	VBN	O
forth	NN	O
in	IN	O
the	DT	O
accompanying	JJ	O
drawings	NNS	O
and	CC	O
the	DT	O
description	NN	O
below	IN	O
.	.	O
Other	JJ	O
features	NNS	O
,	,	O
objects	NNS	O
,	,	O
and	CC	O
advantages	NNS	O
of	IN	O
the	DT	O
invention	NN	O
will	MD	O
be	VB	O
apparent	JJ	O
from	IN	O
the	DT	O
description	NN	O
and	CC	O
drawings	NNS	O
,	,	O
and	CC	O
from	IN	O
the	DT	O
claims	NNS	O
.	.	O
All	DT	O
publications	NNS	O
,	,	O
patents	NNS	O
,	,	O
patent	NN	O
applications	NNS	O
,	,	O
GenBank	NNP	O
sequences	NNS	O
and	CC	O
ATCC	NNP	O
deposits	NNS	O
,	,	O
cited	VBN	O
herein	NN	O
are	VBP	O
hereby	RB	O
expressly	RB	O
incorporated	VBN	O
by	IN	O
reference	NN	O
for	IN	O
all	DT	O
purposes	NNS	O
.	.	O
DESCRIPTION	NNP	O
OF	NNP	O
DRAWINGS	NNP	O
FIG	NNP	O
.	.	O
1	CD	O
is	VBZ	O
a	DT	O
block	NN	O
diagram	NN	O
of	IN	O
a	DT	O
computer	NN	O
system	NN	O
.	.	O
FIG	NNP	O
.	.	O
2	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
a	DT	O
process	NN	O
for	IN	O
comparing	VBG	O
a	DT	O
new	JJ	O
nucleotide	NN	O
or	CC	O
protein	NN	O
sequence	NN	O
with	IN	O
a	DT	O
database	NN	O
of	IN	O
sequences	NNS	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
the	DT	O
homology	NN	O
levels	NNS	O
between	IN	O
the	DT	O
new	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
sequences	NNS	O
in	IN	O
the	DT	O
database	NN	O
.	.	O
FIG	NNP	O
.	.	O
3	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
a	DT	O
process	NN	O
in	IN	O
a	DT	O
computer	NN	O
for	IN	O
determining	VBG	O
whether	IN	O
two	CD	O
sequences	NNS	O
are	VBP	O
homologous	JJ	O
.	.	O
FIG	NNP	O
.	.	O
4	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
an	DT	O
identifier	NN	O
process	NN	O
300	CD	O
for	IN	O
detecting	VBG	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
feature	NN	O
in	IN	O
a	DT	O
sequence	NN	O
.	.	O
FIG	NNP	O
.	.	O
5	CD	O
illustrates	VBZ	O
a	DT	O
sample	JJ	O
Standard	NNP	O
Curve	NNP	O
of	IN	O
the	DT	O
assay	NN	O
of	IN	O
Example	NNP	O
3	CD	O
.	.	O
FIG	NNP	O
.	.	O
6	CD	O
a	DT	O
and	CC	O
FIG	NNP	O
.	.	O
6	CD	O
b	NN	O
show	NN	O
the	DT	O
molecular	JJ	O
weight	NN	O
fragments	NNS	O
in	IN	O
syrups	NNS	O
using	VBG	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
commercial	JJ	O
enzymes	NNS	O
,	,	O
as	IN	O
discussed	VBN	O
below	IN	O
.	.	O
FIG	NNP	O
.	.	O
7	CD	O
illustrates	VBZ	O
the	DT	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
FIG	NNP	O
.	.	O
8	CD	O
shows	VBZ	O
a	DT	O
comparison	NN	O
of	IN	O
oligosaccharide	JJ	O
profiles	NNS	O
for	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
commercial	JJ	O
amylases	NNS	O
.	.	O
Like	IN	O
reference	NN	O
symbols	NNS	O
in	IN	O
the	DT	O
various	JJ	O
drawings	NNS	O
indicate	VBP	O
like	IN	O
elements	NNS	O
.	.	O
DETAILED	JJ	O
DESCRIPTION	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
amylase	JJ	O
enzymes	NNS	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
,	,	O
polynucleotides	VBZ	O
encoding	VBG	O
the	DT	O
enzymes	NNS	O
,	,	O
methods	NNS	O
of	IN	O
making	VBG	O
and	CC	O
using	VBG	O
these	DT	O
polynucleotides	NNS	O
and	CC	O
polypeptides	NNS	O
.	.	O
The	DT	O
invention	NN	O
is	VBZ	O
directed	VBN	O
to	TO	O
novel	VB	O
polypeptides	NNS	O
having	VBG	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
them	PRP	O
and	CC	O
antibodies	NNS	O
that	WDT	O
bind	VBP	O
to	TO	O
them	PRP	O
.	.	O
The	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
diagnostic	JJ	O
,	,	O
therapeutic	JJ	O
,	,	O
and	CC	O
industrial	JJ	O
contexts	NN	O
.	.	O
The	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
additive	NN	O
for	IN	O
a	DT	O
detergent	NN	O
,	,	O
for	IN	O
processing	VBG	O
foods	NNS	O
and	CC	O
for	IN	O
chemical	JJ	O
synthesis	NN	O
utilizing	VBG	O
a	DT	O
reverse	JJ	O
reaction	NN	O
.	.	O
Additionally	RB	O
,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
fabric	JJ	O
treatment	NN	O
,	,	O
alcohol	NN	O
production	NN	O
,	,	O
and	CC	O
as	IN	O
additives	NNS	O
to	TO	O
food	NN	O
or	CC	O
animal	NN	O
feed	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
active	JJ	O
at	IN	O
a	DT	O
high	JJ	O
and/or	NN	O
at	IN	O
a	DT	O
low	JJ	O
temperature	NN	O
,	,	O
or	CC	O
,	,	O
over	IN	O
a	DT	O
wide	JJ	O
range	NN	O
of	IN	O
temperature	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
they	PRP	O
can	MD	O
be	VB	O
active	JJ	O
in	IN	O
the	DT	O
temperatures	NNS	O
ranging	VBG	O
between	IN	O
20°	CD	O
C.	NNP	O
to	TO	O
90°	CD	O
C.	NNP	O
,	,	O
between	IN	O
30°	CD	O
C.	NNP	O
to	TO	O
80°	CD	O
C.	NNP	O
,	,	O
or	CC	O
between	IN	O
40°	CD	O
C.	NNP	O
to	TO	O
70°	CD	O
C.	NNP	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
amylases	NNS	O
that	WDT	O
have	VBP	O
activity	NN	O
at	IN	O
alkaline	JJ	O
pHs	NN	O
or	CC	O
at	IN	O
acidic	JJ	O
pHs	NN	O
,	,	O
e.g.	RB	O
,	,	O
low	JJ	O
water	NN	O
acidity	NN	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
activity	NN	O
in	IN	O
acidic	JJ	O
pHs	NN	O
as	RB	O
low	JJ	O
as	IN	O
pH	NN	O
5.0	CD	O
,	,	O
pH	NN	O
4.5	CD	O
,	,	O
pH	NN	O
4.0	CD	O
,	,	O
and	CC	O
pH	RB	O
3.5	CD	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
activity	NN	O
in	IN	O
alkaline	NN	O
pHs	NN	O
as	RB	O
high	JJ	O
as	IN	O
pH	NN	O
9.5	CD	O
,	,	O
pH	NN	O
10	CD	O
,	,	O
pH	NN	O
10.5	CD	O
,	,	O
and	CC	O
pH	RB	O
11	CD	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
active	JJ	O
in	IN	O
the	DT	O
temperature	NN	O
range	NN	O
of	IN	O
between	IN	O
about	IN	O
40°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
70°	CD	O
C.	NNP	O
under	IN	O
conditions	NNS	O
of	IN	O
low	JJ	O
water	NN	O
activity	NN	O
(	(	O
low	JJ	O
water	NN	O
content	NN	O
)	)	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
methods	NNS	O
for	IN	O
further	JJ	O
modifying	VBG	O
the	DT	O
exemplary	JJ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
generate	VB	O
proteins	NNS	O
with	IN	O
desirable	JJ	O
properties	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
amylases	NNS	O
generated	VBN	O
by	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
altered	VBN	O
enzymatic	JJ	O
activity	NN	O
,	,	O
thermal	JJ	O
stability	NN	O
,	,	O
pH/activity	NN	O
profile	NN	O
,	,	O
pH/stability	NN	O
profile	NN	O
(	(	O
such	JJ	O
as	IN	O
increased	JJ	O
stability	NN	O
at	IN	O
low	JJ	O
,	,	O
e.g	NN	O
.	.	O
pH	NN	O
<	VBZ	O
6	CD	O
or	CC	O
pH	VB	O
<	JJ	O
5	CD	O
,	,	O
or	CC	O
high	JJ	O
,	,	O
e.g	RB	O
.	.	O
pH	NN	O
>	VBZ	O
9	CD	O
,	,	O
pH	NN	O
values	NNS	O
)	)	O
,	,	O
stability	NN	O
towards	NNS	O
oxidation	NN	O
,	,	O
Ca2+	NNP	O
dependency	NN	O
,	,	O
specific	JJ	O
activity	NN	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
for	IN	O
altering	VBG	O
any	DT	O
property	NN	O
of	IN	O
interest	NN	O
.	.	O
For	IN	O
instance	NN	O
,	,	O
the	DT	O
alteration	NN	O
may	MD	O
result	VB	O
in	IN	O
a	DT	O
variant	NN	O
which	WDT	O
,	,	O
as	IN	O
compared	VBN	O
to	TO	O
a	DT	O
parent	NN	O
enzyme	NN	O
,	,	O
has	VBZ	O
altered	VBN	O
enzymatic	JJ	O
activity	NN	O
,	,	O
or	CC	O
,	,	O
pH	''	O
or	CC	O
temperature	NN	O
activity	NN	O
profiles	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
relates	VBZ	O
to	TO	O
alpha	VB	O
amylases	NNS	O
and	CC	O
polynucleotides	NNS	O
encoding	VBG	O
them	PRP	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
the	DT	O
term	NN	O
“	NNP	O
alpha	VBZ	O
amylase	NN	O
”	NN	O
encompasses	VBZ	O
enzymes	RB	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
enzymes	VBZ	O
capable	JJ	O
of	IN	O
hydrolyzing	VBG	O
starch	NN	O
to	TO	O
sugars	NNS	O
.	.	O
Unlike	IN	O
many	JJ	O
known	VBN	O
amylases	NNS	O
,	,	O
the	DT	O
exemplary	JJ	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
is	VBZ	O
not	RB	O
a	DT	O
calcium-dependent	JJ	O
enzyme	NN	O
.	.	O
It	PRP	O
is	VBZ	O
highly	RB	O
desirable	JJ	O
to	TO	O
be	VB	O
able	JJ	O
to	TO	O
decrease	VB	O
the	DT	O
Ca2+	NNP	O
dependency	NN	O
of	IN	O
an	DT	O
alpha	JJ	O
amylase	NN	O
.	.	O
Accordingly	RB	O
,	,	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
amylase	NN	O
enzyme	NN	O
that	WDT	O
has	VBZ	O
a	DT	O
decreased	VBN	O
Ca2+	NNP	O
dependency	NN	O
as	RB	O
compared	VBN	O
to	TO	O
commercial	JJ	O
or	CC	O
parent	JJ	O
amylases	NNS	O
.	.	O
Decreased	VBN	O
Ca2+	NNP	O
dependency	NN	O
will	MD	O
in	IN	O
general	JJ	O
have	VBP	O
the	DT	O
functional	JJ	O
consequence	NN	O
that	IN	O
the	DT	O
variant	JJ	O
exhibits	VBZ	O
a	DT	O
satisfactory	JJ	O
amylolytic	JJ	O
activity	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
lower	JJR	O
concentration	NN	O
of	IN	O
calcium	NN	O
ion	NN	O
in	IN	O
the	DT	O
extraneous	JJ	O
medium	NN	O
than	IN	O
is	VBZ	O
necessary	JJ	O
for	IN	O
a	DT	O
commercial	JJ	O
or	CC	O
parent	JJ	O
enzyme	NN	O
.	.	O
It	PRP	O
will	MD	O
further	RBR	O
often	RB	O
have	VBP	O
the	DT	O
consequence	NN	O
that	IN	O
the	DT	O
variant	NN	O
is	VBZ	O
less	RBR	O
sensitive	JJ	O
to	TO	O
calcium	VB	O
ion-depleting	JJ	O
conditions	NNS	O
such	JJ	O
as	IN	O
those	DT	O
obtained	VBN	O
in	IN	O
media	NNS	O
containing	VBG	O
calcium-complexing	JJ	O
agents	NNS	O
(	(	O
such	JJ	O
as	IN	O
certain	JJ	O
detergent	NN	O
builders	NNS	O
)	)	O
.	.	O
The	DT	O
polynucleotides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
been	VBN	O
identified	VBN	O
as	IN	O
encoding	VBG	O
polypeptides	NNS	O
having	VBG	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
.	.	O
An	DT	O
exemplary	JJ	O
alpha	NN	O
amylase	NN	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
shown	VBN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
also	RB	O
referred	VBD	O
to	TO	O
herein	VB	O
as	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
.	.	O
Such	JJ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
particularly	RB	O
useful	JJ	O
in	IN	O
corn-wet	JJ	O
milling	NN	O
processes	NNS	O
,	,	O
detergents	NNS	O
,	,	O
baking	VBG	O
processes	NNS	O
,	,	O
beverages	NNS	O
and	CC	O
in	IN	O
oilfields	NNS	O
(	(	O
fuel	NN	O
ethanol	NN	O
)	)	O
.	.	O
Alterations	NNS	O
in	IN	O
properties	NNS	O
which	WDT	O
may	MD	O
be	VB	O
achieved	VBN	O
in	IN	O
variants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
alterations	NNS	O
in	IN	O
,	,	O
e.g.	NN	O
,	,	O
substrate	JJ	O
specificity	NN	O
,	,	O
substrate	NN	O
binding	NN	O
,	,	O
substrate	JJ	O
cleavage	NN	O
pattern	NN	O
,	,	O
thermal	JJ	O
stability	NN	O
,	,	O
pH/activity	NN	O
profile	NN	O
,	,	O
pH/stability	NN	O
profile	NN	O
,	,	O
such	JJ	O
as	IN	O
increased	JJ	O
stability	NN	O
at	IN	O
low	JJ	O
(	(	O
e.g	NN	O
.	.	O
pH	NN	O
<	VBZ	O
6	CD	O
,	,	O
in	IN	O
particular	JJ	O
pH	NN	O
<	NNP	O
5	CD	O
)	)	O
or	CC	O
high	JJ	O
(	(	O
e.g	FW	O
.	.	O
pH	NN	O
>	$	O
9	CD	O
)	)	O
pH	NN	O
values	NNS	O
]	VBP	O
,	,	O
stability	NN	O
towards	NNS	O
oxidation	NN	O
,	,	O
Ca2+	NNP	O
dependency	NN	O
,	,	O
specific	JJ	O
activity	NN	O
,	,	O
and	CC	O
other	JJ	O
properties	NNS	O
of	IN	O
interest	NN	O
.	.	O
For	IN	O
instance	NN	O
,	,	O
the	DT	O
alteration	NN	O
may	MD	O
result	VB	O
in	IN	O
a	DT	O
variant	NN	O
which	WDT	O
,	,	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
parent	NN	O
amylase	NN	O
,	,	O
has	VBZ	O
a	DT	O
reduced	VBN	O
Ca2+	NNP	O
dependency	NN	O
and/or	VBD	O
an	DT	O
altered	JJ	O
pH/activity	NN	O
profile	NN	O
.	.	O
Corn	NNP	O
wet	NN	O
milling	NN	O
is	VBZ	O
a	DT	O
process	NN	O
which	WDT	O
produces	VBZ	O
corn	NN	O
oil	NN	O
,	,	O
gluten	VB	O
meal	NN	O
,	,	O
gluten	VBP	O
feed	NN	O
and	CC	O
starch	NN	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
including	VBG	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
are	VBP	O
used	VBN	O
in	IN	O
the	DT	O
liquefaction	NN	O
of	IN	O
starch	NN	O
and	CC	O
glucoamylase	NN	O
is	VBZ	O
used	VBN	O
in	IN	O
saccharification	NN	O
,	,	O
producing	VBG	O
glucose	NN	O
.	.	O
The	DT	O
properties	NNS	O
of	IN	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
are	VBP	O
unique	JJ	O
in	IN	O
that	DT	O
they	PRP	O
allow	VBP	O
production	NN	O
of	IN	O
liquefied	VBN	O
syrups	NNS	O
which	WDT	O
can	MD	O
be	VB	O
converted	VBN	O
to	TO	O
higher	JJR	O
dextrose	NN	O
levels	NNS	O
than	IN	O
a	DT	O
conventional	JJ	O
Bacillus	NNP	O
amylase	NN	O
liquefied	VBD	O
syrup	NN	O
.	.	O
As	IN	O
can	MD	O
be	VB	O
seen	VBN	O
in	IN	O
FIG	NNP	O
.	.	O
6	CD	O
a	DT	O
and	CC	O
FIG	NNP	O
.	.	O
6	CD	O
b	NN	O
and	CC	O
in	IN	O
the	DT	O
Examples	NNP	O
,	,	O
the	DT	O
molecular	JJ	O
weight	NN	O
profile	NN	O
of	IN	O
liquefied	VBN	O
starch	NN	O
produced	VBN	O
by	IN	O
commercial	JJ	O
amylases	NNS	O
derived	VBN	O
from	IN	O
Bacillus	NNP	O
licheniformis	NNS	O
and	CC	O
Bacillus	NNP	O
stearothermophilus	VBP	O
exhibit	VB	O
a	DT	O
bimodal	JJ	O
distribution	NN	O
with	IN	O
a	DT	O
primary	JJ	O
peak	NN	O
at	IN	O
1000-2000	CD	O
MW	NNP	O
representing	VBG	O
approximately	RB	O
60	CD	O
%	NN	O
of	IN	O
the	DT	O
mass	NN	O
with	IN	O
a	DT	O
secondary	JJ	O
peak	NN	O
at	IN	O
30,000-40,000	CD	O
MW	NNP	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	O
substantial	JJ	O
fraction	NN	O
at	IN	O
greater	JJR	O
than	IN	O
100,000	CD	O
MW	NNP	O
.	.	O
The	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
exhibit	NN	O
a	DT	O
homogeneous	JJ	O
MW	NNP	O
distribution	NN	O
centered	VBD	O
at	IN	O
1000-2000	CD	O
MW	NNP	O
with	IN	O
less	JJR	O
than	IN	O
10	CD	O
%	NN	O
of	IN	O
the	DT	O
mass	NN	O
greater	JJR	O
than	IN	O
25,000	CD	O
MW	NNP	O
.	.	O
The	DT	O
higher	JJR	O
MW	NNP	O
oligosaccharides	NNS	O
are	VBP	O
not	RB	O
fully	RB	O
converted	VBN	O
to	TO	O
glucose	VB	O
during	IN	O
saccharification	NN	O
.	.	O
Consequently	RB	O
,	,	O
the	DT	O
commercial	JJ	O
amylases	NNS	O
will	MD	O
contain	VB	O
less	JJR	O
dextrose	JJ	O
than	IN	O
saccharified	JJ	O
syrups	NNS	O
from	IN	O
the	DT	O
liquefaction	NN	O
process	NN	O
carried	VBD	O
out	RP	O
by	IN	O
amylase	JJ	O
enzymes	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
,	,	O
such	JJ	O
as	IN	O
that	DT	O
represented	VBD	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
functional	JJ	O
equivalents	NNS	O
thereof	NN	O
.	.	O
Maltodextrins	NNS	O
are	VBP	O
utilized	VBN	O
in	IN	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
food	NN	O
and	CC	O
coating	NN	O
applications	NNS	O
.	.	O
Amylases	NNS	O
from	IN	O
Archeal	NNP	O
sources	NNS	O
generate	VBP	O
an	DT	O
extremely	RB	O
uniform	JJ	O
maltodextrin	NN	O
composition	NN	O
(	(	O
see	VB	O
also	RB	O
Leveque	NNP	B
et	CC	I
al.	NN	I
,	,	I
Enzyme	NNP	I
and	CC	I
Microbial	NNP	I
Technology	NNP	I
26:3-14	CD	I
,	,	I
2000	CD	I
,	,	O
herein	RB	O
incorporated	VBN	O
by	IN	O
reference	NN	O
)	)	O
.	.	O
The	DT	O
use	NN	O
of	IN	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
liquefy	VB	O
corn	NN	O
starch	NN	O
results	NNS	O
in	IN	O
a	DT	O
uniform	JJ	O
maltodextrin	NN	O
composition	NN	O
.	.	O
The	DT	O
liquefaction	NN	O
can	MD	O
be	VB	O
performed	VBN	O
at	IN	O
a	DT	O
pH	NN	O
of	IN	O
about	IN	O
4.5-6.5	JJ	O
,	,	O
and	CC	O
preferably	RB	O
around	IN	O
pH	JJ	O
5.0	CD	O
and	CC	O
at	IN	O
temperatures	NNS	O
of	IN	O
up	IN	O
to	TO	O
105	CD	O
degrees	NNS	O
C.	NNP	O
or	CC	O
higher	JJR	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
liquefaction	NN	O
is	VBZ	O
performed	VBN	O
at	IN	O
a	DT	O
pH	NN	O
of	IN	O
4.5	CD	O
.	.	O
In	IN	O
addition	NN	O
to	TO	O
the	DT	O
benefits	NNS	O
demonstrated	VBN	O
in	IN	O
saccharification	NN	O
,	,	O
the	DT	O
liquefied	JJ	O
syrups	NNS	O
can	MD	O
be	VB	O
carbon	VBN	O
treated	VBN	O
,	,	O
spray	NN	O
dried	VBD	O
and	CC	O
utilized	JJ	O
as	IN	O
food	NN	O
additives	NNS	O
,	,	O
thickeners	NNS	O
,	,	O
low	JJ	O
caloric	NN	O
bulking	NN	O
agents	NNS	O
,	,	O
film	NN	O
forming	VBG	O
agents	NNS	O
,	,	O
etc	FW	O
.	.	O
It	PRP	O
is	VBZ	O
anticipated	VBN	O
(	(	O
but	CC	O
not	RB	O
yet	RB	O
proven	VBN	O
)	)	O
that	IN	O
the	DT	O
homogenous	JJ	O
molecular	JJ	O
weight	NN	O
profile	NN	O
maltodextrins	NNS	O
will	MD	O
have	VB	O
performance	NN	O
advantages	NNS	O
vs.	VBP	O
the	DT	O
bimodal	JJ	O
distribution	NN	O
maltodextrins	NNS	O
produced	VBN	O
by	IN	O
the	DT	O
conventional	JJ	O
Bacillus	NNP	O
enzymes	NNS	O
.	.	O
Definitions	NNS	O
The	DT	O
term	NN	O
“	NNP	O
amylase	NN	O
”	NNP	O
includes	VBZ	O
all	DT	O
polypeptides	NNS	O
,	,	O
e.g.	NN	O
,	,	O
enzymes	NNS	O
,	,	O
which	WDT	O
catalyze	VBP	O
the	DT	O
hydrolysis	NN	O
of	IN	O
starches	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
an	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
includes	VBZ	O
α-amylase	JJ	O
activity	NN	O
,	,	O
including	VBG	O
the	DT	O
ability	NN	O
to	TO	O
hydrolyze	VB	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
to	TO	O
produce	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
α-amylase	JJ	O
activity	NN	O
includes	VBZ	O
hydrolyzing	VBG	O
internal	JJ	O
alpha-1,4-glucosidic	JJ	O
linkages	NNS	O
in	IN	O
starch	NN	O
at	IN	O
random	NN	O
.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
includes	VBZ	O
polypeptides	NNS	O
having	VBG	O
glucoamylase	NN	O
activity	NN	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
ability	NN	O
to	TO	O
hydrolase	VB	O
glucose	JJ	O
polymers	NNS	O
linked	VBN	O
by	IN	O
α-1,4-	JJ	O
and	CC	O
α-1,6-glucosidic	JJ	O
bonds	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
glucoamylase	VBN	O
activity	NN	O
,	,	O
hydrolyzing	VBG	O
internal	JJ	O
α-1,4-glucosidic	JJ	O
linkages	NNS	O
to	TO	O
yield	VB	O
smaller	JJR	O
molecular	JJ	O
weight	VBD	O
malto-dextrins	NNS	O
.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
glucan	JJ	O
1,4-α-glucosidase	JJ	O
activity	NN	O
,	,	O
or	CC	O
,	,	O
1,4-α-D-glucan	JJ	O
glucohydrolase	NN	O
,	,	O
commonly	RB	O
called	VBD	O
glucoamylase	NN	O
but	CC	O
also	RB	O
called	VBD	O
amyloglucosidase	NN	O
and	CC	O
γ-amylase	NN	O
that	DT	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
releases	VBZ	O
β-D-glucose	JJ	O
from	IN	O
1,4-α-	JJ	O
,	,	O
1,6-α-	JJ	O
and	CC	O
1,3-α-linked	JJ	O
glucans	NNS	O
.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
exo-amylase	JJ	O
activity	NN	O
.	.	O
An	DT	O
amylase	NN	O
activity	NN	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
hydrolyzing	VBG	O
starch	NN	O
at	IN	O
high	JJ	O
temperatures	NNS	O
,	,	O
low	JJ	O
temperatures	NNS	O
,	,	O
alkaline	JJ	O
pHs	NN	O
and	CC	O
at	IN	O
acidic	JJ	O
pHs	NN	O
.	.	O
An	DT	O
“	JJ	O
amylase	NN	O
variant	NN	O
”	NN	O
comprises	VBZ	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
which	WDT	O
is	VBZ	O
derived	VBN	O
from	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
a	DT	O
“	NN	O
precursor	NN	O
amylase	NN	O
”	NNP	O
.	.	O
The	DT	O
precursor	NN	O
amylase	NN	O
can	MD	O
include	VB	O
naturally-occurring	JJ	O
amylases	NNS	O
and	CC	O
recombinant	JJ	O
amylases	NNS	O
.	.	O
The	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
amylase	NN	O
variant	NN	O
can	MD	O
be	VB	O
“	VBN	O
derived	JJ	O
”	NN	O
from	IN	O
the	DT	O
precursor	NN	O
amylase	NN	O
amino	NN	O
acid	JJ	O
sequence	NN	O
by	IN	O
the	DT	O
substitution	NN	O
,	,	O
deletion	NN	O
or	CC	O
insertion	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
amino	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
precursor	NN	O
amino	NN	O
acid	JJ	O
sequence	NN	O
.	.	O
Such	JJ	O
modification	NN	O
can	MD	O
be	VB	O
of	IN	O
the	DT	O
“	NNP	O
precursor	NN	O
DNA	NNP	O
sequence	NN	O
”	NN	O
which	WDT	O
encodes	VBZ	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
precursor	NN	O
amylase	NN	O
rather	RB	O
than	IN	O
manipulation	NN	O
of	IN	O
the	DT	O
precursor	NN	O
amylase	NN	O
enzyme	FW	O
per	IN	O
se	NN	O
.	.	O
Suitable	JJ	O
methods	NNS	O
for	IN	O
such	JJ	O
manipulation	NN	O
of	IN	O
the	DT	O
precursor	NN	O
DNA	NNP	O
sequence	NN	O
include	VBP	O
methods	NNS	O
disclosed	VBD	O
herein	RB	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
methods	NNS	O
known	VBN	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Liquefaction	NNP	O
”	NNP	O
or	CC	O
“	NNP	O
liquefy	VBP	O
”	NNP	O
means	VBZ	O
a	DT	O
process	NN	O
by	IN	O
which	WDT	O
starch	NN	O
is	VBZ	O
converted	VBN	O
to	TO	O
shorter	JJR	O
chain	NN	O
and	CC	O
less	RBR	O
viscous	JJ	O
dextrins	NNS	O
.	.	O
Generally	RB	O
,	,	O
this	DT	O
process	NN	O
involves	VBZ	O
gelatinization	NN	O
of	IN	O
starch	NN	O
simultaneously	RB	O
with	IN	O
or	CC	O
followed	VBN	O
by	IN	O
the	DT	O
addition	NN	O
of	IN	O
alpha	JJ	O
amylase	NN	O
.	.	O
In	IN	O
commercial	JJ	O
processes	NNS	O
,	,	O
it	PRP	O
is	VBZ	O
preferred	VBN	O
that	IN	O
the	DT	O
granular	JJ	O
starch	NN	O
is	VBZ	O
derived	VBN	O
from	IN	O
a	DT	O
source	NN	O
comprising	VBG	O
corn	NN	O
,	,	O
wheat	NN	O
,	,	O
milo	NN	O
,	,	O
sorghum	NN	O
,	,	O
rye	NN	O
or	CC	O
bulgher	NN	O
.	.	O
However	RB	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
applies	NNS	O
to	TO	O
any	DT	O
grain	NN	O
starch	NN	O
source	NN	O
which	WDT	O
is	VBZ	O
useful	JJ	O
in	IN	O
liquefaction	NN	O
,	,	O
e.g.	RB	O
,	,	O
any	DT	O
other	JJ	O
grain	NN	O
or	CC	O
vegetable	JJ	O
source	NN	O
known	VBN	O
to	TO	O
produce	VB	O
starch	NN	O
suitable	JJ	O
for	IN	O
liquefaction	NN	O
.	.	O
“	JJ	O
Granular	NNP	O
starch	NN	O
”	NN	O
or	CC	O
“	JJ	O
starch	NN	O
granules	NNS	O
”	VBP	O
means	VBZ	O
a	DT	O
water-insoluble	JJ	O
component	NN	O
of	IN	O
edible	JJ	O
grains	NNS	O
which	WDT	O
remains	VBZ	O
after	IN	O
removal	NN	O
of	IN	O
the	DT	O
hull	NN	O
,	,	O
fiber	NN	O
,	,	O
protein	NN	O
,	,	O
fat	NN	O
,	,	O
germ	NN	O
,	,	O
and	CC	O
solubles	NNS	O
through	IN	O
the	DT	O
steeping	NN	O
,	,	O
mechanical	JJ	O
cracking	NN	O
,	,	O
separations	NNS	O
,	,	O
screening	VBG	O
,	,	O
countercurrent	NN	O
rinsing	NN	O
and	CC	O
centrifugation	NN	O
steps	NNS	O
typical	JJ	O
of	IN	O
the	DT	O
grain	NN	O
wet-milling	JJ	O
process	NN	O
.	.	O
Granular	JJ	O
starch	NN	O
comprises	VBZ	O
intact	JJ	O
starch	NN	O
granules	NNS	O
containing	VBG	O
,	,	O
almost	RB	O
exclusively	RB	O
,	,	O
packed	VBD	O
starch	NN	O
molecules	NNS	O
(	(	O
i.e.	FW	O
,	,	O
amylopectin	NN	O
and	CC	O
amylose	NN	O
)	)	O
.	.	O
In	IN	O
corn	NN	O
,	,	O
the	DT	O
granular	JJ	O
starch	NN	O
component	NN	O
comprises	VBZ	O
about	IN	O
99	CD	O
%	NN	O
starch	NN	O
;	:	O
the	DT	O
remaining	VBG	O
1	CD	O
%	NN	O
being	VBG	O
comprised	VBN	O
of	IN	O
protein	NN	O
,	,	O
fat	NN	O
,	,	O
ash	NN	O
,	,	O
fiber	NN	O
and	CC	O
trace	NN	O
components	NNS	O
tightly	RB	O
associated	VBN	O
with	IN	O
the	DT	O
granules	NNS	O
.	.	O
The	DT	O
packing	NN	O
structure	NN	O
of	IN	O
granular	JJ	O
starch	NN	O
severely	RB	O
retards	VBZ	O
the	DT	O
ability	NN	O
of	IN	O
.alpha.-amylase	NN	O
to	TO	O
hydrolyze	VB	O
starch	NN	O
.	.	O
Gelatinization	NN	O
of	IN	O
the	DT	O
starch	NN	O
is	VBZ	O
utilized	VBN	O
to	TO	O
disrupt	VB	O
the	DT	O
granules	NNS	O
to	TO	O
form	VB	O
a	DT	O
soluble	JJ	O
starch	NN	O
solution	NN	O
and	CC	O
facilitate	VB	O
enzymatic	JJ	O
hydrolysis	NN	O
.	.	O
“	JJ	O
Starch	NNP	O
solution	NN	O
”	NN	O
means	VBZ	O
the	DT	O
water	NN	O
soluble	JJ	O
gelatinized	VBN	O
starch	NN	O
which	WDT	O
results	NNS	O
from	IN	O
heating	VBG	O
granular	JJ	O
starch	NN	O
.	.	O
Upon	IN	O
heating	NN	O
of	IN	O
the	DT	O
granules	NNS	O
to	TO	O
above	VB	O
about	IN	O
72	CD	O
degrees	NNS	O
C.	NNP	O
,	,	O
granular	JJ	O
starch	NN	O
dissociates	VBZ	O
to	TO	O
form	VB	O
an	DT	O
aqueous	JJ	O
mixture	NN	O
of	IN	O
loose	JJ	O
starch	NN	O
molecules	NNS	O
.	.	O
This	DT	O
mixture	NN	O
comprising	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
about	RB	O
75	CD	O
%	NN	O
amylopectin	NN	O
and	CC	O
25	CD	O
%	NN	O
amylose	NN	O
in	IN	O
yellow	JJ	O
dent	NN	O
corn	NN	O
forms	VBZ	O
a	DT	O
viscous	JJ	O
solution	NN	O
in	IN	O
water	NN	O
.	.	O
In	IN	O
commercial	JJ	O
processes	NNS	O
to	TO	O
form	VB	O
glucose	NN	O
or	CC	O
fructose	NN	O
,	,	O
it	PRP	O
is	VBZ	O
the	DT	O
starch	NN	O
solution	NN	O
which	WDT	O
is	VBZ	O
liquefied	VBN	O
to	TO	O
form	VB	O
a	DT	O
soluble	JJ	O
dextrin	JJ	O
solution	NN	O
.	.	O
“	JJ	O
alpha	JJ	O
amylase	NN	O
”	NNP	O
means	VBZ	O
an	DT	O
enzymatic	JJ	O
activity	NN	O
which	WDT	O
cleaves	VBZ	O
or	CC	O
hydrolyzes	VBZ	O
the	DT	O
alpha	NN	O
(	(	O
1-4	JJ	O
)	)	O
glycosidic	JJ	O
bond	NN	O
,	,	O
e.g.	NN	O
,	,	O
that	IN	O
in	IN	O
starch	NN	O
,	,	O
amylopectin	NN	O
or	CC	O
amylose	JJ	O
polymers	NNS	O
.	.	O
Suitable	JJ	O
alpha	NN	O
amylases	NNS	O
are	VBP	O
the	DT	O
naturally	RB	O
occurring	VBG	O
alpha	JJ	O
amylases	NNS	O
as	RB	O
well	RB	O
as	IN	O
recombinant	NN	O
or	CC	O
mutant	NN	O
amylases	NNS	O
which	WDT	O
are	VBP	O
useful	JJ	O
in	IN	O
liquefaction	NN	O
of	IN	O
starch	NN	O
.	.	O
Techniques	NNS	O
for	IN	O
producing	VBG	O
variant	JJ	O
amylases	NNS	O
having	VBG	O
activity	NN	O
at	IN	O
a	DT	O
pH	NN	O
or	CC	O
temperature	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
that	WDT	O
is	VBZ	O
different	JJ	O
from	IN	O
the	DT	O
wild-type	JJ	O
amylase	NN	O
,	,	O
are	VBP	O
included	VBN	O
herein	NN	O
.	.	O
In	IN	O
practicing	VBG	O
the	DT	O
invention	NN	O
,	,	O
the	DT	O
temperature	NN	O
range	NN	O
of	IN	O
the	DT	O
liquefaction	NN	O
can	MD	O
be	VB	O
any	DT	O
liquefaction	NN	O
temperature	NN	O
which	WDT	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
effective	JJ	O
in	IN	O
liquefying	VBG	O
starch	NN	O
.	.	O
The	DT	O
temperature	NN	O
of	IN	O
the	DT	O
starch	NN	O
can	MD	O
be	VB	O
between	IN	O
about	RB	O
80°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
115°	CD	O
C.	NNP	O
,	,	O
or	CC	O
from	IN	O
about	IN	O
100°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
110°	CD	O
C.	NNP	O
,	,	O
and/or	NN	O
from	IN	O
about	IN	O
105°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
108°	CD	O
C.	NNP	O
The	DT	O
term	NN	O
“	NNP	O
antibody	NN	O
”	NNP	O
includes	VBZ	O
a	DT	O
peptide	NN	O
or	CC	O
polypeptide	NN	O
derived	VBN	O
from	IN	O
,	,	O
modeled	VBN	O
after	IN	O
or	CC	O
substantially	RB	O
encoded	VBN	O
by	IN	O
an	DT	O
immunoglobulin	JJ	O
gene	NN	O
or	CC	O
immunoglobulin	NN	O
genes	NNS	O
,	,	O
or	CC	O
fragments	NNS	O
thereof	JJ	O
,	,	O
capable	JJ	O
of	IN	O
specifically	RB	O
binding	VBG	O
an	DT	O
antigen	NN	O
or	CC	O
epitope	NN	O
,	,	O
see	VBP	O
,	,	O
e.g	FW	O
.	.	O
Fundamental	JJ	B
Immunology	NNP	I
,	,	I
Third	NNP	I
Edition	NNP	I
,	,	I
W.	NNP	I
E.	NNP	I
Paul	NNP	I
,	,	I
ed.	NN	I
,	,	I
Raven	NNP	I
Press	NNP	I
,	,	I
N.Y.	NNP	I
(	(	I
1993	CD	I
)	)	I
;	:	O
Wilson	NNP	B
(	(	I
1994	CD	I
)	)	I
J.	NNP	I
Immunol	NNP	I
.	.	I
Methods	NNS	I
175:267-273	CD	I
;	:	O
Yarmush	NNP	B
(	(	I
1992	CD	I
)	)	I
J.	NNP	I
Biochem	NNP	I
.	.	I
Biophys	NNP	I
.	.	I
Methods	NNS	I
25:85-97	CD	I
.	.	O
The	DT	O
term	NN	O
antibody	NN	O
includes	VBZ	O
antigen-binding	JJ	O
portions	NNS	O
,	,	O
i.e.	FW	O
,	,	O
“	FW	O
antigen	NN	O
binding	VBG	O
sites	NNS	O
,	,	O
”	NNP	O
(	(	O
e.g.	NN	O
,	,	O
fragments	NNS	O
,	,	O
subsequences	NNS	O
,	,	O
complementarity	NN	O
determining	VBG	O
regions	NNS	O
(	(	O
CDRs	NNP	O
)	)	O
)	)	O
that	WDT	O
retain	VBP	O
capacity	NN	O
to	TO	O
bind	VB	O
antigen	NN	O
,	,	O
including	VBG	O
(	(	O
i	NN	O
)	)	O
a	DT	O
Fab	NNP	O
fragment	NN	O
,	,	O
a	DT	O
monovalent	JJ	O
fragment	NN	O
consisting	NN	O
of	IN	O
the	DT	O
VL	NNP	O
,	,	O
VH	NNP	O
,	,	O
CL	NNP	O
and	CC	O
CH1	NNP	O
domains	NNS	O
;	:	O
(	(	O
ii	NN	O
)	)	O
a	DT	O
F	NNP	O
(	(	O
ab′	NN	O
)	)	O
2	CD	O
fragment	NN	O
,	,	O
a	DT	O
bivalent	JJ	O
fragment	NN	O
comprising	VBG	O
two	CD	O
Fab	NNP	O
fragments	NNS	O
linked	VBN	O
by	IN	O
a	DT	O
disulfide	NN	O
bridge	NN	O
at	IN	O
the	DT	O
hinge	NN	O
region	NN	O
;	:	O
(	(	O
iii	NN	O
)	)	O
a	DT	O
Fd	NNP	O
fragment	NN	O
consisting	NN	O
of	IN	O
the	DT	O
VH	NNP	O
and	CC	O
CH1	NNP	O
domains	NNS	O
;	:	O
(	(	O
iv	NN	O
)	)	O
a	DT	O
Fv	NNP	O
fragment	NN	O
consisting	NN	O
of	IN	O
the	DT	O
VL	NNP	O
and	CC	O
VH	NNP	O
domains	NNS	O
of	IN	O
a	DT	O
single	JJ	O
arm	NN	O
of	IN	O
an	DT	O
antibody	NN	O
,	,	O
(	(	O
v	NN	O
)	)	O
a	DT	O
dAb	JJ	O
fragment	NN	O
(	(	O
Ward	NNP	B
et	VBZ	I
al.	NN	I
,	,	I
(	(	I
1989	CD	I
)	)	I
Nature	NNP	I
341:544-546	JJ	I
)	)	O
,	,	O
which	WDT	O
consists	VBZ	O
of	IN	O
a	DT	O
VH	NNP	O
domain	NN	O
;	:	O
and	CC	O
(	(	O
vi	NN	O
)	)	O
an	DT	O
isolated	JJ	O
complementarity	NN	O
determining	VBG	O
region	NN	O
(	(	O
CDR	NNP	O
)	)	O
.	.	O
Single	NNP	O
chain	NN	O
antibodies	NNS	O
are	VBP	O
also	RB	O
included	VBN	O
by	IN	O
reference	NN	O
in	IN	O
the	DT	O
term	NN	O
“	NNP	O
antibody.	VBZ	O
”	VBZ	O
The	DT	O
terms	NNS	O
“	VBP	O
array	NN	O
”	NN	O
or	CC	O
“	JJ	O
microarray	NN	O
”	NN	O
or	CC	O
“	JJ	O
biochip	NN	O
”	NN	O
or	CC	O
“	VB	O
chip	NN	O
”	NNP	O
as	IN	O
used	VBN	O
herein	NN	O
is	VBZ	O
a	DT	O
plurality	NN	O
of	IN	O
target	NN	O
elements	NNS	O
,	,	O
each	DT	O
target	NN	O
element	NN	O
comprising	VBG	O
a	DT	O
defined	JJ	O
amount	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
polypeptides	NNS	O
(	(	O
including	VBG	O
antibodies	NNS	O
)	)	O
or	CC	O
nucleic	JJ	O
acids	NNS	O
immobilized	VBN	O
onto	IN	O
a	DT	O
defined	JJ	O
area	NN	O
of	IN	O
a	DT	O
substrate	JJ	O
surface	NN	O
,	,	O
as	IN	O
discussed	VBN	O
in	IN	O
further	JJ	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
the	DT	O
terms	NNS	O
“	VBP	O
computer	NN	O
,	,	O
”	NNP	O
“	NNP	O
computer	NN	O
program	NN	O
”	NN	O
and	CC	O
“	NN	O
processor	NN	O
”	NN	O
are	VBP	O
used	VBN	O
in	IN	O
their	PRP$	O
broadest	JJS	O
general	JJ	O
contexts	NN	O
and	CC	O
incorporate	VB	O
all	DT	O
such	JJ	O
devices	NNS	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
A	DT	O
“	JJ	O
coding	VBG	O
sequence	NN	O
of	IN	O
”	NN	O
or	CC	O
a	DT	O
“	JJ	O
sequence	NN	O
encodes	NNS	O
”	VBP	O
a	DT	O
particular	JJ	O
polypeptide	NN	O
or	CC	O
protein	NN	O
,	,	O
is	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
which	WDT	O
is	VBZ	O
transcribed	VBN	O
and	CC	O
translated	VBN	O
into	IN	O
a	DT	O
polypeptide	NN	O
or	CC	O
protein	NN	O
when	WRB	O
placed	VBN	O
under	IN	O
the	DT	O
control	NN	O
of	IN	O
appropriate	JJ	O
regulatory	JJ	O
sequences	NNS	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
expression	NN	O
cassette	NN	O
”	NNP	O
as	IN	O
used	VBN	O
herein	NN	O
refers	NNS	O
to	TO	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
which	WDT	O
is	VBZ	O
capable	JJ	O
of	IN	O
affecting	VBG	O
expression	NN	O
of	IN	O
a	DT	O
structural	JJ	O
gene	NN	O
(	(	O
i.e.	FW	O
,	,	O
a	DT	O
protein	NN	O
coding	VBG	O
sequence	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
in	IN	O
a	DT	O
host	NN	O
compatible	JJ	O
with	IN	O
such	JJ	O
sequences	NNS	O
.	.	O
Expression	NN	O
cassettes	NNS	O
include	VBP	O
at	IN	O
least	JJS	O
a	DT	O
promoter	NN	O
operably	RB	O
linked	VBN	O
with	IN	O
the	DT	O
polypeptide	NN	O
coding	VBG	O
sequence	NN	O
;	:	O
and	CC	O
,	,	O
optionally	RB	O
,	,	O
with	IN	O
other	JJ	O
sequences	NNS	O
,	,	O
e.g.	NN	O
,	,	O
transcription	NN	O
termination	NN	O
signals	NNS	O
.	.	O
Additional	JJ	O
factors	NNS	O
necessary	JJ	O
or	CC	O
helpful	JJ	O
in	IN	O
effecting	VBG	O
expression	NN	O
may	MD	O
also	RB	O
be	VB	O
used	VBN	O
,	,	O
e.g.	FW	O
,	,	O
enhancers	NNS	O
.	.	O
Thus	RB	O
,	,	O
expression	NN	O
cassettes	NNS	O
also	RB	O
include	VBP	O
plasmids	NNS	O
,	,	O
expression	NN	O
vectors	NNS	O
,	,	O
recombinant	JJ	O
viruses	NNS	O
,	,	O
any	DT	O
form	NN	O
of	IN	O
recombinant	JJ	O
“	NN	O
naked	VBD	O
DNA	NNP	O
”	NNP	O
vector	NN	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
“	NN	O
Operably	RB	O
linked	VBD	O
”	CC	O
as	IN	O
used	VBN	O
herein	NN	O
refers	NNS	O
to	TO	O
a	DT	O
functional	JJ	O
relationship	NN	O
between	IN	O
two	CD	O
or	CC	O
more	JJR	O
nucleic	JJ	O
acid	NN	O
(	(	O
e.g.	JJ	O
,	,	O
DNA	NNP	O
)	)	O
segments	NNS	O
.	.	O
Typically	RB	O
,	,	O
it	PRP	O
refers	VBZ	O
to	TO	O
the	DT	O
functional	JJ	O
relationship	NN	O
of	IN	O
transcriptional	JJ	O
regulatory	JJ	O
sequence	NN	O
to	TO	O
a	DT	O
transcribed	JJ	O
sequence	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
promoter	NN	O
is	VBZ	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
coding	NN	O
sequence	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
if	IN	O
it	PRP	O
stimulates	VBZ	O
or	CC	O
modulates	VBZ	O
the	DT	O
transcription	NN	O
of	IN	O
the	DT	O
coding	VBG	O
sequence	NN	O
in	IN	O
an	DT	O
appropriate	JJ	O
host	NN	O
cell	NN	O
or	CC	O
other	JJ	O
expression	NN	O
system	NN	O
.	.	O
Generally	RB	O
,	,	O
promoter	NN	O
transcriptional	JJ	O
regulatory	JJ	O
sequences	NNS	O
that	WDT	O
are	VBP	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
transcribed	JJ	O
sequence	NN	O
are	VBP	O
physically	RB	O
contiguous	JJ	O
to	TO	O
the	DT	O
transcribed	JJ	O
sequence	NN	O
,	,	O
i.e.	FW	O
,	,	O
they	PRP	O
are	VBP	O
cis-acting	JJ	O
.	.	O
However	RB	O
,	,	O
some	DT	O
transcriptional	JJ	O
regulatory	JJ	O
sequences	NNS	O
,	,	O
such	JJ	O
as	IN	O
enhancers	NNS	O
,	,	O
need	MD	O
not	RB	O
be	VB	O
physically	RB	O
contiguous	JJ	O
or	CC	O
located	VBN	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
the	DT	O
coding	NN	O
sequences	NNS	O
whose	WP$	O
transcription	NN	O
they	PRP	O
enhance	VBP	O
.	.	O
A	DT	O
“	JJ	O
vector	NN	O
”	NN	O
comprises	VBZ	O
a	DT	O
nucleic	NN	O
acid	NN	O
which	WDT	O
can	MD	O
infect	VB	O
,	,	O
transfect	VB	O
,	,	O
transiently	RB	O
or	CC	O
permanently	RB	O
transduce	VB	O
a	DT	O
cell	NN	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
recognized	VBN	O
that	IN	O
a	DT	O
vector	NN	O
can	MD	O
be	VB	O
a	DT	O
naked	JJ	O
nucleic	JJ	O
acid	NN	O
,	,	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	NN	O
complexed	NN	O
with	IN	O
protein	NN	O
or	CC	O
lipid	NN	O
.	.	O
The	DT	O
vector	NN	O
optionally	RB	O
comprises	VBZ	O
viral	JJ	O
or	CC	O
bacterial	JJ	O
nucleic	JJ	O
acids	NNS	O
and/or	NN	O
proteins	NNS	O
,	,	O
and/or	JJ	O
membranes	NNS	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
cell	NN	O
membrane	NN	O
,	,	O
a	DT	O
viral	JJ	O
lipid	JJ	O
envelope	NN	O
,	,	O
etc	FW	O
.	.	O
)	)	O
.	.	O
Vectors	NNS	O
include	VBP	O
,	,	O
but	CC	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
replicons	NNS	O
(	(	O
e.g.	NN	O
,	,	O
RNA	NNP	O
replicons	NNS	O
,	,	O
bacteriophages	NNS	O
)	)	O
to	TO	O
which	WDT	O
fragments	NNS	O
of	IN	O
DNA	NN	O
may	MD	O
be	VB	O
attached	VBN	O
and	CC	O
become	VBN	O
replicated	JJ	O
.	.	O
Vectors	NNS	O
thus	RB	O
include	VBP	O
,	,	O
but	CC	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
RNA	NNP	O
,	,	O
autonomous	JJ	O
self-replicating	JJ	O
circular	NN	O
or	CC	O
linear	JJ	O
DNA	NN	O
or	CC	O
RNA	NNP	O
(	(	O
e.g.	NN	O
,	,	O
plasmids	NNS	O
,	,	O
viruses	NNS	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
,	,	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,217,879	CD	O
)	)	O
,	,	O
and	CC	O
include	VBP	O
both	DT	O
the	DT	O
expression	NN	O
and	CC	O
non-expression	JJ	O
plasmids	NNS	O
.	.	O
Where	WRB	O
a	DT	O
recombinant	JJ	O
microorganism	NN	O
or	CC	O
cell	NN	O
culture	NN	O
is	VBZ	O
described	VBN	O
as	IN	O
hosting	VBG	O
an	DT	O
“	JJ	O
expression	NN	O
vector	NN	O
”	NN	O
this	DT	O
includes	VBZ	O
both	DT	O
extra-chromosomal	JJ	O
circular	NN	O
and	CC	O
linear	JJ	O
DNA	NNP	O
and	CC	O
DNA	NNP	O
that	WDT	O
has	VBZ	O
been	VBN	O
incorporated	VBN	O
into	IN	O
the	DT	O
host	NN	O
chromosome	NN	O
(	(	O
s	NN	O
)	)	O
.	.	O
Where	WRB	O
a	DT	O
vector	NN	O
is	VBZ	O
being	VBG	O
maintained	VBN	O
by	IN	O
a	DT	O
host	NN	O
cell	NN	O
,	,	O
the	DT	O
vector	NN	O
may	MD	O
either	RB	O
be	VB	O
stably	RB	O
replicated	VBN	O
by	IN	O
the	DT	O
cells	NNS	O
during	IN	O
mitosis	NN	O
as	IN	O
an	DT	O
autonomous	JJ	O
structure	NN	O
,	,	O
or	CC	O
is	VBZ	O
incorporated	VBN	O
within	IN	O
the	DT	O
host	NN	O
's	POS	O
genome	NN	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
the	DT	O
term	NN	O
“	NNP	O
promoter	NN	O
”	NNP	O
includes	VBZ	O
all	DT	O
sequences	NNS	O
capable	JJ	O
of	IN	O
driving	VBG	O
transcription	NN	O
of	IN	O
a	DT	O
coding	VBG	O
sequence	NN	O
in	IN	O
a	DT	O
cell	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
plant	NN	O
cell	NN	O
.	.	O
Thus	RB	O
,	,	O
promoters	NNS	O
used	VBD	O
in	IN	O
the	DT	O
constructs	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
cis-acting	JJ	O
transcriptional	JJ	O
control	NN	O
elements	NNS	O
and	CC	O
regulatory	JJ	O
sequences	NNS	O
that	WDT	O
are	VBP	O
involved	VBN	O
in	IN	O
regulating	VBG	O
or	CC	O
modulating	VBG	O
the	DT	O
timing	NN	O
and/or	JJ	O
rate	NN	O
of	IN	O
transcription	NN	O
of	IN	O
a	DT	O
gene	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
promoter	NN	O
can	MD	O
be	VB	O
a	DT	O
cis-acting	JJ	O
transcriptional	JJ	O
control	NN	O
element	NN	O
,	,	O
including	VBG	O
an	DT	O
enhancer	NN	O
,	,	O
a	DT	O
promoter	NN	O
,	,	O
a	DT	O
transcription	NN	O
terminator	NN	O
,	,	O
an	DT	O
origin	NN	O
of	IN	O
replication	NN	O
,	,	O
a	DT	O
chromosomal	JJ	O
integration	NN	O
sequence	NN	O
,	,	O
5′	CD	O
and	CC	O
3′	CD	O
untranslated	JJ	O
regions	NNS	O
,	,	O
or	CC	O
an	DT	O
intronic	JJ	O
sequence	NN	O
,	,	O
which	WDT	O
are	VBP	O
involved	VBN	O
in	IN	O
transcriptional	JJ	O
regulation	NN	O
.	.	O
These	DT	O
cis-acting	JJ	O
sequences	NNS	O
typically	RB	O
interact	VBP	O
with	IN	O
proteins	NNS	O
or	CC	O
other	JJ	O
biomolecules	NNS	O
to	TO	O
carry	VB	O
out	RP	O
(	(	O
turn	VB	O
on/off	RP	O
,	,	O
regulate	NN	O
,	,	O
modulate	NN	O
,	,	O
etc	FW	O
.	.	O
)	)	O
transcription	NN	O
.	.	O
“	RB	O
Constitutive	NNP	O
”	NN	O
promoters	NNS	O
are	VBP	O
those	DT	O
that	IN	O
drive	JJ	O
expression	NN	O
continuously	RB	O
under	IN	O
most	JJS	O
environmental	JJ	O
conditions	NNS	O
and	CC	O
states	NNS	O
of	IN	O
development	NN	O
or	CC	O
cell	NN	O
differentiation	NN	O
.	.	O
“	NN	O
Inducible	JJ	O
”	NN	O
or	CC	O
“	NN	O
regulatable	JJ	O
”	NN	O
promoters	NNS	O
direct	JJ	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
under	IN	O
the	DT	O
influence	NN	O
of	IN	O
environmental	JJ	O
conditions	NNS	O
or	CC	O
developmental	JJ	O
conditions	NNS	O
.	.	O
Examples	NNS	O
of	IN	O
environmental	JJ	O
conditions	NNS	O
that	WDT	O
may	MD	O
affect	VB	O
transcription	NN	O
by	IN	O
inducible	JJ	O
promoters	NNS	O
include	VBP	O
anaerobic	JJ	O
conditions	NNS	O
,	,	O
elevated	VBN	O
temperature	NN	O
,	,	O
drought	NN	O
,	,	O
or	CC	O
the	DT	O
presence	NN	O
of	IN	O
light	NN	O
.	.	O
“	JJ	O
Tissue-specific	NNP	O
”	NN	O
promoters	NNS	O
are	VBP	O
transcriptional	JJ	O
control	NN	O
elements	NNS	O
that	WDT	O
are	VBP	O
only	RB	O
active	JJ	O
in	IN	O
particular	JJ	O
cells	NNS	O
or	CC	O
tissues	NNS	O
or	CC	O
organs	NNS	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
plants	NNS	O
or	CC	O
animals	NNS	O
.	.	O
Tissue-specific	JJ	O
regulation	NN	O
may	MD	O
be	VB	O
achieved	VBN	O
by	IN	O
certain	JJ	O
intrinsic	JJ	O
factors	NNS	O
which	WDT	O
ensure	VB	O
that	IN	O
genes	NNS	O
encoding	VBG	O
proteins	NNS	O
specific	JJ	O
to	TO	O
a	DT	O
given	VBN	O
tissue	NN	O
are	VBP	O
expressed	VBN	O
.	.	O
Such	JJ	O
factors	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
exist	VB	O
in	IN	O
mammals	NNS	O
and	CC	O
plants	NNS	O
so	RB	O
as	IN	O
to	TO	O
allow	VB	O
for	IN	O
specific	JJ	O
tissues	NNS	O
to	TO	O
develop	VB	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
plant	NN	O
”	NNP	O
includes	VBZ	O
whole	JJ	O
plants	NNS	O
,	,	O
plant	NN	O
parts	NNS	O
(	(	O
e.g.	NN	O
,	,	O
leaves	VBZ	O
,	,	O
stems	VBZ	O
,	,	O
flowers	NNS	O
,	,	O
roots	NNS	O
,	,	O
etc	FW	O
.	.	O
)	)	O
,	,	O
plant	NN	O
protoplasts	NNS	O
,	,	O
seeds	NNS	O
and	CC	O
plant	NN	O
cells	NNS	O
and	CC	O
progeny	NN	O
of	IN	O
same	JJ	O
.	.	O
The	DT	O
class	NN	O
of	IN	O
plants	NNS	O
which	WDT	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
method	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
generally	RB	O
as	RB	O
broad	JJ	O
as	IN	O
the	DT	O
class	NN	O
of	IN	O
higher	JJR	O
plants	NNS	O
amenable	JJ	O
to	TO	O
transformation	NN	O
techniques	NNS	O
,	,	O
including	VBG	O
angiosperms	NNS	O
(	(	O
monocotyledonous	JJ	O
and	CC	O
dicotyledonous	JJ	O
plants	NNS	O
)	)	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
gymnosperms	NNS	O
.	.	O
It	PRP	O
includes	VBZ	O
plants	NNS	O
of	IN	O
a	DT	O
variety	NN	O
of	IN	O
ploidy	NN	O
levels	NNS	O
,	,	O
including	VBG	O
polyploid	NN	O
,	,	O
diploid	NN	O
,	,	O
haploid	NN	O
and	CC	O
hemizygous	JJ	O
states	NNS	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
the	DT	O
term	NN	O
“	NNP	O
transgenic	NN	O
plant	NN	O
”	NNP	O
includes	VBZ	O
plants	NNS	O
or	CC	O
plant	NN	O
cells	NNS	O
into	IN	O
which	WDT	O
a	DT	O
heterologous	JJ	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
has	VBZ	O
been	VBN	O
inserted	VBN	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
and	CC	O
various	JJ	O
recombinant	JJ	O
constructs	NNS	O
(	(	O
e.g.	NN	O
,	,	O
expression	NN	O
cassettes	NNS	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
“	JJ	O
Plasmids	NNP	O
”	NN	O
can	MD	O
be	VB	O
commercially	RB	O
available	JJ	O
,	,	O
publicly	RB	O
available	JJ	O
on	IN	O
an	DT	O
unrestricted	JJ	O
basis	NN	O
,	,	O
or	CC	O
can	MD	O
be	VB	O
constructed	VBN	O
from	IN	O
available	JJ	O
plasmids	NNS	O
in	IN	O
accord	NN	O
with	IN	O
published	JJ	O
procedures	NNS	O
.	.	O
Equivalent	JJ	O
plasmids	NNS	O
to	TO	O
those	DT	O
described	VBN	O
herein	NNS	O
are	VBP	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
and	CC	O
will	MD	O
be	VB	O
apparent	JJ	O
to	TO	O
the	DT	O
ordinarily	RB	O
skilled	VBN	O
artisan	NN	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
gene	NN	O
”	NNP	O
includes	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
comprising	VBG	O
a	DT	O
segment	NN	O
of	IN	O
DNA	NNP	O
involved	VBN	O
in	IN	O
producing	VBG	O
a	DT	O
transcription	NN	O
product	NN	O
(	(	O
e.g.	JJ	O
,	,	O
a	DT	O
message	NN	O
)	)	O
,	,	O
which	WDT	O
in	IN	O
turn	NN	O
is	VBZ	O
translated	VBN	O
to	TO	O
produce	VB	O
a	DT	O
polypeptide	NN	O
chain	NN	O
,	,	O
or	CC	O
regulates	VBZ	O
gene	NN	O
transcription	NN	O
,	,	O
reproduction	NN	O
or	CC	O
stability	NN	O
.	.	O
Genes	NNS	O
can	MD	O
include	VB	O
regions	NNS	O
preceding	VBG	O
and	CC	O
following	VBG	O
the	DT	O
coding	VBG	O
region	NN	O
,	,	O
such	JJ	O
as	IN	O
leader	NN	O
and	CC	O
trailer	NN	O
,	,	O
promoters	NNS	O
and	CC	O
enhancers	NNS	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
,	,	O
where	WRB	O
applicable	JJ	O
,	,	O
intervening	JJ	O
sequences	NNS	O
(	(	O
introns	NNS	O
)	)	O
between	IN	O
individual	JJ	O
coding	NN	O
segments	NNS	O
(	(	O
exons	NNS	O
)	)	O
.	.	O
The	DT	O
phrases	NNS	O
“	VBP	O
nucleic	JJ	O
acid	NN	O
”	NN	O
or	CC	O
“	VB	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
”	NNP	O
includes	VBZ	O
oligonucleotide	RB	O
,	,	O
nucleotide	RB	O
,	,	O
polynucleotide	NN	O
,	,	O
or	CC	O
to	TO	O
a	DT	O
fragment	NN	O
of	IN	O
any	DT	O
of	IN	O
these	DT	O
,	,	O
to	TO	O
DNA	NNP	O
or	CC	O
RNA	NNP	O
(	(	O
e.g.	NN	O
,	,	O
mRNA	NN	O
,	,	O
rRNA	NN	O
,	,	O
tRNA	NN	O
)	)	O
of	IN	O
genomic	NN	O
or	CC	O
synthetic	JJ	O
origin	NN	O
which	WDT	O
may	MD	O
be	VB	O
single-stranded	JJ	O
or	CC	O
double-stranded	JJ	O
and	CC	O
may	MD	O
represent	VB	O
a	DT	O
sense	NN	O
or	CC	O
antisense	NN	O
strand	NN	O
,	,	O
to	TO	O
peptide	VB	O
nucleic	JJ	O
acid	NN	O
(	(	O
PNA	NNP	O
)	)	O
,	,	O
or	CC	O
to	TO	O
any	DT	O
DNA-like	JJ	O
or	CC	O
RNA-like	JJ	O
material	NN	O
,	,	O
natural	JJ	O
or	CC	O
synthetic	JJ	O
in	IN	O
origin	NN	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
iRNA	NN	O
,	,	O
ribonucleoproteins	NNS	O
(	(	O
e.g.	NN	O
,	,	O
iRNPs	NN	O
)	)	O
.	.	O
The	DT	O
term	NN	O
encompasses	VBZ	O
nucleic	JJ	O
acids	NNS	O
,	,	O
i.e.	FW	O
,	,	O
oligonucleotides	NNS	O
,	,	O
containing	VBG	O
known	VBN	O
analogues	NNS	O
of	IN	O
natural	JJ	O
nucleotides	NNS	O
.	.	O
The	DT	O
term	NN	O
also	RB	O
encompasses	VBZ	O
nucleic-acid-like	JJ	O
structures	NNS	O
with	IN	O
synthetic	JJ	O
backbones	NNS	O
,	,	O
see	VBP	O
e.g.	RB	O
,	,	O
Mata	NNP	B
(	(	I
1997	CD	I
)	)	I
Toxicol	NNP	I
.	.	I
Appl	NNP	I
.	.	I
Pharmacol	NNP	I
.	.	I
144:189-197	JJ	I
;	:	O
Strauss-Soukup	NNP	B
(	(	I
1997	CD	I
)	)	I
Biochemistry	NNP	I
36:8692-8698	CD	I
;	:	O
Samstag	NNP	B
(	(	I
1996	CD	I
)	)	I
Antisense	NNP	I
Nucleic	NNP	I
Acid	NNP	I
Drug	NNP	I
Dev	NNP	I
6:153-156	NN	I
.	.	O
“	NN	O
Amino	NNP	O
acid	VBZ	O
”	CD	O
or	CC	O
“	VB	O
amino	JJ	O
acid	JJ	O
sequence	NN	O
”	NNP	O
include	VBP	O
an	DT	O
oligopeptide	NN	O
,	,	O
peptide	NN	O
,	,	O
polypeptide	NN	O
,	,	O
or	CC	O
protein	NN	O
sequence	NN	O
,	,	O
or	CC	O
to	TO	O
a	DT	O
fragment	NN	O
,	,	O
portion	NN	O
,	,	O
or	CC	O
subunit	NN	O
of	IN	O
any	DT	O
of	IN	O
these	DT	O
,	,	O
and	CC	O
to	TO	O
naturally	RB	O
occurring	VBG	O
or	CC	O
synthetic	JJ	O
molecules	NNS	O
.	.	O
The	DT	O
terms	NNS	O
“	VBP	O
polypeptide	NN	O
”	NN	O
and	CC	O
“	NNP	O
protein	VBP	O
”	NNP	O
include	VBP	O
amino	JJ	O
acids	NNS	O
joined	VBD	O
to	TO	O
each	DT	O
other	JJ	O
by	IN	O
peptide	JJ	O
bonds	NNS	O
or	CC	O
modified	VBN	O
peptide	JJ	O
bonds	NNS	O
,	,	O
i.e.	NN	O
,	,	O
peptide	NN	O
isosteres	NNS	O
,	,	O
and	CC	O
may	MD	O
contain	VB	O
modified	JJ	O
amino	NN	O
acids	VBZ	O
other	JJ	O
than	IN	O
the	DT	O
20	CD	O
gene-encoded	JJ	O
amino	NN	O
acids	NNS	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
polypeptide	NN	O
”	NNP	O
also	RB	O
includes	VBZ	O
peptides	NNS	O
and	CC	O
polypeptide	NN	O
fragments	NNS	O
,	,	O
motifs	NNS	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
The	DT	O
term	NN	O
also	RB	O
includes	VBZ	O
glycosylated	JJ	O
polypeptides	NNS	O
.	.	O
The	DT	O
peptides	NNS	O
and	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
also	RB	O
include	VBP	O
all	DT	O
“	NNP	O
mimetic	JJ	O
”	NN	O
and	CC	O
“	NNP	O
peptidomimetic	JJ	O
”	NN	O
forms	NNS	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
further	JJ	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
isolated	VBD	O
”	NNP	O
includes	VBZ	O
a	DT	O
material	NN	O
removed	VBN	O
from	IN	O
its	PRP$	O
original	JJ	O
environment	NN	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
natural	JJ	O
environment	NN	O
if	IN	O
it	PRP	O
is	VBZ	O
naturally	RB	O
occurring	VBG	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
naturally	RB	O
occurring	VBG	O
polynucleotide	NN	O
or	CC	O
polypeptide	JJ	O
present	NN	O
in	IN	O
a	DT	O
living	NN	O
animal	NN	O
is	VBZ	O
not	RB	O
isolated	JJ	O
,	,	O
but	CC	O
the	DT	O
same	JJ	O
polynucleotide	NN	O
or	CC	O
polypeptide	NN	O
,	,	O
separated	VBN	O
from	IN	O
some	DT	O
or	CC	O
all	DT	O
of	IN	O
the	DT	O
coexisting	NN	O
materials	NNS	O
in	IN	O
the	DT	O
natural	JJ	O
system	NN	O
,	,	O
is	VBZ	O
isolated	VBN	O
.	.	O
Such	JJ	O
polynucleotides	NNS	O
could	MD	O
be	VB	O
part	NN	O
of	IN	O
a	DT	O
vector	NN	O
and/or	NN	O
such	JJ	O
polynucleotides	NNS	O
or	CC	O
polypeptides	NNS	O
could	MD	O
be	VB	O
part	NN	O
of	IN	O
a	DT	O
composition	NN	O
,	,	O
and	CC	O
still	RB	O
be	VB	O
isolated	VBN	O
in	IN	O
that	DT	O
such	JJ	O
vector	NN	O
or	CC	O
composition	NN	O
is	VBZ	O
not	RB	O
part	NN	O
of	IN	O
its	PRP$	O
natural	JJ	O
environment	NN	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
an	DT	O
isolated	JJ	O
material	NN	O
or	CC	O
composition	NN	O
can	MD	O
also	RB	O
be	VB	O
a	DT	O
“	JJ	O
purified	JJ	O
”	NN	O
composition	NN	O
,	,	O
i.e.	FW	O
,	,	O
it	PRP	O
does	VBZ	O
not	RB	O
require	VB	O
absolute	JJ	O
purity	NN	O
;	:	O
rather	RB	O
,	,	O
it	PRP	O
is	VBZ	O
intended	VBN	O
as	IN	O
a	DT	O
relative	JJ	O
definition	NN	O
.	.	O
Individual	JJ	O
nucleic	JJ	O
acids	NNS	O
obtained	VBN	O
from	IN	O
a	DT	O
library	NN	O
can	MD	O
be	VB	O
conventionally	RB	O
purified	VBN	O
to	TO	O
electrophoretic	JJ	O
homogeneity	NN	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
nucleic	JJ	O
acids	NNS	O
which	WDT	O
have	VBP	O
been	VBN	O
purified	VBN	O
from	IN	O
genomic	JJ	O
DNA	NN	O
or	CC	O
from	IN	O
other	JJ	O
sequences	NNS	O
in	IN	O
a	DT	O
library	NN	O
or	CC	O
other	JJ	O
environment	NN	O
by	IN	O
at	IN	O
least	JJS	O
one	CD	O
,	,	O
two	CD	O
,	,	O
three	CD	O
,	,	O
four	CD	O
,	,	O
five	CD	O
or	CC	O
more	JJR	O
orders	NNS	O
of	IN	O
magnitude	NN	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
the	DT	O
term	NN	O
“	NNP	O
recombinant	NN	O
”	NN	O
can	MD	O
include	VB	O
nucleic	JJ	O
acids	NNS	O
adjacent	NN	O
to	TO	O
a	DT	O
“	NNP	O
backbone	NN	O
”	NNP	O
nucleic	RB	O
acid	VBZ	O
to	TO	O
which	WDT	O
it	PRP	O
is	VBZ	O
not	RB	O
adjacent	JJ	O
in	IN	O
its	PRP$	O
natural	JJ	O
environment	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
represent	VBP	O
5	CD	O
%	NN	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
number	NN	O
of	IN	O
nucleic	JJ	O
acid	NN	O
inserts	NNS	O
in	IN	O
a	DT	O
population	NN	O
of	IN	O
nucleic	JJ	O
acid	NN	O
“	NNP	O
backbone	NN	O
molecules.	NN	O
”	NNP	O
“	NNP	O
Backbone	NNP	O
molecules	VBZ	O
”	RB	O
according	VBG	O
to	TO	O
the	DT	O
invention	NN	O
include	VBP	O
nucleic	JJ	O
acids	NNS	O
such	JJ	O
as	IN	O
expression	NN	O
vectors	NNS	O
,	,	O
self-replicating	JJ	O
nucleic	JJ	O
acids	NNS	O
,	,	O
viruses	NNS	O
,	,	O
integrating	VBG	O
nucleic	JJ	O
acids	NNS	O
,	,	O
and	CC	O
other	JJ	O
vectors	NNS	O
or	CC	O
nucleic	JJ	O
acids	NNS	O
used	VBN	O
to	TO	O
maintain	VB	O
or	CC	O
manipulate	VB	O
a	DT	O
nucleic	JJ	O
acid	NN	O
insert	NN	O
of	IN	O
interest	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
enriched	JJ	O
nucleic	JJ	O
acids	NNS	O
represent	VBP	O
10	CD	O
%	NN	O
,	,	O
15	CD	O
%	NN	O
,	,	O
20	CD	O
%	NN	O
,	,	O
30	CD	O
%	NN	O
,	,	O
40	CD	O
%	NN	O
,	,	O
50	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
number	NN	O
of	IN	O
nucleic	JJ	O
acid	NN	O
inserts	NNS	O
in	IN	O
the	DT	O
population	NN	O
of	IN	O
recombinant	JJ	O
backbone	NN	O
molecules	NNS	O
.	.	O
“	NN	O
Recombinant	NNP	O
”	NNP	O
polypeptides	VBZ	O
or	CC	O
proteins	VBZ	O
refer	VBP	O
to	TO	O
polypeptides	NNS	O
or	CC	O
proteins	NNS	O
produced	VBN	O
by	IN	O
recombinant	JJ	O
DNA	NNP	O
techniques	NNS	O
;	:	O
e.g.	CC	O
,	,	O
produced	VBN	O
from	IN	O
cells	NNS	O
transformed	VBN	O
by	IN	O
an	DT	O
exogenous	JJ	O
DNA	NNP	O
construct	NN	O
encoding	VBG	O
the	DT	O
desired	JJ	O
polypeptide	NN	O
or	CC	O
protein	NN	O
.	.	O
“	JJ	O
Synthetic	NNP	O
”	NNP	O
polypeptides	VBZ	O
or	CC	O
protein	NN	O
are	VBP	O
those	DT	O
prepared	JJ	O
by	IN	O
chemical	JJ	O
synthesis	NN	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
further	JJ	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
A	DT	O
promoter	NN	O
sequence	NN	O
can	MD	O
be	VB	O
“	VBN	O
operably	RB	O
linked	VBN	O
to	TO	O
”	VB	O
a	DT	O
coding	NN	O
sequence	NN	O
when	WRB	O
RNA	NNP	O
polymerase	NN	O
which	WDT	O
initiates	VBZ	O
transcription	NN	O
at	IN	O
the	DT	O
promoter	NN	O
will	MD	O
transcribe	VB	O
the	DT	O
coding	NN	O
sequence	NN	O
into	IN	O
mRNA	NN	O
,	,	O
as	IN	O
discussed	VBN	O
further	RB	O
,	,	O
below	IN	O
.	.	O
“	JJ	O
Oligonucleotide	NNP	O
”	NNP	O
includes	VBZ	O
either	CC	O
a	DT	O
single	JJ	O
stranded	JJ	O
polydeoxynucleotide	NN	O
or	CC	O
two	CD	O
complementary	JJ	O
polydeoxynucleotide	NN	O
strands	NNS	O
which	WDT	O
may	MD	O
be	VB	O
chemically	RB	O
synthesized	VBN	O
.	.	O
Such	JJ	O
synthetic	JJ	O
oligonucleotides	NNS	O
have	VBP	O
no	DT	O
5′	JJ	O
phosphate	NN	O
and	CC	O
thus	RB	O
will	MD	O
not	RB	O
ligate	VB	O
to	TO	O
another	DT	O
oligonucleotide	NN	O
without	IN	O
adding	VBG	O
a	DT	O
phosphate	NN	O
with	IN	O
an	DT	O
ATP	NNP	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
kinase	NN	O
.	.	O
A	DT	O
synthetic	JJ	O
oligonucleotide	NN	O
can	MD	O
ligate	VB	O
to	TO	O
a	DT	O
fragment	NN	O
that	WDT	O
has	VBZ	O
not	RB	O
been	VBN	O
dephosphorylated	VBN	O
.	.	O
The	DT	O
phrase	NN	O
“	NNP	O
substantially	RB	O
identical	JJ	O
”	NN	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
two	CD	O
nucleic	JJ	O
acids	NNS	O
or	CC	O
polypeptides	NNS	O
,	,	O
can	MD	O
refer	VB	O
to	TO	O
two	CD	O
or	CC	O
more	JJR	O
sequences	NNS	O
that	WDT	O
have	VBP	O
,	,	O
e.g.	FW	O
,	,	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
nucleotide	JJ	O
or	CC	O
amino	JJ	O
acid	NNS	O
residue	JJ	O
(	(	O
sequence	NN	O
)	)	O
identity	NN	O
,	,	O
when	WRB	O
compared	VBN	O
and	CC	O
aligned	VBN	O
for	IN	O
maximum	JJ	O
correspondence	NN	O
,	,	O
as	IN	O
measured	VBN	O
using	VBG	O
one	CD	O
any	DT	O
known	JJ	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
,	,	O
as	IN	O
discussed	VBN	O
in	IN	O
detail	NN	O
below	NN	O
,	,	O
or	CC	O
by	IN	O
visual	JJ	O
inspection	NN	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
nucleic	JJ	O
acid	NN	O
and	CC	O
polypeptide	NN	O
sequences	NNS	O
having	VBG	O
substantial	JJ	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
20	CD	O
,	,	O
30	CD	O
,	,	O
40	CD	O
,	,	O
50	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
,	,	O
or	CC	O
a	DT	O
region	NN	O
ranging	VBG	O
from	IN	O
between	IN	O
about	IN	O
50	CD	O
residues	NNS	O
to	TO	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
or	CC	O
polypeptide	NN	O
.	.	O
Nucleic	NNP	O
acid	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
substantially	RB	O
identical	JJ	O
over	IN	O
the	DT	O
entire	JJ	O
length	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
coding	VBG	O
region	NN	O
.	.	O
A	DT	O
“	NNP	O
substantially	RB	O
identical	JJ	O
”	NNP	O
amino	NN	O
acid	NN	O
sequence	NN	O
also	RB	O
can	MD	O
include	VB	O
a	DT	O
sequence	NN	O
that	WDT	O
differs	VBZ	O
from	IN	O
a	DT	O
reference	NN	O
sequence	NN	O
by	IN	O
one	CD	O
or	CC	O
more	RBR	O
conservative	JJ	O
or	CC	O
non-conservative	JJ	O
amino	NN	O
acid	NN	O
substitutions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
or	CC	O
insertions	NNS	O
,	,	O
particularly	RB	O
when	WRB	O
such	JJ	O
a	DT	O
substitution	NN	O
occurs	VBZ	O
at	IN	O
a	DT	O
site	NN	O
that	WDT	O
is	VBZ	O
not	RB	O
the	DT	O
active	JJ	O
site	NN	O
of	IN	O
the	DT	O
molecule	NN	O
,	,	O
and	CC	O
provided	VBD	O
that	IN	O
the	DT	O
polypeptide	NN	O
essentially	RB	O
retains	VBZ	O
its	PRP$	O
functional	JJ	O
properties	NNS	O
.	.	O
A	DT	O
conservative	JJ	O
amino	NN	O
acid	JJ	O
substitution	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
substitutes	VBZ	O
one	CD	O
amino	NN	O
acid	NN	O
for	IN	O
another	DT	O
of	IN	O
the	DT	O
same	JJ	O
class	NN	O
(	(	O
e.g.	JJ	O
,	,	O
substitution	NN	O
of	IN	O
one	CD	O
hydrophobic	NN	O
amino	NN	O
acid	NN	O
,	,	O
such	JJ	O
as	IN	O
isoleucine	NN	O
,	,	O
valine	NN	O
,	,	O
leucine	NN	O
,	,	O
or	CC	O
methionine	NN	O
,	,	O
for	IN	O
another	DT	O
,	,	O
or	CC	O
substitution	NN	O
of	IN	O
one	CD	O
polar	NN	O
amino	NN	O
acid	NN	O
for	IN	O
another	DT	O
,	,	O
such	JJ	O
as	IN	O
substitution	NN	O
of	IN	O
arginine	NN	O
for	IN	O
lysine	NN	O
,	,	O
glutamic	JJ	O
acid	NN	O
for	IN	O
aspartic	JJ	O
acid	NN	O
or	CC	O
glutamine	NN	O
for	IN	O
asparagine	NN	O
)	)	O
.	.	O
One	CD	O
or	CC	O
more	JJR	O
amino	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
deleted	VBN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
from	IN	O
an	DT	O
amylase	NN	O
,	,	O
resulting	VBG	O
in	IN	O
modification	NN	O
of	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
,	,	O
without	IN	O
significantly	RB	O
altering	VBG	O
its	PRP$	O
biological	JJ	O
activity	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
amino-	JJ	O
or	CC	O
carboxyl-terminal	JJ	O
amino	NN	O
acids	NNS	O
that	WDT	O
are	VBP	O
not	RB	O
required	VBN	O
for	IN	O
amylase	NN	O
activity	NN	O
can	MD	O
be	VB	O
removed	VBN	O
.	.	O
“	JJ	O
Hybridization	NNP	O
”	NNP	O
includes	VBZ	O
the	DT	O
process	NN	O
by	IN	O
which	WDT	O
a	DT	O
nucleic	NN	O
acid	NN	O
strand	NN	O
joins	VBZ	O
with	IN	O
a	DT	O
complementary	JJ	O
strand	NN	O
through	IN	O
base	NN	O
pairing	NN	O
.	.	O
Hybridization	NN	O
reactions	NNS	O
can	MD	O
be	VB	O
sensitive	JJ	O
and	CC	O
selective	JJ	O
so	RB	O
that	IN	O
a	DT	O
particular	JJ	O
sequence	NN	O
of	IN	O
interest	NN	O
can	MD	O
be	VB	O
identified	VBN	O
even	RB	O
in	IN	O
samples	NNS	O
in	IN	O
which	WDT	O
it	PRP	O
is	VBZ	O
present	JJ	O
at	IN	O
low	JJ	O
concentrations	NNS	O
.	.	O
Stringent	JJ	O
conditions	NNS	O
can	MD	O
be	VB	O
defined	VBN	O
by	IN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
the	DT	O
concentrations	NNS	O
of	IN	O
salt	NN	O
or	CC	O
formamide	NN	O
in	IN	O
the	DT	O
prehybridization	NN	O
and	CC	O
hybridization	NN	O
solutions	NNS	O
,	,	O
or	CC	O
by	IN	O
the	DT	O
hybridization	NN	O
temperature	NN	O
,	,	O
and	CC	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
stringency	NN	O
can	MD	O
be	VB	O
increased	VBN	O
by	IN	O
reducing	VBG	O
the	DT	O
concentration	NN	O
of	IN	O
salt	NN	O
,	,	O
increasing	VBG	O
the	DT	O
concentration	NN	O
of	IN	O
formamide	NN	O
,	,	O
or	CC	O
raising	VBG	O
the	DT	O
hybridization	NN	O
temperature	NN	O
,	,	O
altering	VBG	O
the	DT	O
time	NN	O
of	IN	O
hybridization	NN	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
defined	VBN	O
by	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
hybridize	VB	O
under	IN	O
various	JJ	O
stringency	NN	O
conditions	NNS	O
(	(	O
e.g.	NN	O
,	,	O
high	JJ	O
,	,	O
medium	NN	O
,	,	O
and	CC	O
low	JJ	O
)	)	O
,	,	O
as	IN	O
set	VBN	O
forth	NN	O
herein	NN	O
.	.	O
“	NN	O
Variant	NNP	O
”	NNP	O
includes	VBZ	O
polynucleotides	NNS	O
or	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
modified	VBD	O
at	IN	O
one	CD	O
or	CC	O
more	JJR	O
base	NN	O
pairs	NN	O
,	,	O
codons	NNS	O
,	,	O
introns	NNS	O
,	,	O
exons	NNS	O
,	,	O
or	CC	O
amino	NN	O
acid	NN	O
residues	NNS	O
(	(	O
respectively	RB	O
)	)	O
yet	RB	O
still	RB	O
retain	VB	O
the	DT	O
biological	JJ	O
activity	NN	O
of	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Variants	NNS	O
can	MD	O
be	VB	O
produced	VBN	O
by	IN	O
any	DT	O
number	NN	O
of	IN	O
means	NNS	O
included	VBN	O
methods	NNS	O
such	JJ	O
as	IN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
error-prone	JJ	O
PCR	NNP	O
,	,	O
shuffling	VBG	O
,	,	O
oligonucleotide-directed	JJ	O
mutagenesis	NN	O
,	,	O
assembly	RB	O
PCR	NNP	O
,	,	O
sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
,	,	O
in	IN	O
vivo	JJ	O
mutagenesis	NN	O
,	,	O
cassette	NN	O
mutagenesis	NN	O
,	,	O
recursive	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
exponential	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
site-specific	JJ	O
mutagenesis	NN	O
,	,	O
gene	NN	O
reassembly	RB	O
,	,	O
GSSM	NNP	O
and	CC	O
any	DT	O
combination	NN	O
thereof	NN	O
.	.	O
Techniques	NNS	O
for	IN	O
producing	VBG	O
variant	JJ	O
amylase	NN	O
having	VBG	O
activity	NN	O
at	IN	O
a	DT	O
pH	NN	O
or	CC	O
temperature	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
that	WDT	O
is	VBZ	O
different	JJ	O
from	IN	O
a	DT	O
wild-type	JJ	O
amylase	NN	O
,	,	O
are	VBP	O
included	VBN	O
herein	NN	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
saturation	NN	O
mutagenesis	NN	O
”	NN	O
or	CC	O
“	VB	O
GSSM	NNP	O
”	NNP	O
includes	VBZ	O
a	DT	O
method	NN	O
that	WDT	O
uses	VBZ	O
degenerate	JJ	O
oligonucleotide	JJ	O
primers	NNS	O
to	TO	O
introduce	VB	O
point	NN	O
mutations	NNS	O
into	IN	O
a	DT	O
polynucleotide	NN	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
optimized	VBD	O
directed	VBN	O
evolution	NN	O
system	NN	O
”	VBD	O
or	CC	O
“	VB	O
optimized	VBN	O
directed	JJ	O
evolution	NN	O
”	NNP	O
includes	VBZ	O
a	DT	O
method	NN	O
for	IN	O
reassembling	VBG	O
fragments	NNS	O
of	IN	O
related	JJ	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
,	,	O
e.g.	NNS	O
,	,	O
related	VBN	O
genes	NNS	O
,	,	O
and	CC	O
explained	VBD	O
in	IN	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
”	VBD	O
or	CC	O
“	JJ	O
SLR	NNP	O
”	NNP	O
includes	VBZ	O
a	DT	O
method	NN	O
of	IN	O
ligating	VBG	O
oligonucleotide	JJ	O
fragments	NNS	O
in	IN	O
a	DT	O
non-stochastic	JJ	O
fashion	NN	O
,	,	O
and	CC	O
explained	VBD	O
in	IN	O
detail	NN	O
,	,	O
below	IN	O
.	.	O
Generating	VBG	O
and	CC	O
Manipulating	NNP	O
Nucleic	NNP	O
Acids	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
nucleic	JJ	O
acids	NNS	O
,	,	O
including	VBG	O
expression	NN	O
cassettes	NNS	O
such	JJ	O
as	IN	O
expression	NN	O
vectors	NNS	O
,	,	O
encoding	VBG	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
methods	NNS	O
for	IN	O
discovering	VBG	O
new	JJ	O
amylase	NN	O
sequences	NNS	O
using	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
methods	NNS	O
for	IN	O
inhibiting	VBG	O
the	DT	O
expression	NN	O
of	IN	O
amylase	NN	O
genes	NNS	O
,	,	O
transcripts	NNS	O
and	CC	O
polypeptides	NNS	O
using	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Also	RB	O
provided	VBN	O
are	VBP	O
methods	NNS	O
for	IN	O
modifying	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
,	,	O
optimized	VBD	O
directed	VBN	O
evolution	NN	O
system	NN	O
and/or	JJ	O
saturation	NN	O
mutagenesis	NN	O
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
made	VBN	O
,	,	O
isolated	JJ	O
and/or	NN	O
manipulated	VBN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
cloning	VBG	O
and	CC	O
expression	NN	O
of	IN	O
cDNA	NN	O
libraries	NNS	O
,	,	O
amplification	NN	O
of	IN	O
message	NN	O
or	CC	O
genomic	JJ	O
DNA	NN	O
by	IN	O
PCR	NNP	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
In	IN	O
practicing	VBG	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
homologous	JJ	O
genes	NNS	O
can	MD	O
be	VB	O
modified	VBN	O
by	IN	O
manipulating	VBG	O
a	DT	O
template	NN	O
nucleic	NN	O
acid	NN	O
,	,	O
as	IN	O
described	VBN	O
herein	NN	O
.	.	O
The	DT	O
invention	NN	O
can	MD	O
be	VB	O
practiced	VBN	O
in	IN	O
conjunction	NN	O
with	IN	O
any	DT	O
method	NN	O
or	CC	O
protocol	NN	O
or	CC	O
device	NN	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
which	WDT	O
are	VBP	O
well	RB	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
and	CC	O
patent	JJ	O
literature	NN	O
.	.	O
General	NNP	O
Techniques	NNP	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
used	VBD	O
to	TO	O
practice	NN	O
this	DT	O
invention	NN	O
,	,	O
whether	IN	O
RNA	NNP	O
,	,	O
iRNA	NN	O
,	,	O
antisense	JJ	O
nucleic	NN	O
acid	NN	O
,	,	O
cDNA	NN	O
,	,	O
genomic	JJ	O
DNA	NNP	O
,	,	O
vectors	NNS	O
,	,	O
viruses	NNS	O
or	CC	O
hybrids	NNS	O
thereof	NNS	O
,	,	O
may	MD	O
be	VB	O
isolated	VBN	O
from	IN	O
a	DT	O
variety	NN	O
of	IN	O
sources	NNS	O
,	,	O
genetically	RB	O
engineered	VBN	O
,	,	O
amplified	VBN	O
,	,	O
and/or	RB	O
expressed/generated	VBN	O
recombinantly	RB	O
.	.	O
Recombinant	NNP	O
polypeptides	NNS	O
generated	VBD	O
from	IN	O
these	DT	O
nucleic	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
individually	RB	O
isolated	JJ	O
or	CC	O
cloned	VBN	O
and	CC	O
tested	VBN	O
for	IN	O
a	DT	O
desired	JJ	O
activity	NN	O
.	.	O
Any	DT	O
recombinant	JJ	O
expression	NN	O
system	NN	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
including	VBG	O
bacterial	JJ	O
,	,	O
mammalian	JJ	O
,	,	O
yeast	RB	O
,	,	O
insect	NN	O
or	CC	O
plant	NN	O
cell	NN	O
expression	NN	O
systems	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
these	DT	O
nucleic	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
synthesized	VBN	O
in	IN	O
vitro	NN	O
by	IN	O
well-known	JJ	O
chemical	JJ	O
synthesis	NN	O
techniques	NNS	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
,	,	O
e.g.	NN	O
,	,	O
Adams	NNP	B
(	(	I
1983	CD	I
)	)	I
J	NNP	I
.	.	I
Am	NNP	I
.	.	I
Chem	NNP	I
.	.	I
Soc	NNP	I
.	.	I
105:661	CD	I
;	:	O
Belousov	NNP	B
(	(	I
1997	CD	I
)	)	I
Nucleic	NNP	I
Acids	NNP	I
Res	NNP	I
.	.	I
25:3440-3444	JJ	I
;	:	O
Frenkel	NNP	B
(	(	I
1995	CD	I
)	)	I
Free	NNP	I
Radic	NNP	I
.	.	I
Biol	NNP	I
.	.	I
Med	NNP	I
.	.	I
19:373-380	JJ	I
;	:	O
Blommers	NNS	B
(	(	I
1994	CD	I
)	)	I
Biochemistry	NNP	I
33:7886-7896	CD	I
;	:	O
Narang	NNP	B
(	(	I
1979	CD	I
)	)	I
Meth	NNP	I
.	.	I
Enzymol	NNP	I
.	.	I
68:90	CD	I
;	:	O
Brown	NNP	B
(	(	I
1979	CD	I
)	)	I
Meth	NNP	I
.	.	I
Enzymol	NNP	I
.	.	I
68:109	CD	I
;	:	O
Beaucage	NNP	B
(	(	I
1981	CD	I
)	)	I
Tetra	NNP	I
.	.	I
Lett	NNP	I
.	.	I
22:1859	CD	I
;	:	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
4,458,066	CD	O
.	.	O
Techniques	NNS	O
for	IN	O
the	DT	O
manipulation	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
,	,	O
such	JJ	O
as	IN	O
,	,	O
e.g.	NN	O
,	,	O
subcloning	VBG	O
,	,	O
labeling	VBG	O
probes	NNS	O
(	(	O
e.g.	NN	O
,	,	O
random-primer	JJ	O
labeling	NN	O
using	VBG	O
Klenow	NNP	O
polymerase	NN	O
,	,	O
nick	JJ	O
translation	NN	O
,	,	O
amplification	NN	O
)	)	O
,	,	O
sequencing	VBG	O
,	,	O
hybridization	NN	O
and	CC	O
the	DT	O
like	JJ	O
are	VBP	O
well	RB	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
and	CC	O
patent	JJ	O
literature	NN	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Sambrook	NNP	B
,	,	I
ed.	NN	I
,	,	I
MOLECULAR	NNP	I
CLONING	NN	I
:	:	I
A	DT	I
LABORATORY	NNP	I
MANUAL	NNP	I
(	(	I
2ND	CD	I
ED	NNP	I
.	.	I
)	)	I
,	,	I
Vols	NNP	I
.	.	I
1-3	JJ	I
,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor	NNP	I
Laboratory	NNP	I
,	,	I
(	(	I
1989	CD	I
)	)	I
;	:	O
CURRENT	NNP	B
PROTOCOLS	NNP	I
1N	CD	I
MOLECULAR	NNP	I
BIOLOGY	NNP	I
,	,	I
Ausubel	NNP	I
,	,	I
ed	NN	I
.	.	I
John	NNP	I
Wiley	NNP	I
&	CC	I
Sons	NNP	I
,	,	I
Inc.	NNP	I
,	,	I
New	NNP	I
York	NNP	I
(	(	I
1997	CD	I
)	)	I
;	:	O
LABORATORY	NNP	B
TECHNIQUES	NNP	I
IN	NNP	I
BIOCHEMISTRY	NNP	I
AND	NNP	I
MOLECULAR	NNP	I
BIOLOGY	NNP	I
:	:	I
HYBRIDIZATION	NN	I
WITH	NNP	I
NUCLEIC	NNP	I
ACID	NNP	I
PROBES	NNP	I
,	,	I
Part	NNP	I
I	PRP	I
.	.	I
Theory	NN	I
and	CC	I
Nucleic	NNP	I
Acid	NNP	I
Preparation	NNP	I
,	,	I
Tijssen	NNP	I
,	,	I
ed	NN	I
.	.	I
Elsevier	NNP	I
,	,	I
N.Y.	NNP	I
(	(	I
1993	CD	I
)	)	I
.	.	O
Another	DT	O
useful	JJ	O
means	NNS	O
of	IN	O
obtaining	VBG	O
and	CC	O
manipulating	VBG	O
nucleic	JJ	O
acids	NNS	O
used	VBD	O
to	TO	O
practice	NN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
to	TO	O
clone	VB	O
from	IN	O
genomic	JJ	O
samples	NNS	O
,	,	O
and	CC	O
,	,	O
if	IN	O
desired	VBN	O
,	,	O
screen	JJ	O
and	CC	O
re-clone	JJ	O
inserts	NNS	O
isolated	VBD	O
or	CC	O
amplified	VBN	O
from	IN	O
,	,	O
e.g.	NN	O
,	,	O
genomic	JJ	O
clones	NNS	O
or	CC	O
cDNA	NN	O
clones	NNS	O
.	.	O
Sources	NNS	O
of	IN	O
nucleic	JJ	O
acid	NNS	O
used	VBN	O
in	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
genomic	JJ	O
or	CC	O
cDNA	JJ	O
libraries	NNS	O
contained	VBN	O
in	IN	O
,	,	O
e.g.	NN	O
,	,	O
mammalian	JJ	O
artificial	JJ	O
chromosomes	NNS	O
(	(	O
MACs	NNP	O
)	)	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
5,721,118	CD	O
;	:	O
6,025,155	CD	O
;	:	O
human	JJ	O
artificial	JJ	O
chromosomes	NNS	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Rosenfeld	NNP	B
(	(	I
1997	CD	I
)	)	I
Nat	NNP	I
.	.	I
Genet	NNP	I
.	.	I
15:333-335	JJ	I
;	:	O
yeast	CC	O
artificial	JJ	O
chromosomes	NNS	O
(	(	O
YAC	NNP	O
)	)	O
;	:	O
bacterial	JJ	O
artificial	JJ	O
chromosomes	NNS	O
(	(	O
BAC	NNP	O
)	)	O
;	:	O
P1	NNP	O
artificial	JJ	O
chromosomes	NNS	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Woon	NNP	B
(	(	I
1998	CD	I
)	)	I
Genomics	NNPS	I
50:306-316	JJ	I
;	:	O
P1-derived	JJ	O
vectors	NNS	O
(	(	O
PACs	NNPS	O
)	)	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Kern	NNP	B
(	(	I
1997	CD	I
)	)	I
Biotechniques	NNP	I
23:120-124	CD	I
;	:	O
cosmids	NNS	O
,	,	O
recombinant	JJ	O
viruses	NNS	O
,	,	O
phages	NNS	O
or	CC	O
plasmids	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
assembled	VBN	O
in	IN	O
appropriate	JJ	O
phase	NN	O
with	IN	O
a	DT	O
leader	NN	O
sequence	NN	O
capable	JJ	O
of	IN	O
directing	VBG	O
secretion	NN	O
of	IN	O
the	DT	O
translated	JJ	O
polypeptide	NN	O
or	CC	O
fragment	JJ	O
thereof	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
fusion	NN	O
proteins	NNS	O
and	CC	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
them	PRP	O
.	.	O
A	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
fused	VBN	O
to	TO	O
a	DT	O
heterologous	JJ	O
peptide	NN	O
or	CC	O
polypeptide	NN	O
,	,	O
such	JJ	O
as	IN	O
N-terminal	JJ	O
identification	NN	O
peptides	NNS	O
which	WDT	O
impart	VBP	O
desired	VBN	O
characteristics	NNS	O
,	,	O
such	JJ	O
as	IN	O
increased	JJ	O
stability	NN	O
or	CC	O
simplified	VBN	O
purification	NN	O
.	.	O
Peptides	NNS	O
and	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
synthesized	VBN	O
and	CC	O
expressed	VBN	O
as	IN	O
fusion	NN	O
proteins	VBZ	O
with	IN	O
one	CD	O
or	CC	O
more	JJR	O
additional	JJ	O
domains	NNS	O
linked	VBN	O
thereto	NN	O
for	IN	O
,	,	O
e.g.	NN	O
,	,	O
producing	VBG	O
a	DT	O
more	RBR	O
immunogenic	JJ	O
peptide	NN	O
,	,	O
to	TO	O
more	RBR	O
readily	RB	O
isolate	VB	O
a	DT	O
recombinantly	RB	O
synthesized	VBN	O
peptide	NN	O
,	,	O
to	TO	O
identify	VB	O
and	CC	O
isolate	VB	O
antibodies	NNS	O
and	CC	O
antibody-expressing	JJ	O
B	NNP	O
cells	NNS	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Detection	NN	O
and	CC	O
purification	NN	O
facilitating	NN	O
domains	NNS	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
metal	JJ	O
chelating	VBG	O
peptides	NNS	O
such	JJ	O
as	IN	O
polyhistidine	NN	O
tracts	NNS	O
and	CC	O
histidine-tryptophan	JJ	O
modules	NNS	O
that	WDT	O
allow	VBP	O
purification	NN	O
on	IN	O
immobilized	JJ	O
metals	NNS	O
,	,	O
protein	VBP	O
A	DT	O
domains	NNS	O
that	WDT	O
allow	VBP	O
purification	NN	O
on	IN	O
immobilized	JJ	O
immunoglobulin	NN	O
,	,	O
and	CC	O
the	DT	O
domain	NN	O
utilized	JJ	O
in	IN	O
the	DT	O
FLAGS	NNP	O
extension/affinity	NN	O
purification	NN	O
system	NN	O
(	(	O
Immunex	NNP	O
Corp	NNP	O
,	,	O
Seattle	NNP	O
Wash.	NNP	O
)	)	O
.	.	O
The	DT	O
inclusion	NN	O
of	IN	O
a	DT	O
cleavable	JJ	O
linker	NN	O
sequences	NNS	O
such	JJ	O
as	IN	O
Factor	NNP	O
Xa	NNP	O
or	CC	O
enterokinase	NN	O
(	(	O
Invitrogen	NNP	O
,	,	O
San	NNP	O
Diego	NNP	O
Calif.	NNP	O
)	)	O
between	IN	O
a	DT	O
purification	NN	O
domain	NN	O
and	CC	O
the	DT	O
motif-comprising	JJ	O
peptide	NN	O
or	CC	O
polypeptide	NN	O
to	TO	O
facilitate	VB	O
purification	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
an	DT	O
expression	NN	O
vector	NN	O
can	MD	O
include	VB	O
an	DT	O
epitope-encoding	JJ	O
nucleic	NN	O
acid	NN	O
sequence	NN	O
linked	VBD	O
to	TO	O
six	CD	O
histidine	NN	O
residues	NNS	O
followed	VBN	O
by	IN	O
a	DT	O
thioredoxin	NN	O
and	CC	O
an	DT	O
enterokinase	NN	O
cleavage	NN	O
site	NN	O
(	(	O
see	VB	O
e.g.	RB	O
,	,	O
Williams	NNP	B
(	(	I
1995	CD	I
)	)	I
Biochemistry	NNP	I
34:1787-1797	CD	I
;	:	O
Dobeli	NNP	B
(	(	I
1998	CD	I
)	)	I
Protein	NNP	I
Expr	NNP	I
.	.	I
Purif	NNP	I
12:404-414	CD	I
)	)	O
.	.	O
The	DT	O
histidine	NN	O
residues	VBZ	O
facilitate	JJ	O
detection	NN	O
and	CC	O
purification	NN	O
while	IN	O
the	DT	O
enterokinase	NN	O
cleavage	NN	O
site	NN	O
provides	VBZ	O
a	DT	O
means	NN	O
for	IN	O
purifying	VBG	O
the	DT	O
epitope	NN	O
from	IN	O
the	DT	O
remainder	NN	O
of	IN	O
the	DT	O
fusion	NN	O
protein	NN	O
.	.	O
Technology	NN	O
pertaining	VBG	O
to	TO	O
vectors	NNS	O
encoding	VBG	O
fusion	NN	O
proteins	NNS	O
and	CC	O
application	NN	O
of	IN	O
fusion	NN	O
proteins	NNS	O
are	VBP	O
well	RB	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
and	CC	O
patent	JJ	O
literature	NN	O
,	,	O
see	VBP	O
e.g.	RB	O
,	,	O
Kroll	NNP	B
(	(	I
1993	CD	I
)	)	I
DNA	NN	I
Cell	NNP	I
.	.	I
Biol.	NNP	I
,	,	I
12:441-53	JJ	I
.	.	O
Transcriptional	NNP	O
and	CC	O
Translational	NNP	O
Control	NNP	O
Sequences	VBZ	O
The	DT	O
invention	NN	O
provides	VBZ	O
nucleic	JJ	O
acid	NN	O
(	(	O
e.g.	JJ	O
,	,	O
DNA	NNP	O
)	)	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
operatively	RB	O
linked	VBN	O
to	TO	O
expression	NN	O
(	(	O
e.g.	JJ	O
,	,	O
transcriptional	JJ	O
or	CC	O
translational	JJ	O
)	)	O
control	NN	O
sequence	NN	O
(	(	O
s	PRP	O
)	)	O
,	,	O
e.g.	RB	O
,	,	O
promoters	NNS	O
or	CC	O
enhancers	NNS	O
,	,	O
to	TO	O
direct	VB	O
or	CC	O
modulate	VB	O
RNA	NNP	O
synthesis/expression	NN	O
.	.	O
The	DT	O
expression	NN	O
control	NN	O
sequence	NN	O
can	MD	O
be	VB	O
in	IN	O
an	DT	O
expression	NN	O
vector	NN	O
.	.	O
Exemplary	JJ	O
bacterial	JJ	O
promoters	NNS	O
include	VBP	O
lacI	JJ	O
,	,	O
lacZ	JJ	O
,	,	O
T3	NNP	O
,	,	O
T7	NNP	O
,	,	O
gpt	NN	O
,	,	O
lambda	JJ	O
PR	NNP	O
,	,	O
PL	NNP	O
and	CC	O
tip	NN	O
.	.	O
Exemplary	NNP	O
eukaryotic	JJ	O
promoters	NNS	O
include	VBP	O
CMV	NNP	O
immediate	JJ	O
early	JJ	O
,	,	O
HSV	NNP	O
thymidine	NN	O
kinase	NN	O
,	,	O
early	RB	O
and	CC	O
late	JJ	O
SV40	NNP	O
,	,	O
LTRs	NNP	O
from	IN	O
retrovirus	NN	O
,	,	O
and	CC	O
mouse	RB	O
metallothionein	JJ	O
I.	NNP	O
Promoters	NNP	O
suitable	JJ	O
for	IN	O
expressing	VBG	O
a	DT	O
polypeptide	NN	O
in	IN	O
bacteria	NNS	O
include	VBP	O
the	DT	O
E.	NNP	O
coli	NNS	O
lac	VBD	O
or	CC	O
trp	JJ	O
promoters	NNS	O
,	,	O
the	DT	O
lacI	NN	O
promoter	NN	O
,	,	O
the	DT	O
lacZ	NN	O
promoter	NN	O
,	,	O
the	DT	O
T3	NNP	O
promoter	NN	O
,	,	O
the	DT	O
T7	NNP	O
promoter	NN	O
,	,	O
the	DT	O
gpt	NN	O
promoter	NN	O
,	,	O
the	DT	O
lambda	NN	O
PR	NNP	O
promoter	NN	O
,	,	O
the	DT	O
lambda	NN	O
PL	NNP	O
promoter	NN	O
,	,	O
promoters	NNS	O
from	IN	O
operons	NNS	O
encoding	VBG	O
glycolytic	JJ	O
enzymes	NNS	O
such	JJ	O
as	IN	O
3-phosphoglycerate	JJ	O
kinase	NN	O
(	(	O
PGK	NNP	O
)	)	O
,	,	O
and	CC	O
the	DT	O
acid	JJ	O
phosphatase	NN	O
promoter	NN	O
.	.	O
Eukaryotic	JJ	O
promoters	NNS	O
include	VBP	O
the	DT	O
CMV	NNP	O
immediate	VBP	O
early	JJ	O
promoter	NN	O
,	,	O
the	DT	O
HSV	NNP	O
thymidine	NN	O
kinase	NN	O
promoter	NN	O
,	,	O
heat	NN	O
shock	NN	O
promoters	NNS	O
,	,	O
the	DT	O
early	JJ	O
and	CC	O
late	JJ	O
SV40	NNP	O
promoter	NN	O
,	,	O
LTRs	NNP	O
from	IN	O
retroviruses	NNS	O
,	,	O
and	CC	O
the	DT	O
mouse	NN	O
metallothionein-I	JJ	O
promoter	NN	O
.	.	O
Other	JJ	O
promoters	NNS	O
known	VBN	O
to	TO	O
control	VB	O
expression	NN	O
of	IN	O
genes	NNS	O
in	IN	O
prokaryotic	JJ	O
or	CC	O
eukaryotic	JJ	O
cells	NNS	O
or	CC	O
their	PRP$	O
viruses	NNS	O
may	MD	O
also	RB	O
be	VB	O
used	VBN	O
.	.	O
Tissue-Specific	JJ	O
Plant	NNP	O
Promoters	NNPS	O
The	DT	O
invention	NN	O
provides	VBZ	O
expression	NN	O
cassettes	NNS	O
that	WDT	O
can	MD	O
be	VB	O
expressed	VBN	O
in	IN	O
a	DT	O
tissue-specific	JJ	O
manner	NN	O
,	,	O
e.g.	NN	O
,	,	O
that	WDT	O
can	MD	O
express	VB	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
in	IN	O
a	DT	O
tissue-specific	JJ	O
manner	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
plants	NNS	O
or	CC	O
seeds	NNS	O
that	WDT	O
express	VBP	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
in	IN	O
a	DT	O
tissue-specific	JJ	O
manner	NN	O
.	.	O
The	DT	O
tissue-specificity	NN	O
can	MD	O
be	VB	O
seed	NN	O
specific	JJ	O
,	,	O
stem	NN	O
specific	JJ	O
,	,	O
leaf	JJ	O
specific	NN	O
,	,	O
root	NN	O
specific	NN	O
,	,	O
fruit	NN	O
specific	NN	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
constitutive	JJ	O
promoter	NN	O
such	JJ	O
as	IN	O
the	DT	O
CaMV	NNP	O
35S	CD	O
promoter	NN	O
can	MD	O
be	VB	O
used	VBN	O
for	IN	O
expression	NN	O
in	IN	O
specific	JJ	O
parts	NNS	O
of	IN	O
the	DT	O
plant	NN	O
or	CC	O
seed	NN	O
or	CC	O
throughout	IN	O
the	DT	O
plant	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
for	IN	O
overexpression	NN	O
,	,	O
a	DT	O
plant	NN	O
promoter	NN	O
fragment	NN	O
can	MD	O
be	VB	O
employed	VBN	O
which	WDT	O
will	MD	O
direct	VB	O
expression	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
in	IN	O
some	DT	O
or	CC	O
all	DT	O
tissues	NNS	O
of	IN	O
a	DT	O
plant	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
regenerated	JJ	O
plant	NN	O
.	.	O
Such	JJ	O
promoters	NNS	O
are	VBP	O
referred	VBN	O
to	TO	O
herein	VB	O
as	IN	O
“	JJ	O
constitutive	JJ	O
”	NN	O
promoters	NNS	O
and	CC	O
are	VBP	O
active	JJ	O
under	IN	O
most	JJS	O
environmental	JJ	O
conditions	NNS	O
and	CC	O
states	NNS	O
of	IN	O
development	NN	O
or	CC	O
cell	NN	O
differentiation	NN	O
.	.	O
Examples	NNS	O
of	IN	O
constitutive	JJ	O
promoters	NNS	O
include	VBP	O
the	DT	O
cauliflower	JJR	O
mosaic	JJ	O
virus	NN	O
(	(	O
CaMV	NNP	O
)	)	O
35S	CD	O
transcription	NN	O
initiation	NN	O
region	NN	O
,	,	O
the	DT	O
1′-	JJ	O
or	CC	O
2′-promoter	JJ	O
derived	VBN	O
from	IN	O
T-DNA	NNP	O
of	IN	O
Agrobacterium	NNP	O
tumefaciens	NNS	O
,	,	O
and	CC	O
other	JJ	O
transcription	NN	O
initiation	NN	O
regions	NNS	O
from	IN	O
various	JJ	O
plant	NN	O
genes	NNS	O
known	VBN	O
to	TO	O
those	DT	O
of	IN	O
skill	NN	O
.	.	O
Such	JJ	O
genes	NNS	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
ACT11	NNP	O
from	IN	O
Arabidopsis	NNP	O
(	(	O
Huang	NNP	B
(	(	I
1996	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
33:125-139	JJ	I
)	)	O
;	:	O
Cat3	NNP	O
from	IN	O
Arabidopsis	NNP	O
(	(	O
GenBank	NNP	B
No	NNP	I
.	.	I
U43147	NNP	I
,	,	I
Zhong	NNP	I
(	(	I
1996	CD	I
)	)	I
Mol	NNP	I
.	.	I
Gen.	NNP	I
Genet	NNP	I
.	.	I
251:196-203	JJ	I
)	)	O
;	:	O
the	DT	O
gene	NN	O
encoding	VBG	O
stearoyl-acyl	JJ	O
carrier	NN	O
protein	NN	O
desaturase	NN	O
from	IN	O
Brassica	NNP	O
napus	NN	O
(	(	O
Genbank	NNP	B
No	NNP	I
.	.	I
X74782	NN	I
,	,	I
Solocombe	NNP	I
(	(	I
1994	CD	I
)	)	I
Plant	NNP	I
Physiol	NNP	I
.	.	I
104:1167-1176	JJ	I
)	)	O
;	:	O
GPc1	NNP	O
from	IN	O
maize	NN	O
(	(	O
GenBank	NNP	B
No	NNP	I
.	.	I
X15596	NN	I
;	:	I
Martinez	NNP	I
(	(	I
1989	CD	I
)	)	I
J.	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
208:551-565	JJ	I
)	)	O
;	:	O
the	DT	O
Gpc2	NNP	O
from	IN	O
maize	NN	O
(	(	O
GenBank	NNP	B
No	NNP	I
.	.	I
U45855	NNP	I
,	,	I
Manjunath	NNP	I
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
33:97-112	JJ	I
)	)	O
;	:	O
plant	NN	O
promoters	NNS	O
described	VBN	O
in	IN	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
4,962,028	CD	O
;	:	O
5,633,440	CD	O
.	.	O
The	DT	O
invention	NN	O
uses	VBZ	O
tissue-specific	JJ	O
or	CC	O
constitutive	JJ	O
promoters	NNS	O
derived	VBN	O
from	IN	O
viruses	NNS	O
which	WDT	O
can	MD	O
include	VB	O
,	,	O
e.g.	VB	O
,	,	O
the	DT	O
tobamovirus	NN	O
subgenomic	JJ	O
promoter	NN	O
(	(	O
Kumagai	NNP	B
(	(	I
1995	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
92:1679-1683	CD	I
;	:	O
the	DT	O
rice	NN	O
tungro	NN	O
bacilliform	NN	O
virus	NN	O
(	(	O
RTBV	NNP	O
)	)	O
,	,	O
which	WDT	O
replicates	VBZ	O
only	RB	O
in	IN	O
phloem	NN	O
cells	NNS	O
in	IN	O
infected	JJ	O
rice	NN	O
plants	NNS	O
,	,	O
with	IN	O
its	PRP$	O
promoter	NN	O
which	WDT	O
drives	VBZ	O
strong	JJ	O
phloem-specific	JJ	O
reporter	NN	O
gene	NN	O
expression	NN	O
;	:	O
the	DT	O
cassava	NN	O
vein	NN	O
mosaic	NN	O
virus	NN	O
(	(	O
CVMV	NNP	O
)	)	O
promoter	NN	O
,	,	O
with	IN	O
highest	JJS	O
activity	NN	O
in	IN	O
vascular	JJ	O
elements	NNS	O
,	,	O
in	IN	O
leaf	JJ	O
mesophyll	NN	O
cells	NNS	O
,	,	O
and	CC	O
in	IN	O
root	JJ	O
tips	NNS	O
(	(	O
Verdaguer	NNP	B
(	(	I
1996	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
31:1129-1139	JJ	I
)	)	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
plant	NN	O
promoter	NN	O
may	MD	O
direct	VB	O
expression	NN	O
of	IN	O
amylase-expressing	JJ	O
nucleic	JJ	O
acid	NN	O
in	IN	O
a	DT	O
specific	JJ	O
tissue	NN	O
,	,	O
organ	''	O
or	CC	O
cell	VB	O
type	NN	O
(	(	O
i.e	NN	O
.	.	O
tissue-specific	JJ	O
promoters	NNS	O
)	)	O
or	CC	O
may	MD	O
be	VB	O
otherwise	RB	O
under	IN	O
more	RBR	O
precise	JJ	O
environmental	JJ	O
or	CC	O
developmental	JJ	O
control	NN	O
or	CC	O
under	IN	O
the	DT	O
control	NN	O
of	IN	O
an	DT	O
inducible	JJ	O
promoter	NN	O
.	.	O
Examples	NNS	O
of	IN	O
environmental	JJ	O
conditions	NNS	O
that	WDT	O
may	MD	O
affect	VB	O
transcription	NN	O
include	VBP	O
anaerobic	JJ	O
conditions	NNS	O
,	,	O
elevated	VBN	O
temperature	NN	O
,	,	O
the	DT	O
presence	NN	O
of	IN	O
light	NN	O
,	,	O
or	CC	O
sprayed	VBN	O
with	IN	O
chemicals/hormones	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
invention	NN	O
incorporates	VBZ	O
the	DT	O
drought-inducible	JJ	O
promoter	NN	O
of	IN	O
maize	NN	O
(	(	O
Busk	NNP	B
(	(	I
1997	CD	I
)	)	I
supra	NN	I
)	)	O
;	:	O
the	DT	O
cold	NN	O
,	,	O
drought	NN	O
,	,	O
and	CC	O
high	JJ	O
salt	NN	O
inducible	JJ	O
promoter	NN	O
from	IN	O
potato	NN	O
(	(	O
Kirch	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
33:897	CD	I
909	CD	I
)	)	O
.	.	O
Tissue-specific	JJ	O
promoters	NNS	O
can	MD	O
promote	VB	O
transcription	NN	O
only	RB	O
within	IN	O
a	DT	O
certain	JJ	O
time	NN	O
frame	NN	O
of	IN	O
developmental	JJ	O
stage	NN	O
within	IN	O
that	DT	O
tissue	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
Blazquez	NNP	B
(	(	I
1998	CD	I
)	)	I
Plant	NNP	I
Cell	NNP	I
10:791-800	CD	I
,	,	O
characterizing	VBG	O
the	DT	O
Arabidopsis	NNP	O
LEAFY	NNP	O
gene	NN	O
promoter	NN	O
.	.	O
See	NNP	O
also	RB	O
Cardon	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
12:367-77	CD	I
,	,	O
describing	VBG	O
the	DT	O
transcription	NN	O
factor	NN	O
SPL3	NNP	O
,	,	O
which	WDT	O
recognizes	VBZ	O
a	DT	O
conserved	JJ	O
sequence	NN	O
motif	NN	O
in	IN	O
the	DT	O
promoter	NN	O
region	NN	O
of	IN	O
the	DT	O
A.	NNP	O
thaliana	NNP	O
floral	JJ	O
meristem	NN	O
identity	NN	O
gene	NN	O
AP1	NNP	O
;	:	O
and	CC	O
Mandel	NNP	B
(	(	I
1995	CD	I
)	)	I
Plant	NNP	I
Molecular	NNP	I
Biology	NNP	I
,	,	I
Vol	NNP	I
.	.	I
29	CD	I
,	,	I
pp	JJ	I
995-1004	CD	I
,	,	O
describing	VBG	O
the	DT	O
meristem	NN	O
promoter	NN	O
eIF4	NN	O
.	.	O
Tissue	NNP	O
specific	NN	O
promoters	NNS	O
which	WDT	O
are	VBP	O
active	JJ	O
throughout	IN	O
the	DT	O
life	NN	O
cycle	NN	O
of	IN	O
a	DT	O
particular	JJ	O
tissue	NN	O
can	MD	O
be	VB	O
used	VBN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter	NN	O
active	JJ	O
primarily	RB	O
only	RB	O
in	IN	O
cotton	NN	O
fiber	NN	O
cells	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
operably	RB	O
linked	VBN	O
to	TO	O
a	DT	O
promoter	NN	O
active	JJ	O
primarily	RB	O
during	IN	O
the	DT	O
stages	NNS	O
of	IN	O
cotton	NN	O
fiber	NN	O
cell	NN	O
elongation	NN	O
,	,	O
e.g.	RB	O
,	,	O
as	IN	O
described	VBN	O
by	IN	O
Rinehart	NNP	B
(	(	I
1996	CD	I
)	)	I
supra	NN	I
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
operably	RB	O
linked	VBN	O
to	TO	O
the	DT	O
Fbl2A	NNP	O
gene	NN	O
promoter	NN	O
to	TO	O
be	VB	O
preferentially	RB	O
expressed	VBN	O
in	IN	O
cotton	NN	O
fiber	NN	O
cells	NNS	O
(	(	O
Ibid	NNP	O
)	)	O
.	.	O
See	NNP	O
also	RB	O
,	,	O
John	NNP	B
(	(	I
1997	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
89:5769-5773	CD	I
;	:	O
John	NNP	B
,	,	I
et	FW	I
al.	NN	I
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
5,608,148	CD	O
and	CC	O
5,602,321	CD	O
,	,	O
describing	VBG	O
cotton	NN	O
fiber-specific	JJ	O
promoters	NNS	O
and	CC	O
methods	NNS	O
for	IN	O
the	DT	O
construction	NN	O
of	IN	O
transgenic	JJ	O
cotton	NN	O
plants	NNS	O
.	.	O
Root-specific	JJ	O
promoters	NNS	O
may	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
express	VB	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Examples	NNS	O
of	IN	O
root-specific	JJ	O
promoters	NNS	O
include	VBP	O
the	DT	O
promoter	NN	O
from	IN	O
the	DT	O
alcohol	NN	O
dehydrogenase	NN	O
gene	NN	O
(	(	O
DeLisle	NNP	B
(	(	I
1990	CD	I
)	)	I
Int	NNP	I
.	.	I
Rev	NNP	I
.	.	I
Cytol	NNP	I
.	.	I
123:39-60	JJ	I
)	)	O
.	.	O
Other	JJ	O
promoters	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
express	VB	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
ovule-specific	JJ	O
,	,	O
embryo-specific	JJ	O
,	,	O
endosperm-specific	JJ	O
,	,	O
integument-specific	JJ	O
,	,	O
seed	NN	O
coat-specific	JJ	O
promoters	NNS	O
,	,	O
or	CC	O
some	DT	O
combination	NN	O
thereof	NN	O
;	:	O
a	DT	O
leaf-specific	JJ	O
promoter	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Busk	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
.	.	I
11:1285	CD	I
1295	CD	I
,	,	O
describing	VBG	O
a	DT	O
leaf-specific	JJ	O
promoter	NN	O
in	IN	O
maize	NN	O
)	)	O
;	:	O
the	DT	O
ORF13	NNP	O
promoter	NN	O
from	IN	O
Agrobacterium	NNP	O
rhizogenes	NNS	O
(	(	O
which	WDT	O
exhibits	VBZ	O
high	JJ	O
activity	NN	O
in	IN	O
roots	NNS	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Hansen	NNP	B
(	(	I
1997	CD	I
)	)	I
supra	NN	I
)	)	O
;	:	O
a	DT	O
maize	NN	O
pollen	NN	O
specific	JJ	O
promoter	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Guerrero	NNP	B
(	(	I
1990	CD	I
)	)	I
Mol	NNP	I
.	.	I
Gen.	NNP	I
Genet	NNP	I
.	.	I
224:161	CD	I
168	CD	I
)	)	O
;	:	O
a	DT	O
tomato	NN	O
promoter	NN	O
active	JJ	O
during	IN	O
fruit	NN	O
ripening	NN	O
,	,	O
senescence	NN	O
and	CC	O
abscission	NN	O
of	IN	O
leaves	NNS	O
and	CC	O
,	,	O
to	TO	O
a	DT	O
lesser	JJR	O
extent	NN	O
,	,	O
of	IN	O
flowers	NNS	O
can	MD	O
be	VB	O
used	VBN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Blume	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
.	.	I
12:731	CD	I
746	CD	I
)	)	O
;	:	O
a	DT	O
pistil-specific	JJ	O
promoter	NN	O
from	IN	O
the	DT	O
potato	NN	O
SK2	NNP	O
gene	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Ficker	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
35:425	CD	I
431	CD	I
)	)	O
;	:	O
the	DT	O
Blec4	NNP	O
gene	NN	O
from	IN	O
pea	NN	O
,	,	O
which	WDT	O
is	VBZ	O
active	JJ	O
in	IN	O
epidermal	JJ	O
tissue	NN	O
of	IN	O
vegetative	JJ	O
and	CC	O
floral	JJ	O
shoot	NN	O
apices	NNS	O
of	IN	O
transgenic	JJ	O
alfalfa	NN	O
making	VBG	O
it	PRP	O
a	DT	O
useful	JJ	O
tool	NN	O
to	TO	O
target	VB	O
the	DT	O
expression	NN	O
of	IN	O
foreign	JJ	O
genes	NNS	O
to	TO	O
the	DT	O
epidermal	JJ	O
layer	NN	O
of	IN	O
actively	RB	O
growing	VBG	O
shoots	NNS	O
or	CC	O
fibers	NNS	O
;	:	O
the	DT	O
ovule-specific	JJ	O
BEL1	NNP	O
gene	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Reiser	NNP	B
(	(	I
1995	CD	I
)	)	I
Cell	NNP	I
83:735-742	CD	I
,	,	O
GenBank	NNP	O
No	NNP	O
.	.	O
U39944	NNP	O
)	)	O
;	:	O
and/or	UH	O
,	,	O
the	DT	O
promoter	NN	O
in	IN	O
Klee	NNP	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,589,583	CD	O
,	,	O
describing	VBG	O
a	DT	O
plant	NN	O
promoter	NN	O
region	NN	O
is	VBZ	O
capable	JJ	O
of	IN	O
conferring	VBG	O
high	JJ	O
levels	NNS	O
of	IN	O
transcription	NN	O
in	IN	O
meristematic	JJ	O
tissue	NN	O
and/or	RB	O
rapidly	RB	O
dividing	VBG	O
cells	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
plant	NN	O
promoters	NNS	O
which	WDT	O
are	VBP	O
inducible	JJ	O
upon	IN	O
exposure	NN	O
to	TO	O
plant	NN	O
hormones	NNS	O
,	,	O
such	JJ	O
as	IN	O
auxins	NNS	O
,	,	O
are	VBP	O
used	VBN	O
to	TO	O
express	VB	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
invention	NN	O
can	MD	O
use	VB	O
the	DT	O
auxin-response	JJ	O
elements	NNS	O
E1	NNP	O
promoter	NN	O
fragment	NN	O
(	(	O
AuxREs	NNP	O
)	)	O
in	IN	O
the	DT	O
soybean	NN	O
(	(	O
Glycine	NNP	O
max	NNP	O
L.	NNP	O
)	)	O
(	(	O
Liu	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Physiol	NNP	I
.	.	I
115:397-407	JJ	I
)	)	O
;	:	O
the	DT	O
auxin-responsive	JJ	O
Arabidopsis	NNP	O
GST6	NNP	O
promoter	NN	O
(	(	O
also	RB	O
responsive	VBP	O
to	TO	O
salicylic	VB	O
acid	NN	O
and	CC	O
hydrogen	NN	O
peroxide	NN	O
)	)	O
(	(	O
Chen	NNP	B
(	(	I
1996	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
.	.	I
10	CD	I
:	:	I
955-966	CD	I
)	)	O
;	:	O
the	DT	O
auxin-inducible	JJ	O
parC	NN	O
promoter	NN	O
from	IN	O
tobacco	NN	O
(	(	O
Sakai	NNP	B
(	(	I
1996	CD	I
)	)	I
37:906-913	CD	I
)	)	O
;	:	O
a	DT	O
plant	NN	O
biotin	NN	O
response	NN	O
element	NN	O
(	(	O
Streit	NNP	B
(	(	I
1997	CD	I
)	)	I
Mol	NNP	I
.	.	I
Plant	NN	I
Microbe	NNP	I
Interact	NNP	I
.	.	I
10:933-937	JJ	I
)	)	O
;	:	O
and	CC	O
,	,	O
the	DT	O
promoter	NN	O
responsive	NN	O
to	TO	O
the	DT	O
stress	NN	O
hormone	NN	O
abscisic	JJ	O
acid	NN	O
(	(	O
Sheen	NNP	B
(	(	I
1996	CD	I
)	)	I
Science	NNP	I
274:1900-1902	JJ	I
)	)	O
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
operably	RB	O
linked	VBN	O
to	TO	O
plant	NN	O
promoters	NNS	O
which	WDT	O
are	VBP	O
inducible	JJ	O
upon	IN	O
exposure	NN	O
to	TO	O
chemicals	NNS	O
reagents	NNS	O
which	WDT	O
can	MD	O
be	VB	O
applied	VBN	O
to	TO	O
the	DT	O
plant	NN	O
,	,	O
such	JJ	O
as	IN	O
herbicides	NNS	O
or	CC	O
antibiotics	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
maize	JJ	O
In2-2	NNP	O
promoter	NN	O
,	,	O
activated	VBN	O
by	IN	O
benzenesulfonamide	JJ	O
herbicide	NN	O
safeners	NNS	O
,	,	O
can	MD	O
be	VB	O
used	VBN	O
(	(	O
De	NNP	B
Veylder	NNP	I
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Cell	NNP	I
Physiol	NNP	I
.	.	I
38:568-577	JJ	I
)	)	O
;	:	O
application	NN	O
of	IN	O
different	JJ	O
herbicide	NN	O
safeners	NNS	O
induces	NNS	O
distinct	JJ	O
gene	NN	O
expression	NN	O
patterns	NNS	O
,	,	O
including	VBG	O
expression	NN	O
in	IN	O
the	DT	O
root	NN	O
,	,	O
hydathodes	NNS	O
,	,	O
and	CC	O
the	DT	O
shoot	JJ	O
apical	JJ	O
meristem	NN	O
.	.	O
Coding	VBG	O
sequence	NN	O
can	MD	O
be	VB	O
under	IN	O
the	DT	O
control	NN	O
of	IN	O
,	,	O
e.g.	FW	O
,	,	O
a	DT	O
tetracycline-inducible	JJ	O
promoter	NN	O
,	,	O
e.g.	RB	O
,	,	O
as	IN	O
described	VBN	O
with	IN	O
transgenic	JJ	O
tobacco	NN	O
plants	NNS	O
containing	VBG	O
the	DT	O
Avena	NNP	O
sativa	NN	O
L.	NNP	O
(	(	O
oat	NN	O
)	)	O
arginine	NN	O
decarboxylase	NN	O
gene	NN	O
(	(	O
Masgrau	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
.	.	I
11:465-473	JJ	I
)	)	O
;	:	O
or	CC	O
,	,	O
a	DT	O
salicylic	JJ	O
acid-responsive	JJ	O
element	NN	O
(	(	O
Stange	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
.	.	I
11:1315-1324	JJ	I
)	)	O
.	.	O
Using	VBG	O
chemically—	NN	O
(	(	O
e.g.	JJ	O
,	,	O
hormone-	JJ	O
or	CC	O
pesticide-	JJ	O
)	)	O
induced	VBD	O
promoters	NNS	O
,	,	O
i.e.	FW	O
,	,	O
promoter	RB	O
responsive	JJ	O
to	TO	O
a	DT	O
chemical	NN	O
which	WDT	O
can	MD	O
be	VB	O
applied	VBN	O
to	TO	O
the	DT	O
transgenic	JJ	O
plant	NN	O
in	IN	O
the	DT	O
field	NN	O
,	,	O
expression	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
induced	VBN	O
at	IN	O
a	DT	O
particular	JJ	O
stage	NN	O
of	IN	O
development	NN	O
of	IN	O
the	DT	O
plant	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
for	IN	O
transgenic	JJ	O
plants	NNS	O
containing	VBG	O
an	DT	O
inducible	JJ	O
gene	NN	O
encoding	VBG	O
for	IN	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
whose	WP$	O
host	NN	O
range	NN	O
is	VBZ	O
limited	VBN	O
to	TO	O
target	VB	O
plant	NN	O
species	NNS	O
,	,	O
such	JJ	O
as	IN	O
corn	NN	O
,	,	O
rice	NN	O
,	,	O
barley	NN	O
,	,	O
wheat	NN	O
,	,	O
potato	NN	O
or	CC	O
other	JJ	O
crops	NNS	O
,	,	O
inducible	JJ	O
at	IN	O
any	DT	O
stage	NN	O
of	IN	O
development	NN	O
of	IN	O
the	DT	O
crop	NN	O
.	.	O
One	CD	O
of	IN	O
skill	NN	O
will	MD	O
recognize	VB	O
that	IN	O
a	DT	O
tissue-specific	JJ	O
plant	NN	O
promoter	NN	O
may	MD	O
drive	VB	O
expression	NN	O
of	IN	O
operably	RB	O
linked	VBN	O
sequences	NNS	O
in	IN	O
tissues	NNS	O
other	JJ	O
than	IN	O
the	DT	O
target	NN	O
tissue	NN	O
.	.	O
Thus	RB	O
,	,	O
a	DT	O
tissue-specific	JJ	O
promoter	NN	O
is	VBZ	O
one	CD	O
that	WDT	O
drives	VBZ	O
expression	NN	O
preferentially	RB	O
in	IN	O
the	DT	O
target	NN	O
tissue	NN	O
or	CC	O
cell	NN	O
type	NN	O
,	,	O
but	CC	O
may	MD	O
also	RB	O
lead	VB	O
to	TO	O
some	DT	O
expression	NN	O
in	IN	O
other	JJ	O
tissues	NNS	O
as	IN	O
well	RB	O
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
operably	RB	O
linked	VBN	O
to	TO	O
plant	NN	O
promoters	NNS	O
which	WDT	O
are	VBP	O
inducible	JJ	O
upon	IN	O
exposure	NN	O
to	TO	O
chemicals	NNS	O
reagents	NNS	O
.	.	O
These	DT	O
reagents	NNS	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
herbicides	NNS	O
,	,	O
synthetic	JJ	O
auxins	NNS	O
,	,	O
or	CC	O
antibiotics	NNS	O
which	WDT	O
can	MD	O
be	VB	O
applied	VBN	O
,	,	O
e.g.	FW	O
,	,	O
sprayed	VBN	O
,	,	O
onto	IN	O
transgenic	JJ	O
plants	NNS	O
.	.	O
Inducible	JJ	O
expression	NN	O
of	IN	O
the	DT	O
amylase-producing	JJ	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
will	MD	O
allow	VB	O
the	DT	O
grower	NN	O
to	TO	O
select	VB	O
plants	NNS	O
with	IN	O
the	DT	O
optimal	JJ	O
starch/sugar	NN	O
ratio	NN	O
.	.	O
The	DT	O
development	NN	O
of	IN	O
plant	NN	O
parts	NNS	O
can	MD	O
thus	RB	O
controlled	VB	O
.	.	O
In	IN	O
this	DT	O
way	NN	O
the	DT	O
invention	NN	O
provides	VBZ	O
the	DT	O
means	NNS	O
to	TO	O
facilitate	VB	O
the	DT	O
harvesting	NN	O
of	IN	O
plants	NNS	O
and	CC	O
plant	NN	O
parts	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
various	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
maize	JJ	O
In2-2	NNP	O
promoter	NN	O
,	,	O
activated	VBN	O
by	IN	O
benzenesulfonamide	JJ	O
herbicide	NN	O
safeners	NNS	O
,	,	O
is	VBZ	O
used	VBN	O
(	(	O
De	NNP	B
Veylder	NNP	I
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Cell	NNP	I
Physiol	NNP	I
.	.	I
38:568-577	JJ	I
)	)	O
;	:	O
application	NN	O
of	IN	O
different	JJ	O
herbicide	NN	O
safeners	NNS	O
induces	NNS	O
distinct	JJ	O
gene	NN	O
expression	NN	O
patterns	NNS	O
,	,	O
including	VBG	O
expression	NN	O
in	IN	O
the	DT	O
root	NN	O
,	,	O
hydathodes	NNS	O
,	,	O
and	CC	O
the	DT	O
shoot	JJ	O
apical	JJ	O
meristem	NN	O
.	.	O
Coding	VBG	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
also	RB	O
under	IN	O
the	DT	O
control	NN	O
of	IN	O
a	DT	O
tetracycline-inducible	JJ	O
promoter	NN	O
,	,	O
e.g.	RB	O
,	,	O
as	IN	O
described	VBN	O
with	IN	O
transgenic	JJ	O
tobacco	NN	O
plants	NNS	O
containing	VBG	O
the	DT	O
Avena	NNP	O
sativa	NN	O
L.	NNP	O
(	(	O
oat	NN	O
)	)	O
arginine	NN	O
decarboxylase	NN	O
gene	NN	O
(	(	O
Masgrau	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
.	.	I
11:465-473	JJ	I
)	)	O
;	:	O
or	CC	O
,	,	O
a	DT	O
salicylic	JJ	O
acid-responsive	JJ	O
element	NN	O
(	(	O
Stange	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
.	.	I
11:1315-1324	JJ	I
)	)	O
.	.	O
If	IN	O
proper	JJ	O
polypeptide	NN	O
expression	NN	O
is	VBZ	O
desired	VBN	O
,	,	O
a	DT	O
polyadenylation	NN	O
region	NN	O
at	IN	O
the	DT	O
3′-end	CD	O
of	IN	O
the	DT	O
coding	VBG	O
region	NN	O
should	MD	O
be	VB	O
included	VBN	O
.	.	O
The	DT	O
polyadenylation	NN	O
region	NN	O
can	MD	O
be	VB	O
derived	VBN	O
from	IN	O
the	DT	O
natural	JJ	O
gene	NN	O
,	,	O
from	IN	O
a	DT	O
variety	NN	O
of	IN	O
other	JJ	O
plant	NN	O
genes	NNS	O
,	,	O
or	CC	O
from	IN	O
genes	NNS	O
in	IN	O
the	DT	O
Agrobacterial	NNP	O
T-DNA	NNP	O
.	.	O
Expression	NN	O
Vectors	NNS	O
and	CC	O
Cloning	NNP	O
Vehicles	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
expression	NN	O
vectors	NNS	O
and	CC	O
cloning	VBG	O
vehicles	NNS	O
comprising	VBG	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
sequences	NNS	O
encoding	VBG	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Expression	NN	O
vectors	NNS	O
and	CC	O
cloning	VBG	O
vehicles	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
comprise	VB	O
viral	JJ	O
particles	NNS	O
,	,	O
baculovirus	NN	O
,	,	O
phage	NN	O
,	,	O
plasmids	NNS	O
,	,	O
phagemids	NNS	O
,	,	O
cosmids	NNS	O
,	,	O
fosmids	NNS	O
,	,	O
bacterial	JJ	O
artificial	JJ	O
chromosomes	NNS	O
,	,	O
viral	JJ	O
DNA	NNP	O
(	(	O
e.g.	NN	O
,	,	O
vaccinia	NN	O
,	,	O
adenovirus	NN	O
,	,	O
foul	JJ	O
pox	NN	O
virus	NN	O
,	,	O
pseudorabies	NNS	O
and	CC	O
derivatives	NNS	O
of	IN	O
SV40	NNP	O
)	)	O
,	,	O
P1-based	JJ	O
artificial	JJ	O
chromosomes	NNS	O
,	,	O
yeast	NN	O
plasmids	NNS	O
,	,	O
yeast	RB	O
artificial	JJ	O
chromosomes	NNS	O
,	,	O
and	CC	O
any	DT	O
other	JJ	O
vectors	NNS	O
specific	VBP	O
for	IN	O
specific	JJ	O
hosts	NNS	O
of	IN	O
interest	NN	O
(	(	O
such	JJ	O
as	IN	O
bacillus	NN	O
,	,	O
Aspergillus	NNP	O
and	CC	O
yeast	NN	O
)	)	O
.	.	O
Vectors	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
include	VB	O
chromosomal	JJ	O
,	,	O
non-chromosomal	JJ	O
and	CC	O
synthetic	JJ	O
DNA	NNP	O
sequences	NNS	O
.	.	O
Large	JJ	O
numbers	NNS	O
of	IN	O
suitable	JJ	O
vectors	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
those	DT	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
and	CC	O
are	VBP	O
commercially	RB	O
available	JJ	O
.	.	O
Exemplary	JJ	O
vectors	NNS	O
are	VBP	O
include	JJ	O
:	:	O
bacterial	JJ	O
:	:	O
pQE	NN	O
vectors	NNS	O
(	(	O
Qiagen	NNP	O
)	)	O
,	,	O
pBluescript	JJ	O
plasmids	NNS	O
,	,	O
pNH	NN	O
vectors	NNS	O
,	,	O
(	(	O
lambda-ZAP	JJ	O
vectors	NNS	O
(	(	O
Stratagene	NNP	O
)	)	O
;	:	O
ptrc99a	NN	O
,	,	O
pKK223-3	JJ	O
,	,	O
pDR540	NN	O
,	,	O
pRIT2T	NN	O
(	(	O
Pharmacia	NNP	O
)	)	O
;	:	O
Eukaryotic	JJ	O
:	:	O
pXT1	NN	O
,	,	O
pSG5	NN	O
(	(	O
Stratagene	NNP	O
)	)	O
,	,	O
pSVK3	NN	O
,	,	O
pBPV	NN	O
,	,	O
pMSG	NN	O
,	,	O
pSVLSV40	NN	O
(	(	O
Pharmacia	NNP	O
)	)	O
.	.	O
However	RB	O
,	,	O
any	DT	O
other	JJ	O
plasmid	NN	O
or	CC	O
other	JJ	O
vector	NN	O
may	MD	O
be	VB	O
used	VBN	O
so	RB	O
long	RB	O
as	IN	O
they	PRP	O
are	VBP	O
replicable	JJ	O
and	CC	O
viable	JJ	O
in	IN	O
the	DT	O
host	NN	O
.	.	O
Low	JJ	O
copy	NN	O
number	NN	O
or	CC	O
high	JJ	O
copy	NN	O
number	NN	O
vectors	NNS	O
may	MD	O
be	VB	O
employed	VBN	O
with	IN	O
the	DT	O
present	JJ	O
invention	NN	O
.	.	O
The	DT	O
expression	NN	O
vector	NN	O
can	MD	O
comprise	VB	O
a	DT	O
promoter	NN	O
,	,	O
a	DT	O
ribosome	NN	O
binding	NN	O
site	NN	O
for	IN	O
translation	NN	O
initiation	NN	O
and	CC	O
a	DT	O
transcription	NN	O
terminator	NN	O
.	.	O
The	DT	O
vector	NN	O
may	MD	O
also	RB	O
include	VB	O
appropriate	JJ	O
sequences	NNS	O
for	IN	O
amplifying	VBG	O
expression	NN	O
.	.	O
Mammalian	JJ	O
expression	NN	O
vectors	NNS	O
can	MD	O
comprise	VB	O
an	DT	O
origin	NN	O
of	IN	O
replication	NN	O
,	,	O
any	DT	O
necessary	JJ	O
ribosome	NN	O
binding	NN	O
sites	NNS	O
,	,	O
a	DT	O
polyadenylation	NN	O
site	NN	O
,	,	O
splice	JJ	O
donor	NN	O
and	CC	O
acceptor	NN	O
sites	NNS	O
,	,	O
transcriptional	JJ	O
termination	NN	O
sequences	NNS	O
,	,	O
and	CC	O
5′	CD	O
flanking	VBG	O
non-transcribed	JJ	O
sequences	NNS	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
DNA	NNP	O
sequences	VBZ	O
derived	VBN	O
from	IN	O
the	DT	O
SV40	NNP	O
splice	NN	O
and	CC	O
polyadenylation	NN	O
sites	NNS	O
may	MD	O
be	VB	O
used	VBN	O
to	TO	O
provide	VB	O
the	DT	O
required	JJ	O
non-transcribed	JJ	O
genetic	JJ	O
elements	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
expression	NN	O
vectors	NNS	O
contain	VBP	O
one	CD	O
or	CC	O
more	JJR	O
selectable	JJ	O
marker	NN	O
genes	NNS	O
to	TO	O
permit	VB	O
selection	NN	O
of	IN	O
host	NN	O
cells	NNS	O
containing	VBG	O
the	DT	O
vector	NN	O
.	.	O
Such	JJ	O
selectable	JJ	O
markers	NNS	O
include	VBP	O
genes	NNS	O
encoding	VBG	O
dihydrofolate	JJ	O
reductase	NN	O
or	CC	O
genes	NNS	O
conferring	VBG	O
neomycin	JJ	O
resistance	NN	O
for	IN	O
eukaryotic	JJ	O
cell	NN	O
culture	NN	O
,	,	O
genes	NNS	O
conferring	VBG	O
tetracycline	NN	O
or	CC	O
ampicillin	NN	O
resistance	NN	O
in	IN	O
E.	NNP	O
coli	NNS	O
,	,	O
and	CC	O
the	DT	O
S.	NNP	O
cerevisiae	NN	O
TRP1	NNP	O
gene	NN	O
.	.	O
Promoter	NN	O
regions	NNS	O
can	MD	O
be	VB	O
selected	VBN	O
from	IN	O
any	DT	O
desired	JJ	O
gene	NN	O
using	VBG	O
chloramphenicol	JJ	O
transferase	NN	O
(	(	O
CAT	NNP	O
)	)	O
vectors	NNS	O
or	CC	O
other	JJ	O
vectors	NNS	O
with	IN	O
selectable	JJ	O
markers	NNS	O
.	.	O
Vectors	NNS	O
for	IN	O
expressing	VBG	O
the	DT	O
polypeptide	NN	O
or	CC	O
fragment	JJ	O
thereof	NN	O
in	IN	O
eukaryotic	JJ	O
cells	NNS	O
can	MD	O
also	RB	O
contain	VB	O
enhancers	NNS	O
to	TO	O
increase	VB	O
expression	NN	O
levels	NNS	O
.	.	O
Enhancers	NNS	O
are	VBP	O
cis-acting	JJ	O
elements	NNS	O
of	IN	O
DNA	NNP	O
,	,	O
usually	RB	O
from	IN	O
about	RB	O
10	CD	O
to	TO	O
about	IN	O
300	CD	O
bp	NN	O
in	IN	O
length	NN	O
that	WDT	O
act	NN	O
on	IN	O
a	DT	O
promoter	NN	O
to	TO	O
increase	VB	O
its	PRP$	O
transcription	NN	O
.	.	O
Examples	NNS	O
include	VBP	O
the	DT	O
SV40	NNP	O
enhancer	NN	O
on	IN	O
the	DT	O
late	JJ	O
side	NN	O
of	IN	O
the	DT	O
replication	NN	O
origin	NN	O
by	IN	O
100	CD	O
to	TO	O
270	CD	O
,	,	O
the	DT	O
cytomegalovirus	NN	O
early	JJ	O
promoter	NN	O
enhancer	NN	O
,	,	O
the	DT	O
polyoma	NN	O
enhancer	NN	O
on	IN	O
the	DT	O
late	JJ	O
side	NN	O
of	IN	O
the	DT	O
replication	NN	O
origin	NN	O
,	,	O
and	CC	O
the	DT	O
adenovirus	NN	O
enhancers	NNS	O
.	.	O
A	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
can	MD	O
be	VB	O
inserted	VBN	O
into	IN	O
a	DT	O
vector	NN	O
by	IN	O
a	DT	O
variety	NN	O
of	IN	O
procedures	NNS	O
.	.	O
In	IN	O
general	JJ	O
,	,	O
the	DT	O
sequence	NN	O
is	VBZ	O
ligated	VBN	O
to	TO	O
the	DT	O
desired	VBN	O
position	NN	O
in	IN	O
the	DT	O
vector	NN	O
following	VBG	O
digestion	NN	O
of	IN	O
the	DT	O
insert	NN	O
and	CC	O
the	DT	O
vector	NN	O
with	IN	O
appropriate	JJ	O
restriction	NN	O
endonucleases	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
blunt	NN	O
ends	NNS	O
in	IN	O
both	DT	O
the	DT	O
insert	NN	O
and	CC	O
the	DT	O
vector	NN	O
may	MD	O
be	VB	O
ligated	VBN	O
.	.	O
A	DT	O
variety	NN	O
of	IN	O
cloning	VBG	O
techniques	NNS	O
are	VBP	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
e.g.	RB	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
Ausubel	NNP	O
and	CC	O
Sambrook	NNP	O
.	.	O
Such	JJ	O
procedures	NNS	O
and	CC	O
others	NNS	O
are	VBP	O
deemed	VBN	O
to	TO	O
be	VB	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
The	DT	O
vector	NN	O
can	MD	O
be	VB	O
in	IN	O
the	DT	O
form	NN	O
of	IN	O
a	DT	O
plasmid	NN	O
,	,	O
a	DT	O
viral	JJ	O
particle	NN	O
,	,	O
or	CC	O
a	DT	O
phage	NN	O
.	.	O
Other	JJ	O
vectors	NNS	O
include	VBP	O
chromosomal	JJ	O
,	,	O
non-chromosomal	JJ	O
and	CC	O
synthetic	JJ	O
DNA	NNP	O
sequences	NNS	O
,	,	O
derivatives	NNS	O
of	IN	O
SV40	NNP	O
;	:	O
bacterial	JJ	O
plasmids	NNS	O
,	,	O
phage	NN	O
DNA	NNP	O
,	,	O
baculovirus	NN	O
,	,	O
yeast	NN	O
plasmids	NNS	O
,	,	O
vectors	NNS	O
derived	VBD	O
from	IN	O
combinations	NNS	O
of	IN	O
plasmids	NNS	O
and	CC	O
phage	NN	O
DNA	NN	O
,	,	O
viral	JJ	O
DNA	NNP	O
such	JJ	O
as	IN	O
vaccinia	NN	O
,	,	O
adenovirus	NN	O
,	,	O
fowl	NN	O
pox	NN	O
virus	NN	O
,	,	O
and	CC	O
pseudorabies	NNS	O
.	.	O
A	DT	O
variety	NN	O
of	IN	O
cloning	VBG	O
and	CC	O
expression	NN	O
vectors	NNS	O
for	IN	O
use	NN	O
with	IN	O
prokaryotic	JJ	O
and	CC	O
eukaryotic	JJ	O
hosts	NNS	O
are	VBP	O
described	VBN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
Sambrook	NNP	O
.	.	O
Particular	JJ	O
bacterial	NN	O
vectors	NNS	O
which	WDT	O
can	MD	O
be	VB	O
used	VBN	O
include	VBP	O
the	DT	O
commercially	RB	O
available	JJ	O
plasmids	NNS	O
comprising	VBG	O
genetic	JJ	O
elements	NNS	O
of	IN	O
the	DT	O
well	NN	O
known	VBN	O
cloning	VBG	O
vector	NN	O
pBR322	NN	O
(	(	O
ATCC	NNP	O
37017	CD	O
)	)	O
,	,	O
pKK223-3	JJ	O
(	(	O
Pharmacia	NNP	O
Fine	NNP	O
Chemicals	NNP	O
,	,	O
Uppsala	NNP	O
,	,	O
Sweden	NNP	O
)	)	O
,	,	O
GEM1	NNP	O
(	(	O
Promega	NNP	O
Biotec	NNP	O
,	,	O
Madison	NNP	O
,	,	O
Wis.	NNP	O
,	,	O
USA	NNP	O
)	)	O
pQE70	NN	O
,	,	O
pQE60	NN	O
,	,	O
pQE-9	NN	O
(	(	O
Qiagen	NNP	O
)	)	O
,	,	O
pD10	NN	O
,	,	O
psiX174	NN	O
pBluescript	NN	O
II	NNP	O
KS	NNP	O
,	,	O
pNH8A	NN	O
,	,	O
pNH16a	NN	O
,	,	O
pNH18A	NN	O
,	,	O
pNH46A	NN	O
(	(	O
Stratagene	NNP	O
)	)	O
,	,	O
ptrc99a	JJ	O
,	,	O
pKK223-3	JJ	O
,	,	O
pKK233-3	JJ	O
,	,	O
DR540	NNP	O
,	,	O
pRIT5	NN	O
(	(	O
Pharmacia	NNP	O
)	)	O
,	,	O
pKK232-8	JJ	O
and	CC	O
pCM7	NN	O
.	.	O
Particular	JJ	O
eukaryotic	JJ	O
vectors	NNS	O
include	VBP	O
pSV2CAT	NN	O
,	,	O
pOG44	NN	O
,	,	O
pXT1	NN	O
,	,	O
pSG	NN	O
(	(	O
Stratagene	NNP	O
)	)	O
pSVK3	NN	O
,	,	O
pBPV	NN	O
,	,	O
pMSG	NN	O
,	,	O
and	CC	O
pSVL	NN	O
(	(	O
Pharmacia	NNP	O
)	)	O
.	.	O
However	RB	O
,	,	O
any	DT	O
other	JJ	O
vector	NN	O
may	MD	O
be	VB	O
used	VBN	O
as	RB	O
long	RB	O
as	IN	O
it	PRP	O
is	VBZ	O
replicable	JJ	O
and	CC	O
viable	JJ	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
expressed	VBN	O
in	IN	O
expression	NN	O
cassettes	NNS	O
,	,	O
vectors	NNS	O
or	CC	O
viruses	NNS	O
and	CC	O
transiently	RB	O
or	CC	O
stably	RB	O
expressed	VBN	O
in	IN	O
plant	NN	O
cells	NNS	O
and	CC	O
seeds	NNS	O
.	.	O
One	CD	O
exemplary	JJ	O
transient	NN	O
expression	NN	O
system	NN	O
uses	VBZ	O
episomal	JJ	O
expression	NN	O
systems	NNS	O
,	,	O
e.g.	NN	O
,	,	O
cauliflower	JJR	O
mosaic	NN	O
virus	NN	O
(	(	O
CaMV	NNP	O
)	)	O
viral	JJ	O
RNA	NNP	O
generated	VBD	O
in	IN	O
the	DT	O
nucleus	NN	O
by	IN	O
transcription	NN	O
of	IN	O
an	DT	O
episomal	JJ	O
mini-chromosome	JJ	O
containing	NN	O
supercoiled	VBD	O
DNA	NNP	O
,	,	O
see	NN	O
,	,	O
e.g.	VB	O
,	,	O
Covey	NNP	B
(	(	I
1990	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
87:1633-1637	CD	I
.	.	O
Alternatively	RB	O
,	,	O
coding	VBG	O
sequences	NNS	O
,	,	O
i.e.	FW	O
,	,	O
all	DT	O
or	CC	O
sub-fragments	NNS	O
of	IN	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
inserted	VBN	O
into	IN	O
a	DT	O
plant	NN	O
host	NN	O
cell	NN	O
genome	NN	O
becoming	VBG	O
an	DT	O
integral	JJ	O
part	NN	O
of	IN	O
the	DT	O
host	NN	O
chromosomal	JJ	O
DNA	NNP	O
.	.	O
Sense	NN	O
or	CC	O
antisense	NN	O
transcripts	NNS	O
can	MD	O
be	VB	O
expressed	VBN	O
in	IN	O
this	DT	O
manner	NN	O
.	.	O
A	DT	O
vector	NN	O
comprising	VBG	O
the	DT	O
sequences	NNS	O
(	(	O
e.g.	NN	O
,	,	O
promoters	NNS	O
or	CC	O
coding	VBG	O
regions	NNS	O
)	)	O
from	IN	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
comprise	VB	O
a	DT	O
marker	NN	O
gene	NN	O
that	WDT	O
confers	VBZ	O
a	DT	O
selectable	JJ	O
phenotype	NN	O
on	IN	O
a	DT	O
plant	NN	O
cell	NN	O
or	CC	O
a	DT	O
seed	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
marker	NN	O
may	MD	O
encode	VB	O
biocide	NN	O
resistance	NN	O
,	,	O
particularly	RB	O
antibiotic	JJ	O
resistance	NN	O
,	,	O
such	JJ	O
as	IN	O
resistance	NN	O
to	TO	O
kanamycin	VB	O
,	,	O
G418	NNP	O
,	,	O
bleomycin	NN	O
,	,	O
hygromycin	NN	O
,	,	O
or	CC	O
herbicide	NN	O
resistance	NN	O
,	,	O
such	JJ	O
as	IN	O
resistance	NN	O
to	TO	O
chlorosulfuron	VB	O
or	CC	O
Basta	NNP	O
.	.	O
Expression	NN	O
vectors	NNS	O
capable	JJ	O
of	IN	O
expressing	VBG	O
nucleic	JJ	O
acids	NNS	O
and	CC	O
proteins	NNS	O
in	IN	O
plants	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
and	CC	O
can	MD	O
include	VB	O
,	,	O
e.g.	FW	O
,	,	O
vectors	NNS	O
from	IN	O
Agrobacterium	NNP	O
spp.	NN	O
,	,	O
potato	NN	O
virus	NN	O
X	NNP	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Angell	NNP	B
(	(	I
1997	CD	I
)	)	I
EMBO	NNP	I
J	NNP	I
.	.	I
16:3675-3684	JJ	I
)	)	O
,	,	O
tobacco	NN	O
mosaic	NN	O
virus	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Casper	NNP	B
(	(	I
1996	CD	I
)	)	I
Gene	NNP	I
173:69-73	JJ	I
)	)	O
,	,	O
tomato	JJ	O
bushy	NN	O
stunt	NN	O
virus	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Hillman	NNP	B
(	(	I
1989	CD	I
)	)	I
Virology	NNP	I
169:42-50	JJ	I
)	)	O
,	,	O
tobacco	NN	O
etch	NN	O
virus	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Dolja	NNP	B
(	(	I
1997	CD	I
)	)	I
Virology	NNP	I
234:243-252	JJ	I
)	)	O
,	,	O
bean	JJ	O
golden	JJ	O
mosaic	NN	O
virus	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Morinaga	NNP	B
(	(	I
1993	CD	I
)	)	I
Microbiol	NNP	I
Immunol	NNP	I
.	.	I
37:471-476	JJ	I
)	)	O
,	,	O
cauliflower	JJR	O
mosaic	NN	O
virus	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Cecchini	NNP	B
(	(	I
1997	CD	I
)	)	I
Mol	NNP	I
.	.	I
Plant	NN	I
Microbe	NNP	I
Interact	NNP	I
.	.	I
10:1094-1101	JJ	I
)	)	O
,	,	O
maize	VB	O
Ac/Ds	NNP	O
transposable	JJ	O
element	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Rubin	NNP	B
(	(	I
1997	CD	I
)	)	I
Mol	NNP	I
.	.	I
Cell	NNP	I
.	.	I
Biol	NNP	I
.	.	I
17:6294-6302	JJ	I
;	:	O
Kunze	NNP	B
(	(	I
1996	CD	I
)	)	I
Curr	NNP	I
.	.	I
Top	NN	I
.	.	I
Microbiol	NNP	I
.	.	I
Immunol	NNP	I
.	.	I
204:161-194	JJ	I
)	)	O
,	,	O
and	CC	O
the	DT	O
maize	JJ	O
suppressor-mutator	NN	O
(	(	O
Spm	NNP	O
)	)	O
transposable	JJ	O
element	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Schlappi	NNP	B
(	(	I
1996	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
32:717-725	JJ	I
)	)	O
;	:	O
and	CC	O
derivatives	NNS	O
thereof	VBP	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
expression	NN	O
vector	NN	O
can	MD	O
have	VB	O
two	CD	O
replication	NN	O
systems	NNS	O
to	TO	O
allow	VB	O
it	PRP	O
to	TO	O
be	VB	O
maintained	VBN	O
in	IN	O
two	CD	O
organisms	NNS	O
,	,	O
for	IN	O
example	NN	O
in	IN	O
mammalian	JJ	O
or	CC	O
insect	JJ	O
cells	NNS	O
for	IN	O
expression	NN	O
and	CC	O
in	IN	O
a	DT	O
prokaryotic	JJ	O
host	NN	O
for	IN	O
cloning	VBG	O
and	CC	O
amplification	NN	O
.	.	O
Furthermore	RB	O
,	,	O
for	IN	O
integrating	VBG	O
expression	NN	O
vectors	NNS	O
,	,	O
the	DT	O
expression	NN	O
vector	NN	O
can	MD	O
contain	VB	O
at	IN	O
least	JJS	O
one	CD	O
sequence	NN	O
homologous	JJ	O
to	TO	O
the	DT	O
host	NN	O
cell	NN	O
genome	NN	O
.	.	O
It	PRP	O
can	MD	O
contain	VB	O
two	CD	O
homologous	JJ	O
sequences	NNS	O
which	WDT	O
flank	VBP	O
the	DT	O
expression	NN	O
construct	NN	O
.	.	O
The	DT	O
integrating	VBG	O
vector	NN	O
can	MD	O
be	VB	O
directed	VBN	O
to	TO	O
a	DT	O
specific	JJ	O
locus	NN	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
by	IN	O
selecting	VBG	O
the	DT	O
appropriate	JJ	O
homologous	JJ	O
sequence	NN	O
for	IN	O
inclusion	NN	O
in	IN	O
the	DT	O
vector	NN	O
.	.	O
Constructs	NNS	O
for	IN	O
integrating	VBG	O
vectors	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Expression	NN	O
vectors	NNS	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
also	RB	O
include	VB	O
a	DT	O
selectable	JJ	O
marker	NN	O
gene	NN	O
to	TO	O
allow	VB	O
for	IN	O
the	DT	O
selection	NN	O
of	IN	O
bacterial	JJ	O
strains	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
transformed	VBN	O
,	,	O
e.g.	FW	O
,	,	O
genes	NNS	O
which	WDT	O
render	VBP	O
the	DT	O
bacteria	NN	O
resistant	NN	O
to	TO	O
drugs	NNS	O
such	JJ	O
as	IN	O
ampicillin	NN	O
,	,	O
chloramphenicol	NN	O
,	,	O
erythromycin	NN	O
,	,	O
kanamycin	NN	O
,	,	O
neomycin	NN	O
and	CC	O
tetracycline	NN	O
.	.	O
Selectable	JJ	O
markers	NNS	O
can	MD	O
also	RB	O
include	VB	O
biosynthetic	JJ	O
genes	NNS	O
,	,	O
such	JJ	O
as	IN	O
those	DT	O
in	IN	O
the	DT	O
histidine	NN	O
,	,	O
tryptophan	NN	O
and	CC	O
leucine	JJ	O
biosynthetic	JJ	O
pathways	NNS	O
.	.	O
Host	NNP	O
Cells	NNP	O
and	CC	O
Transformed	NNP	O
Cells	NNP	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
transformed	JJ	O
cell	NN	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
sequence	NN	O
encoding	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
vector	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
host	NN	O
cell	NN	O
may	MD	O
be	VB	O
any	DT	O
of	IN	O
the	DT	O
host	NN	O
cells	NNS	O
familiar	JJ	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
including	VBG	O
prokaryotic	JJ	O
cells	NNS	O
,	,	O
eukaryotic	JJ	O
cells	NNS	O
,	,	O
such	JJ	O
as	IN	O
bacterial	JJ	O
cells	NNS	O
,	,	O
fungal	JJ	O
cells	NNS	O
,	,	O
yeast	NN	O
cells	NNS	O
,	,	O
mammalian	JJ	O
cells	NNS	O
,	,	O
insect	JJ	O
cells	NNS	O
,	,	O
or	CC	O
plant	NN	O
cells	NNS	O
.	.	O
Exemplary	JJ	O
bacterial	JJ	O
cells	NNS	O
include	VBP	O
E.	NNP	O
coli	NNS	O
,	,	O
Streptomyces	NNS	O
,	,	O
Bacillus	NNP	O
subtilis	NNS	O
,	,	O
Salmonella	NNP	O
typhimurium	NN	O
and	CC	O
various	JJ	O
species	NNS	O
within	IN	O
the	DT	O
genera	NN	O
Pseudomonas	NNP	O
,	,	O
Streptomyces	NNP	O
,	,	O
and	CC	O
Staphylococcus	NNP	O
.	.	O
Exemplary	JJ	O
insect	NN	O
cells	NNS	O
include	VBP	O
Drosophila	NNP	O
S2	NNP	O
and	CC	O
Spodoptera	NNP	O
Sf9	NNP	O
.	.	O
Exemplary	NNP	O
animal	NN	O
cells	NNS	O
include	VBP	O
CHO	NNP	O
,	,	O
COS	NNP	O
or	CC	O
Bowes	NNP	O
melanoma	CD	O
or	CC	O
any	DT	O
mouse	NN	O
or	CC	O
human	JJ	O
cell	NN	O
line	NN	O
.	.	O
The	DT	O
selection	NN	O
of	IN	O
an	DT	O
appropriate	JJ	O
host	NN	O
is	VBZ	O
within	IN	O
the	DT	O
abilities	NNS	O
of	IN	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Techniques	NNS	O
for	IN	O
transforming	VBG	O
a	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
higher	JJR	O
plant	NN	O
species	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
and	CC	O
described	VBN	O
in	IN	O
the	DT	O
technical	JJ	O
and	CC	O
scientific	JJ	O
literature	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
Weising	NNP	B
(	(	I
1988	CD	I
)	)	I
Ann	NNP	I
.	.	I
Rev	NNP	I
.	.	I
Genet	NNP	I
.	.	I
22:421-477	JJ	I
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,750,870	CD	O
.	.	O
The	DT	O
vector	NN	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
the	DT	O
host	NN	O
cells	NNS	O
using	VBG	O
any	DT	O
of	IN	O
a	DT	O
variety	NN	O
of	IN	O
techniques	NNS	O
,	,	O
including	VBG	O
transformation	NN	O
,	,	O
transfection	NN	O
,	,	O
transduction	NN	O
,	,	O
viral	JJ	O
infection	NN	O
,	,	O
gene	NN	O
guns	NNS	O
,	,	O
or	CC	O
Ti-mediated	JJ	O
gene	NN	O
transfer	NN	O
.	.	O
Particular	JJ	O
methods	NNS	O
include	VBP	O
calcium	JJ	O
phosphate	JJ	O
transfection	NN	O
,	,	O
DEAE-Dextran	NNP	O
mediated	VBD	O
transfection	NN	O
,	,	O
lipofection	NN	O
,	,	O
or	CC	O
electroporation	NN	O
(	(	O
Davis	NNP	B
,	,	I
L.	NNP	I
,	,	I
Dibner	NNP	I
,	,	I
M.	NNP	I
,	,	I
Battey	NNP	I
,	,	I
I.	NNP	I
,	,	I
Basic	NNP	I
Methods	NNP	I
in	IN	I
Molecular	NNP	I
Biology	NNP	I
,	,	I
(	(	I
1986	CD	I
)	)	I
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
or	CC	O
vectors	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
introduced	VBN	O
into	IN	O
the	DT	O
cells	NNS	O
for	IN	O
screening	VBG	O
,	,	O
thus	RB	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
enter	VBP	O
the	DT	O
cells	NNS	O
in	IN	O
a	DT	O
manner	NN	O
suitable	JJ	O
for	IN	O
subsequent	JJ	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
.	.	O
The	DT	O
method	NN	O
of	IN	O
introduction	NN	O
is	VBZ	O
largely	RB	O
dictated	VBN	O
by	IN	O
the	DT	O
targeted	VBN	O
cell	NN	O
type	NN	O
.	.	O
Exemplary	JJ	O
methods	NNS	O
include	VBP	O
CaPO4	NNP	O
precipitation	NN	O
,	,	O
liposome	JJ	O
fusion	NN	O
,	,	O
lipofection	NN	O
(	(	O
e.g.	JJ	O
,	,	O
LIPOFECTIN™	NNP	O
)	)	O
,	,	O
electroporation	NN	O
,	,	O
viral	JJ	O
infection	NN	O
,	,	O
etc	FW	O
.	.	O
The	DT	O
candidate	NN	O
nucleic	JJ	O
acids	NNS	O
may	MD	O
stably	VB	O
integrate	VB	O
into	IN	O
the	DT	O
genome	NN	O
of	IN	O
the	DT	O
host	NN	O
cell	NN	O
(	(	O
for	IN	O
example	NN	O
,	,	O
with	IN	O
retroviral	JJ	O
introduction	NN	O
)	)	O
or	CC	O
may	MD	O
exist	VB	O
either	CC	O
transiently	RB	O
or	CC	O
stably	RB	O
in	IN	O
the	DT	O
cytoplasm	NN	O
(	(	O
i.e	NN	O
.	.	O
through	IN	O
the	DT	O
use	NN	O
of	IN	O
traditional	JJ	O
plasmids	NNS	O
,	,	O
utilizing	VBG	O
standard	JJ	O
regulatory	JJ	O
sequences	NNS	O
,	,	O
selection	NN	O
markers	NNS	O
,	,	O
etc	FW	O
.	.	O
)	)	O
.	.	O
As	IN	O
many	JJ	O
pharmaceutically	RB	O
important	JJ	O
screens	NNS	O
require	VBP	O
human	JJ	O
or	CC	O
model	NN	O
mammalian	JJ	O
cell	NN	O
targets	NNS	O
,	,	O
retroviral	JJ	O
vectors	NNS	O
capable	JJ	O
of	IN	O
transfecting	VBG	O
such	JJ	O
targets	NNS	O
are	VBP	O
preferred	VBN	O
.	.	O
Where	WRB	O
appropriate	NN	O
,	,	O
the	DT	O
engineered	JJ	O
host	NN	O
cells	NNS	O
can	MD	O
be	VB	O
cultured	VBN	O
in	IN	O
conventional	JJ	O
nutrient	JJ	O
media	NNS	O
modified	VBD	O
as	IN	O
appropriate	NN	O
for	IN	O
activating	VBG	O
promoters	NNS	O
,	,	O
selecting	VBG	O
transformants	NNS	O
or	CC	O
amplifying	VBG	O
the	DT	O
genes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Following	VBG	O
transformation	NN	O
of	IN	O
a	DT	O
suitable	JJ	O
host	NN	O
strain	NN	O
and	CC	O
growth	NN	O
of	IN	O
the	DT	O
host	NN	O
strain	NN	O
to	TO	O
an	DT	O
appropriate	JJ	O
cell	NN	O
density	NN	O
,	,	O
the	DT	O
selected	VBN	O
promoter	NN	O
may	MD	O
be	VB	O
induced	VBN	O
by	IN	O
appropriate	JJ	O
means	NNS	O
(	(	O
e.g.	NN	O
,	,	O
temperature	NN	O
shift	NN	O
or	CC	O
chemical	JJ	O
induction	NN	O
)	)	O
and	CC	O
the	DT	O
cells	NNS	O
may	MD	O
be	VB	O
cultured	VBN	O
for	IN	O
an	DT	O
additional	JJ	O
period	NN	O
to	TO	O
allow	VB	O
them	PRP	O
to	TO	O
produce	VB	O
the	DT	O
desired	JJ	O
polypeptide	NN	O
or	CC	O
fragment	JJ	O
thereof	NN	O
.	.	O
Cells	NNS	O
can	MD	O
be	VB	O
harvested	VBN	O
by	IN	O
centrifugation	NN	O
,	,	O
disrupted	VBN	O
by	IN	O
physical	JJ	O
or	CC	O
chemical	NN	O
means	NNS	O
,	,	O
and	CC	O
the	DT	O
resulting	VBG	O
crude	JJ	O
extract	NN	O
is	VBZ	O
retained	VBN	O
for	IN	O
further	JJ	O
purification	NN	O
.	.	O
Microbial	NNP	O
cells	NNS	O
employed	VBN	O
for	IN	O
expression	NN	O
of	IN	O
proteins	NNS	O
can	MD	O
be	VB	O
disrupted	VBN	O
by	IN	O
any	DT	O
convenient	JJ	O
method	NN	O
,	,	O
including	VBG	O
freeze-thaw	JJ	O
cycling	NN	O
,	,	O
sonication	NN	O
,	,	O
mechanical	JJ	O
disruption	NN	O
,	,	O
or	CC	O
use	NN	O
of	IN	O
cell	NN	O
lysing	VBG	O
agents	NNS	O
.	.	O
Such	JJ	O
methods	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
The	DT	O
expressed	JJ	O
polypeptide	NN	O
or	CC	O
fragment	JJ	O
thereof	NN	O
can	MD	O
be	VB	O
recovered	VBN	O
and	CC	O
purified	VBN	O
from	IN	O
recombinant	NN	O
cell	NN	O
cultures	NNS	O
by	IN	O
methods	NNS	O
including	VBG	O
ammonium	NN	O
sulfate	NN	O
or	CC	O
ethanol	JJ	O
precipitation	NN	O
,	,	O
acid	JJ	O
extraction	NN	O
,	,	O
anion	NN	O
or	CC	O
cation	NN	O
exchange	NN	O
chromatography	NN	O
,	,	O
phosphocellulose	JJ	O
chromatography	NN	O
,	,	O
hydrophobic	JJ	O
interaction	NN	O
chromatography	NN	O
,	,	O
affinity	NN	O
chromatography	NN	O
,	,	O
hydroxylapatite	JJ	O
chromatography	NN	O
and	CC	O
lectin	NN	O
chromatography	NN	O
.	.	O
Protein	NNP	O
refolding	VBG	O
steps	NNS	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
as	IN	O
necessary	JJ	O
,	,	O
in	IN	O
completing	VBG	O
configuration	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
.	.	O
If	IN	O
desired	VBN	O
,	,	O
high	JJ	O
performance	NN	O
liquid	NN	O
chromatography	NN	O
(	(	O
HPLC	NNP	O
)	)	O
can	MD	O
be	VB	O
employed	VBN	O
for	IN	O
final	JJ	O
purification	NN	O
steps	NNS	O
.	.	O
Various	JJ	O
mammalian	JJ	O
cell	NN	O
culture	NN	O
systems	NNS	O
can	MD	O
also	RB	O
be	VB	O
employed	VBN	O
to	TO	O
express	VB	O
recombinant	JJ	O
protein	NN	O
.	.	O
Examples	NNS	O
of	IN	O
mammalian	JJ	O
expression	NN	O
systems	NNS	O
include	VBP	O
the	DT	O
COS-7	NNP	O
lines	NNS	O
of	IN	O
monkey	JJ	O
kidney	NN	O
fibroblasts	NNS	O
and	CC	O
other	JJ	O
cell	NN	O
lines	NNS	O
capable	JJ	O
of	IN	O
expressing	VBG	O
proteins	NNS	O
from	IN	O
a	DT	O
compatible	JJ	O
vector	NN	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
C127	NNP	O
,	,	O
3T3	CD	O
,	,	O
CHO	NNP	O
,	,	O
HeLa	NNP	O
and	CC	O
BHK	NNP	O
cell	NN	O
lines	NNS	O
.	.	O
The	DT	O
constructs	NNS	O
in	IN	O
host	NN	O
cells	NNS	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
conventional	JJ	O
manner	NN	O
to	TO	O
produce	VB	O
the	DT	O
gene	NN	O
product	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
recombinant	JJ	O
sequence	NN	O
.	.	O
Depending	VBG	O
upon	IN	O
the	DT	O
host	NN	O
employed	VBN	O
in	IN	O
a	DT	O
recombinant	JJ	O
production	NN	O
procedure	NN	O
,	,	O
the	DT	O
polypeptides	NNS	O
produced	VBN	O
by	IN	O
host	NN	O
cells	NNS	O
containing	VBG	O
the	DT	O
vector	NN	O
may	MD	O
be	VB	O
glycosylated	VBN	O
or	CC	O
may	MD	O
be	VB	O
non-glycosylated	JJ	O
.	.	O
Polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
or	CC	O
may	MD	O
not	RB	O
also	RB	O
include	VBP	O
an	DT	O
initial	JJ	O
methionine	NN	O
amino	NN	O
acid	NN	O
residue	NN	O
.	.	O
Cell-free	JJ	O
translation	NN	O
systems	NNS	O
can	MD	O
also	RB	O
be	VB	O
employed	VBN	O
to	TO	O
produce	VB	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Cell-free	JJ	O
translation	NN	O
systems	NNS	O
can	MD	O
use	VB	O
mRNAs	JJ	O
transcribed	NN	O
from	IN	O
a	DT	O
DNA	NNP	O
construct	NN	O
comprising	VBG	O
a	DT	O
promoter	NN	O
operably	RB	O
linked	VBD	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
the	DT	O
polypeptide	NN	O
or	CC	O
fragment	JJ	O
thereof	NN	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
the	DT	O
DNA	NNP	O
construct	NN	O
may	MD	O
be	VB	O
linearized	VBN	O
prior	RB	O
to	TO	O
conducting	VBG	O
an	DT	O
in	IN	O
vitro	JJ	O
transcription	NN	O
reaction	NN	O
.	.	O
The	DT	O
transcribed	JJ	O
mRNA	NN	O
is	VBZ	O
then	RB	O
incubated	VBN	O
with	IN	O
an	DT	O
appropriate	JJ	O
cell-free	JJ	O
translation	NN	O
extract	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
rabbit	NN	O
reticulocyte	NN	O
extract	NN	O
,	,	O
to	TO	O
produce	VB	O
the	DT	O
desired	JJ	O
polypeptide	NN	O
or	CC	O
fragment	JJ	O
thereof	NN	O
.	.	O
The	DT	O
expression	NN	O
vectors	NNS	O
can	MD	O
contain	VB	O
one	CD	O
or	CC	O
more	JJR	O
selectable	JJ	O
marker	NN	O
genes	NNS	O
to	TO	O
provide	VB	O
a	DT	O
phenotypic	NN	O
trait	NN	O
for	IN	O
selection	NN	O
of	IN	O
transformed	JJ	O
host	NN	O
cells	NNS	O
such	JJ	O
as	IN	O
dihydrofolate	JJ	O
reductase	NN	O
or	CC	O
neomycin	JJ	O
resistance	NN	O
for	IN	O
eukaryotic	JJ	O
cell	NN	O
culture	NN	O
,	,	O
or	CC	O
such	JJ	O
as	IN	O
tetracycline	NN	O
or	CC	O
ampicillin	NN	O
resistance	NN	O
in	IN	O
E.	NNP	O
coli	NNS	O
.	.	O
Amplification	NN	O
of	IN	O
Nucleic	NNP	O
Acids	NNP	O
In	IN	O
practicing	VBG	O
the	DT	O
invention	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
modified	VBN	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
can	MD	O
be	VB	O
reproduced	VBN	O
by	IN	O
amplification	NN	O
.	.	O
Amplification	NN	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
clone	VB	O
or	CC	O
modify	VB	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pairs	NNS	O
for	IN	O
amplifying	VBG	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
One	CD	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
can	MD	O
design	VB	O
amplification	NN	O
primer	NN	O
sequence	NN	O
pairs	NNS	O
for	IN	O
any	DT	O
part	NN	O
of	IN	O
or	CC	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
these	DT	O
sequences	NNS	O
.	.	O
Amplification	NN	O
reactions	NNS	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
quantify	VB	O
the	DT	O
amount	NN	O
of	IN	O
nucleic	JJ	O
acid	NN	O
in	IN	O
a	DT	O
sample	NN	O
(	(	O
such	JJ	O
as	IN	O
the	DT	O
amount	NN	O
of	IN	O
message	NN	O
in	IN	O
a	DT	O
cell	NN	O
sample	NN	O
)	)	O
,	,	O
label	VBZ	O
the	DT	O
nucleic	JJ	O
acid	NN	O
(	(	O
e.g.	UH	O
,	,	O
to	TO	O
apply	VB	O
it	PRP	O
to	TO	O
an	DT	O
array	NN	O
or	CC	O
a	DT	O
blot	NN	O
)	)	O
,	,	O
detect	VBP	O
the	DT	O
nucleic	JJ	O
acid	NN	O
,	,	O
or	CC	O
quantify	VB	O
the	DT	O
amount	NN	O
of	IN	O
a	DT	O
specific	JJ	O
nucleic	JJ	O
acid	NN	O
in	IN	O
a	DT	O
sample	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
message	NN	O
isolated	VBD	O
from	IN	O
a	DT	O
cell	NN	O
or	CC	O
a	DT	O
cDNA	JJ	O
library	NN	O
are	VBP	O
amplified	VBN	O
.	.	O
The	DT	O
skilled	JJ	O
artisan	NN	O
can	MD	O
select	VB	O
and	CC	O
design	VB	O
suitable	JJ	O
oligonucleotide	JJ	O
amplification	NN	O
primers	NNS	O
.	.	O
Amplification	NNP	O
methods	NNS	O
are	VBP	O
also	RB	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
and	CC	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
PCR	NNP	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
PCR	NNP	B
PROTOCOLS	NNP	I
,	,	I
A	NNP	I
GUIDE	NNP	I
TO	NNP	I
METHODS	NNP	I
AND	NNP	I
APPLICATIONS	NNP	I
,	,	I
ed	NN	I
.	.	I
Innis	NNP	I
,	,	I
Academic	NNP	I
Press	NNP	I
,	,	I
N.Y.	NNP	I
(	(	I
1990	CD	I
)	)	I
and	CC	O
PCR	NNP	B
STRATEGIES	NNP	I
(	(	I
1995	CD	I
)	)	I
,	,	I
ed	UH	I
.	.	I
Innis	NNP	I
,	,	I
Academic	NNP	I
Press	NNP	I
,	,	I
Inc.	NNP	I
,	,	I
N.Y.	NNP	I
,	,	O
ligase	NN	O
chain	NN	O
reaction	NN	O
(	(	O
LCR	NNP	O
)	)	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Wu	NNP	B
(	(	I
1989	CD	I
)	)	I
Genomics	NNPS	I
4:560	CD	I
;	:	O
Landegren	NNP	B
(	(	I
1988	CD	I
)	)	I
Science	NN	I
241:1077	CD	I
;	:	O
Barringer	NNP	B
(	(	I
1990	CD	I
)	)	I
Gene	NNP	I
89:117	CD	I
)	)	O
;	:	O
transcription	NN	O
amplification	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Kwoh	NNP	B
(	(	I
1989	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
86:1173	CD	I
)	)	O
;	:	O
and	CC	O
,	,	O
self-sustained	JJ	O
sequence	NN	O
replication	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Guatelli	NNP	B
(	(	I
1990	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
87:1874	CD	I
)	)	O
;	:	O
Q	NNP	O
Beta	NNP	O
replicase	NN	O
amplification	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Smith	NNP	B
(	(	I
1997	CD	I
)	)	I
J.	NNP	I
Clin	NNP	I
.	.	I
Microbiol	NNP	I
.	.	I
35:1477-1491	JJ	I
)	)	O
,	,	O
automated	VBD	O
Q-beta	NNP	O
replicase	NN	O
amplification	NN	O
assay	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Burg	NNP	B
(	(	I
1996	CD	I
)	)	I
Mol	NNP	I
.	.	I
Cell	NNP	I
.	.	I
Probes	NNP	I
10:257-271	JJ	I
)	)	O
and	CC	O
other	JJ	O
RNA	NNP	O
polymerase	NN	O
mediated	VBD	O
techniques	NNS	O
(	(	O
e.g.	NN	O
,	,	O
NASBA	NNP	O
,	,	O
Cangene	NNP	O
,	,	O
Mississauga	NNP	O
,	,	O
Ontario	NNP	O
)	)	O
;	:	O
see	VB	O
also	RB	O
Berger	NNP	B
(	(	I
1987	CD	I
)	)	I
Methods	NNP	I
Enzymol	NNP	I
.	.	I
152:307-316	JJ	I
;	:	O
Sambrook	NNP	B
;	:	O
Ausubel	NNP	B
;	:	I
U.S.	NNP	I
Pat	NNP	I
.	.	I
Nos	NNP	I
.	.	I
4,683,195	CD	I
and	CC	I
4,683,202	CD	I
;	:	O
Sooknanan	NNP	B
(	(	I
1995	CD	I
)	)	I
Biotechnology	NNP	I
13:563-564	CD	I
.	.	O
Determining	VBG	O
the	DT	O
Degree	NNP	O
of	IN	O
Sequence	NNP	O
Identity	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
nucleic	JJ	O
acids	NNS	O
comprising	VBG	O
sequences	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
1050	CD	O
,	,	O
1100	CD	O
,	,	O
1150	CD	O
,	,	O
1200	CD	O
,	,	O
1250	CD	O
,	,	O
1300	CD	O
,	,	O
1350	CD	O
,	,	O
1400	CD	O
,	,	O
1450	CD	O
,	,	O
1500	CD	O
,	,	O
1550	CD	O
or	CC	O
more	JJR	O
,	,	O
residues	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
polypeptides	IN	O
comprising	VBG	O
sequences	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
extent	NN	O
of	IN	O
sequence	NN	O
identity	NN	O
(	(	O
homology	NN	O
)	)	O
may	MD	O
be	VB	O
determined	VBN	O
using	VBG	O
any	DT	O
computer	NN	O
program	NN	O
and	CC	O
associated	JJ	O
parameters	NNS	O
,	,	O
including	VBG	O
those	DT	O
described	JJ	O
herein	NN	O
,	,	O
such	JJ	O
as	IN	O
BLAST	NNP	O
2.2.2.	CD	O
or	CC	O
FASTA	NNP	O
version	NN	O
3.0t78	CD	O
,	,	O
with	IN	O
the	DT	O
default	NN	O
parameters	NNS	O
.	.	O
Homologous	JJ	O
sequences	NNS	O
also	RB	O
include	VBP	O
RNA	NNP	O
sequences	NNS	O
in	IN	O
which	WDT	O
uridines	JJ	O
replace	VB	O
the	DT	O
thymines	NNS	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
.	.	O
The	DT	O
homologous	JJ	O
sequences	NNS	O
may	MD	O
be	VB	O
obtained	VBN	O
using	VBG	O
any	DT	O
of	IN	O
the	DT	O
procedures	NNS	O
described	VBD	O
herein	NNS	O
or	CC	O
may	MD	O
result	VB	O
from	IN	O
the	DT	O
correction	NN	O
of	IN	O
a	DT	O
sequencing	JJ	O
error	NN	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
appreciated	VBN	O
that	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
as	IN	O
set	NN	O
forth	NN	O
herein	NN	O
can	MD	O
be	VB	O
represented	VBN	O
in	IN	O
the	DT	O
traditional	JJ	O
single	JJ	O
character	NN	O
format	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Stryer	NNP	B
,	,	I
Lubert	NNP	I
.	.	I
Biochemistry	NNP	I
,	,	I
3rd	CD	I
Ed.	NNP	I
,	,	I
W.	NNP	I
H	NNP	I
Freeman	NNP	I
&	CC	I
Co.	NNP	I
,	,	I
New	NNP	I
York	NNP	I
)	)	O
or	CC	O
in	IN	O
any	DT	O
other	JJ	O
format	NN	O
which	WDT	O
records	VBZ	O
the	DT	O
identity	NN	O
of	IN	O
the	DT	O
nucleotides	NNS	O
in	IN	O
a	DT	O
sequence	NN	O
.	.	O
Various	JJ	O
sequence	NN	O
comparison	NN	O
programs	NNS	O
identified	VBN	O
herein	NNS	O
are	VBP	O
used	VBN	O
in	IN	O
this	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Protein	NNP	O
and/or	VBZ	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
identities	NNS	O
(	(	O
homologies	NNS	O
)	)	O
may	MD	O
be	VB	O
evaluated	VBN	O
using	VBG	O
any	DT	O
of	IN	O
the	DT	O
variety	NN	O
of	IN	O
sequence	NN	O
comparison	NN	O
algorithms	NN	O
and	CC	O
programs	NNS	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Such	JJ	O
algorithms	NNS	O
and	CC	O
programs	NNS	O
include	VBP	O
,	,	O
but	CC	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
,	,	O
TBLASTN	NNP	O
,	,	O
BLASTP	NNP	O
,	,	O
FASTA	NNP	O
,	,	O
TFASTA	NNP	O
,	,	O
and	CC	O
CLUSTALW	NNP	O
(	(	O
Pearson	NNP	B
and	CC	I
Lipman	NNP	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
85	CD	I
(	(	I
8	CD	I
)	)	I
:2444-2448	NN	I
,	,	I
1988	CD	I
;	:	O
Altschul	NNP	B
et	FW	I
al.	NN	I
,	,	I
J.	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
215	CD	I
(	(	I
3	CD	I
)	)	I
:403-410	NN	I
,	,	I
1990	CD	I
;	:	O
Thompson	NNP	B
et	FW	I
al.	NN	I
,	,	I
Nucleic	NNP	I
Acids	NNP	I
Res	NNP	I
.	.	I
22	CD	I
(	(	I
2	CD	I
)	)	I
:4673-4680	NN	I
,	,	I
1994	CD	I
;	:	O
Higgins	NNP	B
et	FW	I
al.	NN	I
,	,	I
Methods	NNP	I
Enzymol	NNP	I
.	.	I
266:383-402	CD	I
,	,	I
1996	CD	I
;	:	O
Altschul	NNP	B
et	FW	I
al.	NN	I
,	,	I
J.	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
215	CD	I
(	(	I
3	CD	I
)	)	I
:403-410	NN	I
,	,	I
1990	CD	I
;	:	O
Altschul	NNP	B
et	FW	I
al.	NN	I
,	,	I
Nature	NNP	I
Genetics	NNP	I
3:266-272	CD	I
,	,	I
1993	CD	I
)	)	O
.	.	O
Homology	NNP	O
or	CC	O
identity	NN	O
can	MD	O
be	VB	O
measured	VBN	O
using	VBG	O
sequence	NN	O
analysis	NN	O
software	NN	O
(	(	O
e.g.	UH	O
,	,	O
Sequence	NNP	O
Analysis	NNP	O
Software	NNP	O
Package	NNP	O
of	IN	O
the	DT	O
Genetics	NNP	O
Computer	NNP	O
Group	NNP	O
,	,	O
University	NNP	O
of	IN	O
Wisconsin	NNP	O
Biotechnology	NNP	O
Center	NNP	O
,	,	O
1710	CD	O
University	NNP	O
Avenue	NNP	O
,	,	O
Madison	NNP	O
,	,	O
Wis.	NNP	O
53705	CD	O
)	)	O
.	.	O
Such	JJ	O
software	NN	O
matches	NNS	O
similar	JJ	O
sequences	NNS	O
by	IN	O
assigning	VBG	O
degrees	NNS	O
of	IN	O
homology	NN	O
to	TO	O
various	JJ	O
deletions	NNS	O
,	,	O
substitutions	NNS	O
and	CC	O
other	JJ	O
modifications	NNS	O
.	.	O
The	DT	O
terms	NNS	O
“	VBP	O
homology	NN	O
”	NN	O
and	CC	O
“	NNP	O
identity	NN	O
”	NN	O
in	IN	O
the	DT	O
context	NN	O
of	IN	O
two	CD	O
or	CC	O
more	JJR	O
nucleic	JJ	O
acids	NNS	O
or	CC	O
polypeptide	NN	O
sequences	NNS	O
,	,	O
refer	VBP	O
to	TO	O
two	CD	O
or	CC	O
more	JJR	O
sequences	NNS	O
or	CC	O
subsequences	NNS	O
that	WDT	O
are	VBP	O
the	DT	O
same	JJ	O
or	CC	O
have	VBP	O
a	DT	O
specified	VBN	O
percentage	NN	O
of	IN	O
amino	NN	O
acid	NN	O
residues	NNS	O
or	CC	O
nucleotides	NNS	O
that	WDT	O
are	VBP	O
the	DT	O
same	JJ	O
when	WRB	O
compared	VBN	O
and	CC	O
aligned	VBN	O
for	IN	O
maximum	JJ	O
correspondence	NN	O
over	IN	O
a	DT	O
comparison	NN	O
window	NN	O
or	CC	O
designated	VBN	O
region	NN	O
as	IN	O
measured	VBN	O
using	VBG	O
any	DT	O
number	NN	O
of	IN	O
sequence	NN	O
comparison	NN	O
algorithms	NN	O
or	CC	O
by	IN	O
manual	JJ	O
alignment	NN	O
and	CC	O
visual	JJ	O
inspection	NN	O
.	.	O
For	IN	O
sequence	NN	O
comparison	NN	O
,	,	O
one	CD	O
sequence	NN	O
can	MD	O
act	VB	O
as	IN	O
a	DT	O
reference	NN	O
sequence	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
to	TO	O
which	WDT	O
test	NN	O
sequences	NNS	O
are	VBP	O
compared	VBN	O
.	.	O
When	WRB	O
using	VBG	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
,	,	O
test	NN	O
and	CC	O
reference	NN	O
sequences	NNS	O
are	VBP	O
entered	VBN	O
into	IN	O
a	DT	O
computer	NN	O
,	,	O
subsequence	NN	O
coordinates	NNS	O
are	VBP	O
designated	VBN	O
,	,	O
if	IN	O
necessary	JJ	O
,	,	O
and	CC	O
sequence	NN	O
algorithm	NN	O
program	NN	O
parameters	NNS	O
are	VBP	O
designated	VBN	O
.	.	O
Default	NNP	O
program	NN	O
parameters	NNS	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
or	CC	O
alternative	JJ	O
parameters	NNS	O
can	MD	O
be	VB	O
designated	VBN	O
.	.	O
The	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
then	RB	O
calculates	VBZ	O
the	DT	O
percent	NN	O
sequence	NN	O
identities	NNS	O
for	IN	O
the	DT	O
test	NN	O
sequences	NNS	O
relative	VBP	O
to	TO	O
the	DT	O
reference	NN	O
sequence	NN	O
,	,	O
based	VBN	O
on	IN	O
the	DT	O
program	NN	O
parameters	NNS	O
.	.	O
A	DT	O
“	JJ	O
comparison	NN	O
window	NN	O
”	NN	O
,	,	O
as	IN	O
used	VBN	O
herein	NN	O
,	,	O
includes	VBZ	O
reference	NN	O
to	TO	O
a	DT	O
segment	NN	O
of	IN	O
any	DT	O
one	CD	O
of	IN	O
the	DT	O
numbers	NNS	O
of	IN	O
contiguous	JJ	O
residues	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
alternative	JJ	O
aspects	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
contiguous	JJ	O
residues	NNS	O
ranging	VBG	O
anywhere	RB	O
from	IN	O
20	CD	O
to	TO	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
an	DT	O
exemplary	JJ	O
polypeptide	NN	O
or	CC	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
compared	VBN	O
to	TO	O
a	DT	O
reference	NN	O
sequence	NN	O
of	IN	O
the	DT	O
same	JJ	O
number	NN	O
of	IN	O
contiguous	JJ	O
positions	NNS	O
after	IN	O
the	DT	O
two	CD	O
sequences	NNS	O
are	VBP	O
optimally	RB	O
aligned	VBN	O
.	.	O
If	IN	O
the	DT	O
reference	NN	O
sequence	NN	O
has	VBZ	O
the	DT	O
requisite	JJ	O
sequence	NN	O
identity	NN	O
to	TO	O
an	DT	O
exemplary	JJ	O
polypeptide	NN	O
or	CC	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
sequence	NN	O
identity	NN	O
to	TO	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
that	DT	O
sequence	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
alternative	JJ	O
embodiments	NNS	O
,	,	O
subsequences	NNS	O
ranging	VBG	O
from	IN	O
about	IN	O
20	CD	O
to	TO	O
600	CD	O
,	,	O
about	RB	O
50	CD	O
to	TO	O
200	CD	O
,	,	O
and	CC	O
about	RB	O
100	CD	O
to	TO	O
150	CD	O
are	VBP	O
compared	VBN	O
to	TO	O
a	DT	O
reference	NN	O
sequence	NN	O
of	IN	O
the	DT	O
same	JJ	O
number	NN	O
of	IN	O
contiguous	JJ	O
positions	NNS	O
after	IN	O
the	DT	O
two	CD	O
sequences	NNS	O
are	VBP	O
optimally	RB	O
aligned	VBN	O
.	.	O
Methods	NNS	O
of	IN	O
alignment	NN	O
of	IN	O
sequence	NN	O
for	IN	O
comparison	NN	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Optimal	JJ	O
alignment	NN	O
of	IN	O
sequences	NNS	O
for	IN	O
comparison	NN	O
can	MD	O
be	VB	O
conducted	VBN	O
,	,	O
e.g.	NN	O
,	,	O
by	IN	O
the	DT	O
local	JJ	O
homology	NN	O
algorithm	NN	O
of	IN	O
Smith	NNP	B
&	CC	I
Waterman	NNP	I
,	,	I
Adv	NNP	I
.	.	I
Appl	NNP	I
.	.	I
Math	NN	I
.	.	I
2:482	CD	I
,	,	I
1981	CD	I
,	,	O
by	IN	O
the	DT	O
homology	NN	O
alignment	JJ	O
algorithm	NN	O
of	IN	O
Needleman	NNP	B
&	CC	I
Wunsch	NNP	I
,	,	I
J.	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
48:443	CD	I
,	,	I
1970	CD	I
,	,	O
by	IN	O
the	DT	O
search	NN	O
for	IN	O
similarity	NN	O
method	NN	O
of	IN	O
person	NN	B
&	CC	I
Lipman	NNP	I
,	,	I
Proc	NNP	I
.	.	I
Nat	NNP	I
'	POS	I
l	NN	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
85:2444	CD	I
,	,	I
1988	CD	I
,	,	O
by	IN	O
computerized	JJ	O
implementations	NNS	O
of	IN	O
these	DT	O
algorithms	NNS	O
(	(	O
GAP	NNP	O
,	,	O
BESTFIT	NNP	O
,	,	O
FASTA	NNP	O
,	,	O
and	CC	O
TFASTA	NNP	O
in	IN	O
the	DT	O
Wisconsin	NNP	O
Genetics	NNP	O
Software	NNP	O
Package	NNP	O
,	,	O
Genetics	NNP	O
Computer	NNP	O
Group	NNP	O
,	,	O
575	CD	O
Science	NNP	O
Dr.	NNP	O
,	,	O
Madison	NNP	O
,	,	O
Wis.	NNP	O
)	)	O
,	,	O
or	CC	O
by	IN	O
manual	JJ	O
alignment	NN	O
and	CC	O
visual	JJ	O
inspection	NN	O
.	.	O
Other	JJ	O
algorithms	NN	O
for	IN	O
determining	VBG	O
homology	NN	O
or	CC	O
identity	NN	O
include	VBP	O
,	,	O
for	IN	O
example	NN	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
a	DT	O
BLAST	NNP	O
program	NN	O
(	(	O
Basic	NNP	O
Local	NNP	O
Alignment	NNP	O
Search	NNP	O
Tool	NNP	O
at	IN	O
the	DT	O
National	NNP	O
Center	NNP	O
for	IN	O
Biological	NNP	O
Information	NNP	O
)	)	O
,	,	O
ALIGN	NNP	O
,	,	O
AMAS	NNP	O
(	(	O
Analysis	NNP	O
of	IN	O
Multiply	NNP	O
Aligned	NNP	O
Sequences	NNP	O
)	)	O
,	,	O
AMPS	NNP	O
(	(	O
Protein	NNP	O
Multiple	NNP	O
Sequence	NNP	O
Alignment	NNP	O
)	)	O
,	,	O
ASSET	NNP	O
(	(	O
Aligned	VBN	O
Segment	NNP	O
Statistical	NNP	O
Evaluation	NNP	O
Tool	NNP	O
)	)	O
,	,	O
BANDS	NNP	O
,	,	O
BESTSCOR	NNP	O
,	,	O
BIOSCAN	NNP	O
(	(	O
Biological	NNP	O
Sequence	NNP	O
Comparative	NNP	O
Analysis	NNP	O
Node	NNP	O
)	)	O
,	,	O
BLIMPS	NNP	O
(	(	O
BLocks	NNP	O
IMProved	NNP	O
Searcher	NNP	O
)	)	O
,	,	O
FASTA	NNP	O
,	,	O
Intervals	NNP	O
&	CC	O
Points	NNP	O
,	,	O
BMB	NNP	O
,	,	O
CLUSTAL	NNP	O
V	NNP	O
,	,	O
CLUSTAL	NNP	O
W	NNP	O
,	,	O
CONSENSUS	NNP	O
,	,	O
LCONSENSUS	NNP	O
,	,	O
WCONSENSUS	NNP	O
,	,	O
Smith-Waterman	NNP	O
algorithm	NN	O
,	,	O
DARWIN	NNP	O
,	,	O
Las	NNP	O
Vegas	NNP	O
algorithm	NN	O
,	,	O
FNAT	NNP	O
(	(	O
Forced	NNP	O
Nucleotide	NNP	O
Alignment	NNP	O
Tool	NNP	O
)	)	O
,	,	O
Framealign	NNP	O
,	,	O
Framesearch	NNP	O
,	,	O
DYNAMIC	NNP	O
,	,	O
FILTER	NNP	O
,	,	O
FSAP	NNP	O
(	(	O
Fristensky	NNP	O
Sequence	NNP	O
Analysis	NNP	O
Package	NNP	O
)	)	O
,	,	O
GAP	NNP	O
(	(	O
Global	NNP	O
Alignment	NNP	O
Program	NNP	O
)	)	O
,	,	O
GENAL	NNP	O
,	,	O
GIBBS	NNP	O
,	,	O
GenQuest	NNP	O
,	,	O
ISSC	NNP	O
(	(	O
Sensitive	JJ	O
Sequence	NNP	O
Comparison	NNP	O
)	)	O
,	,	O
LALIGN	NNP	O
(	(	O
Local	JJ	O
Sequence	NNP	O
Alignment	NNP	O
)	)	O
,	,	O
LCP	NNP	O
(	(	O
Local	JJ	O
Content	NNP	O
Program	NNP	O
)	)	O
,	,	O
MACAW	NNP	O
(	(	O
Multiple	NNP	O
Alignment	NNP	O
Construction	NNP	O
&	CC	O
Analysis	NNP	O
Workbench	NNP	O
)	)	O
,	,	O
MAP	NNP	O
(	(	O
Multiple	JJ	O
Alignment	NNP	O
Program	NNP	O
)	)	O
,	,	O
MBLKP	NNP	O
,	,	O
MBLKN	NNP	O
,	,	O
PIMA	NNP	O
(	(	O
Pattern-Induced	NNP	O
Multi-sequence	NNP	O
Alignment	NNP	O
)	)	O
,	,	O
SAGA	NNP	O
(	(	O
Sequence	NNP	O
Alignment	NNP	O
by	IN	O
Genetic	NNP	O
Algorithm	NNP	O
)	)	O
and	CC	O
WHAT-IF	NNP	O
.	.	O
Such	JJ	O
alignment	JJ	O
programs	NNS	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
screen	VB	O
genome	JJ	O
databases	NNS	O
to	TO	O
identify	VB	O
polynucleotide	NN	O
sequences	NNS	O
having	VBG	O
substantially	RB	O
identical	JJ	O
sequences	NNS	O
.	.	O
A	DT	O
number	NN	O
of	IN	O
genome	JJ	O
databases	NNS	O
are	VBP	O
available	JJ	O
,	,	O
for	IN	O
example	NN	O
,	,	O
a	DT	O
substantial	JJ	O
portion	NN	O
of	IN	O
the	DT	O
human	JJ	O
genome	NN	O
is	VBZ	O
available	JJ	O
as	IN	O
part	NN	O
of	IN	O
the	DT	O
Human	NNP	O
Genome	NNP	O
Sequencing	NNP	O
Project	NNP	O
(	(	O
Gibbs	NNP	B
,	,	I
1995	CD	I
)	)	O
.	.	O
Several	JJ	O
genomes	NNS	O
have	VBP	O
been	VBN	O
sequenced	VBN	O
,	,	O
e.g.	FW	O
,	,	O
M.	NNP	O
genitalium	NN	O
(	(	O
Fraser	NNP	B
et	RB	I
al.	RB	I
,	,	I
1995	CD	I
)	)	O
,	,	O
M.	NNP	O
jannaschii	NN	O
(	(	O
Bult	NNP	B
et	RB	I
al.	RB	I
,	,	I
1996	CD	I
)	)	O
,	,	O
H.	NNP	O
influenzae	NN	O
(	(	O
Fleischmann	NNP	B
et	RB	I
al.	RB	I
,	,	I
1995	CD	I
)	)	O
,	,	O
E.	NNP	O
coli	NNS	O
(	(	O
Blattner	NNP	B
et	RB	I
al.	RB	I
,	,	I
1997	CD	I
)	)	O
,	,	O
and	CC	O
yeast	NN	O
(	(	O
S.	NNP	O
cerevisiae	NN	O
)	)	O
(	(	O
Mewes	NNP	B
et	RB	I
al.	RB	I
,	,	I
1997	CD	I
)	)	O
,	,	O
and	CC	O
D.	NNP	O
melanogaster	NN	O
(	(	O
Adams	NNP	B
et	RB	I
al.	RB	I
,	,	I
2000	CD	I
)	)	O
.	.	O
Significant	NNP	O
progress	NN	O
has	VBZ	O
also	RB	O
been	VBN	O
made	VBN	O
in	IN	O
sequencing	VBG	O
the	DT	O
genomes	NNS	O
of	IN	O
model	NN	O
organism	NN	O
,	,	O
such	JJ	O
as	IN	O
mouse	NN	O
,	,	O
C.	NNP	O
elegans	VBZ	O
,	,	O
and	CC	O
Arabadopsis	NNP	O
sp	NN	O
.	.	O
Databases	NNS	O
containing	VBG	O
genomic	JJ	O
information	NN	O
annotated	VBN	O
with	IN	O
some	DT	O
functional	JJ	O
information	NN	O
are	VBP	O
maintained	VBN	O
by	IN	O
different	JJ	O
organization	NN	O
,	,	O
and	CC	O
are	VBP	O
accessible	JJ	O
via	IN	O
the	DT	O
internet	NN	O
.	.	O
BLAST	NNP	O
,	,	O
BLAST	NNP	O
2.0	CD	O
and	CC	O
BLAST	NNP	O
2.2.2	CD	O
algorithms	NN	O
are	VBP	O
also	RB	O
used	VBN	O
to	TO	O
practice	NN	O
the	DT	O
invention	NN	O
.	.	O
They	PRP	O
are	VBP	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Altschul	NNP	B
(	(	I
1977	CD	I
)	)	I
Nuc	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
25:3389-3402	JJ	I
;	:	O
Altschul	NNP	B
(	(	I
1990	CD	I
)	)	I
J.	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
215:403-410	JJ	I
.	.	O
Software	NNP	O
for	IN	O
performing	VBG	O
BLAST	NNP	O
analyses	NNS	O
is	VBZ	O
publicly	RB	O
available	JJ	O
through	IN	O
the	DT	O
National	NNP	O
Center	NNP	O
for	IN	O
Biotechnology	NNP	O
Information	NNP	O
.	.	O
This	DT	O
algorithm	NN	O
involves	VBZ	O
first	RB	O
identifying	JJ	O
high	JJ	O
scoring	VBG	O
sequence	NN	O
pairs	NNS	O
(	(	O
HSPs	NNP	O
)	)	O
by	IN	O
identifying	VBG	O
short	JJ	O
words	NNS	O
of	IN	O
length	NN	O
W	NNP	O
in	IN	O
the	DT	O
query	NN	O
sequence	NN	O
,	,	O
which	WDT	O
either	CC	O
match	NN	O
or	CC	O
satisfy	VB	O
some	DT	O
positive-valued	JJ	O
threshold	NN	O
score	NN	O
T	NNP	O
when	WRB	O
aligned	VBN	O
with	IN	O
a	DT	O
word	NN	O
of	IN	O
the	DT	O
same	JJ	O
length	NN	O
in	IN	O
a	DT	O
database	NN	O
sequence	NN	O
.	.	O
T	NNP	O
is	VBZ	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
neighborhood	NN	O
word	NN	O
score	NN	O
threshold	NN	O
(	(	O
Altschul	NNP	B
(	(	I
1990	CD	I
)	)	I
supra	NN	I
)	)	O
.	.	O
These	DT	O
initial	JJ	O
neighborhood	NN	O
word	NN	O
hits	VBZ	O
act	NN	O
as	IN	O
seeds	NNS	O
for	IN	O
initiating	VBG	O
searches	NNS	O
to	TO	O
find	VB	O
longer	JJR	O
HSPs	NNP	O
containing	VBG	O
them	PRP	O
.	.	O
The	DT	O
word	NN	O
hits	NNS	O
are	VBP	O
extended	VBN	O
in	IN	O
both	DT	O
directions	NNS	O
along	IN	O
each	DT	O
sequence	NN	O
for	IN	O
as	RB	O
far	RB	O
as	IN	O
the	DT	O
cumulative	JJ	O
alignment	NN	O
score	NN	O
can	MD	O
be	VB	O
increased	VBN	O
.	.	O
Cumulative	JJ	O
scores	NNS	O
are	VBP	O
calculated	VBN	O
using	VBG	O
,	,	O
for	IN	O
nucleotide	JJ	O
sequences	NNS	O
,	,	O
the	DT	O
parameters	NNS	O
M	NNP	O
(	(	O
reward	NN	O
score	NN	O
for	IN	O
a	DT	O
pair	NN	O
of	IN	O
matching	VBG	O
residues	NNS	O
;	:	O
always	RB	O
>	VBP	O
0	CD	O
)	)	O
.	.	O
For	IN	O
amino	NN	O
acid	NN	O
sequences	NNS	O
,	,	O
a	DT	O
scoring	NN	O
matrix	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
calculate	VB	O
the	DT	O
cumulative	JJ	O
score	NN	O
.	.	O
Extension	NN	O
of	IN	O
the	DT	O
word	NN	O
hits	VBZ	O
in	IN	O
each	DT	O
direction	NN	O
are	VBP	O
halted	VBN	O
when	WRB	O
:	:	O
the	DT	O
cumulative	JJ	O
alignment	NN	O
score	NN	O
falls	VBZ	O
off	RP	O
by	IN	O
the	DT	O
quantity	NN	O
X	NNP	O
from	IN	O
its	PRP$	O
maximum	NN	O
achieved	VBN	O
value	NN	O
;	:	O
the	DT	O
cumulative	JJ	O
score	NN	O
goes	VBZ	O
to	TO	O
zero	CD	O
or	CC	O
below	IN	O
,	,	O
due	JJ	O
to	TO	O
the	DT	O
accumulation	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
negative-scoring	JJ	O
residue	JJ	O
alignments	NNS	O
;	:	O
or	CC	O
the	DT	O
end	NN	O
of	IN	O
either	DT	O
sequence	NN	O
is	VBZ	O
reached	VBN	O
.	.	O
The	DT	O
BLAST	NNP	O
algorithm	NN	O
parameters	NNS	O
W	NNP	O
,	,	O
T	NNP	O
,	,	O
and	CC	O
X	NNP	O
determine	VBP	O
the	DT	O
sensitivity	NN	O
and	CC	O
speed	NN	O
of	IN	O
the	DT	O
alignment	NN	O
.	.	O
The	DT	O
BLASTN	NNP	O
program	NN	O
(	(	O
for	IN	O
nucleotide	RB	O
sequences	NNS	O
)	)	O
uses	VBZ	O
as	IN	O
defaults	NNS	O
a	DT	O
wordlength	NN	O
(	(	O
W	NNP	O
)	)	O
of	IN	O
11	CD	O
,	,	O
an	DT	O
expectation	NN	O
(	(	O
E	NNP	O
)	)	O
of	IN	O
10	CD	O
,	,	O
M=5	NNP	O
,	,	O
N=−4	NNP	O
and	CC	O
a	DT	O
comparison	NN	O
of	IN	O
both	DT	O
strands	NNS	O
.	.	O
For	IN	O
amino	NN	O
acid	NN	O
sequences	NNS	O
,	,	O
the	DT	O
BLASTP	NNP	O
program	NN	O
uses	VBZ	O
as	IN	O
defaults	NNS	O
a	DT	O
wordlength	NN	O
of	IN	O
3	CD	O
,	,	O
and	CC	O
expectations	NNS	O
(	(	O
E	NNP	O
)	)	O
of	IN	O
10	CD	O
,	,	O
and	CC	O
the	DT	O
BLOSUM62	NNP	O
scoring	NN	O
matrix	NN	O
(	(	O
see	VB	O
Henikoff	NNP	B
&	CC	I
Henikoff	NNP	I
(	(	I
1989	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
89:10915	CD	I
)	)	O
alignments	NNS	O
(	(	O
B	NNP	O
)	)	O
of	IN	O
50	CD	O
,	,	O
expectation	NN	O
(	(	O
E	NNP	O
)	)	O
of	IN	O
10	CD	O
,	,	O
M=5	NNP	O
,	,	O
N=−4	NNP	O
,	,	O
and	CC	O
a	DT	O
comparison	NN	O
of	IN	O
both	DT	O
strands	NNS	O
.	.	O
The	DT	O
BLAST	NNP	O
algorithm	NN	O
also	RB	O
performs	VBZ	O
a	DT	O
statistical	JJ	O
analysis	NN	O
of	IN	O
the	DT	O
similarity	NN	O
between	IN	O
two	CD	O
sequences	NNS	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Karlin	NNP	B
&	CC	I
Altschul	NNP	I
(	(	I
1993	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
90:5873	CD	I
)	)	O
.	.	O
One	CD	O
measure	NN	O
of	IN	O
similarity	NN	O
provided	VBN	O
by	IN	O
BLAST	NNP	O
algorithm	NN	O
is	VBZ	O
the	DT	O
smallest	JJS	O
sum	JJ	O
probability	NN	O
(	(	O
P	NNP	O
(	(	O
N	NNP	O
)	)	O
)	)	O
,	,	O
which	WDT	O
provides	VBZ	O
an	DT	O
indication	NN	O
of	IN	O
the	DT	O
probability	NN	O
by	IN	O
which	WDT	O
a	DT	O
match	NN	O
between	IN	O
two	CD	O
nucleotide	NN	O
or	CC	O
amino	NN	O
acid	JJ	O
sequences	NNS	O
would	MD	O
occur	VB	O
by	IN	O
chance	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
considered	VBN	O
similar	JJ	O
to	TO	O
a	DT	O
references	NNS	O
sequence	NN	O
if	IN	O
the	DT	O
smallest	JJS	O
sum	JJ	O
probability	NN	O
in	IN	O
a	DT	O
comparison	NN	O
of	IN	O
the	DT	O
test	NN	O
nucleic	NN	O
acid	NN	O
to	TO	O
the	DT	O
reference	NN	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
less	JJR	O
than	IN	O
about	RB	O
0.2	CD	O
,	,	O
more	JJR	O
preferably	RB	O
less	RBR	O
than	IN	O
about	RB	O
0.01	CD	O
,	,	O
and	CC	O
most	JJS	O
preferably	RB	O
less	JJR	O
than	IN	O
about	RB	O
0.001	CD	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
protein	NN	O
and	CC	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
homologies	NNS	O
are	VBP	O
evaluated	VBN	O
using	VBG	O
the	DT	O
Basic	NNP	O
Local	NNP	O
Alignment	NNP	O
Search	NNP	O
Tool	NNP	O
(	(	O
“	NNP	O
BLAST	NNP	O
”	NNP	O
)	)	O
.	.	O
For	IN	O
example	NN	O
,	,	O
five	CD	O
specific	JJ	O
BLAST	NNP	O
programs	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
perform	VB	O
the	DT	O
following	JJ	O
task	NN	O
:	:	O
(	(	O
1	CD	O
)	)	O
BLASTP	NNP	O
and	CC	O
BLAST3	NNP	O
compare	VBP	O
an	DT	O
amino	NN	O
acid	NN	O
query	NN	O
sequence	NN	O
against	IN	O
a	DT	O
protein	JJ	O
sequence	NN	O
database	NN	O
;	:	O
(	(	O
2	CD	O
)	)	O
BLASTN	NNP	O
compares	VBZ	O
a	DT	O
nucleotide	JJ	O
query	NN	O
sequence	NN	O
against	IN	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
database	NN	O
;	:	O
(	(	O
3	CD	O
)	)	O
BLASTX	NNP	O
compares	VBZ	O
the	DT	O
six-frame	JJ	O
conceptual	JJ	O
translation	NN	O
products	NNS	O
of	IN	O
a	DT	O
query	NN	O
nucleotide	JJ	O
sequence	NN	O
(	(	O
both	DT	O
strands	NNS	O
)	)	O
against	IN	O
a	DT	O
protein	JJ	O
sequence	NN	O
database	NN	O
;	:	O
(	(	O
4	CD	O
)	)	O
TBLASTN	NNP	O
compares	VBZ	O
a	DT	O
query	NN	O
protein	NN	O
sequence	NN	O
against	IN	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
database	NN	O
translated	VBN	O
in	IN	O
all	DT	O
six	CD	O
reading	VBG	O
frames	NNS	O
(	(	O
both	DT	O
strands	NNS	O
)	)	O
;	:	O
and	CC	O
,	,	O
(	(	O
5	CD	O
)	)	O
TBLASTX	NN	O
compares	VBZ	O
the	DT	O
six-frame	JJ	O
translations	NNS	O
of	IN	O
a	DT	O
nucleotide	JJ	O
query	NN	O
sequence	NN	O
against	IN	O
the	DT	O
six-frame	JJ	O
translations	NNS	O
of	IN	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
database	NN	O
.	.	O
The	DT	O
BLAST	NNP	O
programs	NNS	O
identify	VBP	O
homologous	JJ	O
sequences	NNS	O
by	IN	O
identifying	VBG	O
similar	JJ	O
segments	NNS	O
,	,	O
which	WDT	O
are	VBP	O
referred	VBN	O
to	TO	O
herein	VB	O
as	IN	O
“	JJ	O
high-scoring	JJ	O
segment	NN	O
pairs	NNS	O
,	,	O
”	VBP	O
between	IN	O
a	DT	O
query	NN	O
amino	NN	O
or	CC	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
and	CC	O
a	DT	O
test	NN	O
sequence	NN	O
which	WDT	O
is	VBZ	O
preferably	RB	O
obtained	VBN	O
from	IN	O
a	DT	O
protein	NN	O
or	CC	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
database	NN	O
.	.	O
High-scoring	JJ	O
segment	NN	O
pairs	NNS	O
are	VBP	O
preferably	RB	O
identified	VBN	O
(	(	O
i.e.	FW	O
,	,	O
aligned	VBN	O
)	)	O
by	IN	O
means	NNS	O
of	IN	O
a	DT	O
scoring	NN	O
matrix	NN	O
,	,	O
many	JJ	O
of	IN	O
which	WDT	O
are	VBP	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Preferably	RB	O
,	,	O
the	DT	O
scoring	VBG	O
matrix	NN	O
used	VBN	O
is	VBZ	O
the	DT	O
BLOSUM62	NNP	O
matrix	NN	O
(	(	O
Gonnet	NNP	B
et	RB	I
al.	RB	I
,	,	I
Science	NNP	I
256:1443-1445	CD	I
,	,	I
1992	CD	I
;	:	O
Henikoff	NNP	B
and	CC	I
Henikoff	NNP	I
,	,	I
Proteins	NNP	I
17:49-61	CD	I
,	,	I
1993	CD	I
)	)	O
.	.	O
Less	NNP	O
preferably	RB	O
,	,	O
the	DT	O
PAM	NNP	O
or	CC	O
PAM250	NNP	O
matrices	NNS	O
may	MD	O
also	RB	O
be	VB	O
used	VBN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Schwartz	NNP	B
and	CC	I
Dayhoff	NNP	I
,	,	I
eds.	NN	I
,	,	I
1978	CD	I
,	,	I
Matrices	NNS	I
for	IN	I
Detecting	VBG	I
Distance	NNP	I
Relationships	NNP	I
:	:	I
Atlas	NNP	I
of	IN	I
Protein	NNP	I
Sequence	NNP	I
and	CC	I
Structure	NNP	I
,	,	I
Washington	NNP	I
:	:	I
National	NNP	I
Biomedical	NNP	I
Research	NNP	I
Foundation	NNP	I
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
to	TO	O
determine	VB	O
if	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
has	VBZ	O
the	DT	O
requisite	JJ	O
sequence	NN	O
identity	NN	O
to	TO	O
be	VB	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
the	DT	O
NCBI	NNP	O
BLAST	NNP	O
2.2.2	CD	O
programs	NNS	O
is	VBZ	O
used	VBN	O
,	,	O
default	NN	O
options	NNS	O
to	TO	O
blastp	VB	O
.	.	O
There	EX	O
are	VBP	O
about	IN	O
38	CD	O
setting	NN	O
options	NNS	O
in	IN	O
the	DT	O
BLAST	NNP	O
2.2.2	CD	O
program	NN	O
.	.	O
In	IN	O
this	DT	O
exemplary	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
all	DT	O
default	NN	O
values	NNS	O
are	VBP	O
used	VBN	O
except	IN	O
for	IN	O
the	DT	O
default	NN	O
filtering	VBG	O
setting	NN	O
(	(	O
i.e.	FW	O
,	,	O
all	DT	O
parameters	NNS	O
set	VBD	O
to	TO	O
default	VB	O
except	IN	O
filtering	VBG	O
which	WDT	O
is	VBZ	O
set	VBN	O
to	TO	O
OFF	NNP	O
)	)	O
;	:	O
in	IN	O
its	PRP$	O
place	NN	O
a	DT	O
“	NN	O
-F	NNP	O
F	NNP	O
”	NNP	O
setting	NN	O
is	VBZ	O
used	VBN	O
,	,	O
which	WDT	O
disables	VBZ	O
filtering	NN	O
.	.	O
Use	NNP	O
of	IN	O
default	NN	O
filtering	VBG	O
often	RB	O
results	NNS	O
in	IN	O
Karlin-Altschul	NNP	O
violations	NNS	O
due	JJ	O
to	TO	O
short	JJ	O
length	NN	O
of	IN	O
sequence	NN	O
.	.	O
The	DT	O
default	NN	O
values	NNS	O
used	VBN	O
in	IN	O
this	DT	O
exemplary	JJ	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
:	:	O
Other	JJ	O
default	NN	O
settings	NNS	O
can	MD	O
be	VB	O
:	:	O
filter	NN	O
for	IN	O
low	JJ	O
complexity	NN	O
OFF	NNP	O
,	,	O
word	NN	O
size	NN	O
of	IN	O
3	CD	O
for	IN	O
protein	NN	O
,	,	O
BLOSUM62	NNP	O
matrix	NN	O
,	,	O
gap	NN	O
existence	NN	O
penalty	NN	O
of	IN	O
−11	NNP	O
and	CC	O
a	DT	O
gap	NN	O
extension	NN	O
penalty	NN	O
of	IN	O
−1	NN	O
.	.	O
An	DT	O
exemplary	JJ	O
NCBI	NNP	O
BLAST	NNP	O
2.2.2	CD	O
program	NN	O
setting	NN	O
has	VBZ	O
the	DT	O
“	NNP	O
−W	NNP	O
”	NNP	O
option	NN	O
default	NN	O
to	TO	O
0	CD	O
.	.	O
This	DT	O
means	VBZ	O
that	IN	O
,	,	O
if	IN	O
not	RB	O
set	VBN	O
,	,	O
the	DT	O
word	NN	O
size	NN	O
defaults	NNS	O
to	TO	O
3	CD	O
for	IN	O
proteins	NNS	O
and	CC	O
11	CD	O
for	IN	O
nucleotides	NNS	O
.	.	O
Computer	NNP	O
Systems	NNPS	O
and	CC	O
Computer	NNP	O
Program	NNP	O
Products	NNPS	O
To	TO	O
determine	VB	O
and	CC	O
identify	VB	O
sequence	NN	O
identities	NNS	O
,	,	O
structural	JJ	O
homologies	NNS	O
,	,	O
motifs	NNS	O
and	CC	O
the	DT	O
like	JJ	O
in	IN	O
silico	NN	O
,	,	O
the	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
stored	VBN	O
,	,	O
recorded	VBN	O
,	,	O
and	CC	O
manipulated	VBD	O
on	IN	O
any	DT	O
medium	NN	O
which	WDT	O
can	MD	O
be	VB	O
read	VBN	O
and	CC	O
accessed	VBN	O
by	IN	O
a	DT	O
computer	NN	O
.	.	O
Accordingly	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
computers	NNS	O
,	,	O
computer	NN	O
systems	NNS	O
,	,	O
computer	NN	O
readable	JJ	O
mediums	NNS	O
,	,	O
computer	NN	O
programs	NNS	O
products	NNS	O
and	CC	O
the	DT	O
like	JJ	O
recorded	VBD	O
or	CC	O
stored	VBD	O
thereon	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
and	CC	O
polypeptide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
the	DT	O
words	NNS	O
“	NNP	O
recorded	VBD	O
”	NNP	O
and	CC	O
“	NNP	O
stored	VBD	O
”	NNP	O
refer	NN	O
to	TO	O
a	DT	O
process	NN	O
for	IN	O
storing	VBG	O
information	NN	O
on	IN	O
a	DT	O
computer	NN	O
medium	NN	O
.	.	O
A	DT	O
skilled	JJ	O
artisan	NN	O
can	MD	O
readily	VB	O
adopt	VB	O
any	DT	O
known	JJ	O
methods	NNS	O
for	IN	O
recording	VBG	O
information	NN	O
on	IN	O
a	DT	O
computer	NN	O
readable	JJ	O
medium	NN	O
to	TO	O
generate	VB	O
manufactures	NNS	O
comprising	VBG	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
and/or	NN	O
polypeptide	NN	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Another	DT	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
computer	NN	O
readable	JJ	O
medium	NN	O
having	VBG	O
recorded	VBN	O
thereon	NN	O
at	IN	O
least	JJS	O
one	CD	O
nucleic	JJ	O
acid	NN	O
and/or	NN	O
polypeptide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Computer	NNP	O
readable	JJ	O
media	NNS	O
include	VBP	O
magnetically	RB	O
readable	JJ	O
media	NNS	O
,	,	O
optically	RB	O
readable	JJ	O
media	NNS	O
,	,	O
electronically	RB	O
readable	JJ	O
media	NNS	O
and	CC	O
magnetic/optical	JJ	O
media	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
computer	NN	O
readable	JJ	O
media	NNS	O
may	MD	O
be	VB	O
a	DT	O
hard	JJ	O
disk	NN	O
,	,	O
a	DT	O
floppy	JJ	O
disk	NN	O
,	,	O
a	DT	O
magnetic	JJ	O
tape	NN	O
,	,	O
CD-ROM	NNP	O
,	,	O
Digital	NNP	O
Versatile	NNP	O
Disk	NNP	O
(	(	O
DVD	NNP	O
)	)	O
,	,	O
Random	NNP	O
Access	NNP	O
Memory	NNP	O
(	(	O
RAM	NNP	O
)	)	O
,	,	O
or	CC	O
Read	NNP	O
Only	RB	O
Memory	NNP	O
(	(	O
ROM	NNP	O
)	)	O
as	RB	O
well	RB	O
as	IN	O
other	JJ	O
types	NNS	O
of	IN	O
other	JJ	O
media	NNS	O
known	VBN	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Aspects	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
systems	NNS	O
(	(	O
e.g.	JJ	O
,	,	O
internet	NN	O
based	VBN	O
systems	NNS	O
)	)	O
,	,	O
particularly	RB	O
computer	NN	O
systems	NNS	O
,	,	O
which	WDT	O
store	NN	O
and	CC	O
manipulate	VB	O
the	DT	O
sequences	NNS	O
and	CC	O
sequence	NN	O
information	NN	O
described	VBD	O
herein	NN	O
.	.	O
One	CD	O
example	NN	O
of	IN	O
a	DT	O
computer	NN	O
system	NN	O
100	CD	O
is	VBZ	O
illustrated	VBN	O
in	IN	O
block	NN	O
diagram	NN	O
form	NN	O
in	IN	O
FIG	NNP	O
.	.	O
1	CD	O
.	.	O
As	IN	O
used	VBN	O
herein	NN	O
,	,	O
“	VBZ	O
a	DT	O
computer	NN	O
system	NN	O
”	JJ	O
refers	NNS	O
to	TO	O
the	DT	O
hardware	NN	O
components	NNS	O
,	,	O
software	NN	O
components	NNS	O
,	,	O
and	CC	O
data	NNS	O
storage	NN	O
components	NNS	O
used	VBN	O
to	TO	O
analyze	VB	O
a	DT	O
nucleotide	NN	O
or	CC	O
polypeptide	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
computer	NN	O
system	NN	O
100	CD	O
can	MD	O
include	VB	O
a	DT	O
processor	NN	O
for	IN	O
processing	NN	O
,	,	O
accessing	VBG	O
and	CC	O
manipulating	VBG	O
the	DT	O
sequence	NN	O
data	NNS	O
.	.	O
The	DT	O
processor	NN	O
105	CD	O
can	MD	O
be	VB	O
any	DT	O
well-known	JJ	O
type	NN	O
of	IN	O
central	JJ	O
processing	NN	O
unit	NN	O
,	,	O
such	JJ	O
as	IN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
the	DT	O
Pentium	NNP	O
III	NNP	O
from	IN	O
Intel	NNP	O
Corporation	NNP	O
,	,	O
or	CC	O
similar	JJ	O
processor	NN	O
from	IN	O
Sun	NNP	O
,	,	O
Motorola	NNP	O
,	,	O
Compaq	NNP	O
,	,	O
AMD	NNP	O
or	CC	O
International	NNP	O
Business	NNP	O
Machines	NNPS	O
.	.	O
The	DT	O
computer	NN	O
system	NN	O
100	CD	O
is	VBZ	O
a	DT	O
general	JJ	O
purpose	NN	O
system	NN	O
that	WDT	O
comprises	VBZ	O
the	DT	O
processor	NN	O
105	CD	O
and	CC	O
one	CD	O
or	CC	O
more	JJR	O
internal	JJ	O
data	NNS	O
storage	NN	O
components	NNS	O
110	CD	O
for	IN	O
storing	VBG	O
data	NNS	O
,	,	O
and	CC	O
one	CD	O
or	CC	O
more	JJR	O
data	NNS	O
retrieving	VBG	O
devices	NNS	O
for	IN	O
retrieving	VBG	O
the	DT	O
data	NN	O
stored	VBD	O
on	IN	O
the	DT	O
data	NNS	O
storage	NN	O
components	NNS	O
.	.	O
A	DT	O
skilled	JJ	O
artisan	NN	O
can	MD	O
readily	VB	O
appreciate	VB	O
that	IN	O
any	DT	O
one	CD	O
of	IN	O
the	DT	O
currently	RB	O
available	JJ	O
computer	NN	O
systems	NNS	O
are	VBP	O
suitable	JJ	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
computer	NN	O
system	NN	O
100	CD	O
includes	VBZ	O
a	DT	O
processor	NN	O
105	CD	O
connected	VBN	O
to	TO	O
a	DT	O
bus	NN	O
which	WDT	O
is	VBZ	O
connected	VBN	O
to	TO	O
a	DT	O
main	JJ	O
memory	NN	O
115	CD	O
(	(	O
preferably	RB	O
implemented	VBN	O
as	IN	O
RAM	NNP	O
)	)	O
and	CC	O
one	CD	O
or	CC	O
more	JJR	O
internal	JJ	O
data	NNS	O
storage	NN	O
devices	NNS	O
110	CD	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
hard	JJ	O
drive	NN	O
and/or	NN	O
other	JJ	O
computer	NN	O
readable	JJ	O
media	NNS	O
having	VBG	O
data	NNS	O
recorded	VBN	O
thereon	NN	O
.	.	O
The	DT	O
computer	NN	O
system	NN	O
100	CD	O
can	MD	O
further	RB	O
include	VB	O
one	CD	O
or	CC	O
more	JJR	O
data	NNS	O
retrieving	VBG	O
device	NN	O
118	CD	O
for	IN	O
reading	VBG	O
the	DT	O
data	NNS	O
stored	VBD	O
on	IN	O
the	DT	O
internal	JJ	O
data	NNS	O
storage	NN	O
devices	NNS	O
110	CD	O
.	.	O
The	DT	O
data	NN	O
retrieving	NN	O
device	NN	O
118	CD	O
may	MD	O
represent	VB	O
,	,	O
for	IN	O
example	NN	O
,	,	O
a	DT	O
floppy	JJ	O
disk	NN	O
drive	NN	O
,	,	O
a	DT	O
compact	JJ	O
disk	NN	O
drive	NN	O
,	,	O
a	DT	O
magnetic	JJ	O
tape	NN	O
drive	NN	O
,	,	O
or	CC	O
a	DT	O
modem	NN	O
capable	JJ	O
of	IN	O
connection	NN	O
to	TO	O
a	DT	O
remote	JJ	O
data	NN	O
storage	NN	O
system	NN	O
(	(	O
e.g.	JJ	O
,	,	O
via	IN	O
the	DT	O
internet	NN	O
)	)	O
etc	NN	O
.	.	O
In	IN	O
some	DT	O
embodiments	NNS	O
,	,	O
the	DT	O
internal	JJ	O
data	NNS	O
storage	NN	O
device	NN	O
110	CD	O
is	VBZ	O
a	DT	O
removable	JJ	O
computer	NN	O
readable	JJ	O
medium	NN	O
such	JJ	O
as	IN	O
a	DT	O
floppy	JJ	O
disk	NN	O
,	,	O
a	DT	O
compact	JJ	O
disk	NN	O
,	,	O
a	DT	O
magnetic	JJ	O
tape	NN	O
,	,	O
etc	FW	O
.	.	O
containing	VBG	O
control	NN	O
logic	JJ	O
and/or	NN	O
data	NNS	O
recorded	VBD	O
thereon	NN	O
.	.	O
The	DT	O
computer	NN	O
system	NN	O
100	CD	O
may	MD	O
advantageously	RB	O
include	VB	O
or	CC	O
be	VB	O
programmed	VBN	O
by	IN	O
appropriate	JJ	O
software	NN	O
for	IN	O
reading	VBG	O
the	DT	O
control	NN	O
logic	VBZ	O
and/or	VBP	O
the	DT	O
data	NN	O
from	IN	O
the	DT	O
data	NNS	O
storage	NN	O
component	NN	O
once	RB	O
inserted	VBN	O
in	IN	O
the	DT	O
data	NNS	O
retrieving	NN	O
device	NN	O
.	.	O
The	DT	O
computer	NN	O
system	NN	O
100	CD	O
includes	VBZ	O
a	DT	O
display	NN	O
120	CD	O
which	WDT	O
is	VBZ	O
used	VBN	O
to	TO	O
display	VB	O
output	NN	O
to	TO	O
a	DT	O
computer	NN	O
user	NN	O
.	.	O
It	PRP	O
should	MD	O
also	RB	O
be	VB	O
noted	VBN	O
that	IN	O
the	DT	O
computer	NN	O
system	NN	O
100	CD	O
can	MD	O
be	VB	O
linked	VBN	O
to	TO	O
other	JJ	O
computer	NN	O
systems	NNS	O
125	CD	O
a-c	JJ	O
in	IN	O
a	DT	O
network	NN	O
or	CC	O
wide	JJ	O
area	NN	O
network	NN	O
to	TO	O
provide	VB	O
centralized	JJ	O
access	NN	O
to	TO	O
the	DT	O
computer	NN	O
system	NN	O
100	CD	O
.	.	O
Software	NNP	O
for	IN	O
accessing	VBG	O
and	CC	O
processing	VBG	O
the	DT	O
nucleotide	NN	O
or	CC	O
amino	NN	O
acid	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
reside	VB	O
in	IN	O
main	JJ	O
memory	NN	O
115	CD	O
during	IN	O
execution	NN	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
the	DT	O
computer	NN	O
system	NN	O
100	CD	O
may	MD	O
further	RB	O
comprise	VB	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
for	IN	O
comparing	VBG	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
algorithm	NN	O
and	CC	O
sequence	NN	O
(	(	O
s	PRP	O
)	)	O
can	MD	O
be	VB	O
stored	VBN	O
on	IN	O
a	DT	O
computer	NN	O
readable	JJ	O
medium	NN	O
.	.	O
A	DT	O
“	JJ	O
sequence	NN	O
comparison	NN	O
algorithm	JJ	O
”	NN	O
refers	NNS	O
to	TO	O
one	CD	O
or	CC	O
more	JJR	O
programs	NNS	O
which	WDT	O
are	VBP	O
implemented	VBN	O
(	(	O
locally	RB	O
or	CC	O
remotely	RB	O
)	)	O
on	IN	O
the	DT	O
computer	NN	O
system	NN	O
100	CD	O
to	TO	O
compare	VB	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
with	IN	O
other	JJ	O
nucleotide	JJ	O
sequences	NNS	O
and/or	VBP	O
compounds	NNS	O
stored	VBN	O
within	IN	O
a	DT	O
data	NN	O
storage	NN	O
means	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
may	MD	O
compare	VB	O
the	DT	O
nucleotide	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
stored	VBN	O
on	IN	O
a	DT	O
computer	NN	O
readable	JJ	O
medium	NN	O
to	TO	O
reference	VB	O
sequences	NNS	O
stored	VBN	O
on	IN	O
a	DT	O
computer	NN	O
readable	JJ	O
medium	NN	O
to	TO	O
identify	VB	O
homologies	NNS	O
or	CC	O
structural	JJ	O
motifs	NNS	O
.	.	O
The	DT	O
parameters	NNS	O
used	VBN	O
with	IN	O
the	DT	O
above	JJ	O
algorithms	NN	O
may	MD	O
be	VB	O
adapted	VBN	O
depending	VBG	O
on	IN	O
the	DT	O
sequence	NN	O
length	NN	O
and	CC	O
degree	NN	O
of	IN	O
homology	NN	O
studied	VBN	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
the	DT	O
parameters	NNS	O
may	MD	O
be	VB	O
the	DT	O
default	NN	O
parameters	NNS	O
used	VBN	O
by	IN	O
the	DT	O
algorithms	NN	O
in	IN	O
the	DT	O
absence	NN	O
of	IN	O
instructions	NNS	O
from	IN	O
the	DT	O
user	NN	O
.	.	O
FIG	NNP	O
.	.	O
2	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
a	DT	O
process	NN	O
200	CD	O
for	IN	O
comparing	VBG	O
a	DT	O
new	JJ	O
nucleotide	NN	O
or	CC	O
protein	NN	O
sequence	NN	O
with	IN	O
a	DT	O
database	NN	O
of	IN	O
sequences	NNS	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
the	DT	O
homology	NN	O
levels	NNS	O
between	IN	O
the	DT	O
new	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
sequences	NNS	O
in	IN	O
the	DT	O
database	NN	O
.	.	O
The	DT	O
database	NN	O
of	IN	O
sequences	NNS	O
can	MD	O
be	VB	O
a	DT	O
private	JJ	O
database	NN	O
stored	VBD	O
within	IN	O
the	DT	O
computer	NN	O
system	NN	O
100	CD	O
,	,	O
or	CC	O
a	DT	O
public	JJ	O
database	NN	O
such	JJ	O
as	IN	O
GENBANK	NNP	O
that	WDT	O
is	VBZ	O
available	JJ	O
through	IN	O
the	DT	O
Internet	NNP	O
.	.	O
The	DT	O
process	NN	O
200	CD	O
begins	NNS	O
at	IN	O
a	DT	O
start	NN	O
state	NN	O
201	CD	O
and	CC	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
202	CD	O
wherein	VBD	O
the	DT	O
new	JJ	O
sequence	NN	O
to	TO	O
be	VB	O
compared	VBN	O
is	VBZ	O
stored	VBN	O
to	TO	O
a	DT	O
memory	NN	O
in	IN	O
a	DT	O
computer	NN	O
system	NN	O
100	CD	O
.	.	O
As	IN	O
discussed	VBN	O
above	IN	O
,	,	O
the	DT	O
memory	NN	O
could	MD	O
be	VB	O
any	DT	O
type	NN	O
of	IN	O
memory	NN	O
,	,	O
including	VBG	O
RAM	NNP	O
or	CC	O
an	DT	O
internal	JJ	O
storage	NN	O
device	NN	O
.	.	O
The	DT	O
process	NN	O
200	CD	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
204	CD	O
wherein	NN	O
a	DT	O
database	NN	O
of	IN	O
sequences	NNS	O
is	VBZ	O
opened	VBN	O
for	IN	O
analysis	NN	O
and	CC	O
comparison	NN	O
.	.	O
The	DT	O
process	NN	O
200	CD	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
206	CD	O
wherein	NN	O
the	DT	O
first	JJ	O
sequence	NN	O
stored	VBN	O
in	IN	O
the	DT	O
database	NN	O
is	VBZ	O
read	VBN	O
into	IN	O
a	DT	O
memory	NN	O
on	IN	O
the	DT	O
computer	NN	O
.	.	O
A	DT	O
comparison	NN	O
is	VBZ	O
then	RB	O
performed	VBN	O
at	IN	O
a	DT	O
state	NN	O
210	CD	O
to	TO	O
determine	VB	O
if	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
is	VBZ	O
the	DT	O
same	JJ	O
as	IN	O
the	DT	O
second	JJ	O
sequence	NN	O
.	.	O
It	PRP	O
is	VBZ	O
important	JJ	O
to	TO	O
note	VB	O
that	IN	O
this	DT	O
step	NN	O
is	VBZ	O
not	RB	O
limited	VBN	O
to	TO	O
performing	VBG	O
an	DT	O
exact	JJ	O
comparison	NN	O
between	IN	O
the	DT	O
new	JJ	O
sequence	NN	O
and	CC	O
the	DT	O
first	JJ	O
sequence	NN	O
in	IN	O
the	DT	O
database	NN	O
.	.	O
Well-known	JJ	O
methods	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
those	DT	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
for	IN	O
comparing	VBG	O
two	CD	O
nucleotide	JJ	O
or	CC	O
protein	JJ	O
sequences	NNS	O
,	,	O
even	RB	O
if	IN	O
they	PRP	O
are	VBP	O
not	RB	O
identical	JJ	O
.	.	O
For	IN	O
example	NN	O
,	,	O
gaps	NNS	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
one	CD	O
sequence	NN	O
in	IN	O
order	NN	O
to	TO	O
raise	VB	O
the	DT	O
homology	NN	O
level	NN	O
between	IN	O
the	DT	O
two	CD	O
tested	VBD	O
sequences	NNS	O
.	.	O
The	DT	O
parameters	NNS	O
that	WDT	O
control	VBP	O
whether	IN	O
gaps	NNS	O
or	CC	O
other	JJ	O
features	NNS	O
are	VBP	O
introduced	VBN	O
into	IN	O
a	DT	O
sequence	NN	O
during	IN	O
comparison	NN	O
are	VBP	O
normally	RB	O
entered	VBN	O
by	IN	O
the	DT	O
user	NN	O
of	IN	O
the	DT	O
computer	NN	O
system	NN	O
.	.	O
Once	RB	O
a	DT	O
comparison	NN	O
of	IN	O
the	DT	O
two	CD	O
sequences	NNS	O
has	VBZ	O
been	VBN	O
performed	VBN	O
at	IN	O
the	DT	O
state	NN	O
210	CD	O
,	,	O
a	DT	O
determination	NN	O
is	VBZ	O
made	VBN	O
at	IN	O
a	DT	O
decision	NN	O
state	NN	O
210	CD	O
whether	IN	O
the	DT	O
two	CD	O
sequences	NNS	O
are	VBP	O
the	DT	O
same	JJ	O
.	.	O
Of	IN	O
course	NN	O
,	,	O
the	DT	O
term	NN	O
“	NNP	O
same	JJ	O
”	NNP	O
is	VBZ	O
not	RB	O
limited	VBN	O
to	TO	O
sequences	NNS	O
that	WDT	O
are	VBP	O
absolutely	RB	O
identical	JJ	O
.	.	O
Sequences	NNS	O
that	WDT	O
are	VBP	O
within	IN	O
the	DT	O
homology	NN	O
parameters	NNS	O
entered	VBN	O
by	IN	O
the	DT	O
user	NN	O
will	MD	O
be	VB	O
marked	VBN	O
as	IN	O
“	JJ	O
same	JJ	O
”	NN	O
in	IN	O
the	DT	O
process	NN	O
200	CD	O
.	.	O
If	IN	O
a	DT	O
determination	NN	O
is	VBZ	O
made	VBN	O
that	IN	O
the	DT	O
two	CD	O
sequences	NNS	O
are	VBP	O
the	DT	O
same	JJ	O
,	,	O
the	DT	O
process	NN	O
200	CD	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
214	CD	O
wherein	NN	O
the	DT	O
name	NN	O
of	IN	O
the	DT	O
sequence	NN	O
from	IN	O
the	DT	O
database	NN	O
is	VBZ	O
displayed	VBN	O
to	TO	O
the	DT	O
user	NN	O
.	.	O
This	DT	O
state	NN	O
notifies	VBZ	O
the	DT	O
user	NN	O
that	IN	O
the	DT	O
sequence	NN	O
with	IN	O
the	DT	O
displayed	JJ	O
name	NN	O
fulfills	VBZ	O
the	DT	O
homology	NN	O
constraints	NNS	O
that	WDT	O
were	VBD	O
entered	VBN	O
.	.	O
Once	RB	O
the	DT	O
name	NN	O
of	IN	O
the	DT	O
stored	JJ	O
sequence	NN	O
is	VBZ	O
displayed	VBN	O
to	TO	O
the	DT	O
user	NN	O
,	,	O
the	DT	O
process	NN	O
200	CD	O
moves	NNS	O
to	TO	O
a	DT	O
decision	NN	O
state	NN	O
218	CD	O
wherein	NN	O
a	DT	O
determination	NN	O
is	VBZ	O
made	VBN	O
whether	IN	O
more	JJR	O
sequences	NNS	O
exist	VBP	O
in	IN	O
the	DT	O
database	NN	O
.	.	O
If	IN	O
no	DT	O
more	JJR	O
sequences	NNS	O
exist	VBP	O
in	IN	O
the	DT	O
database	NN	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
200	CD	O
terminates	NNS	O
at	IN	O
an	DT	O
end	NN	O
state	NN	O
220	CD	O
.	.	O
However	RB	O
,	,	O
if	IN	O
more	JJR	O
sequences	NNS	O
do	VBP	O
exist	VB	O
in	IN	O
the	DT	O
database	NN	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
200	CD	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
224	CD	O
wherein	NN	O
a	DT	O
pointer	NN	O
is	VBZ	O
moved	VBN	O
to	TO	O
the	DT	O
next	JJ	O
sequence	NN	O
in	IN	O
the	DT	O
database	NN	O
so	RB	O
that	IN	O
it	PRP	O
can	MD	O
be	VB	O
compared	VBN	O
to	TO	O
the	DT	O
new	JJ	O
sequence	NN	O
.	.	O
In	IN	O
this	DT	O
manner	NN	O
,	,	O
the	DT	O
new	JJ	O
sequence	NN	O
is	VBZ	O
aligned	VBN	O
and	CC	O
compared	VBN	O
with	IN	O
every	DT	O
sequence	NN	O
in	IN	O
the	DT	O
database	NN	O
.	.	O
It	PRP	O
should	MD	O
be	VB	O
noted	VBN	O
that	IN	O
if	IN	O
a	DT	O
determination	NN	O
had	VBD	O
been	VBN	O
made	VBN	O
at	IN	O
the	DT	O
decision	NN	O
state	NN	O
212	CD	O
that	IN	O
the	DT	O
sequences	NNS	O
were	VBD	O
not	RB	O
homologous	JJ	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
200	CD	O
would	MD	O
move	VB	O
immediately	RB	O
to	TO	O
the	DT	O
decision	NN	O
state	NN	O
218	CD	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
if	IN	O
any	DT	O
other	JJ	O
sequences	NNS	O
were	VBD	O
available	JJ	O
in	IN	O
the	DT	O
database	NN	O
for	IN	O
comparison	NN	O
.	.	O
Accordingly	RB	O
,	,	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
a	DT	O
computer	NN	O
system	NN	O
comprising	VBG	O
a	DT	O
processor	NN	O
,	,	O
a	DT	O
data	NN	O
storage	NN	O
device	NN	O
having	VBG	O
stored	VBN	O
thereon	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
a	DT	O
sequence	NN	O
comparer	NN	O
for	IN	O
conducting	VBG	O
the	DT	O
comparison	NN	O
.	.	O
The	DT	O
sequence	NN	O
comparer	NN	O
may	MD	O
indicate	VB	O
a	DT	O
homology	NN	O
level	NN	O
between	IN	O
the	DT	O
sequences	NNS	O
compared	VBN	O
or	CC	O
identify	VB	O
structural	JJ	O
motifs	NNS	O
,	,	O
or	CC	O
it	PRP	O
may	MD	O
identify	VB	O
structural	JJ	O
motifs	NNS	O
in	IN	O
sequences	NNS	O
which	WDT	O
are	VBP	O
compared	VBN	O
to	TO	O
these	DT	O
nucleic	JJ	O
acid	NN	O
codes	NNS	O
and	CC	O
polypeptide	NN	O
codes	NNS	O
.	.	O
FIG	NNP	O
.	.	O
3	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
embodiment	NN	O
of	IN	O
a	DT	O
process	NN	O
250	CD	O
in	IN	O
a	DT	O
computer	NN	O
for	IN	O
determining	VBG	O
whether	IN	O
two	CD	O
sequences	NNS	O
are	VBP	O
homologous	JJ	O
.	.	O
The	DT	O
process	NN	O
250	CD	O
begins	NNS	O
at	IN	O
a	DT	O
start	NN	O
state	NN	O
252	CD	O
and	CC	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
254	CD	O
wherein	NN	O
a	DT	O
first	JJ	O
sequence	NN	O
to	TO	O
be	VB	O
compared	VBN	O
is	VBZ	O
stored	VBN	O
to	TO	O
a	DT	O
memory	NN	O
.	.	O
The	DT	O
second	JJ	O
sequence	NN	O
to	TO	O
be	VB	O
compared	VBN	O
is	VBZ	O
then	RB	O
stored	VBN	O
to	TO	O
a	DT	O
memory	NN	O
at	IN	O
a	DT	O
state	NN	O
256	CD	O
.	.	O
The	DT	O
process	NN	O
250	CD	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
260	CD	O
wherein	NN	O
the	DT	O
first	JJ	O
character	NN	O
in	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
is	VBZ	O
read	VBN	O
and	CC	O
then	RB	O
to	TO	O
a	DT	O
state	NN	O
262	CD	O
wherein	NN	O
the	DT	O
first	JJ	O
character	NN	O
of	IN	O
the	DT	O
second	JJ	O
sequence	NN	O
is	VBZ	O
read	VBN	O
.	.	O
It	PRP	O
should	MD	O
be	VB	O
understood	VBN	O
that	IN	O
if	IN	O
the	DT	O
sequence	NN	O
is	VBZ	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
,	,	O
then	RB	O
the	DT	O
character	NN	O
would	MD	O
normally	RB	O
be	VB	O
either	CC	O
A	NNP	O
,	,	O
T	NNP	O
,	,	O
C	NNP	O
,	,	O
G	NNP	O
or	CC	O
U	NNP	O
.	.	O
If	IN	O
the	DT	O
sequence	NN	O
is	VBZ	O
a	DT	O
protein	JJ	O
sequence	NN	O
,	,	O
then	RB	O
it	PRP	O
can	MD	O
be	VB	O
a	DT	O
single	JJ	O
letter	NN	O
amino	NN	O
acid	NN	O
code	NN	O
so	IN	O
that	IN	O
the	DT	O
first	JJ	O
and	CC	O
sequence	NN	O
sequences	NNS	O
can	MD	O
be	VB	O
easily	RB	O
compared	VBN	O
.	.	O
A	DT	O
determination	NN	O
is	VBZ	O
then	RB	O
made	VBN	O
at	IN	O
a	DT	O
decision	NN	O
state	NN	O
264	CD	O
whether	IN	O
the	DT	O
two	CD	O
characters	NNS	O
are	VBP	O
the	DT	O
same	JJ	O
.	.	O
If	IN	O
they	PRP	O
are	VBP	O
the	DT	O
same	JJ	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
250	CD	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
268	CD	O
wherein	IN	O
the	DT	O
next	JJ	O
characters	NNS	O
in	IN	O
the	DT	O
first	JJ	O
and	CC	O
second	JJ	O
sequences	NNS	O
are	VBP	O
read	VBN	O
.	.	O
A	DT	O
determination	NN	O
is	VBZ	O
then	RB	O
made	VBN	O
whether	IN	O
the	DT	O
next	JJ	O
characters	NNS	O
are	VBP	O
the	DT	O
same	JJ	O
.	.	O
If	IN	O
they	PRP	O
are	VBP	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
250	CD	O
continues	VBZ	O
this	DT	O
loop	NN	O
until	IN	O
two	CD	O
characters	NNS	O
are	VBP	O
not	RB	O
the	DT	O
same	JJ	O
.	.	O
If	IN	O
a	DT	O
determination	NN	O
is	VBZ	O
made	VBN	O
that	IN	O
the	DT	O
next	JJ	O
two	CD	O
characters	NNS	O
are	VBP	O
not	RB	O
the	DT	O
same	JJ	O
,	,	O
the	DT	O
process	NN	O
250	CD	O
moves	NNS	O
to	TO	O
a	DT	O
decision	NN	O
state	NN	O
274	CD	O
to	TO	O
determine	VB	O
whether	IN	O
there	EX	O
are	VBP	O
any	DT	O
more	JJR	O
characters	NNS	O
either	CC	O
sequence	NN	O
to	TO	O
read	VB	O
.	.	O
If	IN	O
there	EX	O
are	VBP	O
not	RB	O
any	DT	O
more	JJR	O
characters	NNS	O
to	TO	O
read	VB	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
250	CD	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
276	CD	O
wherein	VBD	O
the	DT	O
level	NN	O
of	IN	O
homology	NN	O
between	IN	O
the	DT	O
first	JJ	O
and	CC	O
second	JJ	O
sequences	NNS	O
is	VBZ	O
displayed	VBN	O
to	TO	O
the	DT	O
user	NN	O
.	.	O
The	DT	O
level	NN	O
of	IN	O
homology	NN	O
is	VBZ	O
determined	VBN	O
by	IN	O
calculating	VBG	O
the	DT	O
proportion	NN	O
of	IN	O
characters	NNS	O
between	IN	O
the	DT	O
sequences	NNS	O
that	WDT	O
were	VBD	O
the	DT	O
same	JJ	O
out	IN	O
of	IN	O
the	DT	O
total	JJ	O
number	NN	O
of	IN	O
sequences	NNS	O
in	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
.	.	O
Thus	RB	O
,	,	O
if	IN	O
every	DT	O
character	NN	O
in	IN	O
a	DT	O
first	JJ	O
100	CD	O
nucleotide	JJ	O
sequence	NN	O
aligned	VBN	O
with	IN	O
an	DT	O
every	DT	O
character	NN	O
in	IN	O
a	DT	O
second	JJ	O
sequence	NN	O
,	,	O
the	DT	O
homology	NN	O
level	NN	O
would	MD	O
be	VB	O
100	CD	O
%	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
computer	NN	O
program	NN	O
can	MD	O
compare	VB	O
a	DT	O
reference	NN	O
sequence	NN	O
to	TO	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
sequences	NNS	O
differ	VBP	O
at	IN	O
one	CD	O
or	CC	O
more	JJR	O
positions	NNS	O
.	.	O
The	DT	O
program	NN	O
can	MD	O
record	VB	O
the	DT	O
length	NN	O
and	CC	O
identity	NN	O
of	IN	O
inserted	JJ	O
,	,	O
deleted	VBD	O
or	CC	O
substituted	VBD	O
nucleotides	NNS	O
or	CC	O
amino	NN	O
acid	NN	O
residues	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
sequence	NN	O
of	IN	O
either	CC	O
the	DT	O
reference	NN	O
or	CC	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
computer	NN	O
program	NN	O
may	MD	O
be	VB	O
a	DT	O
program	NN	O
which	WDT	O
determines	VBZ	O
whether	IN	O
a	DT	O
reference	NN	O
sequence	NN	O
contains	VBZ	O
a	DT	O
single	JJ	O
nucleotide	NN	O
polymorphism	NN	O
(	(	O
SNP	NNP	O
)	)	O
with	IN	O
respect	NN	O
to	TO	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
,	,	O
whether	IN	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprises	VBZ	O
a	DT	O
SNP	NNP	O
of	IN	O
a	DT	O
known	JJ	O
sequence	NN	O
.	.	O
Thus	RB	O
,	,	O
in	IN	O
some	DT	O
aspects	NNS	O
,	,	O
the	DT	O
computer	NN	O
program	NN	O
is	VBZ	O
a	DT	O
program	NN	O
which	WDT	O
identifies	VBZ	O
SNPs	NNP	O
.	.	O
The	DT	O
method	NN	O
may	MD	O
be	VB	O
implemented	VBN	O
by	IN	O
the	DT	O
computer	NN	O
systems	NNS	O
described	VBN	O
above	IN	O
and	CC	O
the	DT	O
method	NN	O
illustrated	VBN	O
in	IN	O
FIG	NNP	O
.	.	O
3	CD	O
.	.	O
The	DT	O
method	NN	O
can	MD	O
be	VB	O
performed	VBN	O
by	IN	O
reading	VBG	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
the	DT	O
reference	NN	O
sequences	NNS	O
through	IN	O
the	DT	O
use	NN	O
of	IN	O
the	DT	O
computer	NN	O
program	NN	O
and	CC	O
identifying	VBG	O
differences	NNS	O
with	IN	O
the	DT	O
computer	NN	O
program	NN	O
.	.	O
In	IN	O
other	JJ	O
aspects	NNS	O
the	DT	O
computer	NN	O
based	VBN	O
system	NN	O
comprises	VBZ	O
an	DT	O
identifier	NN	O
for	IN	O
identifying	VBG	O
features	NNS	O
within	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
or	CC	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
An	DT	O
“	NN	O
identifier	NN	O
”	VBZ	O
refers	NNS	O
to	TO	O
one	CD	O
or	CC	O
more	JJR	O
programs	NNS	O
which	WDT	O
identifies	VBP	O
certain	JJ	O
features	NNS	O
within	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
an	DT	O
identifier	NN	O
may	MD	O
comprise	VB	O
a	DT	O
program	NN	O
which	WDT	O
identifies	VBZ	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
(	(	O
ORF	NNP	O
)	)	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
.	.	O
FIG	NNP	O
.	.	O
4	CD	O
is	VBZ	O
a	DT	O
flow	JJ	O
diagram	NN	O
illustrating	VBG	O
one	CD	O
aspect	NN	O
of	IN	O
an	DT	O
identifier	NN	O
process	NN	O
300	CD	O
for	IN	O
detecting	VBG	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
feature	NN	O
in	IN	O
a	DT	O
sequence	NN	O
.	.	O
The	DT	O
process	NN	O
300	CD	O
begins	NNS	O
at	IN	O
a	DT	O
start	NN	O
state	NN	O
302	CD	O
and	CC	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
304	CD	O
wherein	NN	O
a	DT	O
first	JJ	O
sequence	NN	O
that	WDT	O
is	VBZ	O
to	TO	O
be	VB	O
checked	VBN	O
for	IN	O
features	NNS	O
is	VBZ	O
stored	VBN	O
to	TO	O
a	DT	O
memory	NN	O
115	CD	O
in	IN	O
the	DT	O
computer	NN	O
system	NN	O
100	CD	O
.	.	O
The	DT	O
process	NN	O
300	CD	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
306	CD	O
wherein	NN	O
a	DT	O
database	NN	O
of	IN	O
sequence	NN	O
features	NNS	O
is	VBZ	O
opened	VBN	O
.	.	O
Such	JJ	O
a	DT	O
database	NN	O
would	MD	O
include	VB	O
a	DT	O
list	NN	O
of	IN	O
each	DT	O
feature	NN	O
's	POS	O
attributes	NNS	O
along	IN	O
with	IN	O
the	DT	O
name	NN	O
of	IN	O
the	DT	O
feature	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
feature	NN	O
name	NN	O
could	MD	O
be	VB	O
“	JJ	O
Initiation	NNP	O
Codon	NNP	O
”	NNP	O
and	CC	O
the	DT	O
attribute	NN	O
would	MD	O
be	VB	O
“	JJ	O
ATG	NNP	O
”	NNP	O
.	.	O
Another	DT	O
example	NN	O
would	MD	O
be	VB	O
the	DT	O
feature	NN	O
name	NN	O
“	NNP	O
TAATAA	NNP	O
Box	NNP	O
”	NNP	O
and	CC	O
the	DT	O
feature	NN	O
attribute	NN	O
would	MD	O
be	VB	O
“	JJ	O
TAATAA	NNP	O
”	NNP	O
.	.	O
An	DT	O
example	NN	O
of	IN	O
such	PDT	O
a	DT	O
database	NN	O
is	VBZ	O
produced	VBN	O
by	IN	O
the	DT	O
University	NNP	O
of	IN	O
Wisconsin	NNP	O
Genetics	NNP	O
Computer	NNP	O
Group	NNP	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
features	NNS	O
may	MD	O
be	VB	O
structural	JJ	O
polypeptide	JJ	O
motifs	NNS	O
such	JJ	O
as	IN	O
alpha	JJ	O
helices	NNS	O
,	,	O
beta	NN	O
sheets	NNS	O
,	,	O
or	CC	O
functional	JJ	O
polypeptide	NN	O
motifs	NNS	O
such	JJ	O
as	IN	O
enzymatic	JJ	O
active	JJ	O
sites	NNS	O
,	,	O
helix-turn-helix	JJ	O
motifs	NNS	O
or	CC	O
other	JJ	O
motifs	NNS	O
known	VBN	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Once	RB	O
the	DT	O
database	NN	O
of	IN	O
features	NNS	O
is	VBZ	O
opened	VBN	O
at	IN	O
the	DT	O
state	NN	O
306	CD	O
,	,	O
the	DT	O
process	NN	O
300	CD	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
308	CD	O
wherein	NN	O
the	DT	O
first	JJ	O
feature	NN	O
is	VBZ	O
read	VBN	O
from	IN	O
the	DT	O
database	NN	O
.	.	O
A	DT	O
comparison	NN	O
of	IN	O
the	DT	O
attribute	NN	O
of	IN	O
the	DT	O
first	JJ	O
feature	NN	O
with	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
is	VBZ	O
then	RB	O
made	VBN	O
at	IN	O
a	DT	O
state	NN	O
310	CD	O
.	.	O
A	DT	O
determination	NN	O
is	VBZ	O
then	RB	O
made	VBN	O
at	IN	O
a	DT	O
decision	NN	O
state	NN	O
316	CD	O
whether	IN	O
the	DT	O
attribute	NN	O
of	IN	O
the	DT	O
feature	NN	O
was	VBD	O
found	VBN	O
in	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
.	.	O
If	IN	O
the	DT	O
attribute	NN	O
was	VBD	O
found	VBN	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
300	CD	O
moves	NNS	O
to	TO	O
a	DT	O
state	NN	O
318	CD	O
wherein	NN	O
the	DT	O
name	NN	O
of	IN	O
the	DT	O
found	JJ	O
feature	NN	O
is	VBZ	O
displayed	VBN	O
to	TO	O
the	DT	O
user	NN	O
.	.	O
The	DT	O
process	NN	O
300	CD	O
then	RB	O
moves	NNS	O
to	TO	O
a	DT	O
decision	NN	O
state	NN	O
320	CD	O
wherein	NN	O
a	DT	O
determination	NN	O
is	VBZ	O
made	VBN	O
whether	IN	O
move	NN	O
features	NNS	O
exist	VBP	O
in	IN	O
the	DT	O
database	NN	O
.	.	O
If	IN	O
no	DT	O
more	JJR	O
features	NNS	O
do	VBP	O
exist	VB	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
300	CD	O
terminates	NNS	O
at	IN	O
an	DT	O
end	NN	O
state	NN	O
324	CD	O
.	.	O
However	RB	O
,	,	O
if	IN	O
more	JJR	O
features	NNS	O
do	VBP	O
exist	VB	O
in	IN	O
the	DT	O
database	NN	O
,	,	O
then	RB	O
the	DT	O
process	NN	O
300	CD	O
reads	VBZ	O
the	DT	O
next	JJ	O
sequence	NN	O
feature	NN	O
at	IN	O
a	DT	O
state	NN	O
326	CD	O
and	CC	O
loops	VBZ	O
back	RB	O
to	TO	O
the	DT	O
state	NN	O
310	CD	O
wherein	VBD	O
the	DT	O
attribute	NN	O
of	IN	O
the	DT	O
next	JJ	O
feature	NN	O
is	VBZ	O
compared	VBN	O
against	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
.	.	O
If	IN	O
the	DT	O
feature	NN	O
attribute	NN	O
is	VBZ	O
not	RB	O
found	VBN	O
in	IN	O
the	DT	O
first	JJ	O
sequence	NN	O
at	IN	O
the	DT	O
decision	NN	O
state	NN	O
316	CD	O
,	,	O
the	DT	O
process	NN	O
300	CD	O
moves	NNS	O
directly	RB	O
to	TO	O
the	DT	O
decision	NN	O
state	NN	O
320	CD	O
in	IN	O
order	NN	O
to	TO	O
determine	VB	O
if	IN	O
any	DT	O
more	JJR	O
features	NNS	O
exist	VBP	O
in	IN	O
the	DT	O
database	NN	O
.	.	O
Thus	RB	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
computer	NN	O
program	NN	O
that	WDT	O
identifies	VBZ	O
open	JJ	O
reading	VBG	O
frames	NNS	O
(	(	O
ORFs	NNP	O
)	)	O
.	.	O
A	DT	O
polypeptide	NN	O
or	CC	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
stored	VBN	O
and	CC	O
manipulated	VBN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
data	NNS	O
processor	NN	O
programs	NNS	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
formats	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
sequence	NN	O
can	MD	O
be	VB	O
stored	VBN	O
as	IN	O
text	NN	O
in	IN	O
a	DT	O
word	NN	O
processing	NN	O
file	NN	O
,	,	O
such	JJ	O
as	IN	O
MicrosoftWORD	NNP	O
or	CC	O
WORDPERFECT	NNP	O
or	CC	O
as	IN	O
an	DT	O
ASCII	NNP	O
file	NN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
database	NN	O
programs	NNS	O
familiar	JJ	O
to	TO	O
those	DT	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
such	JJ	O
as	IN	O
DB2	NNP	O
,	,	O
SYBASE	NNP	O
,	,	O
or	CC	O
ORACLE	NNP	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
many	JJ	O
computer	NN	O
programs	NNS	O
and	CC	O
databases	NNS	O
may	MD	O
be	VB	O
used	VBN	O
as	IN	O
sequence	NN	O
comparison	NN	O
algorithms	NN	O
,	,	O
identifiers	NNS	O
,	,	O
or	CC	O
sources	NNS	O
of	IN	O
reference	NN	O
nucleotide	JJ	O
sequences	NNS	O
or	CC	O
polypeptide	VB	O
sequences	NNS	O
to	TO	O
be	VB	O
compared	VBN	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
programs	NNS	O
and	CC	O
databases	NNS	O
used	VBN	O
to	TO	O
practice	NN	O
the	DT	O
invention	NN	O
include	VBP	O
,	,	O
but	CC	O
are	VBP	O
not	RB	O
limited	VBN	O
to	TO	O
:	:	O
MacPattern	NNP	O
(	(	O
EMBL	NNP	O
)	)	O
,	,	O
DiscoveryBase	NNP	O
(	(	O
Molecular	NNP	O
Applications	NNP	O
Group	NNP	O
)	)	O
,	,	O
GeneMine	NNP	O
(	(	O
Molecular	NNP	O
Applications	NNP	O
Group	NNP	O
)	)	O
,	,	O
Look	NNP	O
(	(	O
Molecular	NNP	O
Applications	NNP	O
Group	NNP	O
)	)	O
,	,	O
MacLook	NNP	O
(	(	O
Molecular	NNP	O
Applications	NNP	O
Group	NNP	O
)	)	O
,	,	O
BLAST	NNP	O
and	CC	O
BLAST2	NNP	O
(	(	O
NCBI	NNP	O
)	)	O
,	,	O
BLASTN	NNP	O
and	CC	O
BLASTX	NNP	O
(	(	O
Altschul	NNP	B
et	RB	I
al	RB	I
,	,	I
J.	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
215	CD	I
:	:	I
403	CD	I
,	,	I
1990	CD	I
)	)	O
,	,	O
FASTA	NNP	O
(	(	O
Pearson	NNP	B
and	CC	I
Lipman	NNP	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
85	CD	I
:	:	I
2444	CD	I
,	,	I
1988	CD	I
)	)	O
,	,	O
FASTDB	NNP	O
(	(	O
Brutlag	NNP	B
et	RB	I
al	RB	I
.	.	I
Comp	NNP	I
.	.	I
App	NNP	I
.	.	I
Biosci	NNP	I
.	.	I
6:237-245	CD	I
,	,	I
1990	CD	I
)	)	O
,	,	O
Catalyst	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Catalyst/SHAPE	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Cerius2.DBAccess	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
HypoGen	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Insight	NNP	O
II	NNP	O
,	,	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Discover	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
CHARMm	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Felix	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
DelPhi	NNP	O
,	,	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
QuanteMM	NNP	O
,	,	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Homology	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Modeler	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
ISIS	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Quanta/Protein	NNP	O
Design	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
WebLab	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
WebLab	NNP	O
Diversity	NNP	O
Explorer	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
Gene	NNP	O
Explorer	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
SeqFold	NNP	O
(	(	O
Molecular	NNP	O
Simulations	NNP	O
Inc.	NNP	O
)	)	O
,	,	O
the	DT	O
MDL	NNP	O
Available	NNP	O
Chemicals	NNPS	O
Directory	NNP	O
database	NN	O
,	,	O
the	DT	O
MDL	NNP	O
Drug	NNP	O
Data	NNP	O
Report	NNP	O
data	NNS	O
base	NN	O
,	,	O
the	DT	O
Comprehensive	NNP	O
Medicinal	NNP	O
Chemistry	NNP	O
database	NN	O
,	,	O
Derwent	NNP	O
's	POS	O
World	NNP	O
Drug	NNP	O
Index	NNP	O
database	NN	O
,	,	O
the	DT	O
BioByteMasterFile	NNP	O
database	NN	O
,	,	O
the	DT	O
Genbank	NNP	O
database	NN	O
,	,	O
and	CC	O
the	DT	O
Genseqn	NNP	O
database	NN	O
.	.	O
Many	JJ	O
other	JJ	O
programs	NNS	O
and	CC	O
data	NNS	O
bases	NNS	O
would	MD	O
be	VB	O
apparent	JJ	O
to	TO	O
one	CD	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
given	VBN	O
the	DT	O
present	JJ	O
disclosure	NN	O
.	.	O
Motifs	NNP	O
which	WDT	O
may	MD	O
be	VB	O
detected	VBN	O
using	VBG	O
the	DT	O
above	JJ	O
programs	NNS	O
include	VBP	O
sequences	NNS	O
encoding	VBG	O
leucine	NN	O
zippers	NNS	O
,	,	O
helix-turn-helix	JJ	O
motifs	NNS	O
,	,	O
glycosylation	NN	O
sites	NNS	O
,	,	O
ubiquitination	NN	O
sites	NNS	O
,	,	O
alpha	JJ	O
helices	NNS	O
,	,	O
and	CC	O
beta	NN	O
sheets	NNS	O
,	,	O
signal	JJ	O
sequences	NNS	O
encoding	VBG	O
signal	NN	O
peptides	NNS	O
which	WDT	O
direct	VBP	O
the	DT	O
secretion	NN	O
of	IN	O
the	DT	O
encoded	JJ	O
proteins	NNS	O
,	,	O
sequences	NNS	O
implicated	VBN	O
in	IN	O
transcription	NN	O
regulation	NN	O
such	JJ	O
as	IN	O
homeoboxes	NNS	O
,	,	O
acidic	JJ	O
stretches	NNS	O
,	,	O
enzymatic	JJ	O
active	JJ	O
sites	NNS	O
,	,	O
substrate	NN	O
binding	NN	O
sites	NNS	O
,	,	O
and	CC	O
enzymatic	JJ	O
cleavage	NN	O
sites	NNS	O
.	.	O
Hybridization	NN	O
of	IN	O
Nucleic	NNP	O
Acids	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
that	IN	O
hybridize	NN	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
to	TO	O
an	DT	O
exemplary	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
nucleic	JJ	O
acid	NN	O
that	WDT	O
encodes	VBZ	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
stringent	JJ	O
conditions	NNS	O
can	MD	O
be	VB	O
highly	RB	O
stringent	JJ	O
conditions	NNS	O
,	,	O
medium	NN	O
stringent	NN	O
conditions	NNS	O
,	,	O
low	JJ	O
stringent	NN	O
conditions	NNS	O
,	,	O
including	VBG	O
the	DT	O
high	JJ	O
and	CC	O
reduced	JJ	O
stringency	NN	O
conditions	NNS	O
described	VBD	O
herein	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
it	PRP	O
is	VBZ	O
the	DT	O
stringency	NN	O
of	IN	O
the	DT	O
wash	NN	O
conditions	NNS	O
that	WDT	O
set	VBP	O
forth	VBP	O
the	DT	O
conditions	NNS	O
which	WDT	O
determine	VBP	O
whether	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
as	IN	O
discussed	VBN	O
below	IN	O
.	.	O
In	IN	O
alternative	JJ	O
embodiments	NNS	O
,	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
as	IN	O
defined	VBN	O
by	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
hybridize	VB	O
under	IN	O
stringent	JJ	O
conditions	NNS	O
can	MD	O
be	VB	O
between	IN	O
about	RB	O
five	CD	O
residues	NNS	O
and	CC	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
e.g.	CC	O
,	,	O
they	PRP	O
can	MD	O
be	VB	O
at	IN	O
least	JJS	O
5	CD	O
,	,	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
50	CD	O
,	,	O
55	CD	O
,	,	O
60	CD	O
,	,	O
65	CD	O
,	,	O
70	CD	O
,	,	O
75	CD	O
,	,	O
80	CD	O
,	,	O
90	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
residues	NNS	O
in	IN	O
length	NN	O
.	.	O
Nucleic	NNP	O
acids	NNS	O
shorter	JJR	O
than	IN	O
full	JJ	O
length	NN	O
are	VBP	O
also	RB	O
included	VBN	O
.	.	O
These	DT	O
nucleic	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
useful	JJ	O
as	IN	O
,	,	O
e.g.	NN	O
,	,	O
hybridization	NN	O
probes	NNS	O
,	,	O
labeling	VBG	O
probes	NNS	O
,	,	O
PCR	NNP	O
oligonucleotide	IN	O
probes	NNS	O
,	,	O
iRNA	NN	O
,	,	O
antisense	NN	O
or	CC	O
sequences	NNS	O
encoding	VBG	O
antibody	NN	O
binding	VBG	O
peptides	NNS	O
(	(	O
epitopes	NNS	O
)	)	O
,	,	O
motifs	UH	O
,	,	O
active	JJ	O
sites	NNS	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
defined	VBN	O
by	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
hybridize	VB	O
under	IN	O
high	JJ	O
stringency	NN	O
comprises	NNS	O
conditions	NNS	O
of	IN	O
about	RB	O
50	CD	O
%	NN	O
formamide	NN	O
at	IN	O
about	IN	O
37°	CD	O
C.	NNP	O
to	TO	O
42°	CD	O
C.	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
defined	VBN	O
by	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
hybridize	VB	O
under	IN	O
reduced	JJ	O
stringency	NN	O
comprising	VBG	O
conditions	NNS	O
in	IN	O
about	RB	O
35	CD	O
%	NN	O
to	TO	O
25	CD	O
%	NN	O
formamide	NN	O
at	IN	O
about	IN	O
30°	CD	O
C.	NNP	O
to	TO	O
35°	CD	O
C.	NNP	O
Alternatively	RB	O
,	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
defined	VBN	O
by	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
hybridize	VB	O
under	IN	O
high	JJ	O
stringency	NN	O
comprising	VBG	O
conditions	NNS	O
at	IN	O
42°	CD	O
C.	NNP	O
in	IN	O
50	CD	O
%	NN	O
formamide	NN	O
,	,	O
5×SSPE	CD	O
,	,	O
0.3	CD	O
%	NN	O
SDS	NNP	O
,	,	O
and	CC	O
a	DT	O
repetitive	JJ	O
sequence	NN	O
blocking	VBG	O
nucleic	JJ	O
acid	NN	O
,	,	O
such	JJ	O
as	IN	O
cot-1	NN	O
or	CC	O
salmon	JJ	O
sperm	NN	O
DNA	NNP	O
(	(	O
e.g.	NN	O
,	,	O
200	CD	O
n/ml	NN	O
sheared	VBN	O
and	CC	O
denatured	VBN	O
salmon	JJ	O
sperm	JJ	O
DNA	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
defined	VBN	O
by	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
hybridize	VB	O
under	IN	O
reduced	JJ	O
stringency	NN	O
conditions	NNS	O
comprising	VBG	O
35	CD	O
%	NN	O
formamide	NN	O
at	IN	O
a	DT	O
reduced	JJ	O
temperature	NN	O
of	IN	O
35°	CD	O
C.	NNP	O
Following	NNP	O
hybridization	NN	O
,	,	O
the	DT	O
filter	NN	O
may	MD	O
be	VB	O
washed	VBN	O
with	IN	O
6×SSC	CD	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
50°	CD	O
C.	NNP	O
These	DT	O
conditions	NNS	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
“	JJ	O
moderate	JJ	O
”	NN	O
conditions	NNS	O
above	IN	O
25	CD	O
%	NN	O
formamide	NN	O
and	CC	O
“	NNP	O
low	JJ	O
”	NNP	O
conditions	NNS	O
below	IN	O
25	CD	O
%	NN	O
formamide	NN	O
.	.	O
A	DT	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
moderate	JJ	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
30	CD	O
%	NN	O
formamide	NN	O
.	.	O
A	DT	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
low	JJ	O
stringency	NN	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
10	CD	O
%	NN	O
formamide	NN	O
.	.	O
The	DT	O
temperature	NN	O
range	NN	O
corresponding	VBG	O
to	TO	O
a	DT	O
particular	JJ	O
level	NN	O
of	IN	O
stringency	NN	O
can	MD	O
be	VB	O
further	JJ	O
narrowed	VBN	O
by	IN	O
calculating	VBG	O
the	DT	O
purine	NN	O
to	TO	O
pyrimidine	VB	O
ratio	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
interest	NN	O
and	CC	O
adjusting	VBG	O
the	DT	O
temperature	NN	O
accordingly	RB	O
.	.	O
Nucleic	NNP	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
also	RB	O
defined	VBN	O
by	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
hybridize	VB	O
under	IN	O
high	JJ	O
,	,	O
medium	NN	O
,	,	O
and	CC	O
low	JJ	O
stringency	NN	O
conditions	NNS	O
as	IN	O
set	NN	O
forth	NN	O
in	IN	O
Ausubel	NNP	O
and	CC	O
Sambrook	NNP	O
.	.	O
Variations	NNS	O
on	IN	O
the	DT	O
above	JJ	O
ranges	NNS	O
and	CC	O
conditions	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Hybridization	NN	O
conditions	NNS	O
are	VBP	O
discussed	VBN	O
further	RB	O
,	,	O
below	IN	O
.	.	O
The	DT	O
above	JJ	O
procedure	NN	O
may	MD	O
be	VB	O
modified	VBN	O
to	TO	O
identify	VB	O
nucleic	JJ	O
acids	NNS	O
having	VBG	O
decreasing	VBG	O
levels	NNS	O
of	IN	O
homology	NN	O
to	TO	O
the	DT	O
probe	NN	O
sequence	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
to	TO	O
obtain	VB	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
decreasing	VBG	O
homology	NN	O
to	TO	O
the	DT	O
detectable	JJ	O
probe	NN	O
,	,	O
less	RBR	O
stringent	JJ	O
conditions	NNS	O
may	MD	O
be	VB	O
used	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
hybridization	NN	O
temperature	NN	O
may	MD	O
be	VB	O
decreased	VBN	O
in	IN	O
increments	NNS	O
of	IN	O
5°	CD	O
C.	NNP	O
from	IN	O
68°	CD	O
C.	NNP	O
to	TO	O
42°	CD	O
C.	NNP	O
in	IN	O
a	DT	O
hybridization	NN	O
buffer	NN	O
having	VBG	O
a	DT	O
Na+	NNP	O
concentration	NN	O
of	IN	O
approximately	RB	O
1M	CD	O
.	.	O
Following	VBG	O
hybridization	NN	O
,	,	O
the	DT	O
filter	NN	O
may	MD	O
be	VB	O
washed	VBN	O
with	IN	O
2×SSC	CD	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
the	DT	O
temperature	NN	O
of	IN	O
hybridization	NN	O
.	.	O
These	DT	O
conditions	NNS	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
“	JJ	O
moderate	JJ	O
”	NN	O
conditions	NNS	O
above	IN	O
50°	CD	O
C.	NNP	O
and	CC	O
“	NNP	O
low	JJ	O
”	NNP	O
conditions	NNS	O
below	IN	O
50°	CD	O
C.	NNP	O
A	NNP	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
moderate	JJ	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
55°	CD	O
C.	NNP	O
A	NNP	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
low	JJ	O
stringency	NN	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
45°	CD	O
C.	NNP	O
Alternatively	RB	O
,	,	O
the	DT	O
hybridization	NN	O
may	MD	O
be	VB	O
carried	VBN	O
out	RP	O
in	IN	O
buffers	NNS	O
,	,	O
such	JJ	O
as	IN	O
6×SSC	CD	O
,	,	O
containing	VBG	O
formamide	NN	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
42°	CD	O
C.	NNP	O
In	IN	O
this	DT	O
case	NN	O
,	,	O
the	DT	O
concentration	NN	O
of	IN	O
formamide	NN	O
in	IN	O
the	DT	O
hybridization	NN	O
buffer	NN	O
may	MD	O
be	VB	O
reduced	VBN	O
in	IN	O
5	CD	O
%	NN	O
increments	NNS	O
from	IN	O
50	CD	O
%	NN	O
to	TO	O
0	CD	O
%	NN	O
to	TO	O
identify	VB	O
clones	NNS	O
having	VBG	O
decreasing	VBG	O
levels	NNS	O
of	IN	O
homology	NN	O
to	TO	O
the	DT	O
probe	NN	O
.	.	O
Following	VBG	O
hybridization	NN	O
,	,	O
the	DT	O
filter	NN	O
may	MD	O
be	VB	O
washed	VBN	O
with	IN	O
6×SSC	CD	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
50°	CD	O
C.	NNP	O
These	DT	O
conditions	NNS	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
“	JJ	O
moderate	JJ	O
”	NN	O
conditions	NNS	O
above	IN	O
25	CD	O
%	NN	O
formamide	NN	O
and	CC	O
“	NNP	O
low	JJ	O
”	NNP	O
conditions	NNS	O
below	IN	O
25	CD	O
%	NN	O
formamide	NN	O
.	.	O
A	DT	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
moderate	JJ	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
30	CD	O
%	NN	O
formamide	NN	O
.	.	O
A	DT	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
low	JJ	O
stringency	NN	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
10	CD	O
%	NN	O
formamide	NN	O
.	.	O
However	RB	O
,	,	O
the	DT	O
selection	NN	O
of	IN	O
a	DT	O
hybridization	NN	O
format	NN	O
is	VBZ	O
not	RB	O
critical—it	JJ	O
is	VBZ	O
the	DT	O
stringency	NN	O
of	IN	O
the	DT	O
wash	NN	O
conditions	NNS	O
that	WDT	O
set	VBP	O
forth	VBP	O
the	DT	O
conditions	NNS	O
which	WDT	O
determine	VBP	O
whether	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Wash	JJ	O
conditions	NNS	O
used	VBN	O
to	TO	O
identify	VB	O
nucleic	JJ	O
acids	NNS	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
,	,	O
e.g	FW	O
.	.	O
:	:	O
a	DT	O
salt	JJ	O
concentration	NN	O
of	IN	O
about	IN	O
0.02	CD	O
molar	NN	O
at	IN	O
pH	NN	O
7	CD	O
and	CC	O
a	DT	O
temperature	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50°	CD	O
C.	NNP	O
or	CC	O
about	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
60°	CD	O
C.	NNP	O
;	:	O
or	CC	O
,	,	O
a	DT	O
salt	JJ	O
concentration	NN	O
of	IN	O
about	IN	O
0.15	CD	O
M	NNP	O
NaCl	NNP	O
at	IN	O
72°	CD	O
C.	NNP	O
for	IN	O
about	RB	O
15	CD	O
minutes	NNS	O
;	:	O
or	CC	O
,	,	O
a	DT	O
salt	JJ	O
concentration	NN	O
of	IN	O
about	RB	O
0.2×SSC	CD	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50°	CD	O
C.	NNP	O
or	CC	O
about	IN	O
55°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
60°	CD	O
C.	NNP	O
for	IN	O
about	RB	O
15	CD	O
to	TO	O
about	IN	O
20	CD	O
minutes	NNS	O
;	:	O
or	CC	O
,	,	O
the	DT	O
hybridization	NN	O
complex	NN	O
is	VBZ	O
washed	VBN	O
twice	RB	O
with	IN	O
a	DT	O
solution	NN	O
with	IN	O
a	DT	O
salt	JJ	O
concentration	NN	O
of	IN	O
about	IN	O
2×SSC	CD	O
containing	VBG	O
0.1	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
15	CD	O
minutes	NNS	O
and	CC	O
then	RB	O
washed	VBD	O
twice	RB	O
by	IN	O
0.1×SSC	CD	O
containing	VBG	O
0.1	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
68°	CD	O
C.	NNP	O
for	IN	O
15	CD	O
minutes	NNS	O
;	:	O
or	CC	O
,	,	O
equivalent	JJ	O
conditions	NNS	O
.	.	O
See	VB	O
Sambrook	NNP	O
,	,	O
Tijssen	NNP	O
and	CC	O
Ausubel	NNP	O
for	IN	O
a	DT	O
description	NN	O
of	IN	O
SSC	NNP	O
buffer	NN	O
and	CC	O
equivalent	JJ	O
conditions	NNS	O
.	.	O
These	DT	O
methods	NNS	O
may	MD	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Oligonucleotides	NNP	O
Probes	NNP	O
and	CC	O
Methods	NNP	O
for	IN	O
Using	VBG	O
them	PRP	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
nucleic	JJ	O
acid	NN	O
probes	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
e.g.	FW	O
,	,	O
for	IN	O
identifying	VBG	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
with	IN	O
an	DT	O
amylase	NN	O
activity	NN	O
or	CC	O
fragments	NNS	O
thereof	VBP	O
or	CC	O
for	IN	O
identifying	VBG	O
amylase	NN	O
genes	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
probe	NN	O
comprises	VBZ	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Alternatively	RB	O
,	,	O
a	DT	O
probe	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
at	IN	O
least	JJS	O
about	IN	O
5	CD	O
,	,	O
6	CD	O
,	,	O
7	CD	O
,	,	O
8	CD	O
,	,	O
9	CD	O
,	,	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
45	CD	O
,	,	O
50	CD	O
,	,	O
60	CD	O
,	,	O
70	CD	O
,	,	O
80	CD	O
,	,	O
90	CD	O
,	,	O
100	CD	O
,	,	O
110	CD	O
,	,	O
120	CD	O
,	,	O
130	CD	O
,	,	O
150	CD	O
or	CC	O
about	RB	O
10	CD	O
to	TO	O
50	CD	O
,	,	O
about	RB	O
20	CD	O
to	TO	O
60	CD	O
about	RB	O
30	CD	O
to	TO	O
70	CD	O
,	,	O
consecutive	JJ	O
bases	NNS	O
of	IN	O
a	DT	O
sequence	NN	O
as	IN	O
set	VBN	O
forth	NN	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
probes	NNS	O
identify	VB	O
a	DT	O
nucleic	JJ	O
acid	NN	O
by	IN	O
binding	VBG	O
and/or	JJ	O
hybridization	NN	O
.	.	O
The	DT	O
probes	NNS	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
arrays	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
see	VBP	O
discussion	NN	O
below	IN	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
capillary	JJ	O
arrays	NNS	O
.	.	O
The	DT	O
probes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
other	JJ	O
nucleic	JJ	O
acids	NNS	O
or	CC	O
polypeptides	NNS	O
.	.	O
The	DT	O
probes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
determine	VB	O
whether	IN	O
a	DT	O
biological	JJ	O
sample	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
soil	NN	O
sample	NN	O
,	,	O
contains	VBZ	O
an	DT	O
organism	NN	O
having	VBG	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
an	DT	O
organism	NN	O
from	IN	O
which	WDT	O
the	DT	O
nucleic	NN	O
acid	NN	O
was	VBD	O
obtained	VBN	O
.	.	O
In	IN	O
such	JJ	O
procedures	NNS	O
,	,	O
a	DT	O
biological	JJ	O
sample	NN	O
potentially	RB	O
harboring	VBG	O
the	DT	O
organism	NN	O
from	IN	O
which	WDT	O
the	DT	O
nucleic	NN	O
acid	NN	O
was	VBD	O
isolated	VBN	O
is	VBZ	O
obtained	VBN	O
and	CC	O
nucleic	JJ	O
acids	NNS	O
are	VBP	O
obtained	VBN	O
from	IN	O
the	DT	O
sample	NN	O
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
are	VBP	O
contacted	VBN	O
with	IN	O
the	DT	O
probe	NN	O
under	IN	O
conditions	NNS	O
which	WDT	O
permit	VBP	O
the	DT	O
probe	NN	O
to	TO	O
specifically	RB	O
hybridize	VB	O
to	TO	O
any	DT	O
complementary	JJ	O
sequences	NNS	O
present	JJ	O
in	IN	O
the	DT	O
sample	NN	O
.	.	O
Where	WRB	O
necessary	JJ	O
,	,	O
conditions	NNS	O
which	WDT	O
permit	VBP	O
the	DT	O
probe	NN	O
to	TO	O
specifically	RB	O
hybridize	VB	O
to	TO	O
complementary	JJ	O
sequences	NNS	O
may	MD	O
be	VB	O
determined	VBN	O
by	IN	O
placing	VBG	O
the	DT	O
probe	NN	O
in	IN	O
contact	NN	O
with	IN	O
complementary	JJ	O
sequences	NNS	O
from	IN	O
samples	NNS	O
known	VBN	O
to	TO	O
contain	VB	O
the	DT	O
complementary	JJ	O
sequence	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
control	NN	O
sequences	NNS	O
which	WDT	O
do	VBP	O
not	RB	O
contain	VB	O
the	DT	O
complementary	JJ	O
sequence	NN	O
.	.	O
Hybridization	NN	O
conditions	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
salt	NN	O
concentration	NN	O
of	IN	O
the	DT	O
hybridization	NN	O
buffer	NN	O
,	,	O
the	DT	O
formamide	JJ	O
concentration	NN	O
of	IN	O
the	DT	O
hybridization	NN	O
buffer	NN	O
,	,	O
or	CC	O
the	DT	O
hybridization	NN	O
temperature	NN	O
,	,	O
may	MD	O
be	VB	O
varied	VBN	O
to	TO	O
identify	VB	O
conditions	NNS	O
which	WDT	O
allow	VBP	O
the	DT	O
probe	NN	O
to	TO	O
hybridize	VB	O
specifically	RB	O
to	TO	O
complementary	VB	O
nucleic	JJ	O
acids	NNS	O
(	(	O
see	VB	O
discussion	NN	O
on	IN	O
specific	JJ	O
hybridization	NN	O
conditions	NNS	O
)	)	O
.	.	O
If	IN	O
the	DT	O
sample	NN	O
contains	VBZ	O
the	DT	O
organism	NN	O
from	IN	O
which	WDT	O
the	DT	O
nucleic	NN	O
acid	NN	O
was	VBD	O
isolated	VBN	O
,	,	O
specific	JJ	O
hybridization	NN	O
of	IN	O
the	DT	O
probe	NN	O
is	VBZ	O
then	RB	O
detected	VBN	O
.	.	O
Hybridization	NN	O
may	MD	O
be	VB	O
detected	VBN	O
by	IN	O
labeling	VBG	O
the	DT	O
probe	NN	O
with	IN	O
a	DT	O
detectable	JJ	O
agent	NN	O
such	JJ	O
as	IN	O
a	DT	O
radioactive	JJ	O
isotope	NN	O
,	,	O
a	DT	O
fluorescent	JJ	O
dye	NN	O
or	CC	O
an	DT	O
enzyme	JJ	O
capable	NN	O
of	IN	O
catalyzing	VBG	O
the	DT	O
formation	NN	O
of	IN	O
a	DT	O
detectable	JJ	O
product	NN	O
.	.	O
Many	JJ	O
methods	NNS	O
for	IN	O
using	VBG	O
the	DT	O
labeled	VBN	O
probes	NNS	O
to	TO	O
detect	VB	O
the	DT	O
presence	NN	O
of	IN	O
complementary	JJ	O
nucleic	JJ	O
acids	NNS	O
in	IN	O
a	DT	O
sample	NN	O
are	VBP	O
familiar	JJ	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
These	DT	O
include	VBP	O
Southern	NNP	O
Blots	NNP	O
,	,	O
Northern	NNP	O
Blots	NNP	O
,	,	O
colony	NN	O
hybridization	NN	O
procedures	NNS	O
,	,	O
and	CC	O
dot	JJ	O
blots	NNS	O
.	.	O
Protocols	NNS	O
for	IN	O
each	DT	O
of	IN	O
these	DT	O
procedures	NNS	O
are	VBP	O
provided	VBN	O
in	IN	O
Ausubel	NNP	O
and	CC	O
Sambrook	NNP	O
.	.	O
Alternatively	RB	O
,	,	O
more	JJR	O
than	IN	O
one	CD	O
probe	NN	O
(	(	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
which	WDT	O
is	VBZ	O
capable	JJ	O
of	IN	O
specifically	RB	O
hybridizing	VBG	O
to	TO	O
any	DT	O
complementary	JJ	O
sequences	NNS	O
which	WDT	O
are	VBP	O
present	JJ	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	JJ	O
sample	NN	O
)	)	O
,	,	O
may	MD	O
be	VB	O
used	VBN	O
in	IN	O
an	DT	O
amplification	NN	O
reaction	NN	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
sample	NN	O
contains	VBZ	O
an	DT	O
organism	NN	O
containing	VBG	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
organism	NN	O
from	IN	O
which	WDT	O
the	DT	O
nucleic	NN	O
acid	NN	O
was	VBD	O
isolated	VBN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
probes	NNS	O
comprise	NN	O
oligonucleotides	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amplification	NN	O
reaction	NN	O
may	MD	O
comprise	VB	O
a	DT	O
PCR	NNP	O
reaction	NN	O
.	.	O
PCR	NNP	O
protocols	NNS	O
are	VBP	O
described	VBN	O
in	IN	O
Ausubel	NNP	O
and	CC	O
Sambrook	NNP	O
(	(	O
see	VB	O
discussion	NN	O
on	IN	O
amplification	NN	O
reactions	NNS	O
)	)	O
.	.	O
In	IN	O
such	JJ	O
procedures	NNS	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
in	IN	O
the	DT	O
sample	NN	O
are	VBP	O
contacted	VBN	O
with	IN	O
the	DT	O
probes	NNS	O
,	,	O
the	DT	O
amplification	NN	O
reaction	NN	O
is	VBZ	O
performed	VBN	O
,	,	O
and	CC	O
any	DT	O
resulting	JJ	O
amplification	NN	O
product	NN	O
is	VBZ	O
detected	VBN	O
.	.	O
The	DT	O
amplification	NN	O
product	NN	O
may	MD	O
be	VB	O
detected	VBN	O
by	IN	O
performing	VBG	O
gel	JJ	O
electrophoresis	NN	O
on	IN	O
the	DT	O
reaction	NN	O
products	NNS	O
and	CC	O
staining	VBG	O
the	DT	O
gel	NN	O
with	IN	O
an	DT	O
intercalator	NN	O
such	JJ	O
as	IN	O
ethidium	NN	O
bromide	NN	O
.	.	O
Alternatively	RB	O
,	,	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
probes	NNS	O
may	MD	O
be	VB	O
labeled	VBN	O
with	IN	O
a	DT	O
radioactive	JJ	O
isotope	NN	O
and	CC	O
the	DT	O
presence	NN	O
of	IN	O
a	DT	O
radioactive	JJ	O
amplification	NN	O
product	NN	O
may	MD	O
be	VB	O
detected	VBN	O
by	IN	O
autoradiography	NN	O
after	IN	O
gel	JJ	O
electrophoresis	NN	O
.	.	O
Probes	NNS	O
derived	VBN	O
from	IN	O
sequences	NNS	O
near	IN	O
the	DT	O
3′	CD	O
or	CC	O
5′	CD	O
ends	NNS	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
in	IN	O
chromosome	NN	O
walking	NN	O
procedures	NNS	O
to	TO	O
identify	VB	O
clones	NNS	O
containing	VBG	O
additional	JJ	O
,	,	O
e.g.	JJ	O
,	,	O
genomic	JJ	O
sequences	NNS	O
.	.	O
Such	JJ	O
methods	NNS	O
allow	VBP	O
the	DT	O
isolation	NN	O
of	IN	O
genes	NNS	O
which	WDT	O
encode	VBP	O
additional	JJ	O
proteins	NNS	O
of	IN	O
interest	NN	O
from	IN	O
the	DT	O
host	NN	O
organism	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
used	VBN	O
as	IN	O
probes	NNS	O
to	TO	O
identify	VB	O
and	CC	O
isolate	VB	O
related	VBN	O
nucleic	JJ	O
acids	NNS	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
the	DT	O
so-identified	JJ	O
related	JJ	O
nucleic	JJ	O
acids	NNS	O
may	MD	O
be	VB	O
cDNAs	NN	O
or	CC	O
genomic	JJ	O
DNAs	NNP	O
from	IN	O
organisms	IN	O
other	JJ	O
than	IN	O
the	DT	O
one	CD	O
from	IN	O
which	WDT	O
the	DT	O
nucleic	NN	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
was	VBD	O
first	RB	O
isolated	VBN	O
.	.	O
In	IN	O
such	JJ	O
procedures	NNS	O
,	,	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sample	NN	O
is	VBZ	O
contacted	VBN	O
with	IN	O
the	DT	O
probe	NN	O
under	IN	O
conditions	NNS	O
which	WDT	O
permit	VBP	O
the	DT	O
probe	NN	O
to	TO	O
specifically	RB	O
hybridize	VB	O
to	TO	O
related	JJ	O
sequences	NNS	O
.	.	O
Hybridization	NN	O
of	IN	O
the	DT	O
probe	NN	O
to	TO	O
nucleic	JJ	O
acids	NNS	O
from	IN	O
the	DT	O
related	JJ	O
organism	NN	O
is	VBZ	O
then	RB	O
detected	VBN	O
using	VBG	O
any	DT	O
of	IN	O
the	DT	O
methods	NNS	O
described	VBN	O
above	IN	O
.	.	O
In	IN	O
nucleic	JJ	O
acid	JJ	O
hybridization	NN	O
reactions	NNS	O
,	,	O
the	DT	O
conditions	NNS	O
used	VBD	O
to	TO	O
achieve	VB	O
a	DT	O
particular	JJ	O
level	NN	O
of	IN	O
stringency	NN	O
can	MD	O
vary	VB	O
,	,	O
depending	VBG	O
on	IN	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
being	VBG	O
hybridized	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
length	NN	O
,	,	O
degree	NN	O
of	IN	O
complementarity	NN	O
,	,	O
nucleotide	JJ	O
sequence	NN	O
composition	NN	O
(	(	O
e.g.	JJ	O
,	,	O
GC	NNP	O
v.	NN	O
AT	NNP	O
content	NN	O
)	)	O
,	,	O
and	CC	O
nucleic	JJ	O
acid	NN	O
type	NN	O
(	(	O
e.g.	JJ	O
,	,	O
RNA	NNP	O
v.	NNP	O
DNA	NNP	O
)	)	O
of	IN	O
the	DT	O
hybridizing	VBG	O
regions	NNS	O
of	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
considered	VBN	O
in	IN	O
selecting	VBG	O
hybridization	NN	O
conditions	NNS	O
.	.	O
An	DT	O
additional	JJ	O
consideration	NN	O
is	VBZ	O
whether	IN	O
one	CD	O
of	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
is	VBZ	O
immobilized	VBN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
on	IN	O
a	DT	O
filter	NN	O
.	.	O
Hybridization	NN	O
can	MD	O
be	VB	O
carried	VBN	O
out	RP	O
under	IN	O
conditions	NNS	O
of	IN	O
low	JJ	O
stringency	NN	O
,	,	O
moderate	JJ	O
stringency	NN	O
or	CC	O
high	JJ	O
stringency	NN	O
.	.	O
As	IN	O
an	DT	O
example	NN	O
of	IN	O
nucleic	JJ	O
acid	JJ	O
hybridization	NN	O
,	,	O
a	DT	O
polymer	NN	O
membrane	NN	O
containing	VBG	O
immobilized	VBN	O
denatured	JJ	O
nucleic	JJ	O
acids	NNS	O
is	VBZ	O
first	JJ	O
prehybridized	VBN	O
for	IN	O
30	CD	O
minutes	NNS	O
at	IN	O
45°	CD	O
C.	NNP	O
in	IN	O
a	DT	O
solution	NN	O
consisting	NN	O
of	IN	O
0.9	CD	O
M	NNP	O
NaCl	NNP	O
,	,	O
50	CD	O
mM	NN	O
NaH2PO4	NNP	O
,	,	O
pH	NN	O
7.0	CD	O
,	,	O
5.0	CD	O
mM	NN	O
Na2EDTA	NNP	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
,	,	O
10×Denhardt	CD	O
's	POS	O
,	,	O
and	CC	O
0.5	CD	O
mg/ml	NNS	O
polyriboadenylic	JJ	O
acid	NN	O
.	.	O
Approximately	RB	O
2×107	CD	O
cpm	NN	O
(	(	O
specific	JJ	O
activity	NN	O
4-9×108	JJ	O
cpm/ug	NN	O
)	)	O
of	IN	O
32P	CD	O
end-labeled	JJ	O
oligonucleotide	IN	O
probe	NN	O
can	MD	O
then	RB	O
added	VB	O
to	TO	O
the	DT	O
solution	NN	O
.	.	O
After	IN	O
12-16	JJ	O
hours	NNS	O
of	IN	O
incubation	NN	O
,	,	O
the	DT	O
membrane	NN	O
is	VBZ	O
washed	VBN	O
for	IN	O
30	CD	O
minutes	NNS	O
at	IN	O
room	NN	O
temperature	NN	O
(	(	O
RT	NNP	O
)	)	O
in	IN	O
1×SET	CD	O
(	(	O
150	CD	O
mM	NN	O
NaCl	NNP	O
,	,	O
20	CD	O
mM	NN	O
Tris	NNP	O
hydrochloride	NN	O
,	,	O
pH	NN	O
7.8	CD	O
,	,	O
1	CD	O
mM	NN	O
Na2EDTA	NNP	O
)	)	O
containing	VBG	O
0.5	CD	O
%	NN	O
SDS	NNP	O
,	,	O
followed	VBN	O
by	IN	O
a	DT	O
30	CD	O
minute	NN	O
wash	NN	O
in	IN	O
fresh	JJ	O
1×SET	CD	O
at	IN	O
Tm	NNP	O
−10°	NNP	O
C.	NNP	O
for	IN	O
the	DT	O
oligonucleotide	JJ	O
probe	NN	O
.	.	O
The	DT	O
membrane	NN	O
is	VBZ	O
then	RB	O
exposed	VBN	O
to	TO	O
auto-radiographic	JJ	O
film	NN	O
for	IN	O
detection	NN	O
of	IN	O
hybridization	NN	O
signals	NNS	O
.	.	O
By	IN	O
varying	VBG	O
the	DT	O
stringency	NN	O
of	IN	O
the	DT	O
hybridization	NN	O
conditions	NNS	O
used	VBD	O
to	TO	O
identify	VB	O
nucleic	JJ	O
acids	NNS	O
,	,	O
such	JJ	O
as	IN	O
cDNAs	NN	O
or	CC	O
genomic	JJ	O
DNAs	NNP	O
,	,	O
which	WDT	O
hybridize	VBP	O
to	TO	O
the	DT	O
detectable	JJ	O
probe	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
having	VBG	O
different	JJ	O
levels	NNS	O
of	IN	O
homology	NN	O
to	TO	O
the	DT	O
probe	NN	O
can	MD	O
be	VB	O
identified	VBN	O
and	CC	O
isolated	VBN	O
.	.	O
Stringency	NN	O
may	MD	O
be	VB	O
varied	VBN	O
by	IN	O
conducting	VBG	O
the	DT	O
hybridization	NN	O
at	IN	O
varying	VBG	O
temperatures	NNS	O
below	IN	O
the	DT	O
melting	VBG	O
temperatures	NNS	O
of	IN	O
the	DT	O
probes	NNS	O
.	.	O
The	DT	O
melting	NN	O
temperature	NN	O
,	,	O
Tm	NNP	O
,	,	O
is	VBZ	O
the	DT	O
temperature	NN	O
(	(	O
under	IN	O
defined	VBN	O
ionic	JJ	O
strength	NN	O
and	CC	O
pH	NN	O
)	)	O
at	IN	O
which	WDT	O
50	CD	O
%	NN	O
of	IN	O
the	DT	O
target	NN	O
sequence	NN	O
hybridizes	VBZ	O
to	TO	O
a	DT	O
perfectly	RB	O
complementary	JJ	O
probe	NN	O
.	.	O
Very	RB	O
stringent	JJ	O
conditions	NNS	O
are	VBP	O
selected	VBN	O
to	TO	O
be	VB	O
equal	JJ	O
to	TO	O
or	CC	O
about	IN	O
5°	CD	O
C.	NNP	O
lower	JJR	O
than	IN	O
the	DT	O
Tm	NNP	O
for	IN	O
a	DT	O
particular	JJ	O
probe	NN	O
.	.	O
The	DT	O
melting	JJ	O
temperature	NN	O
of	IN	O
the	DT	O
probe	NN	O
may	MD	O
be	VB	O
calculated	VBN	O
using	VBG	O
the	DT	O
following	JJ	O
exemplary	JJ	O
formulas	NNS	O
.	.	O
For	IN	O
probes	NNS	O
between	IN	O
14	CD	O
and	CC	O
70	CD	O
nucleotides	NNS	O
in	IN	O
length	NN	O
the	DT	O
melting	NN	O
temperature	NN	O
(	(	O
Tm	NNP	O
)	)	O
is	VBZ	O
calculated	VBN	O
using	VBG	O
the	DT	O
formula	NN	O
:	:	O
Tm=81.5+16.6	NNP	O
(	(	O
log	JJ	O
[	NNP	O
Na+	NNP	O
]	NNP	O
)	)	O
+0.41	NN	O
(	(	O
fraction	NN	O
G+C	NNP	O
)	)	O
−	NNP	O
(	(	O
600/N	CD	O
)	)	O
where	WRB	O
N	NNP	O
is	VBZ	O
the	DT	O
length	NN	O
of	IN	O
the	DT	O
probe	NN	O
.	.	O
If	IN	O
the	DT	O
hybridization	NN	O
is	VBZ	O
carried	VBN	O
out	RP	O
in	IN	O
a	DT	O
solution	NN	O
containing	VBG	O
formamide	NN	O
,	,	O
the	DT	O
melting	JJ	O
temperature	NN	O
may	MD	O
be	VB	O
calculated	VBN	O
using	VBG	O
the	DT	O
equation	NN	O
:	:	O
Tm=81.5+16.6	NNP	O
(	(	O
log	JJ	O
[	NNP	O
Na+	NNP	O
]	NNP	O
)	)	O
+0.41	NN	O
(	(	O
fraction	NN	O
G+C	NNP	O
)	)	O
−	NNP	O
(	(	O
0.63	CD	O
%	NN	O
formamide	NN	O
)	)	O
−	NN	O
(	(	O
600/N	CD	O
)	)	O
where	WRB	O
N	NNP	O
is	VBZ	O
the	DT	O
length	NN	O
of	IN	O
the	DT	O
probe	NN	O
.	.	O
Prehybridization	NN	O
may	MD	O
be	VB	O
carried	VBN	O
out	IN	O
in	IN	O
6×SSC	CD	O
,	,	O
5×Denhardt	CD	O
's	POS	O
reagent	NN	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
,	,	O
100	CD	O
μg	NN	O
denatured	VBD	O
fragmented	JJ	O
salmon	JJ	O
sperm	NN	O
DNA	NNP	O
or	CC	O
6×SSC	CD	O
,	,	O
5×Denhardt	CD	O
's	POS	O
reagent	NN	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
,	,	O
100	CD	O
μg	NN	O
denatured	VBD	O
fragmented	JJ	O
salmon	JJ	O
sperm	NN	O
DNA	NNP	O
,	,	O
50	CD	O
%	NN	O
formamide	NN	O
.	.	O
Formulas	NNS	O
for	IN	O
SSC	NNP	O
and	CC	O
Denhardt	NNP	O
's	POS	O
and	CC	O
other	JJ	O
solutions	NNS	O
are	VBP	O
listed	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Sambrook	NNP	O
.	.	O
Hybridization	NN	O
is	VBZ	O
conducted	VBN	O
by	IN	O
adding	VBG	O
the	DT	O
detectable	JJ	O
probe	NN	O
to	TO	O
the	DT	O
prehybridization	NN	O
solutions	NNS	O
listed	VBN	O
above	RB	O
.	.	O
Where	WRB	O
the	DT	O
probe	NN	O
comprises	VBZ	O
double	RB	O
stranded	VBN	O
DNA	NN	O
,	,	O
it	PRP	O
is	VBZ	O
denatured	VBN	O
before	IN	O
addition	NN	O
to	TO	O
the	DT	O
hybridization	NN	O
solution	NN	O
.	.	O
The	DT	O
filter	NN	O
is	VBZ	O
contacted	VBN	O
with	IN	O
the	DT	O
hybridization	NN	O
solution	NN	O
for	IN	O
a	DT	O
sufficient	JJ	O
period	NN	O
of	IN	O
time	NN	O
to	TO	O
allow	VB	O
the	DT	O
probe	NN	O
to	TO	O
hybridize	VB	O
to	TO	O
cDNAs	VB	O
or	CC	O
genomic	VB	O
DNAs	NNP	O
containing	VBG	O
sequences	NNS	O
complementary	JJ	O
thereto	NN	O
or	CC	O
homologous	JJ	O
thereto	NN	O
.	.	O
For	IN	O
probes	NNS	O
over	IN	O
200	CD	O
nucleotides	NNS	O
in	IN	O
length	NN	O
,	,	O
the	DT	O
hybridization	NN	O
may	MD	O
be	VB	O
carried	VBN	O
out	RP	O
at	IN	O
15-25°	JJ	O
C.	NNP	O
below	IN	O
the	DT	O
Tm	NNP	O
.	.	O
For	IN	O
shorter	JJR	O
probes	NNS	O
,	,	O
such	JJ	O
as	IN	O
oligonucleotide	JJ	O
probes	NNS	O
,	,	O
the	DT	O
hybridization	NN	O
may	MD	O
be	VB	O
conducted	VBN	O
at	IN	O
5-10°	JJ	O
C.	NNP	O
below	IN	O
the	DT	O
Tm	NNP	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
hybridizations	NNS	O
in	IN	O
6×SSC	CD	O
are	VBP	O
conducted	VBN	O
at	IN	O
approximately	RB	O
68°	CD	O
C.	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
hybridizations	NNS	O
in	IN	O
50	CD	O
%	NN	O
formamide	JJ	O
containing	NN	O
solutions	NNS	O
are	VBP	O
conducted	VBN	O
at	IN	O
approximately	RB	O
42°	CD	O
C.	NNP	O
All	NNP	O
of	IN	O
the	DT	O
foregoing	NN	O
hybridizations	NNS	O
would	MD	O
be	VB	O
considered	VBN	O
to	TO	O
be	VB	O
under	IN	O
conditions	NNS	O
of	IN	O
high	JJ	O
stringency	NN	O
.	.	O
Following	VBG	O
hybridization	NN	O
,	,	O
the	DT	O
filter	NN	O
is	VBZ	O
washed	VBN	O
to	TO	O
remove	VB	O
any	DT	O
non-specifically	RB	O
bound	NN	O
detectable	JJ	O
probe	NN	O
.	.	O
The	DT	O
stringency	NN	O
used	VBN	O
to	TO	O
wash	VB	O
the	DT	O
filters	NNS	O
can	MD	O
also	RB	O
be	VB	O
varied	VBN	O
depending	VBG	O
on	IN	O
the	DT	O
nature	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
being	VBG	O
hybridized	VBN	O
,	,	O
the	DT	O
length	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
being	VBG	O
hybridized	VBN	O
,	,	O
the	DT	O
degree	NN	O
of	IN	O
complementarity	NN	O
,	,	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
composition	NN	O
(	(	O
e.g.	JJ	O
,	,	O
GC	NNP	O
v.	NN	O
AT	NNP	O
content	NN	O
)	)	O
,	,	O
and	CC	O
the	DT	O
nucleic	JJ	O
acid	NN	O
type	NN	O
(	(	O
e.g.	JJ	O
,	,	O
RNA	NNP	O
v.	NNP	O
DNA	NNP	O
)	)	O
.	.	O
Examples	NNS	O
of	IN	O
progressively	RB	O
higher	JJR	O
stringency	NN	O
condition	NN	O
washes	NNS	O
are	VBP	O
as	IN	O
follows	VBZ	O
:	:	O
2×SSC	CD	O
,	,	O
0.1	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
15	CD	O
minutes	NNS	O
(	(	O
low	JJ	O
stringency	NN	O
)	)	O
;	:	O
0.1×SSC	CD	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
room	NN	O
temperature	NN	O
for	IN	O
30	CD	O
minutes	NNS	O
to	TO	O
1	CD	O
hour	NN	O
(	(	O
moderate	JJ	O
stringency	NN	O
)	)	O
;	:	O
0.1×SSC	CD	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
for	IN	O
15	CD	O
to	TO	O
30	CD	O
minutes	NNS	O
at	IN	O
between	IN	O
the	DT	O
hybridization	NN	O
temperature	NN	O
and	CC	O
68°	CD	O
C.	NNP	O
(	(	O
high	JJ	O
stringency	NN	O
)	)	O
;	:	O
and	CC	O
0.15M	CD	O
NaCl	NNP	O
for	IN	O
15	CD	O
minutes	NNS	O
at	IN	O
72°	CD	O
C.	NNP	O
(	(	O
very	RB	O
high	JJ	O
stringency	NN	O
)	)	O
.	.	O
A	DT	O
final	JJ	O
low	JJ	O
stringency	NN	O
wash	NN	O
can	MD	O
be	VB	O
conducted	VBN	O
in	IN	O
0.1×SSC	CD	O
at	IN	O
room	NN	O
temperature	NN	O
.	.	O
The	DT	O
examples	NNS	O
above	IN	O
are	VBP	O
merely	RB	O
illustrative	JJ	O
of	IN	O
one	CD	O
set	NN	O
of	IN	O
conditions	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
wash	VB	O
filters	NNS	O
.	.	O
One	CD	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
would	MD	O
know	VB	O
that	IN	O
there	EX	O
are	VBP	O
numerous	JJ	O
recipes	NNS	O
for	IN	O
different	JJ	O
stringency	NN	O
washes	NNS	O
.	.	O
Nucleic	NNP	O
acids	NNS	O
which	WDT	O
have	VBP	O
hybridized	VBN	O
to	TO	O
the	DT	O
probe	NN	O
can	MD	O
be	VB	O
identified	VBN	O
by	IN	O
autoradiography	NN	O
or	CC	O
other	JJ	O
conventional	JJ	O
techniques	NNS	O
.	.	O
The	DT	O
above	JJ	O
procedure	NN	O
may	MD	O
be	VB	O
modified	VBN	O
to	TO	O
identify	VB	O
nucleic	JJ	O
acids	NNS	O
having	VBG	O
decreasing	VBG	O
levels	NNS	O
of	IN	O
homology	NN	O
to	TO	O
the	DT	O
probe	NN	O
sequence	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
to	TO	O
obtain	VB	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
decreasing	VBG	O
homology	NN	O
to	TO	O
the	DT	O
detectable	JJ	O
probe	NN	O
,	,	O
less	RBR	O
stringent	JJ	O
conditions	NNS	O
may	MD	O
be	VB	O
used	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
hybridization	NN	O
temperature	NN	O
may	MD	O
be	VB	O
decreased	VBN	O
in	IN	O
increments	NNS	O
of	IN	O
5°	CD	O
C.	NNP	O
from	IN	O
68°	CD	O
C.	NNP	O
to	TO	O
42°	CD	O
C.	NNP	O
in	IN	O
a	DT	O
hybridization	NN	O
buffer	NN	O
having	VBG	O
a	DT	O
Na+	NNP	O
concentration	NN	O
of	IN	O
approximately	RB	O
1M	CD	O
.	.	O
Following	VBG	O
hybridization	NN	O
,	,	O
the	DT	O
filter	NN	O
may	MD	O
be	VB	O
washed	VBN	O
with	IN	O
2×SSC	CD	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
the	DT	O
temperature	NN	O
of	IN	O
hybridization	NN	O
.	.	O
These	DT	O
conditions	NNS	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
“	JJ	O
moderate	JJ	O
”	NN	O
conditions	NNS	O
above	IN	O
50°	CD	O
C.	NNP	O
and	CC	O
“	NNP	O
low	JJ	O
”	NNP	O
conditions	NNS	O
below	IN	O
50°	CD	O
C.	NNP	O
An	DT	O
example	NN	O
of	IN	O
“	NNP	O
moderate	JJ	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
55°	CD	O
C.	NNP	O
An	DT	O
example	NN	O
of	IN	O
“	NNP	O
low	JJ	O
stringency	NN	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
45°	CD	O
C.	NNP	O
Alternatively	RB	O
,	,	O
the	DT	O
hybridization	NN	O
may	MD	O
be	VB	O
carried	VBN	O
out	RP	O
in	IN	O
buffers	NNS	O
,	,	O
such	JJ	O
as	IN	O
6×SSC	CD	O
,	,	O
containing	VBG	O
formamide	NN	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
42°	CD	O
C.	NNP	O
In	IN	O
this	DT	O
case	NN	O
,	,	O
the	DT	O
concentration	NN	O
of	IN	O
formamide	NN	O
in	IN	O
the	DT	O
hybridization	NN	O
buffer	NN	O
may	MD	O
be	VB	O
reduced	VBN	O
in	IN	O
5	CD	O
%	NN	O
increments	NNS	O
from	IN	O
50	CD	O
%	NN	O
to	TO	O
0	CD	O
%	NN	O
to	TO	O
identify	VB	O
clones	NNS	O
having	VBG	O
decreasing	VBG	O
levels	NNS	O
of	IN	O
homology	NN	O
to	TO	O
the	DT	O
probe	NN	O
.	.	O
Following	VBG	O
hybridization	NN	O
,	,	O
the	DT	O
filter	NN	O
may	MD	O
be	VB	O
washed	VBN	O
with	IN	O
6×SSC	CD	O
,	,	O
0.5	CD	O
%	NN	O
SDS	NNP	O
at	IN	O
50°	CD	O
C.	NNP	O
These	DT	O
conditions	NNS	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
“	JJ	O
moderate	JJ	O
”	NN	O
conditions	NNS	O
above	IN	O
25	CD	O
%	NN	O
formamide	NN	O
and	CC	O
“	NNP	O
low	JJ	O
”	NNP	O
conditions	NNS	O
below	IN	O
25	CD	O
%	NN	O
formamide	NN	O
.	.	O
A	DT	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
moderate	JJ	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
30	CD	O
%	NN	O
formamide	NN	O
.	.	O
A	DT	O
specific	JJ	O
example	NN	O
of	IN	O
“	NNP	O
low	JJ	O
stringency	NN	O
”	NNP	O
hybridization	NN	O
conditions	NNS	O
is	VBZ	O
when	WRB	O
the	DT	O
above	JJ	O
hybridization	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
10	CD	O
%	NN	O
formamide	NN	O
.	.	O
These	DT	O
probes	NNS	O
and	CC	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
nucleic	JJ	O
acids	NNS	O
having	VBG	O
a	DT	O
sequence	NN	O
with	IN	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
homology	NN	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
about	IN	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
750	CD	O
,	,	O
800	CD	O
,	,	O
850	CD	O
,	,	O
900	CD	O
,	,	O
950	CD	O
,	,	O
1000	CD	O
,	,	O
or	CC	O
more	RBR	O
consecutive	JJ	O
bases	NNS	O
thereof	NN	O
,	,	O
and	CC	O
the	DT	O
sequences	NNS	O
complementary	JJ	O
thereto	NN	O
.	.	O
Homology	NN	O
may	MD	O
be	VB	O
measured	VBN	O
using	VBG	O
an	DT	O
alignment	NN	O
algorithm	NN	O
,	,	O
as	IN	O
discussed	VBN	O
herein	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
homologous	JJ	O
polynucleotides	NNS	O
may	MD	O
have	VB	O
a	DT	O
coding	NN	O
sequence	NN	O
which	WDT	O
is	VBZ	O
a	DT	O
naturally	RB	O
occurring	VBG	O
allelic	JJ	O
variant	NN	O
of	IN	O
one	CD	O
of	IN	O
the	DT	O
coding	NN	O
sequences	NNS	O
described	VBD	O
herein	NN	O
.	.	O
Such	JJ	O
allelic	JJ	O
variants	NNS	O
may	MD	O
have	VB	O
a	DT	O
substitution	NN	O
,	,	O
deletion	NN	O
or	CC	O
addition	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
when	WRB	O
compared	VBN	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Additionally	RB	O
,	,	O
the	DT	O
probes	NNS	O
and	CC	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
nucleic	JJ	O
acids	NNS	O
which	WDT	O
encode	VBP	O
polypeptides	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
sequence	NN	O
identity	NN	O
(	(	O
homology	NN	O
)	)	O
to	TO	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprising	VBG	O
at	IN	O
least	JJS	O
5	CD	O
,	,	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
50	CD	O
,	,	O
75	CD	O
,	,	O
100	CD	O
,	,	O
or	CC	O
150	CD	O
consecutive	JJ	O
amino	NN	O
acids	NNS	O
,	,	O
as	IN	O
determined	VBN	O
using	VBG	O
a	DT	O
sequence	NN	O
alignment	NN	O
algorithm	NN	O
(	(	O
e.g.	JJ	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
FASTA	NNP	O
version	NN	O
3.0t78	CD	O
algorithm	NN	O
with	IN	O
the	DT	O
default	NN	O
parameters	NNS	O
,	,	O
or	CC	O
a	DT	O
BLAST	JJ	O
2.2.2	CD	O
program	NN	O
with	IN	O
exemplary	JJ	O
settings	NNS	O
as	IN	O
set	NN	O
forth	NN	O
herein	NN	O
)	)	O
.	.	O
Inhibiting	VBG	O
Expression	NN	O
of	IN	O
Amylase	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
nucleic	JJ	O
acids	NNS	O
complementary	JJ	O
to	TO	O
(	(	O
e.g.	VB	O
,	,	O
antisense	JJ	O
sequences	NNS	O
to	TO	O
)	)	O
the	DT	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Antisense	NNP	O
sequences	NNS	O
are	VBP	O
capable	JJ	O
of	IN	O
inhibiting	VBG	O
the	DT	O
transport	NN	O
,	,	O
splicing	VBG	O
or	CC	O
transcription	NN	O
of	IN	O
amylase-encoding	JJ	O
genes	NNS	O
.	.	O
The	DT	O
inhibition	NN	O
can	MD	O
be	VB	O
effected	VBN	O
through	IN	O
the	DT	O
targeting	NN	O
of	IN	O
genomic	JJ	O
DNA	NNP	O
or	CC	O
messenger	JJR	O
RNA	NNP	O
.	.	O
The	DT	O
transcription	NN	O
or	CC	O
function	NN	O
of	IN	O
targeted	JJ	O
nucleic	JJ	O
acid	NN	O
can	MD	O
be	VB	O
inhibited	VBN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
by	IN	O
hybridization	NN	O
and/or	NN	O
cleavage	NN	O
.	.	O
One	CD	O
particularly	RB	O
useful	JJ	O
set	NN	O
of	IN	O
inhibitors	NNS	O
provided	VBN	O
by	IN	O
the	DT	O
present	JJ	O
invention	NN	O
includes	VBZ	O
oligonucleotides	IN	O
which	WDT	O
are	VBP	O
able	JJ	O
to	TO	O
either	DT	O
bind	NN	O
amylase	NN	O
gene	NN	O
or	CC	O
message	NN	O
,	,	O
in	IN	O
either	DT	O
case	NN	O
preventing	VBG	O
or	CC	O
inhibiting	VBG	O
the	DT	O
production	NN	O
or	CC	O
function	NN	O
of	IN	O
amylase	NN	O
.	.	O
The	DT	O
association	NN	O
can	MD	O
be	VB	O
through	IN	O
sequence	NN	O
specific	JJ	O
hybridization	NN	O
.	.	O
Another	DT	O
useful	JJ	O
class	NN	O
of	IN	O
inhibitors	NNS	O
includes	VBZ	O
oligonucleotides	NNS	O
which	WDT	O
cause	VBP	O
inactivation	NN	O
or	CC	O
cleavage	NN	O
of	IN	O
amylase	JJ	O
message	NN	O
.	.	O
The	DT	O
oligonucleotide	NN	O
can	MD	O
have	VB	O
enzyme	VBN	O
activity	NN	O
which	WDT	O
causes	VBZ	O
such	JJ	O
cleavage	NN	O
,	,	O
such	JJ	O
as	IN	O
ribozymes	NNS	O
.	.	O
The	DT	O
oligonucleotide	NN	O
can	MD	O
be	VB	O
chemically	RB	O
modified	VBN	O
or	CC	O
conjugated	VBN	O
to	TO	O
an	DT	O
enzyme	NN	O
or	CC	O
composition	NN	O
capable	JJ	O
of	IN	O
cleaving	VBG	O
the	DT	O
complementary	JJ	O
nucleic	NN	O
acid	NN	O
.	.	O
A	DT	O
pool	NN	O
of	IN	O
many	JJ	O
different	JJ	O
such	JJ	O
oligonucleotides	NNS	O
can	MD	O
be	VB	O
screened	VBN	O
for	IN	O
those	DT	O
with	IN	O
the	DT	O
desired	JJ	O
activity	NN	O
.	.	O
Antisense	NNP	O
Oligonucleotides	VBZ	O
The	DT	O
invention	NN	O
provides	VBZ	O
antisense	JJ	O
oligonucleotides	NNS	O
capable	JJ	O
of	IN	O
binding	VBG	O
amylase	NN	O
message	NN	O
which	WDT	O
can	MD	O
inhibit	VB	O
proteolytic	JJ	O
activity	NN	O
by	IN	O
targeting	VBG	O
mRNA	NN	O
.	.	O
Strategies	NNS	O
for	IN	O
designing	VBG	O
antisense	NN	O
oligonucleotides	NNS	O
are	VBP	O
well	RB	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
and	CC	O
patent	JJ	O
literature	NN	O
,	,	O
and	CC	O
the	DT	O
skilled	JJ	O
artisan	NN	O
can	MD	O
design	VB	O
such	JJ	O
amylase	NN	O
oligonucleotides	NNS	O
using	VBG	O
the	DT	O
novel	JJ	O
reagents	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
gene	NN	O
walking/RNA	NN	O
mapping	NN	O
protocols	NNS	O
to	TO	O
screen	VB	O
for	IN	O
effective	JJ	O
antisense	NN	O
oligonucleotides	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
see	NN	O
,	,	O
e.g.	VB	O
,	,	O
Ho	NNP	B
(	(	I
2000	CD	I
)	)	I
Methods	NNP	I
Enzymol	NNP	I
.	.	I
314:168-183	JJ	I
,	,	O
describing	VBG	O
an	DT	O
RNA	NNP	O
mapping	NN	O
assay	NN	O
,	,	O
which	WDT	O
is	VBZ	O
based	VBN	O
on	IN	O
standard	JJ	O
molecular	NN	O
techniques	NNS	O
to	TO	O
provide	VB	O
an	DT	O
easy	JJ	O
and	CC	O
reliable	JJ	O
method	NN	O
for	IN	O
potent	JJ	O
antisense	JJ	O
sequence	NN	O
selection	NN	O
.	.	O
See	NNP	O
also	RB	O
Smith	NNP	B
(	(	I
2000	CD	I
)	)	I
Eur	NNP	I
.	.	I
J.	NNP	I
Pharm	NNP	I
.	.	I
Sci	NNP	I
.	.	I
11:191-198	JJ	I
.	.	O
Naturally	RB	O
occurring	VBG	O
nucleic	JJ	O
acids	NNS	O
are	VBP	O
used	VBN	O
as	IN	O
antisense	JJ	O
oligonucleotides	NNS	O
.	.	O
The	DT	O
antisense	NN	O
oligonucleotides	NNS	O
can	MD	O
be	VB	O
of	IN	O
any	DT	O
length	NN	O
;	:	O
for	IN	O
example	NN	O
,	,	O
in	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
antisense	NN	O
oligonucleotides	NNS	O
are	VBP	O
between	IN	O
about	RB	O
5	CD	O
to	TO	O
100	CD	O
,	,	O
about	RB	O
10	CD	O
to	TO	O
80	CD	O
,	,	O
about	RB	O
15	CD	O
to	TO	O
60	CD	O
,	,	O
about	RB	O
18	CD	O
to	TO	O
40	CD	O
.	.	O
The	DT	O
optimal	JJ	O
length	NN	O
can	MD	O
be	VB	O
determined	VBN	O
by	IN	O
routine	JJ	O
screening	NN	O
.	.	O
The	DT	O
antisense	NN	O
oligonucleotides	NNS	O
can	MD	O
be	VB	O
present	JJ	O
at	IN	O
any	DT	O
concentration	NN	O
.	.	O
The	DT	O
optimal	JJ	O
concentration	NN	O
can	MD	O
be	VB	O
determined	VBN	O
by	IN	O
routine	JJ	O
screening	NN	O
.	.	O
A	DT	O
wide	JJ	O
variety	NN	O
of	IN	O
synthetic	JJ	O
,	,	O
non-naturally	RB	O
occurring	VBG	O
nucleotide	NN	O
and	CC	O
nucleic	JJ	O
acid	NN	O
analogues	NNS	O
are	VBP	O
known	VBN	O
which	WDT	O
can	MD	O
address	VB	O
this	DT	O
potential	JJ	O
problem	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
peptide	RB	O
nucleic	JJ	O
acids	NNS	O
(	(	O
PNAs	NNP	O
)	)	O
containing	VBG	O
non-ionic	JJ	O
backbones	NNS	O
,	,	O
such	JJ	O
as	IN	O
N-	NNP	O
(	(	O
2-aminoethyl	JJ	O
)	)	O
glycine	VBP	O
units	NNS	O
can	MD	O
be	VB	O
used	VBN	O
.	.	O
Antisense	NNP	O
oligonucleotides	VBZ	O
having	VBG	O
phosphorothioate	JJ	O
linkages	NNS	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
,	,	O
as	IN	O
described	VBN	O
in	IN	O
WO	NNP	O
97/03211	CD	O
;	:	O
WO	NNP	O
96/39154	CD	O
;	:	O
Mata	NNP	B
(	(	I
1997	CD	I
)	)	I
Toxicol	NNP	I
Appl	NNP	I
Pharmacol	NNP	I
144:189-197	CD	I
;	:	O
Antisense	NNP	B
Therapeutics	NNPS	I
,	,	I
ed	NN	I
.	.	I
Agrawal	NNP	I
(	(	I
Humana	NNP	I
Press	NNP	I
,	,	I
Totowa	NNP	I
,	,	I
N.J.	NNP	I
,	,	I
1996	CD	I
)	)	I
.	.	O
Antisense	NNP	O
oligonucleotides	VBZ	O
having	VBG	O
synthetic	JJ	O
DNA	NNP	O
backbone	NN	O
analogues	NNS	O
provided	VBN	O
by	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
include	VB	O
phosphoro-dithioate	JJ	O
,	,	O
methylphosphonate	NN	O
,	,	O
phosphoramidate	NN	O
,	,	O
alkyl	JJ	O
phosphotriester	NN	O
,	,	O
sulfamate	NN	O
,	,	O
3′-thioacetal	JJ	O
,	,	O
methylene	NN	O
(	(	O
methylimino	NN	O
)	)	O
,	,	O
3′-N-carbamate	JJ	O
,	,	O
and	CC	O
morpholino	NN	O
carbamate	NN	O
nucleic	JJ	O
acids	NNS	O
,	,	O
as	IN	O
described	VBN	O
above	IN	O
.	.	O
Combinatorial	JJ	O
chemistry	NN	O
methodology	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
create	VB	O
vast	JJ	O
numbers	NNS	O
of	IN	O
oligonucleotides	NNS	O
that	WDT	O
can	MD	O
be	VB	O
rapidly	RB	O
screened	VBN	O
for	IN	O
specific	JJ	O
oligonucleotides	NNS	O
that	WDT	O
have	VBP	O
appropriate	JJ	O
binding	NN	O
affinities	NNS	O
and	CC	O
specificities	NNS	O
toward	IN	O
any	DT	O
target	NN	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
sense	NN	O
and	CC	O
antisense	JJ	O
amylase	NN	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Gold	NNP	B
(	(	I
1995	CD	I
)	)	I
J.	NNP	I
of	IN	I
Biol	NNP	I
.	.	I
Chem	NNP	I
.	.	I
270:13581-13584	JJ	I
)	)	O
.	.	O
Inhibitory	NNP	O
Ribozymes	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
ribozymes	NNS	O
capable	JJ	O
of	IN	O
binding	VBG	O
amylase	JJ	O
message	NN	O
.	.	O
These	DT	O
ribozymes	NNS	O
can	MD	O
inhibit	VB	O
amylase	JJ	O
activity	NN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
targeting	VBG	O
mRNA	NN	O
.	.	O
Strategies	NNS	O
for	IN	O
designing	VBG	O
ribozymes	NNS	O
and	CC	O
selecting	VBG	O
the	DT	O
amylase-specific	JJ	O
antisense	NN	O
sequence	NN	O
for	IN	O
targeting	VBG	O
are	VBP	O
well	RB	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
and	CC	O
patent	JJ	O
literature	NN	O
,	,	O
and	CC	O
the	DT	O
skilled	JJ	O
artisan	NN	O
can	MD	O
design	VB	O
such	JJ	O
ribozymes	NNS	O
using	VBG	O
the	DT	O
novel	JJ	O
reagents	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Ribozymes	NNP	O
act	NN	O
by	IN	O
binding	VBG	O
to	TO	O
a	DT	O
target	NN	O
RNA	NNP	O
through	IN	O
the	DT	O
target	NN	O
RNA	NNP	O
binding	VBG	O
portion	NN	O
of	IN	O
a	DT	O
ribozyme	NN	O
which	WDT	O
is	VBZ	O
held	VBN	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
an	DT	O
enzymatic	JJ	O
portion	NN	O
of	IN	O
the	DT	O
RNA	NNP	O
that	WDT	O
cleaves	VBZ	O
the	DT	O
target	NN	O
RNA	NNP	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
ribozyme	NN	O
recognizes	VBZ	O
and	CC	O
binds	VBZ	O
a	DT	O
target	NN	O
RNA	NNP	O
through	IN	O
complementary	JJ	O
base-pairing	NN	O
,	,	O
and	CC	O
once	RB	O
bound	VBN	O
to	TO	O
the	DT	O
correct	JJ	O
site	NN	O
,	,	O
acts	VBZ	O
enzymatically	RB	O
to	TO	O
cleave	VB	O
and	CC	O
inactivate	VB	O
the	DT	O
target	NN	O
RNA	NNP	O
.	.	O
Cleavage	NN	O
of	IN	O
a	DT	O
target	NN	O
RNA	NNP	O
in	IN	O
such	JJ	O
a	DT	O
manner	NN	O
will	MD	O
destroy	VB	O
its	PRP$	O
ability	NN	O
to	TO	O
direct	JJ	O
synthesis	NN	O
of	IN	O
an	DT	O
encoded	JJ	O
protein	NN	O
if	IN	O
the	DT	O
cleavage	NN	O
occurs	VBZ	O
in	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
.	.	O
After	IN	O
a	DT	O
ribozyme	NN	O
has	VBZ	O
bound	VBN	O
and	CC	O
cleaved	VBN	O
its	PRP$	O
RNA	NNP	O
target	NN	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
released	VBN	O
from	IN	O
that	DT	O
RNA	NNP	O
to	TO	O
bind	VB	O
and	CC	O
cleave	VB	O
new	JJ	O
targets	NNS	O
repeatedly	RB	O
.	.	O
In	IN	O
some	DT	O
circumstances	NNS	O
,	,	O
the	DT	O
enzymatic	JJ	O
nature	NN	O
of	IN	O
a	DT	O
ribozyme	NN	O
can	MD	O
be	VB	O
advantageous	JJ	O
over	IN	O
other	JJ	O
technologies	NNS	O
,	,	O
such	JJ	O
as	IN	O
antisense	JJ	O
technology	NN	O
(	(	O
where	WRB	O
a	DT	O
nucleic	JJ	O
acid	NN	O
molecule	NN	O
simply	RB	O
binds	VBZ	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
target	NN	O
to	TO	O
block	VB	O
its	PRP$	O
transcription	NN	O
,	,	O
translation	NN	O
or	CC	O
association	NN	O
with	IN	O
another	DT	O
molecule	NN	O
)	)	O
as	IN	O
the	DT	O
effective	JJ	O
concentration	NN	O
of	IN	O
ribozyme	JJ	O
necessary	JJ	O
to	TO	O
effect	NN	O
a	DT	O
therapeutic	JJ	O
treatment	NN	O
can	MD	O
be	VB	O
lower	JJR	O
than	IN	O
that	DT	O
of	IN	O
an	DT	O
antisense	JJ	O
oligonucleotide	NN	O
.	.	O
This	DT	O
potential	JJ	O
advantage	NN	O
reflects	VBZ	O
the	DT	O
ability	NN	O
of	IN	O
the	DT	O
ribozyme	NN	O
to	TO	O
act	VB	O
enzymatically	RB	O
.	.	O
Thus	RB	O
,	,	O
a	DT	O
single	JJ	O
ribozyme	NN	O
molecule	NN	O
is	VBZ	O
able	JJ	O
to	TO	O
cleave	VB	O
many	JJ	O
molecules	NNS	O
of	IN	O
target	NN	O
RNA	NNP	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
a	DT	O
ribozyme	NN	O
is	VBZ	O
typically	RB	O
a	DT	O
highly	RB	O
specific	JJ	O
inhibitor	NN	O
,	,	O
with	IN	O
the	DT	O
specificity	NN	O
of	IN	O
inhibition	NN	O
depending	VBG	O
not	RB	O
only	RB	O
on	IN	O
the	DT	O
base	NN	O
pairing	VBG	O
mechanism	NN	O
of	IN	O
binding	NN	O
,	,	O
but	CC	O
also	RB	O
on	IN	O
the	DT	O
mechanism	NN	O
by	IN	O
which	WDT	O
the	DT	O
molecule	NN	O
inhibits	VBZ	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
RNA	NNP	O
to	TO	O
which	WDT	O
it	PRP	O
binds	VBZ	O
.	.	O
That	DT	O
is	VBZ	O
,	,	O
the	DT	O
inhibition	NN	O
is	VBZ	O
caused	VBN	O
by	IN	O
cleavage	NN	O
of	IN	O
the	DT	O
RNA	NNP	O
target	NN	O
and	CC	O
so	RB	O
specificity	NN	O
is	VBZ	O
defined	VBN	O
as	IN	O
the	DT	O
ratio	NN	O
of	IN	O
the	DT	O
rate	NN	O
of	IN	O
cleavage	NN	O
of	IN	O
the	DT	O
targeted	JJ	O
RNA	NNP	O
over	IN	O
the	DT	O
rate	NN	O
of	IN	O
cleavage	NN	O
of	IN	O
non-targeted	JJ	O
RNA	NNP	O
.	.	O
This	DT	O
cleavage	NN	O
mechanism	NN	O
is	VBZ	O
dependent	JJ	O
upon	IN	O
factors	NNS	O
additional	JJ	O
to	TO	O
those	DT	O
involved	VBN	O
in	IN	O
base	NN	O
pairing	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
specificity	NN	O
of	IN	O
action	NN	O
of	IN	O
a	DT	O
ribozyme	NN	O
can	MD	O
be	VB	O
greater	JJR	O
than	IN	O
that	DT	O
of	IN	O
antisense	JJ	O
oligonucleotide	IN	O
binding	VBG	O
the	DT	O
same	JJ	O
RNA	NNP	O
site	NN	O
.	.	O
The	DT	O
ribozyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
enzymatic	JJ	O
ribozyme	NN	O
RNA	NNP	O
molecule	NN	O
,	,	O
can	MD	O
be	VB	O
formed	VBN	O
in	IN	O
a	DT	O
hammerhead	NN	O
motif	NN	O
,	,	O
a	DT	O
hairpin	NN	O
motif	NN	O
,	,	O
as	IN	O
a	DT	O
hepatitis	NN	O
delta	NN	O
virus	NN	O
motif	NN	O
,	,	O
a	DT	O
group	NN	O
I	PRP	O
intron	VBP	O
motif	JJ	O
and/or	IN	O
an	DT	O
RNaseP-like	JJ	O
RNA	NNP	O
in	IN	O
association	NN	O
with	IN	O
an	DT	O
RNA	NNP	O
guide	NN	O
sequence	NN	O
.	.	O
Examples	NNS	O
of	IN	O
hammerhead	JJ	O
motifs	NNS	O
are	VBP	O
described	VBN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
Rossi	NNP	B
(	(	I
1992	CD	I
)	)	I
Aids	NNP	I
Research	NNP	I
and	CC	I
Human	NNP	I
Retroviruses	VBZ	I
8:183	CD	I
;	:	O
hairpin	VBN	O
motifs	NNS	O
by	IN	O
Hampel	NNP	B
(	(	I
1989	CD	I
)	)	I
Biochemistry	NNP	I
28:4929	CD	I
,	,	O
and	CC	O
Hampel	NNP	B
(	(	I
1990	CD	I
)	)	I
Nuc	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
18:299	CD	I
;	:	O
the	DT	O
hepatitis	NN	O
delta	NN	O
virus	NN	O
motif	NN	O
by	IN	O
Perrotta	NNP	B
(	(	I
1992	CD	I
)	)	I
Biochemistry	NNP	I
31:16	CD	I
;	:	O
the	DT	O
RNaseP	NNP	O
motif	NN	O
by	IN	O
Guerrier-Takada	NNP	B
(	(	I
1983	CD	I
)	)	I
Cell	NNP	I
35:849	CD	I
;	:	O
and	CC	O
the	DT	O
group	NN	O
I	PRP	O
intron	VBP	O
by	IN	O
Cech	NNP	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
4,987,071	CD	O
.	.	O
The	DT	O
recitation	NN	O
of	IN	O
these	DT	O
specific	JJ	O
motifs	NNS	O
is	VBZ	O
not	RB	O
intended	VBN	O
to	TO	O
be	VB	O
limiting	VBG	O
.	.	O
Those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
will	MD	O
recognize	VB	O
that	IN	O
a	DT	O
ribozyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
enzymatic	JJ	O
RNA	NNP	O
molecule	NN	O
of	IN	O
this	DT	O
invention	NN	O
,	,	O
can	MD	O
have	VB	O
a	DT	O
specific	JJ	O
substrate	NN	O
binding	NN	O
site	NN	O
complementary	JJ	O
to	TO	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
target	NN	O
gene	NN	O
RNA	NNP	O
regions	NNS	O
.	.	O
A	DT	O
ribozyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
within	IN	O
or	CC	O
surrounding	VBG	O
that	IN	O
substrate	NN	O
binding	NN	O
site	NN	O
which	WDT	O
imparts	VBZ	O
an	DT	O
RNA	NNP	O
cleaving	NN	O
activity	NN	O
to	TO	O
the	DT	O
molecule	NN	O
.	.	O
RNA	NNP	O
Interference	NNP	O
(	(	O
RNAi	NNP	O
)	)	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
RNA	NNP	O
inhibitory	NN	O
molecule	NN	O
,	,	O
a	DT	O
so-called	JJ	O
“	NN	O
RNAi	NNP	O
”	NNP	O
molecule	NN	O
,	,	O
comprising	VBG	O
an	DT	O
amylase	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
RNAi	NNP	O
molecule	NN	O
comprises	VBZ	O
a	DT	O
double-stranded	JJ	O
RNA	NNP	O
(	(	O
dsRNA	NN	O
)	)	O
molecule	NN	O
.	.	O
The	DT	O
RNAi	NNP	O
can	MD	O
inhibit	VB	O
expression	NN	O
of	IN	O
an	DT	O
amylase	JJ	O
gene	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
RNAi	NNP	O
is	VBZ	O
about	IN	O
15	CD	O
,	,	O
16	CD	O
,	,	O
17	CD	O
,	,	O
18	CD	O
,	,	O
19	CD	O
,	,	O
20	CD	O
,	,	O
21	CD	O
,	,	O
22	CD	O
,	,	O
23	CD	O
,	,	O
24	CD	O
,	,	O
25	CD	O
or	CC	O
more	JJR	O
duplex	JJ	O
nucleotides	NNS	O
in	IN	O
length	NN	O
.	.	O
While	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
not	RB	O
limited	VBN	O
by	IN	O
any	DT	O
particular	JJ	O
mechanism	NN	O
of	IN	O
action	NN	O
,	,	O
the	DT	O
RNAi	NNP	O
can	MD	O
enter	VB	O
a	DT	O
cell	NN	O
and	CC	O
cause	VB	O
the	DT	O
degradation	NN	O
of	IN	O
a	DT	O
single-stranded	JJ	O
RNA	NNP	O
(	(	O
ssRNA	NN	O
)	)	O
of	IN	O
similar	JJ	O
or	CC	O
identical	JJ	O
sequences	NNS	O
,	,	O
including	VBG	O
endogenous	JJ	O
mRNAs	NN	O
.	.	O
When	WRB	O
a	DT	O
cell	NN	O
is	VBZ	O
exposed	VBN	O
to	TO	O
double-stranded	JJ	O
RNA	NNP	O
(	(	O
dsRNA	NN	O
)	)	O
,	,	O
mRNA	RB	O
from	IN	O
the	DT	O
homologous	JJ	O
gene	NN	O
is	VBZ	O
selectively	RB	O
degraded	VBN	O
by	IN	O
a	DT	O
process	NN	O
called	VBN	O
RNA	NNP	O
interference	NN	O
(	(	O
RNAi	NNP	O
)	)	O
.	.	O
A	DT	O
possible	JJ	O
basic	JJ	O
mechanism	NN	O
behind	IN	O
RNAi	NNP	O
is	VBZ	O
the	DT	O
breaking	NN	O
of	IN	O
a	DT	O
double-stranded	JJ	O
RNA	NNP	O
(	(	O
dsRNA	NN	O
)	)	O
matching	VBG	O
a	DT	O
specific	JJ	O
gene	NN	O
sequence	NN	O
into	IN	O
short	JJ	O
pieces	NNS	O
called	VBN	O
short	JJ	O
interfering	NN	O
RNA	NNP	O
,	,	O
which	WDT	O
trigger	VBZ	O
the	DT	O
degradation	NN	O
of	IN	O
mRNA	NN	O
that	WDT	O
matches	VBZ	O
its	PRP$	O
sequence	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
RNAi	NNP	O
's	POS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
used	VBN	O
in	IN	O
gene-silencing	JJ	O
therapeutics	NNS	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Shuey	NNP	B
(	(	I
2002	CD	I
)	)	I
Drug	NNP	I
Discov	NNP	I
.	.	I
Today	NN	I
7:1040-1046	CD	I
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
to	TO	O
selectively	RB	O
degrade	VB	O
RNA	NNP	O
using	VBG	O
the	DT	O
RNAi	NNP	O
's	POS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
process	NN	O
may	MD	O
be	VB	O
practiced	VBN	O
in	IN	O
vitro	NN	O
,	,	O
ex	FW	O
vivo	FW	O
or	CC	O
in	IN	O
vivo	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
RNAi	NNP	O
molecules	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
generate	VB	O
a	DT	O
loss-of-function	JJ	O
mutation	NN	O
in	IN	O
a	DT	O
cell	NN	O
,	,	O
an	DT	O
organ	NN	O
or	CC	O
an	DT	O
animal	NN	O
.	.	O
Methods	NNS	O
for	IN	O
making	VBG	O
and	CC	O
using	VBG	O
RNAi	NNP	O
molecules	NNS	O
for	IN	O
selectively	RB	O
degrade	JJ	O
RNA	NNP	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
see	NN	O
,	,	O
e.g.	RB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,506,559	CD	O
;	:	O
6,511,824	CD	O
;	:	O
6,515,109	CD	O
;	:	O
6,489,127	CD	O
.	.	O
Modification	NN	O
of	IN	O
Nucleic	NNP	O
Acids	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
generating	VBG	O
variants	NNS	O
of	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
those	DT	O
encoding	VBG	O
an	DT	O
amylase	NN	O
.	.	O
These	DT	O
methods	NNS	O
can	MD	O
be	VB	O
repeated	VBN	O
or	CC	O
used	VBN	O
in	IN	O
various	JJ	O
combinations	NNS	O
to	TO	O
generate	VB	O
amylases	NNS	O
having	VBG	O
an	DT	O
altered	JJ	O
or	CC	O
different	JJ	O
activity	NN	O
or	CC	O
an	DT	O
altered	JJ	O
or	CC	O
different	JJ	O
stability	NN	O
from	IN	O
that	DT	O
of	IN	O
an	DT	O
amylase	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
template	NN	O
nucleic	JJ	O
acid	NN	O
.	.	O
These	DT	O
methods	NNS	O
also	RB	O
can	MD	O
be	VB	O
repeated	VBN	O
or	CC	O
used	VBN	O
in	IN	O
various	JJ	O
combinations	NNS	O
,	,	O
e.g.	NN	O
,	,	O
to	TO	O
generate	VB	O
variations	NNS	O
in	IN	O
gene/message	NN	O
expression	NN	O
,	,	O
message	NN	O
translation	NN	O
or	CC	O
message	NN	O
stability	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
genetic	JJ	O
composition	NN	O
of	IN	O
a	DT	O
cell	NN	O
is	VBZ	O
altered	VBN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
modification	NN	O
of	IN	O
a	DT	O
homologous	JJ	O
gene	NN	O
ex	NN	O
vivo	NN	O
,	,	O
followed	VBN	O
by	IN	O
its	PRP$	O
reinsertion	NN	O
into	IN	O
the	DT	O
cell	NN	O
.	.	O
A	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
altered	VBN	O
by	IN	O
any	DT	O
means	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
random	NN	O
or	CC	O
stochastic	JJ	O
methods	NNS	O
,	,	O
or	CC	O
,	,	O
non-stochastic	JJ	O
,	,	O
or	CC	O
“	RB	O
directed	JJ	O
evolution	NN	O
,	,	O
”	NNP	O
methods	NNS	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,361,974	CD	O
.	.	O
Methods	NNS	O
for	IN	O
random	JJ	O
mutation	NN	O
of	IN	O
genes	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
see	NN	O
,	,	O
e.g.	RB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,830,696	CD	O
.	.	O
For	IN	O
example	NN	O
,	,	O
mutagens	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
randomly	VB	O
mutate	VB	O
a	DT	O
gene	NN	O
.	.	O
Mutagens	NNP	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
ultraviolet	JJ	O
light	NN	O
or	CC	O
gamma	JJ	O
irradiation	NN	O
,	,	O
or	CC	O
a	DT	O
chemical	NN	O
mutagen	NN	O
,	,	O
e.g.	NN	O
,	,	O
mitomycin	NN	O
,	,	O
nitrous	JJ	O
acid	NN	O
,	,	O
photoactivated	VBD	O
psoralens	NNS	O
,	,	O
alone	RB	O
or	CC	O
in	IN	O
combination	NN	O
,	,	O
to	TO	O
induce	VB	O
DNA	NNP	O
breaks	NNS	O
amenable	JJ	O
to	TO	O
repair	VB	O
by	IN	O
recombination	NN	O
.	.	O
Other	JJ	O
chemical	NN	O
mutagens	NNS	O
include	VBP	O
,	,	O
for	IN	O
example	NN	O
,	,	O
sodium	NN	O
bisulfite	NN	O
,	,	O
nitrous	JJ	O
acid	NN	O
,	,	O
hydroxylamine	NN	O
,	,	O
hydrazine	NN	O
or	CC	O
formic	JJ	O
acid	NN	O
.	.	O
Other	JJ	O
mutagens	NNS	O
are	VBP	O
analogues	NNS	O
of	IN	O
nucleotide	JJ	O
precursors	NNS	O
,	,	O
e.g.	NN	O
,	,	O
nitrosoguanidine	JJ	O
,	,	O
5-bromouracil	JJ	O
,	,	O
2-aminopurine	JJ	O
,	,	O
or	CC	O
acridine	NN	O
.	.	O
These	DT	O
agents	NNS	O
can	MD	O
be	VB	O
added	VBN	O
to	TO	O
a	DT	O
PCR	NNP	O
reaction	NN	O
in	IN	O
place	NN	O
of	IN	O
the	DT	O
nucleotide	NN	O
precursor	NN	O
thereby	RB	O
mutating	VBG	O
the	DT	O
sequence	NN	O
.	.	O
Intercalating	VBG	O
agents	NNS	O
such	JJ	O
as	IN	O
proflavine	NN	O
,	,	O
acriflavine	NN	O
,	,	O
quinacrine	NN	O
and	CC	O
the	DT	O
like	JJ	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
.	.	O
Any	DT	O
technique	NN	O
in	IN	O
molecular	JJ	O
biology	NN	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
e.g.	FW	O
,	,	O
random	JJ	O
PCR	NNP	O
mutagenesis	NN	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Rice	NNP	B
(	(	I
1992	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
89:5467-5471	CD	I
;	:	O
or	CC	O
,	,	O
combinatorial	JJ	O
multiple	NN	O
cassette	NN	O
mutagenesis	NN	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Crameri	NNP	B
(	(	I
1995	CD	I
)	)	I
Biotechniques	VBZ	I
18:194-196	JJ	I
.	.	O
Alternatively	RB	O
,	,	O
nucleic	JJ	O
acids	NNS	O
,	,	O
e.g.	NN	O
,	,	O
genes	NNS	O
,	,	O
can	MD	O
be	VB	O
reassembled	VBN	O
after	IN	O
random	NN	O
,	,	O
or	CC	O
“	NNP	O
stochastic	JJ	O
,	,	O
”	JJ	O
fragmentation	NN	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,291,242	CD	O
;	:	O
6,287,862	CD	O
;	:	O
6,287,861	CD	O
;	:	O
5,955,358	CD	O
;	:	O
5,830,721	CD	O
;	:	O
5,824,514	CD	O
;	:	O
5,811,238	CD	O
;	:	O
5,605,793	CD	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
modifications	NNS	O
,	,	O
additions	NNS	O
or	CC	O
deletions	NNS	O
are	VBP	O
introduced	VBN	O
by	IN	O
error-prone	JJ	O
PCR	NNP	O
,	,	O
shuffling	VBG	O
,	,	O
oligonucleotide-directed	JJ	O
mutagenesis	NN	O
,	,	O
assembly	RB	O
PCR	NNP	O
,	,	O
sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
,	,	O
in	IN	O
vivo	JJ	O
mutagenesis	NN	O
,	,	O
cassette	NN	O
mutagenesis	NN	O
,	,	O
recursive	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
exponential	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
site-specific	JJ	O
mutagenesis	NN	O
,	,	O
gene	NN	O
reassembly	RB	O
,	,	O
gene	NN	O
site	NN	O
saturated	VBN	O
mutagenesis	NN	O
(	(	O
GSSM	NNP	O
)	)	O
,	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(	(	O
SLR	NNP	O
)	)	O
,	,	O
recombination	NN	O
,	,	O
recursive	JJ	O
sequence	NN	O
recombination	NN	O
,	,	O
phosphothioate-modified	JJ	O
DNA	NNP	O
mutagenesis	NN	O
,	,	O
uracil-containing	JJ	O
template	NN	O
mutagenesis	NN	O
,	,	O
gapped	VBD	O
duplex	JJ	O
mutagenesis	NN	O
,	,	O
point	NN	O
mismatch	NN	O
repair	NN	O
mutagenesis	NN	O
,	,	O
repair-deficient	JJ	O
host	NN	O
strain	NN	O
mutagenesis	NN	O
,	,	O
chemical	JJ	O
mutagenesis	NN	O
,	,	O
radiogenic	JJ	O
mutagenesis	NN	O
,	,	O
deletion	NN	O
mutagenesis	NN	O
,	,	O
restriction-selection	NN	O
mutagenesis	NN	O
,	,	O
restriction-purification	NN	O
mutagenesis	NN	O
,	,	O
artificial	JJ	O
gene	NN	O
synthesis	NN	O
,	,	O
ensemble	JJ	O
mutagenesis	NN	O
,	,	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
multimer	NN	O
creation	NN	O
,	,	O
and/or	VBZ	O
a	DT	O
combination	NN	O
of	IN	O
these	DT	O
and	CC	O
other	JJ	O
methods	NNS	O
.	.	O
The	DT	O
following	JJ	O
publications	NNS	O
describe	VBP	O
a	DT	O
variety	NN	O
of	IN	O
recursive	JJ	O
recombination	NN	O
procedures	NNS	O
and/or	VBP	O
methods	NNS	O
which	WDT	O
can	MD	O
be	VB	O
incorporated	VBN	O
into	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
:	:	O
Stemmer	NNP	B
(	(	I
1999	CD	I
)	)	I
“	FW	I
Molecular	JJ	I
breeding	NN	I
of	IN	I
viruses	NNS	I
for	IN	I
targeting	VBG	I
and	CC	I
other	JJ	I
clinical	JJ	I
properties	NNS	I
”	VBP	I
Tumor	NNP	I
Targeting	NNP	I
4:1-4	JJ	I
;	:	O
Ness	NNP	B
(	(	I
1999	CD	I
)	)	I
Nature	NNP	I
Biotechnology	NNP	I
17:893-896	CD	I
;	:	O
Chang	NNP	B
(	(	I
1999	CD	I
)	)	I
“	FW	I
Evolution	NNP	I
of	IN	I
a	DT	I
cytokine	NN	I
using	VBG	I
DNA	NNP	I
family	NN	I
shuffling	VBG	I
”	JJ	I
Nature	NNP	I
Biotechnology	NNP	I
17:793-797	CD	I
;	:	O
Minshull	NNP	B
(	(	I
1999	CD	I
)	)	I
“	FW	I
Protein	NNP	I
evolution	NN	I
by	IN	I
molecular	JJ	I
breeding	NN	I
”	JJ	I
Current	NNP	I
Opinion	NN	I
in	IN	I
Chemical	NNP	I
Biology	NNP	I
3:284-290	CD	I
;	:	O
Christians	NNPS	B
(	(	I
1999	CD	I
)	)	I
“	NN	I
Directed	NNP	I
evolution	NN	I
of	IN	I
thymidine	JJ	I
kinase	NN	I
for	IN	I
AZT	NNP	I
phosphorylation	NN	I
using	VBG	I
DNA	NNP	I
family	NN	I
shuffling	VBG	I
”	JJ	I
Nature	NNP	I
Biotechnology	NNP	I
17:259-264	CD	I
;	:	O
Crameri	NNP	B
(	(	I
1998	CD	I
)	)	I
“	FW	I
DNA	NNP	I
shuffling	NN	I
of	IN	I
a	DT	I
family	NN	I
of	IN	I
genes	NNS	I
from	IN	I
diverse	JJ	I
species	NNS	I
accelerates	VBZ	I
directed	JJ	I
evolution	NN	I
”	JJ	I
Nature	NNP	I
391:288-291	CD	I
;	:	O
Crameri	NNP	B
(	(	I
1997	CD	I
)	)	I
“	FW	I
Molecular	JJ	I
evolution	NN	I
of	IN	I
an	DT	I
arsenate	JJ	I
detoxification	NN	I
pathway	NN	I
by	IN	I
DNA	NNP	I
shuffling	NN	I
,	,	I
”	JJ	I
Nature	NNP	I
Biotechnology	NNP	I
15:436-438	CD	I
;	:	O
Zhang	NNP	B
(	(	I
1997	CD	I
)	)	I
“	NN	I
Directed	NNP	I
evolution	NN	I
of	IN	I
an	DT	I
effective	JJ	I
fucosidase	NN	I
from	IN	I
a	DT	I
galactosidase	NN	I
by	IN	I
DNA	NNP	I
shuffling	NN	I
and	CC	I
screening	VBG	I
”	JJ	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
94:4504-4509	CD	I
;	:	O
Patten	NNP	B
et	VBZ	I
al	NN	I
.	.	I
(	(	I
1997	CD	I
)	)	I
“	NN	I
Applications	NNP	I
of	IN	I
DNA	NNP	I
Shuffling	VBG	I
to	TO	I
Pharmaceuticals	NNP	I
and	CC	I
Vaccines	NNP	I
”	NNP	I
Current	NNP	I
Opinion	NNP	I
in	IN	I
Biotechnology	NNP	I
8:724-733	CD	I
;	:	O
Crameri	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
1996	CD	I
)	)	I
“	FW	I
Construction	NNP	I
and	CC	I
evolution	NN	I
of	IN	I
antibody-phage	JJ	I
libraries	NNS	I
by	IN	I
DNA	NNP	I
shuffling	VBG	I
”	JJ	I
Nature	NNP	I
Medicine	NNP	I
2:100-103	CD	I
;	:	O
Gates	NNP	B
et	VBP	I
al	NN	I
.	.	I
(	(	I
1996	CD	I
)	)	I
“	FW	I
Affinity	NNP	I
selective	JJ	I
isolation	NN	I
of	IN	I
ligands	NNS	I
from	IN	I
peptide	NN	I
libraries	NNS	I
through	IN	I
display	NN	I
on	IN	I
a	DT	I
lac	NN	I
repressor	NN	I
‘	NNP	I
headpiece	NN	I
dimer	NN	I
’	NNP	I
”	NNP	I
Journal	NNP	I
of	IN	I
Molecular	NNP	I
Biology	NNP	I
255:373-386	CD	I
;	:	O
Stemmer	NNP	B
(	(	I
1996	CD	I
)	)	I
“	FW	I
Sexual	JJ	I
PCR	NNP	I
and	CC	I
Assembly	NNP	I
PCR	NNP	I
”	NNP	I
In	IN	I
:	:	I
The	DT	I
Encyclopedia	NNP	I
of	IN	I
Molecular	NNP	I
Biology	NNP	I
.	.	I
VCH	NNP	I
Publishers	NNP	I
,	,	I
New	NNP	I
York	NNP	I
.	.	I
pp	NN	I
.	.	I
447-457	JJ	I
;	:	O
Crameri	NNP	B
and	CC	I
Stemmer	NNP	I
(	(	I
1995	CD	I
)	)	I
“	VBP	I
Combinatorial	JJ	I
multiple	JJ	I
cassette	NN	I
mutagenesis	NN	I
creates	VBZ	I
all	PDT	I
the	DT	I
permutations	NNS	I
of	IN	I
mutant	NN	I
and	CC	I
wildtype	NN	I
cassettes	NNS	I
”	VBP	I
BioTechniques	NNP	I
18:194-195	CD	I
;	:	O
Stemmer	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
1995	CD	I
)	)	I
“	VBD	I
Single-step	NNP	I
assembly	NN	I
of	IN	I
a	DT	I
gene	NN	I
and	CC	I
entire	JJ	I
plasmid	NN	I
form	NN	I
large	JJ	I
numbers	NNS	I
of	IN	I
oligodeoxyribonucleotides	NNS	I
”	NNP	I
Gene	NNP	I
,	,	I
164:49-53	JJ	I
;	:	O
Stemmer	NNP	B
(	(	I
1995	CD	I
)	)	I
“	VBD	I
The	DT	I
Evolution	NNP	I
of	IN	I
Molecular	NNP	I
Computation	NNP	I
”	NNP	I
Science	NNP	I
270	CD	I
:	:	I
1510	CD	I
;	:	O
Stemmer	NNP	B
(	(	I
1995	CD	I
)	)	I
“	FW	I
Searching	VBG	I
Sequence	NNP	I
Space	NNP	I
”	NNP	I
Bio/Technology	NNP	I
13:549-553	CD	I
;	:	O
Stemmer	NNP	B
(	(	I
1994	CD	I
)	)	I
“	FW	I
Rapid	JJ	I
evolution	NN	I
of	IN	I
a	DT	I
protein	NN	I
in	IN	I
vitro	NN	I
by	IN	I
DNA	NNP	I
shuffling	VBG	I
”	JJ	I
Nature	NNP	I
370:389-391	CD	I
;	:	O
and	CC	O
Stemmer	NNP	B
(	(	I
1994	CD	I
)	)	I
“	FW	I
DNA	NNP	I
shuffling	NN	I
by	IN	I
random	JJ	I
fragmentation	NN	I
and	CC	I
reassembly	NN	I
:	:	I
In	IN	I
vitro	NN	I
recombination	NN	I
for	IN	I
molecular	JJ	I
evolution.	NN	I
”	NNP	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
91:10747-10751	CD	I
.	.	O
Mutational	NNP	O
methods	NNS	O
of	IN	O
generating	VBG	O
diversity	NN	O
include	VBP	O
,	,	O
for	IN	O
example	NN	O
,	,	O
site-directed	JJ	O
mutagenesis	NN	O
(	(	O
Ling	VBG	B
et	RB	I
al	NN	I
.	.	I
(	(	I
1997	CD	I
)	)	I
“	NN	I
Approaches	NNP	I
to	TO	I
DNA	VB	I
mutagenesis	NN	I
:	:	I
an	DT	I
overview	NN	I
”	NNP	I
Anal	NNP	I
Biochem	NNP	I
.	.	I
254	CD	I
(	(	I
2	CD	I
)	)	I
:	:	I
157-178	JJ	I
;	:	O
Dale	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
1996	CD	I
)	)	I
“	VBD	I
Oligonucleotide-directed	JJ	I
random	JJ	I
mutagenesis	NN	I
using	VBG	I
the	DT	I
phosphorothioate	NN	I
method	NN	I
”	NNP	I
Methods	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
57:369-374	JJ	I
;	:	O
Smith	NNP	B
(	(	I
1985	CD	I
)	)	I
“	NN	I
In	IN	I
vitro	JJ	I
mutagenesis	NN	I
”	NNP	I
Ann	NNP	I
.	.	I
Rev	NNP	I
.	.	I
Genet	NNP	I
.	.	I
19:423-462	JJ	I
;	:	O
Botstein	NNP	B
&	CC	I
Shortle	NNP	I
(	(	I
1985	CD	I
)	)	I
“	NN	I
Strategies	NNPS	I
and	CC	I
applications	NNS	I
of	IN	I
in	IN	I
vitro	JJ	I
mutagenesis	NN	I
”	JJ	I
Science	NNP	I
229:1193-1201	CD	I
;	:	O
Carter	NNP	B
(	(	I
1986	CD	I
)	)	I
“	VBD	I
Site-directed	JJ	I
mutagenesis	NN	I
”	NNP	I
Biochem	NNP	I
.	.	I
J	NNP	I
.	.	I
237:1-7	JJ	I
;	:	O
and	CC	O
Kunkel	NNP	B
(	(	I
1987	CD	I
)	)	I
“	VBD	I
The	DT	I
efficiency	NN	I
of	IN	I
oligonucleotide	NN	I
directed	VBN	I
mutagenesis	NN	I
”	NN	I
in	IN	I
Nucleic	NNP	I
Acids	NNP	I
&	CC	I
Molecular	NNP	I
Biology	NNP	I
(	(	I
Eckstein	NNP	I
,	,	I
F.	NNP	I
and	CC	I
Lilley	NNP	I
,	,	I
D.	NNP	I
M.	NNP	I
J	NNP	I
.	.	I
eds.	NN	I
,	,	I
Springer	NNP	I
Verlag	NNP	I
,	,	I
Berlin	NNP	I
)	)	I
)	)	O
;	:	O
mutagenesis	NN	O
using	VBG	O
uracil	JJ	O
containing	VBG	O
templates	NNS	O
(	(	O
Kunkel	NNP	B
(	(	I
1985	CD	I
)	)	I
“	FW	I
Rapid	NNP	I
and	CC	I
efficient	JJ	I
site-specific	JJ	I
mutagenesis	NN	I
without	IN	I
phenotypic	NN	I
selection	NN	I
”	NNP	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
82:488-492	CD	I
;	:	O
Kunkel	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
1987	CD	I
)	)	I
“	FW	I
Rapid	NNP	I
and	CC	I
efficient	JJ	I
site-specific	JJ	I
mutagenesis	NN	I
without	IN	I
phenotypic	NN	I
selection	NN	I
”	NNP	I
Methods	NNP	I
in	IN	I
Enzymol	NNP	I
.	.	I
154	CD	I
,	,	I
367-382	JJ	I
;	:	O
and	CC	O
Bass	NNP	B
et	VBP	I
al	NN	I
.	.	I
(	(	I
1988	CD	I
)	)	I
“	FW	I
Mutant	NNP	I
Tip	NNP	I
repressors	NNS	I
with	IN	I
new	JJ	I
DNA-binding	JJ	I
specificities	NNS	I
”	VBP	I
Science	NNP	I
242:240-245	JJ	I
)	)	O
;	:	O
oligonucleotide-directed	JJ	O
mutagenesis	NN	O
(	(	O
Methods	NNP	B
in	IN	I
Enzymol	NNP	I
.	.	I
100	CD	I
:	:	I
468-500	CD	I
(	(	I
1983	CD	I
)	)	I
;	:	O
Methods	NNS	B
in	IN	I
Enzymol	NNP	I
.	.	I
154	CD	I
:	:	I
329-350	CD	I
(	(	I
1987	CD	I
)	)	I
;	:	O
Zoller	NNP	B
&	CC	I
Smith	NNP	I
(	(	I
1982	CD	I
)	)	I
“	VBD	I
Oligonucleotide-directed	JJ	I
mutagenesis	NN	I
using	VBG	I
M13-derived	JJ	I
vectors	NNS	I
:	:	I
an	DT	I
efficient	NN	I
and	CC	I
general	JJ	I
procedure	NN	I
for	IN	I
the	DT	I
production	NN	I
of	IN	I
point	NN	I
mutations	NNS	I
in	IN	I
any	DT	I
DNA	NNP	I
fragment	NN	I
”	NNP	I
Nucleic	NNP	I
Acids	NNP	I
Res	NNP	I
.	.	I
10:6487-6500	CD	I
;	:	O
Zoller	NNP	B
&	CC	I
Smith	NNP	I
(	(	I
1983	CD	I
)	)	I
“	VBD	I
Oligonucleotide-directed	JJ	I
mutagenesis	NN	I
of	IN	I
DNA	NN	I
fragments	NNS	I
cloned	VBD	I
into	IN	I
M13	NNP	I
vectors	NNS	I
”	VBP	I
Methods	NNS	I
in	IN	I
Enzymol	NNP	I
.	.	I
100:468-500	CD	I
;	:	O
and	CC	O
Zoller	NNP	B
&	CC	I
Smith	NNP	I
(	(	I
1987	CD	I
)	)	I
Oligonucleotide-directed	JJ	I
mutagenesis	NN	I
:	:	I
a	DT	I
simple	JJ	I
method	NN	I
using	VBG	I
two	CD	I
oligonucleotide	JJ	I
primers	NNS	I
and	CC	I
a	DT	I
single-stranded	JJ	I
DNA	NNP	I
template	NN	I
”	NNP	I
Methods	NNP	I
in	IN	I
Enzymol	NNP	I
.	.	I
154:329-350	JJ	I
)	)	I
;	:	O
phosphorothioate-modified	JJ	O
DNA	NNP	O
mutagenesis	NN	O
(	(	O
Taylor	NNP	B
et	RB	I
al	RB	I
.	.	I
(	(	I
1985	CD	I
)	)	I
“	VBP	I
The	DT	I
use	NN	I
of	IN	I
phosphorothioate-modified	JJ	I
DNA	NNP	I
in	IN	I
restriction	NN	I
enzyme	NN	I
reactions	NNS	I
to	TO	I
prepare	VB	I
nicked	JJ	I
DNA	NNP	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
13	CD	I
:	:	I
8749-8764	JJ	I
;	:	O
Taylor	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
1985	CD	I
)	)	I
“	VBD	I
The	DT	I
rapid	JJ	I
generation	NN	I
of	IN	I
oligonucleotide-directed	JJ	I
mutations	NNS	I
at	IN	I
high	JJ	I
frequency	NN	I
using	VBG	I
phosphorothioate-modified	JJ	I
DNA	NNP	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
13	CD	I
:	:	I
8765-8787	CD	I
(	(	I
1985	CD	I
)	)	I
;	:	O
Nakamaye	NNP	B
(	(	I
1986	CD	I
)	)	I
“	FW	I
Inhibition	NNP	I
of	IN	I
restriction	NN	I
endonuclease	NN	I
Nci	NNP	I
I	PRP	I
cleavage	VBP	I
by	IN	I
phosphorothioate	NN	I
groups	NNS	I
and	CC	I
its	PRP$	I
application	NN	I
to	TO	I
oligonucleotide-directed	JJ	I
mutagenesis	NN	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
14	CD	I
:	:	I
9679-9698	CD	I
;	:	O
Sayers	NNP	B
et	VBP	I
al	NN	I
.	.	I
(	(	I
1988	CD	I
)	)	I
“	VBD	I
Y-T	JJ	I
Exonucleases	NNS	I
in	IN	I
phosphorothioate-based	JJ	I
oligonucleotide-directed	JJ	I
mutagenesis	NN	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
16:791-802	JJ	I
;	:	O
and	CC	O
Sayers	NNP	B
et	VBP	I
al	NN	I
.	.	I
(	(	I
1988	CD	I
)	)	I
“	NN	I
Strand	NNP	I
specific	JJ	I
cleavage	NN	I
of	IN	I
phosphorothioate-containing	JJ	I
DNA	NN	I
by	IN	I
reaction	NN	I
with	IN	I
restriction	NN	I
endonucleases	NNS	I
in	IN	I
the	DT	I
presence	NN	I
of	IN	I
ethidium	NN	I
bromide	NN	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
16	CD	I
:	:	I
803-814	JJ	I
)	)	O
;	:	O
mutagenesis	NN	O
using	VBG	O
gapped	VBD	O
duplex	JJ	O
DNA	NNP	O
(	(	O
Kramer	NNP	B
et	RB	I
al	RB	I
.	.	I
(	(	I
1984	CD	I
)	)	I
“	VBD	I
The	DT	I
gapped	JJ	I
duplex	NN	I
DNA	NNP	I
approach	NN	I
to	TO	I
oligonucleotide-directed	JJ	I
mutation	NN	I
construction	NN	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
12	CD	I
:	:	I
9441-9456	CD	I
;	:	O
Kramer	NNP	B
&	CC	I
Fritz	NNP	I
(	(	I
1987	CD	I
)	)	I
Methods	NNS	I
in	IN	I
Enzymol	NNP	I
.	.	I
“	JJ	I
Oligonucleotide-directed	JJ	I
construction	NN	I
of	IN	I
mutations	NNS	I
via	IN	I
gapped	JJ	I
duplex	JJ	I
DNA	NNP	I
”	NNP	I
154:350-367	JJ	I
;	:	O
Kramer	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
1988	CD	I
)	)	I
“	FW	I
Improved	VBN	I
enzymatic	JJ	I
in	IN	I
vitro	JJ	I
reactions	NNS	I
in	IN	I
the	DT	I
gapped	JJ	I
duplex	NN	I
DNA	NNP	I
approach	NN	I
to	TO	I
oligonucleotide-directed	JJ	I
construction	NN	I
of	IN	I
mutations	NNS	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
16	CD	I
:	:	I
7207	CD	I
;	:	O
and	CC	O
Fritz	NNP	B
et	VBP	I
al	NN	I
.	.	I
(	(	I
1988	CD	I
)	)	I
“	VBD	I
Oligonucleotide-directed	JJ	I
construction	NN	I
of	IN	I
mutations	NNS	I
:	:	I
a	DT	I
gapped	JJ	I
duplex	NN	I
DNA	NNP	I
procedure	NN	I
without	IN	I
enzymatic	JJ	I
reactions	NNS	I
in	IN	I
vitro	JJ	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
16	CD	I
:	:	I
6987-6999	JJ	I
)	)	O
.	.	O
Additional	NNP	O
protocols	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
practice	NN	O
the	DT	O
invention	NN	O
include	VBP	O
point	NN	O
mismatch	NN	O
repair	NN	O
(	(	O
Kramer	NNP	B
(	(	I
1984	CD	I
)	)	I
“	FW	I
Point	NNP	I
Mismatch	NNP	I
Repair	NNP	I
”	NNP	I
Cell	NNP	I
38:879-887	NNP	I
)	)	O
,	,	O
mutagenesis	NN	O
using	VBG	O
repair-deficient	JJ	O
host	NN	O
strains	NNS	O
(	(	O
Carter	NNP	B
et	RB	I
al	RB	I
.	.	I
(	(	I
1985	CD	I
)	)	I
“	FW	I
Improved	VBN	I
oligonucleotide	IN	I
site-directed	JJ	I
mutagenesis	NN	I
using	VBG	I
M13	NNP	I
vectors	NNS	I
”	VBP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
13	CD	I
:	:	I
4431-4443	JJ	I
;	:	O
and	CC	O
Carter	NNP	B
(	(	I
1987	CD	I
)	)	I
“	FW	I
Improved	VBN	I
oligonucleotide-directed	JJ	I
mutagenesis	NN	I
using	VBG	I
M13	NNP	I
vectors	NNS	I
”	VBP	I
Methods	NNS	I
in	IN	I
Enzymol	NNP	I
.	.	I
154	CD	I
:	:	I
382-403	JJ	I
)	)	O
,	,	O
deletion	NN	O
mutagenesis	NN	O
(	(	O
Eghtedarzadeh	NNP	B
(	(	I
1986	CD	I
)	)	I
“	NN	I
Use	NNP	I
of	IN	I
oligonucleotides	NNS	I
to	TO	I
generate	VB	I
large	JJ	I
deletions	NNS	I
”	VBP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
14	CD	I
:	:	I
5115	CD	I
)	)	O
,	,	O
restriction-selection	JJ	O
and	CC	O
restriction-selection	NN	O
and	CC	O
restriction-purification	NN	O
(	(	O
Wells	NNP	B
et	VBZ	I
al	NN	I
.	.	I
(	(	I
1986	CD	I
)	)	I
“	FW	I
Importance	NNP	I
of	IN	I
hydrogen-bond	NN	I
formation	NN	I
in	IN	I
stabilizing	VBG	I
the	DT	I
transition	NN	I
state	NN	I
of	IN	I
subtilisin	NN	I
”	NNP	I
Phil	NNP	I
.	.	I
Trans	NNS	I
.	.	I
R.	NNP	I
Soc	NNP	I
.	.	I
Lond	NN	I
.	.	I
A	DT	I
317	CD	I
:	:	I
415-423	JJ	I
)	)	O
,	,	O
mutagenesis	NN	O
by	IN	O
total	JJ	O
gene	NN	O
synthesis	NN	O
(	(	O
Nambiar	NNP	B
et	RB	I
al	RB	I
.	.	I
(	(	I
1984	CD	I
)	)	I
“	FW	I
Total	JJ	I
synthesis	NN	I
and	CC	I
cloning	NN	I
of	IN	I
a	DT	I
gene	NN	I
coding	VBG	I
for	IN	I
the	DT	I
ribonuclease	NN	I
S	NNP	I
protein	NN	I
”	VBD	I
Science	NNP	I
223	CD	I
:	:	I
1299-1301	JJ	I
;	:	O
Sakamar	NNP	B
and	CC	I
Khorana	NNP	I
(	(	I
1988	CD	I
)	)	I
“	FW	I
Total	JJ	I
synthesis	NN	I
and	CC	I
expression	NN	I
of	IN	I
a	DT	I
gene	NN	I
for	IN	I
the	DT	I
a-subunit	NN	I
of	IN	I
bovine	NN	I
rod	NN	I
outer	NN	I
segment	NN	I
guanine	NN	I
nucleotide-binding	JJ	I
protein	NN	I
(	(	I
transducin	NN	I
)	)	I
”	NN	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
14	CD	I
:	:	I
6361-6372	JJ	I
;	:	O
Wells	NNP	B
et	VBZ	I
al	NN	I
.	.	I
(	(	I
1985	CD	I
)	)	I
“	FW	I
Cassette	NNP	I
mutagenesis	NN	I
:	:	I
an	DT	I
efficient	JJ	I
method	NN	I
for	IN	I
generation	NN	I
of	IN	I
multiple	JJ	I
mutations	NNS	I
at	IN	I
defined	VBN	I
sites	NNS	I
”	JJ	I
Gene	NNP	I
34:315-323	CD	I
;	:	O
and	CC	O
Grundstrom	NNP	B
et	VBP	I
al	NN	I
.	.	I
(	(	I
1985	CD	I
)	)	I
“	VBD	I
Oligonucleotide-directed	JJ	I
mutagenesis	NN	I
by	IN	I
microscale	JJ	I
‘	JJ	I
shot-gun	JJ	I
’	NNP	I
gene	NN	I
synthesis	NN	I
”	NNP	I
Nucl	NNP	I
.	.	I
Acids	NNP	I
Res	NNP	I
.	.	I
13	CD	I
:	:	I
3305-3316	JJ	I
)	)	O
,	,	O
double-strand	JJ	O
break	NN	O
repair	NN	O
(	(	O
Mandecki	NNP	B
(	(	I
1986	CD	I
)	)	I
;	:	I
Arnold	NNP	I
(	(	I
1993	CD	I
)	)	I
“	FW	I
Protein	NNP	I
engineering	NN	I
for	IN	I
unusual	JJ	I
environments	NNS	I
”	VBP	I
Current	JJ	I
Opinion	NN	I
in	IN	I
Biotechnology	NNP	I
4:450-455	JJ	I
.	.	O
“	JJ	B
Oligonucleotide-directed	JJ	I
double-strand	JJ	I
break	NN	I
repair	NN	I
in	IN	I
plasmids	NNS	I
of	IN	I
Escherichia	NNP	I
coli	NNS	I
:	:	I
a	DT	I
method	NN	I
for	IN	I
site-specific	JJ	I
mutagenesis	NN	I
”	NNP	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
,	,	I
83:7177-7181	JJ	I
)	)	O
.	.	O
Additional	NNP	O
details	NNS	O
on	IN	O
many	JJ	O
of	IN	O
the	DT	O
above	JJ	O
methods	NNS	O
can	MD	O
be	VB	O
found	VBN	O
in	IN	O
Methods	NNP	B
in	IN	I
Enzymology	NNP	I
Volume	NN	I
154	CD	I
,	,	O
which	WDT	O
also	RB	O
describes	VBZ	O
useful	JJ	O
controls	NNS	O
for	IN	O
trouble-shooting	JJ	O
problems	NNS	O
with	IN	O
various	JJ	O
mutagenesis	NN	O
methods	NNS	O
.	.	O
Protocols	NNS	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
practice	NN	O
the	DT	O
invention	NN	O
are	VBP	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,605,793	CD	O
to	TO	O
Stemmer	NNP	B
(	(	I
Feb.	NNP	I
25	CD	I
,	,	I
1997	CD	I
)	)	I
,	,	I
“	JJ	I
Methods	NNP	I
for	IN	I
In	IN	I
Vitro	NNP	I
Recombination	NNP	I
;	:	I
”	NNP	I
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,811,238	CD	O
to	TO	O
Stemmer	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
Sep.	NNP	I
22	CD	I
,	,	I
1998	CD	I
)	)	I
“	FW	I
Methods	NNP	I
for	IN	I
Generating	VBG	I
Polynucleotides	NNP	I
having	VBG	I
Desired	VBN	I
Characteristics	NNS	I
by	IN	I
Iterative	NNP	I
Selection	NNP	I
and	CC	I
Recombination	NNP	I
;	:	I
”	NNP	I
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,830,721	CD	O
to	TO	O
Stemmer	NNP	B
et	FW	I
al	NN	I
.	.	I
(	(	I
Nov.	NNP	I
3	CD	I
,	,	I
1998	CD	I
)	)	I
,	,	I
“	JJ	I
DNA	NNP	I
Mutagenesis	NNP	I
by	IN	I
Random	NNP	I
Fragmentation	NNP	I
and	CC	I
Reassembly	NNP	I
;	:	I
”	NNP	I
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,834,252	CD	O
to	TO	O
Stemmer	NNP	B
,	,	I
et	RB	I
al	NN	I
.	.	I
(	(	I
Nov.	NNP	I
10	CD	I
,	,	I
1998	CD	I
)	)	I
“	VBD	I
End-Complementary	JJ	I
Polymerase	NNP	I
Reaction	NNP	I
;	:	I
”	NNP	I
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,837,458	CD	O
to	TO	O
Minshull	NNP	B
,	,	I
et	RB	I
al	NN	I
.	.	I
(	(	I
Nov.	NNP	I
17	CD	I
,	,	I
1998	CD	I
)	)	I
,	,	I
“	JJ	I
Methods	NNP	I
and	CC	I
Compositions	NNP	I
for	IN	I
Cellular	NNP	I
and	CC	I
Metabolic	NNP	I
Engineering	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
95/22625	CD	O
,	,	O
Stemmer	NNP	B
and	CC	I
Crameri	NNP	I
,	,	I
“	NNP	I
Mutagenesis	NNP	I
by	IN	I
Random	NNP	I
Fragmentation	NNP	I
and	CC	I
Reassembly	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
96/33207	CD	O
by	IN	O
Stemmer	NNP	B
and	CC	I
Lipschutz	NNP	I
“	NNP	I
End	NNP	I
Complementary	NNP	I
Polymerase	NNP	I
Chain	NNP	I
Reaction	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
97/20078	CD	O
by	IN	O
Stemmer	NNP	B
and	CC	I
Crameri	NNP	I
“	NNP	I
Methods	NNP	I
for	IN	I
Generating	VBG	I
Polynucleotides	NNP	I
having	VBG	I
Desired	VBN	I
Characteristics	NNS	I
by	IN	I
Iterative	NNP	I
Selection	NNP	I
and	CC	I
Recombination	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
97/35966	CD	O
by	IN	O
Minshull	NNP	B
and	CC	I
Stemmer	NNP	I
,	,	I
“	NNP	I
Methods	NNP	I
and	CC	I
Compositions	NNP	I
for	IN	I
Cellular	NNP	I
and	CC	I
Metabolic	NNP	I
Engineering	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
99/41402	CD	O
by	IN	O
Punnonen	NNP	B
et	CC	I
al	NN	I
.	.	I
“	JJ	I
Targeting	NNP	I
of	IN	I
Genetic	NNP	I
Vaccine	NNP	I
Vectors	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
99/41383	CD	O
by	IN	O
Punnonen	NNP	B
et	CC	I
al	NN	I
.	.	I
“	JJ	I
Antigen	NNP	I
Library	NNP	I
Immunization	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
99/41369	CD	O
by	IN	O
Punnonen	NNP	B
et	CC	I
al	NN	I
.	.	I
“	JJ	I
Genetic	NNP	I
Vaccine	NNP	I
Vector	NNP	I
Engineering	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
99/41368	CD	O
by	IN	O
Punnonen	NNP	B
et	CC	I
al	NN	I
.	.	I
“	JJ	I
Optimization	NNP	I
of	IN	I
Immunomodulatory	NNP	I
Properties	NNP	I
of	IN	I
Genetic	NNP	I
Vaccines	NNP	I
;	:	I
”	NNP	I
EP	NNP	O
752008	CD	O
by	IN	O
Stemmer	NNP	B
and	CC	I
Crameri	NNP	I
,	,	I
“	NNP	I
DNA	NNP	I
Mutagenesis	NNP	I
by	IN	I
Random	NNP	I
Fragmentation	NNP	I
and	CC	I
Reassembly	NNP	I
;	:	I
”	NNP	I
EP	NNP	O
0932670	CD	O
by	IN	O
Stemmer	NNP	B
“	NNP	I
Evolving	NNP	I
Cellular	NNP	I
DNA	NNP	I
Uptake	NNP	I
by	IN	I
Recursive	NNP	I
Sequence	NNP	I
Recombination	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
99/23107	CD	O
by	IN	O
Stemmer	NNP	B
et	FW	I
al.	NN	I
,	,	I
“	JJ	I
Modification	NNP	I
of	IN	I
Virus	NNP	I
Tropism	NNP	I
and	CC	I
Host	NNP	I
Range	NNP	I
by	IN	I
Viral	NNP	I
Genome	NNP	I
Shuffling	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
99/21979	CD	O
by	IN	O
Apt	NNP	B
et	FW	I
al.	NN	I
,	,	I
“	NNP	I
Human	NNP	I
Papillomavirus	NNP	I
Vectors	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
98/31837	CD	O
by	IN	O
del	NN	B
Cardayre	NNP	I
et	CC	I
al	NN	I
.	.	I
“	JJ	I
Evolution	NNP	I
of	IN	I
Whole	NNP	I
Cells	NNP	I
and	CC	I
Organisms	NNP	I
by	IN	I
Recursive	NNP	I
Sequence	NNP	I
Recombination	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
98/27230	CD	O
by	IN	O
Patten	NNP	B
and	CC	I
Stemmer	NNP	I
,	,	I
“	NNP	I
Methods	NNP	I
and	CC	I
Compositions	NNP	I
for	IN	I
Polypeptide	NNP	I
Engineering	NNP	I
;	:	I
”	NNP	I
WO	NNP	O
98/27230	CD	O
by	IN	O
Stemmer	NNP	B
et	FW	I
al.	NN	I
,	,	I
“	NNP	I
Methods	NNP	I
for	IN	I
Optimization	NNP	I
of	IN	I
Gene	NNP	I
Therapy	NNP	I
by	IN	I
Recursive	NNP	I
Sequence	NNP	I
Shuffling	NNP	I
and	CC	I
Selection	NNP	I
,	,	I
”	NNP	I
WO	NNP	O
00/00632	CD	O
,	,	O
“	JJR	O
Methods	NNS	O
for	IN	O
Generating	VBG	O
Highly	NNP	O
Diverse	NNP	O
Libraries	NNP	O
,	,	O
”	NNP	O
WO	NNP	O
00/09679	CD	O
,	,	O
“	JJR	O
Methods	NNS	O
for	IN	O
Obtaining	VBG	O
in	IN	O
Vitro	NNP	O
Recombined	NNP	O
Polynucleotide	NNP	O
Sequence	NNP	O
Banks	NNP	O
and	CC	O
Resulting	NNP	O
Sequences	NNP	O
,	,	O
”	NNP	O
WO	NNP	O
98/42832	CD	O
by	IN	O
Arnold	NNP	B
et	FW	I
al.	NN	I
,	,	I
“	NNP	I
Recombination	NNP	I
of	IN	I
Polynucleotide	NNP	I
Sequences	NNP	I
Using	NNP	I
Random	NNP	I
or	CC	I
Defined	VBN	I
Primers	NNS	I
,	,	I
”	NNP	I
WO	NNP	O
99/29902	CD	O
by	IN	O
Arnold	NNP	B
et	FW	I
al.	NN	I
,	,	I
“	NNP	I
Method	NNP	I
for	IN	I
Creating	NNP	I
Polynucleotide	NNP	I
and	CC	I
Polypeptide	NNP	I
Sequences	NNP	I
,	,	I
”	NNP	I
WO	NNP	O
98/41653	CD	O
by	IN	O
Vind	NNP	B
,	,	I
“	NNP	I
An	DT	I
in	IN	I
Vitro	NNP	I
Method	NNP	I
for	IN	I
Construction	NNP	I
of	IN	I
a	DT	I
DNA	NNP	I
Library	NNP	I
,	,	I
”	NNP	I
WO	NNP	O
98/41622	CD	O
by	IN	O
Borchert	NNP	B
et	FW	I
al.	NN	I
,	,	I
“	NNP	I
Method	NNP	I
for	IN	I
Constructing	VBG	I
a	DT	I
Library	NNP	I
Using	NNP	I
DNA	NNP	I
Shuffling	NNP	I
,	,	I
”	NNP	I
and	CC	O
WO	NNP	O
98/42727	CD	O
by	IN	O
Pati	NNP	B
and	CC	I
Zarling	NNP	I
,	,	I
“	NNP	I
Sequence	NNP	I
Alterations	NNP	I
using	VBG	I
Homologous	NNP	I
Recombination.	NNP	I
”	NNP	I
Protocols	NNP	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
practice	NN	O
the	DT	O
invention	NN	O
(	(	O
providing	VBG	O
details	NNS	O
regarding	VBG	O
various	JJ	O
diversity	NN	O
generating	VBG	O
methods	NNS	O
)	)	O
are	VBP	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
U.S.	NNP	O
patent	NN	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/407,800	CD	O
,	,	O
“	NNP	O
SHUFFLING	NNP	O
OF	NNP	O
CODON	NNP	O
ALTERED	NNP	O
GENES	NNP	O
”	NNP	O
by	IN	O
Patten	NNP	O
et	CC	O
al	NN	O
.	.	O
filed	VBN	O
Sep.	NNP	O
28	CD	O
,	,	O
1999	CD	O
;	:	O
“	CC	O
EVOLUTION	NNP	O
OF	NNP	O
WHOLE	NNP	O
CELLS	NNP	O
AND	NNP	O
ORGANISMS	NNP	O
BY	NNP	O
RECURSIVE	NNP	O
SEQUENCE	NNP	O
RECOMBINATION	NNP	O
”	NNP	O
by	IN	O
del	NN	O
Cardayre	NNP	O
et	CC	O
al.	NN	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,379,964	CD	O
;	:	O
“	NNP	O
OLIGONUCLEOTIDE	NNP	O
MEDIATED	NNP	O
NUCLEIC	NNP	O
ACID	NNP	O
RECOMBINATION	NNP	O
”	NNP	O
by	IN	O
Crameri	NNP	O
et	FW	O
al.	NN	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,319,714	CD	O
;	:	O
6,368,861	CD	O
;	:	O
6,376,246	CD	O
;	:	O
6,423,542	CD	O
;	:	O
6,426,224	CD	O
and	CC	O
PCT/US00/01203	NNP	O
;	:	O
“	NNP	O
USE	NNP	O
OF	IN	O
CODON-VARIED	NNP	O
OLIGONUCLEOTIDE	NNP	O
SYNTHESIS	NNP	O
FOR	NNP	O
SYNTHETIC	NNP	O
SHUFFLING	NNP	O
”	NN	O
by	IN	O
Welch	NNP	O
et	FW	O
al.	NN	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,436,675	CD	O
;	:	O
“	CC	O
METHODS	NNP	O
FOR	NNP	O
MAKING	NNP	O
CHARACTER	NNP	O
STRINGS	NNP	O
,	,	O
POLYNUCLEOTIDES	NNP	O
&	CC	O
POLYPEPTIDES	NNP	O
HAVING	NNP	O
DESIRED	NNP	O
CHARACTERISTICS	NNP	O
”	NN	O
by	IN	O
Selifonov	NNP	O
et	FW	O
al.	NN	O
,	,	O
filed	VBD	O
Jan.	NNP	O
18	CD	O
,	,	O
2000	CD	O
,	,	O
(	(	O
PCT/US00/01202	NNP	O
)	)	O
and	CC	O
,	,	O
e.g	FW	O
.	.	O
“	JJ	O
METHODS	NNP	O
FOR	NNP	O
MAKING	NNP	O
CHARACTER	NNP	O
STRINGS	NNP	O
,	,	O
POLYNUCLEOTIDES	NNP	O
&	CC	O
POLYPEPTIDES	NNP	O
HAVING	NNP	O
DESIRED	NNP	O
CHARACTERISTICS	NNP	O
”	NN	O
by	IN	O
Selifonov	NNP	O
et	FW	O
al.	NN	O
,	,	O
filed	VBD	O
Jul	NNP	O
.	.	O
18	CD	O
,	,	O
2000	CD	O
(	(	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/618,579	CD	O
)	)	O
;	:	O
“	CC	O
METHODS	NNP	O
OF	IN	O
POPULATING	NNP	O
DATA	NNP	O
STRUCTURES	NNP	O
FOR	NNP	O
USE	NNP	O
IN	NNP	O
EVOLUTIONARY	NNP	O
SIMULATIONS	NNP	O
”	NNP	O
by	IN	O
Selifonov	NNP	O
and	CC	O
Stemmer	NNP	O
,	,	O
filed	VBD	O
Jan.	NNP	O
18	CD	O
,	,	O
2000	CD	O
(	(	O
PCT/US00/01138	NNP	O
)	)	O
;	:	O
and	CC	O
“	VB	O
SINGLE-STRANDED	NNP	O
NUCLEIC	NNP	O
ACID	NNP	O
TEMPLATE-MEDIATED	NNP	O
RECOMBINATION	NNP	O
AND	NNP	O
NUCLEIC	NNP	O
ACID	NNP	O
FRAGMENT	NNP	O
ISOLATION	NNP	O
”	NNP	O
by	IN	O
Affholter	NNP	O
,	,	O
filed	VBD	O
Sep.	NNP	O
6	CD	O
,	,	O
2000	CD	O
(	(	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/656,549	CD	O
)	)	O
;	:	O
and	CC	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,177,263	CD	O
;	:	O
6,153,410	CD	O
.	.	O
Non-stochastic	JJ	O
,	,	O
or	CC	O
“	RB	O
directed	JJ	O
evolution	NN	O
,	,	O
”	JJ	O
methods	NNS	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
saturation	JJ	O
mutagenesis	NN	O
(	(	O
GSSM	NNP	O
)	)	O
,	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(	(	O
SLR	NNP	O
)	)	O
,	,	O
or	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
are	VBP	O
used	VBN	O
to	TO	O
modify	VB	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
generate	VB	O
amylases	NNS	O
with	IN	O
new	JJ	O
or	CC	O
altered	JJ	O
properties	NNS	O
(	(	O
e.g.	NN	O
,	,	O
activity	NN	O
under	IN	O
highly	RB	O
acidic	JJ	O
or	CC	O
alkaline	JJ	O
conditions	NNS	O
,	,	O
high	JJ	O
temperatures	NNS	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
)	)	O
.	.	O
Polypeptides	NNS	O
encoded	VBN	O
by	IN	O
the	DT	O
modified	JJ	O
nucleic	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
screened	VBN	O
for	IN	O
an	DT	O
activity	NN	O
before	IN	O
testing	VBG	O
for	IN	O
proteolytic	JJ	O
or	CC	O
other	JJ	O
activity	NN	O
.	.	O
Any	DT	O
testing	JJ	O
modality	NN	O
or	CC	O
protocol	NN	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
e.g.	FW	O
,	,	O
using	VBG	O
a	DT	O
capillary	JJ	O
array	NN	O
platform	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,361,974	CD	O
;	:	O
6,280,926	CD	O
;	:	O
5,939,250	CD	O
.	.	O
Saturation	NN	O
Mutagenesis	NNP	O
,	,	O
or	CC	O
,	,	O
GSSM	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
codon	NN	O
primers	NNS	O
containing	VBG	O
a	DT	O
degenerate	NN	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
sequence	NN	O
are	VBP	O
used	VBN	O
to	TO	O
introduce	VB	O
point	NN	O
mutations	NNS	O
into	IN	O
a	DT	O
polynucleotide	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
or	CC	O
an	DT	O
antibody	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
so	RB	O
as	IN	O
to	TO	O
generate	VB	O
a	DT	O
set	NN	O
of	IN	O
progeny	NN	O
polypeptides	NNS	O
in	IN	O
which	WDT	O
a	DT	O
full	JJ	O
range	NN	O
of	IN	O
single	JJ	O
amino	NN	O
acid	JJ	O
substitutions	NNS	O
is	VBZ	O
represented	VBN	O
at	IN	O
each	DT	O
amino	NN	O
acid	JJ	O
position	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
amino	NN	O
acid	NN	O
residue	NN	O
in	IN	O
an	DT	O
enzyme	NN	O
active	JJ	O
site	NN	O
or	CC	O
ligand	NN	O
binding	VBG	O
site	NN	O
targeted	VBN	O
to	TO	O
be	VB	O
modified	VBN	O
.	.	O
These	DT	O
oligonucleotides	NNS	O
can	MD	O
comprise	VB	O
a	DT	O
contiguous	JJ	O
first	JJ	O
homologous	JJ	O
sequence	NN	O
,	,	O
a	DT	O
degenerate	NN	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
sequence	NN	O
,	,	O
and	CC	O
,	,	O
optionally	RB	O
,	,	O
a	DT	O
second	JJ	O
homologous	JJ	O
sequence	NN	O
.	.	O
The	DT	O
downstream	NN	O
progeny	VBP	O
translational	JJ	O
products	NNS	O
from	IN	O
the	DT	O
use	NN	O
of	IN	O
such	JJ	O
oligonucleotides	NNS	O
include	VBP	O
all	DT	O
possible	JJ	O
amino	NN	O
acid	NN	O
changes	NNS	O
at	IN	O
each	DT	O
amino	NN	O
acid	VBZ	O
site	NN	O
along	IN	O
the	DT	O
polypeptide	NN	O
,	,	O
because	IN	O
the	DT	O
degeneracy	NN	O
of	IN	O
the	DT	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
sequence	NN	O
includes	VBZ	O
codons	NNS	O
for	IN	O
all	DT	O
20	CD	O
amino	NN	O
acids	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
one	CD	O
such	JJ	O
degenerate	NN	O
oligonucleotide	NN	O
(	(	O
comprised	VBN	O
of	IN	O
,	,	O
e.g.	UH	O
,	,	O
one	CD	O
degenerate	NN	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
cassette	NN	O
)	)	O
is	VBZ	O
used	VBN	O
for	IN	O
subjecting	VBG	O
each	DT	O
original	JJ	O
codon	NN	O
in	IN	O
a	DT	O
parental	JJ	O
polynucleotide	NN	O
template	NN	O
to	TO	O
a	DT	O
full	JJ	O
range	NN	O
of	IN	O
codon	JJ	O
substitutions	NNS	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
at	IN	O
least	JJS	O
two	CD	O
degenerate	NN	O
cassettes	NNS	O
are	VBP	O
used—either	RB	O
in	IN	O
the	DT	O
same	JJ	O
oligonucleotide	NN	O
or	CC	O
not	RB	O
,	,	O
for	IN	O
subjecting	VBG	O
at	IN	O
least	JJS	O
two	CD	O
original	JJ	O
codons	NNS	O
in	IN	O
a	DT	O
parental	JJ	O
polynucleotide	NN	O
template	NN	O
to	TO	O
a	DT	O
full	JJ	O
range	NN	O
of	IN	O
codon	JJ	O
substitutions	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
more	JJR	O
than	IN	O
one	CD	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
sequence	NN	O
can	MD	O
be	VB	O
contained	VBN	O
in	IN	O
one	CD	O
oligonucleotide	NN	O
to	TO	O
introduce	VB	O
amino	JJ	O
acid	JJ	O
mutations	NNS	O
at	IN	O
more	JJR	O
than	IN	O
one	CD	O
site	NN	O
.	.	O
This	DT	O
plurality	NN	O
of	IN	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
sequences	NNS	O
can	MD	O
be	VB	O
directly	RB	O
contiguous	JJ	O
,	,	O
or	CC	O
separated	VBN	O
by	IN	O
one	CD	O
or	CC	O
more	JJR	O
additional	JJ	O
nucleotide	NN	O
sequence	NN	O
(	(	O
s	JJ	O
)	)	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
oligonucleotides	VBZ	O
serviceable	JJ	O
for	IN	O
introducing	VBG	O
additions	NNS	O
and	CC	O
deletions	NNS	O
can	MD	O
be	VB	O
used	VBN	O
either	DT	O
alone	RB	O
or	CC	O
in	IN	O
combination	NN	O
with	IN	O
the	DT	O
codons	NNS	O
containing	VBG	O
an	DT	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
sequence	NN	O
,	,	O
to	TO	O
introduce	VB	O
any	DT	O
combination	NN	O
or	CC	O
permutation	NN	O
of	IN	O
amino	NN	O
acid	NN	O
additions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
and/or	JJ	O
substitutions	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
simultaneous	JJ	O
mutagenesis	NN	O
of	IN	O
two	CD	O
or	CC	O
more	JJR	O
contiguous	JJ	O
amino	NN	O
acid	NN	O
positions	NNS	O
is	VBZ	O
done	VBN	O
using	VBG	O
an	DT	O
oligonucleotide	NN	O
that	WDT	O
contains	VBZ	O
contiguous	JJ	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
triplets	NNS	O
,	,	O
i.e	NN	O
.	.	O
a	DT	O
degenerate	NN	O
(	(	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
)	)	O
n	FW	O
sequence	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
degenerate	NN	O
cassettes	NNS	O
having	VBG	O
less	JJR	O
degeneracy	NN	O
than	IN	O
the	DT	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
sequence	NN	O
are	VBP	O
used	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
it	PRP	O
may	MD	O
be	VB	O
desirable	JJ	O
in	IN	O
some	DT	O
instances	NNS	O
to	TO	O
use	VB	O
(	(	O
e.g	NN	O
.	.	O
in	IN	O
an	DT	O
oligonucleotide	NN	O
)	)	O
a	DT	O
degenerate	JJ	O
triplet	NN	O
sequence	NN	O
comprised	VBD	O
of	IN	O
only	RB	O
one	CD	O
N	NNP	O
,	,	O
where	WRB	O
said	VBD	O
N	NNP	O
can	MD	O
be	VB	O
in	IN	O
the	DT	O
first	JJ	O
second	NN	O
or	CC	O
third	JJ	O
position	NN	O
of	IN	O
the	DT	O
triplet	NN	O
.	.	O
Any	DT	O
other	JJ	O
bases	NNS	O
including	VBG	O
any	DT	O
combinations	NNS	O
and	CC	O
permutations	NNS	O
thereof	NNS	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
remaining	VBG	O
two	CD	O
positions	NNS	O
of	IN	O
the	DT	O
triplet	NN	O
.	.	O
Alternatively	RB	O
,	,	O
it	PRP	O
may	MD	O
be	VB	O
desirable	JJ	O
in	IN	O
some	DT	O
instances	NNS	O
to	TO	O
use	VB	O
(	(	O
e.g	NN	O
.	.	O
in	IN	O
an	DT	O
oligo	NN	O
)	)	O
a	DT	O
degenerate	NN	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
N	NNP	O
triplet	NN	O
sequence	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
use	NN	O
of	IN	O
degenerate	NN	O
triplets	NNS	O
(	(	O
e.g.	NN	O
,	,	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
triplets	NNS	O
)	)	O
allows	VBZ	O
for	IN	O
systematic	JJ	O
and	CC	O
easy	JJ	O
generation	NN	O
of	IN	O
a	DT	O
full	JJ	O
range	NN	O
of	IN	O
possible	JJ	O
natural	JJ	O
amino	NN	O
acids	NNS	O
(	(	O
for	IN	O
a	DT	O
total	NN	O
of	IN	O
20	CD	O
amino	JJ	O
acids	NNS	O
)	)	O
into	IN	O
each	DT	O
and	CC	O
every	DT	O
amino	NN	O
acid	JJ	O
position	NN	O
in	IN	O
a	DT	O
polypeptide	NN	O
(	(	O
in	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
methods	NNS	O
also	RB	O
include	VBP	O
generation	NN	O
of	IN	O
less	JJR	O
than	IN	O
all	DT	O
possible	JJ	O
substitutions	NNS	O
per	IN	O
amino	NN	O
acid	NN	O
residue	NN	O
,	,	O
or	CC	O
codon	NN	O
,	,	O
position	NN	O
)	)	O
.	.	O
For	IN	O
example	NN	O
,	,	O
for	IN	O
a	DT	O
100	CD	O
amino	NN	O
acid	NN	O
polypeptide	NN	O
,	,	O
2000	CD	O
distinct	JJ	O
species	NNS	O
(	(	O
i.e	NN	O
.	.	O
20	CD	O
possible	JJ	O
amino	NN	O
acids	NNS	O
per	IN	O
position×100	NN	O
amino	NN	O
acid	IN	O
positions	NNS	O
)	)	O
can	MD	O
be	VB	O
generated	VBN	O
.	.	O
Through	IN	O
the	DT	O
use	NN	O
of	IN	O
an	DT	O
oligonucleotide	NN	O
or	CC	O
set	NN	O
of	IN	O
oligonucleotides	NNS	O
containing	VBG	O
a	DT	O
degenerate	NN	O
N	NNP	O
,	,	O
N	NNP	O
,	,	O
G/T	NNP	O
triplet	NN	O
,	,	O
32	CD	O
individual	JJ	O
sequences	NNS	O
can	MD	O
code	VB	O
for	IN	O
all	DT	O
20	CD	O
possible	JJ	O
natural	JJ	O
amino	NN	O
acids	NNS	O
.	.	O
Thus	RB	O
,	,	O
in	IN	O
a	DT	O
reaction	NN	O
vessel	NN	O
in	IN	O
which	WDT	O
a	DT	O
parental	JJ	O
polynucleotide	NN	O
sequence	NN	O
is	VBZ	O
subjected	VBN	O
to	TO	O
saturation	VB	O
mutagenesis	NN	O
using	VBG	O
at	IN	O
least	JJS	O
one	CD	O
such	JJ	O
oligonucleotide	NN	O
,	,	O
there	EX	O
are	VBP	O
generated	VBN	O
32	CD	O
distinct	JJ	O
progeny	NN	O
polynucleotides	NNS	O
encoding	VBG	O
20	CD	O
distinct	JJ	O
polypeptides	NNS	O
.	.	O
In	IN	O
contrast	NN	O
,	,	O
the	DT	O
use	NN	O
of	IN	O
a	DT	O
non-degenerate	JJ	O
oligonucleotide	NN	O
in	IN	O
site-directed	JJ	O
mutagenesis	NN	O
leads	VBZ	O
to	TO	O
only	RB	O
one	CD	O
progeny	NN	O
polypeptide	JJ	O
product	NN	O
per	IN	O
reaction	NN	O
vessel	NN	O
.	.	O
Nondegenerate	NNP	O
oligonucleotides	NNS	O
can	MD	O
optionally	RB	O
be	VB	O
used	VBN	O
in	IN	O
combination	NN	O
with	IN	O
degenerate	NN	O
primers	NNS	O
disclosed	VBD	O
;	:	O
for	IN	O
example	NN	O
,	,	O
nondegenerate	JJ	O
oligonucleotides	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
generate	VB	O
specific	JJ	O
point	NN	O
mutations	NNS	O
in	IN	O
a	DT	O
working	JJ	O
polynucleotide	NN	O
.	.	O
This	DT	O
provides	VBZ	O
one	CD	O
means	VBZ	O
to	TO	O
generate	VB	O
specific	JJ	O
silent	JJ	O
point	NN	O
mutations	NNS	O
,	,	O
point	NN	O
mutations	NNS	O
leading	VBG	O
to	TO	O
corresponding	VBG	O
amino	JJ	O
acid	NN	O
changes	NNS	O
,	,	O
and	CC	O
point	NN	O
mutations	NNS	O
that	WDT	O
cause	VBP	O
the	DT	O
generation	NN	O
of	IN	O
stop	JJ	O
codons	NNS	O
and	CC	O
the	DT	O
corresponding	JJ	O
expression	NN	O
of	IN	O
polypeptide	NN	O
fragments	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
each	DT	O
saturation	NN	O
mutagenesis	NN	O
reaction	NN	O
vessel	NN	O
contains	VBZ	O
polynucleotides	NNS	O
encoding	VBG	O
at	IN	O
least	JJS	O
20	CD	O
progeny	JJ	O
polypeptide	NN	O
(	(	O
e.g.	JJ	O
,	,	O
amylases	NNS	O
)	)	O
molecules	NNS	O
such	JJ	O
that	IN	O
all	DT	O
20	CD	O
natural	JJ	O
amino	NN	O
acids	NNS	O
are	VBP	O
represented	VBN	O
at	IN	O
the	DT	O
one	CD	O
specific	NN	O
amino	NN	O
acid	JJ	O
position	NN	O
corresponding	VBG	O
to	TO	O
the	DT	O
codon	JJ	O
position	NN	O
mutagenized	VBN	O
in	IN	O
the	DT	O
parental	JJ	O
polynucleotide	NN	O
(	(	O
other	JJ	O
aspects	NNS	O
use	VBP	O
less	JJR	O
than	IN	O
all	DT	O
20	CD	O
natural	JJ	O
combinations	NNS	O
)	)	O
.	.	O
The	DT	O
32-fold	JJ	O
degenerate	NN	O
progeny	NN	O
polypeptides	NNS	O
generated	VBD	O
from	IN	O
each	DT	O
saturation	NN	O
mutagenesis	NN	O
reaction	NN	O
vessel	NN	O
can	MD	O
be	VB	O
subjected	VBN	O
to	TO	O
clonal	JJ	O
amplification	NN	O
(	(	O
e.g	NN	O
.	.	O
cloned	VBN	O
into	IN	O
a	DT	O
suitable	JJ	O
host	NN	O
,	,	O
e.g.	NN	O
,	,	O
E.	NNP	O
coli	VBZ	O
host	NN	O
,	,	O
using	VBG	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
expression	NN	O
vector	NN	O
)	)	O
and	CC	O
subjected	VBN	O
to	TO	O
expression	VB	O
screening	NN	O
.	.	O
When	WRB	O
an	DT	O
individual	JJ	O
progeny	NN	O
polypeptide	NN	O
is	VBZ	O
identified	VBN	O
by	IN	O
screening	VBG	O
to	TO	O
display	VB	O
a	DT	O
favorable	JJ	O
change	NN	O
in	IN	O
property	NN	O
(	(	O
when	WRB	O
compared	VBN	O
to	TO	O
the	DT	O
parental	JJ	O
polypeptide	NN	O
,	,	O
such	JJ	O
as	IN	O
increased	JJ	O
proteolytic	JJ	O
activity	NN	O
under	IN	O
alkaline	NN	O
or	CC	O
acidic	JJ	O
conditions	NNS	O
)	)	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
sequenced	VBN	O
to	TO	O
identify	VB	O
the	DT	O
correspondingly	RB	O
favorable	JJ	O
amino	NN	O
acid	JJ	O
substitution	NN	O
contained	VBD	O
therein	RB	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
upon	IN	O
mutagenizing	VBG	O
each	DT	O
and	CC	O
every	DT	O
amino	NN	O
acid	JJ	O
position	NN	O
in	IN	O
a	DT	O
parental	JJ	O
polypeptide	NN	O
using	VBG	O
saturation	NN	O
mutagenesis	NN	O
as	IN	O
disclosed	JJ	O
herein	NN	O
,	,	O
favorable	JJ	O
amino	NN	O
acid	IN	O
changes	NNS	O
may	MD	O
be	VB	O
identified	VBN	O
at	IN	O
more	JJR	O
than	IN	O
one	CD	O
amino	NN	O
acid	JJ	O
position	NN	O
.	.	O
One	CD	O
or	CC	O
more	JJR	O
new	JJ	O
progeny	NN	O
molecules	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
that	DT	O
contain	VBP	O
a	DT	O
combination	NN	O
of	IN	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
these	DT	O
favorable	JJ	O
amino	NN	O
acid	JJ	O
substitutions	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
if	IN	O
2	CD	O
specific	JJ	O
favorable	JJ	O
amino	NN	O
acid	NN	O
changes	NNS	O
are	VBP	O
identified	VBN	O
in	IN	O
each	DT	O
of	IN	O
3	CD	O
amino	JJ	O
acid	NN	O
positions	NNS	O
in	IN	O
a	DT	O
polypeptide	NN	O
,	,	O
the	DT	O
permutations	NNS	O
include	VBP	O
3	CD	O
possibilities	NNS	O
at	IN	O
each	DT	O
position	NN	O
(	(	O
no	DT	O
change	NN	O
from	IN	O
the	DT	O
original	JJ	O
amino	NN	O
acid	NN	O
,	,	O
and	CC	O
each	DT	O
of	IN	O
two	CD	O
favorable	JJ	O
changes	NNS	O
)	)	O
and	CC	O
3	CD	O
positions	NNS	O
.	.	O
Thus	RB	O
,	,	O
there	EX	O
are	VBP	O
3×3×3	CD	O
or	CC	O
27	CD	O
total	JJ	O
possibilities	NNS	O
,	,	O
including	VBG	O
7	CD	O
that	WDT	O
were	VBD	O
previously	RB	O
examined—6	JJ	O
single	JJ	O
point	NN	O
mutations	NNS	O
(	(	O
i.e	NN	O
.	.	O
2	CD	O
at	IN	O
each	DT	O
of	IN	O
three	CD	O
positions	NNS	O
)	)	O
and	CC	O
no	DT	O
change	NN	O
at	IN	O
any	DT	O
position	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
site-saturation	JJ	O
mutagenesis	NN	O
can	MD	O
be	VB	O
used	VBN	O
together	RB	O
with	IN	O
another	DT	O
stochastic	JJ	O
or	CC	O
non-stochastic	JJ	O
means	NNS	O
to	TO	O
vary	JJ	O
sequence	NN	O
,	,	O
e.g.	NN	O
,	,	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
(	(	O
see	VB	O
below	IN	O
)	)	O
,	,	O
shuffling	VBG	O
,	,	O
chimerization	NN	O
,	,	O
recombination	NN	O
and	CC	O
other	JJ	O
mutagenizing	NN	O
processes	NNS	O
and	CC	O
mutagenizing	VBG	O
agents	NNS	O
.	.	O
This	DT	O
invention	NN	O
provides	VBZ	O
for	IN	O
the	DT	O
use	NN	O
of	IN	O
any	DT	O
mutagenizing	JJ	O
process	NN	O
(	(	O
es	NN	O
)	)	O
,	,	O
including	VBG	O
saturation	NN	O
mutagenesis	NN	O
,	,	O
in	IN	O
an	DT	O
iterative	JJ	O
manner	NN	O
.	.	O
Synthetic	JJ	O
Ligation	NNP	O
Reassembly	NNP	O
(	(	O
SLR	NNP	O
)	)	O
The	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
non-stochastic	JJ	O
gene	NN	O
modification	NN	O
system	NN	O
termed	VBD	O
“	NNP	O
synthetic	JJ	O
ligation	NN	O
reassembly	RB	O
,	,	O
”	''	O
or	CC	O
simply	RB	O
“	JJ	O
SLR	NNP	O
,	,	O
”	VBZ	O
a	DT	O
“	NN	O
directed	VBN	O
evolution	NN	O
process	NN	O
,	,	O
”	NN	O
to	TO	O
generate	VB	O
polypeptides	NNS	O
,	,	O
e.g.	NN	O
,	,	O
amylases	VBZ	O
or	CC	O
antibodies	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
with	IN	O
new	JJ	O
or	CC	O
altered	JJ	O
properties	NNS	O
.	.	O
SLR	NNP	O
is	VBZ	O
a	DT	O
method	NN	O
of	IN	O
ligating	VBG	O
oligonucleotide	JJ	O
fragments	NNS	O
together	RB	O
non-stochastically	RB	O
.	.	O
This	DT	O
method	NN	O
differs	NNS	O
from	IN	O
stochastic	JJ	O
oligonucleotide	NN	O
shuffling	VBG	O
in	IN	O
that	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
are	VBP	O
not	RB	O
shuffled	VBN	O
,	,	O
concatenated	VBD	O
or	CC	O
chimerized	VBD	O
randomly	RB	O
,	,	O
but	CC	O
rather	RB	O
are	VBP	O
assembled	VBN	O
non-stochastically	RB	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
patent	NN	O
application	NN	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/332,835	CD	O
entitled	VBN	O
“	NNP	O
Synthetic	NNP	O
Ligation	NNP	O
Reassembly	NNP	O
in	IN	O
Directed	NNP	O
Evolution	NNP	O
”	NNP	O
and	CC	O
filed	VBN	O
on	IN	O
Jun	NNP	O
.	.	O
14	CD	O
,	,	O
1999	CD	O
(	(	O
“	JJ	O
U.S	NNP	O
.	.	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/332,835	CD	O
”	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
SLR	NNP	O
comprises	VBZ	O
the	DT	O
following	JJ	O
steps	NNS	O
:	:	O
(	(	O
a	DT	O
)	)	O
providing	VBG	O
a	DT	O
template	JJ	O
polynucleotide	NN	O
,	,	O
wherein	VBP	O
the	DT	O
template	NN	O
polynucleotide	NN	O
comprises	VBZ	O
sequence	NN	O
encoding	VBG	O
a	DT	O
homologous	JJ	O
gene	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
providing	VBG	O
a	DT	O
plurality	NN	O
of	IN	O
building	NN	O
block	NN	O
polynucleotides	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
building	NN	O
block	NN	O
polynucleotides	NNS	O
are	VBP	O
designed	VBN	O
to	TO	O
cross-over	VB	O
reassemble	JJ	O
with	IN	O
the	DT	O
template	NN	O
polynucleotide	NN	O
at	IN	O
a	DT	O
predetermined	JJ	O
sequence	NN	O
,	,	O
and	CC	O
a	DT	O
building	NN	O
block	NN	O
polynucleotide	NN	O
comprises	VBZ	O
a	DT	O
sequence	NN	O
that	WDT	O
is	VBZ	O
a	DT	O
variant	NN	O
of	IN	O
the	DT	O
homologous	JJ	O
gene	NN	O
and	CC	O
a	DT	O
sequence	NN	O
homologous	JJ	O
to	TO	O
the	DT	O
template	NN	O
polynucleotide	NN	O
flanking	VBG	O
the	DT	O
variant	JJ	O
sequence	NN	O
;	:	O
(	(	O
c	NN	O
)	)	O
combining	VBG	O
a	DT	O
building	NN	O
block	NN	O
polynucleotide	NN	O
with	IN	O
a	DT	O
template	JJ	O
polynucleotide	NN	O
such	JJ	O
that	IN	O
the	DT	O
building	NN	O
block	NN	O
polynucleotide	IN	O
cross-over	NN	O
reassembles	NNS	O
with	IN	O
the	DT	O
template	NN	O
polynucleotide	NN	O
to	TO	O
generate	VB	O
polynucleotides	NNS	O
comprising	VBG	O
homologous	JJ	O
gene	NN	O
sequence	NN	O
variations	NNS	O
.	.	O
SLR	NN	O
does	VBZ	O
not	RB	O
depend	VB	O
on	IN	O
the	DT	O
presence	NN	O
of	IN	O
high	JJ	O
levels	NNS	O
of	IN	O
homology	NN	O
between	IN	O
polynucleotides	NNS	O
to	TO	O
be	VB	O
rearranged	VBN	O
.	.	O
Thus	RB	O
,	,	O
this	DT	O
method	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
non-stochastically	RB	O
generate	VB	O
libraries	NNS	O
(	(	O
or	CC	O
sets	NNS	O
)	)	O
of	IN	O
progeny	NN	O
molecules	NNS	O
comprised	VBN	O
of	IN	O
over	IN	O
10100	CD	O
different	JJ	O
chimeras	NNS	O
.	.	O
SLR	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
generate	VB	O
libraries	NNS	O
comprised	VBN	O
of	IN	O
over	IN	O
101000	CD	O
different	JJ	O
progeny	NN	O
chimeras	NNS	O
.	.	O
Thus	RB	O
,	,	O
aspects	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
include	VBP	O
non-stochastic	JJ	O
methods	NNS	O
of	IN	O
producing	VBG	O
a	DT	O
set	NN	O
of	IN	O
finalized	JJ	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
molecule	NN	O
shaving	VBG	O
an	DT	O
overall	JJ	O
assembly	NN	O
order	NN	O
that	WDT	O
is	VBZ	O
chosen	VBN	O
by	IN	O
design	NN	O
.	.	O
This	DT	O
method	NN	O
includes	VBZ	O
the	DT	O
steps	NNS	O
of	IN	O
generating	VBG	O
by	IN	O
design	NN	O
a	DT	O
plurality	NN	O
of	IN	O
specific	JJ	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
having	VBG	O
serviceable	JJ	O
mutually	RB	O
compatible	JJ	O
ligatable	JJ	O
ends	NNS	O
,	,	O
and	CC	O
assembling	VBG	O
these	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
,	,	O
such	JJ	O
that	IN	O
a	DT	O
designed	VBN	O
overall	JJ	O
assembly	NN	O
order	NN	O
is	VBZ	O
achieved	VBN	O
.	.	O
The	DT	O
mutually	RB	O
compatible	JJ	O
ligatable	JJ	O
ends	NNS	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
to	TO	O
be	VB	O
assembled	VBN	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
“	JJ	O
serviceable	JJ	O
”	NN	O
for	IN	O
this	DT	O
type	NN	O
of	IN	O
ordered	VBN	O
assembly	NN	O
if	IN	O
they	PRP	O
enable	VBP	O
the	DT	O
building	NN	O
blocks	NNS	O
to	TO	O
be	VB	O
coupled	VBN	O
in	IN	O
predetermined	JJ	O
orders	NNS	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
overall	JJ	O
assembly	NN	O
order	NN	O
in	IN	O
which	WDT	O
the	DT	O
nucleic	NN	O
acid	NN	O
building	NN	O
blocks	NNS	O
can	MD	O
be	VB	O
coupled	VBN	O
is	VBZ	O
specified	VBN	O
by	IN	O
the	DT	O
design	NN	O
of	IN	O
the	DT	O
ligatable	JJ	O
ends	NNS	O
.	.	O
If	IN	O
more	JJR	O
than	IN	O
one	CD	O
assembly	JJ	O
step	NN	O
is	VBZ	O
to	TO	O
be	VB	O
used	VBN	O
,	,	O
then	RB	O
the	DT	O
overall	JJ	O
assembly	NN	O
order	NN	O
in	IN	O
which	WDT	O
the	DT	O
nucleic	NN	O
acid	NN	O
building	NN	O
blocks	NNS	O
can	MD	O
be	VB	O
coupled	VBN	O
is	VBZ	O
also	RB	O
specified	VBN	O
by	IN	O
the	DT	O
sequential	JJ	O
order	NN	O
of	IN	O
the	DT	O
assembly	JJ	O
step	NN	O
(	(	O
s	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
annealed	JJ	O
building	NN	O
pieces	NNS	O
are	VBP	O
treated	VBN	O
with	IN	O
an	DT	O
enzyme	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
ligase	NN	O
(	(	O
e.g	NN	O
.	.	O
T4	NNP	O
DNA	NNP	O
ligase	NN	O
)	)	O
,	,	O
to	TO	O
achieve	VB	O
covalent	NN	O
bonding	NN	O
of	IN	O
the	DT	O
building	NN	O
pieces	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
design	NN	O
of	IN	O
the	DT	O
oligonucleotide	NN	O
building	NN	O
blocks	NNS	O
is	VBZ	O
obtained	VBN	O
by	IN	O
analyzing	VBG	O
a	DT	O
set	NN	O
of	IN	O
progenitor	NN	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
templates	NNS	O
that	WDT	O
serve	VBP	O
as	IN	O
a	DT	O
basis	NN	O
for	IN	O
producing	VBG	O
a	DT	O
progeny	NN	O
set	NN	O
of	IN	O
finalized	JJ	O
chimeric	JJ	O
polynucleotides	NNS	O
.	.	O
These	DT	O
parental	JJ	O
oligonucleotide	NN	O
templates	VBZ	O
thus	RB	O
serve	VBN	O
as	IN	O
a	DT	O
source	NN	O
of	IN	O
sequence	NN	O
information	NN	O
that	WDT	O
aids	VBZ	O
in	IN	O
the	DT	O
design	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
that	WDT	O
are	VBP	O
to	TO	O
be	VB	O
mutagenized	VBN	O
,	,	O
e.g.	FW	O
,	,	O
chimerized	VBD	O
or	CC	O
shuffled	VBD	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
this	DT	O
method	NN	O
,	,	O
the	DT	O
sequences	NNS	O
of	IN	O
a	DT	O
plurality	NN	O
of	IN	O
parental	JJ	O
nucleic	JJ	O
acid	NN	O
templates	NNS	O
are	VBP	O
aligned	VBN	O
in	IN	O
order	NN	O
to	TO	O
select	VB	O
one	CD	O
or	CC	O
more	JJR	O
demarcation	NN	O
points	NNS	O
.	.	O
The	DT	O
demarcation	NN	O
points	NNS	O
can	MD	O
be	VB	O
located	VBN	O
at	IN	O
an	DT	O
area	NN	O
of	IN	O
homology	NN	O
,	,	O
and	CC	O
are	VBP	O
comprised	VBN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
.	.	O
These	DT	O
demarcation	NN	O
points	NNS	O
are	VBP	O
preferably	RB	O
shared	VBN	O
by	IN	O
at	IN	O
least	JJS	O
two	CD	O
of	IN	O
the	DT	O
progenitor	NN	O
templates	VBZ	O
.	.	O
The	DT	O
demarcation	NN	O
points	NNS	O
can	MD	O
thereby	RB	O
be	VB	O
used	VBN	O
to	TO	O
delineate	VB	O
the	DT	O
boundaries	NNS	O
of	IN	O
oligonucleotide	JJ	O
building	NN	O
blocks	NNS	O
to	TO	O
be	VB	O
generated	VBN	O
in	IN	O
order	NN	O
to	TO	O
rearrange	VB	O
the	DT	O
parental	JJ	O
polynucleotides	NNS	O
.	.	O
The	DT	O
demarcation	NN	O
points	NNS	O
identified	VBN	O
and	CC	O
selected	VBN	O
in	IN	O
the	DT	O
progenitor	NN	O
molecules	VBZ	O
serve	VBP	O
as	IN	O
potential	JJ	O
chimerization	NN	O
points	NNS	O
in	IN	O
the	DT	O
assembly	NN	O
of	IN	O
the	DT	O
final	JJ	O
chimeric	NN	O
progeny	NN	O
molecules	NNS	O
.	.	O
A	DT	O
demarcation	NN	O
point	NN	O
can	MD	O
be	VB	O
an	DT	O
area	NN	O
of	IN	O
homology	NN	O
(	(	O
comprised	VBN	O
of	IN	O
at	IN	O
least	JJS	O
one	CD	O
homologous	JJ	O
nucleotide	IN	O
base	NN	O
)	)	O
shared	VBN	O
by	IN	O
at	IN	O
least	JJS	O
two	CD	O
parental	JJ	O
polynucleotide	NN	O
sequences	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
a	DT	O
demarcation	NN	O
point	NN	O
can	MD	O
be	VB	O
an	DT	O
area	NN	O
of	IN	O
homology	NN	O
that	WDT	O
is	VBZ	O
shared	VBN	O
by	IN	O
at	IN	O
least	JJS	O
half	NN	O
of	IN	O
the	DT	O
parental	JJ	O
polynucleotide	NN	O
sequences	NNS	O
,	,	O
or	CC	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
an	DT	O
area	NN	O
of	IN	O
homology	NN	O
that	WDT	O
is	VBZ	O
shared	VBN	O
by	IN	O
at	IN	O
least	JJS	O
two	CD	O
thirds	NNS	O
of	IN	O
the	DT	O
parental	JJ	O
polynucleotide	NN	O
sequences	NNS	O
.	.	O
Even	RB	O
more	RBR	O
preferably	RB	O
a	DT	O
serviceable	JJ	O
demarcation	NN	O
points	NNS	O
is	VBZ	O
an	DT	O
area	NN	O
of	IN	O
homology	NN	O
that	WDT	O
is	VBZ	O
shared	VBN	O
by	IN	O
at	IN	O
least	JJS	O
three	CD	O
fourths	NNS	O
of	IN	O
the	DT	O
parental	JJ	O
polynucleotide	NN	O
sequences	NNS	O
,	,	O
or	CC	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
shared	VBN	O
by	IN	O
at	IN	O
almost	RB	O
all	DT	O
of	IN	O
the	DT	O
parental	JJ	O
polynucleotide	NN	O
sequences	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
demarcation	NN	O
point	NN	O
is	VBZ	O
an	DT	O
area	NN	O
of	IN	O
homology	NN	O
that	WDT	O
is	VBZ	O
shared	VBN	O
by	IN	O
all	DT	O
of	IN	O
the	DT	O
parental	JJ	O
polynucleotide	NN	O
sequences	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
ligation	NN	O
reassembly	RB	O
process	NN	O
is	VBZ	O
performed	VBN	O
exhaustively	RB	O
in	IN	O
order	NN	O
to	TO	O
generate	VB	O
an	DT	O
exhaustive	JJ	O
library	NN	O
of	IN	O
progeny	NN	O
chimeric	JJ	O
polynucleotides	NNS	O
.	.	O
In	IN	O
other	JJ	O
words	NNS	O
,	,	O
all	DT	O
possible	JJ	O
ordered	JJ	O
combinations	NNS	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
are	VBP	O
represented	VBN	O
in	IN	O
the	DT	O
set	NN	O
of	IN	O
finalized	JJ	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
molecules	NNS	O
.	.	O
At	IN	O
the	DT	O
same	JJ	O
time	NN	O
,	,	O
in	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
assembly	NN	O
order	NN	O
(	(	O
i.e	NN	O
.	.	O
the	DT	O
order	NN	O
of	IN	O
assembly	NN	O
of	IN	O
each	DT	O
building	NN	O
block	NN	O
in	IN	O
the	DT	O
5′	CD	O
to	TO	O
3	CD	O
sequence	NN	O
of	IN	O
each	DT	O
finalized	VBN	O
chimeric	NN	O
nucleic	JJ	O
acid	NN	O
)	)	O
in	IN	O
each	DT	O
combination	NN	O
is	VBZ	O
by	IN	O
design	NN	O
(	(	O
or	CC	O
non-stochastic	JJ	O
)	)	O
as	IN	O
described	VBN	O
above	IN	O
.	.	O
Because	IN	O
of	IN	O
the	DT	O
non-stochastic	JJ	O
nature	NN	O
of	IN	O
this	DT	O
invention	NN	O
,	,	O
the	DT	O
possibility	NN	O
of	IN	O
unwanted	JJ	O
side	NN	O
products	NNS	O
is	VBZ	O
greatly	RB	O
reduced	VBN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
ligation	NN	O
reassembly	RB	O
method	NN	O
is	VBZ	O
performed	VBN	O
systematically	RB	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
method	NN	O
is	VBZ	O
performed	VBN	O
in	IN	O
order	NN	O
to	TO	O
generate	VB	O
a	DT	O
systematically	RB	O
compartmentalized	JJ	O
library	NN	O
of	IN	O
progeny	NN	O
molecules	NNS	O
,	,	O
with	IN	O
compartments	NNS	O
that	WDT	O
can	MD	O
be	VB	O
screened	VBN	O
systematically	RB	O
,	,	O
e.g	NN	O
.	.	O
one	CD	O
by	IN	O
one	CD	O
.	.	O
In	IN	O
other	JJ	O
words	NNS	O
this	DT	O
invention	NN	O
provides	VBZ	O
that	IN	O
,	,	O
through	IN	O
the	DT	O
selective	JJ	O
and	CC	O
judicious	JJ	O
use	NN	O
of	IN	O
specific	JJ	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
,	,	O
coupled	VBN	O
with	IN	O
the	DT	O
selective	JJ	O
and	CC	O
judicious	JJ	O
use	NN	O
of	IN	O
sequentially	RB	O
stepped	VBN	O
assembly	NN	O
reactions	NNS	O
,	,	O
a	DT	O
design	NN	O
can	MD	O
be	VB	O
achieved	VBN	O
where	WRB	O
specific	JJ	O
sets	NNS	O
of	IN	O
progeny	NN	O
products	NNS	O
are	VBP	O
made	VBN	O
in	IN	O
each	DT	O
of	IN	O
several	JJ	O
reaction	NN	O
vessels	NNS	O
.	.	O
This	DT	O
allows	VBZ	O
a	DT	O
systematic	JJ	O
examination	NN	O
and	CC	O
screening	JJ	O
procedure	NN	O
to	TO	O
be	VB	O
performed	VBN	O
.	.	O
Thus	RB	O
,	,	O
these	DT	O
methods	NNS	O
allow	VBP	O
a	DT	O
potentially	RB	O
very	RB	O
large	JJ	O
number	NN	O
of	IN	O
progeny	JJ	O
molecules	NNS	O
to	TO	O
be	VB	O
examined	VBN	O
systematically	RB	O
in	IN	O
smaller	JJR	O
groups	NNS	O
.	.	O
Because	IN	O
of	IN	O
its	PRP$	O
ability	NN	O
to	TO	O
perform	VB	O
chimerizations	NNS	O
in	IN	O
a	DT	O
manner	NN	O
that	WDT	O
is	VBZ	O
highly	RB	O
flexible	JJ	O
yet	RB	O
exhaustive	JJ	O
and	CC	O
systematic	JJ	O
as	RB	O
well	RB	O
,	,	O
particularly	RB	O
when	WRB	O
there	EX	O
is	VBZ	O
a	DT	O
low	JJ	O
level	NN	O
of	IN	O
homology	NN	O
among	IN	O
the	DT	O
progenitor	NN	O
molecules	NNS	O
,	,	O
these	DT	O
methods	NNS	O
provide	VBP	O
for	IN	O
the	DT	O
generation	NN	O
of	IN	O
a	DT	O
library	JJ	O
(	(	O
or	CC	O
set	VBN	O
)	)	O
comprised	VBD	O
of	IN	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
progeny	JJ	O
molecules	NNS	O
.	.	O
Because	IN	O
of	IN	O
the	DT	O
non-stochastic	JJ	O
nature	NN	O
of	IN	O
the	DT	O
instant	JJ	O
ligation	NN	O
reassembly	RB	O
invention	NN	O
,	,	O
the	DT	O
progeny	NN	O
molecules	NNS	O
generated	VBD	O
preferably	RB	O
comprise	VB	O
a	DT	O
library	NN	O
of	IN	O
finalized	JJ	O
chimeric	JJ	O
nucleic	NN	O
acid	NN	O
molecules	NNS	O
having	VBG	O
an	DT	O
overall	JJ	O
assembly	NN	O
order	NN	O
that	WDT	O
is	VBZ	O
chosen	VBN	O
by	IN	O
design	NN	O
.	.	O
The	DT	O
saturation	NN	O
mutagenesis	NN	O
and	CC	O
optimized	VBN	O
directed	JJ	O
evolution	NN	O
methods	NNS	O
also	RB	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
generate	VB	O
different	JJ	O
progeny	NNS	O
molecular	JJ	O
species	NNS	O
.	.	O
It	PRP	O
is	VBZ	O
appreciated	VBN	O
that	IN	O
the	DT	O
invention	NN	O
provides	VBZ	O
freedom	NN	O
of	IN	O
choice	NN	O
and	CC	O
control	NN	O
regarding	VBG	O
the	DT	O
selection	NN	O
of	IN	O
demarcation	NN	O
points	NNS	O
,	,	O
the	DT	O
size	NN	O
and	CC	O
number	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
,	,	O
and	CC	O
the	DT	O
size	NN	O
and	CC	O
design	NN	O
of	IN	O
the	DT	O
couplings	NNS	O
.	.	O
It	PRP	O
is	VBZ	O
appreciated	VBN	O
,	,	O
furthermore	RB	O
,	,	O
that	IN	O
the	DT	O
requirement	NN	O
for	IN	O
intermolecular	JJ	O
homology	NN	O
is	VBZ	O
highly	RB	O
relaxed	VBN	O
for	IN	O
the	DT	O
operability	NN	O
of	IN	O
this	DT	O
invention	NN	O
.	.	O
In	IN	O
fact	NN	O
,	,	O
demarcation	NN	O
points	NNS	O
can	MD	O
even	RB	O
be	VB	O
chosen	VBN	O
in	IN	O
areas	NNS	O
of	IN	O
little	JJ	O
or	CC	O
no	DT	O
intermolecular	JJ	O
homology	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
because	IN	O
of	IN	O
codon	NN	O
wobble	JJ	O
,	,	O
i.e	NN	O
.	.	O
the	DT	O
degeneracy	NN	O
of	IN	O
codons	NNS	O
,	,	O
nucleotide	JJ	O
substitutions	NNS	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
nucleic	JJ	O
acid	NN	O
building	NN	O
blocks	NNS	O
without	IN	O
altering	VBG	O
the	DT	O
amino	NN	O
acid	VBZ	O
originally	RB	O
encoded	VBN	O
in	IN	O
the	DT	O
corresponding	JJ	O
progenitor	NN	O
template	NN	O
.	.	O
Alternatively	RB	O
,	,	O
a	DT	O
codon	NN	O
can	MD	O
be	VB	O
altered	VBN	O
such	JJ	O
that	IN	O
the	DT	O
coding	NN	O
for	IN	O
an	DT	O
originally	RB	O
amino	JJ	O
acid	NN	O
is	VBZ	O
altered	VBN	O
.	.	O
This	DT	O
invention	NN	O
provides	VBZ	O
that	IN	O
such	JJ	O
substitutions	NNS	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
block	NN	O
in	IN	O
order	NN	O
to	TO	O
increase	VB	O
the	DT	O
incidence	NN	O
of	IN	O
intermolecular	JJ	O
homologous	JJ	O
demarcation	NN	O
points	NNS	O
and	CC	O
thus	RB	O
to	TO	O
allow	VB	O
an	DT	O
increased	JJ	O
number	NN	O
of	IN	O
couplings	NNS	O
to	TO	O
be	VB	O
achieved	VBN	O
among	IN	O
the	DT	O
building	NN	O
blocks	NNS	O
,	,	O
which	WDT	O
in	IN	O
turn	NN	O
allows	VBZ	O
a	DT	O
greater	JJR	O
number	NN	O
of	IN	O
progeny	JJ	O
chimeric	JJ	O
molecules	NNS	O
to	TO	O
be	VB	O
generated	VBN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
synthetic	JJ	O
nature	NN	O
of	IN	O
the	DT	O
step	NN	O
in	IN	O
which	WDT	O
the	DT	O
building	NN	O
blocks	NNS	O
are	VBP	O
generated	VBN	O
allows	IN	O
the	DT	O
design	NN	O
and	CC	O
introduction	NN	O
of	IN	O
nucleotides	NNS	O
(	(	O
e.g.	NN	O
,	,	O
one	CD	O
or	CC	O
more	JJR	O
nucleotides	NNS	O
,	,	O
which	WDT	O
may	MD	O
be	VB	O
,	,	O
for	IN	O
example	NN	O
,	,	O
codons	NNS	O
or	CC	O
introns	NNS	O
or	CC	O
regulatory	JJ	O
sequences	NNS	O
)	)	O
that	WDT	O
can	MD	O
later	RB	O
be	VB	O
optionally	RB	O
removed	VBN	O
in	IN	O
an	DT	O
in	IN	O
vitro	NN	O
process	NN	O
(	(	O
e.g	NN	O
.	.	O
by	IN	O
mutagenesis	NN	O
)	)	O
or	CC	O
in	IN	O
an	DT	O
in	IN	O
vivo	NN	O
process	NN	O
(	(	O
e.g	NN	O
.	.	O
by	IN	O
utilizing	VBG	O
the	DT	O
gene	NN	O
splicing	VBG	O
ability	NN	O
of	IN	O
a	DT	O
host	NN	O
organism	NN	O
)	)	O
.	.	O
It	PRP	O
is	VBZ	O
appreciated	VBN	O
that	IN	O
in	IN	O
many	JJ	O
instances	NNS	O
the	DT	O
introduction	NN	O
of	IN	O
these	DT	O
nucleotides	NNS	O
may	MD	O
also	RB	O
be	VB	O
desirable	JJ	O
for	IN	O
many	JJ	O
other	JJ	O
reasons	NNS	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	O
potential	JJ	O
benefit	NN	O
of	IN	O
creating	VBG	O
a	DT	O
serviceable	JJ	O
demarcation	NN	O
point	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
nucleic	JJ	O
acid	NN	O
building	NN	O
block	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
introduce	VB	O
an	DT	O
intron	NN	O
.	.	O
Thus	RB	O
,	,	O
functional	JJ	O
introns	NNS	O
are	VBP	O
introduced	VBN	O
into	IN	O
a	DT	O
man-made	JJ	O
gene	NN	O
manufactured	VBD	O
according	VBG	O
to	TO	O
the	DT	O
methods	NNS	O
described	VBD	O
herein	NN	O
.	.	O
The	DT	O
artificially	RB	O
introduced	VBN	O
intron	NN	O
(	(	O
s	PRP	O
)	)	O
can	MD	O
be	VB	O
functional	JJ	O
in	IN	O
a	DT	O
host	NN	O
cells	NNS	O
for	IN	O
gene	NN	O
splicing	VBG	O
much	JJ	O
in	IN	O
the	DT	O
way	NN	O
that	IN	O
naturally-occurring	JJ	O
introns	NNS	O
serve	VBP	O
functionally	RB	O
in	IN	O
gene	NN	O
splicing	NN	O
.	.	O
Optimized	VBN	O
Directed	NNP	O
Evolution	NNP	O
System	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
non-stochastic	JJ	O
gene	NN	O
modification	NN	O
system	NN	O
termed	VBD	O
“	NNP	O
optimized	VBD	O
directed	VBN	O
evolution	NN	O
system	NN	O
”	VBZ	O
to	TO	O
generate	VB	O
polypeptides	NNS	O
,	,	O
e.g.	NN	O
,	,	O
amylases	VBZ	O
or	CC	O
antibodies	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
with	IN	O
new	JJ	O
or	CC	O
altered	JJ	O
properties	NNS	O
.	.	O
Optimized	VBN	O
directed	JJ	O
evolution	NN	O
is	VBZ	O
directed	VBN	O
to	TO	O
the	DT	O
use	NN	O
of	IN	O
repeated	JJ	O
cycles	NNS	O
of	IN	O
reductive	JJ	O
reassortment	NN	O
,	,	O
recombination	NN	O
and	CC	O
selection	NN	O
that	WDT	O
allow	VBP	O
for	IN	O
the	DT	O
directed	JJ	O
molecular	JJ	O
evolution	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
through	IN	O
recombination	NN	O
.	.	O
Optimized	VBN	O
directed	JJ	O
evolution	NN	O
allows	VBZ	O
generation	NN	O
of	IN	O
a	DT	O
large	JJ	O
population	NN	O
of	IN	O
evolved	JJ	O
chimeric	JJ	O
sequences	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
generated	JJ	O
population	NN	O
is	VBZ	O
significantly	RB	O
enriched	VBN	O
for	IN	O
sequences	NNS	O
that	WDT	O
have	VBP	O
a	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
A	DT	O
crossover	NN	O
event	NN	O
is	VBZ	O
a	DT	O
point	NN	O
in	IN	O
a	DT	O
chimeric	JJ	O
sequence	NN	O
where	WRB	O
a	DT	O
shift	NN	O
in	IN	O
sequence	NN	O
occurs	NNS	O
from	IN	O
one	CD	O
parental	NN	O
variant	NN	O
to	TO	O
another	DT	O
parental	JJ	O
variant	NN	O
.	.	O
Such	JJ	O
a	DT	O
point	NN	O
is	VBZ	O
normally	RB	O
at	IN	O
the	DT	O
juncture	NN	O
of	IN	O
where	WRB	O
oligonucleotides	NNS	O
from	IN	O
two	CD	O
parents	NNS	O
are	VBP	O
ligated	VBN	O
together	RB	O
to	TO	O
form	VB	O
a	DT	O
single	JJ	O
sequence	NN	O
.	.	O
This	DT	O
method	NN	O
allows	VBZ	O
calculation	NN	O
of	IN	O
the	DT	O
correct	JJ	O
concentrations	NNS	O
of	IN	O
oligonucleotide	JJ	O
sequences	NNS	O
so	RB	O
that	IN	O
the	DT	O
final	JJ	O
chimeric	JJ	O
population	NN	O
of	IN	O
sequences	NNS	O
is	VBZ	O
enriched	VBN	O
for	IN	O
the	DT	O
chosen	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
This	DT	O
provides	VBZ	O
more	JJR	O
control	NN	O
over	IN	O
choosing	VBG	O
chimeric	JJ	O
variants	NNS	O
having	VBG	O
a	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
this	DT	O
method	NN	O
provides	VBZ	O
a	DT	O
convenient	NN	O
means	VBZ	O
for	IN	O
exploring	VBG	O
a	DT	O
tremendous	JJ	O
amount	NN	O
of	IN	O
the	DT	O
possible	JJ	O
protein	NN	O
variant	JJ	O
space	NN	O
in	IN	O
comparison	NN	O
to	TO	O
other	JJ	O
systems	NNS	O
.	.	O
Previously	RB	O
,	,	O
if	IN	O
one	CD	O
generated	VBD	O
,	,	O
for	IN	O
example	NN	O
,	,	O
1013	CD	O
chimeric	JJ	O
molecules	NNS	O
during	IN	O
a	DT	O
reaction	NN	O
,	,	O
it	PRP	O
would	MD	O
be	VB	O
extremely	RB	O
difficult	JJ	O
to	TO	O
test	VB	O
such	PDT	O
a	DT	O
high	JJ	O
number	NN	O
of	IN	O
chimeric	JJ	O
variants	NNS	O
for	IN	O
a	DT	O
particular	JJ	O
activity	NN	O
.	.	O
Moreover	RB	O
,	,	O
a	DT	O
significant	JJ	O
portion	NN	O
of	IN	O
the	DT	O
progeny	JJ	O
population	NN	O
would	MD	O
have	VB	O
a	DT	O
very	RB	O
high	JJ	O
number	NN	O
of	IN	O
crossover	NN	O
events	NNS	O
which	WDT	O
resulted	VBD	O
in	IN	O
proteins	NNS	O
that	WDT	O
were	VBD	O
less	RBR	O
likely	JJ	O
to	TO	O
have	VB	O
increased	VBN	O
levels	NNS	O
of	IN	O
a	DT	O
particular	JJ	O
activity	NN	O
.	.	O
By	IN	O
using	VBG	O
these	DT	O
methods	NNS	O
,	,	O
the	DT	O
population	NN	O
of	IN	O
chimerics	NNS	O
molecules	NNS	O
can	MD	O
be	VB	O
enriched	VBN	O
for	IN	O
those	DT	O
variants	NNS	O
that	WDT	O
have	VBP	O
a	DT	O
particular	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
Thus	RB	O
,	,	O
although	IN	O
one	CD	O
can	MD	O
still	RB	O
generate	VB	O
1013	CD	O
chimeric	JJ	O
molecules	NNS	O
during	IN	O
a	DT	O
reaction	NN	O
,	,	O
each	DT	O
of	IN	O
the	DT	O
molecules	NNS	O
chosen	VBN	O
for	IN	O
further	JJ	O
analysis	NN	O
most	RBS	O
likely	JJ	O
has	VBZ	O
,	,	O
for	IN	O
example	NN	O
,	,	O
only	RB	O
three	CD	O
crossover	NN	O
events	NNS	O
.	.	O
Because	IN	O
the	DT	O
resulting	VBG	O
progeny	JJ	O
population	NN	O
can	MD	O
be	VB	O
skewed	VBN	O
to	TO	O
have	VB	O
a	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
,	,	O
the	DT	O
boundaries	NNS	O
on	IN	O
the	DT	O
functional	JJ	O
variety	NN	O
between	IN	O
the	DT	O
chimeric	JJ	O
molecules	NNS	O
is	VBZ	O
reduced	VBN	O
.	.	O
This	DT	O
provides	VBZ	O
a	DT	O
more	RBR	O
manageable	JJ	O
number	NN	O
of	IN	O
variables	NNS	O
when	WRB	O
calculating	VBG	O
which	WDT	O
oligonucleotide	RB	O
from	IN	O
the	DT	O
original	JJ	O
parental	JJ	O
polynucleotides	NNS	O
might	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
affecting	VBG	O
a	DT	O
particular	JJ	O
trait	NN	O
.	.	O
One	CD	O
method	NN	O
for	IN	O
creating	VBG	O
a	DT	O
chimeric	JJ	O
progeny	NN	O
polynucleotide	NN	O
sequence	NN	O
is	VBZ	O
to	TO	O
create	VB	O
oligonucleotides	NNS	O
corresponding	VBG	O
to	TO	O
fragments	NNS	O
or	CC	O
portions	NNS	O
of	IN	O
each	DT	O
parental	JJ	O
sequence	NN	O
.	.	O
Each	DT	O
oligonucleotide	NN	O
preferably	RB	O
includes	VBZ	O
a	DT	O
unique	JJ	O
region	NN	O
of	IN	O
overlap	NNS	O
so	IN	O
that	IN	O
mixing	VBG	O
the	DT	O
oligonucleotides	NNS	O
together	RB	O
results	NNS	O
in	IN	O
a	DT	O
new	JJ	O
variant	NN	O
that	WDT	O
has	VBZ	O
each	DT	O
oligonucleotide	JJ	O
fragment	NN	O
assembled	VBN	O
in	IN	O
the	DT	O
correct	JJ	O
order	NN	O
.	.	O
Additional	JJ	O
information	NN	O
can	MD	O
also	RB	O
be	VB	O
found	VBN	O
,	,	O
e.g.	FW	O
,	,	O
in	IN	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/332,835	CD	O
;	:	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,361,974	CD	O
.	.	O
The	DT	O
number	NN	O
of	IN	O
oligonucleotides	NNS	O
generated	VBN	O
for	IN	O
each	DT	O
parental	JJ	O
variant	NN	O
bears	VBZ	O
a	DT	O
relationship	NN	O
to	TO	O
the	DT	O
total	JJ	O
number	NN	O
of	IN	O
resulting	VBG	O
crossovers	NNS	O
in	IN	O
the	DT	O
chimeric	JJ	O
molecule	NN	O
that	WDT	O
is	VBZ	O
ultimately	RB	O
created	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
three	CD	O
parental	JJ	O
nucleotide	RB	O
sequence	NN	O
variants	NNS	O
might	MD	O
be	VB	O
provided	VBN	O
to	TO	O
undergo	VB	O
a	DT	O
ligation	NN	O
reaction	NN	O
in	IN	O
order	NN	O
to	TO	O
find	VB	O
a	DT	O
chimeric	JJ	O
variant	NN	O
having	VBG	O
,	,	O
for	IN	O
example	NN	O
,	,	O
greater	JJR	O
activity	NN	O
at	IN	O
high	JJ	O
temperature	NN	O
.	.	O
As	IN	O
one	CD	O
example	NN	O
,	,	O
a	DT	O
set	NN	O
of	IN	O
50	CD	O
oligonucleotide	JJ	O
sequences	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
corresponding	VBG	O
to	TO	O
each	DT	O
portions	NNS	O
of	IN	O
each	DT	O
parental	JJ	O
variant	NN	O
.	.	O
Accordingly	RB	O
,	,	O
during	IN	O
the	DT	O
ligation	NN	O
reassembly	RB	O
process	NN	O
there	EX	O
could	MD	O
be	VB	O
up	RB	O
to	TO	O
50	CD	O
crossover	NN	O
events	NNS	O
within	IN	O
each	DT	O
of	IN	O
the	DT	O
chimeric	JJ	O
sequences	NNS	O
.	.	O
The	DT	O
probability	NN	O
that	IN	O
each	DT	O
of	IN	O
the	DT	O
generated	JJ	O
chimeric	NN	O
polynucleotides	NNS	O
will	MD	O
contain	VB	O
oligonucleotides	NNS	O
from	IN	O
each	DT	O
parental	JJ	O
variant	NN	O
in	IN	O
alternating	VBG	O
order	NN	O
is	VBZ	O
very	RB	O
low	JJ	O
.	.	O
If	IN	O
each	DT	O
oligonucleotide	NN	O
fragment	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
the	DT	O
ligation	NN	O
reaction	NN	O
in	IN	O
the	DT	O
same	JJ	O
molar	JJ	O
quantity	NN	O
it	PRP	O
is	VBZ	O
likely	JJ	O
that	IN	O
in	IN	O
some	DT	O
positions	NNS	O
oligonucleotides	IN	O
from	IN	O
the	DT	O
same	JJ	O
parental	JJ	O
polynucleotide	NN	O
will	MD	O
ligate	VB	O
next	JJ	O
to	TO	O
one	CD	O
another	DT	O
and	CC	O
thus	RB	O
not	RB	O
result	VB	O
in	IN	O
a	DT	O
crossover	NN	O
event	NN	O
.	.	O
If	IN	O
the	DT	O
concentration	NN	O
of	IN	O
each	DT	O
oligonucleotide	NN	O
from	IN	O
each	DT	O
parent	NN	O
is	VBZ	O
kept	JJ	O
constant	JJ	O
during	IN	O
any	DT	O
ligation	JJ	O
step	NN	O
in	IN	O
this	DT	O
example	NN	O
,	,	O
there	EX	O
is	VBZ	O
a	DT	O
1/3	JJ	O
chance	NN	O
(	(	O
assuming	VBG	O
3	CD	O
parents	NNS	O
)	)	O
that	IN	O
an	DT	O
oligonucleotide	NN	O
from	IN	O
the	DT	O
same	JJ	O
parental	JJ	O
variant	NN	O
will	MD	O
ligate	VB	O
within	IN	O
the	DT	O
chimeric	JJ	O
sequence	NN	O
and	CC	O
produce	VB	O
no	DT	O
crossover	NN	O
.	.	O
Accordingly	RB	O
,	,	O
a	DT	O
probability	NN	O
density	NN	O
function	NN	O
(	(	O
PDF	NNP	O
)	)	O
can	MD	O
be	VB	O
determined	VBN	O
to	TO	O
predict	VB	O
the	DT	O
population	NN	O
of	IN	O
crossover	NN	O
events	NNS	O
that	WDT	O
are	VBP	O
likely	JJ	O
to	TO	O
occur	VB	O
during	IN	O
each	DT	O
step	NN	O
in	IN	O
a	DT	O
ligation	NN	O
reaction	NN	O
given	VBN	O
a	DT	O
set	NN	O
number	NN	O
of	IN	O
parental	JJ	O
variants	NNS	O
,	,	O
a	DT	O
number	NN	O
of	IN	O
oligonucleotides	NNS	O
corresponding	VBG	O
to	TO	O
each	DT	O
variant	NN	O
,	,	O
and	CC	O
the	DT	O
concentrations	NNS	O
of	IN	O
each	DT	O
variant	NN	O
during	IN	O
each	DT	O
step	NN	O
in	IN	O
the	DT	O
ligation	NN	O
reaction	NN	O
.	.	O
The	DT	O
statistics	NNS	O
and	CC	O
mathematics	NNS	O
behind	IN	O
determining	VBG	O
the	DT	O
PDF	NNP	O
is	VBZ	O
described	VBN	O
below	IN	O
.	.	O
By	IN	O
utilizing	VBG	O
these	DT	O
methods	NNS	O
,	,	O
one	CD	O
can	MD	O
calculate	VB	O
such	JJ	O
a	DT	O
probability	NN	O
density	NN	O
function	NN	O
,	,	O
and	CC	O
thus	RB	O
enrich	VB	O
the	DT	O
chimeric	JJ	O
progeny	NN	O
population	NN	O
for	IN	O
a	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
resulting	VBG	O
from	IN	O
a	DT	O
particular	JJ	O
ligation	NN	O
reaction	NN	O
.	.	O
Moreover	RB	O
,	,	O
a	DT	O
target	NN	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
can	MD	O
be	VB	O
predetermined	VBN	O
,	,	O
and	CC	O
the	DT	O
system	NN	O
then	RB	O
programmed	VBD	O
to	TO	O
calculate	VB	O
the	DT	O
starting	VBG	O
quantities	NNS	O
of	IN	O
each	DT	O
parental	JJ	O
oligonucleotide	NN	O
during	IN	O
each	DT	O
step	NN	O
in	IN	O
the	DT	O
ligation	NN	O
reaction	NN	O
to	TO	O
result	VB	O
in	IN	O
a	DT	O
probability	NN	O
density	NN	O
function	NN	O
that	WDT	O
centers	VBZ	O
on	IN	O
the	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
These	DT	O
methods	NNS	O
are	VBP	O
directed	VBN	O
to	TO	O
the	DT	O
use	NN	O
of	IN	O
repeated	JJ	O
cycles	NNS	O
of	IN	O
reductive	JJ	O
reassortment	NN	O
,	,	O
recombination	NN	O
and	CC	O
selection	NN	O
that	WDT	O
allow	VBP	O
for	IN	O
the	DT	O
directed	JJ	O
molecular	JJ	O
evolution	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
through	IN	O
recombination	NN	O
.	.	O
This	DT	O
system	NN	O
allows	VBZ	O
generation	NN	O
of	IN	O
a	DT	O
large	JJ	O
population	NN	O
of	IN	O
evolved	JJ	O
chimeric	JJ	O
sequences	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
generated	JJ	O
population	NN	O
is	VBZ	O
significantly	RB	O
enriched	VBN	O
for	IN	O
sequences	NNS	O
that	WDT	O
have	VBP	O
a	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
A	DT	O
crossover	NN	O
event	NN	O
is	VBZ	O
a	DT	O
point	NN	O
in	IN	O
a	DT	O
chimeric	JJ	O
sequence	NN	O
where	WRB	O
a	DT	O
shift	NN	O
in	IN	O
sequence	NN	O
occurs	NNS	O
from	IN	O
one	CD	O
parental	NN	O
variant	NN	O
to	TO	O
another	DT	O
parental	JJ	O
variant	NN	O
.	.	O
Such	JJ	O
a	DT	O
point	NN	O
is	VBZ	O
normally	RB	O
at	IN	O
the	DT	O
juncture	NN	O
of	IN	O
where	WRB	O
oligonucleotides	NNS	O
from	IN	O
two	CD	O
parents	NNS	O
are	VBP	O
ligated	VBN	O
together	RB	O
to	TO	O
form	VB	O
a	DT	O
single	JJ	O
sequence	NN	O
.	.	O
The	DT	O
method	NN	O
allows	VBZ	O
calculation	NN	O
of	IN	O
the	DT	O
correct	JJ	O
concentrations	NNS	O
of	IN	O
oligonucleotide	JJ	O
sequences	NNS	O
so	RB	O
that	IN	O
the	DT	O
final	JJ	O
chimeric	JJ	O
population	NN	O
of	IN	O
sequences	NNS	O
is	VBZ	O
enriched	VBN	O
for	IN	O
the	DT	O
chosen	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
This	DT	O
provides	VBZ	O
more	JJR	O
control	NN	O
over	IN	O
choosing	VBG	O
chimeric	JJ	O
variants	NNS	O
having	VBG	O
a	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
these	DT	O
methods	NNS	O
provide	VBP	O
a	DT	O
convenient	NN	O
means	VBZ	O
for	IN	O
exploring	VBG	O
a	DT	O
tremendous	JJ	O
amount	NN	O
of	IN	O
the	DT	O
possible	JJ	O
protein	NN	O
variant	JJ	O
space	NN	O
in	IN	O
comparison	NN	O
to	TO	O
other	JJ	O
systems	NNS	O
.	.	O
By	IN	O
using	VBG	O
the	DT	O
methods	NNS	O
described	VBD	O
herein	RB	O
,	,	O
the	DT	O
population	NN	O
of	IN	O
chimerics	NNS	O
molecules	NNS	O
can	MD	O
be	VB	O
enriched	VBN	O
for	IN	O
those	DT	O
variants	NNS	O
that	WDT	O
have	VBP	O
a	DT	O
particular	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
.	.	O
Thus	RB	O
,	,	O
although	IN	O
one	CD	O
can	MD	O
still	RB	O
generate	VB	O
1013	CD	O
chimeric	JJ	O
molecules	NNS	O
during	IN	O
a	DT	O
reaction	NN	O
,	,	O
each	DT	O
of	IN	O
the	DT	O
molecules	NNS	O
chosen	VBN	O
for	IN	O
further	JJ	O
analysis	NN	O
most	RBS	O
likely	JJ	O
has	VBZ	O
,	,	O
for	IN	O
example	NN	O
,	,	O
only	RB	O
three	CD	O
crossover	NN	O
events	NNS	O
.	.	O
Because	IN	O
the	DT	O
resulting	VBG	O
progeny	JJ	O
population	NN	O
can	MD	O
be	VB	O
skewed	VBN	O
to	TO	O
have	VB	O
a	DT	O
predetermined	JJ	O
number	NN	O
of	IN	O
crossover	JJ	O
events	NNS	O
,	,	O
the	DT	O
boundaries	NNS	O
on	IN	O
the	DT	O
functional	JJ	O
variety	NN	O
between	IN	O
the	DT	O
chimeric	JJ	O
molecules	NNS	O
is	VBZ	O
reduced	VBN	O
.	.	O
This	DT	O
provides	VBZ	O
a	DT	O
more	RBR	O
manageable	JJ	O
number	NN	O
of	IN	O
variables	NNS	O
when	WRB	O
calculating	VBG	O
which	WDT	O
oligonucleotide	RB	O
from	IN	O
the	DT	O
original	JJ	O
parental	JJ	O
polynucleotides	NNS	O
might	MD	O
be	VB	O
responsible	JJ	O
for	IN	O
affecting	VBG	O
a	DT	O
particular	JJ	O
trait	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
method	NN	O
creates	VBZ	O
a	DT	O
chimeric	JJ	O
progeny	NN	O
polynucleotide	NN	O
sequence	NN	O
by	IN	O
creating	VBG	O
oligonucleotides	NNS	O
corresponding	VBG	O
to	TO	O
fragments	NNS	O
or	CC	O
portions	NNS	O
of	IN	O
each	DT	O
parental	JJ	O
sequence	NN	O
.	.	O
Each	DT	O
oligonucleotide	NN	O
preferably	RB	O
includes	VBZ	O
a	DT	O
unique	JJ	O
region	NN	O
of	IN	O
overlap	NNS	O
so	IN	O
that	IN	O
mixing	VBG	O
the	DT	O
oligonucleotides	NNS	O
together	RB	O
results	NNS	O
in	IN	O
a	DT	O
new	JJ	O
variant	NN	O
that	WDT	O
has	VBZ	O
each	DT	O
oligonucleotide	JJ	O
fragment	NN	O
assembled	VBN	O
in	IN	O
the	DT	O
correct	JJ	O
order	NN	O
.	.	O
See	NNP	O
also	RB	O
U.S.	NNP	O
Ser	NNP	O
.	.	O
No	DT	O
.	.	O
09/332,835	CD	O
.	.	O
Determining	VBG	O
Crossover	NNP	O
Events	NNP	O
Aspects	NNP	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
a	DT	O
system	NN	O
and	CC	O
software	NN	O
that	WDT	O
receive	VBP	O
a	DT	O
desired	JJ	O
crossover	NN	O
probability	NN	O
density	NN	O
function	NN	O
(	(	O
PDF	NNP	O
)	)	O
,	,	O
the	DT	O
number	NN	O
of	IN	O
parent	NN	O
genes	NNS	O
to	TO	O
be	VB	O
reassembled	VBN	O
,	,	O
and	CC	O
the	DT	O
number	NN	O
of	IN	O
fragments	NNS	O
in	IN	O
the	DT	O
reassembly	NN	O
as	IN	O
inputs	NNS	O
.	.	O
The	DT	O
output	NN	O
of	IN	O
this	DT	O
program	NN	O
is	VBZ	O
a	DT	O
“	JJ	O
fragment	NN	O
PDF	NNP	O
”	VBZ	O
that	IN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
determine	VB	O
a	DT	O
recipe	NN	O
for	IN	O
producing	VBG	O
reassembled	VBN	O
genes	NNS	O
,	,	O
and	CC	O
the	DT	O
estimated	VBN	O
crossover	NN	O
PDF	NNP	O
of	IN	O
those	DT	O
genes	NNS	O
.	.	O
The	DT	O
processing	NN	O
described	JJ	O
herein	NN	O
is	VBZ	O
preferably	RB	O
performed	VBN	O
in	IN	O
MATLAB™	NNP	O
(	(	O
The	DT	O
Mathworks	NNP	O
,	,	O
Natick	NNP	O
,	,	O
Mass	NNP	O
.	.	O
)	)	O
a	DT	O
programming	JJ	O
language	NN	O
and	CC	O
development	NN	O
environment	NN	O
for	IN	O
technical	JJ	O
computing	NN	O
.	.	O
Iterative	JJ	O
Processes	NNS	O
In	IN	O
practicing	VBG	O
the	DT	O
invention	NN	O
,	,	O
these	DT	O
processes	NNS	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
nucleic	JJ	O
acid	NN	O
(	(	O
or	CC	O
,	,	O
the	DT	O
nucleic	JJ	O
acid	NN	O
)	)	O
responsible	JJ	O
for	IN	O
an	DT	O
altered	JJ	O
or	CC	O
new	JJ	O
amylase	NN	O
phenotype	NN	O
is	VBZ	O
identified	VBN	O
,	,	O
re-isolated	JJ	O
,	,	O
again	RB	O
modified	VBN	O
,	,	O
re-tested	JJ	O
for	IN	O
activity	NN	O
.	.	O
This	DT	O
process	NN	O
can	MD	O
be	VB	O
iteratively	RB	O
repeated	VBN	O
until	IN	O
a	DT	O
desired	JJ	O
phenotype	NN	O
is	VBZ	O
engineered	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
an	DT	O
entire	JJ	O
biochemical	JJ	O
anabolic	NN	O
or	CC	O
catabolic	JJ	O
pathway	NN	O
can	MD	O
be	VB	O
engineered	VBN	O
into	IN	O
a	DT	O
cell	NN	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
starch	JJ	O
hydrolysis	NN	O
activity	NN	O
.	.	O
Similarly	RB	O
,	,	O
if	IN	O
it	PRP	O
is	VBZ	O
determined	VBN	O
that	IN	O
a	DT	O
particular	JJ	O
oligonucleotide	NN	O
has	VBZ	O
no	DT	O
affect	NN	O
at	IN	O
all	DT	O
on	IN	O
the	DT	O
desired	JJ	O
trait	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
new	JJ	O
amylase	NN	O
phenotype	NN	O
)	)	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
removed	VBN	O
as	IN	O
a	DT	O
variable	JJ	O
by	IN	O
synthesizing	VBG	O
larger	JJR	O
parental	JJ	O
oligonucleotides	NNS	O
that	WDT	O
include	VBP	O
the	DT	O
sequence	NN	O
to	TO	O
be	VB	O
removed	VBN	O
.	.	O
Since	IN	O
incorporating	VBG	O
the	DT	O
sequence	NN	O
within	IN	O
a	DT	O
larger	JJR	O
sequence	NN	O
prevents	NNS	O
any	DT	O
crossover	NN	O
events	NNS	O
,	,	O
there	EX	O
will	MD	O
no	RB	O
longer	RB	O
be	VB	O
any	DT	O
variation	NN	O
of	IN	O
this	DT	O
sequence	NN	O
in	IN	O
the	DT	O
progeny	NN	O
polynucleotides	NNS	O
.	.	O
This	DT	O
iterative	JJ	O
practice	NN	O
of	IN	O
determining	VBG	O
which	WDT	O
oligonucleotides	NNS	O
are	VBP	O
most	RBS	O
related	JJ	O
to	TO	O
the	DT	O
desired	JJ	O
trait	NN	O
,	,	O
and	CC	O
which	WDT	O
are	VBP	O
unrelated	JJ	O
,	,	O
allows	VBZ	O
more	RBR	O
efficient	JJ	O
exploration	NN	O
all	DT	O
of	IN	O
the	DT	O
possible	JJ	O
protein	NN	O
variants	NNS	O
that	WDT	O
might	MD	O
be	VB	O
provide	VB	O
a	DT	O
particular	JJ	O
trait	NN	O
or	CC	O
activity	NN	O
.	.	O
In	IN	O
Vivo	NNP	O
Shuffling	NNP	O
In	IN	O
vivo	JJ	O
shuffling	NN	O
of	IN	O
molecules	NNS	O
is	VBZ	O
use	NN	O
in	IN	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
that	WDT	O
provide	VBP	O
variants	NNS	O
of	IN	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
antibodies	NNS	O
,	,	O
amylases	NNS	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
In	IN	O
vivo	JJ	O
shuffling	NN	O
can	MD	O
be	VB	O
performed	VBN	O
utilizing	VBG	O
the	DT	O
natural	JJ	O
property	NN	O
of	IN	O
cells	NNS	O
to	TO	O
recombine	VB	O
multimers	NNS	O
.	.	O
While	IN	O
recombination	NN	O
in	IN	O
vivo	NN	O
has	VBZ	O
provided	VBN	O
the	DT	O
major	JJ	O
natural	JJ	O
route	NN	O
to	TO	O
molecular	JJ	O
diversity	NN	O
,	,	O
genetic	JJ	O
recombination	NN	O
remains	VBZ	O
a	DT	O
relatively	RB	O
complex	JJ	O
process	NN	O
that	WDT	O
involves	VBZ	O
1	CD	O
)	)	O
the	DT	O
recognition	NN	O
of	IN	O
homologies	NNS	O
;	:	O
2	CD	O
)	)	O
strand	NN	O
cleavage	NN	O
,	,	O
strand	NN	O
invasion	NN	O
,	,	O
and	CC	O
metabolic	JJ	O
steps	NNS	O
leading	VBG	O
to	TO	O
the	DT	O
production	NN	O
of	IN	O
recombinant	JJ	O
chiasma	NN	O
;	:	O
and	CC	O
finally	RB	O
3	CD	O
)	)	O
the	DT	O
resolution	NN	O
of	IN	O
chiasma	NN	O
into	IN	O
discrete	JJ	O
recombined	VBN	O
molecules	NNS	O
.	.	O
The	DT	O
formation	NN	O
of	IN	O
the	DT	O
chiasma	NN	O
requires	VBZ	O
the	DT	O
recognition	NN	O
of	IN	O
homologous	JJ	O
sequences	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
producing	VBG	O
a	DT	O
hybrid	JJ	O
polynucleotide	NN	O
from	IN	O
at	IN	O
least	JJS	O
a	DT	O
first	JJ	O
polynucleotide	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
and	CC	O
a	DT	O
second	JJ	O
polynucleotide	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
enzyme	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
any	DT	O
other	JJ	O
amylase	NN	O
,	,	O
or	CC	O
,	,	O
a	DT	O
tag	NN	O
or	CC	O
an	DT	O
epitope	NN	O
)	)	O
.	.	O
The	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
produce	VB	O
a	DT	O
hybrid	JJ	O
polynucleotide	NN	O
by	IN	O
introducing	VBG	O
at	IN	O
least	JJS	O
a	DT	O
first	JJ	O
polynucleotide	NN	O
and	CC	O
a	DT	O
second	JJ	O
polynucleotide	NN	O
which	WDT	O
share	NN	O
at	IN	O
least	JJS	O
one	CD	O
region	NN	O
of	IN	O
partial	JJ	O
sequence	NN	O
homology	NN	O
into	IN	O
a	DT	O
suitable	JJ	O
host	NN	O
cell	NN	O
.	.	O
The	DT	O
regions	NNS	O
of	IN	O
partial	JJ	O
sequence	NN	O
homology	NN	O
promote	NN	O
processes	VBZ	O
which	WDT	O
result	NN	O
in	IN	O
sequence	NN	O
reorganization	NN	O
producing	VBG	O
a	DT	O
hybrid	JJ	O
polynucleotide	NN	O
.	.	O
The	DT	O
term	NN	O
“	NNP	O
hybrid	JJ	O
polynucleotide	NN	O
”	NN	O
,	,	O
as	IN	O
used	VBN	O
herein	NN	O
,	,	O
is	VBZ	O
any	DT	O
nucleotide	JJ	O
sequence	NN	O
which	WDT	O
results	NNS	O
from	IN	O
the	DT	O
method	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
and	CC	O
contains	NNS	O
sequence	NN	O
from	IN	O
at	IN	O
least	JJS	O
two	CD	O
original	JJ	O
polynucleotide	NN	O
sequences	NNS	O
.	.	O
Such	JJ	O
hybrid	JJ	O
polynucleotides	NNS	O
can	MD	O
result	VB	O
from	IN	O
intermolecular	JJ	O
recombination	NN	O
events	NNS	O
which	WDT	O
promote	VBP	O
sequence	NN	O
integration	NN	O
between	IN	O
DNA	NNP	O
molecules	NNS	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
such	JJ	O
hybrid	JJ	O
polynucleotides	NNS	O
can	MD	O
result	VB	O
from	IN	O
intramolecular	JJ	O
reductive	JJ	O
reassortment	NN	O
processes	VBZ	O
which	WDT	O
utilize	RB	O
repeated	VBD	O
sequences	NNS	O
to	TO	O
alter	VB	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
within	IN	O
a	DT	O
DNA	NN	O
molecule	NN	O
.	.	O
Producing	VBG	O
Sequence	NN	O
Variants	VBZ	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
additional	JJ	O
methods	NNS	O
for	IN	O
making	VBG	O
sequence	JJ	O
variants	NNS	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
(	(	O
e.g.	JJ	O
,	,	O
amylase	NN	O
)	)	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
additional	JJ	O
methods	NNS	O
for	IN	O
isolating	VBG	O
amylases	NNS	O
using	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
and	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
for	IN	O
variants	NNS	O
of	IN	O
an	DT	O
amylase	NN	O
coding	VBG	O
sequence	NN	O
(	(	O
e.g.	JJ	O
,	,	O
a	DT	O
gene	NN	O
,	,	O
cDNA	NN	O
or	CC	O
message	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
altered	VBN	O
by	IN	O
any	DT	O
means	NNS	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
random	NN	O
or	CC	O
stochastic	JJ	O
methods	NNS	O
,	,	O
or	CC	O
,	,	O
non-stochastic	JJ	O
,	,	O
or	CC	O
“	RB	O
directed	JJ	O
evolution	NN	O
,	,	O
”	NNP	O
methods	NNS	O
,	,	O
as	IN	O
described	VBN	O
above	IN	O
.	.	O
The	DT	O
isolated	JJ	O
variants	NNS	O
may	MD	O
be	VB	O
naturally	RB	O
occurring	VBG	O
.	.	O
Variant	NN	O
can	MD	O
also	RB	O
be	VB	O
created	VBN	O
in	IN	O
vitro	NN	O
.	.	O
Variants	NNS	O
may	MD	O
be	VB	O
created	VBN	O
using	VBG	O
genetic	JJ	O
engineering	NN	O
techniques	NNS	O
such	JJ	O
as	IN	O
site	NN	O
directed	VBN	O
mutagenesis	NN	O
,	,	O
random	JJ	O
chemical	NN	O
mutagenesis	NN	O
,	,	O
Exonuclease	NNP	O
III	NNP	O
deletion	NN	O
procedures	NNS	O
,	,	O
and	CC	O
standard	JJ	O
cloning	NN	O
techniques	NNS	O
.	.	O
Alternatively	RB	O
,	,	O
such	JJ	O
variants	NNS	O
,	,	O
fragments	NNS	O
,	,	O
analogs	NNS	O
,	,	O
or	CC	O
derivatives	NNS	O
may	MD	O
be	VB	O
created	VBN	O
using	VBG	O
chemical	JJ	O
synthesis	NN	O
or	CC	O
modification	NN	O
procedures	NNS	O
.	.	O
Other	JJ	O
methods	NNS	O
of	IN	O
making	VBG	O
variants	NNS	O
are	VBP	O
also	RB	O
familiar	JJ	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
These	DT	O
include	VBP	O
procedures	NNS	O
in	IN	O
which	WDT	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
obtained	VBN	O
from	IN	O
natural	JJ	O
isolates	NNS	O
are	VBP	O
modified	VBN	O
to	TO	O
generate	VB	O
nucleic	JJ	O
acids	NNS	O
which	WDT	O
encode	VBP	O
polypeptides	NNS	O
having	VBG	O
characteristics	NNS	O
which	WDT	O
enhance	VBP	O
their	PRP$	O
value	NN	O
in	IN	O
industrial	JJ	O
or	CC	O
laboratory	JJ	O
applications	NNS	O
.	.	O
In	IN	O
such	JJ	O
procedures	NNS	O
,	,	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
variant	JJ	O
sequences	NNS	O
having	VBG	O
one	CD	O
or	CC	O
more	JJR	O
nucleotide	JJ	O
differences	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
sequence	NN	O
obtained	VBN	O
from	IN	O
the	DT	O
natural	JJ	O
isolate	NN	O
are	VBP	O
generated	VBN	O
and	CC	O
characterized	VBN	O
.	.	O
These	DT	O
nucleotide	JJ	O
differences	NNS	O
can	MD	O
result	VB	O
in	IN	O
amino	NN	O
acid	NN	O
changes	NNS	O
with	IN	O
respect	NN	O
to	TO	O
the	DT	O
polypeptides	NNS	O
encoded	VBN	O
by	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
from	IN	O
the	DT	O
natural	JJ	O
isolates	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
variants	NNS	O
may	MD	O
be	VB	O
created	VBN	O
using	VBG	O
error	NN	O
prone	NN	O
PCR	NNP	O
.	.	O
In	IN	O
error	NN	O
prone	NN	O
PCR	NNP	O
,	,	O
PCR	NNP	O
is	VBZ	O
performed	VBN	O
under	IN	O
conditions	NNS	O
where	WRB	O
the	DT	O
copying	NN	O
fidelity	NN	O
of	IN	O
the	DT	O
DNA	NNP	O
polymerase	NN	O
is	VBZ	O
low	JJ	O
,	,	O
such	JJ	O
that	IN	O
a	DT	O
high	JJ	O
rate	NN	O
of	IN	O
point	NN	O
mutations	NNS	O
is	VBZ	O
obtained	VBN	O
along	IN	O
the	DT	O
entire	JJ	O
length	NN	O
of	IN	O
the	DT	O
PCR	NNP	O
product	NN	O
.	.	O
Error	NNP	O
prone	NN	O
PCR	NNP	O
is	VBZ	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Leung	NNP	B
,	,	I
D.	NNP	I
W.	NNP	I
,	,	I
et	FW	I
al.	NN	I
,	,	I
Technique	NNP	I
,	,	I
1:11-15	CD	I
,	,	I
1989	CD	I
)	)	O
and	CC	O
Caldwell	NNP	B
,	,	I
R.	NNP	I
C.	NNP	I
&	CC	I
Joyce	NNP	I
G.	NNP	I
F.	NNP	I
,	,	I
PCR	NNP	I
Methods	NNP	I
Applic.	NNP	I
,	,	I
2:28-33	CD	I
,	,	I
1992	CD	I
.	.	O
Briefly	NNP	O
,	,	O
in	IN	O
such	JJ	O
procedures	NNS	O
,	,	O
nucleic	JJ	O
acids	NNS	O
to	TO	O
be	VB	O
mutagenized	VBN	O
are	VBP	O
mixed	JJ	O
with	IN	O
PCR	NNP	O
primers	NNS	O
,	,	O
reaction	NN	O
buffer	NN	O
,	,	O
MgCl2	NNP	O
,	,	O
MnCl2	NNP	O
,	,	O
Taq	NNP	O
polymerase	NN	O
and	CC	O
an	DT	O
appropriate	JJ	O
concentration	NN	O
of	IN	O
dNTPs	NN	O
for	IN	O
achieving	VBG	O
a	DT	O
high	JJ	O
rate	NN	O
of	IN	O
point	NN	O
mutation	NN	O
along	IN	O
the	DT	O
entire	JJ	O
length	NN	O
of	IN	O
the	DT	O
PCR	NNP	O
product	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
reaction	NN	O
may	MD	O
be	VB	O
performed	VBN	O
using	VBG	O
20	CD	O
fmoles	NNS	O
of	IN	O
nucleic	JJ	O
acid	NN	O
to	TO	O
be	VB	O
mutagenized	VBN	O
,	,	O
30	CD	O
pmole	NN	O
of	IN	O
each	DT	O
PCR	NNP	O
primer	NN	O
,	,	O
a	DT	O
reaction	NN	O
buffer	NN	O
comprising	VBG	O
50	CD	O
mM	JJ	O
KCl	NNP	O
,	,	O
10	CD	O
mM	NN	O
Tris	NNP	O
HCl	NNP	O
(	(	O
pH	VB	O
8.3	CD	O
)	)	O
and	CC	O
0.01	CD	O
%	NN	O
gelatin	NN	O
,	,	O
7	CD	O
mM	NN	O
MgCl2	NNP	O
,	,	O
0.5	CD	O
mM	NN	O
MnCl2	NNP	O
,	,	O
5	CD	O
units	NNS	O
of	IN	O
Taq	NNP	O
polymerase	NN	O
,	,	O
0.2	CD	O
mM	NN	O
dGTP	NN	O
,	,	O
0.2	CD	O
mM	NN	O
dATP	NN	O
,	,	O
1	CD	O
mM	NN	O
dCTP	NN	O
,	,	O
and	CC	O
1	CD	O
mM	NN	O
dTTP	NN	O
.	.	O
PCR	NN	O
may	MD	O
be	VB	O
performed	VBN	O
for	IN	O
30	CD	O
cycles	NNS	O
of	IN	O
94°	CD	O
C.	NNP	O
for	IN	O
1	CD	O
min	NN	O
,	,	O
45°	CD	O
C.	NNP	O
for	IN	O
1	CD	O
min	NN	O
,	,	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
1	CD	O
min	NN	O
.	.	O
However	RB	O
,	,	O
it	PRP	O
will	MD	O
be	VB	O
appreciated	VBN	O
that	IN	O
these	DT	O
parameters	NNS	O
may	MD	O
be	VB	O
varied	VBN	O
as	IN	O
appropriate	NN	O
.	.	O
The	DT	O
mutagenized	JJ	O
nucleic	JJ	O
acids	NNS	O
are	VBP	O
cloned	VBN	O
into	IN	O
an	DT	O
appropriate	JJ	O
vector	NN	O
and	CC	O
the	DT	O
activities	NNS	O
of	IN	O
the	DT	O
polypeptides	NNS	O
encoded	VBN	O
by	IN	O
the	DT	O
mutagenized	JJ	O
nucleic	JJ	O
acids	NNS	O
is	VBZ	O
evaluated	VBN	O
.	.	O
Variants	NNS	O
may	MD	O
also	RB	O
be	VB	O
created	VBN	O
using	VBG	O
oligonucleotide	RB	O
directed	VBN	O
mutagenesis	NN	O
to	TO	O
generate	VB	O
site-specific	JJ	O
mutations	NNS	O
in	IN	O
any	DT	O
cloned	JJ	O
DNA	NN	O
of	IN	O
interest	NN	O
.	.	O
Oligonucleotide	IN	O
mutagenesis	NN	O
is	VBZ	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Reidhaar-Olson	NNP	B
(	(	I
1988	CD	I
)	)	I
Science	NNP	I
241:53-57	CD	I
.	.	O
Briefly	NNP	O
,	,	O
in	IN	O
such	JJ	O
procedures	NNS	O
a	DT	O
plurality	NN	O
of	IN	O
double	JJ	O
stranded	JJ	O
oligonucleotides	NNS	O
bearing	VBG	O
one	CD	O
or	CC	O
more	JJR	O
mutations	NNS	O
to	TO	O
be	VB	O
introduced	VBN	O
into	IN	O
the	DT	O
cloned	VBN	O
DNA	NN	O
are	VBP	O
synthesized	VBN	O
and	CC	O
inserted	VBN	O
into	IN	O
the	DT	O
cloned	JJ	O
DNA	NN	O
to	TO	O
be	VB	O
mutagenized	VBN	O
.	.	O
Clones	NNS	O
containing	VBG	O
the	DT	O
mutagenized	VBN	O
DNA	NN	O
are	VBP	O
recovered	VBN	O
and	CC	O
the	DT	O
activities	NNS	O
of	IN	O
the	DT	O
polypeptides	NNS	O
they	PRP	O
encode	VBP	O
are	VBP	O
assessed	VBN	O
.	.	O
Another	DT	O
method	NN	O
for	IN	O
generating	VBG	O
variants	NNS	O
is	VBZ	O
assembly	RB	O
PCR	NNP	O
.	.	O
Assembly	RB	O
PCR	NNP	O
involves	VBZ	O
the	DT	O
assembly	NN	O
of	IN	O
a	DT	O
PCR	NNP	O
product	NN	O
from	IN	O
a	DT	O
mixture	NN	O
of	IN	O
small	JJ	O
DNA	NNP	O
fragments	NNS	O
.	.	O
A	DT	O
large	JJ	O
number	NN	O
of	IN	O
different	JJ	O
PCR	NNP	O
reactions	NNS	O
occur	VBP	O
in	IN	O
parallel	NN	O
in	IN	O
the	DT	O
same	JJ	O
vial	NN	O
,	,	O
with	IN	O
the	DT	O
products	NNS	O
of	IN	O
one	CD	O
reaction	NN	O
priming	VBG	O
the	DT	O
products	NNS	O
of	IN	O
another	DT	O
reaction	NN	O
.	.	O
Assembly	RB	O
PCR	NNP	O
is	VBZ	O
described	VBN	O
in	IN	O
,	,	O
e.g.	NN	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,965,408	CD	O
.	.	O
Still	RB	O
another	DT	O
method	NN	O
of	IN	O
generating	VBG	O
variants	NNS	O
is	VBZ	O
sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
.	.	O
In	IN	O
sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
,	,	O
forced	VBD	O
homologous	JJ	O
recombination	NN	O
occurs	VBZ	O
between	IN	O
DNA	NNP	O
molecules	NNS	O
of	IN	O
different	JJ	O
but	CC	O
highly	RB	O
related	JJ	O
DNA	NNP	O
sequence	NN	O
in	IN	O
vitro	NN	O
,	,	O
as	IN	O
a	DT	O
result	NN	O
of	IN	O
random	JJ	O
fragmentation	NN	O
of	IN	O
the	DT	O
DNA	NNP	O
molecule	NN	O
based	VBN	O
on	IN	O
sequence	NN	O
homology	NN	O
,	,	O
followed	VBN	O
by	IN	O
fixation	NN	O
of	IN	O
the	DT	O
crossover	NN	O
by	IN	O
primer	JJ	O
extension	NN	O
in	IN	O
a	DT	O
PCR	NNP	O
reaction	NN	O
.	.	O
Sexual	JJ	O
PCR	NNP	O
mutagenesis	NN	O
is	VBZ	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Stemmer	NNP	B
(	(	I
1994	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
91:10747-10751	CD	I
.	.	O
Briefly	NNP	O
,	,	O
in	IN	O
such	JJ	O
procedures	NNS	O
a	DT	O
plurality	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
to	TO	O
be	VB	O
recombined	VBN	O
are	VBP	O
digested	VBN	O
with	IN	O
DNase	NNP	O
to	TO	O
generate	VB	O
fragments	NNS	O
having	VBG	O
an	DT	O
average	JJ	O
size	NN	O
of	IN	O
50-200	JJ	O
nucleotides	NNS	O
.	.	O
Fragments	NNS	O
of	IN	O
the	DT	O
desired	JJ	O
average	JJ	O
size	NN	O
are	VBP	O
purified	VBN	O
and	CC	O
resuspended	VBN	O
in	IN	O
a	DT	O
PCR	NNP	O
mixture	NN	O
.	.	O
PCR	NNP	O
is	VBZ	O
conducted	VBN	O
under	IN	O
conditions	NNS	O
which	WDT	O
facilitate	VBP	O
recombination	NN	O
between	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
fragments	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
PCR	NNP	O
may	MD	O
be	VB	O
performed	VBN	O
by	IN	O
resuspending	VBG	O
the	DT	O
purified	JJ	O
fragments	NNS	O
at	IN	O
a	DT	O
concentration	NN	O
of	IN	O
10-30	JJ	O
ng/:1	NN	O
in	IN	O
a	DT	O
solution	NN	O
of	IN	O
0.2	CD	O
mM	NNS	O
of	IN	O
each	DT	O
dNTP	NN	O
,	,	O
2.2	CD	O
mM	NN	O
MgCl2	NNP	O
,	,	O
50	CD	O
mM	NN	O
KCL	NNP	O
,	,	O
10	CD	O
mM	NN	O
Tris	NNP	O
HCl	NNP	O
,	,	O
pH	NN	O
9.0	CD	O
,	,	O
and	CC	O
0.1	CD	O
%	NN	O
Triton	NNP	O
X-100	NNP	O
.	.	O
2.5	CD	O
units	NNS	O
of	IN	O
Taq	NNP	O
polymerase	NN	O
per	IN	O
100:1	CD	O
of	IN	O
reaction	NN	O
mixture	NN	O
is	VBZ	O
added	VBN	O
and	CC	O
PCR	NNP	O
is	VBZ	O
performed	VBN	O
using	VBG	O
the	DT	O
following	JJ	O
regime	NN	O
:	:	O
94°	CD	O
C.	NNP	O
for	IN	O
60	CD	O
seconds	NNS	O
,	,	O
94°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
50-55°	JJ	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
,	,	O
72°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
seconds	NNS	O
(	(	O
30-45	JJ	O
times	NNS	O
)	)	O
and	CC	O
72°	CD	O
C.	NNP	O
for	IN	O
5	CD	O
minutes	NNS	O
.	.	O
However	RB	O
,	,	O
it	PRP	O
will	MD	O
be	VB	O
appreciated	VBN	O
that	IN	O
these	DT	O
parameters	NNS	O
may	MD	O
be	VB	O
varied	VBN	O
as	IN	O
appropriate	NN	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
oligonucleotides	NNS	O
may	MD	O
be	VB	O
included	VBN	O
in	IN	O
the	DT	O
PCR	NNP	O
reactions	NNS	O
.	.	O
In	IN	O
other	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
Klenow	NNP	O
fragment	NN	O
of	IN	O
DNA	NNP	O
polymerase	NN	O
I	PRP	O
may	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
first	JJ	O
set	NN	O
of	IN	O
PCR	NNP	O
reactions	NNS	O
and	CC	O
Taq	NNP	O
polymerase	NN	O
may	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
subsequent	JJ	O
set	NN	O
of	IN	O
PCR	NNP	O
reactions	NNS	O
.	.	O
Recombinant	JJ	O
sequences	NNS	O
are	VBP	O
isolated	VBN	O
and	CC	O
the	DT	O
activities	NNS	O
of	IN	O
the	DT	O
polypeptides	NNS	O
they	PRP	O
encode	VBP	O
are	VBP	O
assessed	VBN	O
.	.	O
Variants	NNS	O
may	MD	O
also	RB	O
be	VB	O
created	VBN	O
by	IN	O
in	IN	O
vivo	JJ	O
mutagenesis	NN	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
random	JJ	O
mutations	NNS	O
in	IN	O
a	DT	O
sequence	NN	O
of	IN	O
interest	NN	O
are	VBP	O
generated	VBN	O
by	IN	O
propagating	VBG	O
the	DT	O
sequence	NN	O
of	IN	O
interest	NN	O
in	IN	O
a	DT	O
bacterial	JJ	O
strain	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
E.	NNP	O
coli	NNS	O
strain	NN	O
,	,	O
which	WDT	O
carries	VBZ	O
mutations	NNS	O
in	IN	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
DNA	NNP	O
repair	NN	O
pathways	NNS	O
.	.	O
Such	JJ	O
“	NNP	O
mutator	NN	O
”	NN	O
strains	NNS	O
have	VBP	O
a	DT	O
higher	JJR	O
random	JJ	O
mutation	NN	O
rate	NN	O
than	IN	O
that	DT	O
of	IN	O
a	DT	O
wild-type	JJ	O
parent	NN	O
.	.	O
Propagating	VBG	O
the	DT	O
DNA	NN	O
in	IN	O
one	CD	O
of	IN	O
these	DT	O
strains	NNS	O
will	MD	O
eventually	RB	O
generate	VB	O
random	NN	O
mutations	NNS	O
within	IN	O
the	DT	O
DNA	NN	O
.	.	O
Mutator	NNP	O
strains	VBZ	O
suitable	JJ	O
for	IN	O
use	NN	O
for	IN	O
in	IN	O
vivo	JJ	O
mutagenesis	NN	O
are	VBP	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
PCT	NNP	O
Publication	NNP	O
No	NNP	O
.	.	O
WO	$	O
91/16427	CD	O
.	.	O
Variants	NNS	O
may	MD	O
also	RB	O
be	VB	O
generated	VBN	O
using	VBG	O
cassette	JJ	O
mutagenesis	NN	O
.	.	O
In	IN	O
cassette	NN	O
mutagenesis	NN	O
a	DT	O
small	JJ	O
region	NN	O
of	IN	O
a	DT	O
double	JJ	O
stranded	JJ	O
DNA	NN	O
molecule	NN	O
is	VBZ	O
replaced	VBN	O
with	IN	O
a	DT	O
synthetic	JJ	O
oligonucleotide	NN	O
“	NNP	O
cassette	NN	O
”	NN	O
that	WDT	O
differs	VBZ	O
from	IN	O
the	DT	O
native	JJ	O
sequence	NN	O
.	.	O
The	DT	O
oligonucleotide	NN	O
often	RB	O
contains	VBZ	O
completely	RB	O
and/or	JJ	O
partially	RB	O
randomized	VBN	O
native	JJ	O
sequence	NN	O
.	.	O
Recursive	NNP	O
ensemble	JJ	O
mutagenesis	NN	O
may	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
generate	VB	O
variants	NNS	O
.	.	O
Recursive	NNP	O
ensemble	JJ	O
mutagenesis	NN	O
is	VBZ	O
an	DT	O
algorithm	NN	O
for	IN	O
protein	NN	O
engineering	NN	O
(	(	O
protein	JJ	O
mutagenesis	NN	O
)	)	O
developed	VBD	O
to	TO	O
produce	VB	O
diverse	JJ	O
populations	NNS	O
of	IN	O
phenotypically	RB	O
related	JJ	O
mutants	NNS	O
whose	WP$	O
members	NNS	O
differ	VBP	O
in	IN	O
amino	NN	O
acid	NN	O
sequence	NN	O
.	.	O
This	DT	O
method	NN	O
uses	VBZ	O
a	DT	O
feedback	NN	O
mechanism	NN	O
to	TO	O
control	VB	O
successive	JJ	O
rounds	NNS	O
of	IN	O
combinatorial	JJ	O
cassette	NN	O
mutagenesis	NN	O
.	.	O
Recursive	NNP	O
ensemble	JJ	O
mutagenesis	NN	O
is	VBZ	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Arkin	NNP	B
(	(	I
1992	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
89:7811-7815	CD	I
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
variants	NNS	O
are	VBP	O
created	VBN	O
using	VBG	O
exponential	JJ	O
ensemble	JJ	O
mutagenesis	NN	O
.	.	O
Exponential	NNP	O
ensemble	JJ	O
mutagenesis	NN	O
is	VBZ	O
a	DT	O
process	NN	O
for	IN	O
generating	VBG	O
combinatorial	JJ	O
libraries	NNS	O
with	IN	O
a	DT	O
high	JJ	O
percentage	NN	O
of	IN	O
unique	NN	O
and	CC	O
functional	JJ	O
mutants	NNS	O
,	,	O
wherein	VBP	O
small	JJ	O
groups	NNS	O
of	IN	O
residues	NNS	O
are	VBP	O
randomized	VBN	O
in	IN	O
parallel	NN	O
to	TO	O
identify	VB	O
,	,	O
at	IN	O
each	DT	O
altered	JJ	O
position	NN	O
,	,	O
amino	NN	O
acids	NNS	O
which	WDT	O
lead	VBP	O
to	TO	O
functional	JJ	O
proteins	NNS	O
.	.	O
Exponential	NNP	O
ensemble	JJ	O
mutagenesis	NN	O
is	VBZ	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Delegrave	NNP	B
(	(	I
1993	CD	I
)	)	I
Biotechnology	NNP	I
Res	NNP	I
.	.	I
11:1548-1552	JJ	I
.	.	O
Random	NNP	O
and	CC	O
site-directed	JJ	O
mutagenesis	NN	O
are	VBP	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
Arnold	NNP	B
(	(	I
1993	CD	I
)	)	I
Current	NNP	I
Opinion	NNP	I
in	IN	I
Biotechnology	NNP	I
4:450-455	JJ	I
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
the	DT	O
variants	NNS	O
are	VBP	O
created	VBN	O
using	VBG	O
shuffling	VBG	O
procedures	NNS	O
wherein	JJ	O
portions	NNS	O
of	IN	O
a	DT	O
plurality	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
which	WDT	O
encode	VBP	O
distinct	JJ	O
polypeptides	NNS	O
are	VBP	O
fused	VBN	O
together	RB	O
to	TO	O
create	VB	O
chimeric	JJ	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
which	WDT	O
encode	VBP	O
chimeric	JJ	O
polypeptides	NNS	O
as	IN	O
described	NN	O
in	IN	O
,	,	O
e.g.	NN	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
5,965,408	CD	O
;	:	O
5,939,250	CD	O
(	(	O
see	VB	O
also	RB	O
discussion	NN	O
,	,	O
above	IN	O
)	)	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
variants	NNS	O
of	IN	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
e.g.	JJ	O
,	,	O
amylases	NNS	O
)	)	O
comprising	VBG	O
sequences	NNS	O
in	IN	O
which	WDT	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
amino	NN	O
acid	NN	O
residues	NNS	O
(	(	O
e.g.	NN	O
,	,	O
of	IN	O
an	DT	O
exemplary	JJ	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
are	VBP	O
substituted	VBN	O
with	IN	O
a	DT	O
conserved	JJ	O
or	CC	O
non-conserved	JJ	O
amino	NN	O
acid	NN	O
residue	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
conserved	VBN	O
amino	NN	O
acid	NN	O
residue	NN	O
)	)	O
and	CC	O
such	JJ	O
substituted	VBN	O
amino	NN	O
acid	NNS	O
residue	VBP	O
may	MD	O
or	CC	O
may	MD	O
not	RB	O
be	VB	O
one	CD	O
encoded	VBN	O
by	IN	O
the	DT	O
genetic	JJ	O
code	NN	O
.	.	O
Conservative	JJ	O
substitutions	NNS	O
are	VBP	O
those	DT	O
that	IN	O
substitute	VBP	O
a	DT	O
given	VBN	O
amino	NN	O
acid	NN	O
in	IN	O
a	DT	O
polypeptide	NN	O
by	IN	O
another	DT	O
amino	NN	O
acid	NN	O
of	IN	O
like	IN	O
characteristics	NNS	O
.	.	O
Thus	RB	O
,	,	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
those	DT	O
with	IN	O
conservative	JJ	O
substitutions	NNS	O
of	IN	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
exemplary	JJ	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
including	VBG	O
but	CC	O
not	RB	O
limited	JJ	O
to	TO	O
the	DT	O
following	JJ	O
replacements	NNS	O
:	:	O
replacements	NNS	O
of	IN	O
an	DT	O
aliphatic	JJ	O
amino	NN	O
acid	NN	O
such	JJ	O
as	IN	O
Alanine	NNP	O
,	,	O
Valine	NNP	O
,	,	O
Leucine	NNP	O
and	CC	O
Isoleucine	NNP	O
with	IN	O
another	DT	O
aliphatic	JJ	O
amino	NN	O
acid	NN	O
;	:	O
replacement	NN	O
of	IN	O
a	DT	O
Serine	NNP	O
with	IN	O
a	DT	O
Threonine	NNP	O
or	CC	O
vice	NN	O
versa	NN	O
;	:	O
replacement	NN	O
of	IN	O
an	DT	O
acidic	JJ	O
residue	NN	O
such	JJ	O
as	IN	O
Aspartic	JJ	O
acid	NN	O
and	CC	O
Glutamic	NNP	O
acid	NN	O
with	IN	O
another	DT	O
acidic	JJ	O
residue	NN	O
;	:	O
replacement	NN	O
of	IN	O
a	DT	O
residue	JJ	O
bearing	NN	O
an	DT	O
amide	NN	O
group	NN	O
,	,	O
such	JJ	O
as	IN	O
Asparagine	NNP	O
and	CC	O
Glutamine	NNP	O
,	,	O
with	IN	O
another	DT	O
residue	JJ	O
bearing	VBG	O
an	DT	O
amide	JJ	O
group	NN	O
;	:	O
exchange	NN	O
of	IN	O
a	DT	O
basic	JJ	O
residue	NN	O
such	JJ	O
as	IN	O
Lysine	NNP	O
and	CC	O
Arginine	NNP	O
with	IN	O
another	DT	O
basic	JJ	O
residue	NN	O
;	:	O
and	CC	O
replacement	NN	O
of	IN	O
an	DT	O
aromatic	JJ	O
residue	NN	O
such	JJ	O
as	IN	O
Phenylalanine	NNP	O
,	,	O
Tyrosine	NNP	O
with	IN	O
another	DT	O
aromatic	JJ	O
residue	NN	O
.	.	O
Other	JJ	O
variants	NNS	O
are	VBP	O
those	DT	O
in	IN	O
which	WDT	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
the	DT	O
amino	NN	O
acid	NN	O
residues	NNS	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
includes	VBZ	O
a	DT	O
substituent	NN	O
group	NN	O
.	.	O
Other	JJ	O
variants	NNS	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
those	DT	O
in	IN	O
which	WDT	O
the	DT	O
polypeptide	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
another	DT	O
compound	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
compound	NN	O
to	TO	O
increase	VB	O
the	DT	O
half-life	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
polyethylene	NN	O
glycol	NN	O
.	.	O
Additional	JJ	O
variants	NNS	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
those	DT	O
in	IN	O
which	WDT	O
additional	JJ	O
amino	NN	O
acids	NNS	O
are	VBP	O
fused	VBN	O
to	TO	O
the	DT	O
polypeptide	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
leader	NN	O
sequence	NN	O
,	,	O
a	DT	O
secretory	JJ	O
sequence	NN	O
,	,	O
a	DT	O
proprotein	JJ	O
sequence	NN	O
or	CC	O
a	DT	O
sequence	NN	O
which	WDT	O
facilitates	VBZ	O
purification	NN	O
,	,	O
enrichment	NN	O
,	,	O
or	CC	O
stabilization	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
.	.	O
In	IN	O
some	DT	O
aspects	NNS	O
,	,	O
the	DT	O
variants	NNS	O
,	,	O
fragments	NNS	O
,	,	O
derivatives	NNS	O
and	CC	O
analogs	NNS	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
retain	VBP	O
the	DT	O
same	JJ	O
biological	JJ	O
function	NN	O
or	CC	O
activity	NN	O
as	IN	O
the	DT	O
exemplary	JJ	O
polypeptides	NNS	O
,	,	O
e.g.	NN	O
,	,	O
amylase	NN	O
activity	NN	O
,	,	O
as	IN	O
described	VBN	O
herein	NN	O
.	.	O
In	IN	O
other	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
variant	NN	O
,	,	O
fragment	NN	O
,	,	O
derivative	JJ	O
,	,	O
or	CC	O
analog	NN	O
includes	VBZ	O
a	DT	O
proprotein	NN	O
,	,	O
such	JJ	O
that	IN	O
the	DT	O
variant	NN	O
,	,	O
fragment	NN	O
,	,	O
derivative	JJ	O
,	,	O
or	CC	O
analog	NN	O
can	MD	O
be	VB	O
activated	VBN	O
by	IN	O
cleavage	NN	O
of	IN	O
the	DT	O
proprotein	NN	O
portion	NN	O
to	TO	O
produce	VB	O
an	DT	O
active	JJ	O
polypeptide	NN	O
.	.	O
Optimizing	VBG	O
Codons	NNS	O
to	TO	O
Achieve	NNP	O
High	NNP	O
Levels	NNP	O
of	IN	O
Protein	NNP	O
Expression	NNP	O
in	IN	O
Host	NNP	O
Cells	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
amylase-encoding	JJ	O
nucleic	JJ	O
acids	NNS	O
to	TO	O
modify	VB	O
codon	JJ	O
usage	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
codons	NNS	O
in	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
an	DT	O
amylase	NN	O
to	TO	O
increase	VB	O
or	CC	O
decrease	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
an	DT	O
amylase	NN	O
modified	VBD	O
to	TO	O
increase	VB	O
its	PRP$	O
expression	NN	O
in	IN	O
a	DT	O
host	NN	O
cell	NN	O
,	,	O
amylase	NN	O
so	RB	O
modified	JJ	O
,	,	O
and	CC	O
methods	NNS	O
of	IN	O
making	VBG	O
the	DT	O
modified	JJ	O
amylases	NNS	O
.	.	O
The	DT	O
method	NN	O
comprises	VBZ	O
identifying	VBG	O
a	DT	O
“	JJ	O
non-preferred	JJ	O
”	NN	O
or	CC	O
a	DT	O
“	JJ	O
less	RBR	O
preferred	JJ	O
”	NNP	O
codon	NN	O
in	IN	O
amylase-encoding	JJ	O
nucleic	JJ	O
acid	NN	O
and	CC	O
replacing	VBG	O
one	CD	O
or	CC	O
more	JJR	O
of	IN	O
these	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codons	NNS	O
with	IN	O
a	DT	O
“	NN	O
preferred	JJ	O
codon	NN	O
”	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
as	IN	O
the	DT	O
replaced	JJ	O
codon	NN	O
and	CC	O
at	IN	O
least	JJS	O
one	CD	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
has	VBZ	O
been	VBN	O
replaced	VBN	O
by	IN	O
a	DT	O
preferred	JJ	O
codon	NN	O
encoding	VBG	O
the	DT	O
same	JJ	O
amino	NN	O
acid	NN	O
.	.	O
A	DT	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
over-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
and	CC	O
a	DT	O
non-preferred	JJ	O
or	CC	O
less	RBR	O
preferred	JJ	O
codon	NN	O
is	VBZ	O
a	DT	O
codon	JJ	O
under-represented	JJ	O
in	IN	O
coding	VBG	O
sequences	NNS	O
in	IN	O
genes	NNS	O
in	IN	O
the	DT	O
host	NN	O
cell	NN	O
.	.	O
Host	NNP	O
cells	NNS	O
for	IN	O
expressing	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
,	,	O
expression	NN	O
cassettes	NNS	O
and	CC	O
vectors	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
bacteria	NNS	O
,	,	O
yeast	NN	O
,	,	O
fungi	NNS	O
,	,	O
plant	NN	O
cells	NNS	O
,	,	O
insect	JJ	O
cells	NNS	O
and	CC	O
mammalian	JJ	O
cells	NNS	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
optimizing	VBG	O
codon	JJ	O
usage	NN	O
in	IN	O
all	DT	O
of	IN	O
these	DT	O
cells	NNS	O
,	,	O
codon-altered	JJ	O
nucleic	JJ	O
acids	NNS	O
and	CC	O
polypeptides	NNS	O
made	VBN	O
by	IN	O
the	DT	O
codon-altered	JJ	O
nucleic	JJ	O
acids	NNS	O
.	.	O
Exemplary	JJ	O
host	NN	O
cells	NNS	O
include	VBP	O
gram	JJ	O
negative	JJ	O
bacteria	NNS	O
,	,	O
such	JJ	O
as	IN	O
Escherichia	NNP	O
coli	NN	O
and	CC	O
Pseudomonas	NNP	O
fluorescens	NNS	O
;	:	O
gram	VB	O
positive	JJ	O
bacteria	NNS	O
,	,	O
such	JJ	O
as	IN	O
Streptomyces	NNS	O
diversa	VBP	O
,	,	O
Lactobacillus	NNP	O
gasseri	NN	O
,	,	O
Lactococcus	NNP	O
lactis	NN	O
,	,	O
Lactococcus	NNP	O
cremoris	NN	O
,	,	O
Bacillus	NNP	O
subtilis	NNS	O
.	.	O
Exemplary	JJ	O
host	NN	O
cells	NNS	O
also	RB	O
include	VBP	O
eukaryotic	JJ	O
organisms	NNS	O
,	,	O
e.g.	NN	O
,	,	O
various	JJ	O
yeast	NN	O
,	,	O
such	JJ	O
as	IN	O
Saccharomyces	NNS	O
sp.	VBP	O
,	,	O
including	VBG	O
Saccharomyces	NNS	O
cerevisiae	NN	O
,	,	O
Schizosaccharomyces	NNP	O
pombe	NN	O
,	,	O
Pichia	NNP	O
pastoris	NN	O
,	,	O
and	CC	O
Kluyveromyces	NNP	O
lactis	NN	O
,	,	O
Hansenula	NNP	O
polymorphs	NN	O
,	,	O
Aspergillus	NNP	O
niger	NN	O
,	,	O
and	CC	O
mammalian	JJ	O
cells	NNS	O
and	CC	O
cell	NN	O
lines	NNS	O
and	CC	O
insect	JJ	O
cells	NNS	O
and	CC	O
cell	NN	O
lines	NNS	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
nucleic	JJ	O
acids	NNS	O
and	CC	O
polypeptides	NNS	O
optimized	VBN	O
for	IN	O
expression	NN	O
in	IN	O
these	DT	O
organisms	NNS	O
and	CC	O
species	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
codons	NNS	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
encoding	VBG	O
an	DT	O
amylase	NN	O
isolated	VBD	O
from	IN	O
a	DT	O
bacterial	JJ	O
cell	NN	O
are	VBP	O
modified	VBN	O
such	JJ	O
that	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
optimally	RB	O
expressed	VBN	O
in	IN	O
a	DT	O
bacterial	JJ	O
cell	NN	O
different	JJ	O
from	IN	O
the	DT	O
bacteria	NN	O
from	IN	O
which	WDT	O
the	DT	O
amylase	NN	O
was	VBD	O
derived	VBN	O
,	,	O
a	DT	O
yeast	NN	O
,	,	O
a	DT	O
fungi	NN	O
,	,	O
a	DT	O
plant	NN	O
cell	NN	O
,	,	O
an	DT	O
insect	NN	O
cell	NN	O
or	CC	O
a	DT	O
mammalian	JJ	O
cell	NN	O
.	.	O
Methods	NNS	O
for	IN	O
optimizing	VBG	O
codons	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
see	NN	O
,	,	O
e.g.	RB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,795,737	CD	O
;	:	O
Baca	NNP	B
(	(	I
2000	CD	I
)	)	I
Int	NNP	I
.	.	I
J.	NNP	I
Parasitol	NNP	I
.	.	I
30:113-118	JJ	I
;	:	O
Hale	NNP	B
(	(	I
1998	CD	I
)	)	I
Protein	NNP	I
Expr	NNP	I
.	.	I
Purif	NNP	I
.	.	I
12:185-188	JJ	I
;	:	O
Narum	NNP	B
(	(	I
2001	CD	I
)	)	I
Infect	NNP	I
.	.	I
Immun	NNP	I
.	.	I
69:7250-7253	JJ	I
.	.	O
See	NNP	O
also	RB	O
Narum	NNP	B
(	(	I
2001	CD	I
)	)	I
Infect	NNP	I
.	.	I
Immun	NNP	I
.	.	I
69:7250-7253	JJ	I
,	,	O
describing	VBG	O
optimizing	VBG	O
codons	NNS	O
in	IN	O
mouse	NN	O
systems	NNS	O
;	:	O
Outchkourov	NNP	B
(	(	I
2002	CD	I
)	)	I
Protein	NNP	I
Expr	NNP	I
.	.	I
Purif	NNP	I
.	.	I
24:18-24	JJ	I
,	,	O
describing	VBG	O
optimizing	VBG	O
codons	NNS	O
in	IN	O
yeast	NN	O
;	:	O
Feng	NNP	B
(	(	I
2000	CD	I
)	)	I
Biochemistry	NNP	I
39:15399-15409	CD	I
,	,	O
describing	VBG	O
optimizing	VBG	O
codons	NNS	O
in	IN	O
E.	NNP	O
coli	NNS	O
;	:	O
Humphreys	NNP	B
(	(	I
2000	CD	I
)	)	I
Protein	NNP	I
Expr	NNP	I
.	.	I
Purif	NNP	I
.	.	I
20:252-264	JJ	I
,	,	O
describing	VBG	O
optimizing	VBG	O
codon	JJ	O
usage	NN	O
that	WDT	O
affects	VBZ	O
secretion	NN	O
in	IN	O
E.	NNP	O
coli	NNS	O
.	.	O
Transgenic	JJ	O
Non-Human	JJ	O
Animals	NNS	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
non-human	JJ	O
animals	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
)	)	O
,	,	O
an	DT	O
expression	NN	O
cassette	NN	O
or	CC	O
vector	NN	O
or	CC	O
a	DT	O
transfected	JJ	O
or	CC	O
transformed	VBN	O
cell	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
and	CC	O
using	VBG	O
these	DT	O
transgenic	JJ	O
non-human	JJ	O
animals	NNS	O
.	.	O
The	DT	O
transgenic	JJ	O
non-human	JJ	O
animals	NNS	O
can	MD	O
be	VB	O
,	,	O
e.g.	FW	O
,	,	O
goats	NNS	O
,	,	O
rabbits	NNS	O
,	,	O
sheep	NN	O
,	,	O
pigs	NNS	O
,	,	O
cows	NNS	O
,	,	O
rats	NNS	O
and	CC	O
mice	NN	O
,	,	O
comprising	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
These	DT	O
animals	NNS	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
e.g.	RB	O
,	,	O
as	IN	O
in	IN	O
vivo	NN	O
models	NNS	O
to	TO	O
study	VB	O
amylase	JJ	O
activity	NN	O
,	,	O
or	CC	O
,	,	O
as	IN	O
models	NNS	O
to	TO	O
screen	VB	O
for	IN	O
agents	NNS	O
that	WDT	O
change	VBP	O
the	DT	O
amylase	NN	O
activity	NN	O
in	IN	O
vivo	NN	O
.	.	O
The	DT	O
coding	NN	O
sequences	NNS	O
for	IN	O
the	DT	O
polypeptides	NNS	O
to	TO	O
be	VB	O
expressed	VBN	O
in	IN	O
the	DT	O
transgenic	JJ	O
non-human	JJ	O
animals	NNS	O
can	MD	O
be	VB	O
designed	VBN	O
to	TO	O
be	VB	O
constitutive	JJ	O
,	,	O
or	CC	O
,	,	O
under	IN	O
the	DT	O
control	NN	O
of	IN	O
tissue-specific	JJ	O
,	,	O
developmental-specific	JJ	O
or	CC	O
inducible	JJ	O
transcriptional	JJ	O
regulatory	JJ	O
factors	NNS	O
.	.	O
Transgenic	JJ	O
non-human	JJ	O
animals	NNS	O
can	MD	O
be	VB	O
designed	VBN	O
and	CC	O
generated	VBN	O
using	VBG	O
any	DT	O
method	NN	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
;	:	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,211,428	CD	O
;	:	O
6,187,992	CD	O
;	:	O
6,156,952	CD	O
;	:	O
6,118,044	CD	O
;	:	O
6,111,166	CD	O
;	:	O
6,107,541	CD	O
;	:	O
5,959,171	CD	O
;	:	O
5,922,854	CD	O
;	:	O
5,892,070	CD	O
;	:	O
5,880,327	CD	O
;	:	O
5,891,698	CD	O
;	:	O
5,639,940	CD	O
;	:	O
5,573,933	CD	O
;	:	O
5,387,742	CD	O
;	:	O
5,087,571	CD	O
,	,	O
describing	VBG	O
making	NN	O
and	CC	O
using	VBG	O
transformed	JJ	O
cells	NNS	O
and	CC	O
eggs	NNS	O
and	CC	O
transgenic	JJ	O
mice	NN	O
,	,	O
rats	NNS	O
,	,	O
rabbits	NNS	O
,	,	O
sheep	NN	O
,	,	O
pigs	NNS	O
and	CC	O
cows	NNS	O
.	.	O
See	NNP	O
also	RB	O
,	,	O
e.g.	RB	O
,	,	O
Pollock	NNP	B
(	(	I
1999	CD	I
)	)	I
J.	NNP	I
Immunol	NNP	I
.	.	I
Methods	NNS	I
231:147-157	CD	I
,	,	O
describing	VBG	O
the	DT	O
production	NN	O
of	IN	O
recombinant	JJ	O
proteins	NNS	O
in	IN	O
the	DT	O
milk	NN	O
of	IN	O
transgenic	JJ	O
dairy	NN	O
animals	NNS	O
;	:	O
Baguisi	NNP	B
(	(	I
1999	CD	I
)	)	I
Nat	NNP	I
.	.	I
Biotechnol	NNP	I
.	.	I
17:456-461	JJ	I
,	,	O
demonstrating	VBG	O
the	DT	O
production	NN	O
of	IN	O
transgenic	JJ	O
goats	NNS	O
.	.	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,211,428	CD	O
,	,	O
describes	NNS	O
making	VBG	O
and	CC	O
using	VBG	O
transgenic	JJ	O
non-human	JJ	O
mammals	NNS	O
which	WDT	O
express	VBP	O
in	IN	O
their	PRP$	O
brains	NNS	O
a	DT	O
nucleic	JJ	O
acid	NN	O
construct	NN	O
comprising	VBG	O
a	DT	O
DNA	NN	O
sequence	NN	O
.	.	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,387,742	CD	O
,	,	O
describes	VBZ	O
injecting	VBG	O
cloned	VBN	O
recombinant	NN	O
or	CC	O
synthetic	JJ	O
DNA	NN	O
sequences	NNS	O
into	IN	O
fertilized	VBN	O
mouse	NN	O
eggs	NNS	O
,	,	O
implanting	VBG	O
the	DT	O
injected	VBN	O
eggs	NNS	O
in	IN	O
pseudo-pregnant	JJ	O
females	NNS	O
,	,	O
and	CC	O
growing	VBG	O
to	TO	O
term	NN	O
transgenic	JJ	O
mice	NN	O
whose	WP$	O
cells	NNS	O
express	VBP	O
proteins	NNS	O
related	VBN	O
to	TO	O
the	DT	O
pathology	NN	O
of	IN	O
Alzheimer	NNP	O
's	POS	O
disease	NN	O
.	.	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,187,992	CD	O
,	,	O
describes	NNS	O
making	VBG	O
and	CC	O
using	VBG	O
a	DT	O
transgenic	JJ	O
mouse	NN	O
whose	WP$	O
genome	NN	O
comprises	VBZ	O
a	DT	O
disruption	NN	O
of	IN	O
the	DT	O
gene	NN	O
encoding	VBG	O
amyloid	JJ	O
precursor	NN	O
protein	NN	O
(	(	O
APP	NNP	O
)	)	O
.	.	O
“	NN	O
Knockout	NNP	O
animals	NNS	O
”	VBP	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
practice	NN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
transgenic	NN	O
or	CC	O
modified	VBN	O
animals	NNS	O
of	IN	O
the	DT	O
invention	NN	O
comprise	NN	O
a	DT	O
“	NN	O
knockout	NN	O
animal	NN	O
,	,	O
”	NNP	O
e.g.	NN	O
,	,	O
a	DT	O
“	NN	O
knockout	NN	O
mouse	NN	O
,	,	O
”	RB	O
engineered	VBD	O
not	RB	O
to	TO	O
express	VB	O
an	DT	O
endogenous	JJ	O
gene	NN	O
,	,	O
which	WDT	O
is	VBZ	O
replaced	VBN	O
with	IN	O
a	DT	O
gene	NN	O
expressing	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
,	,	O
a	DT	O
fusion	NN	O
protein	NN	O
comprising	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Transgenic	JJ	O
Plants	NNS	O
and	CC	O
Seeds	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
plants	NNS	O
and	CC	O
seeds	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
alpha	JJ	O
amylase	NN	O
)	)	O
,	,	O
an	DT	O
expression	NN	O
cassette	NN	O
or	CC	O
vector	NN	O
or	CC	O
a	DT	O
transfected	JJ	O
or	CC	O
transformed	VBN	O
cell	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
plant	NN	O
products	NNS	O
,	,	O
e.g.	NN	O
,	,	O
oils	NNS	O
,	,	O
seeds	NNS	O
,	,	O
leaves	NNS	O
,	,	O
extracts	NNS	O
and	CC	O
the	DT	O
like	JJ	O
,	,	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
and/or	VBZ	O
a	DT	O
polypeptide	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
alpha	JJ	O
amylase	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
transgenic	JJ	O
plant	NN	O
can	MD	O
be	VB	O
dicotyledonous	JJ	O
(	(	O
a	DT	O
dicot	NN	O
)	)	O
or	CC	O
monocotyledonous	JJ	O
(	(	O
a	DT	O
monocot	NN	O
)	)	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
and	CC	O
using	VBG	O
these	DT	O
transgenic	JJ	O
plants	NNS	O
and	CC	O
seeds	NNS	O
.	.	O
The	DT	O
transgenic	JJ	O
plant	NN	O
or	CC	O
plant	NN	O
cell	NN	O
expressing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
may	MD	O
be	VB	O
constructed	VBN	O
in	IN	O
accordance	NN	O
with	IN	O
any	DT	O
method	NN	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
See	VB	O
,	,	O
for	IN	O
example	NN	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,309,872	CD	O
.	.	O
Nucleic	NNP	O
acids	NNS	O
and	CC	O
expression	NN	O
constructs	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
a	DT	O
plant	NN	O
cell	NN	O
by	IN	O
any	DT	O
means	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
or	CC	O
expression	NN	O
constructs	NNS	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
the	DT	O
genome	NN	O
of	IN	O
a	DT	O
desired	JJ	O
plant	NN	O
host	NN	O
,	,	O
or	CC	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
or	CC	O
expression	NN	O
constructs	NNS	O
can	MD	O
be	VB	O
episomes	RB	O
.	.	O
Introduction	NN	O
into	IN	O
the	DT	O
genome	NN	O
of	IN	O
a	DT	O
desired	JJ	O
plant	NN	O
can	MD	O
be	VB	O
such	JJ	O
that	IN	O
the	DT	O
host	NN	O
's	POS	O
α-amylase	JJ	O
production	NN	O
is	VBZ	O
regulated	VBN	O
by	IN	O
endogenous	JJ	O
transcriptional	JJ	O
or	CC	O
translational	JJ	O
control	NN	O
elements	NNS	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
“	JJ	O
knockout	NN	O
plants	NNS	O
”	VBP	O
where	WRB	O
insertion	NN	O
of	IN	O
gene	NN	O
sequence	NN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
homologous	JJ	O
recombination	NN	O
,	,	O
has	VBZ	O
disrupted	VBN	O
the	DT	O
expression	NN	O
of	IN	O
the	DT	O
endogenous	JJ	O
gene	NN	O
.	.	O
Means	NNS	O
to	TO	O
generate	VB	O
“	NN	O
knockout	IN	O
”	JJ	O
plants	NNS	O
are	VBP	O
well-known	JJ	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
see	NN	O
,	,	O
e.g.	VB	O
,	,	O
Strepp	NNP	B
(	(	I
1998	CD	I
)	)	I
Proc	NNP	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
95:4368-4373	CD	I
;	:	O
Miao	NNP	B
(	(	I
1995	CD	I
)	)	I
Plant	NNP	I
J	NNP	I
7:359-365	NNP	I
.	.	O
See	VB	O
discussion	NN	O
on	IN	O
transgenic	JJ	O
plants	NNS	O
,	,	O
below	IN	O
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
confer	VB	O
desired	JJ	O
traits	NNS	O
on	IN	O
essentially	RB	O
any	DT	O
plant	NN	O
,	,	O
e.g.	RB	O
,	,	O
on	IN	O
starch-producing	JJ	O
plants	NNS	O
,	,	O
such	JJ	O
as	IN	O
potato	NN	O
,	,	O
wheat	NN	O
,	,	O
rice	NN	O
,	,	O
barley	NN	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Nucleic	NNP	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
manipulate	VB	O
metabolic	JJ	O
pathways	NNS	O
of	IN	O
a	DT	O
plant	NN	O
in	IN	O
order	NN	O
to	TO	O
optimize	VB	O
or	CC	O
alter	VB	O
host	NN	O
's	POS	O
expression	NN	O
of	IN	O
α-amylase	NN	O
.	.	O
The	DT	O
can	MD	O
change	VB	O
the	DT	O
ratio	NN	O
of	IN	O
starch/sugar	NN	O
conversion	NN	O
in	IN	O
a	DT	O
plant	NN	O
.	.	O
This	DT	O
can	MD	O
facilitate	VB	O
industrial	JJ	O
processing	NN	O
of	IN	O
a	DT	O
plant	NN	O
.	.	O
Alternatively	RB	O
,	,	O
alpha-amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
production	NN	O
of	IN	O
a	DT	O
transgenic	JJ	O
plant	NN	O
to	TO	O
produce	VB	O
a	DT	O
compound	NN	O
not	RB	O
naturally	RB	O
produced	VBN	O
by	IN	O
that	DT	O
plant	NN	O
.	.	O
This	DT	O
can	MD	O
lower	VB	O
production	NN	O
costs	NNS	O
or	CC	O
create	VB	O
a	DT	O
novel	JJ	O
product	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
first	JJ	O
step	NN	O
in	IN	O
production	NN	O
of	IN	O
a	DT	O
transgenic	JJ	O
plant	NN	O
involves	VBZ	O
making	VBG	O
an	DT	O
expression	NN	O
construct	NN	O
for	IN	O
expression	NN	O
in	IN	O
a	DT	O
plant	NN	O
cell	NN	O
.	.	O
These	DT	O
techniques	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
They	PRP	O
can	MD	O
include	VB	O
selecting	VBG	O
and	CC	O
cloning	VBG	O
a	DT	O
promoter	NN	O
,	,	O
a	DT	O
coding	NN	O
sequence	NN	O
for	IN	O
facilitating	VBG	O
efficient	JJ	O
binding	NN	O
of	IN	O
ribosomes	NNS	O
to	TO	O
mRNA	VB	O
and	CC	O
selecting	VBG	O
the	DT	O
appropriate	JJ	O
gene	NN	O
terminator	NN	O
sequences	NNS	O
.	.	O
One	CD	O
exemplary	JJ	O
constitutive	JJ	O
promoter	NN	O
is	VBZ	O
CaMV35S	NNP	O
,	,	O
from	IN	O
the	DT	O
cauliflower	NN	O
mosaic	NN	O
virus	NN	O
,	,	O
which	WDT	O
generally	RB	O
results	NNS	O
in	IN	O
a	DT	O
high	JJ	O
degree	NN	O
of	IN	O
expression	NN	O
in	IN	O
plants	NNS	O
.	.	O
Other	JJ	O
promoters	NNS	O
are	VBP	O
more	RBR	O
specific	JJ	O
and	CC	O
respond	NN	O
to	TO	O
cues	NNS	O
in	IN	O
the	DT	O
plant	NN	O
's	POS	O
internal	JJ	O
or	CC	O
external	JJ	O
environment	NN	O
.	.	O
An	DT	O
exemplary	JJ	O
light-inducible	JJ	O
promoter	NN	O
is	VBZ	O
the	DT	O
promoter	NN	O
from	IN	O
the	DT	O
cab	NN	O
gene	NN	O
,	,	O
encoding	VBG	O
the	DT	O
major	JJ	O
chlorophyll	NN	O
a/b	NN	O
binding	VBG	O
protein	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
modified	VBN	O
to	TO	O
achieve	VB	O
greater	JJR	O
expression	NN	O
in	IN	O
a	DT	O
plant	NN	O
cell	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
likely	JJ	O
to	TO	O
have	VB	O
a	DT	O
higher	JJR	O
percentage	NN	O
of	IN	O
A-T	NNP	O
nucleotide	JJ	O
pairs	NNS	O
compared	VBN	O
to	TO	O
that	DT	O
seen	VBN	O
in	IN	O
a	DT	O
plant	NN	O
,	,	O
some	DT	O
of	IN	O
which	WDT	O
prefer	VBP	O
G-C	NNP	O
nucleotide	JJ	O
pairs	NNS	O
.	.	O
Therefore	RB	O
,	,	O
A-T	NNP	O
nucleotides	NNS	O
in	IN	O
the	DT	O
coding	NN	O
sequence	NN	O
can	MD	O
be	VB	O
substituted	VBN	O
with	IN	O
G-C	NNP	O
nucleotides	NNS	O
without	IN	O
significantly	RB	O
changing	VBG	O
the	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
to	TO	O
enhance	VB	O
production	NN	O
of	IN	O
the	DT	O
gene	NN	O
product	NN	O
in	IN	O
plant	NN	O
cells	NNS	O
.	.	O
Selectable	JJ	O
marker	NN	O
gene	NN	O
can	MD	O
be	VB	O
added	VBN	O
to	TO	O
the	DT	O
gene	NN	O
construct	NN	O
in	IN	O
order	NN	O
to	TO	O
identify	VB	O
plant	NN	O
cells	NNS	O
or	CC	O
tissues	NNS	O
that	WDT	O
have	VBP	O
successfully	RB	O
integrated	VBN	O
the	DT	O
transgene	NN	O
.	.	O
This	DT	O
may	MD	O
be	VB	O
necessary	JJ	O
because	IN	O
achieving	VBG	O
incorporation	NN	O
and	CC	O
expression	NN	O
of	IN	O
genes	NNS	O
in	IN	O
plant	NN	O
cells	NNS	O
is	VBZ	O
a	DT	O
rare	JJ	O
event	NN	O
,	,	O
occurring	VBG	O
in	IN	O
just	RB	O
a	DT	O
few	JJ	O
percent	NN	O
of	IN	O
the	DT	O
targeted	JJ	O
tissues	NNS	O
or	CC	O
cells	NNS	O
.	.	O
Selectable	JJ	O
marker	NN	O
genes	NNS	O
encode	VBP	O
proteins	NNS	O
that	WDT	O
provide	VBP	O
resistance	NN	O
to	TO	O
agents	NNS	O
that	WDT	O
are	VBP	O
normally	RB	O
toxic	JJ	O
to	TO	O
plants	NNS	O
,	,	O
such	JJ	O
as	IN	O
antibiotics	NNS	O
or	CC	O
herbicides	NNS	O
.	.	O
Only	RB	O
plant	NN	O
cells	NNS	O
that	WDT	O
have	VBP	O
integrated	VBN	O
the	DT	O
selectable	JJ	O
marker	NN	O
gene	NN	O
will	MD	O
survive	VB	O
when	WRB	O
grown	VBN	O
on	IN	O
a	DT	O
medium	NN	O
containing	VBG	O
the	DT	O
appropriate	JJ	O
antibiotic	JJ	O
or	CC	O
herbicide	NN	O
.	.	O
As	IN	O
for	IN	O
other	JJ	O
inserted	JJ	O
genes	NNS	O
,	,	O
marker	NN	O
genes	NNS	O
also	RB	O
require	VBP	O
promoter	NN	O
and	CC	O
termination	NN	O
sequences	NNS	O
for	IN	O
proper	JJ	O
function	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
making	VBG	O
transgenic	JJ	O
plants	NNS	O
or	CC	O
seeds	NNS	O
comprises	NNS	O
incorporating	VBG	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
,	,	O
optionally	RB	O
,	,	O
marker	JJR	O
genes	NNS	O
into	IN	O
a	DT	O
target	NN	O
expression	NN	O
construct	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
plasmid	NN	O
)	)	O
,	,	O
along	IN	O
with	IN	O
positioning	NN	O
of	IN	O
the	DT	O
promoter	NN	O
and	CC	O
the	DT	O
terminator	NN	O
sequences	NNS	O
.	.	O
This	DT	O
can	MD	O
involve	VB	O
transferring	VBG	O
the	DT	O
modified	JJ	O
gene	NN	O
into	IN	O
the	DT	O
plant	NN	O
through	IN	O
a	DT	O
suitable	JJ	O
method	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
construct	NN	O
may	MD	O
be	VB	O
introduced	VBN	O
directly	RB	O
into	IN	O
the	DT	O
genomic	JJ	O
DNA	NN	O
of	IN	O
the	DT	O
plant	NN	O
cell	NN	O
using	VBG	O
techniques	NNS	O
such	JJ	O
as	IN	O
electroporation	NN	O
and	CC	O
microinjection	NN	O
of	IN	O
plant	NN	O
cell	NN	O
protoplasts	NNS	O
,	,	O
or	CC	O
the	DT	O
constructs	NNS	O
can	MD	O
be	VB	O
introduced	VBN	O
directly	RB	O
to	TO	O
plant	NN	O
tissue	NN	O
using	VBG	O
ballistic	JJ	O
methods	NNS	O
,	,	O
such	JJ	O
as	IN	O
DNA	NNP	O
particle	NN	O
bombardment	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Christou	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
35:197-203	JJ	I
;	:	O
Pawlowski	NNP	B
(	(	I
1996	CD	I
)	)	I
Mol	NNP	I
.	.	I
Biotechnol	NNP	I
.	.	I
6:17-30	JJ	I
;	:	O
Klein	NNP	B
(	(	I
1987	CD	I
)	)	I
Nature	NNP	I
327:70-73	CD	I
;	:	O
Takumi	NNP	B
(	(	I
1997	CD	I
)	)	I
Genes	NNPS	I
Genet	NNP	I
.	.	I
Syst	NN	I
.	.	I
72:63-69	JJ	I
,	,	O
discussing	VBG	O
use	NN	O
of	IN	O
particle	NN	O
bombardment	NN	O
to	TO	O
introduce	VB	O
transgenes	NNS	O
into	IN	O
wheat	NN	O
;	:	O
and	CC	O
Adam	NNP	O
(	(	O
1997	CD	O
)	)	O
supra	NN	O
,	,	O
for	IN	O
use	NN	O
of	IN	O
particle	NN	O
bombardment	NN	O
to	TO	O
introduce	VB	O
YACs	NNP	O
into	IN	O
plant	NN	O
cells	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
Rinehart	NNP	O
(	(	O
1997	CD	O
)	)	O
supra	NN	O
,	,	O
used	VBD	O
particle	NN	O
bombardment	NN	O
to	TO	O
generate	VB	O
transgenic	JJ	O
cotton	NN	O
plants	NNS	O
.	.	O
Apparatus	NNP	O
for	IN	O
accelerating	VBG	O
particles	NNS	O
is	VBZ	O
described	JJ	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,015,580	CD	O
;	:	O
and	CC	O
,	,	O
the	DT	O
commercially	RB	O
available	JJ	O
BioRad	NNP	O
(	(	O
Biolistics	NNPS	O
)	)	O
PDS-2000	CD	O
particle	NN	O
acceleration	NN	O
instrument	NN	O
;	:	O
see	NN	O
also	RB	O
,	,	O
John	NNP	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,608,148	CD	O
;	:	O
and	CC	O
Ellis	NNP	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,681,730	CD	O
,	,	O
describing	VBG	O
particle-mediated	JJ	O
transformation	NN	O
of	IN	O
gymnosperms	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
protoplasts	NNS	O
can	MD	O
be	VB	O
immobilized	VBN	O
and	CC	O
injected	VBN	O
with	IN	O
a	DT	O
nucleic	JJ	O
acids	NNS	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
expression	NN	O
construct	NN	O
.	.	O
Although	IN	O
plant	NN	O
regeneration	NN	O
from	IN	O
protoplasts	NNS	O
is	VBZ	O
not	RB	O
easy	JJ	O
with	IN	O
cereals	NNS	O
,	,	O
plant	NN	O
regeneration	NN	O
is	VBZ	O
possible	JJ	O
in	IN	O
legumes	NNS	O
using	VBG	O
somatic	JJ	O
embryogenesis	NN	O
from	IN	O
protoplast	NN	O
derived	VBN	O
callus	NN	O
.	.	O
Organized	VBN	O
tissues	NNS	O
can	MD	O
be	VB	O
transformed	VBN	O
with	IN	O
naked	JJ	O
DNA	NNP	O
using	VBG	O
gene	NN	O
gun	NN	O
technique	NN	O
,	,	O
where	WRB	O
DNA	NN	O
is	VBZ	O
coated	VBN	O
on	IN	O
tungsten	JJ	O
microprojectiles	NNS	O
,	,	O
shot	VBD	O
1/100th	CD	O
the	DT	O
size	NN	O
of	IN	O
cells	NNS	O
,	,	O
which	WDT	O
carry	VBP	O
the	DT	O
DNA	NN	O
deep	RB	O
into	IN	O
cells	NNS	O
and	CC	O
organelles	NNS	O
.	.	O
Transformed	NNP	O
tissue	NN	O
is	VBZ	O
then	RB	O
induced	VBN	O
to	TO	O
regenerate	VB	O
,	,	O
usually	RB	O
by	IN	O
somatic	JJ	O
embryogenesis	NN	O
.	.	O
This	DT	O
technique	NN	O
has	VBZ	O
been	VBN	O
successful	JJ	O
in	IN	O
several	JJ	O
cereal	NN	O
species	NNS	O
including	VBG	O
maize	NN	O
and	CC	O
rice	NN	O
.	.	O
Nucleic	NNP	O
acids	NNS	O
,	,	O
e.g.	NN	O
,	,	O
expression	NN	O
constructs	NNS	O
,	,	O
can	MD	O
also	RB	O
be	VB	O
introduced	VBN	O
in	IN	O
to	TO	O
plant	NN	O
cells	NNS	O
using	VBG	O
recombinant	JJ	O
viruses	NNS	O
.	.	O
Plant	NN	O
cells	NNS	O
can	MD	O
be	VB	O
transformed	VBN	O
using	VBG	O
viral	JJ	O
vectors	NNS	O
,	,	O
such	JJ	O
as	IN	O
,	,	O
e.g.	UH	O
,	,	O
tobacco	NN	O
mosaic	NN	O
virus	NN	O
derived	VBN	O
vectors	NNS	O
(	(	O
Rouwendal	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
33:989-999	JJ	I
)	)	O
,	,	O
see	VBP	O
Porta	NNP	B
(	(	I
1996	CD	I
)	)	I
“	NN	I
Use	NNP	I
of	IN	I
viral	JJ	I
replicons	NNS	I
for	IN	I
the	DT	I
expression	NN	I
of	IN	I
genes	NNS	I
in	IN	I
plants	NNS	I
,	,	I
”	NNP	I
Mol	NNP	I
.	.	I
Biotechnol	NNP	I
.	.	I
5:209-221	JJ	I
.	.	O
Alternatively	RB	O
,	,	O
nucleic	JJ	O
acids	NNS	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
expression	NN	O
construct	NN	O
,	,	O
can	MD	O
be	VB	O
combined	VBN	O
with	IN	O
suitable	JJ	O
T-DNA	JJ	O
flanking	NN	O
regions	NNS	O
and	CC	O
introduced	VBN	O
into	IN	O
a	DT	O
conventional	JJ	O
Agrobacterium	NNP	O
tumefaciens	VBZ	O
host	NN	O
vector	NN	O
.	.	O
The	DT	O
virulence	NN	O
functions	NNS	O
of	IN	O
the	DT	O
Agrobacterium	NNP	O
tumefaciens	VBZ	O
host	NN	O
will	MD	O
direct	VB	O
the	DT	O
insertion	NN	O
of	IN	O
the	DT	O
construct	NN	O
and	CC	O
adjacent	JJ	O
marker	NN	O
into	IN	O
the	DT	O
plant	NN	O
cell	NN	O
DNA	NNP	O
when	WRB	O
the	DT	O
cell	NN	O
is	VBZ	O
infected	VBN	O
by	IN	O
the	DT	O
bacteria	NNS	O
.	.	O
Agrobacterium	NNP	O
tumefaciens-mediated	JJ	O
transformation	NN	O
techniques	NNS	O
,	,	O
including	VBG	O
disarming	NN	O
and	CC	O
use	NN	O
of	IN	O
binary	JJ	O
vectors	NNS	O
,	,	O
are	VBP	O
well	RB	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
literature	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
Horsch	NNP	B
(	(	I
1984	CD	I
)	)	I
Science	NNP	I
233:496-498	CD	I
;	:	O
Fraley	NNP	B
(	(	I
1983	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
80:4803	CD	I
(	(	I
1983	CD	I
)	)	I
;	:	O
Gene	NNP	B
Transfer	NNP	I
to	TO	I
Plants	NNS	I
,	,	I
Potrykus	NNP	I
,	,	I
ed	NN	I
.	.	I
(	(	I
Springer-Verlag	NNP	I
,	,	I
Berlin	NNP	I
1995	CD	I
)	)	I
.	.	O
The	DT	O
DNA	NN	O
in	IN	O
an	DT	O
A.	NN	O
tumefaciens	NNS	O
cell	NN	O
is	VBZ	O
contained	VBN	O
in	IN	O
the	DT	O
bacterial	JJ	O
chromosome	NN	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
another	DT	O
structure	NN	O
known	VBN	O
as	IN	O
a	DT	O
Ti	NNP	O
(	(	O
tumor-inducing	VBG	O
)	)	O
plasmid	NN	O
.	.	O
The	DT	O
Ti	NNP	O
plasmid	NN	O
contains	VBZ	O
a	DT	O
stretch	NN	O
of	IN	O
DNA	NNP	O
termed	VBD	O
T-DNA	NNP	O
(	(	O
˜20	NNP	O
kb	NNP	O
long	RB	O
)	)	O
that	WDT	O
is	VBZ	O
transferred	VBN	O
to	TO	O
the	DT	O
plant	NN	O
cell	NN	O
in	IN	O
the	DT	O
infection	NN	O
process	NN	O
and	CC	O
a	DT	O
series	NN	O
of	IN	O
vir	NN	O
(	(	O
virulence	NN	O
)	)	O
genes	NNS	O
that	WDT	O
direct	VBP	O
the	DT	O
infection	NN	O
process	NN	O
.	.	O
A.	NN	O
tumefaciens	NNS	O
can	MD	O
only	RB	O
infect	VB	O
a	DT	O
plant	NN	O
through	IN	O
wounds	NNS	O
:	:	O
when	WRB	O
a	DT	O
plant	NN	O
root	NN	O
or	CC	O
stem	NN	O
is	VBZ	O
wounded	VBN	O
it	PRP	O
gives	VBZ	O
off	RP	O
certain	JJ	O
chemical	NN	O
signals	NNS	O
,	,	O
in	IN	O
response	NN	O
to	TO	O
which	WDT	O
,	,	O
the	DT	O
vir	NN	O
genes	NNS	O
of	IN	O
A.	NN	O
tumefaciens	NNS	O
become	VBP	O
activated	JJ	O
and	CC	O
direct	VB	O
a	DT	O
series	NN	O
of	IN	O
events	NNS	O
necessary	JJ	O
for	IN	O
the	DT	O
transfer	NN	O
of	IN	O
the	DT	O
T-DNA	NN	O
from	IN	O
the	DT	O
Ti	NNP	O
plasmid	NN	O
to	TO	O
the	DT	O
plant	NN	O
's	POS	O
chromosome	NN	O
.	.	O
The	DT	O
T-DNA	NNP	O
then	RB	O
enters	VBZ	O
the	DT	O
plant	NN	O
cell	NN	O
through	IN	O
the	DT	O
wound	NN	O
.	.	O
One	CD	O
speculation	NN	O
is	VBZ	O
that	IN	O
the	DT	O
T-DNA	NNP	O
waits	NNS	O
until	IN	O
the	DT	O
plant	NN	O
DNA	NN	O
is	VBZ	O
being	VBG	O
replicated	VBN	O
or	CC	O
transcribed	VBN	O
,	,	O
then	RB	O
inserts	VBZ	O
itself	PRP	O
into	IN	O
the	DT	O
exposed	JJ	O
plant	NN	O
DNA	NN	O
.	.	O
In	IN	O
order	NN	O
to	TO	O
use	VB	O
A.	NN	O
tumefaciens	NNS	O
as	IN	O
a	DT	O
transgene	NN	O
vector	NN	O
,	,	O
the	DT	O
tumor-inducing	JJ	O
section	NN	O
of	IN	O
T-DNA	NNP	O
have	VBP	O
to	TO	O
be	VB	O
removed	VBN	O
,	,	O
while	IN	O
retaining	VBG	O
the	DT	O
T-DNA	JJ	O
border	NN	O
regions	NNS	O
and	CC	O
the	DT	O
vir	NN	O
genes	NNS	O
.	.	O
The	DT	O
transgene	NN	O
is	VBZ	O
then	RB	O
inserted	VBN	O
between	IN	O
the	DT	O
T-DNA	NNP	O
border	NN	O
regions	NNS	O
,	,	O
where	WRB	O
it	PRP	O
is	VBZ	O
transferred	VBN	O
to	TO	O
the	DT	O
plant	NN	O
cell	NN	O
and	CC	O
becomes	VBZ	O
integrated	VBN	O
into	IN	O
the	DT	O
plant	NN	O
's	POS	O
chromosomes	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
for	IN	O
the	DT	O
transformation	NN	O
of	IN	O
monocotyledonous	JJ	O
plants	NNS	O
using	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
including	VBG	O
important	JJ	O
cereals	NNS	O
,	,	O
see	VBP	O
Hiei	NNP	B
(	(	I
1997	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
35:205-218	JJ	I
.	.	O
See	NNP	O
also	RB	O
,	,	O
e.g.	RB	O
,	,	O
Horsch	NNP	B
,	,	I
Science	NNP	I
(	(	I
1984	CD	I
)	)	I
233:496	CD	I
;	:	O
Fraley	NNP	B
(	(	I
1983	CD	I
)	)	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci	NNP	I
.	.	I
USA	NNP	I
80:4803	CD	I
;	:	O
Thykjaer	NNP	B
(	(	I
1997	CD	I
)	)	I
supra	NN	I
;	:	O
Park	NNP	B
(	(	I
1996	CD	I
)	)	I
Plant	NNP	I
Mol	NNP	I
.	.	I
Biol	NNP	I
.	.	I
32:1135-1148	JJ	I
,	,	O
discussing	VBG	O
T-DNA	JJ	O
integration	NN	O
into	IN	O
genomic	JJ	O
DNA	NN	O
.	.	O
See	NNP	O
also	RB	O
D'Halluin	NNP	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,712,135	CD	O
,	,	O
describing	VBG	O
a	DT	O
process	NN	O
for	IN	O
the	DT	O
stable	JJ	O
integration	NN	O
of	IN	O
a	DT	O
DNA	NN	O
comprising	VBG	O
a	DT	O
gene	NN	O
that	WDT	O
is	VBZ	O
functional	JJ	O
in	IN	O
a	DT	O
cell	NN	O
of	IN	O
a	DT	O
cereal	NN	O
,	,	O
or	CC	O
other	JJ	O
monocotyledonous	JJ	O
plant	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
third	JJ	O
step	NN	O
can	MD	O
involve	VB	O
selection	NN	O
and	CC	O
regeneration	NN	O
of	IN	O
whole	JJ	O
plants	NNS	O
capable	JJ	O
of	IN	O
transmitting	VBG	O
the	DT	O
incorporated	VBN	O
target	NN	O
gene	NN	O
to	TO	O
the	DT	O
next	JJ	O
generation	NN	O
.	.	O
Such	JJ	O
regeneration	NN	O
techniques	NNS	O
rely	VBP	O
on	IN	O
manipulation	NN	O
of	IN	O
certain	JJ	O
phytohormones	NNS	O
in	IN	O
a	DT	O
tissue	NN	O
culture	NN	O
growth	NN	O
medium	NN	O
,	,	O
typically	RB	O
relying	VBG	O
on	IN	O
a	DT	O
biocide	JJ	O
and/or	NN	O
herbicide	NN	O
marker	NN	O
that	WDT	O
has	VBZ	O
been	VBN	O
introduced	VBN	O
together	RB	O
with	IN	O
the	DT	O
desired	JJ	O
nucleotide	JJ	O
sequences	NNS	O
.	.	O
Plant	JJ	O
regeneration	NN	O
from	IN	O
cultured	JJ	O
protoplasts	NNS	O
is	VBZ	O
described	VBN	O
in	IN	O
Evans	NNP	B
et	CC	I
al.	NN	I
,	,	I
Protoplasts	NNPS	I
Isolation	NNP	I
and	CC	I
Culture	NNP	I
,	,	I
Handbook	NNP	I
of	IN	I
Plant	NNP	I
Cell	NNP	I
Culture	NNP	I
,	,	I
pp	NN	I
.	.	I
124-176	JJ	I
,	,	I
MacMillilan	NNP	I
Publishing	NNP	I
Company	NNP	I
,	,	I
New	NNP	I
York	NNP	I
,	,	I
1983	CD	I
;	:	O
and	CC	O
Binding	NNP	B
,	,	I
Regeneration	NNP	I
of	IN	I
Plants	NNP	I
,	,	I
Plant	NNP	I
Protoplasts	NNP	I
,	,	I
pp	NN	I
.	.	I
21-73	JJ	I
,	,	I
CRC	NNP	I
Press	NNP	I
,	,	I
Boca	NNP	I
Raton	NNP	I
,	,	I
1985	CD	I
.	.	O
Regeneration	NN	O
can	MD	O
also	RB	O
be	VB	O
obtained	VBN	O
from	IN	O
plant	NN	O
callus	NN	O
,	,	O
explants	NNS	O
,	,	O
organs	NNS	O
,	,	O
or	CC	O
parts	NNS	O
thereof	NN	O
.	.	O
Such	JJ	O
regeneration	NN	O
techniques	NNS	O
are	VBP	O
described	VBN	O
generally	RB	O
in	IN	O
Klee	NNP	B
(	(	I
1987	CD	I
)	)	I
Ann	NNP	I
.	.	I
Rev	NNP	I
.	.	I
of	IN	I
Plant	NNP	I
Phys	NNP	I
.	.	I
38:467-486	CD	I
.	.	O
To	TO	O
obtain	VB	O
whole	JJ	O
plants	NNS	O
from	IN	O
transgenic	JJ	O
tissues	NNS	O
such	JJ	O
as	IN	O
immature	NN	O
embryos	NN	O
,	,	O
they	PRP	O
can	MD	O
be	VB	O
grown	VBN	O
under	IN	O
controlled	JJ	O
environmental	JJ	O
conditions	NNS	O
in	IN	O
a	DT	O
series	NN	O
of	IN	O
media	NNS	O
containing	VBG	O
nutrients	NNS	O
and	CC	O
hormones	NNS	O
,	,	O
a	DT	O
process	NN	O
known	VBN	O
as	IN	O
tissue	NN	O
culture	NN	O
.	.	O
Once	RB	O
whole	JJ	O
plants	NNS	O
are	VBP	O
generated	VBN	O
and	CC	O
produce	VBP	O
seed	NN	O
,	,	O
evaluation	NN	O
of	IN	O
the	DT	O
progeny	NN	O
begins	VBZ	O
.	.	O
After	IN	O
the	DT	O
expression	NN	O
cassette	NN	O
is	VBZ	O
stably	RB	O
incorporated	VBN	O
in	IN	O
transgenic	JJ	O
plants	NNS	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
other	JJ	O
plants	NNS	O
by	IN	O
sexual	JJ	O
crossing	NN	O
.	.	O
Any	DT	O
of	IN	O
a	DT	O
number	NN	O
of	IN	O
standard	JJ	O
breeding	VBG	O
techniques	NNS	O
can	MD	O
be	VB	O
used	VBN	O
,	,	O
depending	VBG	O
upon	IN	O
the	DT	O
species	NNS	O
to	TO	O
be	VB	O
crossed	VBN	O
.	.	O
Since	IN	O
transgenic	JJ	O
expression	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
leads	VBZ	O
to	TO	O
phenotypic	VB	O
changes	NNS	O
,	,	O
plants	NNS	O
comprising	VBG	O
the	DT	O
recombinant	JJ	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
sexually	RB	O
crossed	VBN	O
with	IN	O
a	DT	O
second	JJ	O
plant	NN	O
to	TO	O
obtain	VB	O
a	DT	O
final	JJ	O
product	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
seed	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
derived	VBN	O
from	IN	O
a	DT	O
cross	NN	O
between	IN	O
two	CD	O
transgenic	JJ	O
plants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
a	DT	O
cross	NN	O
between	IN	O
a	DT	O
plant	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
another	DT	O
plant	NN	O
.	.	O
The	DT	O
desired	JJ	O
effects	NNS	O
(	(	O
e.g.	NN	O
,	,	O
expression	NN	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
produce	VB	O
a	DT	O
plant	NN	O
in	IN	O
which	WDT	O
flowering	VBG	O
behavior	NN	O
is	VBZ	O
altered	VBN	O
)	)	O
can	MD	O
be	VB	O
enhanced	VBN	O
when	WRB	O
both	DT	O
parental	JJ	O
plants	NNS	O
express	VB	O
the	DT	O
polypeptides	NNS	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
alpha	JJ	O
amylase	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
desired	JJ	O
effects	NNS	O
can	MD	O
be	VB	O
passed	VBN	O
to	TO	O
future	VB	O
plant	NN	O
generations	NNS	O
by	IN	O
standard	JJ	O
propagation	NN	O
means	NNS	O
.	.	O
The	DT	O
nucleic	JJ	O
acids	NNS	O
and	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
expressed	VBN	O
in	IN	O
or	CC	O
inserted	VBN	O
in	IN	O
any	DT	O
plant	NN	O
or	CC	O
seed	NN	O
.	.	O
Transgenic	JJ	O
plants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
dicotyledonous	JJ	O
or	CC	O
monocotyledonous	JJ	O
.	.	O
Examples	NNS	O
of	IN	O
monocot	NN	O
transgenic	JJ	O
plants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
grasses	NNS	O
,	,	O
such	JJ	O
as	IN	O
meadow	JJ	O
grass	NN	O
(	(	O
blue	JJ	O
grass	NN	O
,	,	O
Poa	NNP	O
)	)	O
,	,	O
forage	JJ	O
grass	NN	O
such	JJ	O
as	IN	O
festuca	NN	O
,	,	O
lolium	NN	O
,	,	O
temperate	JJ	O
grass	NN	O
,	,	O
such	JJ	O
as	IN	O
Agrostis	NNP	O
,	,	O
and	CC	O
cereals	NNS	O
,	,	O
e.g.	NN	O
,	,	O
wheat	NN	O
,	,	O
oats	NNS	O
,	,	O
rye	NN	O
,	,	O
barley	NN	O
,	,	O
rice	NN	O
,	,	O
sorghum	NN	O
,	,	O
and	CC	O
maize	NN	O
(	(	O
corn	NN	O
)	)	O
.	.	O
Examples	NNS	O
of	IN	O
dicot	JJ	O
transgenic	JJ	O
plants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
tobacco	NN	O
,	,	O
legumes	RB	O
,	,	O
such	JJ	O
as	IN	O
lupins	NNS	O
,	,	O
potato	NN	O
,	,	O
sugar	NN	O
beet	NN	O
,	,	O
pea	NN	O
,	,	O
bean	NN	O
and	CC	O
soybean	NN	O
,	,	O
and	CC	O
cruciferous	JJ	O
plants	NNS	O
(	(	O
family	NN	O
Brassicaceae	NNP	O
)	)	O
,	,	O
such	JJ	O
as	IN	O
cauliflower	NN	O
,	,	O
rape	NN	O
seed	NN	O
,	,	O
and	CC	O
the	DT	O
closely	RB	O
related	JJ	O
model	NN	O
organism	NN	O
Arabidopsis	NNP	O
thaliana	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
transgenic	JJ	O
plants	NNS	O
and	CC	O
seeds	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
a	DT	O
broad	JJ	O
range	NN	O
of	IN	O
plants	NNS	O
,	,	O
including	VBG	O
,	,	O
but	CC	O
not	RB	O
limited	JJ	O
to	TO	O
,	,	O
species	NNS	O
from	IN	O
the	DT	O
genera	NN	O
Anacardium	NNP	O
,	,	O
Arachis	NNP	O
,	,	O
Asparagus	NNP	O
,	,	O
Atropa	NNP	O
,	,	O
Avena	NNP	O
,	,	O
Brassica	NNP	O
,	,	O
Citrus	NNP	O
,	,	O
Citrullus	NNP	O
,	,	O
Capsicum	NNP	O
,	,	O
Carthamus	NNP	O
,	,	O
Cocos	NNP	O
,	,	O
Coffea	NNP	O
,	,	O
Cucumis	NNP	O
,	,	O
Cucurbita	NNP	O
,	,	O
Daucus	NNP	O
,	,	O
Elaeis	NNP	O
,	,	O
Fragaria	NNP	O
,	,	O
Glycine	NNP	O
,	,	O
Gossypium	NNP	O
,	,	O
Helianthus	NNP	O
,	,	O
Heterocallis	NNP	O
,	,	O
Hordeum	NNP	O
,	,	O
Hyoscyamus	NNP	O
,	,	O
Lactuca	NNP	O
,	,	O
Linum	NNP	O
,	,	O
Lolium	NNP	O
,	,	O
Lupinus	NNP	O
,	,	O
Lycopersicon	NNP	O
,	,	O
Malus	NNP	O
,	,	O
Manihot	NNP	O
,	,	O
Majorana	NNP	O
,	,	O
Medicago	NNP	O
,	,	O
Nicotiana	NNP	O
,	,	O
Olea	NNP	O
,	,	O
Oryza	NNP	O
,	,	O
Panieum	NNP	O
,	,	O
Pannisetum	NNP	O
,	,	O
Persea	NNP	O
,	,	O
Phaseolus	NNP	O
,	,	O
Pistachia	NNP	O
,	,	O
Pisum	NNP	O
,	,	O
Pyrus	NNP	O
,	,	O
Prunus	NNP	O
,	,	O
Raphanus	NNP	O
,	,	O
Ricinus	NNP	O
,	,	O
Secale	NNP	O
,	,	O
Senecio	NNP	O
,	,	O
Sinapis	NNP	O
,	,	O
Solanum	NNP	O
,	,	O
Sorghum	NNP	O
,	,	O
Theobromus	NNP	O
,	,	O
Trigonella	NNP	O
,	,	O
Triticum	NNP	O
,	,	O
Vicia	NNP	O
,	,	O
Vitis	NNP	O
,	,	O
Vigna	NNP	O
,	,	O
and	CC	O
Zea	NNP	O
.	.	O
In	IN	O
alternative	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
expressed	VBN	O
in	IN	O
plants	NNS	O
which	WDT	O
contain	VBP	O
fiber	JJ	O
cells	NNS	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
cotton	NN	O
,	,	O
silk	JJ	O
cotton	NN	O
tree	NN	O
(	(	O
Kapok	NNP	O
,	,	O
Ceiba	NNP	O
pentandra	NN	O
)	)	O
,	,	O
desert	JJ	O
willow	NN	O
,	,	O
creosote	NN	O
bush	NN	O
,	,	O
winterfat	NN	O
,	,	O
balsa	NN	O
,	,	O
ramie	NN	O
,	,	O
kenaf	NN	O
,	,	O
hemp	NN	O
,	,	O
roselle	NN	O
,	,	O
jute	NN	O
,	,	O
sisal	JJ	O
abaca	NN	O
and	CC	O
flax	NN	O
.	.	O
In	IN	O
alternative	JJ	O
embodiments	NNS	O
,	,	O
the	DT	O
transgenic	JJ	O
plants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
members	NNS	O
of	IN	O
the	DT	O
genus	NN	O
Gossypium	NNP	O
,	,	O
including	VBG	O
members	NNS	O
of	IN	O
any	DT	O
Gossypium	NNP	O
species	NNS	O
,	,	O
such	JJ	O
as	IN	O
G.	NNP	O
arboreum	NN	O
;	:	O
G.	NNP	O
herbaceum	NN	O
,	,	O
G.	NNP	O
barbadense	NN	O
,	,	O
and	CC	O
G.	NNP	O
hirsutum	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
for	IN	O
transgenic	JJ	O
plants	NNS	O
to	TO	O
be	VB	O
used	VBN	O
for	IN	O
producing	VBG	O
large	JJ	O
amounts	NNS	O
of	IN	O
the	DT	O
polypeptides	NNS	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
alpha	JJ	O
amylase	NN	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
see	VBP	O
Palmgren	NNP	B
(	(	I
1997	CD	I
)	)	I
Trends	NNPS	I
Genet	NNP	I
.	.	I
13:348	CD	I
;	:	O
Chong	NNP	B
(	(	I
1997	CD	I
)	)	I
Transgenic	NNP	I
Res	NNP	I
.	.	I
6:289-296	JJ	I
(	(	O
producing	VBG	O
human	JJ	O
milk	NN	O
protein	NN	O
beta-casein	NN	O
in	IN	O
transgenic	JJ	O
potato	NN	O
plants	NNS	O
using	VBG	O
an	DT	O
auxin-inducible	JJ	O
,	,	O
bidirectional	JJ	O
mannopine	NN	O
synthase	NN	O
(	(	O
mas1′,2′	NN	O
)	)	O
promoter	NN	O
with	IN	O
Agrobacterium	NNP	O
tumefaciens-mediated	JJ	O
leaf	NN	O
disc	NN	O
transformation	NN	O
methods	NNS	O
)	)	O
.	.	O
Using	VBG	O
known	VBN	O
procedures	NNS	O
,	,	O
one	CD	O
of	IN	O
skill	NN	O
can	MD	O
screen	VB	O
for	IN	O
plants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
by	IN	O
detecting	VBG	O
the	DT	O
increase	NN	O
or	CC	O
decrease	NN	O
of	IN	O
transgene	JJ	O
mRNA	NN	O
or	CC	O
protein	NN	O
in	IN	O
transgenic	JJ	O
plants	NNS	O
.	.	O
Means	NNS	O
for	IN	O
detecting	VBG	O
and	CC	O
quantitation	NN	O
of	IN	O
mRNAs	NN	O
or	CC	O
proteins	NNS	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Polypeptides	NNS	O
and	CC	O
Peptides	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
polypeptides	NNS	O
having	VBG	O
a	DT	O
sequence	NN	O
identity	NN	O
(	(	O
e.g.	JJ	O
,	,	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
,	,	O
51	CD	O
%	NN	O
,	,	O
52	CD	O
%	NN	O
,	,	O
53	CD	O
%	NN	O
,	,	O
54	CD	O
%	NN	O
,	,	O
55	CD	O
%	NN	O
,	,	O
56	CD	O
%	NN	O
,	,	O
57	CD	O
%	NN	O
,	,	O
58	CD	O
%	NN	O
,	,	O
59	CD	O
%	NN	O
,	,	O
60	CD	O
%	NN	O
,	,	O
61	CD	O
%	NN	O
,	,	O
62	CD	O
%	NN	O
,	,	O
63	CD	O
%	NN	O
,	,	O
64	CD	O
%	NN	O
,	,	O
65	CD	O
%	NN	O
,	,	O
66	CD	O
%	NN	O
,	,	O
67	CD	O
%	NN	O
,	,	O
68	CD	O
%	NN	O
,	,	O
69	CD	O
%	NN	O
,	,	O
70	CD	O
%	NN	O
,	,	O
71	CD	O
%	NN	O
,	,	O
72	CD	O
%	NN	O
,	,	O
73	CD	O
%	NN	O
,	,	O
74	CD	O
%	NN	O
,	,	O
75	CD	O
%	NN	O
,	,	O
76	CD	O
%	NN	O
,	,	O
77	CD	O
%	NN	O
,	,	O
78	CD	O
%	NN	O
,	,	O
79	CD	O
%	NN	O
,	,	O
80	CD	O
%	NN	O
,	,	O
81	CD	O
%	NN	O
,	,	O
82	CD	O
%	NN	O
,	,	O
83	CD	O
%	NN	O
,	,	O
84	CD	O
%	NN	O
,	,	O
85	CD	O
%	NN	O
,	,	O
86	CD	O
%	NN	O
,	,	O
87	CD	O
%	NN	O
,	,	O
88	CD	O
%	NN	O
,	,	O
89	CD	O
%	NN	O
,	,	O
90	CD	O
%	NN	O
,	,	O
91	CD	O
%	NN	O
,	,	O
92	CD	O
%	NN	O
,	,	O
93	CD	O
%	NN	O
,	,	O
94	CD	O
%	NN	O
,	,	O
95	CD	O
%	NN	O
,	,	O
96	CD	O
%	NN	O
,	,	O
97	CD	O
%	NN	O
,	,	O
98	CD	O
%	NN	O
,	,	O
99	CD	O
%	NN	O
,	,	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
complete	JJ	O
(	(	O
100	CD	O
%	NN	O
)	)	O
sequence	NN	O
identity	NN	O
)	)	O
to	TO	O
an	DT	O
exemplary	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
subsequences	NNS	O
thereof	NN	O
and	CC	O
variants	NNS	O
thereof	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
has	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
.	.	O
The	DT	O
identity	NN	O
can	MD	O
be	VB	O
over	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
,	,	O
or	CC	O
,	,	O
the	DT	O
identity	NN	O
can	MD	O
be	VB	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
,	,	O
60	CD	O
,	,	O
70	CD	O
,	,	O
80	CD	O
,	,	O
90	CD	O
,	,	O
100	CD	O
,	,	O
150	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
or	CC	O
more	JJR	O
residues	NNS	O
.	.	O
Polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
shorter	JJR	O
than	IN	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
exemplary	JJ	O
polypeptides	NNS	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
polypeptides	NNS	O
(	(	O
peptides	NNS	O
,	,	O
fragments	NNS	O
)	)	O
ranging	VBG	O
in	IN	O
size	NN	O
between	IN	O
about	IN	O
5	CD	O
and	CC	O
the	DT	O
full	JJ	O
length	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
enzyme	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
amylase	NN	O
;	:	O
exemplary	JJ	O
sizes	NNS	O
being	VBG	O
of	IN	O
about	IN	O
5	CD	O
,	,	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
25	CD	O
,	,	O
30	CD	O
,	,	O
35	CD	O
,	,	O
40	CD	O
,	,	O
45	CD	O
,	,	O
50	CD	O
,	,	O
55	CD	O
,	,	O
60	CD	O
,	,	O
65	CD	O
,	,	O
70	CD	O
,	,	O
75	CD	O
,	,	O
80	CD	O
,	,	O
85	CD	O
,	,	O
90	CD	O
,	,	O
100	CD	O
,	,	O
125	CD	O
,	,	O
150	CD	O
,	,	O
175	CD	O
,	,	O
200	CD	O
,	,	O
250	CD	O
,	,	O
300	CD	O
,	,	O
350	CD	O
,	,	O
400	CD	O
,	,	O
450	CD	O
,	,	O
500	CD	O
,	,	O
550	CD	O
,	,	O
600	CD	O
,	,	O
650	CD	O
,	,	O
700	CD	O
,	,	O
or	CC	O
more	JJR	O
residues	NNS	O
,	,	O
e.g.	NN	O
,	,	O
contiguous	JJ	O
residues	NNS	O
of	IN	O
an	DT	O
exemplary	JJ	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Peptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
useful	JJ	O
as	IN	O
,	,	O
e.g.	NN	O
,	,	O
labeling	VBG	O
probes	NNS	O
,	,	O
antigens	NNS	O
,	,	O
toleragens	NNS	O
,	,	O
motifs	NNS	O
,	,	O
amylase	RB	O
active	JJ	O
sites	NNS	O
.	.	O
Polypeptides	NNS	O
and	CC	O
peptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
isolated	VBN	O
from	IN	O
natural	JJ	O
sources	NNS	O
,	,	O
be	VB	O
synthetic	JJ	O
,	,	O
or	CC	O
be	VB	O
recombinantly	RB	O
generated	VBN	O
polypeptides	NNS	O
.	.	O
Peptides	NNS	O
and	CC	O
proteins	NNS	O
can	MD	O
be	VB	O
recombinantly	RB	O
expressed	VBN	O
in	IN	O
vitro	NN	O
or	CC	O
in	IN	O
vivo	NN	O
.	.	O
The	DT	O
peptides	NNS	O
and	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
made	VBN	O
and	CC	O
isolated	JJ	O
using	VBG	O
any	DT	O
method	NN	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
Polypeptide	NNP	O
and	CC	O
peptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
synthesized	VBN	O
,	,	O
whole	JJ	O
or	CC	O
in	IN	O
part	NN	O
,	,	O
using	VBG	O
chemical	NN	O
methods	NNS	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
See	VB	O
e.g.	NN	O
,	,	O
Caruthers	NNP	B
(	(	I
1980	CD	I
)	)	I
Nucleic	NNP	I
Acids	NNP	I
Res	NNP	I
.	.	I
Symp	NNP	I
.	.	I
Ser	NNP	I
.	.	I
215-223	JJ	I
;	:	O
Horn	NNP	B
(	(	I
1980	CD	I
)	)	I
Nucleic	NNP	I
Acids	NNP	I
Res	NNP	I
.	.	I
Symp	NNP	I
.	.	I
Ser	NNP	I
.	.	I
225-232	JJ	I
;	:	O
Banga	NNP	B
,	,	I
A.	NNP	I
K.	NNP	I
,	,	I
Therapeutic	NNP	I
Peptides	NNP	I
and	CC	I
Proteins	NNP	I
,	,	I
Formulation	NNP	I
,	,	I
Processing	NNP	I
and	CC	I
Delivery	NNP	I
Systems	NNP	I
(	(	I
1995	CD	I
)	)	I
Technomic	NNP	I
Publishing	NNP	I
Co.	NNP	I
,	,	I
Lancaster	NNP	I
,	,	I
Pa.	NNP	O
For	IN	O
example	NN	O
,	,	O
peptide	IN	O
synthesis	NN	O
can	MD	O
be	VB	O
performed	VBN	O
using	VBG	O
various	JJ	O
solid-phase	JJ	O
techniques	NNS	O
(	(	O
see	VB	O
e.g.	RB	O
,	,	O
Roberge	NNP	B
(	(	I
1995	CD	I
)	)	I
Science	NN	I
269:202	CD	I
;	:	O
Merrifield	NNP	B
(	(	I
1997	CD	I
)	)	I
Methods	NNP	I
Enzymol	NNP	I
.	.	I
289:3-13	JJ	I
)	)	O
and	CC	O
automated	VBN	O
synthesis	NN	O
may	MD	O
be	VB	O
achieved	VBN	O
,	,	O
e.g.	FW	O
,	,	O
using	VBG	O
the	DT	O
ABI	NNP	O
431A	CD	O
Peptide	NNP	O
Synthesizer	NNP	O
(	(	O
Perkin	NNP	O
Elmer	NNP	O
)	)	O
in	IN	O
accordance	NN	O
with	IN	O
the	DT	O
instructions	NNS	O
provided	VBN	O
by	IN	O
the	DT	O
manufacturer	NN	O
.	.	O
The	DT	O
peptides	NNS	O
and	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
glycosylated	VBN	O
.	.	O
The	DT	O
glycosylation	NN	O
can	MD	O
be	VB	O
added	VBN	O
post-translationally	RB	O
either	DT	O
chemically	RB	O
or	CC	O
by	IN	O
cellular	JJ	O
biosynthetic	JJ	O
mechanisms	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
later	NN	O
incorporates	VBZ	O
the	DT	O
use	NN	O
of	IN	O
known	VBN	O
glycosylation	NN	O
motifs	NNS	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
native	JJ	O
to	TO	O
the	DT	O
sequence	NN	O
or	CC	O
can	MD	O
be	VB	O
added	VBN	O
as	IN	O
a	DT	O
peptide	NN	O
or	CC	O
added	VBN	O
in	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
coding	VBG	O
sequence	NN	O
.	.	O
The	DT	O
glycosylation	NN	O
can	MD	O
be	VB	O
O-linked	JJ	O
or	CC	O
N-linked	JJ	O
.	.	O
The	DT	O
peptides	NNS	O
and	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
as	IN	O
defined	VBN	O
above	IN	O
,	,	O
include	VBP	O
all	DT	O
“	NNP	O
mimetic	JJ	O
”	NN	O
and	CC	O
“	NNP	O
peptidomimetic	JJ	O
”	NN	O
forms	NNS	O
.	.	O
The	DT	O
terms	NNS	O
“	VBP	O
mimetic	JJ	O
”	NN	O
and	CC	O
“	NNP	O
peptidomimetic	JJ	O
”	NNP	O
refer	NN	O
to	TO	O
a	DT	O
synthetic	JJ	O
chemical	NN	O
compound	NN	O
which	WDT	O
has	VBZ	O
substantially	RB	O
the	DT	O
same	JJ	O
structural	JJ	O
and/or	IN	O
functional	JJ	O
characteristics	NNS	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
mimetic	JJ	O
can	MD	O
be	VB	O
either	RB	O
entirely	RB	O
composed	VBN	O
of	IN	O
synthetic	JJ	O
,	,	O
non-natural	JJ	O
analogues	NNS	O
of	IN	O
amino	NN	O
acids	NNS	O
,	,	O
or	CC	O
,	,	O
is	VBZ	O
a	DT	O
chimeric	JJ	O
molecule	NN	O
of	IN	O
partly	RB	O
natural	JJ	O
peptide	NN	O
amino	NN	O
acids	NNS	O
and	CC	O
partly	RB	O
non-natural	JJ	O
analogs	NNS	O
of	IN	O
amino	JJ	O
acids	NNS	O
.	.	O
The	DT	O
mimetic	NN	O
can	MD	O
also	RB	O
incorporate	VB	O
any	DT	O
amount	NN	O
of	IN	O
natural	JJ	O
amino	JJ	O
acid	NN	O
conservative	JJ	O
substitutions	NNS	O
as	RB	O
long	RB	O
as	IN	O
such	JJ	O
substitutions	NNS	O
also	RB	O
do	VBP	O
not	RB	O
substantially	RB	O
alter	VB	O
the	DT	O
mimetic	NN	O
's	POS	O
structure	NN	O
and/or	NN	O
activity	NN	O
.	.	O
As	IN	O
with	IN	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
which	WDT	O
are	VBP	O
conservative	JJ	O
variants	NNS	O
,	,	O
routine	JJ	O
experimentation	NN	O
will	MD	O
determine	VB	O
whether	IN	O
a	DT	O
mimetic	JJ	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
i.e.	FW	O
,	,	O
that	IN	O
its	PRP$	O
structure	NN	O
and/or	NN	O
function	NN	O
is	VBZ	O
not	RB	O
substantially	RB	O
altered	VBN	O
.	.	O
Thus	RB	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
mimetic	JJ	O
composition	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
if	IN	O
it	PRP	O
has	VBZ	O
an	DT	O
amylase	NN	O
activity	NN	O
.	.	O
Polypeptide	NNP	O
mimetic	JJ	O
compositions	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
contain	VB	O
any	DT	O
combination	NN	O
of	IN	O
non-natural	JJ	O
structural	JJ	O
components	NNS	O
.	.	O
In	IN	O
alternative	JJ	O
aspect	NN	O
,	,	O
mimetic	JJ	O
compositions	NNS	O
of	IN	O
the	DT	O
invention	NN	O
include	VBP	O
one	CD	O
or	CC	O
all	DT	O
of	IN	O
the	DT	O
following	JJ	O
three	CD	O
structural	JJ	O
groups	NNS	O
:	:	O
a	DT	O
)	)	O
residue	JJ	O
linkage	NN	O
groups	NNS	O
other	JJ	O
than	IN	O
the	DT	O
natural	JJ	O
amide	NN	O
bond	NN	O
(	(	O
“	JJ	O
peptide	NN	O
bond	NN	O
”	NNP	O
)	)	O
linkages	VBZ	O
;	:	O
b	NN	O
)	)	O
non-natural	JJ	O
residues	NNS	O
in	IN	O
place	NN	O
of	IN	O
naturally	RB	O
occurring	VBG	O
amino	NN	O
acid	NN	O
residues	NNS	O
;	:	O
or	CC	O
c	VB	O
)	)	O
residues	NNS	O
which	WDT	O
induce	VBP	O
secondary	JJ	O
structural	JJ	O
mimicry	NN	O
,	,	O
i.e.	FW	O
,	,	O
to	TO	O
induce	VB	O
or	CC	O
stabilize	VB	O
a	DT	O
secondary	JJ	O
structure	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
beta	NN	O
turn	NN	O
,	,	O
gamma	JJ	O
turn	NN	O
,	,	O
beta	JJ	O
sheet	NN	O
,	,	O
alpha	JJ	O
helix	NN	O
conformation	NN	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
characterized	VBN	O
as	IN	O
a	DT	O
mimetic	JJ	O
when	WRB	O
all	DT	O
or	CC	O
some	DT	O
of	IN	O
its	PRP$	O
residues	NNS	O
are	VBP	O
joined	VBN	O
by	IN	O
chemical	NN	O
means	NNS	O
other	JJ	O
than	IN	O
natural	JJ	O
peptide	JJ	O
bonds	NNS	O
.	.	O
Individual	NNP	O
peptidomimetic	JJ	O
residues	NNS	O
can	MD	O
be	VB	O
joined	VBN	O
by	IN	O
peptide	NN	O
bonds	NNS	O
,	,	O
other	JJ	O
chemical	JJ	O
bonds	NNS	O
or	CC	O
coupling	NN	O
means	NNS	O
,	,	O
such	JJ	O
as	IN	O
,	,	O
e.g.	NN	O
,	,	O
glutaraldehyde	NN	O
,	,	O
N-hydroxysuccinimide	JJ	O
esters	NNS	O
,	,	O
bifunctional	JJ	O
maleimides	NNS	O
,	,	O
N	NNP	O
,	,	O
N′-dicyclohexylcarbodiimide	NNP	O
(	(	O
DCC	NNP	O
)	)	O
or	CC	O
N	NNP	O
,	,	O
N′-diisopropylcarbodiimide	NNP	O
(	(	O
DIC	NNP	O
)	)	O
.	.	O
Linking	VBG	O
groups	NNS	O
that	WDT	O
can	MD	O
be	VB	O
an	DT	O
alternative	JJ	O
to	TO	O
the	DT	O
traditional	JJ	O
amide	NN	O
bond	NN	O
(	(	O
“	JJ	O
peptide	NN	O
bond	NN	O
”	NNP	O
)	)	O
linkages	VBZ	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
ketomethylene	NN	O
(	(	O
e.g.	JJ	O
,	,	O
—C	NNP	O
(	(	O
═O	NNP	O
)	)	O
—CH2—	NN	O
for	IN	O
—C	NNP	O
(	(	O
═O	NNP	O
)	)	O
—NH—	NN	O
)	)	O
,	,	O
aminomethylene	NN	O
(	(	O
CH2—NH	NNP	O
)	)	O
,	,	O
ethylene	UH	O
,	,	O
olefin	FW	O
(	(	O
CH═CH	NNP	O
)	)	O
,	,	O
ether	RB	O
(	(	O
CH2—O	NNP	O
)	)	O
,	,	O
thioether	RB	O
(	(	O
CH2—S	NNP	O
)	)	O
,	,	O
tetrazole	JJ	O
(	(	O
CN4—	NNP	O
)	)	O
,	,	O
thiazole	JJ	O
,	,	O
retroamide	VB	O
,	,	O
thioamide	VB	O
,	,	O
or	CC	O
ester	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Spatola	NNP	B
(	(	I
1983	CD	I
)	)	I
in	IN	I
Chemistry	NNP	I
and	CC	I
Biochemistry	NNP	I
of	IN	I
Amino	NNP	I
Acids	NNP	I
,	,	I
Peptides	NNP	I
and	CC	I
Proteins	NNP	I
,	,	I
Vol	NNP	I
.	.	I
7	CD	I
,	,	I
pp	JJ	I
267-357	JJ	I
,	,	I
“	JJ	I
Peptide	NNP	I
Backbone	NNP	I
Modifications	NNP	I
,	,	I
”	NNP	I
Marcell	NNP	I
Dekker	NNP	I
,	,	I
NY	NNP	I
)	)	O
.	.	O
A	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
characterized	VBN	O
as	IN	O
a	DT	O
mimetic	JJ	O
by	IN	O
containing	VBG	O
all	DT	O
or	CC	O
some	DT	O
non-natural	JJ	O
residues	NNS	O
in	IN	O
place	NN	O
of	IN	O
naturally	RB	O
occurring	VBG	O
amino	NN	O
acid	NN	O
residues	NNS	O
.	.	O
Non-natural	JJ	O
residues	NNS	O
are	VBP	O
well	RB	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
and	CC	O
patent	JJ	O
literature	NN	O
;	:	O
a	DT	O
few	JJ	O
exemplary	JJ	O
non-natural	JJ	O
compositions	NNS	O
useful	JJ	O
as	IN	O
mimetics	NNS	O
of	IN	O
natural	JJ	O
amino	NN	O
acid	NN	O
residues	NNS	O
and	CC	O
guidelines	NNS	O
are	VBP	O
described	VBN	O
below	IN	O
.	.	O
Mimetics	NNS	O
of	IN	O
aromatic	JJ	O
amino	NN	O
acids	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
replacing	VBG	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
D-	NNP	O
or	CC	O
L-naphylalanine	NNP	O
;	:	O
D-	NNP	O
or	CC	O
L-phenylglycine	NNP	O
;	:	O
D-	NNP	O
or	CC	O
L-2	NNP	O
thieneylalanine	NN	O
;	:	O
D-	NNP	O
or	CC	O
L-1	NNP	O
,	,	O
-2	NNP	O
,	,	O
3-	JJ	O
,	,	O
or	CC	O
4-pyreneylalanine	JJ	O
;	:	O
D-	NNP	O
or	CC	O
L-3	NNP	O
thieneylalanine	NN	O
;	:	O
D-	NNP	O
or	CC	O
L-	NNP	O
(	(	O
2-pyridinyl	JJ	O
)	)	O
-alanine	NN	O
;	:	O
D-	NNP	O
or	CC	O
L-	NNP	O
(	(	O
3-pyridinyl	CD	O
)	)	O
-alanine	NN	O
;	:	O
D-	NNP	O
or	CC	O
L-	NNP	O
(	(	O
2-pyrazinyl	JJ	O
)	)	O
-alanine	NN	O
;	:	O
D-	NNP	O
or	CC	O
L-	NNP	O
(	(	O
4-isopropyl	JJ	O
)	)	O
-phenylglycine	NN	O
;	:	O
D-	NNP	O
(	(	O
trifluoromethyl	NN	O
)	)	O
-phenylglycine	NN	O
;	:	O
D-	NNP	O
(	(	O
trifluoromethyl	NN	O
)	)	O
-phenylalanine	NN	O
;	:	O
D-p-fluoro-phenylalanine	NNP	O
;	:	O
D-	NNP	O
or	CC	O
L-p-biphenylphenylalanine	NNP	O
;	:	O
D-	NNP	O
or	CC	O
L-p-methoxy-biphenylphenylalanine	NNP	O
;	:	O
D-	NNP	O
or	CC	O
L-2-indole	NNP	O
(	(	O
alkyl	NN	O
)	)	O
alanines	VBZ	O
;	:	O
and	CC	O
,	,	O
D-	NNP	O
or	CC	O
L-alkylainines	NNS	O
,	,	O
where	WRB	O
alkyl	NN	O
can	MD	O
be	VB	O
substituted	VBN	O
or	CC	O
unsubstituted	JJ	O
methyl	NN	O
,	,	O
ethyl	NN	O
,	,	O
propyl	NN	O
,	,	O
hexyl	NN	O
,	,	O
butyl	NN	O
,	,	O
pentyl	NN	O
,	,	O
isopropyl	NN	O
,	,	O
iso-butyl	JJ	O
,	,	O
sec-isotyl	JJ	O
,	,	O
iso-pentyl	JJ	O
,	,	O
or	CC	O
a	DT	O
non-acidic	JJ	O
amino	NN	O
acids	NNS	O
.	.	O
Aromatic	JJ	O
rings	NNS	O
of	IN	O
a	DT	O
non-natural	JJ	O
amino	NN	O
acid	NN	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
thiazolyl	NN	O
,	,	O
thiophenyl	NN	O
,	,	O
pyrazolyl	NN	O
,	,	O
benzimidazolyl	NN	O
,	,	O
naphthyl	RB	O
,	,	O
furanyl	NN	O
,	,	O
pyrrolyl	NN	O
,	,	O
and	CC	O
pyridyl	RB	O
aromatic	JJ	O
rings	NNS	O
.	.	O
Mimetics	NNS	O
of	IN	O
acidic	JJ	O
amino	JJ	O
acids	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
substitution	NN	O
by	IN	O
,	,	O
e.g.	NN	O
,	,	O
non-carboxylate	JJ	O
amino	NN	O
acids	NNS	O
while	IN	O
maintaining	VBG	O
a	DT	O
negative	JJ	O
charge	NN	O
;	:	O
(	(	O
phosphono	NN	O
)	)	O
alanine	NN	O
;	:	O
sulfated	VBN	O
threonine	NN	O
.	.	O
Carboxyl	NNP	O
side	NN	O
groups	NNS	O
(	(	O
e.g.	NN	O
,	,	O
aspartyl	NN	O
or	CC	O
glutamyl	NN	O
)	)	O
can	MD	O
also	RB	O
be	VB	O
selectively	RB	O
modified	VBN	O
by	IN	O
reaction	NN	O
with	IN	O
carbodiimides	NNS	O
(	(	O
R′—N—C—N—R′	NNP	O
)	)	O
such	JJ	O
as	IN	O
,	,	O
e.g.	UH	O
,	,	O
1-cyclohexyl-3	JJ	O
(	(	O
2-morpholinyl-	JJ	O
(	(	O
4-ethyl	JJ	O
)	)	O
carbodiimide	NN	O
or	CC	O
1-ethyl-3	JJ	O
(	(	O
4-azonia-4,4-dimetholpentyl	JJ	O
)	)	O
carbodiimide	NN	O
.	.	O
Aspartyl	NNP	O
or	CC	O
glutamyl	NN	O
can	MD	O
also	RB	O
be	VB	O
converted	VBN	O
to	TO	O
asparaginyl	VB	O
and	CC	O
glutaminyl	VB	O
residues	NNS	O
by	IN	O
reaction	NN	O
with	IN	O
ammonium	NN	O
ions	NNS	O
.	.	O
Mimetics	NNS	O
of	IN	O
basic	JJ	O
amino	NN	O
acids	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
substitution	NN	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
(	(	O
in	IN	O
addition	NN	O
to	TO	O
lysine	VB	O
and	CC	O
arginine	VB	O
)	)	O
the	DT	O
amino	NN	O
acids	NNS	O
ornithine	NN	O
,	,	O
citrulline	NN	O
,	,	O
or	CC	O
(	(	O
guanidino	NN	O
)	)	O
-acetic	JJ	O
acid	NN	O
,	,	O
or	CC	O
(	(	O
guanidino	NN	O
)	)	O
alkyl-acetic	JJ	O
acid	NN	O
,	,	O
where	WRB	O
alkyl	NN	O
is	VBZ	O
defined	VBN	O
above	IN	O
.	.	O
Nitrile	NNP	O
derivative	NN	O
(	(	O
e.g.	JJ	O
,	,	O
containing	VBG	O
the	DT	O
CN-moiety	NN	O
in	IN	O
place	NN	O
of	IN	O
COOH	NNP	O
)	)	O
can	MD	O
be	VB	O
substituted	VBN	O
for	IN	O
asparagine	NN	O
or	CC	O
glutamine	NN	O
.	.	O
Asparaginyl	NNP	O
and	CC	O
glutaminyl	NN	O
residues	NNS	O
can	MD	O
be	VB	O
deaminated	VBN	O
to	TO	O
the	DT	O
corresponding	JJ	O
aspartyl	NN	O
or	CC	O
glutamyl	NN	O
residues	NNS	O
.	.	O
Arginine	NNP	O
residue	JJ	O
mimetics	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
reacting	VBG	O
arginyl	NN	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
one	CD	O
or	CC	O
more	JJR	O
conventional	JJ	O
reagents	NNS	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
phenylglyoxal	NN	O
,	,	O
2,3-butanedione	CD	O
,	,	O
1,2-cyclo-hexanedione	CD	O
,	,	O
or	CC	O
ninhydrin	RB	O
,	,	O
preferably	RB	O
under	IN	O
alkaline	JJ	O
conditions	NNS	O
.	.	O
Tyrosine	NNP	O
residue	JJ	O
mimetics	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
reacting	VBG	O
tyrosyl	NN	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
aromatic	JJ	O
diazonium	NN	O
compounds	NNS	O
or	CC	O
tetranitromethane	NN	O
.	.	O
N-acetylimidizol	NNP	O
and	CC	O
tetranitromethane	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
form	VB	O
O-acetyl	NNP	O
tyrosyl	NN	O
species	NNS	O
and	CC	O
3-nitro	JJ	O
derivatives	NNS	O
,	,	O
respectively	RB	O
.	.	O
Cysteine	NNP	O
residue	JJ	O
mimetics	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
reacting	VBG	O
cysteinyl	NN	O
residues	NNS	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
alpha-haloacetates	NNS	O
such	JJ	O
as	IN	O
2-chloroacetic	JJ	O
acid	NN	O
or	CC	O
chloroacetamide	NN	O
and	CC	O
corresponding	JJ	O
amines	NNS	O
;	:	O
to	TO	O
give	VB	O
carboxymethyl	NN	O
or	CC	O
carboxyamidomethyl	NN	O
derivatives	NNS	O
.	.	O
Cysteine	NNP	O
residue	JJ	O
mimetics	NNS	O
can	MD	O
also	RB	O
be	VB	O
generated	VBN	O
by	IN	O
reacting	VBG	O
cysteinyl	NN	O
residues	NNS	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
bromo-trifluoroacetone	NN	O
,	,	O
alpha-bromo-beta-	JJ	O
(	(	O
5-imidozoyl	JJ	O
)	)	O
propionic	JJ	O
acid	NN	O
;	:	O
chloroacetyl	JJ	O
phosphate	NN	O
,	,	O
N-alkylmaleimides	NNP	O
,	,	O
3-nitro-2-pyridyl	JJ	O
disulfide	NN	O
;	:	O
methyl	CC	O
2-pyridyl	JJ	O
disulfide	NN	O
;	:	O
p-chloromercuribenzoate	JJ	O
;	:	O
2-chloromercuri-4	JJ	O
nitrophenol	NN	O
;	:	O
or	CC	O
,	,	O
chloro-7-nitrobenzo-oxa-1,3-diazole	JJ	O
.	.	O
Lysine	JJ	O
mimetics	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
(	(	O
and	CC	O
amino	VBZ	O
terminal	JJ	O
residues	NNS	O
can	MD	O
be	VB	O
altered	VBN	O
)	)	O
by	IN	O
reacting	VBG	O
lysinyl	NN	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
succinic	JJ	O
or	CC	O
other	JJ	O
carboxylic	JJ	O
acid	NN	O
anhydrides	NNS	O
.	.	O
Lysine	NNP	O
and	CC	O
other	JJ	O
alpha-amino-containing	JJ	O
residue	JJ	O
mimetics	NNS	O
can	MD	O
also	RB	O
be	VB	O
generated	VBN	O
by	IN	O
reaction	NN	O
with	IN	O
imidoesters	NNS	O
,	,	O
such	JJ	O
as	IN	O
methyl	NN	O
picolinimidate	NN	O
,	,	O
pyridoxal	NN	O
phosphate	NN	O
,	,	O
pyridoxal	NN	O
,	,	O
chloroborohydride	NN	O
,	,	O
trinitro-benzenesulfonic	JJ	O
acid	NN	O
,	,	O
O-methylisourea	NNP	O
,	,	O
2,4	CD	O
,	,	O
pentanedione	NN	O
,	,	O
and	CC	O
transamidase-catalyzed	JJ	O
reactions	NNS	O
with	IN	O
glyoxylate	NN	O
.	.	O
Mimetics	NNS	O
of	IN	O
methionine	NN	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
reaction	NN	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
methionine	JJ	O
sulfoxide	NN	O
.	.	O
Mimetics	NNS	O
of	IN	O
proline	NN	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
pipecolic	JJ	O
acid	NN	O
,	,	O
thiazolidine	JJ	O
carboxylic	JJ	O
acid	NN	O
,	,	O
3-	JJ	O
or	CC	O
4-hydroxy	JJ	O
proline	NN	O
,	,	O
dehydroproline	NN	O
,	,	O
3-	JJ	O
or	CC	O
4-methylproline	JJ	O
,	,	O
or	CC	O
3,3	CD	O
,	,	O
-dimethylproline	NN	O
.	.	O
Histidine	NNP	O
residue	JJ	O
mimetics	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
reacting	VBG	O
histidyl	NN	O
with	IN	O
,	,	O
e.g.	NN	O
,	,	O
diethylprocarbonate	NN	O
or	CC	O
para-bromophenacyl	JJ	O
bromide	NN	O
.	.	O
Other	JJ	O
mimetics	NNS	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
those	DT	O
generated	VBN	O
by	IN	O
hydroxylation	NN	O
of	IN	O
proline	NN	O
and	CC	O
lysine	NN	O
;	:	O
phosphorylation	NN	O
of	IN	O
the	DT	O
hydroxyl	NN	O
groups	NNS	O
of	IN	O
seryl	NN	O
or	CC	O
threonyl	NN	O
residues	NNS	O
;	:	O
methylation	NN	O
of	IN	O
the	DT	O
alpha-amino	JJ	O
groups	NNS	O
of	IN	O
lysine	NN	O
,	,	O
arginine	NN	O
and	CC	O
histidine	NN	O
;	:	O
acetylation	NN	O
of	IN	O
the	DT	O
N-terminal	JJ	O
amine	NN	O
;	:	O
methylation	NN	O
of	IN	O
main	JJ	O
chain	NN	O
amide	IN	O
residues	NNS	O
or	CC	O
substitution	NN	O
with	IN	O
N-methyl	NNP	O
amino	NN	O
acids	NNS	O
;	:	O
or	CC	O
amidation	NN	O
of	IN	O
C-terminal	JJ	O
carboxyl	NN	O
groups	NNS	O
.	.	O
A	DT	O
residue	JJ	O
,	,	O
e.g.	RB	O
,	,	O
an	DT	O
amino	NN	O
acid	NN	O
,	,	O
of	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
also	RB	O
be	VB	O
replaced	VBN	O
by	IN	O
an	DT	O
amino	NN	O
acid	NN	O
(	(	O
or	CC	O
peptidomimetic	JJ	O
residue	NN	O
)	)	O
of	IN	O
the	DT	O
opposite	JJ	O
chirality	NN	O
.	.	O
Thus	RB	O
,	,	O
any	DT	O
amino	JJ	O
acid	NN	O
naturally	RB	O
occurring	VBG	O
in	IN	O
the	DT	O
L-configuration	NNP	O
(	(	O
which	WDT	O
can	MD	O
also	RB	O
be	VB	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
R	NNP	O
or	CC	O
S	NNP	O
,	,	O
depending	VBG	O
upon	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
chemical	NN	O
entity	NN	O
)	)	O
can	MD	O
be	VB	O
replaced	VBN	O
with	IN	O
the	DT	O
amino	NN	O
acid	NN	O
of	IN	O
the	DT	O
same	JJ	O
chemical	JJ	O
structural	JJ	O
type	NN	O
or	CC	O
a	DT	O
peptidomimetic	JJ	O
,	,	O
but	CC	O
of	IN	O
the	DT	O
opposite	JJ	O
chirality	NN	O
,	,	O
referred	VBD	O
to	TO	O
as	IN	O
the	DT	O
D-amino	NNP	O
acid	NN	O
,	,	O
but	CC	O
also	RB	O
can	MD	O
be	VB	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
R-	NNP	O
or	CC	O
S-form	NNP	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
methods	NNS	O
for	IN	O
modifying	VBG	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
by	IN	O
either	DT	O
natural	JJ	O
processes	NNS	O
,	,	O
such	JJ	O
as	IN	O
post-translational	JJ	O
processing	NN	O
(	(	O
e.g.	JJ	O
,	,	O
phosphorylation	NN	O
,	,	O
acylation	NN	O
,	,	O
etc	NN	O
)	)	O
,	,	O
or	CC	O
by	IN	O
chemical	JJ	O
modification	NN	O
techniques	NNS	O
,	,	O
and	CC	O
the	DT	O
resulting	VBG	O
modified	JJ	O
polypeptides	NNS	O
.	.	O
Modifications	NNS	O
can	MD	O
occur	VB	O
anywhere	RB	O
in	IN	O
the	DT	O
polypeptide	NN	O
,	,	O
including	VBG	O
the	DT	O
peptide	NN	O
backbone	NN	O
,	,	O
the	DT	O
amino	NN	O
acid	JJ	O
side-chains	NNS	O
and	CC	O
the	DT	O
amino	NN	O
or	CC	O
carboxyl	NN	O
termini	NN	O
.	.	O
It	PRP	O
will	MD	O
be	VB	O
appreciated	VBN	O
that	IN	O
the	DT	O
same	JJ	O
type	NN	O
of	IN	O
modification	NN	O
may	MD	O
be	VB	O
present	JJ	O
in	IN	O
the	DT	O
same	JJ	O
or	CC	O
varying	VBG	O
degrees	NNS	O
at	IN	O
several	JJ	O
sites	NNS	O
in	IN	O
a	DT	O
given	VBN	O
polypeptide	NN	O
.	.	O
Also	RB	O
a	DT	O
given	VBN	O
polypeptide	NN	O
may	MD	O
have	VB	O
many	JJ	O
types	NNS	O
of	IN	O
modifications	NNS	O
.	.	O
Modifications	NNS	O
include	VBP	O
acetylation	NN	O
,	,	O
acylation	NN	O
,	,	O
ADP-ribosylation	NNP	O
,	,	O
amidation	NN	O
,	,	O
covalent	JJ	O
attachment	NN	O
of	IN	O
flavin	NN	O
,	,	O
covalent	JJ	O
attachment	NN	O
of	IN	O
a	DT	O
heme	NN	O
moiety	NN	O
,	,	O
covalent	JJ	O
attachment	NN	O
of	IN	O
a	DT	O
nucleotide	NN	O
or	CC	O
nucleotide	RB	O
derivative	JJ	O
,	,	O
covalent	JJ	O
attachment	NN	O
of	IN	O
a	DT	O
lipid	JJ	O
or	CC	O
lipid	JJ	O
derivative	JJ	O
,	,	O
covalent	JJ	O
attachment	NN	O
of	IN	O
a	DT	O
phosphatidylinositol	NN	O
,	,	O
cross-linking	JJ	O
cyclization	NN	O
,	,	O
disulfide	JJ	O
bond	NN	O
formation	NN	O
,	,	O
demethylation	NN	O
,	,	O
formation	NN	O
of	IN	O
covalent	JJ	O
cross-links	NNS	O
,	,	O
formation	NN	O
of	IN	O
cysteine	NN	O
,	,	O
formation	NN	O
of	IN	O
pyroglutamate	NN	O
,	,	O
formylation	NN	O
,	,	O
gamma-carboxylation	NN	O
,	,	O
glycosylation	NN	O
,	,	O
GPI	NNP	O
anchor	NN	O
formation	NN	O
,	,	O
hydroxylation	NN	O
,	,	O
iodination	NN	O
,	,	O
methylation	NN	O
,	,	O
myristolyation	NN	O
,	,	O
oxidation	NN	O
,	,	O
pegylation	NN	O
,	,	O
proteolytic	JJ	O
processing	NN	O
,	,	O
phosphorylation	NN	O
,	,	O
prenylation	NN	O
,	,	O
racemization	NN	O
,	,	O
selenoylation	NN	O
,	,	O
sulfation	NN	O
,	,	O
and	CC	O
transfer-RNA	JJ	O
mediated	JJ	O
addition	NN	O
of	IN	O
amino	NN	O
acids	NNS	O
to	TO	O
protein	VB	O
such	JJ	O
as	IN	O
arginylation	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
Creighton	NNP	B
,	,	I
T.	NNP	I
E.	NNP	I
,	,	I
Proteins—Structure	NNP	I
and	CC	I
Molecular	NNP	I
Properties	NNP	I
2nd	CD	I
Ed.	NNP	I
,	,	I
W.H	NNP	I
.	.	I
Freeman	NNP	I
and	CC	I
Company	NNP	I
,	,	I
New	NNP	I
York	NNP	I
(	(	I
1993	CD	I
)	)	I
;	:	O
Posttranslational	NNP	B
Covalent	NNP	I
Modification	NNP	I
of	IN	I
Proteins	NNP	I
,	,	I
B.	NNP	I
C.	NNP	I
Johnson	NNP	I
,	,	I
Ed.	NNP	I
,	,	I
Academic	NNP	I
Press	NNP	I
,	,	I
New	NNP	I
York	NNP	I
,	,	I
pp	NN	I
.	.	I
1-12	CD	I
(	(	I
1983	CD	I
)	)	I
.	.	O
Solid-phase	JJ	O
chemical	NN	O
peptide	NN	O
synthesis	NN	O
methods	NNS	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
synthesize	VB	O
the	DT	O
polypeptide	NN	O
or	CC	O
fragments	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Such	JJ	O
method	NNS	O
have	VBP	O
been	VBN	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
since	IN	O
the	DT	O
early	JJ	O
1960	CD	O
's	POS	O
(	(	O
Merrifield	NNP	B
,	,	I
R.	NNP	I
B.	NNP	I
,	,	I
J	NNP	I
.	.	I
Am	NNP	I
.	.	I
Chem	NNP	I
.	.	I
Soc.	NNP	I
,	,	I
85:2149-2154	CD	I
,	,	I
1963	CD	I
)	)	O
(	(	O
See	NNP	O
also	RB	O
Stewart	NNP	B
,	,	I
J.	NNP	I
M.	NNP	I
and	CC	I
Young	NNP	I
,	,	I
J.	NNP	I
D.	NNP	I
,	,	I
Solid	NNP	I
Phase	NNP	I
Peptide	NNP	I
Synthesis	NNP	I
,	,	I
2nd	CD	I
Ed.	NNP	I
,	,	I
Pierce	NNP	I
Chemical	NNP	I
Co.	NNP	I
,	,	I
Rockford	NNP	I
,	,	I
Ill.	NNP	I
,	,	I
pp	NN	I
.	.	I
11-12	JJ	I
)	)	O
)	)	O
and	CC	O
have	VBP	O
recently	RB	O
been	VBN	O
employed	VBN	O
in	IN	O
commercially	RB	O
available	JJ	O
laboratory	NN	O
peptide	NN	O
design	NN	O
and	CC	O
synthesis	NN	O
kits	NNS	O
(	(	O
Cambridge	NNP	O
Research	NNP	O
Biochemicals	NNP	O
)	)	O
.	.	O
Such	JJ	O
commercially	RB	O
available	JJ	O
laboratory	NN	O
kits	NNS	O
have	VBP	O
generally	RB	O
utilized	VBN	O
the	DT	O
teachings	NNS	O
of	IN	O
H.	NNP	B
M.	NNP	I
Geysen	NNP	I
et	FW	I
al	NN	I
,	,	I
Proc	NNP	I
.	.	I
Natl	NNP	I
.	.	I
Acad	NNP	I
.	.	I
Sci.	NNP	I
,	,	I
USA	NNP	I
,	,	I
81:3998	CD	I
(	(	I
1984	CD	I
)	)	I
and	CC	O
provide	VB	O
for	IN	O
synthesizing	VBG	O
peptides	NNS	O
upon	IN	O
the	DT	O
tips	NNS	O
of	IN	O
a	DT	O
multitude	NN	O
of	IN	O
“	NNP	O
rods	NNS	O
”	VBD	O
or	CC	O
“	JJ	O
pins	NNS	O
”	VBP	O
all	DT	O
of	IN	O
which	WDT	O
are	VBP	O
connected	VBN	O
to	TO	O
a	DT	O
single	JJ	O
plate	NN	O
.	.	O
When	WRB	O
such	PDT	O
a	DT	O
system	NN	O
is	VBZ	O
utilized	JJ	O
,	,	O
a	DT	O
plate	NN	O
of	IN	O
rods	NNS	O
or	CC	O
pins	NNS	O
is	VBZ	O
inverted	VBN	O
and	CC	O
inserted	VBN	O
into	IN	O
a	DT	O
second	JJ	O
plate	NN	O
of	IN	O
corresponding	VBG	O
wells	NNS	O
or	CC	O
reservoirs	NNS	O
,	,	O
which	WDT	O
contain	VBP	O
solutions	NNS	O
for	IN	O
attaching	VBG	O
or	CC	O
anchoring	VBG	O
an	DT	O
appropriate	JJ	O
amino	NN	O
acid	NN	O
to	TO	O
the	DT	O
pin	NN	O
's	POS	O
or	CC	O
rod	NN	O
's	POS	O
tips	NNS	O
.	.	O
By	IN	O
repeating	VBG	O
such	JJ	O
a	DT	O
process	JJ	O
step	NN	O
,	,	O
i.e.	FW	O
,	,	O
inverting	VBG	O
and	CC	O
inserting	VBG	O
the	DT	O
rod	NN	O
's	POS	O
and	CC	O
pin	NN	O
's	POS	O
tips	NNS	O
into	IN	O
appropriate	JJ	O
solutions	NNS	O
,	,	O
amino	JJ	O
acids	NNS	O
are	VBP	O
built	VBN	O
into	IN	O
desired	JJ	O
peptides	NNS	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
a	DT	O
number	NN	O
of	IN	O
available	JJ	O
FMOC	NNP	O
peptide	NN	O
synthesis	NN	O
systems	NNS	O
are	VBP	O
available	JJ	O
.	.	O
For	IN	O
example	NN	O
,	,	O
assembly	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
or	CC	O
fragment	NN	O
can	MD	O
be	VB	O
carried	VBN	O
out	RP	O
on	IN	O
a	DT	O
solid	JJ	O
support	NN	O
using	VBG	O
an	DT	O
Applied	NNP	O
Biosystems	NNP	O
,	,	O
Inc.	NNP	O
Model	NNP	O
431A™	CD	O
automated	VBD	O
peptide	JJ	O
synthesizer	NN	O
.	.	O
Such	JJ	O
equipment	NN	O
provides	VBZ	O
ready	JJ	O
access	NN	O
to	TO	O
the	DT	O
peptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
either	RB	O
by	IN	O
direct	JJ	O
synthesis	NN	O
or	CC	O
by	IN	O
synthesis	NN	O
of	IN	O
a	DT	O
series	NN	O
of	IN	O
fragments	NNS	O
that	WDT	O
can	MD	O
be	VB	O
coupled	VBN	O
using	VBG	O
other	JJ	O
known	VBN	O
techniques	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
novel	JJ	O
amylases	NNS	O
(	(	O
e.g.	NN	O
,	,	O
alpha	JJ	O
amylases	NNS	O
)	)	O
,	,	O
including	VBG	O
the	DT	O
exemplary	JJ	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
them	PRP	O
,	,	O
antibodies	VBZ	O
that	IN	O
bind	VB	O
them	PRP	O
,	,	O
and	CC	O
methods	NNS	O
for	IN	O
making	VBG	O
and	CC	O
using	VBG	O
them	PRP	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
as	IN	O
described	VBN	O
herein	NN	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
ability	NN	O
to	TO	O
hydrolyze	VB	O
starches	NNS	O
into	IN	O
sugars	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
an	DT	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
activities	NNS	O
that	WDT	O
have	VBP	O
been	VBN	O
modified	VBN	O
from	IN	O
those	DT	O
of	IN	O
the	DT	O
exemplary	JJ	O
amylases	NNS	O
described	VBD	O
herein	NN	O
.	.	O
The	DT	O
invention	NN	O
includes	VBZ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
with	IN	O
and	CC	O
without	IN	O
signal	JJ	O
sequences	NNS	O
(	(	O
including	VBG	O
signal	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
or	CC	O
other	JJ	O
signal	JJ	O
sequences	NNS	O
)	)	O
and	CC	O
the	DT	O
signal	JJ	O
sequences	NNS	O
themselves	PRP	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
include	VBP	O
polypeptides	NNS	O
(	(	O
e.g.	NN	O
,	,	O
fusion	NN	O
proteins	NNS	O
)	)	O
comprising	VBG	O
a	DT	O
signal	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
polypeptide	NN	O
comprising	VBG	O
a	DT	O
signal	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
another	DT	O
amylase	NN	O
or	CC	O
another	DT	O
enzyme	NN	O
or	CC	O
other	JJ	O
polypeptide	NN	O
.	.	O
The	DT	O
invention	NN	O
includes	VBZ	O
immobilized	JJ	O
amylases	NNS	O
,	,	O
anti-amylase	JJ	O
antibodies	NNS	O
and	CC	O
fragments	NNS	O
thereof	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
inhibiting	VBG	O
amylase	NN	O
activity	NN	O
,	,	O
e.g	NN	O
,	,	O
using	VBG	O
dominant	JJ	O
negative	JJ	O
mutants	NNS	O
or	CC	O
anti-amylase	JJ	O
antibodies	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
includes	VBZ	O
heterocomplexes	NNS	O
,	,	O
e.g.	NN	O
,	,	O
fusion	NN	O
proteins	NNS	O
,	,	O
heterodimers	NNS	O
,	,	O
etc.	FW	O
,	,	O
comprising	VBG	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
amylases	NNS	O
(	(	O
e.g.	NN	O
,	,	O
alpha	JJ	O
amylases	NNS	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
hydrolyze	VBD	O
internal	JJ	O
polysaccharide	NN	O
bonds	NNS	O
,	,	O
e.g.	NN	O
,	,	O
α-1,4-	JJ	O
and	CC	O
1,6-glucosidic	JJ	O
bonds	NNS	O
in	IN	O
starch	NN	O
to	TO	O
produce	VB	O
smaller	JJR	O
molecular	JJ	O
weight	NN	O
maltodextrines	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
this	DT	O
hydrolysis	NN	O
is	VBZ	O
largely	RB	O
at	IN	O
random	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
producing	VBG	O
smaller	JJR	O
molecular	JJ	O
weight	NN	O
maltodextrines	NNS	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
laboratory	NN	O
and	CC	O
industrial	JJ	O
settings	NNS	O
to	TO	O
hydrolyze	VB	O
starch	NN	O
or	CC	O
any	DT	O
maltodextrine-comprising	JJ	O
compound	NN	O
for	IN	O
a	DT	O
variety	NN	O
of	IN	O
purposes	NNS	O
.	.	O
These	DT	O
amylases	NNS	O
can	MD	O
be	VB	O
used	VBN	O
alone	RB	O
to	TO	O
provide	VB	O
specific	JJ	O
hydrolysis	NN	O
or	CC	O
can	MD	O
be	VB	O
combined	VBN	O
with	IN	O
other	JJ	O
amylases	NNS	O
to	TO	O
provide	VB	O
a	DT	O
“	JJ	O
cocktail	NN	O
”	NN	O
with	IN	O
a	DT	O
broad	JJ	O
spectrum	NN	O
of	IN	O
activity	NN	O
.	.	O
Exemplary	JJ	O
uses	NNS	O
include	VBP	O
the	DT	O
removal	NN	O
or	CC	O
partial	JJ	O
or	CC	O
complete	JJ	O
hydrolysis	NN	O
of	IN	O
starch	NN	O
or	CC	O
any	DT	O
maltodextrine-comprising	JJ	O
compound	NN	O
from	IN	O
biological	JJ	O
,	,	O
food	NN	O
,	,	O
animal	NN	O
feed	NN	O
,	,	O
pharmaceutical	JJ	O
or	CC	O
industrial	JJ	O
samples	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
formulated	VBN	O
in	IN	O
laundry	JJ	O
detergents	NNS	O
to	TO	O
aid	VB	O
in	IN	O
the	DT	O
removal	NN	O
of	IN	O
starch-containing	JJ	O
stains	NNS	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
cleaning	NN	O
agents	NNS	O
in	IN	O
detergent	NN	O
matrices	NNS	O
(	(	O
see	VB	O
industrial	JJ	O
applications	NNS	O
below	IN	O
)	)	O
.	.	O
The	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
initial	JJ	O
stages	NNS	O
(	(	O
liquefaction	NN	O
)	)	O
of	IN	O
starch	NN	O
processing	NN	O
,	,	O
in	IN	O
wet	JJ	O
corn	NN	O
milling	NN	O
,	,	O
in	IN	O
alcohol	NN	O
production	NN	O
,	,	O
in	IN	O
the	DT	O
textile	NN	O
industry	NN	O
for	IN	O
starch	NN	O
desizing	NN	O
,	,	O
in	IN	O
baking	VBG	O
applications	NNS	O
,	,	O
in	IN	O
the	DT	O
beverage	NN	O
industry	NN	O
,	,	O
in	IN	O
oilfields	NNS	O
in	IN	O
drilling	NN	O
processes	NNS	O
;	:	O
in	IN	O
inking	NN	O
of	IN	O
recycled	JJ	O
paper	NN	O
;	:	O
and	CC	O
in	IN	O
animal	JJ	O
feed	NN	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
an	DT	O
amylase	NN	O
activity	NN	O
under	IN	O
various	JJ	O
conditions	NNS	O
,	,	O
e.g.	NN	O
,	,	O
extremes	RB	O
in	IN	O
pH	NN	O
and/or	NN	O
temperature	NN	O
,	,	O
oxidizing	VBG	O
agents	NNS	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
leading	VBG	O
to	TO	O
alternative	JJ	O
amylase	NN	O
preparations	NNS	O
with	IN	O
different	JJ	O
catalytic	JJ	O
efficiencies	NNS	O
and	CC	O
stabilities	NNS	O
,	,	O
e.g.	NN	O
,	,	O
towards	NNS	O
temperature	NN	O
,	,	O
oxidizing	VBG	O
agents	NNS	O
and	CC	O
changing	VBG	O
wash	JJ	O
conditions	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
amylase	NN	O
variants	NNS	O
can	MD	O
be	VB	O
produced	VBN	O
using	VBG	O
techniques	NNS	O
of	IN	O
site-directed	JJ	O
mutagenesis	NN	O
and/or	NN	O
random	JJ	O
mutagenesis	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
directed	VBN	O
evolution	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
produce	VB	O
a	DT	O
great	JJ	O
variety	NN	O
of	IN	O
amylase	JJ	O
variants	NNS	O
with	IN	O
alternative	JJ	O
specificities	NNS	O
and	CC	O
stability	NN	O
.	.	O
The	DT	O
proteins	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
also	RB	O
useful	JJ	O
as	IN	O
research	NN	O
reagents	NNS	O
to	TO	O
identify	VB	O
amylase	JJ	O
modulators	NNS	O
,	,	O
e.g.	NN	O
,	,	O
activators	NNS	O
or	CC	O
inhibitors	NNS	O
of	IN	O
amylase	NN	O
activity	NN	O
.	.	O
Briefly	NNP	O
,	,	O
test	NN	O
samples	NNS	O
(	(	O
compounds	NNS	O
,	,	O
broths	NNS	O
,	,	O
extracts	NNS	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
)	)	O
are	VBP	O
added	VBN	O
to	TO	O
amylase	VB	O
assays	NNS	O
to	TO	O
determine	VB	O
their	PRP$	O
ability	NN	O
to	TO	O
inhibit	VB	O
substrate	JJ	O
cleavage	NN	O
.	.	O
Inhibitors	NNS	O
identified	VBN	O
in	IN	O
this	DT	O
way	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
industry	NN	O
and	CC	O
research	NN	O
to	TO	O
reduce	VB	O
or	CC	O
prevent	VB	O
undesired	JJ	O
proteolysis	NN	O
.	.	O
As	IN	O
with	IN	O
amylases	NNS	O
,	,	O
inhibitors	NNS	O
can	MD	O
be	VB	O
combined	VBN	O
to	TO	O
increase	VB	O
the	DT	O
spectrum	NN	O
of	IN	O
activity	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
methods	NNS	O
of	IN	O
discovering	VBG	O
new	JJ	O
amylases	NNS	O
using	VBG	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
,	,	O
polypeptides	NNS	O
and	CC	O
antibodies	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
lambda	JJ	O
phage	NN	O
libraries	NNS	O
are	VBP	O
screened	VBN	O
for	IN	O
expression-based	JJ	O
discovery	NN	O
of	IN	O
amylases	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
uses	VBZ	O
lambda	JJ	O
phage	NN	O
libraries	NNS	O
in	IN	O
screening	VBG	O
to	TO	O
allow	VB	O
detection	NN	O
of	IN	O
toxic	JJ	O
clones	NNS	O
;	:	O
improved	VBN	O
access	NN	O
to	TO	O
substrate	VB	O
;	:	O
reduced	VBN	O
need	NN	O
for	IN	O
engineering	NN	O
a	DT	O
host	NN	O
,	,	O
by-passing	VBG	O
the	DT	O
potential	NN	O
for	IN	O
any	DT	O
bias	JJ	O
resulting	VBG	O
from	IN	O
mass	NN	O
excision	NN	O
of	IN	O
the	DT	O
library	NN	O
;	:	O
and	CC	O
,	,	O
faster	JJR	O
growth	NN	O
at	IN	O
low	JJ	O
clone	NN	O
densities	NNS	O
.	.	O
Screening	VBG	O
of	IN	O
lambda	JJ	O
phage	NN	O
libraries	NNS	O
can	MD	O
be	VB	O
in	IN	O
liquid	JJ	O
phase	NN	O
or	CC	O
in	IN	O
solid	JJ	O
phase	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
screening	VBG	O
in	IN	O
liquid	JJ	O
phase	NN	O
.	.	O
This	DT	O
gives	VBZ	O
a	DT	O
greater	JJR	O
flexibility	NN	O
in	IN	O
assay	JJ	O
conditions	NNS	O
;	:	O
additional	JJ	O
substrate	NN	O
flexibility	NN	O
;	:	O
higher	JJR	O
sensitivity	NN	O
for	IN	O
weak	JJ	O
clones	NNS	O
;	:	O
and	CC	O
ease	NN	O
of	IN	O
automation	NN	O
over	IN	O
solid	JJ	O
phase	NN	O
screening	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
screening	VBG	O
methods	NNS	O
using	VBG	O
the	DT	O
proteins	NNS	O
and	CC	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
robotic	JJ	O
automation	NN	O
to	TO	O
enable	VB	O
the	DT	O
execution	NN	O
of	IN	O
many	JJ	O
thousands	NNS	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
and	CC	O
screening	VBG	O
assays	NNS	O
in	IN	O
a	DT	O
short	JJ	O
period	NN	O
of	IN	O
time	NN	O
,	,	O
e.g.	NN	O
,	,	O
per	IN	O
day	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
ensuring	VBG	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
accuracy	NN	O
and	CC	O
reproducibility	NN	O
(	(	O
see	VB	O
discussion	NN	O
of	IN	O
arrays	NNS	O
,	,	O
below	IN	O
)	)	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
library	NN	O
of	IN	O
derivative	JJ	O
compounds	NNS	O
can	MD	O
be	VB	O
produced	VBN	O
in	IN	O
a	DT	O
matter	NN	O
of	IN	O
weeks	NNS	O
.	.	O
For	IN	O
further	JJ	O
teachings	NNS	O
on	IN	O
modification	NN	O
of	IN	O
molecules	NNS	O
,	,	O
including	VBG	O
small	JJ	O
molecules	NNS	O
,	,	O
see	VBP	O
PCT/US94/09174	NNP	O
.	.	O
The	DT	O
present	JJ	O
invention	NN	O
includes	VBZ	O
amylase	NN	O
enzymes	NNS	O
which	WDT	O
are	VBP	O
non-naturally	RB	O
occurring	VBG	O
carbonyl	JJ	O
hydrolase	NN	O
variants	NNS	O
(	(	O
e.g.	NN	O
,	,	O
amylase	JJ	O
variants	NNS	O
)	)	O
having	VBG	O
a	DT	O
different	JJ	O
proteolytic	JJ	O
activity	NN	O
,	,	O
stability	NN	O
,	,	O
substrate	JJ	O
specificity	NN	O
,	,	O
pH	NN	O
profile	NN	O
and/or	JJ	O
performance	NN	O
characteristic	NN	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
precursor	NN	O
carbonyl	NN	O
hydrolase	NN	O
from	IN	O
which	WDT	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
variant	NN	O
is	VBZ	O
derived	VBN	O
.	.	O
Specifically	RB	O
,	,	O
such	JJ	O
amylase	NN	O
variants	NNS	O
have	VBP	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
not	RB	O
found	VBN	O
in	IN	O
nature	NN	O
,	,	O
which	WDT	O
is	VBZ	O
derived	VBN	O
by	IN	O
substitution	NN	O
of	IN	O
a	DT	O
plurality	NN	O
of	IN	O
amino	NN	O
acid	NN	O
residues	NNS	O
of	IN	O
a	DT	O
precursor	NN	O
amylase	NN	O
with	IN	O
different	JJ	O
amino	NN	O
acids	NNS	O
.	.	O
The	DT	O
precursor	NN	O
amylase	NN	O
may	MD	O
be	VB	O
a	DT	O
naturally-occurring	JJ	O
amylase	NN	O
or	CC	O
a	DT	O
recombinant	JJ	O
amylase	NN	O
.	.	O
The	DT	O
useful	JJ	O
amylase	NN	O
variants	NNS	O
encompass	VBP	O
the	DT	O
substitution	NN	O
of	IN	O
any	DT	O
of	IN	O
the	DT	O
naturally	RB	O
occurring	VBG	O
L-amino	JJ	O
acids	NNS	O
at	IN	O
the	DT	O
designated	JJ	O
amino	NN	O
acid	NN	O
residue	JJ	O
positions	NNS	O
.	.	O
Amylase	NNP	O
Signal	NNP	O
Sequences	VBZ	O
The	DT	O
invention	NN	O
provides	VBZ	O
amylase	JJ	O
signal	JJ	O
sequences	NNS	O
and	CC	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
these	DT	O
signal	JJ	O
sequences	NNS	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
amino	JJ	O
terminal	JJ	O
13	CD	O
to	TO	O
36	CD	O
residues	NNS	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
.	.	O
The	DT	O
amylase	JJ	O
signal	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
isolated	VBN	O
peptides	NNS	O
,	,	O
or	CC	O
,	,	O
sequences	NNS	O
joined	VBD	O
to	TO	O
another	DT	O
amylase	NN	O
or	CC	O
a	DT	O
non-amylase	JJ	O
polypeptide	NN	O
,	,	O
e.g.	RB	O
,	,	O
as	IN	O
a	DT	O
fusion	NN	O
protein	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
polypeptides	IN	O
comprising	VBG	O
amylase	JJ	O
signal	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
polypeptides	NNS	O
comprising	VBG	O
amylase	JJ	O
signal	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
comprise	NN	O
sequences	VBZ	O
heterologous	JJ	O
to	TO	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
fusion	NN	O
protein	NN	O
comprising	VBG	O
an	DT	O
amylase	JJ	O
signal	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
sequences	NNS	O
from	IN	O
another	DT	O
amylase	NN	O
or	CC	O
a	DT	O
non-amylase	JJ	O
protein	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
with	IN	O
heterologous	JJ	O
signal	JJ	O
sequences	NNS	O
,	,	O
e.g.	NN	O
,	,	O
sequences	NNS	O
with	IN	O
a	DT	O
yeast	JJ	O
signal	JJ	O
sequence	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprising	VBG	O
a	DT	O
heterologous	JJ	O
signal	JJ	O
sequence	NN	O
in	IN	O
a	DT	O
vectors	NNS	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
pPIC	JJ	O
series	NN	O
vector	NN	O
(	(	O
Invitrogen	NNP	O
,	,	O
Carlsbad	NNP	O
,	,	O
Calif.	NNP	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
signal	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
identified	VBN	O
following	VBG	O
identification	NN	O
of	IN	O
novel	JJ	O
amylase	NN	O
polypeptides	NNS	O
.	.	O
The	DT	O
pathways	NNS	O
by	IN	O
which	WDT	O
proteins	NNS	O
are	VBP	O
sorted	VBN	O
and	CC	O
transported	VBN	O
to	TO	O
their	PRP$	O
proper	JJ	O
cellular	JJ	O
location	NN	O
are	VBP	O
often	RB	O
referred	VBN	O
to	TO	O
as	IN	O
protein	NN	O
targeting	VBG	O
pathways	NNS	O
.	.	O
One	CD	O
of	IN	O
the	DT	O
most	RBS	O
important	JJ	O
elements	NNS	O
in	IN	O
all	DT	O
of	IN	O
these	DT	O
targeting	VBG	O
systems	NNS	O
is	VBZ	O
a	DT	O
short	JJ	O
amino	NN	O
acid	JJ	O
sequence	NN	O
at	IN	O
the	DT	O
amino	NN	O
terminus	NN	O
of	IN	O
a	DT	O
newly	RB	O
synthesized	VBN	O
polypeptide	NN	O
called	VBD	O
the	DT	O
signal	NN	O
sequence	NN	O
.	.	O
This	DT	O
signal	JJ	O
sequence	NN	O
directs	VBZ	O
a	DT	O
protein	NN	O
to	TO	O
its	PRP$	O
appropriate	JJ	O
location	NN	O
in	IN	O
the	DT	O
cell	NN	O
and	CC	O
is	VBZ	O
removed	VBN	O
during	IN	O
transport	NN	O
or	CC	O
when	WRB	O
the	DT	O
protein	NN	O
reaches	VBZ	O
its	PRP$	O
final	JJ	O
destination	NN	O
.	.	O
Most	JJS	O
lysosomal	JJ	O
,	,	O
membrane	NN	O
,	,	O
or	CC	O
secreted	VBN	O
proteins	NNS	O
have	VBP	O
an	DT	O
amino-terminal	JJ	O
signal	NN	O
sequence	NN	O
that	WDT	O
marks	VBZ	O
them	PRP	O
for	IN	O
translocation	NN	O
into	IN	O
the	DT	O
lumen	NNS	O
of	IN	O
the	DT	O
endoplasmic	JJ	O
reticulum	NN	O
.	.	O
More	JJR	O
than	IN	O
100	CD	O
signal	JJ	O
sequences	NNS	O
for	IN	O
proteins	NNS	O
in	IN	O
this	DT	O
group	NN	O
have	VBP	O
been	VBN	O
determined	VBN	O
.	.	O
The	DT	O
signal	JJ	O
sequences	NNS	O
can	MD	O
vary	VB	O
in	IN	O
length	NN	O
from	IN	O
13	CD	O
to	TO	O
36	CD	O
amino	NN	O
acid	NN	O
residues	NNS	O
.	.	O
Various	JJ	O
methods	NNS	O
of	IN	O
recognition	NN	O
of	IN	O
signal	JJ	O
sequences	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
those	DT	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
novel	JJ	O
amylase	JJ	O
signal	NN	O
peptides	NNS	O
are	VBP	O
identified	VBN	O
by	IN	O
a	DT	O
method	NN	O
referred	VBD	O
to	TO	O
as	IN	O
SignalP	NNP	O
.	.	O
SignalP	NNP	O
uses	VBZ	O
a	DT	O
combined	JJ	O
neural	JJ	O
network	NN	O
which	WDT	O
recognizes	VBZ	O
both	DT	O
signal	JJ	O
peptides	NNS	O
and	CC	O
their	PRP$	O
cleavage	NN	O
sites	NNS	O
.	.	O
(	(	O
Nielsen	NNP	B
,	,	I
et	FW	I
al.	NN	I
,	,	I
“	JJ	I
Identification	NNP	I
of	IN	I
prokaryotic	JJ	I
and	CC	I
eukaryotic	JJ	I
signal	NN	I
peptides	NNS	I
and	CC	I
prediction	NN	I
of	IN	I
their	PRP$	I
cleavage	NN	I
sites.	NN	I
”	NNP	I
Protein	NNP	I
Engineering	NNP	I
,	,	I
vol	NN	I
.	.	I
10	CD	I
,	,	I
no	DT	I
.	.	I
1	CD	I
,	,	I
p.	JJ	I
1-6	CD	I
(	(	I
1997	CD	I
)	)	I
.	.	O
It	PRP	O
should	MD	O
be	VB	O
understood	JJ	O
that	IN	O
in	IN	O
some	DT	O
aspects	NNS	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
not	RB	O
have	VB	O
signal	JJ	O
sequences	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
lacking	VBG	O
all	DT	O
or	CC	O
part	NN	O
of	IN	O
a	DT	O
signal	JJ	O
sequence	NN	O
,	,	O
e.g	NN	O
.	.	O
the	DT	O
signal	JJ	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
encoding	VBG	O
a	DT	O
signal	JJ	O
sequence	NN	O
from	IN	O
one	CD	O
amylase	NN	O
operably	RB	O
linked	VBD	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	JJ	O
sequence	NN	O
of	IN	O
a	DT	O
different	JJ	O
amylase	NN	O
or	CC	O
,	,	O
optionally	RB	O
,	,	O
a	DT	O
signal	JJ	O
sequence	NN	O
from	IN	O
a	DT	O
non-amylase	JJ	O
protein	NN	O
may	MD	O
be	VB	O
desired	VBN	O
.	.	O
Hybrid	JJ	O
Amylases	NNS	O
and	CC	O
Peptide	NNP	O
Libraries	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
hybrid	JJ	O
amylases	NNS	O
and	CC	O
fusion	NN	O
proteins	NNS	O
,	,	O
including	VBG	O
peptide	JJ	O
libraries	NNS	O
,	,	O
comprising	VBG	O
sequences	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
peptide	JJ	O
libraries	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
peptide	JJ	O
modulators	NNS	O
(	(	O
e.g.	NN	O
,	,	O
activators	NNS	O
or	CC	O
inhibitors	NNS	O
)	)	O
of	IN	O
targets	NNS	O
,	,	O
such	JJ	O
as	IN	O
amylase	NN	O
substrates	NNS	O
,	,	O
receptors	NNS	O
,	,	O
enzymes	NNS	O
.	.	O
The	DT	O
peptide	JJ	O
libraries	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
identify	VB	O
formal	JJ	O
binding	VBG	O
partners	NNS	O
of	IN	O
targets	NNS	O
,	,	O
such	JJ	O
as	IN	O
ligands	NNS	O
,	,	O
e.g.	NN	O
,	,	O
cytokines	NNS	O
,	,	O
hormones	NNS	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
fusion	NN	O
proteins	NNS	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
e.g.	UH	O
,	,	O
the	DT	O
peptide	JJ	O
moiety	NN	O
)	)	O
are	VBP	O
conformationally	RB	O
stabilized	VBN	O
(	(	O
relative	JJ	O
to	TO	O
linear	VB	O
peptides	NNS	O
)	)	O
to	TO	O
allow	VB	O
a	DT	O
higher	JJR	O
binding	NN	O
affinity	NN	O
for	IN	O
targets	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
fusions	NNS	O
of	IN	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
other	JJ	O
peptides	NNS	O
,	,	O
including	VBG	O
known	VBN	O
and	CC	O
random	JJ	O
peptides	NNS	O
.	.	O
They	PRP	O
can	MD	O
be	VB	O
fused	VBN	O
in	IN	O
such	JJ	O
a	DT	O
manner	NN	O
that	IN	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
amylases	NNS	O
is	VBZ	O
not	RB	O
significantly	RB	O
perturbed	VBN	O
and	CC	O
the	DT	O
peptide	NN	O
is	VBZ	O
metabolically	RB	O
or	CC	O
structurally	RB	O
conformationally	RB	O
stabilized	VBN	O
.	.	O
This	DT	O
allows	VBZ	O
the	DT	O
creation	NN	O
of	IN	O
a	DT	O
peptide	JJ	O
library	NN	O
that	WDT	O
is	VBZ	O
easily	RB	O
monitored	VBN	O
both	DT	O
for	IN	O
its	PRP$	O
presence	NN	O
within	IN	O
cells	NNS	O
and	CC	O
its	PRP$	O
quantity	NN	O
.	.	O
Amino	NNP	O
acid	JJ	O
sequence	NN	O
variants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
characterized	VBN	O
by	IN	O
a	DT	O
predetermined	JJ	O
nature	NN	O
of	IN	O
the	DT	O
variation	NN	O
,	,	O
a	DT	O
feature	NN	O
that	WDT	O
sets	VBZ	O
them	PRP	O
apart	RB	O
from	IN	O
a	DT	O
naturally	RB	O
occurring	VBG	O
form	NN	O
,	,	O
e.g	NN	O
,	,	O
an	DT	O
allelic	NN	O
or	CC	O
interspecies	NNS	O
variation	NN	O
of	IN	O
an	DT	O
amylase	NN	O
sequence	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
variants	NNS	O
of	IN	O
the	DT	O
invention	NN	O
exhibit	VBZ	O
the	DT	O
same	JJ	O
qualitative	JJ	O
biological	JJ	O
activity	NN	O
as	IN	O
the	DT	O
naturally	RB	O
occurring	VBG	O
analogue	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
variants	NNS	O
can	MD	O
be	VB	O
selected	VBN	O
for	IN	O
having	VBG	O
modified	VBN	O
characteristics	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
while	IN	O
the	DT	O
site	NN	O
or	CC	O
region	NN	O
for	IN	O
introducing	VBG	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
variation	NN	O
is	VBZ	O
predetermined	VBN	O
,	,	O
the	DT	O
mutation	NN	O
per	IN	O
se	FW	O
need	MD	O
not	RB	O
be	VB	O
predetermined	VBN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
order	NN	O
to	TO	O
optimize	VB	O
the	DT	O
performance	NN	O
of	IN	O
a	DT	O
mutation	NN	O
at	IN	O
a	DT	O
given	VBN	O
site	NN	O
,	,	O
random	JJ	O
mutagenesis	NN	O
may	MD	O
be	VB	O
conducted	VBN	O
at	IN	O
the	DT	O
target	NN	O
codon	NN	O
or	CC	O
region	NN	O
and	CC	O
the	DT	O
expressed	JJ	O
amylase	NN	O
variants	NNS	O
screened	VBD	O
for	IN	O
the	DT	O
optimal	JJ	O
combination	NN	O
of	IN	O
desired	JJ	O
activity	NN	O
.	.	O
Techniques	NNS	O
for	IN	O
making	VBG	O
substitution	NN	O
mutations	NNS	O
at	IN	O
predetermined	VBN	O
sites	NNS	O
in	IN	O
DNA	NNP	O
having	VBG	O
a	DT	O
known	VBN	O
sequence	NN	O
are	VBP	O
well	RB	O
known	VBN	O
,	,	O
as	IN	O
discussed	VBN	O
herein	NN	O
for	IN	O
example	NN	O
,	,	O
M13	NNP	O
primer	NN	O
mutagenesis	NN	O
and	CC	O
PCR	NNP	O
mutagenesis	NN	O
.	.	O
Screening	NN	O
of	IN	O
the	DT	O
mutants	NNS	O
can	MD	O
be	VB	O
done	VBN	O
using	VBG	O
assays	NNS	O
of	IN	O
proteolytic	JJ	O
activities	NNS	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
amino	NN	O
acid	JJ	O
substitutions	NNS	O
can	MD	O
be	VB	O
single	JJ	O
residues	NNS	O
;	:	O
insertions	NNS	O
can	MD	O
be	VB	O
on	IN	O
the	DT	O
order	NN	O
of	IN	O
from	IN	O
about	IN	O
1	CD	O
to	TO	O
20	CD	O
amino	NN	O
acids	NNS	O
,	,	O
although	IN	O
considerably	RB	O
larger	JJR	O
insertions	NNS	O
can	MD	O
be	VB	O
done	VBN	O
.	.	O
Deletions	NNS	O
can	MD	O
range	VB	O
from	IN	O
about	RB	O
1	CD	O
to	TO	O
about	IN	O
20	CD	O
,	,	O
30	CD	O
,	,	O
40	CD	O
,	,	O
50	CD	O
,	,	O
60	CD	O
,	,	O
70	CD	O
residues	NNS	O
or	CC	O
more	JJR	O
.	.	O
To	TO	O
obtain	VB	O
a	DT	O
final	JJ	O
derivative	NN	O
with	IN	O
the	DT	O
optimal	JJ	O
properties	NNS	O
,	,	O
substitutions	NNS	O
,	,	O
deletions	NNS	O
,	,	O
insertions	NNS	O
or	CC	O
any	DT	O
combination	NN	O
thereof	NN	O
may	MD	O
be	VB	O
used	VBN	O
.	.	O
Generally	RB	O
,	,	O
these	DT	O
changes	NNS	O
are	VBP	O
done	VBN	O
on	IN	O
a	DT	O
few	JJ	O
amino	NN	O
acids	NNS	O
to	TO	O
minimize	VB	O
the	DT	O
alteration	NN	O
of	IN	O
the	DT	O
molecule	NN	O
.	.	O
However	RB	O
,	,	O
larger	JJR	O
changes	NNS	O
may	MD	O
be	VB	O
tolerated	VBN	O
in	IN	O
certain	JJ	O
circumstances	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
amylases	NNS	O
where	WRB	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
backbone	NN	O
,	,	O
the	DT	O
secondary	JJ	O
or	CC	O
the	DT	O
tertiary	JJ	O
structure	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
alpha-helical	JJ	O
or	CC	O
beta-sheet	JJ	O
structure	NN	O
,	,	O
has	VBZ	O
been	VBN	O
modified	VBN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
charge	NN	O
or	CC	O
hydrophobicity	NN	O
has	VBZ	O
been	VBN	O
modified	VBN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
bulk	NN	O
of	IN	O
a	DT	O
side	NN	O
chain	NN	O
has	VBZ	O
been	VBN	O
modified	VBN	O
.	.	O
Substantial	JJ	O
changes	NNS	O
in	IN	O
function	NN	O
or	CC	O
immunological	JJ	O
identity	NN	O
are	VBP	O
made	VBN	O
by	IN	O
selecting	VBG	O
substitutions	NNS	O
that	WDT	O
are	VBP	O
less	RBR	O
conservative	JJ	O
.	.	O
For	IN	O
example	NN	O
,	,	O
substitutions	NNS	O
can	MD	O
be	VB	O
made	VBN	O
which	WDT	O
more	RBR	O
significantly	RB	O
affect	JJ	O
:	:	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
backbone	NN	O
in	IN	O
the	DT	O
area	NN	O
of	IN	O
the	DT	O
alteration	NN	O
,	,	O
for	IN	O
example	NN	O
a	DT	O
alpha-helical	JJ	O
or	CC	O
a	DT	O
beta-sheet	JJ	O
structure	NN	O
;	:	O
a	DT	O
charge	NN	O
or	CC	O
a	DT	O
hydrophobic	JJ	O
site	NN	O
of	IN	O
the	DT	O
molecule	NN	O
,	,	O
which	WDT	O
can	MD	O
be	VB	O
at	IN	O
an	DT	O
active	JJ	O
site	NN	O
;	:	O
or	CC	O
a	DT	O
side	NN	O
chain	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
substitutions	NNS	O
in	IN	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
where	WRB	O
(	(	O
a	DT	O
)	)	O
a	DT	O
hydrophilic	JJ	O
residues	NNS	O
,	,	O
e.g	NN	O
.	.	O
seryl	NN	O
or	CC	O
threonyl	NN	O
,	,	O
is	VBZ	O
substituted	VBN	O
for	IN	O
(	(	O
or	CC	O
by	IN	O
)	)	O
a	DT	O
hydrophobic	JJ	O
residue	NN	O
,	,	O
e.g	NN	O
.	.	O
leucyl	NN	O
,	,	O
isoleucyl	NN	O
,	,	O
phenylalanyl	NN	O
,	,	O
valyl	NN	O
or	CC	O
alanyl	NN	O
;	:	O
(	(	O
b	NN	O
)	)	O
a	DT	O
cysteine	NN	O
or	CC	O
proline	NN	O
is	VBZ	O
substituted	VBN	O
for	IN	O
(	(	O
or	CC	O
by	IN	O
)	)	O
any	DT	O
other	JJ	O
residue	NN	O
;	:	O
(	(	O
c	NN	O
)	)	O
a	DT	O
residue	JJ	O
having	VBG	O
an	DT	O
electropositive	JJ	O
side	NN	O
chain	NN	O
,	,	O
e.g	NN	O
.	.	O
lysyl	NN	O
,	,	O
arginyl	NN	O
,	,	O
or	CC	O
histidyl	NN	O
,	,	O
is	VBZ	O
substituted	VBN	O
for	IN	O
(	(	O
or	CC	O
by	IN	O
)	)	O
an	DT	O
electronegative	JJ	O
residue	NN	O
,	,	O
e.g	NN	O
.	.	O
glutamyl	NN	O
or	CC	O
aspartyl	NN	O
;	:	O
or	CC	O
(	(	O
d	NN	O
)	)	O
a	DT	O
residue	JJ	O
having	VBG	O
a	DT	O
bulky	JJ	O
side	NN	O
chain	NN	O
,	,	O
e.g	NN	O
.	.	O
phenylalanine	NN	O
,	,	O
is	VBZ	O
substituted	VBN	O
for	IN	O
(	(	O
or	CC	O
by	IN	O
)	)	O
one	CD	O
not	RB	O
having	VBG	O
a	DT	O
side	NN	O
chain	NN	O
,	,	O
e.g	NN	O
.	.	O
glycine	NN	O
.	.	O
The	DT	O
variants	NNS	O
can	MD	O
exhibit	VB	O
the	DT	O
same	JJ	O
qualitative	JJ	O
biological	JJ	O
activity	NN	O
(	(	O
i.e	NN	O
.	.	O
amylase	NN	O
activity	NN	O
)	)	O
although	IN	O
variants	NNS	O
can	MD	O
be	VB	O
selected	VBN	O
to	TO	O
modify	VB	O
the	DT	O
characteristics	NNS	O
of	IN	O
the	DT	O
amylases	NNS	O
as	IN	O
needed	VBN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
comprise	NN	O
epitopes	VBZ	O
or	CC	O
purification	NN	O
tags	NNS	O
,	,	O
signal	JJ	O
sequences	NNS	O
or	CC	O
other	JJ	O
fusion	NN	O
sequences	NNS	O
,	,	O
etc	FW	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
fused	VBN	O
to	TO	O
a	DT	O
random	JJ	O
peptide	NN	O
to	TO	O
form	VB	O
a	DT	O
fusion	NN	O
polypeptide	NN	O
.	.	O
By	IN	O
“	NNP	O
fused	VBD	O
”	NNP	O
or	CC	O
“	NNP	O
operably	RB	O
linked	VBD	O
”	JJ	O
herein	NN	O
is	VBZ	O
meant	VBN	O
that	IN	O
the	DT	O
random	NN	O
peptide	NN	O
and	CC	O
the	DT	O
amylase	NN	O
are	VBP	O
linked	VBN	O
together	RB	O
,	,	O
in	IN	O
such	PDT	O
a	DT	O
manner	NN	O
as	IN	O
to	TO	O
minimize	VB	O
the	DT	O
disruption	NN	O
to	TO	O
the	DT	O
stability	NN	O
of	IN	O
the	DT	O
amylase	NN	O
structure	NN	O
,	,	O
e.g.	NN	O
,	,	O
it	PRP	O
retains	VBZ	O
amylase	JJ	O
activity	NN	O
.	.	O
The	DT	O
fusion	NN	O
polypeptide	NN	O
(	(	O
or	CC	O
fusion	NN	O
polynucleotide	IN	O
encoding	VBG	O
the	DT	O
fusion	NN	O
polypeptide	NN	O
)	)	O
can	MD	O
comprise	VB	O
further	JJ	O
components	NNS	O
as	IN	O
well	RB	O
,	,	O
including	VBG	O
multiple	JJ	O
peptides	NNS	O
at	IN	O
multiple	JJ	O
loops	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
peptides	NNS	O
and	CC	O
nucleic	JJ	O
acids	NNS	O
encoding	VBG	O
them	PRP	O
are	VBP	O
randomized	VBN	O
,	,	O
either	DT	O
fully	RB	O
randomized	VBN	O
or	CC	O
they	PRP	O
are	VBP	O
biased	VBN	O
in	IN	O
their	PRP$	O
randomization	NN	O
,	,	O
e.g	NN	O
.	.	O
in	IN	O
nucleotide/residue	JJ	O
frequency	NN	O
generally	RB	O
or	CC	O
per	IN	O
position	NN	O
.	.	O
“	NNS	O
Randomized	NNP	O
”	NN	O
means	VBZ	O
that	IN	O
each	DT	O
nucleic	JJ	O
acid	NN	O
and	CC	O
peptide	NN	O
consists	NNS	O
of	IN	O
essentially	RB	O
random	JJ	O
nucleotides	NNS	O
and	CC	O
amino	JJ	O
acids	NNS	O
,	,	O
respectively	RB	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
nucleic	NN	O
acids	NNS	O
which	WDT	O
give	VBP	O
rise	NN	O
to	TO	O
the	DT	O
peptides	NNS	O
can	MD	O
be	VB	O
chemically	RB	O
synthesized	VBN	O
,	,	O
and	CC	O
thus	RB	O
may	MD	O
incorporate	VB	O
any	DT	O
nucleotide	NN	O
at	IN	O
any	DT	O
position	NN	O
.	.	O
Thus	RB	O
,	,	O
when	WRB	O
the	DT	O
nucleic	JJ	O
acids	NNS	O
are	VBP	O
expressed	VBN	O
to	TO	O
form	VB	O
peptides	NNS	O
,	,	O
any	DT	O
amino	JJ	O
acid	NNS	O
residue	JJ	O
may	MD	O
be	VB	O
incorporated	VBN	O
at	IN	O
any	DT	O
position	NN	O
.	.	O
The	DT	O
synthetic	JJ	O
process	NN	O
can	MD	O
be	VB	O
designed	VBN	O
to	TO	O
generate	VB	O
randomized	JJ	O
nucleic	JJ	O
acids	NNS	O
,	,	O
to	TO	O
allow	VB	O
the	DT	O
formation	NN	O
of	IN	O
all	DT	O
or	CC	O
most	JJS	O
of	IN	O
the	DT	O
possible	JJ	O
combinations	NNS	O
over	IN	O
the	DT	O
length	NN	O
of	IN	O
the	DT	O
nucleic	JJ	O
acid	NN	O
,	,	O
thus	RB	O
forming	VBG	O
a	DT	O
library	NN	O
of	IN	O
randomized	JJ	O
nucleic	JJ	O
acids	NNS	O
.	.	O
The	DT	O
library	NN	O
can	MD	O
provide	VB	O
a	DT	O
sufficiently	RB	O
structurally	RB	O
diverse	JJ	O
population	NN	O
of	IN	O
randomized	JJ	O
expression	NN	O
products	NNS	O
to	TO	O
affect	VB	O
a	DT	O
probabilistically	RB	O
sufficient	JJ	O
range	NN	O
of	IN	O
cellular	JJ	O
responses	NNS	O
to	TO	O
provide	VB	O
one	CD	O
or	CC	O
more	JJR	O
cells	NNS	O
exhibiting	VBG	O
a	DT	O
desired	JJ	O
response	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
interaction	NN	O
library	JJ	O
large	JJ	O
enough	RB	O
so	IN	O
that	DT	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
its	PRP$	O
members	NNS	O
will	MD	O
have	VB	O
a	DT	O
structure	NN	O
that	WDT	O
gives	VBZ	O
it	PRP	O
affinity	NN	O
for	IN	O
some	DT	O
molecule	NN	O
,	,	O
protein	NN	O
,	,	O
or	CC	O
other	JJ	O
factor	NN	O
.	.	O
Screening	VBG	O
Methodologies	NNS	O
and	CC	O
“	JJ	O
On-Line	NNP	O
”	NNP	O
Monitoring	NNP	O
Devices	NNPS	O
In	IN	O
practicing	VBG	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
a	DT	O
variety	NN	O
of	IN	O
apparatus	NN	O
and	CC	O
methodologies	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
in	IN	O
conjunction	NN	O
with	IN	O
the	DT	O
polypeptides	NNS	O
and	CC	O
nucleic	JJ	O
acids	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
to	TO	O
screen	VB	O
polypeptides	NNS	O
for	IN	O
amylase	NN	O
activity	NN	O
,	,	O
to	TO	O
screen	VB	O
compounds	NNS	O
as	IN	O
potential	JJ	O
modulators	NNS	O
,	,	O
e.g.	NN	O
,	,	O
activators	NNS	O
or	CC	O
inhibitors	NNS	O
,	,	O
of	IN	O
an	DT	O
amylase	NN	O
activity	NN	O
,	,	O
for	IN	O
antibodies	NNS	O
that	WDT	O
bind	VBP	O
to	TO	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
for	IN	O
nucleic	JJ	O
acids	NNS	O
that	WDT	O
hybridize	VBP	O
to	TO	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
to	TO	O
screen	VB	O
for	IN	O
cells	NNS	O
expressing	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Capillary	NNP	O
Arrays	NNP	O
Capillary	NNP	O
arrays	NNS	O
,	,	O
such	JJ	O
as	IN	O
the	DT	O
GIGAMATRIX™	NNP	O
,	,	O
Diversa	NNP	O
Corporation	NNP	O
,	,	O
San	NNP	O
Diego	NNP	O
,	,	O
Calif.	NNP	O
,	,	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
in	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Nucleic	NNP	O
acids	NNS	O
or	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
immobilized	VBN	O
to	TO	O
or	CC	O
applied	VBN	O
to	TO	O
an	DT	O
array	NN	O
,	,	O
including	VBG	O
capillary	JJ	O
arrays	NNS	O
.	.	O
Arrays	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
screen	VB	O
for	IN	O
or	CC	O
monitor	VB	O
libraries	NNS	O
of	IN	O
compositions	NNS	O
(	(	O
e.g.	NN	O
,	,	O
small	JJ	O
molecules	NNS	O
,	,	O
antibodies	NNS	O
,	,	O
nucleic	JJ	O
acids	NNS	O
,	,	O
etc	FW	O
.	.	O
)	)	O
for	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
bind	VB	O
to	TO	O
or	CC	O
modulate	VB	O
the	DT	O
activity	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Capillary	NNP	O
arrays	NNS	O
provide	VBP	O
another	DT	O
system	NN	O
for	IN	O
holding	VBG	O
and	CC	O
screening	VBG	O
samples	NNS	O
.	.	O
For	IN	O
example	NN	O
,	,	O
a	DT	O
sample	NN	O
screening	VBG	O
apparatus	NN	O
can	MD	O
include	VB	O
a	DT	O
plurality	NN	O
of	IN	O
capillaries	NNS	O
formed	VBN	O
into	IN	O
an	DT	O
array	NN	O
of	IN	O
adjacent	JJ	O
capillaries	NNS	O
,	,	O
wherein	VBP	O
each	DT	O
capillary	JJ	O
comprises	NNS	O
at	IN	O
least	JJS	O
one	CD	O
wall	NN	O
defining	VBG	O
a	DT	O
lumen	NN	O
for	IN	O
retaining	VBG	O
a	DT	O
sample	NN	O
.	.	O
The	DT	O
apparatus	NN	O
can	MD	O
further	VB	O
include	VB	O
interstitial	JJ	O
material	NN	O
disposed	VBD	O
between	IN	O
adjacent	JJ	O
capillaries	NNS	O
in	IN	O
the	DT	O
array	NN	O
,	,	O
and	CC	O
one	CD	O
or	CC	O
more	JJR	O
reference	NN	O
indicia	NN	O
formed	VBD	O
within	IN	O
of	IN	O
the	DT	O
interstitial	JJ	O
material	NN	O
.	.	O
A	DT	O
capillary	NN	O
for	IN	O
screening	VBG	O
a	DT	O
sample	NN	O
,	,	O
wherein	VBP	O
the	DT	O
capillary	NN	O
is	VBZ	O
adapted	VBN	O
for	IN	O
being	VBG	O
bound	VBN	O
in	IN	O
an	DT	O
array	NN	O
of	IN	O
capillaries	NNS	O
,	,	O
can	MD	O
include	VB	O
a	DT	O
first	JJ	O
wall	NN	O
defining	VBG	O
a	DT	O
lumen	NN	O
for	IN	O
retaining	VBG	O
the	DT	O
sample	NN	O
,	,	O
and	CC	O
a	DT	O
second	JJ	O
wall	NN	O
formed	VBN	O
of	IN	O
a	DT	O
filtering	JJ	O
material	NN	O
,	,	O
for	IN	O
filtering	VBG	O
excitation	NN	O
energy	NN	O
provided	VBD	O
to	TO	O
the	DT	O
lumen	NNS	O
to	TO	O
excite	VB	O
the	DT	O
sample	NN	O
.	.	O
A	DT	O
polypeptide	NN	O
or	CC	O
nucleic	JJ	O
acid	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
ligand	NN	O
,	,	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
a	DT	O
first	JJ	O
component	NN	O
into	IN	O
at	IN	O
least	JJS	O
a	DT	O
portion	NN	O
of	IN	O
a	DT	O
capillary	NN	O
of	IN	O
a	DT	O
capillary	JJ	O
array	NN	O
.	.	O
Each	DT	O
capillary	NN	O
of	IN	O
the	DT	O
capillary	JJ	O
array	NN	O
can	MD	O
comprise	VB	O
at	IN	O
least	JJS	O
one	CD	O
wall	NN	O
defining	VBG	O
a	DT	O
lumen	NN	O
for	IN	O
retaining	VBG	O
the	DT	O
first	JJ	O
component	NN	O
.	.	O
An	DT	O
air	NN	O
bubble	JJ	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
the	DT	O
capillary	JJ	O
behind	IN	O
the	DT	O
first	JJ	O
component	NN	O
.	.	O
A	DT	O
second	JJ	O
component	NN	O
can	MD	O
be	VB	O
introduced	VBN	O
into	IN	O
the	DT	O
capillary	JJ	O
,	,	O
wherein	VBD	O
the	DT	O
second	JJ	O
component	NN	O
is	VBZ	O
separated	VBN	O
from	IN	O
the	DT	O
first	JJ	O
component	NN	O
by	IN	O
the	DT	O
air	NN	O
bubble	JJ	O
.	.	O
A	DT	O
sample	NN	O
of	IN	O
interest	NN	O
can	MD	O
be	VB	O
introduced	VBN	O
as	IN	O
a	DT	O
first	JJ	O
liquid	NN	O
labeled	VBN	O
with	IN	O
a	DT	O
detectable	JJ	O
particle	NN	O
into	IN	O
a	DT	O
capillary	NN	O
of	IN	O
a	DT	O
capillary	JJ	O
array	NN	O
,	,	O
wherein	WP	O
each	DT	O
capillary	NN	O
of	IN	O
the	DT	O
capillary	JJ	O
array	NN	O
comprises	NNS	O
at	IN	O
least	JJS	O
one	CD	O
wall	NN	O
defining	VBG	O
a	DT	O
lumen	NN	O
for	IN	O
retaining	VBG	O
the	DT	O
first	JJ	O
liquid	NN	O
and	CC	O
the	DT	O
detectable	JJ	O
particle	NN	O
,	,	O
and	CC	O
wherein	VBD	O
the	DT	O
at	IN	O
least	JJS	O
one	CD	O
wall	NN	O
is	VBZ	O
coated	VBN	O
with	IN	O
a	DT	O
binding	VBG	O
material	NN	O
for	IN	O
binding	VBG	O
the	DT	O
detectable	JJ	O
particle	NN	O
to	TO	O
the	DT	O
at	IN	O
least	JJS	O
one	CD	O
wall	NN	O
.	.	O
The	DT	O
method	NN	O
can	MD	O
further	VB	O
include	VB	O
removing	VBG	O
the	DT	O
first	JJ	O
liquid	NN	O
from	IN	O
the	DT	O
capillary	JJ	O
tube	NN	O
,	,	O
wherein	VBP	O
the	DT	O
bound	NN	O
detectable	JJ	O
particle	NN	O
is	VBZ	O
maintained	VBN	O
within	IN	O
the	DT	O
capillary	JJ	O
,	,	O
and	CC	O
introducing	VBG	O
a	DT	O
second	JJ	O
liquid	NN	O
into	IN	O
the	DT	O
capillary	JJ	O
tube	NN	O
.	.	O
The	DT	O
capillary	JJ	O
array	NN	O
can	MD	O
include	VB	O
a	DT	O
plurality	NN	O
of	IN	O
individual	JJ	O
capillaries	NNS	O
comprising	VBG	O
at	IN	O
least	JJS	O
one	CD	O
outer	NN	O
wall	NN	O
defining	VBG	O
a	DT	O
lumen	NN	O
.	.	O
The	DT	O
outer	NN	O
wall	NN	O
of	IN	O
the	DT	O
capillary	NN	O
can	MD	O
be	VB	O
one	CD	O
or	CC	O
more	JJR	O
walls	NNS	O
fused	VBN	O
together	RB	O
.	.	O
Similarly	RB	O
,	,	O
the	DT	O
wall	NN	O
can	MD	O
define	VB	O
a	DT	O
lumen	NNS	O
that	WDT	O
is	VBZ	O
cylindrical	JJ	O
,	,	O
square	JJ	O
,	,	O
hexagonal	JJ	O
or	CC	O
any	DT	O
other	JJ	O
geometric	JJ	O
shape	NN	O
so	RB	O
long	RB	O
as	IN	O
the	DT	O
walls	NNS	O
form	VBP	O
a	DT	O
lumen	NNS	O
for	IN	O
retention	NN	O
of	IN	O
a	DT	O
liquid	NN	O
or	CC	O
sample	NN	O
.	.	O
The	DT	O
capillaries	NNS	O
of	IN	O
the	DT	O
capillary	JJ	O
array	NN	O
can	MD	O
be	VB	O
held	VBN	O
together	RB	O
in	IN	O
close	JJ	O
proximity	NN	O
to	TO	O
form	VB	O
a	DT	O
planar	NN	O
structure	NN	O
.	.	O
The	DT	O
capillaries	NNS	O
can	MD	O
be	VB	O
bound	VBN	O
together	RB	O
,	,	O
by	IN	O
being	VBG	O
fused	VBN	O
(	(	O
e.g.	NN	O
,	,	O
where	WRB	O
the	DT	O
capillaries	NNS	O
are	VBP	O
made	VBN	O
of	IN	O
glass	NN	O
)	)	O
,	,	O
glued	VBN	O
,	,	O
bonded	VBN	O
,	,	O
or	CC	O
clamped	VBD	O
side-by-side	NN	O
.	.	O
The	DT	O
capillary	JJ	O
array	NN	O
can	MD	O
be	VB	O
formed	VBN	O
of	IN	O
any	DT	O
number	NN	O
of	IN	O
individual	JJ	O
capillaries	NNS	O
,	,	O
for	IN	O
example	NN	O
,	,	O
a	DT	O
range	NN	O
from	IN	O
100	CD	O
to	TO	O
4,000,000	CD	O
capillaries	NNS	O
.	.	O
A	DT	O
capillary	JJ	O
array	NN	O
can	MD	O
form	VB	O
a	DT	O
micro	NN	O
titer	NN	O
plate	NN	O
having	VBG	O
about	IN	O
100,000	CD	O
or	CC	O
more	JJR	O
individual	JJ	O
capillaries	NNS	O
bound	IN	O
together	RB	O
.	.	O
Arrays	NNS	O
,	,	O
or	CC	O
“	JJ	O
Biochips	NNP	O
”	NNP	O
Nucleic	NNP	O
acids	NNS	O
or	CC	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
immobilized	VBN	O
to	TO	O
or	CC	O
applied	VBN	O
to	TO	O
an	DT	O
array	NN	O
.	.	O
Arrays	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
screen	VB	O
for	IN	O
or	CC	O
monitor	VB	O
libraries	NNS	O
of	IN	O
compositions	NNS	O
(	(	O
e.g.	NN	O
,	,	O
small	JJ	O
molecules	NNS	O
,	,	O
antibodies	NNS	O
,	,	O
nucleic	JJ	O
acids	NNS	O
,	,	O
etc	FW	O
.	.	O
)	)	O
for	IN	O
their	PRP$	O
ability	NN	O
to	TO	O
bind	VB	O
to	TO	O
or	CC	O
modulate	VB	O
the	DT	O
activity	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
or	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
a	DT	O
monitored	JJ	O
parameter	NN	O
is	VBZ	O
transcript	JJ	O
expression	NN	O
of	IN	O
an	DT	O
amylase	JJ	O
gene	NN	O
.	.	O
One	CD	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
,	,	O
all	PDT	O
the	DT	O
transcripts	NNS	O
of	IN	O
a	DT	O
cell	NN	O
can	MD	O
be	VB	O
measured	VBN	O
by	IN	O
hybridization	NN	O
of	IN	O
a	DT	O
sample	NN	O
comprising	VBG	O
transcripts	NNS	O
of	IN	O
the	DT	O
cell	NN	O
,	,	O
or	CC	O
,	,	O
nucleic	JJ	O
acids	NNS	O
representative	NN	O
of	IN	O
or	CC	O
complementary	JJ	O
to	TO	O
transcripts	NNS	O
of	IN	O
a	DT	O
cell	NN	O
,	,	O
by	IN	O
hybridization	NN	O
to	TO	O
immobilized	VB	O
nucleic	JJ	O
acids	NNS	O
on	IN	O
an	DT	O
array	NN	O
,	,	O
or	CC	O
“	VB	O
biochip.	JJ	O
”	NN	O
By	IN	O
using	VBG	O
an	DT	O
“	JJ	O
array	NN	O
”	NN	O
of	IN	O
nucleic	JJ	O
acids	NNS	O
on	IN	O
a	DT	O
microchip	NN	O
,	,	O
some	DT	O
or	CC	O
all	DT	O
of	IN	O
the	DT	O
transcripts	NNS	O
of	IN	O
a	DT	O
cell	NN	O
can	MD	O
be	VB	O
simultaneously	RB	O
quantified	VBN	O
.	.	O
Alternatively	RB	O
,	,	O
arrays	NNS	O
comprising	VBG	O
genomic	JJ	O
nucleic	JJ	O
acid	NN	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
determine	VB	O
the	DT	O
genotype	NN	O
of	IN	O
a	DT	O
newly	RB	O
engineered	VBN	O
strain	NN	O
made	VBN	O
by	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Polypeptide	NNP	O
arrays	VBZ	O
”	NN	O
can	MD	O
also	RB	O
be	VB	O
used	VBN	O
to	TO	O
simultaneously	RB	O
quantify	VB	O
a	DT	O
plurality	NN	O
of	IN	O
proteins	NNS	O
.	.	O
The	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
practiced	VBN	O
with	IN	O
any	DT	O
known	JJ	O
“	JJ	O
array	NN	O
,	,	O
”	NNP	O
also	RB	O
referred	VBD	O
to	TO	O
as	IN	O
a	DT	O
“	JJ	O
microarray	NN	O
”	NN	O
or	CC	O
“	VB	O
nucleic	JJ	O
acid	JJ	O
array	NN	O
”	NN	O
or	CC	O
“	JJ	O
polypeptide	JJ	O
array	NN	O
”	NN	O
or	CC	O
“	VB	O
antibody	JJ	O
array	JJ	O
”	NN	O
or	CC	O
“	JJ	O
biochip	NN	O
,	,	O
”	''	O
or	CC	O
variation	NN	O
thereof	NN	O
.	.	O
Arrays	NNS	O
are	VBP	O
generically	RB	O
a	DT	O
plurality	NN	O
of	IN	O
“	JJ	O
spots	NNS	O
”	VBP	O
or	CC	O
“	VBP	O
target	NN	O
elements	NNS	O
,	,	O
”	NNP	O
each	DT	O
target	NN	O
element	NN	O
comprising	VBG	O
a	DT	O
defined	JJ	O
amount	NN	O
of	IN	O
one	CD	O
or	CC	O
more	JJR	O
biological	JJ	O
molecules	NNS	O
,	,	O
e.g.	NN	O
,	,	O
oligonucleotides	NNS	O
,	,	O
immobilized	VBN	O
onto	IN	O
a	DT	O
defined	JJ	O
area	NN	O
of	IN	O
a	DT	O
substrate	JJ	O
surface	NN	O
for	IN	O
specific	JJ	O
binding	VBG	O
to	TO	O
a	DT	O
sample	NN	O
molecule	NN	O
,	,	O
e.g.	NN	O
,	,	O
mRNA	NN	O
transcripts	NNS	O
.	.	O
In	IN	O
practicing	VBG	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
any	DT	O
known	JJ	O
array	NN	O
and/or	NN	O
method	NN	O
of	IN	O
making	VBG	O
and	CC	O
using	VBG	O
arrays	NNS	O
can	MD	O
be	VB	O
incorporated	VBN	O
in	IN	O
whole	JJ	O
or	CC	O
in	IN	O
part	NN	O
,	,	O
or	CC	O
variations	NNS	O
thereof	RB	O
,	,	O
as	IN	O
described	VBN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
in	IN	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,277,628	CD	O
;	:	O
6,277,489	CD	O
;	:	O
6,261,776	CD	O
;	:	O
6,258,606	CD	O
;	:	O
6,054,270	CD	O
;	:	O
6,048,695	CD	O
;	:	O
6,045,996	CD	O
;	:	O
6,022,963	CD	O
;	:	O
6,013,440	CD	O
;	:	O
5,965,452	CD	O
;	:	O
5,959,098	CD	O
;	:	O
5,856,174	CD	O
;	:	O
5,830,645	CD	O
;	:	O
5,770,456	CD	O
;	:	O
5,632,957	CD	O
;	:	O
5,556,752	CD	O
;	:	O
5,143,854	CD	O
;	:	O
5,807,522	CD	O
;	:	O
5,800,992	CD	O
;	:	O
5,744,305	CD	O
;	:	O
5,700,637	CD	O
;	:	O
5,556,752	CD	O
;	:	O
5,434,049	CD	O
;	:	O
see	NN	O
also	RB	O
,	,	O
e.g.	NN	O
,	,	O
WO	NNP	O
99/51773	CD	O
;	:	O
WO	NNP	O
99/09217	CD	O
;	:	O
WO	NNP	O
97/46313	CD	O
;	:	O
WO	NNP	O
96/17958	CD	O
;	:	O
see	NN	O
also	RB	O
,	,	O
e.g.	RB	O
,	,	O
Johnston	NNP	B
(	(	I
1998	CD	I
)	)	I
Curr	NNP	I
.	.	I
Biol	NNP	I
.	.	I
8	CD	I
:	:	I
R171-R174	JJ	I
;	:	O
Schummer	NNP	B
(	(	I
1997	CD	I
)	)	I
Biotechniques	NNP	I
23:1087-1092	CD	I
;	:	O
Kern	NNP	B
(	(	I
1997	CD	I
)	)	I
Biotechniques	NNP	I
23:120-124	JJ	I
;	:	O
Solinas-Toldo	NNP	B
(	(	I
1997	CD	I
)	)	I
Genes	NNPS	I
,	,	I
Chromosomes	NNP	I
&	CC	I
Cancer	NNP	I
20:399-407	CD	I
;	:	O
Bowtell	NNP	B
(	(	I
1999	CD	I
)	)	I
Nature	NN	I
Genetics	NNP	I
Supp	NNP	I
.	.	I
21:25-32	JJ	I
.	.	O
See	NNP	O
also	RB	O
published	VBD	O
U.S.	NNP	O
patent	NN	O
applications	NNS	O
Nos	NNP	O
.	.	O
20010018642	CD	O
;	:	O
20010019827	CD	O
;	:	O
20010016322	CD	O
;	:	O
20010014449	CD	O
;	:	O
20010014448	CD	O
;	:	O
20010012537	CD	O
;	:	O
20010008765	CD	O
.	.	O
Antibodies	NNS	O
and	CC	O
Antibody-Based	JJ	O
Screening	NNP	O
Methods	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
isolated	JJ	O
or	CC	O
recombinant	JJ	O
antibodies	NNS	O
that	WDT	O
specifically	RB	O
bind	VBP	O
to	TO	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
These	DT	O
antibodies	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
,	,	O
identify	VB	O
or	CC	O
quantify	VB	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
related	VBN	O
polypeptides	NNS	O
.	.	O
These	DT	O
antibodies	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
other	JJ	O
polypeptides	NNS	O
within	IN	O
the	DT	O
scope	NN	O
the	DT	O
invention	NN	O
or	CC	O
other	JJ	O
related	JJ	O
amylases	NNS	O
.	.	O
The	DT	O
antibodies	NNS	O
can	MD	O
be	VB	O
designed	VBN	O
to	TO	O
bind	VB	O
to	TO	O
an	DT	O
active	JJ	O
site	NN	O
of	IN	O
an	DT	O
amylase	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
inhibiting	VBG	O
amylases	NNS	O
using	VBG	O
the	DT	O
antibodies	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
antibodies	NNS	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
immunoprecipitation	NN	O
,	,	O
staining	VBG	O
,	,	O
immunoaffinity	NN	O
columns	NN	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
If	IN	O
desired	VBN	O
,	,	O
nucleic	JJ	O
acid	NN	O
sequences	NNS	O
encoding	VBG	O
for	IN	O
specific	JJ	O
antigens	NNS	O
can	MD	O
be	VB	O
generated	VBN	O
by	IN	O
immunization	NN	O
followed	VBN	O
by	IN	O
isolation	NN	O
of	IN	O
polypeptide	NN	O
or	CC	O
nucleic	JJ	O
acid	NN	O
,	,	O
amplification	NN	O
or	CC	O
cloning	NN	O
and	CC	O
immobilization	NN	O
of	IN	O
polypeptide	NN	O
onto	IN	O
an	DT	O
array	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
modify	VB	O
the	DT	O
structure	NN	O
of	IN	O
an	DT	O
antibody	NN	O
produced	VBN	O
by	IN	O
a	DT	O
cell	NN	O
to	TO	O
be	VB	O
modified	VBN	O
,	,	O
e.g.	RB	O
,	,	O
an	DT	O
antibody	NN	O
's	POS	O
affinity	NN	O
can	MD	O
be	VB	O
increased	VBN	O
or	CC	O
decreased	VBN	O
.	.	O
Furthermore	RB	O
,	,	O
the	DT	O
ability	NN	O
to	TO	O
make	VB	O
or	CC	O
modify	VB	O
antibodies	NNS	O
can	MD	O
be	VB	O
a	DT	O
phenotype	NN	O
engineered	VBN	O
into	IN	O
a	DT	O
cell	NN	O
by	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Methods	NNS	O
of	IN	O
immunization	NN	O
,	,	O
producing	VBG	O
and	CC	O
isolating	VBG	O
antibodies	NNS	O
(	(	O
polyclonal	JJ	O
and	CC	O
monoclonal	JJ	O
)	)	O
are	VBP	O
known	VBN	O
to	TO	O
those	DT	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
and	CC	O
described	VBN	O
in	IN	O
the	DT	O
scientific	JJ	O
and	CC	O
patent	JJ	O
literature	NN	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
Coligan	NNP	B
,	,	I
CURRENT	NNP	I
PROTOCOLS	NNP	I
IN	NNP	I
IMMUNOLOGY	NNP	I
,	,	I
Wiley/Greene	NNP	I
,	,	I
NY	NNP	I
(	(	I
1991	CD	I
)	)	I
;	:	O
Stites	NNP	B
(	(	I
eds	NNS	I
.	.	I
)	)	I
BASIC	NNP	I
AND	CC	I
CLINICAL	NNP	I
IMMUNOLOGY	NNP	I
(	(	I
7th	CD	I
ed	RB	I
.	.	I
)	)	I
Lange	NNP	I
Medical	NNP	I
Publications	NNP	I
,	,	I
Los	NNP	I
Altos	NNP	I
,	,	I
Calif.	NNP	I
(	(	I
“	JJ	I
Stites	NNP	I
”	NNP	I
)	)	I
;	:	O
Goding	NNP	B
,	,	I
MONOCLONAL	NNP	I
ANTIBODIES	NNP	I
:	:	I
PRINCIPLES	NN	I
AND	CC	I
PRACTICE	NNP	I
(	(	I
2d	CD	I
ed	RB	I
.	.	I
)	)	I
Academic	NNP	I
Press	NNP	I
,	,	I
New	NNP	I
York	NNP	I
,	,	I
N.Y.	NNP	I
(	(	I
1986	CD	I
)	)	O
;	:	O
Kohler	NNP	B
(	(	I
1975	CD	I
)	)	I
Nature	NN	I
256:495	CD	I
;	:	O
Harlow	NNP	B
(	(	I
1988	CD	I
)	)	I
ANTIBODIES	NNP	I
,	,	I
A	NNP	I
LABORATORY	NNP	I
MANUAL	NNP	I
,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor	NNP	I
Publications	NNP	I
,	,	I
New	NNP	I
York	NNP	I
.	.	O
Antibodies	NNS	O
also	RB	O
can	MD	O
be	VB	O
generated	VBN	O
in	IN	O
vitro	NN	O
,	,	O
e.g.	NN	O
,	,	O
using	VBG	O
recombinant	JJ	O
antibody	NN	O
binding	VBG	O
site	NN	O
expressing	VBG	O
phage	NN	O
display	NN	O
libraries	NNS	O
,	,	O
in	IN	O
addition	NN	O
to	TO	O
the	DT	O
traditional	JJ	O
in	IN	O
vivo	NN	O
methods	NNS	O
using	VBG	O
animals	NNS	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
Hoogenboom	NNP	B
(	(	I
1997	CD	I
)	)	I
Trends	VBZ	I
Biotechnol	NNP	I
.	.	I
15:62-70	JJ	I
;	:	O
Katz	NNP	B
(	(	I
1997	CD	I
)	)	I
Annu	NNP	I
.	.	I
Rev	NNP	I
.	.	I
Biophys	NNP	I
.	.	I
Biomol	NNP	I
.	.	I
Struct	NN	I
.	.	I
26:27-45	JJ	I
.	.	O
Polypeptides	NNS	O
or	CC	O
peptides	NNS	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
generate	VB	O
antibodies	NNS	O
which	WDT	O
bind	VBP	O
specifically	RB	O
to	TO	O
the	DT	O
polypeptides	NNS	O
,	,	O
e.g.	NN	O
,	,	O
the	DT	O
amylases	NNS	O
,	,	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
resulting	VBG	O
antibodies	NNS	O
may	MD	O
be	VB	O
used	VBN	O
in	IN	O
immunoaffinity	NN	O
chromatography	NN	O
procedures	NNS	O
to	TO	O
isolate	VB	O
or	CC	O
purify	VB	O
the	DT	O
polypeptide	NN	O
or	CC	O
to	TO	O
determine	VB	O
whether	IN	O
the	DT	O
polypeptide	NN	O
is	VBZ	O
present	JJ	O
in	IN	O
a	DT	O
biological	JJ	O
sample	NN	O
.	.	O
In	IN	O
such	JJ	O
procedures	NNS	O
,	,	O
a	DT	O
protein	NN	O
preparation	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
extract	NN	O
,	,	O
or	CC	O
a	DT	O
biological	JJ	O
sample	NN	O
is	VBZ	O
contacted	VBN	O
with	IN	O
an	DT	O
antibody	NN	O
capable	JJ	O
of	IN	O
specifically	RB	O
binding	VBG	O
to	TO	O
one	CD	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
immunoaffinity	NN	O
procedures	NNS	O
,	,	O
the	DT	O
antibody	NN	O
is	VBZ	O
attached	VBN	O
to	TO	O
a	DT	O
solid	JJ	O
support	NN	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
bead	NN	O
or	CC	O
other	JJ	O
column	NN	O
matrix	NN	O
.	.	O
The	DT	O
protein	NN	O
preparation	NN	O
is	VBZ	O
placed	VBN	O
in	IN	O
contact	NN	O
with	IN	O
the	DT	O
antibody	NN	O
under	IN	O
conditions	NNS	O
in	IN	O
which	WDT	O
the	DT	O
antibody	NN	O
specifically	RB	O
binds	VBZ	O
to	TO	O
one	CD	O
of	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
After	IN	O
a	DT	O
wash	NN	O
to	TO	O
remove	VB	O
non-specifically	RB	O
bound	JJ	O
proteins	NNS	O
,	,	O
the	DT	O
specifically	RB	O
bound	JJ	O
polypeptides	NNS	O
are	VBP	O
eluted	VBN	O
.	.	O
The	DT	O
ability	NN	O
of	IN	O
proteins	NNS	O
in	IN	O
a	DT	O
biological	JJ	O
sample	NN	O
to	TO	O
bind	VB	O
to	TO	O
the	DT	O
antibody	NN	O
may	MD	O
be	VB	O
determined	VBN	O
using	VBG	O
any	DT	O
of	IN	O
a	DT	O
variety	NN	O
of	IN	O
procedures	NNS	O
familiar	JJ	O
to	TO	O
those	DT	O
skilled	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
binding	NN	O
may	MD	O
be	VB	O
determined	VBN	O
by	IN	O
labeling	VBG	O
the	DT	O
antibody	NN	O
with	IN	O
a	DT	O
detectable	JJ	O
label	NN	O
such	JJ	O
as	IN	O
a	DT	O
fluorescent	NN	O
agent	NN	O
,	,	O
an	DT	O
enzymatic	JJ	O
label	NN	O
,	,	O
or	CC	O
a	DT	O
radioisotope	NN	O
.	.	O
Alternatively	RB	O
,	,	O
binding	NN	O
of	IN	O
the	DT	O
antibody	NN	O
to	TO	O
the	DT	O
sample	NN	O
may	MD	O
be	VB	O
detected	VBN	O
using	VBG	O
a	DT	O
secondary	JJ	O
antibody	NN	O
having	VBG	O
such	JJ	O
a	DT	O
detectable	JJ	O
label	NN	O
thereon	NN	O
.	.	O
Particular	JJ	O
assays	NNS	O
include	VBP	O
ELISA	NNP	O
assays	NNS	O
,	,	O
sandwich	JJ	O
assays	NNS	O
,	,	O
radioimmunoassays	NNS	O
,	,	O
and	CC	O
Western	JJ	O
Blots	NNP	O
.	.	O
Polyclonal	NNP	O
antibodies	NNS	O
generated	VBD	O
against	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
obtained	VBN	O
by	IN	O
direct	JJ	O
injection	NN	O
of	IN	O
the	DT	O
polypeptides	NNS	O
into	IN	O
an	DT	O
animal	NN	O
or	CC	O
by	IN	O
administering	VBG	O
the	DT	O
polypeptides	NNS	O
to	TO	O
a	DT	O
non-human	JJ	O
animal	NN	O
.	.	O
The	DT	O
antibody	NN	O
so	RB	O
obtained	VBN	O
will	MD	O
then	RB	O
bind	VB	O
the	DT	O
polypeptide	NN	O
itself	PRP	O
.	.	O
In	IN	O
this	DT	O
manner	NN	O
,	,	O
even	RB	O
a	DT	O
sequence	NN	O
encoding	VBG	O
only	RB	O
a	DT	O
fragment	NN	O
of	IN	O
the	DT	O
polypeptide	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
generate	VB	O
antibodies	NNS	O
which	WDT	O
may	MD	O
bind	VB	O
to	TO	O
the	DT	O
whole	JJ	O
native	JJ	O
polypeptide	NN	O
.	.	O
Such	JJ	O
antibodies	NNS	O
can	MD	O
then	RB	O
be	VB	O
used	VBN	O
to	TO	O
isolate	VB	O
the	DT	O
polypeptide	NN	O
from	IN	O
cells	NNS	O
expressing	VBG	O
that	IN	O
polypeptide	NN	O
.	.	O
For	IN	O
preparation	NN	O
of	IN	O
monoclonal	JJ	O
antibodies	NNS	O
,	,	O
any	DT	O
technique	NN	O
which	WDT	O
provides	VBZ	O
antibodies	NNS	O
produced	VBN	O
by	IN	O
continuous	JJ	O
cell	NN	O
line	NN	O
cultures	NNS	O
can	MD	O
be	VB	O
used	VBN	O
.	.	O
Examples	NNS	O
include	VBP	O
the	DT	O
hybridoma	NN	O
technique	NN	O
,	,	O
the	DT	O
trioma	NN	O
technique	NN	O
,	,	O
the	DT	O
human	JJ	O
B-cell	NNP	O
hybridoma	NN	O
technique	NN	O
,	,	O
and	CC	O
the	DT	O
EBV-hybridoma	NNP	O
technique	NN	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Cole	NNP	B
(	(	I
1985	CD	I
)	)	I
in	IN	I
Monoclonal	NNP	I
Antibodies	NNPS	I
and	CC	I
Cancer	NNP	I
Therapy	NNP	I
,	,	I
Alan	NNP	I
R.	NNP	I
Liss	NNP	I
,	,	I
Inc.	NNP	I
,	,	I
pp	NN	I
.	.	I
77-96	JJ	I
)	)	O
.	.	O
Techniques	NNS	O
described	VBN	O
for	IN	O
the	DT	O
production	NN	O
of	IN	O
single	JJ	O
chain	NN	O
antibodies	NNS	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
4,946,778	CD	O
)	)	O
can	MD	O
be	VB	O
adapted	VBN	O
to	TO	O
produce	VB	O
single	JJ	O
chain	NN	O
antibodies	NNS	O
to	TO	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Alternatively	RB	O
,	,	O
transgenic	JJ	O
mice	NN	O
may	MD	O
be	VB	O
used	VBN	O
to	TO	O
express	VB	O
humanized	JJ	O
antibodies	NNS	O
to	TO	O
these	DT	O
polypeptides	NNS	O
or	CC	O
fragments	NNS	O
thereof	NN	O
.	.	O
Antibodies	NNS	O
generated	VBN	O
against	IN	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
be	VB	O
used	VBN	O
in	IN	O
screening	VBG	O
for	IN	O
similar	JJ	O
polypeptides	NNS	O
(	(	O
e.g.	NN	O
,	,	O
amylases	NNS	O
)	)	O
from	IN	O
other	JJ	O
organisms	NNS	O
and	CC	O
samples	NNS	O
.	.	O
In	IN	O
such	JJ	O
techniques	NNS	O
,	,	O
polypeptides	NNS	O
from	IN	O
the	DT	O
organism	NN	O
are	VBP	O
contacted	VBN	O
with	IN	O
the	DT	O
antibody	NN	O
and	CC	O
those	DT	O
polypeptides	NNS	O
which	WDT	O
specifically	RB	O
bind	VBP	O
the	DT	O
antibody	NN	O
are	VBP	O
detected	VBN	O
.	.	O
Any	DT	O
of	IN	O
the	DT	O
procedures	NNS	O
described	VBN	O
above	IN	O
may	MD	O
be	VB	O
used	VBN	O
to	TO	O
detect	VB	O
antibody	NN	O
binding	NN	O
.	.	O
Kits	VBZ	O
The	DT	O
invention	NN	O
provides	VBZ	O
kits	NNS	O
comprising	VBG	O
the	DT	O
compositions	NNS	O
,	,	O
e.g.	NN	O
,	,	O
nucleic	JJ	O
acids	NNS	O
,	,	O
expression	NN	O
cassettes	NNS	O
,	,	O
vectors	NNS	O
,	,	O
cells	NNS	O
,	,	O
transgenic	JJ	O
seeds	NNS	O
or	CC	O
plants	NNS	O
or	CC	O
plant	NN	O
parts	NNS	O
,	,	O
polypeptides	NNS	O
(	(	O
e.g.	NN	O
,	,	O
amylases	NNS	O
)	)	O
and/or	VBP	O
antibodies	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
kits	NNS	O
also	RB	O
can	MD	O
contain	VB	O
instructional	JJ	O
material	NN	O
teaching	VBG	O
the	DT	O
methodologies	NNS	O
and	CC	O
industrial	JJ	O
uses	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
as	IN	O
described	VBN	O
herein	NN	O
.	.	O
Measuring	VBG	O
Metabolic	NNP	O
Parameters	NNPS	O
The	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
provide	VBP	O
whole	JJ	O
cell	NN	O
evolution	NN	O
,	,	O
or	CC	O
whole	JJ	O
cell	NN	O
engineering	NN	O
,	,	O
of	IN	O
a	DT	O
cell	NN	O
to	TO	O
develop	VB	O
a	DT	O
new	JJ	O
cell	NN	O
strain	NN	O
having	VBG	O
a	DT	O
new	JJ	O
phenotype	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
new	JJ	O
or	CC	O
modified	JJ	O
amylase	NN	O
activity	NN	O
,	,	O
by	IN	O
modifying	VBG	O
the	DT	O
genetic	JJ	O
composition	NN	O
of	IN	O
the	DT	O
cell	NN	O
.	.	O
The	DT	O
genetic	JJ	O
composition	NN	O
can	MD	O
be	VB	O
modified	VBN	O
by	IN	O
addition	NN	O
to	TO	O
the	DT	O
cell	NN	O
of	IN	O
a	DT	O
nucleic	JJ	O
acid	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
To	TO	O
detect	VB	O
the	DT	O
new	JJ	O
phenotype	NN	O
,	,	O
at	IN	O
least	JJS	O
one	CD	O
metabolic	JJ	O
parameter	NN	O
of	IN	O
a	DT	O
modified	VBN	O
cell	NN	O
is	VBZ	O
monitored	VBN	O
in	IN	O
the	DT	O
cell	NN	O
in	IN	O
a	DT	O
“	JJ	O
real	JJ	O
time	NN	O
”	NN	O
or	CC	O
“	VB	O
on-line	JJ	O
”	JJ	O
time	NN	O
frame	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
plurality	NN	O
of	IN	O
cells	NNS	O
,	,	O
such	JJ	O
as	IN	O
a	DT	O
cell	NN	O
culture	NN	O
,	,	O
is	VBZ	O
monitored	VBN	O
in	IN	O
“	JJ	O
real	JJ	O
time	NN	O
”	NN	O
or	CC	O
“	VB	O
on-line.	JJ	O
”	NN	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
a	DT	O
plurality	NN	O
of	IN	O
metabolic	JJ	O
parameters	NNS	O
is	VBZ	O
monitored	VBN	O
in	IN	O
“	JJ	O
real	JJ	O
time	NN	O
”	NN	O
or	CC	O
“	VB	O
on-line.	JJ	O
”	NNP	O
Metabolic	NNP	O
parameters	NNS	O
can	MD	O
be	VB	O
monitored	VBN	O
using	VBG	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Metabolic	NNP	O
flux	NN	O
analysis	NN	O
(	(	O
MFA	NNP	O
)	)	O
is	VBZ	O
based	VBN	O
on	IN	O
a	DT	O
known	VBN	O
biochemistry	NN	O
framework	NN	O
.	.	O
A	DT	O
linearly	JJ	O
independent	JJ	O
metabolic	JJ	O
matrix	NN	O
is	VBZ	O
constructed	VBN	O
based	VBN	O
on	IN	O
the	DT	O
law	NN	O
of	IN	O
mass	NN	O
conservation	NN	O
and	CC	O
on	IN	O
the	DT	O
pseudo-steady	JJ	O
state	NN	O
hypothesis	NN	O
(	(	O
PSSH	NNP	O
)	)	O
on	IN	O
the	DT	O
intracellular	JJ	O
metabolites	NNS	O
.	.	O
In	IN	O
practicing	VBG	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
metabolic	JJ	O
networks	NNS	O
are	VBP	O
established	VBN	O
,	,	O
including	VBG	O
the	DT	O
:	:	O
Once	RB	O
the	DT	O
metabolic	NN	O
network	NN	O
for	IN	O
a	DT	O
given	VBN	O
strain	NN	O
is	VBZ	O
built	VBN	O
,	,	O
mathematic	JJ	O
presentation	NN	O
by	IN	O
matrix	JJ	O
notion	NN	O
can	MD	O
be	VB	O
introduced	VBN	O
to	TO	O
estimate	VB	O
the	DT	O
intracellular	JJ	O
metabolic	NN	O
fluxes	NNS	O
if	IN	O
the	DT	O
on-line	JJ	O
metabolome	NN	O
data	NNS	O
is	VBZ	O
available	JJ	O
.	.	O
Metabolic	NNP	O
phenotype	NN	O
relies	NNS	O
on	IN	O
the	DT	O
changes	NNS	O
of	IN	O
the	DT	O
whole	JJ	O
metabolic	NN	O
network	NN	O
within	IN	O
a	DT	O
cell	NN	O
.	.	O
Metabolic	NNP	O
phenotype	NN	O
relies	NNS	O
on	IN	O
the	DT	O
change	NN	O
of	IN	O
pathway	NN	O
utilization	NN	O
with	IN	O
respect	NN	O
to	TO	O
environmental	JJ	O
conditions	NNS	O
,	,	O
genetic	JJ	O
regulation	NN	O
,	,	O
developmental	JJ	O
state	NN	O
and	CC	O
the	DT	O
genotype	NN	O
,	,	O
etc	FW	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
after	IN	O
the	DT	O
on-line	JJ	O
MFA	NNP	O
calculation	NN	O
,	,	O
the	DT	O
dynamic	JJ	O
behavior	NN	O
of	IN	O
the	DT	O
cells	NNS	O
,	,	O
their	PRP$	O
phenotype	NN	O
and	CC	O
other	JJ	O
properties	NNS	O
are	VBP	O
analyzed	VBN	O
by	IN	O
investigating	VBG	O
the	DT	O
pathway	NN	O
utilization	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
if	IN	O
the	DT	O
glucose	JJ	O
supply	NN	O
is	VBZ	O
increased	VBN	O
and	CC	O
the	DT	O
oxygen	NN	O
decreased	VBD	O
during	IN	O
the	DT	O
yeast	JJ	O
fermentation	NN	O
,	,	O
the	DT	O
utilization	NN	O
of	IN	O
respiratory	NN	O
pathways	NNS	O
will	MD	O
be	VB	O
reduced	VBN	O
and/or	JJ	O
stopped	VBD	O
,	,	O
and	CC	O
the	DT	O
utilization	NN	O
of	IN	O
the	DT	O
fermentative	JJ	O
pathways	NNS	O
will	MD	O
dominate	VB	O
.	.	O
Control	NN	O
of	IN	O
physiological	JJ	O
state	NN	O
of	IN	O
cell	NN	O
cultures	NNS	O
will	MD	O
become	VB	O
possible	JJ	O
after	IN	O
the	DT	O
pathway	NN	O
analysis	NN	O
.	.	O
The	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
help	VB	O
determine	VB	O
how	WRB	O
to	TO	O
manipulate	VB	O
the	DT	O
fermentation	NN	O
by	IN	O
determining	VBG	O
how	WRB	O
to	TO	O
change	VB	O
the	DT	O
substrate	NN	O
supply	NN	O
,	,	O
temperature	NN	O
,	,	O
use	NN	O
of	IN	O
inducers	NNS	O
,	,	O
etc	FW	O
.	.	O
to	TO	O
control	VB	O
the	DT	O
physiological	JJ	O
state	NN	O
of	IN	O
cells	NNS	O
to	TO	O
move	VB	O
along	RB	O
desirable	JJ	O
direction	NN	O
.	.	O
In	IN	O
practicing	VBG	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
the	DT	O
MFA	NNP	O
results	NNS	O
can	MD	O
also	RB	O
be	VB	O
compared	VBN	O
with	IN	O
transcriptome	NN	O
and	CC	O
proteome	VB	O
data	NNS	O
to	TO	O
design	VB	O
experiments	NNS	O
and	CC	O
protocols	NNS	O
for	IN	O
metabolic	JJ	O
engineering	NN	O
or	CC	O
gene	NN	O
shuffling	NN	O
,	,	O
etc	FW	O
.	.	O
In	IN	O
practicing	VBG	O
the	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
any	DT	O
modified	VBD	O
or	CC	O
new	JJ	O
phenotype	NN	O
can	MD	O
be	VB	O
conferred	VBN	O
and	CC	O
detected	VBN	O
,	,	O
including	VBG	O
new	JJ	O
or	CC	O
improved	JJ	O
characteristics	NNS	O
in	IN	O
the	DT	O
cell	NN	O
.	.	O
Any	DT	O
aspect	NN	O
of	IN	O
metabolism	NN	O
or	CC	O
growth	NN	O
can	MD	O
be	VB	O
monitored	VBN	O
.	.	O
Monitoring	VBG	O
Expression	NNP	O
of	IN	O
an	DT	O
mRNA	NN	O
Transcript	NN	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
the	DT	O
engineered	JJ	O
phenotype	NN	O
comprises	VBZ	O
increasing	VBG	O
or	CC	O
decreasing	VBG	O
the	DT	O
expression	NN	O
of	IN	O
an	DT	O
mRNA	NN	O
transcript	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	JJ	O
message	NN	O
)	)	O
or	CC	O
generating	VBG	O
new	JJ	O
(	(	O
e.g.	JJ	O
,	,	O
amylase	NN	O
)	)	O
transcripts	NNS	O
in	IN	O
a	DT	O
cell	NN	O
.	.	O
This	DT	O
increased	VBD	O
or	CC	O
decreased	JJ	O
expression	NN	O
can	MD	O
be	VB	O
traced	VBN	O
by	IN	O
testing	VBG	O
for	IN	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
or	CC	O
by	IN	O
amylase	JJ	O
activity	NN	O
assays	NNS	O
.	.	O
mRNA	NN	O
transcripts	NNS	O
,	,	O
or	CC	O
messages	NNS	O
,	,	O
also	RB	O
can	MD	O
be	VB	O
detected	VBN	O
and	CC	O
quantified	VBN	O
by	IN	O
any	DT	O
method	NN	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
Northern	NNP	O
blots	NNS	O
,	,	O
quantitative	JJ	O
amplification	NN	O
reactions	NNS	O
,	,	O
hybridization	NN	O
to	TO	O
arrays	VB	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Quantitative	JJ	O
amplification	NN	O
reactions	NNS	O
include	VBP	O
,	,	O
e.g.	JJ	O
,	,	O
quantitative	JJ	O
PCR	NNP	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
quantitative	JJ	O
reverse	NN	O
transcription	NN	O
polymerase	NN	O
chain	NN	O
reaction	NN	O
,	,	O
or	CC	O
RT-PCR	NNP	O
;	:	O
quantitative	JJ	O
real	JJ	O
time	NN	O
RT-PCR	NNP	O
,	,	O
or	CC	O
“	VB	O
real-time	JJ	O
kinetic	JJ	O
RT-PCR	NNP	O
”	NNP	O
(	(	O
see	VB	O
,	,	O
e.g.	VB	O
,	,	O
Kreuzer	NNP	B
(	(	I
2001	CD	I
)	)	I
Br	NNP	I
.	.	I
J.	NNP	I
Haematol	NNP	I
.	.	I
114:313-318	JJ	I
;	:	O
Xia	NNP	B
(	(	I
2001	CD	I
)	)	I
Transplantation	NNP	I
72:907-914	JJ	I
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
the	DT	O
engineered	JJ	O
phenotype	NN	O
is	VBZ	O
generated	VBN	O
by	IN	O
knocking	VBG	O
out	RP	O
expression	NN	O
of	IN	O
a	DT	O
homologous	JJ	O
gene	NN	O
.	.	O
The	DT	O
gene	NN	O
's	POS	O
coding	VBG	O
sequence	NN	O
or	CC	O
one	CD	O
or	CC	O
more	JJR	O
transcriptional	JJ	O
control	NN	O
elements	NNS	O
can	MD	O
be	VB	O
knocked	VBN	O
out	RP	O
,	,	O
e.g.	RB	O
,	,	O
promoters	NNS	O
or	CC	O
enhancers	NNS	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
expression	NN	O
of	IN	O
a	DT	O
transcript	NN	O
can	MD	O
be	VB	O
completely	RB	O
ablated	VBN	O
or	CC	O
only	RB	O
decreased	JJ	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
the	DT	O
engineered	JJ	O
phenotype	NN	O
comprises	NNS	O
increasing	VBG	O
the	DT	O
expression	NN	O
of	IN	O
a	DT	O
homologous	JJ	O
gene	NN	O
.	.	O
This	DT	O
can	MD	O
be	VB	O
effected	VBN	O
by	IN	O
knocking	VBG	O
out	IN	O
of	IN	O
a	DT	O
negative	JJ	O
control	NN	O
element	NN	O
,	,	O
including	VBG	O
a	DT	O
transcriptional	JJ	O
regulatory	JJ	O
element	NN	O
acting	VBG	O
in	IN	O
cis-	JJ	O
or	CC	O
trans-	JJ	O
,	,	O
or	CC	O
,	,	O
mutagenizing	VBG	O
a	DT	O
positive	JJ	O
control	NN	O
element	NN	O
.	.	O
One	CD	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
,	,	O
all	PDT	O
the	DT	O
transcripts	NNS	O
of	IN	O
a	DT	O
cell	NN	O
can	MD	O
be	VB	O
measured	VBN	O
by	IN	O
hybridization	NN	O
of	IN	O
a	DT	O
sample	NN	O
comprising	VBG	O
transcripts	NNS	O
of	IN	O
the	DT	O
cell	NN	O
,	,	O
or	CC	O
,	,	O
nucleic	JJ	O
acids	NNS	O
representative	NN	O
of	IN	O
or	CC	O
complementary	JJ	O
to	TO	O
transcripts	NNS	O
of	IN	O
a	DT	O
cell	NN	O
,	,	O
by	IN	O
hybridization	NN	O
to	TO	O
immobilized	VB	O
nucleic	JJ	O
acids	NNS	O
on	IN	O
an	DT	O
array	NN	O
.	.	O
Monitoring	VBG	O
Expression	NNP	O
of	IN	O
a	DT	O
Polypeptides	NNP	O
,	,	O
Peptides	NNP	O
and	CC	O
Amino	NNP	O
Acids	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
the	DT	O
engineered	JJ	O
phenotype	NN	O
comprises	VBZ	O
increasing	VBG	O
or	CC	O
decreasing	VBG	O
the	DT	O
expression	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
(	(	O
e.g.	NN	O
,	,	O
an	DT	O
amylase	NN	O
)	)	O
or	CC	O
generating	VBG	O
new	JJ	O
polypeptides	NNS	O
in	IN	O
a	DT	O
cell	NN	O
.	.	O
This	DT	O
increased	VBD	O
or	CC	O
decreased	JJ	O
expression	NN	O
can	MD	O
be	VB	O
traced	VBN	O
by	IN	O
determining	VBG	O
the	DT	O
amount	NN	O
of	IN	O
amylase	JJ	O
present	NN	O
or	CC	O
by	IN	O
amylase	JJ	O
activity	NN	O
assays	NNS	O
.	.	O
Polypeptides	NNS	O
,	,	O
peptides	NNS	O
and	CC	O
amino	NN	O
acids	NNS	O
also	RB	O
can	MD	O
be	VB	O
detected	VBN	O
and	CC	O
quantified	VBN	O
by	IN	O
any	DT	O
method	NN	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
including	VBG	O
,	,	O
e.g.	NN	O
,	,	O
nuclear	JJ	O
magnetic	JJ	O
resonance	NN	O
(	(	O
NMR	NNP	O
)	)	O
,	,	O
spectrophotometry	NN	O
,	,	O
radiography	NN	O
(	(	O
protein	IN	O
radiolabeling	VBG	O
)	)	O
,	,	O
electrophoresis	NN	O
,	,	O
capillary	JJ	O
electrophoresis	NN	O
,	,	O
high	JJ	O
performance	NN	O
liquid	NN	O
chromatography	NN	O
(	(	O
HPLC	NNP	O
)	)	O
,	,	O
thin	JJ	O
layer	NN	O
chromatography	NN	O
(	(	O
TLC	NNP	O
)	)	O
,	,	O
hyperdiffusion	NN	O
chromatography	NN	O
,	,	O
various	JJ	O
immunological	JJ	O
methods	NNS	O
,	,	O
e.g	NN	O
.	.	O
immunoprecipitation	NN	O
,	,	O
immunodiffusion	NN	O
,	,	O
immuno-electrophoresis	NN	O
,	,	O
radioimmunoassays	NNS	O
(	(	O
RIAs	NNP	O
)	)	O
,	,	O
enzyme-linked	JJ	O
immunosorbent	NN	O
assays	NNS	O
(	(	O
ELISAs	NNP	O
)	)	O
,	,	O
immuno-fluorescent	JJ	O
assays	NNS	O
,	,	O
gel	JJ	O
electrophoresis	NN	O
(	(	O
e.g.	JJ	O
,	,	O
SDS-PAGE	NNP	O
)	)	O
,	,	O
staining	VBG	O
with	IN	O
antibodies	NNS	O
,	,	O
fluorescent	NN	O
activated	VBD	O
cell	NN	O
sorter	NN	O
(	(	O
FACS	NNP	O
)	)	O
,	,	O
pyrolysis	JJ	O
mass	NN	O
spectrometry	NN	O
,	,	O
Fourier-Transform	NNP	O
Infrared	NNP	O
Spectrometry	NNP	O
,	,	O
Raman	NNP	O
spectrometry	NN	O
,	,	O
GC-MS	NNP	O
,	,	O
and	CC	O
LC-Electrospray	NNP	O
and	CC	O
cap-LC-tandem-electrospray	JJ	O
mass	NN	O
spectrometries	NNS	O
,	,	O
and	CC	O
the	DT	O
like	JJ	O
.	.	O
Novel	NNP	O
bioactivities	NNS	O
can	MD	O
also	RB	O
be	VB	O
screened	VBN	O
using	VBG	O
methods	NNS	O
,	,	O
or	CC	O
variations	NNS	O
thereof	VBP	O
,	,	O
described	VBN	O
in	IN	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,057,103	CD	O
.	.	O
Furthermore	RB	O
,	,	O
as	IN	O
discussed	VBN	O
below	IN	O
in	IN	O
detail	NN	O
,	,	O
one	CD	O
or	CC	O
more	JJR	O
,	,	O
or	CC	O
,	,	O
all	PDT	O
the	DT	O
polypeptides	NNS	O
of	IN	O
a	DT	O
cell	NN	O
can	MD	O
be	VB	O
measured	VBN	O
using	VBG	O
a	DT	O
protein	JJ	O
array	NN	O
.	.	O
Industrial	NNP	O
Applications	NNP	O
Detergent	NNP	O
Compositions	NNP	O
The	DT	O
invention	NN	O
provides	VBZ	O
detergent	JJ	O
compositions	NNS	O
comprising	VBG	O
one	CD	O
or	CC	O
more	JJR	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
and	CC	O
methods	NNS	O
of	IN	O
making	VBG	O
and	CC	O
using	VBG	O
these	DT	O
compositions	NNS	O
.	.	O
The	DT	O
invention	NN	O
incorporates	VBZ	O
all	DT	O
methods	NNS	O
of	IN	O
making	VBG	O
and	CC	O
using	VBG	O
detergent	JJ	O
compositions	NNS	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,413,928	CD	O
;	:	O
6,399,561	CD	O
;	:	O
6,365,561	CD	O
;	:	O
6,380,147	CD	O
.	.	O
The	DT	O
detergent	NN	O
compositions	NNS	O
can	MD	O
be	VB	O
a	DT	O
one	CD	O
and	CC	O
two	CD	O
part	NN	O
aqueous	JJ	O
composition	NN	O
,	,	O
a	DT	O
non-aqueous	JJ	O
liquid	NN	O
composition	NN	O
,	,	O
a	DT	O
cast	NN	O
solid	JJ	O
,	,	O
a	DT	O
granular	JJ	O
form	NN	O
,	,	O
a	DT	O
particulate	JJ	O
form	NN	O
,	,	O
a	DT	O
compressed	JJ	O
tablet	NN	O
,	,	O
a	DT	O
gel	NN	O
and/or	VBZ	O
a	DT	O
paste	NN	O
and	CC	O
a	DT	O
slurry	JJ	O
form	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
methods	NNS	O
capable	JJ	O
of	IN	O
a	DT	O
rapid	JJ	O
removal	NN	O
of	IN	O
gross	JJ	O
food	NN	O
soils	NNS	O
,	,	O
films	NNS	O
of	IN	O
food	NN	O
residue	NNS	O
and	CC	O
other	JJ	O
minor	JJ	O
food	NN	O
compositions	NNS	O
using	VBG	O
these	DT	O
detergent	JJ	O
compositions	NNS	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
facilitate	VB	O
the	DT	O
removal	NN	O
of	IN	O
starchy	NN	O
stains	NNS	O
by	IN	O
means	NNS	O
of	IN	O
catalytic	JJ	O
hydrolysis	NN	O
of	IN	O
the	DT	O
starch	NN	O
polysaccharide	NN	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
dishwashing	VBG	O
detergents	NNS	O
in	IN	O
textile	NN	O
laundering	NN	O
detergents	NNS	O
.	.	O
The	DT	O
actual	JJ	O
active	JJ	O
enzyme	NN	O
content	NN	O
depends	VBZ	O
upon	IN	O
the	DT	O
method	NN	O
of	IN	O
manufacture	NN	O
of	IN	O
a	DT	O
detergent	JJ	O
composition	NN	O
and	CC	O
is	VBZ	O
not	RB	O
critical	JJ	O
,	,	O
assuming	VBG	O
the	DT	O
detergent	NN	O
solution	NN	O
has	VBZ	O
the	DT	O
desired	VBN	O
enzymatic	JJ	O
activity	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
amount	NN	O
of	IN	O
amylase	NN	O
present	NN	O
in	IN	O
the	DT	O
final	JJ	O
solution	NN	O
ranges	VBZ	O
from	IN	O
about	IN	O
0.001	CD	O
mg	NNS	O
to	TO	O
0.5	CD	O
mg	NNS	O
per	IN	O
gram	NN	O
of	IN	O
the	DT	O
detergent	NN	O
composition	NN	O
.	.	O
The	DT	O
particular	JJ	O
enzyme	NN	O
chosen	NN	O
for	IN	O
use	NN	O
in	IN	O
the	DT	O
process	NN	O
and	CC	O
products	NNS	O
of	IN	O
this	DT	O
invention	NN	O
depends	VBZ	O
upon	IN	O
the	DT	O
conditions	NNS	O
of	IN	O
final	JJ	O
utility	NN	O
,	,	O
including	VBG	O
the	DT	O
physical	JJ	O
product	NN	O
form	NN	O
,	,	O
use	NN	O
pH	NN	O
,	,	O
use	NN	O
temperature	NN	O
,	,	O
and	CC	O
soil	NN	O
types	NNS	O
to	TO	O
be	VB	O
degraded	VBN	O
or	CC	O
altered	VBN	O
.	.	O
The	DT	O
enzyme	NN	O
can	MD	O
be	VB	O
chosen	VBN	O
to	TO	O
provide	VB	O
optimum	JJ	O
activity	NN	O
and	CC	O
stability	NN	O
for	IN	O
any	DT	O
given	VBN	O
set	NN	O
of	IN	O
utility	NN	O
conditions	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
are	VBP	O
active	JJ	O
in	IN	O
the	DT	O
pH	NN	O
ranges	VBZ	O
of	IN	O
from	IN	O
about	IN	O
4	CD	O
to	TO	O
about	IN	O
12	CD	O
and	CC	O
in	IN	O
the	DT	O
temperature	NN	O
range	NN	O
of	IN	O
from	IN	O
about	IN	O
20°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
95°	CD	O
C.	NNP	O
The	DT	O
detergents	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
comprise	VB	O
cationic	JJ	O
,	,	O
semi-polar	JJ	O
nonionic	NN	O
or	CC	O
zwitterionic	JJ	O
surfactants	NNS	O
;	:	O
or	CC	O
,	,	O
mixtures	NNS	O
thereof	VBP	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
formulated	VBN	O
into	IN	O
powdered	JJ	O
and	CC	O
liquid	JJ	O
detergents	NNS	O
having	VBG	O
pH	NN	O
between	IN	O
4.0	CD	O
and	CC	O
12.0	CD	O
at	IN	O
levels	NNS	O
of	IN	O
about	RB	O
0.01	CD	O
to	TO	O
about	IN	O
5	CD	O
%	NN	O
(	(	O
preferably	RB	O
0.1	CD	O
%	NN	O
to	TO	O
0.5	CD	O
%	NN	O
)	)	O
by	IN	O
weight	NN	O
.	.	O
These	DT	O
detergent	JJ	O
compositions	NNS	O
can	MD	O
also	RB	O
include	VB	O
other	JJ	O
enzymes	NNS	O
such	JJ	O
as	IN	O
known	JJ	O
proteases	NNS	O
,	,	O
cellulases	NNS	O
,	,	O
lipases	VBZ	O
or	CC	O
endoglycosidases	VBZ	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
builders	NNS	O
and	CC	O
stabilizers	NNS	O
.	.	O
The	DT	O
addition	NN	O
of	IN	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
conventional	JJ	O
cleaning	JJ	O
compositions	NNS	O
does	VBZ	O
not	RB	O
create	VB	O
any	DT	O
special	JJ	O
use	NN	O
limitation	NN	O
.	.	O
In	IN	O
other	JJ	O
words	NNS	O
,	,	O
any	DT	O
temperature	NN	O
and	CC	O
pH	NN	O
suitable	NN	O
for	IN	O
the	DT	O
detergent	NN	O
is	VBZ	O
also	RB	O
suitable	JJ	O
for	IN	O
the	DT	O
present	JJ	O
compositions	NNS	O
as	RB	O
long	RB	O
as	IN	O
the	DT	O
pH	NN	O
is	VBZ	O
within	IN	O
the	DT	O
above	JJ	O
range	NN	O
,	,	O
and	CC	O
the	DT	O
temperature	NN	O
is	VBZ	O
below	IN	O
the	DT	O
described	JJ	O
enzyme	NN	O
's	POS	O
denaturing	JJ	O
temperature	NN	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
the	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
cleaning	NN	O
composition	NN	O
without	IN	O
detergents	NNS	O
,	,	O
again	RB	O
either	CC	O
alone	RB	O
or	CC	O
in	IN	O
combination	NN	O
with	IN	O
builders	NNS	O
and	CC	O
stabilizers	NNS	O
.	.	O
The	DT	O
present	JJ	O
invention	NN	O
provides	VBZ	O
cleaning	JJ	O
compositions	NNS	O
including	VBG	O
detergent	NN	O
compositions	NNS	O
for	IN	O
cleaning	VBG	O
hard	JJ	O
surfaces	NNS	O
,	,	O
detergent	NN	O
compositions	NNS	O
for	IN	O
cleaning	VBG	O
fabrics	NNS	O
,	,	O
dishwashing	VBG	O
compositions	NNS	O
,	,	O
oral	JJ	O
cleaning	NN	O
compositions	NNS	O
,	,	O
denture	NN	O
cleaning	NN	O
compositions	NNS	O
,	,	O
and	CC	O
contact	NN	O
lens	NNS	O
cleaning	VBG	O
solutions	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
washing	VBG	O
an	DT	O
object	JJ	O
comprising	NN	O
contacting	VBG	O
the	DT	O
object	NN	O
with	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
under	IN	O
conditions	NNS	O
sufficient	JJ	O
for	IN	O
washing	VBG	O
.	.	O
A	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
be	VB	O
included	VBN	O
as	IN	O
a	DT	O
detergent	NN	O
additive	NN	O
.	.	O
The	DT	O
detergent	JJ	O
composition	NN	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
,	,	O
for	IN	O
example	NN	O
,	,	O
be	VB	O
formulated	VBN	O
as	IN	O
a	DT	O
hand	NN	O
or	CC	O
machine	NN	O
laundry	JJ	O
detergent	NN	O
composition	NN	O
comprising	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
A	DT	O
laundry	JJ	O
additive	NN	O
suitable	NN	O
for	IN	O
pre-treatment	NN	O
of	IN	O
stained	JJ	O
fabrics	NNS	O
can	MD	O
comprise	VB	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
A	DT	O
fabric	JJ	O
softener	NN	O
composition	NN	O
can	MD	O
comprise	VB	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Alternatively	RB	O
,	,	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
formulated	VBN	O
as	IN	O
a	DT	O
detergent	NN	O
composition	NN	O
for	IN	O
use	NN	O
in	IN	O
general	JJ	O
household	NN	O
hard	JJ	O
surface	NN	O
cleaning	VBG	O
operations	NNS	O
.	.	O
In	IN	O
alternative	JJ	O
aspects	NNS	O
,	,	O
detergent	NN	O
additives	NNS	O
and	CC	O
detergent	JJ	O
compositions	NNS	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
comprise	VB	O
one	CD	O
or	CC	O
more	JJR	O
other	JJ	O
enzymes	NNS	O
such	JJ	O
as	IN	O
a	DT	O
protease	NN	O
,	,	O
a	DT	O
lipase	NN	O
,	,	O
a	DT	O
cutinase	NN	O
,	,	O
another	DT	O
amylase	NN	O
,	,	O
a	DT	O
carbohydrase	NN	O
,	,	O
a	DT	O
cellulase	NN	O
,	,	O
a	DT	O
pectinase	NN	O
,	,	O
a	DT	O
mannanase	NN	O
,	,	O
an	DT	O
arabinase	NN	O
,	,	O
a	DT	O
galactanase	NN	O
,	,	O
a	DT	O
xylanase	NN	O
,	,	O
an	DT	O
oxidase	NN	O
,	,	O
e.g.	NN	O
,	,	O
a	DT	O
lactase	NN	O
,	,	O
and/or	VBZ	O
a	DT	O
peroxidase	NN	O
.	.	O
The	DT	O
properties	NNS	O
of	IN	O
the	DT	O
enzyme	NN	O
(	(	O
s	JJ	O
)	)	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
chosen	VBN	O
to	TO	O
be	VB	O
compatible	JJ	O
with	IN	O
the	DT	O
selected	VBN	O
detergent	NN	O
(	(	O
i.e	NN	O
.	.	O
pH-optimum	JJ	O
,	,	O
compatibility	NN	O
with	IN	O
other	JJ	O
enzymatic	JJ	O
and	CC	O
non-enzymatic	JJ	O
ingredients	NNS	O
,	,	O
etc	FW	O
.	.	O
)	)	O
and	CC	O
the	DT	O
enzyme	NN	O
(	(	O
s	NN	O
)	)	O
is	VBZ	O
present	JJ	O
in	IN	O
effective	JJ	O
amounts	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
amylase	NN	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
used	VBN	O
to	TO	O
remove	VB	O
malodorous	JJ	O
materials	NNS	O
from	IN	O
fabrics	NNS	O
.	.	O
Various	JJ	O
detergent	NN	O
compositions	NNS	O
and	CC	O
methods	NNS	O
for	IN	O
making	VBG	O
them	PRP	O
that	WDT	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
practicing	VBG	O
the	DT	O
invention	NN	O
are	VBP	O
described	VBN	O
in	IN	O
,	,	O
e.g.	NN	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,333,301	CD	O
;	:	O
6,329,333	CD	O
;	:	O
6,326,341	CD	O
;	:	O
6,297,038	CD	O
;	:	O
6,309,871	CD	O
;	:	O
6,204,232	CD	O
;	:	O
6,197,070	CD	O
;	:	O
5,856,164	CD	O
.	.	O
Treating	VBG	O
Fabrics	NNS	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
treating	VBG	O
fabrics	NNS	O
using	VBG	O
one	CD	O
or	CC	O
more	JJR	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
any	DT	O
fabric-treating	JJ	O
method	NN	O
,	,	O
which	WDT	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
see	NN	O
,	,	O
e.g.	RB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,077,316	CD	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
feel	NN	O
and	CC	O
appearance	NN	O
of	IN	O
a	DT	O
fabric	NN	O
is	VBZ	O
improved	VBN	O
by	IN	O
a	DT	O
method	NN	O
comprising	VBG	O
contacting	VBG	O
the	DT	O
fabric	NN	O
with	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
in	IN	O
a	DT	O
solution	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
fabric	NN	O
is	VBZ	O
treated	VBN	O
with	IN	O
the	DT	O
solution	NN	O
under	IN	O
pressure	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
applied	VBN	O
during	IN	O
or	CC	O
after	IN	O
the	DT	O
weaving	NN	O
of	IN	O
textiles	NNS	O
,	,	O
or	CC	O
during	IN	O
the	DT	O
desizing	NN	O
stage	NN	O
,	,	O
or	CC	O
one	CD	O
or	CC	O
more	JJR	O
additional	JJ	O
fabric	NN	O
processing	NN	O
steps	NNS	O
.	.	O
During	IN	O
the	DT	O
weaving	NN	O
of	IN	O
textiles	NNS	O
,	,	O
the	DT	O
threads	NNS	O
are	VBP	O
exposed	VBN	O
to	TO	O
considerable	JJ	O
mechanical	JJ	O
strain	NN	O
.	.	O
Prior	RB	O
to	TO	O
weaving	VBG	O
on	IN	O
mechanical	JJ	O
looms	NNS	O
,	,	O
warp	NN	O
yarns	NNS	O
are	VBP	O
often	RB	O
coated	VBN	O
with	IN	O
sizing	VBG	O
starch	NN	O
or	CC	O
starch	NN	O
derivatives	NNS	O
in	IN	O
order	NN	O
to	TO	O
increase	VB	O
their	PRP$	O
tensile	JJ	O
strength	NN	O
and	CC	O
to	TO	O
prevent	VB	O
breaking	NN	O
.	.	O
The	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
applied	VBN	O
to	TO	O
remove	VB	O
these	DT	O
sizing	VBG	O
starch	NN	O
or	CC	O
starch	NN	O
derivatives	NNS	O
.	.	O
After	IN	O
the	DT	O
textiles	NNS	O
have	VBP	O
been	VBN	O
woven	VBN	O
,	,	O
a	DT	O
fabric	NN	O
can	MD	O
proceed	VB	O
to	TO	O
a	DT	O
desizing	NN	O
stage	NN	O
.	.	O
This	DT	O
can	MD	O
be	VB	O
followed	VBN	O
by	IN	O
one	CD	O
or	CC	O
more	JJR	O
additional	JJ	O
fabric	NN	O
processing	NN	O
steps	NNS	O
.	.	O
Desizing	NN	O
is	VBZ	O
the	DT	O
act	NN	O
of	IN	O
removing	VBG	O
size	NN	O
from	IN	O
textiles	NNS	O
.	.	O
After	IN	O
weaving	VBG	O
,	,	O
the	DT	O
size	NN	O
coating	NN	O
must	MD	O
be	VB	O
removed	VBN	O
before	IN	O
further	JJ	O
processing	VBG	O
the	DT	O
fabric	NN	O
in	IN	O
order	NN	O
to	TO	O
ensure	VB	O
a	DT	O
homogeneous	JJ	O
and	CC	O
wash-proof	JJ	O
result	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
method	NN	O
of	IN	O
desizing	VBG	O
comprising	VBG	O
enzymatic	JJ	O
hydrolysis	NN	O
of	IN	O
the	DT	O
size	NN	O
by	IN	O
the	DT	O
action	NN	O
of	IN	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
desize	VB	O
fabrics	NNS	O
,	,	O
including	VBG	O
cotton-containing	JJ	O
fabrics	NNS	O
,	,	O
as	IN	O
detergent	NN	O
additives	NNS	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
aqueous	JJ	O
compositions	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
producing	VBG	O
a	DT	O
stonewashed	JJ	O
look	NN	O
on	IN	O
indigo-dyed	JJ	O
denim	NN	O
fabric	NN	O
and	CC	O
garments	NNS	O
.	.	O
For	IN	O
the	DT	O
manufacture	NN	O
of	IN	O
clothes	NNS	O
,	,	O
the	DT	O
fabric	NN	O
can	MD	O
be	VB	O
cut	VBN	O
and	CC	O
sewn	VBN	O
into	IN	O
clothes	NNS	O
or	CC	O
garments	NNS	O
,	,	O
which	WDT	O
is	VBZ	O
afterwards	NNS	O
finished	VBN	O
.	.	O
In	IN	O
particular	JJ	O
,	,	O
for	IN	O
the	DT	O
manufacture	NN	O
of	IN	O
denim	JJ	O
jeans	NNS	O
,	,	O
different	JJ	O
enzymatic	JJ	O
finishing	NN	O
methods	NNS	O
have	VBP	O
been	VBN	O
developed	VBN	O
.	.	O
The	DT	O
finishing	NN	O
of	IN	O
denim	JJ	O
garment	NN	O
normally	RB	O
is	VBZ	O
initiated	VBN	O
with	IN	O
an	DT	O
enzymatic	JJ	O
desizing	NN	O
step	NN	O
,	,	O
during	IN	O
which	WDT	O
garments	NNS	O
are	VBP	O
subjected	VBN	O
to	TO	O
the	DT	O
action	NN	O
of	IN	O
amylolytic	JJ	O
enzymes	NNS	O
in	IN	O
order	NN	O
to	TO	O
provide	VB	O
softness	NN	O
to	TO	O
the	DT	O
fabric	NN	O
and	CC	O
make	VB	O
the	DT	O
cotton	NN	O
more	RBR	O
accessible	JJ	O
to	TO	O
the	DT	O
subsequent	JJ	O
enzymatic	JJ	O
finishing	NN	O
steps	NNS	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
finishing	VBG	O
denim	JJ	O
garments	NNS	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
“	JJ	O
bio-stoning	JJ	O
process	NN	O
”	NN	O
)	)	O
,	,	O
enzymatic	JJ	O
desizing	NN	O
and	CC	O
providing	VBG	O
softness	NN	O
to	TO	O
fabrics	NNS	O
using	VBG	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
quickly	RB	O
softening	VBG	O
denim	JJ	O
garments	NNS	O
in	IN	O
a	DT	O
desizing	NN	O
and/or	RP	O
finishing	VBG	O
process	NN	O
.	.	O
Foods	NNS	O
and	CC	O
Food	NNP	O
Processing	NNP	O
The	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
numerous	JJ	O
applications	NNS	O
in	IN	O
food	NN	O
processing	NN	O
industry	NN	O
.	.	O
The	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
used	VBN	O
in	IN	O
starch	NN	O
to	TO	O
fructose	VB	O
processing	NN	O
.	.	O
Starch	NN	O
to	TO	O
fructose	VB	O
processing	NN	O
can	MD	O
consist	VB	O
of	IN	O
four	CD	O
steps	NNS	O
:	:	O
liquefaction	NN	O
of	IN	O
granular	JJ	O
starch	NN	O
,	,	O
saccharification	NN	O
of	IN	O
the	DT	O
liquefied	JJ	O
starch	NN	O
into	IN	O
dextrose	JJ	O
,	,	O
purification	NN	O
,	,	O
and	CC	O
isomerization	NN	O
to	TO	O
fructose	VB	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
starch	NN	O
liquefaction	NN	O
using	VBG	O
the	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Concentrated	JJ	O
suspensions	NNS	O
of	IN	O
starch	NN	O
polymer	NN	O
granules	NNS	O
are	VBP	O
converted	VBN	O
into	IN	O
a	DT	O
solution	NN	O
of	IN	O
soluble	JJ	O
shorter	NN	O
chain	NN	O
length	NN	O
dextrins	NNS	O
of	IN	O
low	JJ	O
viscosity	NN	O
.	.	O
This	DT	O
step	NN	O
is	VBZ	O
useful	JJ	O
for	IN	O
convenient	NN	O
handling	VBG	O
with	IN	O
standard	JJ	O
equipment	NN	O
and	CC	O
for	IN	O
efficient	JJ	O
conversion	NN	O
to	TO	O
glucose	VB	O
or	CC	O
103	CD	O
other	JJ	O
sugars	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
granular	JJ	O
starch	NN	O
is	VBZ	O
liquefied	VBN	O
by	IN	O
gelatinizing	VBG	O
the	DT	O
granules	NNS	O
by	IN	O
raising	VBG	O
the	DT	O
temperature	NN	O
of	IN	O
the	DT	O
granular	JJ	O
starch	NN	O
to	TO	O
over	VB	O
about	IN	O
72°	CD	O
C.	NNP	O
The	DT	O
heating	NN	O
process	NN	O
instantaneously	RB	O
disrupts	VBZ	O
the	DT	O
insoluble	JJ	O
starch	NN	O
granules	NNS	O
to	TO	O
produce	VB	O
a	DT	O
water	NN	O
soluble	JJ	O
starch	NN	O
solution	NN	O
.	.	O
The	DT	O
solubilized	VBN	O
starch	NN	O
solution	NN	O
can	MD	O
then	RB	O
be	VB	O
liquefied	VBN	O
by	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
enzymatic	JJ	O
starch	NN	O
liquefaction	NN	O
processes	VBZ	O
using	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
An	DT	O
exemplary	JJ	O
enzymatic	JJ	O
liquefaction	NN	O
process	NN	O
involves	VBZ	O
adjusting	VBG	O
the	DT	O
pH	NN	O
of	IN	O
a	DT	O
granular	JJ	O
starch	NN	O
slurry	NN	O
to	TO	O
between	IN	O
6.0	CD	O
and	CC	O
6.5	CD	O
and	CC	O
the	DT	O
addition	NN	O
of	IN	O
calcium	NN	O
hydroxide	NN	O
,	,	O
sodium	NN	O
hydroxide	NN	O
or	CC	O
sodium	NN	O
carbonate	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
calcium	NN	O
hydroxide	NN	O
is	VBZ	O
added	VBN	O
.	.	O
This	DT	O
provides	VBZ	O
calcium	NN	O
ions	NNS	O
to	TO	O
stabilize	VB	O
the	DT	O
glucoamylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
against	IN	O
inactivation	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
upon	IN	O
addition	NN	O
of	IN	O
amylase	NN	O
,	,	O
the	DT	O
suspension	NN	O
is	VBZ	O
pumped	VBN	O
through	IN	O
a	DT	O
steam	NN	O
jet	NN	O
to	TO	O
instantaneously	RB	O
raise	VB	O
the	DT	O
temperature	NN	O
to	TO	O
between	IN	O
80°-115°	JJ	O
C.	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
starch	NN	O
is	VBZ	O
immediately	RB	O
gelatinized	VBN	O
and	CC	O
,	,	O
due	JJ	O
to	TO	O
the	DT	O
presence	NN	O
of	IN	O
amylase	NN	O
,	,	O
depolymerized	VBN	O
through	IN	O
random	JJ	O
hydrolysis	NN	O
of	IN	O
α-1,4-glycosidic	JJ	O
bonds	NNS	O
by	IN	O
amylase	NN	O
to	TO	O
a	DT	O
fluid	JJ	O
mass	NN	O
.	.	O
The	DT	O
fluid	JJ	O
mass	NN	O
can	MD	O
be	VB	O
easily	RB	O
pumped	VBN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
various	JJ	O
enzymatic	JJ	O
starch	NN	O
liquefaction	NN	O
processes	VBZ	O
using	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
of	IN	O
the	DT	O
liquefaction	NN	O
process	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
an	DT	O
amylase	NN	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
starch	NN	O
suspension	NN	O
and	CC	O
the	DT	O
suspension	NN	O
is	VBZ	O
held	VBN	O
at	IN	O
a	DT	O
temperature	NN	O
of	IN	O
between	IN	O
about	IN	O
80°-100°	JJ	O
C.	NNP	O
to	TO	O
partially	RB	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
granules	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
partially	RB	O
hydrolyzed	VBN	O
starch	NN	O
suspension	NN	O
is	VBZ	O
pumped	VBN	O
through	IN	O
a	DT	O
jet	NN	O
at	IN	O
temperatures	NNS	O
in	IN	O
excess	NN	O
of	IN	O
about	IN	O
105°	CD	O
C.	NNP	O
to	TO	O
thoroughly	VB	O
gelatinize	VB	O
any	DT	O
remaining	VBG	O
granular	JJ	O
structure	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
after	IN	O
cooling	VBG	O
the	DT	O
gelatinized	VBN	O
starch	NN	O
,	,	O
a	DT	O
second	JJ	O
addition	NN	O
of	IN	O
amylase	NN	O
is	VBZ	O
made	VBN	O
to	TO	O
further	RBR	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
enzymatic	JJ	O
dry	JJ	O
milling	NN	O
processes	VBZ	O
using	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
dry	JJ	O
milling	NN	O
,	,	O
whole	JJ	O
grain	NN	O
is	VBZ	O
ground	NN	O
and	CC	O
combined	VBN	O
with	IN	O
water	NN	O
.	.	O
The	DT	O
germ	NN	O
is	VBZ	O
optionally	RB	O
removed	VBN	O
by	IN	O
flotation	NN	O
separation	NN	O
or	CC	O
equivalent	JJ	O
techniques	NNS	O
.	.	O
The	DT	O
resulting	JJ	O
mixture	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
starch	NN	O
,	,	O
fiber	NN	O
,	,	O
protein	NN	O
and	CC	O
other	JJ	O
components	NNS	O
of	IN	O
the	DT	O
grain	NN	O
,	,	O
is	VBZ	O
liquefied	VBN	O
using	VBG	O
amylase	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
enzymatic	JJ	O
liquefaction	NN	O
is	VBZ	O
done	VBN	O
at	IN	O
lower	JJR	O
temperatures	NNS	O
than	IN	O
the	DT	O
starch	JJ	O
liquification	NN	O
processes	NNS	O
discussed	VBN	O
above	IN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
after	IN	O
gelatinization	NN	O
the	DT	O
starch	NN	O
solution	NN	O
is	VBZ	O
held	VBN	O
at	IN	O
an	DT	O
elevated	JJ	O
temperature	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
amylase	NN	O
until	IN	O
a	DT	O
DE	NNP	O
of	IN	O
10-20	JJ	O
is	VBZ	O
achieved	VBN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
this	DT	O
is	VBZ	O
a	DT	O
period	NN	O
of	IN	O
about	IN	O
1-3	JJ	O
hours	NNS	O
.	.	O
Dextrose	NNP	O
equivalent	JJ	O
(	(	O
DE	NNP	O
)	)	O
is	VBZ	O
the	DT	O
industry	NN	O
standard	NN	O
for	IN	O
measuring	VBG	O
the	DT	O
concentration	NN	O
of	IN	O
total	JJ	O
reducing	VBG	O
sugars	NNS	O
,	,	O
calculated	VBD	O
as	IN	O
D-glucose	NNP	O
on	IN	O
a	DT	O
dry	JJ	O
weight	JJ	O
basis	NN	O
.	.	O
Unhydrolyzed	VBN	O
granular	JJ	O
starch	NN	O
has	VBZ	O
a	DT	O
DE	NNP	O
of	IN	O
virtually	RB	O
zero	CD	O
,	,	O
whereas	IN	O
the	DT	O
DE	NNP	O
of	IN	O
D-glucose	NNP	O
is	VBZ	O
defined	VBN	O
as	IN	O
100	CD	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
wet	JJ	O
milling	NN	O
processes	NNS	O
,	,	O
e.g.	NN	O
,	,	O
corn	NN	O
wet	NN	O
milling	NN	O
,	,	O
using	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Corn	NNP	O
wet	NN	O
milling	NN	O
is	VBZ	O
a	DT	O
process	NN	O
which	WDT	O
produces	VBZ	O
corn	NN	O
oil	NN	O
,	,	O
gluten	VB	O
meal	NN	O
,	,	O
gluten	VBP	O
feed	NN	O
and	CC	O
starch	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
making	VBG	O
corn	NN	O
oil	NN	O
,	,	O
gluten	VB	O
meal	NN	O
,	,	O
gluten	VBP	O
feed	NN	O
and	CC	O
starch	NN	O
using	VBG	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
an	DT	O
alkaline-amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
used	VBN	O
in	IN	O
the	DT	O
liquefaction	NN	O
of	IN	O
starch	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
glucoamylase	NN	O
is	VBZ	O
used	VBN	O
in	IN	O
saccharification	NN	O
to	TO	O
produce	VB	O
glucose	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
corn	NN	O
(	(	O
a	DT	O
kernel	NN	O
that	IN	O
consists	VBZ	O
of	IN	O
a	DT	O
outer	NN	O
seed	NN	O
coat	NN	O
(	(	O
fiber	NN	O
)	)	O
,	,	O
starch	NN	O
,	,	O
a	DT	O
combination	NN	O
of	IN	O
starch	NN	O
and	CC	O
glucose	NN	O
and	CC	O
the	DT	O
inner	JJ	O
germ	NN	O
)	)	O
,	,	O
is	VBZ	O
subjected	VBN	O
to	TO	O
a	DT	O
four	CD	O
step	NN	O
process	NN	O
,	,	O
which	WDT	O
results	NNS	O
in	IN	O
the	DT	O
production	NN	O
of	IN	O
starch	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
corn	NN	O
is	VBZ	O
steeped	VBN	O
,	,	O
de-germed	JJ	O
,	,	O
de-fibered	JJ	O
,	,	O
and	CC	O
the	DT	O
gluten	NN	O
is	VBZ	O
separated	VBN	O
.	.	O
In	IN	O
a	DT	O
steeping	NN	O
process	NN	O
the	DT	O
solubles	NNS	O
are	VBP	O
taken	VBN	O
out	RP	O
.	.	O
The	DT	O
product	NN	O
remaining	VBG	O
after	IN	O
removal	NN	O
of	IN	O
the	DT	O
solubles	NNS	O
is	VBZ	O
de-germed	JJ	O
,	,	O
resulting	VBG	O
in	IN	O
production	NN	O
of	IN	O
corn	NN	O
oil	NN	O
and	CC	O
production	NN	O
of	IN	O
an	DT	O
oil	NN	O
cake	NN	O
,	,	O
which	WDT	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
solubles	NNS	O
from	IN	O
the	DT	O
steeping	VBG	O
step	NN	O
.	.	O
The	DT	O
remaining	VBG	O
product	NN	O
is	VBZ	O
de-fibered	JJ	O
and	CC	O
the	DT	O
fiber	NN	O
solids	NNS	O
are	VBP	O
added	VBN	O
to	TO	O
the	DT	O
oil	NN	O
cake/solubles	VBZ	O
mixture	NN	O
.	.	O
This	DT	O
mixture	NN	O
of	IN	O
fiber	NN	O
solids	NNS	O
,	,	O
oil	NN	O
cake	NN	O
and	CC	O
solubles	NNS	O
forms	VBZ	O
a	DT	O
gluten	JJ	O
feed	NN	O
.	.	O
After	IN	O
de-fibering	NN	O
,	,	O
the	DT	O
remaining	VBG	O
product	NN	O
is	VBZ	O
subjected	VBN	O
to	TO	O
gluten	VB	O
separation	NN	O
.	.	O
This	DT	O
separation	NN	O
results	NNS	O
in	IN	O
a	DT	O
gluten	JJ	O
meal	NN	O
and	CC	O
starch	NN	O
.	.	O
The	DT	O
starch	NN	O
is	VBZ	O
then	RB	O
subjected	VBN	O
to	TO	O
liquefaction	NN	O
and	CC	O
saccharification	NN	O
using	VBG	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
produce	VB	O
glucose	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
anti-staling	JJ	O
processes	NNS	O
(	(	O
e.g.	NN	O
,	,	O
of	IN	O
baked	JJ	O
products	NNS	O
such	JJ	O
as	IN	O
bread	NN	O
)	)	O
using	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
to	TO	O
slow	VB	O
the	DT	O
increase	NN	O
of	IN	O
the	DT	O
firmness	NN	O
of	IN	O
the	DT	O
crumb	NN	O
(	(	O
of	IN	O
the	DT	O
baked	JJ	O
product	NN	O
)	)	O
and	CC	O
a	DT	O
decrease	NN	O
of	IN	O
the	DT	O
elasticity	NN	O
of	IN	O
the	DT	O
crumb	NN	O
using	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Staling	VBG	O
of	IN	O
baked	JJ	O
products	NNS	O
(	(	O
such	JJ	O
as	IN	O
bread	NN	O
)	)	O
is	VBZ	O
more	RBR	O
serious	JJ	O
as	IN	O
time	NN	O
passes	NNS	O
between	IN	O
the	DT	O
moment	NN	O
of	IN	O
preparation	NN	O
of	IN	O
the	DT	O
bread	JJ	O
product	NN	O
and	CC	O
the	DT	O
moment	NN	O
of	IN	O
consumption	NN	O
.	.	O
The	DT	O
term	NN	O
staling	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
describe	VB	O
changes	NNS	O
undesirable	JJ	O
to	TO	O
the	DT	O
consumer	NN	O
in	IN	O
the	DT	O
properties	NNS	O
of	IN	O
the	DT	O
bread	JJ	O
product	NN	O
after	IN	O
leaving	VBG	O
the	DT	O
oven	NN	O
,	,	O
such	JJ	O
as	IN	O
an	DT	O
increase	NN	O
of	IN	O
the	DT	O
firmness	NN	O
of	IN	O
the	DT	O
crumb	NN	O
,	,	O
a	DT	O
decrease	NN	O
of	IN	O
the	DT	O
elasticity	NN	O
of	IN	O
the	DT	O
crumb	NN	O
,	,	O
and	CC	O
changes	NNS	O
in	IN	O
the	DT	O
crust	NN	O
,	,	O
which	WDT	O
becomes	VBZ	O
tough	JJ	O
and	CC	O
leathery	NN	O
.	.	O
The	DT	O
firmness	NN	O
of	IN	O
the	DT	O
bread	NN	O
crumb	NN	O
increases	VBZ	O
further	RBR	O
during	IN	O
storage	NN	O
up	RB	O
to	TO	O
a	DT	O
level	NN	O
,	,	O
which	WDT	O
is	VBZ	O
considered	VBN	O
as	IN	O
negative	JJ	O
.	.	O
Amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
used	VBN	O
to	TO	O
retard	VB	O
staling	NN	O
of	IN	O
the	DT	O
bread	NN	O
as	IN	O
described	JJ	O
e.g.	NN	O
,	,	O
in	IN	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,197,352	CD	O
;	:	O
2,615,810	CD	O
and	CC	O
3,026,205	CD	O
;	:	O
Silberstein	NNP	B
(	(	I
1964	CD	I
)	)	I
Baker	NNP	I
's	POS	I
Digest	NNP	I
38:66-72	CD	I
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
used	VBN	O
to	TO	O
retard	VB	O
the	DT	O
staling	NN	O
of	IN	O
baked	JJ	O
products	NNS	O
while	IN	O
not	RB	O
hydrolyzing	VBG	O
starch	NN	O
into	IN	O
the	DT	O
branched	JJ	O
dextrins	NNS	O
.	.	O
Branched	VBN	O
dextrins	NNS	O
are	VBP	O
formed	VBN	O
by	IN	O
cleaving	VBG	O
off	RP	O
the	DT	O
branched	JJ	O
chains	NNS	O
of	IN	O
the	DT	O
dextrins	NNS	O
generated	VBN	O
by	IN	O
α-amylase	JJ	O
hydrolysis	NN	O
which	WDT	O
can	MD	O
not	RB	O
be	VB	O
degraded	VBN	O
further	RB	O
by	IN	O
the	DT	O
α-amylase	NN	O
.	.	O
This	DT	O
can	MD	O
produce	VB	O
a	DT	O
gummy	NN	O
crumb	NN	O
in	IN	O
the	DT	O
resulting	VBG	O
bread	NN	O
.	.	O
Accordingly	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
process	NN	O
for	IN	O
retarding	VBG	O
the	DT	O
staling	NN	O
of	IN	O
baked	JJ	O
products	NNS	O
(	(	O
e.g.	NN	O
,	,	O
leavened	VBD	O
baked	JJ	O
products	NNS	O
)	)	O
comprising	VBG	O
adding	VBG	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
comprising	VBG	O
exoamylase	NN	O
activity	NN	O
to	TO	O
a	DT	O
flour	NN	O
or	CC	O
a	DT	O
dough	NN	O
used	VBN	O
for	IN	O
producing	VBG	O
a	DT	O
baked	JJ	O
product	NN	O
.	.	O
Exoamylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
have	VB	O
glucoamylase	NN	O
,	,	O
β-amylase	NNP	O
(	(	O
which	WDT	O
releases	VBZ	O
maltose	NN	O
in	IN	O
the	DT	O
beta-configuration	NN	O
)	)	O
and/or	VBZ	O
maltogenic	JJ	O
amylase	NN	O
activity	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
process	NN	O
for	IN	O
preparing	VBG	O
a	DT	O
dough	NN	O
or	CC	O
a	DT	O
baked	JJ	O
product	NN	O
prepared	VBN	O
from	IN	O
the	DT	O
dough	NN	O
which	WDT	O
comprises	VBZ	O
adding	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
the	DT	O
dough	NN	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
effective	JJ	O
to	TO	O
retard	VB	O
the	DT	O
staling	NN	O
of	IN	O
the	DT	O
bread	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
dough	NN	O
comprising	NN	O
said	VBD	O
amylase	NN	O
and	CC	O
a	DT	O
premix	NN	O
comprising	VBG	O
flour	PRP$	O
together	NN	O
with	IN	O
said	VBD	O
amylase	NN	O
.	.	O
Finally	RB	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
an	DT	O
enzymatic	JJ	O
baking	NN	O
additive	NN	O
,	,	O
which	WDT	O
contains	VBZ	O
said	VBD	O
amylase	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
high	JJ	O
yield	NN	O
process	NN	O
for	IN	O
producing	VBG	O
high	JJ	O
quality	NN	O
corn	NN	O
fiber	NN	O
gum	NN	O
by	IN	O
treatment	NN	O
of	IN	O
corn	NN	O
fiber	NN	O
with	IN	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
followed	VBN	O
by	IN	O
hydrogen	NN	O
peroxide	NN	O
treatment	NN	O
to	TO	O
obtain	VB	O
an	DT	O
extract	NN	O
of	IN	O
milled	JJ	O
corn	NN	O
fiber	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,147,206	CD	O
.	.	O
Animal	NNP	O
Feeds	NNP	O
and	CC	O
Additives	VBZ	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
for	IN	O
treating	VBG	O
animal	JJ	O
feeds	NNS	O
and	CC	O
additives	NNS	O
using	VBG	O
amylase	JJ	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
animal	JJ	O
feeds	NNS	O
and	CC	O
additives	NNS	O
comprising	VBG	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
treating	VBG	O
animal	JJ	O
feeds	NNS	O
and	CC	O
additives	NNS	O
using	VBG	O
amylase	JJ	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
help	VB	O
in	IN	O
the	DT	O
availability	NN	O
of	IN	O
starch	NN	O
in	IN	O
the	DT	O
animal	JJ	O
feed	NN	O
or	CC	O
additive	NN	O
.	.	O
This	DT	O
can	MD	O
result	VB	O
in	IN	O
release	NN	O
of	IN	O
readily	RB	O
digestible	JJ	O
and	CC	O
easily	RB	O
absorbed	JJ	O
sugars	NNS	O
.	.	O
Use	NNP	O
of	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
increase	VB	O
the	DT	O
digestive	JJ	O
capacity	NN	O
of	IN	O
animals	NNS	O
and	CC	O
birds	NNS	O
.	.	O
Use	NNP	O
of	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
ensure	VB	O
availability	NN	O
of	IN	O
an	DT	O
adequate	JJ	O
nutrient	NN	O
supply	NN	O
for	IN	O
better	JJR	O
growth	NN	O
and	CC	O
performance	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
added	VBN	O
as	IN	O
feed	NN	O
additives	NNS	O
for	IN	O
animals	NNS	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
animal	JJ	O
feed	NN	O
can	MD	O
be	VB	O
treated	VBN	O
with	IN	O
amylases	NNS	O
prior	RB	O
to	TO	O
animal	VB	O
consumption	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
amylases	NNS	O
may	MD	O
be	VB	O
supplied	VBN	O
by	IN	O
expressing	VBG	O
the	DT	O
enzymes	NNS	O
directly	RB	O
in	IN	O
transgenic	JJ	O
feed	NN	O
crops	NNS	O
(	(	O
as	IN	O
,	,	O
e.g.	NN	O
,	,	O
transgenic	JJ	O
plants	NNS	O
,	,	O
seeds	NNS	O
and	CC	O
the	DT	O
like	JJ	O
)	)	O
,	,	O
such	JJ	O
as	IN	O
corn	NN	O
.	.	O
As	IN	O
discussed	VBN	O
above	IN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
transgenic	JJ	O
plants	NNS	O
,	,	O
plant	NN	O
parts	NNS	O
and	CC	O
plant	NN	O
cells	NNS	O
comprising	VBG	O
a	DT	O
nucleic	JJ	O
acid	NN	O
sequence	NN	O
encoding	VBG	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
nucleic	JJ	O
acid	NN	O
is	VBZ	O
expressed	VBN	O
such	JJ	O
that	IN	O
the	DT	O
amylase	NN	O
is	VBZ	O
produced	VBN	O
in	IN	O
recoverable	JJ	O
quantities	NNS	O
.	.	O
The	DT	O
amylase	NN	O
can	MD	O
be	VB	O
recovered	VBN	O
from	IN	O
any	DT	O
plant	NN	O
or	CC	O
plant	NN	O
part	NN	O
.	.	O
Alternatively	RB	O
,	,	O
the	DT	O
plant	NN	O
or	CC	O
plant	NN	O
part	NN	O
containing	VBG	O
the	DT	O
recombinant	JJ	O
polypeptide	NN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
such	JJ	O
for	IN	O
improving	VBG	O
the	DT	O
quality	NN	O
of	IN	O
a	DT	O
food	NN	O
or	CC	O
feed	NN	O
,	,	O
e.g.	NN	O
,	,	O
improving	VBG	O
nutritional	JJ	O
value	NN	O
,	,	O
palatability	NN	O
,	,	O
and	CC	O
rheological	JJ	O
properties	NNS	O
,	,	O
or	CC	O
to	TO	O
destroy	VB	O
an	DT	O
antinutritive	JJ	O
factor	NN	O
.	.	O
Paper	NN	O
or	CC	O
Pulp	NNP	O
Treatment	NNP	O
The	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
in	IN	O
paper	NN	O
or	CC	O
pulp	NN	O
treatment	NN	O
or	CC	O
paper	NN	O
deinking	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
paper	NN	O
treatment	NN	O
process	NN	O
using	VBG	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
to	TO	O
modify	VB	O
starch	NN	O
in	IN	O
the	DT	O
paper	NN	O
thereby	RB	O
converting	VBG	O
it	PRP	O
into	IN	O
a	DT	O
liquefied	JJ	O
form	NN	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
paper	NN	O
components	NNS	O
of	IN	O
recycled	JJ	O
photocopied	JJ	O
paper	NN	O
during	IN	O
chemical	NN	O
and	CC	O
enzymatic	JJ	O
deinking	NN	O
processes	NNS	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
combination	NN	O
with	IN	O
cellulases	NNS	O
.	.	O
The	DT	O
paper	NN	O
can	MD	O
be	VB	O
treated	VBN	O
by	IN	O
the	DT	O
following	JJ	O
three	CD	O
processes	NNS	O
:	:	O
1	CD	O
)	)	O
disintegration	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
2	CD	O
)	)	O
disintegration	NN	O
with	IN	O
a	DT	O
deinking	VBG	O
chemical	NN	O
and	CC	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
and/or	RB	O
3	CD	O
)	)	O
disintegration	NN	O
after	IN	O
soaking	VBG	O
with	IN	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
recycled	JJ	O
paper	NN	O
treated	VBN	O
with	IN	O
amylase	NN	O
can	MD	O
have	VB	O
a	DT	O
higher	JJR	O
brightness	NN	O
due	JJ	O
to	TO	O
removal	VB	O
of	IN	O
toner	NN	O
particles	NNS	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
paper	NN	O
treated	VBN	O
with	IN	O
just	RB	O
cellulase	NN	O
.	.	O
While	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
not	RB	O
limited	VBN	O
by	IN	O
any	DT	O
particular	JJ	O
mechanism	NN	O
,	,	O
the	DT	O
effect	NN	O
of	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
be	VB	O
due	JJ	O
to	TO	O
its	PRP$	O
behavior	NN	O
as	IN	O
surface-active	JJ	O
agents	NNS	O
in	IN	O
pulp	NN	O
suspension	NN	O
.	.	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
treating	VBG	O
paper	NN	O
and	CC	O
paper	NN	O
pulp	NN	O
using	VBG	O
one	CD	O
or	CC	O
more	JJR	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
polypeptides	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
any	DT	O
paper-	JJ	O
or	CC	O
pulp-treating	JJ	O
method	NN	O
,	,	O
which	WDT	O
are	VBP	O
well	RB	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
,	,	O
see	NN	O
,	,	O
e.g.	RB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
6,241,849	CD	O
;	:	O
6,066,233	CD	O
;	:	O
5,582,681	CD	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
deinking	VBG	O
and	CC	O
decolorizing	VBG	O
a	DT	O
printed	JJ	O
paper	NN	O
containing	VBG	O
a	DT	O
dye	NN	O
,	,	O
comprising	VBG	O
pulping	VBG	O
a	DT	O
printed	JJ	O
paper	NN	O
to	TO	O
obtain	VB	O
a	DT	O
pulp	NN	O
slurry	NN	O
,	,	O
and	CC	O
dislodging	VBG	O
an	DT	O
ink	NN	O
from	IN	O
the	DT	O
pulp	NN	O
slurry	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
other	JJ	O
enzymes	NNS	O
can	MD	O
also	RB	O
be	VB	O
added	VBN	O
)	)	O
.	.	O
In	IN	O
another	DT	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
enhancing	VBG	O
the	DT	O
freeness	NN	O
of	IN	O
pulp	NN	O
,	,	O
e.g.	NN	O
,	,	O
pulp	NN	O
made	VBN	O
from	IN	O
secondary	JJ	O
fiber	NN	O
,	,	O
by	IN	O
adding	VBG	O
an	DT	O
enzymatic	JJ	O
mixture	NN	O
comprising	VBG	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
can	MD	O
also	RB	O
include	VB	O
other	JJ	O
enzymes	NNS	O
,	,	O
e.g.	NN	O
,	,	O
pectinase	NN	O
enzymes	NNS	O
)	)	O
to	TO	O
the	DT	O
pulp	NN	O
and	CC	O
treating	VBG	O
under	IN	O
conditions	NNS	O
to	TO	O
cause	VB	O
a	DT	O
reaction	NN	O
to	TO	O
produce	VB	O
an	DT	O
enzymatically	RB	O
treated	JJ	O
pulp	NN	O
.	.	O
The	DT	O
freeness	NN	O
of	IN	O
the	DT	O
enzymatically	RB	O
treated	JJ	O
pulp	NN	O
is	VBZ	O
increased	VBN	O
from	IN	O
the	DT	O
initial	JJ	O
freeness	NN	O
of	IN	O
the	DT	O
secondary	JJ	O
fiber	NN	O
pulp	NN	O
without	IN	O
a	DT	O
loss	NN	O
in	IN	O
brightness	NN	O
.	.	O
Repulping	VBG	O
:	:	O
Treatment	NN	O
of	IN	O
Lignocellulosic	JJ	O
Materials	NNPS	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
the	DT	O
treatment	NN	O
of	IN	O
lignocellulosic	JJ	O
fibers	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
fibers	NNS	O
are	VBP	O
treated	VBN	O
with	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
efficient	JJ	O
for	IN	O
improving	VBG	O
the	DT	O
fiber	NN	O
properties	NNS	O
.	.	O
The	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
also	RB	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
production	NN	O
of	IN	O
lignocellulosic	JJ	O
materials	NNS	O
such	JJ	O
as	IN	O
pulp	NN	O
,	,	O
paper	NN	O
and	CC	O
cardboard	NN	O
,	,	O
from	IN	O
starch	NN	O
reinforced	VBN	O
waste	NN	O
paper	NN	O
and	CC	O
cardboard	NN	O
,	,	O
especially	RB	O
where	WRB	O
repulping	VBG	O
occurs	NNS	O
at	IN	O
pH	NNS	O
above	IN	O
7	CD	O
and	CC	O
where	WRB	O
amylases	NNS	O
can	MD	O
facilitate	VB	O
the	DT	O
disintegration	NN	O
of	IN	O
the	DT	O
waste	NN	O
material	NN	O
through	IN	O
degradation	NN	O
of	IN	O
the	DT	O
reinforcing	NN	O
starch	NN	O
.	.	O
The	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
useful	JJ	O
in	IN	O
a	DT	O
process	NN	O
for	IN	O
producing	VBG	O
a	DT	O
papermaking	VBG	O
pulp	NN	O
from	IN	O
starch-coated	JJ	O
printed	JJ	O
paper	NN	O
.	.	O
The	DT	O
process	NN	O
may	MD	O
be	VB	O
performed	VBN	O
as	IN	O
described	NN	O
in	IN	O
,	,	O
e.g.	NN	O
,	,	O
WO	NNP	O
95/14807	CD	O
.	.	O
An	DT	O
exemplary	JJ	O
process	NN	O
comprises	NNS	O
disintegrating	VBG	O
the	DT	O
paper	NN	O
to	TO	O
produce	VB	O
a	DT	O
pulp	NN	O
,	,	O
treating	VBG	O
with	IN	O
a	DT	O
starch-degrading	JJ	O
enzyme	NN	O
before	IN	O
,	,	O
during	IN	O
or	CC	O
after	IN	O
the	DT	O
disintegrating	NN	O
,	,	O
and	CC	O
separating	VBG	O
ink	NN	O
particles	NNS	O
from	IN	O
the	DT	O
pulp	NN	O
after	IN	O
disintegrating	VBG	O
and	CC	O
enzyme	JJ	O
treatment	NN	O
.	.	O
See	NNP	O
also	RB	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,309,871	CD	O
and	CC	O
other	JJ	O
US	NNP	O
patents	NNS	O
cited	VBD	O
herein	NN	O
.	.	O
Thus	RB	O
,	,	O
the	DT	O
invention	NN	O
includes	VBZ	O
a	DT	O
method	NN	O
for	IN	O
enzymatic	JJ	O
deinking	NN	O
of	IN	O
recycled	JJ	O
paper	NN	O
pulp	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
is	VBZ	O
applied	VBN	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
efficient	JJ	O
for	IN	O
effective	JJ	O
de-inking	NN	O
of	IN	O
the	DT	O
fiber	NN	O
surface	NN	O
.	.	O
Waste	NNP	O
Treatment	NNP	O
The	DT	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
a	DT	O
variety	NN	O
of	IN	O
other	JJ	O
industrial	JJ	O
applications	NNS	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
waste	NN	O
treatment	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
solid	JJ	O
waste	NN	O
digestion	NN	O
process	NN	O
using	VBG	O
enzymes	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
methods	NNS	O
can	MD	O
comprise	VB	O
reducing	VBG	O
the	DT	O
mass	NN	O
and	CC	O
volume	NN	O
of	IN	O
substantially	RB	O
untreated	JJ	O
solid	JJ	O
waste	NN	O
.	.	O
Solid	JJ	O
waste	NN	O
can	MD	O
be	VB	O
treated	VBN	O
with	IN	O
an	DT	O
enzymatic	JJ	O
digestive	NN	O
process	NN	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
an	DT	O
enzymatic	JJ	O
solution	NN	O
(	(	O
including	VBG	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
at	IN	O
a	DT	O
controlled	JJ	O
temperature	NN	O
.	.	O
This	DT	O
results	NNS	O
in	IN	O
a	DT	O
reaction	NN	O
without	IN	O
appreciable	JJ	O
bacterial	JJ	O
fermentation	NN	O
from	IN	O
added	VBN	O
microorganisms	NN	O
.	.	O
The	DT	O
solid	JJ	O
waste	NN	O
is	VBZ	O
converted	VBN	O
into	IN	O
a	DT	O
liquefied	JJ	O
waste	NN	O
and	CC	O
any	DT	O
residual	JJ	O
solid	JJ	O
waste	NN	O
.	.	O
The	DT	O
resulting	VBG	O
liquefied	JJ	O
waste	NN	O
can	MD	O
be	VB	O
separated	VBN	O
from	IN	O
said	VBD	O
any	DT	O
residual	JJ	O
solidified	JJ	O
waste	NN	O
.	.	O
See	VB	O
e.g.	JJ	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
5,709,796	CD	O
.	.	O
Oral	NNP	O
Care	NNP	O
Products	VBZ	O
The	DT	O
invention	NN	O
provides	VBZ	O
oral	JJ	O
care	NN	O
product	NN	O
comprising	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Exemplary	JJ	O
oral	JJ	O
care	NN	O
products	NNS	O
include	VBP	O
toothpastes	NNS	O
,	,	O
dental	JJ	O
creams	NN	O
,	,	O
gels	NNS	O
or	CC	O
tooth	JJ	O
powders	NNS	O
,	,	O
odontics	NNS	O
,	,	O
mouth	NN	O
washes	NNS	O
,	,	O
pre-	NN	O
or	CC	O
post	NN	O
brushing	NN	O
rinse	NN	O
formulations	NNS	O
,	,	O
chewing	VBG	O
gums	NNS	O
,	,	O
lozenges	NNS	O
,	,	O
or	CC	O
candy	NN	O
.	.	O
See	VB	O
,	,	O
e.g.	VB	O
,	,	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
No	DT	O
.	.	O
6,264,925	CD	O
.	.	O
Brewing	NN	O
and	CC	O
Fermenting	VBG	O
The	DT	O
invention	NN	O
provides	VBZ	O
methods	NNS	O
of	IN	O
brewing	NN	O
(	(	O
e.g.	NN	O
,	,	O
fermenting	VBG	O
)	)	O
beer	NN	O
comprising	VBG	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
exemplary	JJ	O
process	NN	O
,	,	O
starch-containing	JJ	O
raw	JJ	O
materials	NNS	O
are	VBP	O
disintegrated	VBN	O
and	CC	O
processed	VBN	O
to	TO	O
form	VB	O
a	DT	O
malt	NN	O
.	.	O
An	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
used	VBN	O
at	IN	O
any	DT	O
point	NN	O
in	IN	O
the	DT	O
fermentation	NN	O
process	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
the	DT	O
processing	NN	O
of	IN	O
barley	NN	O
malt	NN	O
.	.	O
The	DT	O
major	JJ	O
raw	JJ	O
material	NN	O
of	IN	O
beer	NN	O
brewing	NN	O
is	VBZ	O
barley	JJ	O
malt	NN	O
.	.	O
This	DT	O
can	MD	O
be	VB	O
a	DT	O
three	CD	O
stage	NN	O
process	NN	O
.	.	O
First	RB	O
,	,	O
the	DT	O
barley	NN	O
grain	NN	O
can	MD	O
be	VB	O
steeped	VBN	O
to	TO	O
increase	VB	O
water	NN	O
content	NN	O
,	,	O
e.g.	NN	O
,	,	O
to	TO	O
around	IN	O
about	RB	O
40	CD	O
%	NN	O
.	.	O
Second	JJ	O
,	,	O
the	DT	O
grain	NN	O
can	MD	O
be	VB	O
germinated	VBN	O
by	IN	O
incubation	NN	O
at	IN	O
15-25°	JJ	O
C.	NNP	O
for	IN	O
3	CD	O
to	TO	O
6	CD	O
days	NNS	O
when	WRB	O
enzyme	JJ	O
synthesis	NN	O
is	VBZ	O
stimulated	VBN	O
under	IN	O
the	DT	O
control	NN	O
of	IN	O
gibberellins	NNS	O
.	.	O
During	IN	O
this	DT	O
time	NN	O
amylase	NN	O
levels	NNS	O
rise	VBP	O
significantly	RB	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
added	VBN	O
at	IN	O
this	DT	O
(	(	O
or	CC	O
any	DT	O
other	JJ	O
)	)	O
stage	NN	O
of	IN	O
the	DT	O
process	NN	O
.	.	O
The	DT	O
action	NN	O
of	IN	O
the	DT	O
amylase	NN	O
results	NNS	O
in	IN	O
an	DT	O
increase	NN	O
in	IN	O
fermentable	JJ	O
reducing	VBG	O
sugars	NNS	O
.	.	O
This	DT	O
can	MD	O
be	VB	O
expressed	VBN	O
as	IN	O
the	DT	O
diastatic	JJ	O
power	NN	O
,	,	O
DP	NNP	O
,	,	O
which	WDT	O
can	MD	O
rise	VB	O
from	IN	O
around	RB	O
80	CD	O
to	TO	O
190	CD	O
in	IN	O
5	CD	O
days	NNS	O
at	IN	O
12°	CD	O
C.	NNP	O
Amylases	NNP	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
any	DT	O
beer	NN	O
producing	VBG	O
process	NN	O
,	,	O
as	IN	O
described	VBN	O
,	,	O
e.g.	NN	O
,	,	O
in	IN	O
U.S.	NNP	O
Pat	NNP	O
.	.	O
Nos	NNP	O
.	.	O
5,762,991	CD	O
;	:	O
5,536,650	CD	O
;	:	O
5,405,624	CD	O
;	:	O
5,021,246	CD	O
;	:	O
4,788,066	CD	O
.	.	O
Other	JJ	O
Industrial	NNP	O
Applications	NNP	O
The	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
a	DT	O
method	NN	O
of	IN	O
increasing	VBG	O
the	DT	O
flow	NN	O
of	IN	O
production	NN	O
fluids	NNS	O
from	IN	O
a	DT	O
subterranean	JJ	O
formation	NN	O
by	IN	O
removing	VBG	O
a	DT	O
viscous	JJ	O
,	,	O
starch-containing	JJ	O
,	,	O
damaging	JJ	O
fluid	NN	O
formed	VBD	O
during	IN	O
production	NN	O
operations	NNS	O
and	CC	O
found	VBN	O
within	IN	O
the	DT	O
subterranean	JJ	O
formation	NN	O
which	WDT	O
surrounds	VBZ	O
a	DT	O
completed	VBN	O
well	RB	O
bore	RB	O
comprising	VBG	O
allowing	VBG	O
production	NN	O
fluids	NNS	O
to	TO	O
flow	VB	O
from	IN	O
the	DT	O
well	NN	O
bore	RB	O
;	:	O
reducing	VBG	O
the	DT	O
flow	NN	O
of	IN	O
production	NN	O
fluids	NNS	O
from	IN	O
the	DT	O
formation	NN	O
below	IN	O
expected	VBN	O
flow	NN	O
rates	NNS	O
;	:	O
formulating	VBG	O
an	DT	O
enzyme	NN	O
treatment	NN	O
by	IN	O
blending	VBG	O
together	RB	O
an	DT	O
aqueous	JJ	O
fluid	NN	O
and	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
pumping	VBG	O
the	DT	O
enzyme	NN	O
treatment	NN	O
to	TO	O
a	DT	O
desired	VBN	O
location	NN	O
within	IN	O
the	DT	O
well	NN	O
bore	RB	O
;	:	O
allowing	VBG	O
the	DT	O
enzyme	NN	O
treatment	NN	O
to	TO	O
degrade	VB	O
the	DT	O
viscous	JJ	O
,	,	O
starch-containing	JJ	O
,	,	O
damaging	JJ	O
fluid	NN	O
,	,	O
whereby	WRB	O
the	DT	O
fluid	NN	O
can	MD	O
be	VB	O
removed	VBN	O
from	IN	O
the	DT	O
subterranean	JJ	O
formation	NN	O
to	TO	O
the	DT	O
well	NN	O
surface	NN	O
;	:	O
and	CC	O
wherein	VB	O
the	DT	O
enzyme	NN	O
treatment	NN	O
is	VBZ	O
effective	JJ	O
to	TO	O
attack	VB	O
the	DT	O
alpha	NN	O
glucosidic	JJ	O
linkages	NNS	O
in	IN	O
the	DT	O
starch-containing	JJ	O
fluid	NN	O
.	.	O
In	IN	O
summary	JJ	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
enzymes	NNS	O
and	CC	O
processes	NNS	O
for	IN	O
hydrolyzing	VBG	O
liquid	NN	O
(	(	O
liquefied	VBN	O
)	)	O
and	CC	O
granular	JJ	O
starch	NN	O
.	.	O
Such	JJ	O
starch	NN	O
can	MD	O
be	VB	O
derived	VBN	O
from	IN	O
any	DT	O
source	NN	O
,	,	O
e.g.	NN	O
,	,	O
corn	NN	O
,	,	O
wheat	NN	O
,	,	O
milo	NN	O
,	,	O
sorghum	NN	O
,	,	O
rye	NN	O
or	CC	O
bulgher	NN	O
.	.	O
The	DT	O
invention	NN	O
applies	NNS	O
to	TO	O
any	DT	O
grain	NN	O
starch	NN	O
source	NN	O
which	WDT	O
is	VBZ	O
useful	JJ	O
in	IN	O
liquefaction	NN	O
,	,	O
e.g.	RB	O
,	,	O
any	DT	O
other	JJ	O
grain	NN	O
or	CC	O
vegetable	JJ	O
source	NN	O
known	VBN	O
to	TO	O
produce	VB	O
starch	NN	O
suitable	JJ	O
for	IN	O
liquefaction	NN	O
.	.	O
The	DT	O
methods	NNS	O
of	IN	O
the	DT	O
invention	NN	O
comprise	NN	O
liquefying	VBG	O
starch	NN	O
from	IN	O
any	DT	O
natural	JJ	O
material	NN	O
,	,	O
such	JJ	O
as	IN	O
rice	NN	O
,	,	O
germinated	VBN	O
rice	NN	O
,	,	O
corn	NN	O
,	,	O
barley	NN	O
,	,	O
milo	NN	O
,	,	O
wheat	NN	O
,	,	O
legumes	NNS	O
and	CC	O
sweet	JJ	O
potato	NN	O
.	.	O
The	DT	O
liquefying	VBG	O
process	NN	O
can	MD	O
substantially	RB	O
hydrolyze	VB	O
the	DT	O
starch	NN	O
to	TO	O
produce	VB	O
a	DT	O
syrup	NN	O
.	.	O
The	DT	O
temperature	NN	O
range	NN	O
of	IN	O
the	DT	O
liquefaction	NN	O
can	MD	O
be	VB	O
any	DT	O
liquefaction	NN	O
temperature	NN	O
which	WDT	O
is	VBZ	O
known	VBN	O
to	TO	O
be	VB	O
effective	JJ	O
in	IN	O
liquefying	VBG	O
starch	NN	O
.	.	O
For	IN	O
example	NN	O
,	,	O
the	DT	O
temperature	NN	O
of	IN	O
the	DT	O
starch	NN	O
can	MD	O
be	VB	O
between	IN	O
about	RB	O
80°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
115°	CD	O
C.	NNP	O
,	,	O
between	IN	O
about	IN	O
100°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
110°	CD	O
C.	NNP	O
,	,	O
and	CC	O
from	IN	O
about	IN	O
105°	CD	O
C.	NNP	O
to	TO	O
about	IN	O
108°	CD	O
C.	NNP	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
includes	VBZ	O
a	DT	O
method	NN	O
for	IN	O
liquefying	VBG	O
a	DT	O
starch	NN	O
containing	VBG	O
composition	NN	O
comprising	VBG	O
contacting	VBG	O
the	DT	O
starch	NN	O
with	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
(	(	O
e.g.	NN	O
,	,	O
a	DT	O
purified	JJ	O
polypeptide	NN	O
selected	VBN	O
from	IN	O
polypeptides	NNS	O
having	VBG	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
selected	VBN	O
from	IN	O
the	DT	O
group	NN	O
consisting	VBG	O
of	IN	O
:	:	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
;	:	O
variants	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
homology	NN	O
to	TO	O
at	IN	O
least	JJS	O
one	CD	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
100	CD	O
residues	NNS	O
,	,	O
as	IN	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
visual	JJ	O
inspection	NN	O
;	:	O
sequences	NNS	O
complementary	VBP	O
to	TO	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
;	:	O
and	CC	O
sequences	NNS	O
complementary	VBP	O
to	TO	O
variants	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
about	IN	O
50	CD	O
%	NN	O
homology	NN	O
to	TO	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
over	IN	O
a	DT	O
region	NN	O
of	IN	O
at	IN	O
least	JJS	O
about	IN	O
100	CD	O
residues	NNS	O
,	,	O
as	IN	O
determined	VBN	O
by	IN	O
analysis	NN	O
with	IN	O
a	DT	O
sequence	NN	O
comparison	NN	O
algorithm	NN	O
or	CC	O
by	IN	O
visual	JJ	O
inspection	NN	O
;	:	O
and	CC	O
polypeptides	NNS	O
having	VBG	O
at	IN	O
least	JJS	O
10	CD	O
consecutive	JJ	O
amino	NN	O
acids	NNS	O
of	IN	O
a	DT	O
polypeptide	NN	O
having	VBG	O
a	DT	O
sequence	NN	O
selected	VBN	O
from	IN	O
the	DT	O
group	NN	O
consisting	VBG	O
of	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
polypeptide	NN	O
is	VBZ	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
.	.	O
The	DT	O
starch	NN	O
may	MD	O
be	VB	O
from	IN	O
a	DT	O
material	NN	O
selected	VBN	O
from	IN	O
rice	NN	O
,	,	O
germinated	VBN	O
rice	NN	O
,	,	O
corn	NN	O
,	,	O
barley	NN	O
,	,	O
wheat	NN	O
,	,	O
legumes	NNS	O
and	CC	O
sweet	JJ	O
potato	NN	O
.	.	O
A	DT	O
glucose	JJ	O
syrup	NN	O
produced	VBN	O
by	IN	O
the	DT	O
method	NN	O
of	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
included	VBN	O
herein	NN	O
and	CC	O
is	VBZ	O
described	VBN	O
in	IN	O
the	DT	O
examples	NNS	O
.	.	O
Such	JJ	O
a	DT	O
syrup	NN	O
can	MD	O
be	VB	O
a	DT	O
maltose	JJ	O
syrup	NN	O
,	,	O
a	DT	O
glucose	JJ	O
syrup	NN	O
,	,	O
or	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
.	.	O
In	IN	O
particular	JJ	O
,	,	O
the	DT	O
syrups	NNS	O
produced	VBD	O
using	VBG	O
the	DT	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
there	EX	O
is	VBZ	O
a	DT	O
higher	JJR	O
level	NN	O
of	IN	O
DP2	NNP	O
fraction	NN	O
and	CC	O
a	DT	O
higher	JJR	O
level	NN	O
of	IN	O
DP3	NNP	O
(	(	O
maltotriose	JJ	O
and/or	NNS	O
panose	VBP	O
)	)	O
and	CC	O
less	JJR	O
of	IN	O
the	DT	O
greater	JJR	O
than	IN	O
DP7	NNP	O
fragments	NNS	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
syrups	NNS	O
produced	VBN	O
by	IN	O
commercial	JJ	O
enzymes	NNS	O
.	.	O
This	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
liquefaction	NN	O
profile	NN	O
since	IN	O
less	JJR	O
of	IN	O
the	DT	O
large	JJ	O
fragments	NNS	O
are	VBP	O
in	IN	O
the	DT	O
invention	NN	O
liquefied	VBD	O
syrups	NNS	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
removing	VBG	O
starch	NN	O
containing	VBG	O
stains	NNS	O
from	IN	O
a	DT	O
material	NN	O
comprising	VBG	O
contacting	VBG	O
the	DT	O
material	NN	O
with	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
invention	NN	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
washing	VBG	O
an	DT	O
object	JJ	O
comprising	NN	O
contacting	VBG	O
the	DT	O
object	NN	O
with	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
under	IN	O
conditions	NNS	O
sufficient	JJ	O
for	IN	O
washing	VBG	O
.	.	O
A	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
may	MD	O
be	VB	O
included	VBN	O
as	IN	O
a	DT	O
detergent	NN	O
additive	NN	O
for	IN	O
example	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
a	DT	O
method	NN	O
for	IN	O
textile	NN	O
desizing	VBG	O
comprising	VBG	O
contacting	VBG	O
the	DT	O
textile	NN	O
with	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
under	IN	O
conditions	NNS	O
sufficient	JJ	O
for	IN	O
desizing	VBG	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
method	NN	O
of	IN	O
reducing	VBG	O
the	DT	O
staling	NN	O
of	IN	O
bakery	NN	O
products	NNS	O
comprising	VBG	O
addition	NN	O
of	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
the	DT	O
bakery	NN	O
product	NN	O
,	,	O
prior	RB	O
to	TO	O
baking	VBG	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
provides	VBZ	O
a	DT	O
method	NN	O
for	IN	O
the	DT	O
treatment	NN	O
of	IN	O
lignocellulosic	JJ	O
fibers	NNS	O
,	,	O
wherein	VBP	O
the	DT	O
fibers	NNS	O
are	VBP	O
treated	VBN	O
with	IN	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
efficient	JJ	O
for	IN	O
improving	VBG	O
the	DT	O
fiber	NN	O
properties	NNS	O
.	.	O
The	DT	O
invention	NN	O
includes	VBZ	O
a	DT	O
method	NN	O
for	IN	O
enzymatic	JJ	O
deinking	NN	O
of	IN	O
recycled	JJ	O
paper	NN	O
pulp	NN	O
,	,	O
wherein	VBP	O
the	DT	O
polypeptide	NN	O
is	VBZ	O
applied	VBN	O
in	IN	O
an	DT	O
amount	NN	O
which	WDT	O
is	VBZ	O
efficient	JJ	O
for	IN	O
effective	JJ	O
deinking	NN	O
of	IN	O
the	DT	O
fiber	NN	O
surface	NN	O
.	.	O
Any	DT	O
of	IN	O
the	DT	O
methods	NNS	O
described	VBD	O
herein	JJ	O
include	VBP	O
the	DT	O
possibility	NN	O
of	IN	O
the	DT	O
addition	NN	O
of	IN	O
a	DT	O
second	JJ	O
alpha	JJ	O
amylase	NN	O
or	CC	O
a	DT	O
beta	JJ	O
amylase	NN	O
or	CC	O
a	DT	O
combination	NN	O
thereof	NN	O
.	.	O
Commercial	JJ	O
amylases	NNS	O
or	CC	O
other	JJ	O
enzymes	NNS	O
suitable	JJ	O
for	IN	O
use	NN	O
in	IN	O
combination	NN	O
with	IN	O
an	DT	O
enzyme	NN	O
of	IN	O
the	DT	O
invention	NN	O
are	VBP	O
known	VBN	O
to	TO	O
those	DT	O
of	IN	O
skill	NN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
The	DT	O
invention	NN	O
also	RB	O
includes	VBZ	O
a	DT	O
method	NN	O
of	IN	O
increasing	VBG	O
the	DT	O
flow	NN	O
of	IN	O
production	NN	O
fluids	NNS	O
from	IN	O
a	DT	O
subterranean	JJ	O
formation	NN	O
by	IN	O
removing	VBG	O
a	DT	O
viscous	JJ	O
,	,	O
starch-containing	JJ	O
,	,	O
damaging	JJ	O
fluid	NN	O
formed	VBD	O
during	IN	O
production	NN	O
operations	NNS	O
and	CC	O
found	VBN	O
within	IN	O
the	DT	O
subterranean	JJ	O
formation	NN	O
which	WDT	O
surrounds	VBZ	O
a	DT	O
completed	VBN	O
well	RB	O
bore	RB	O
comprising	VBG	O
allowing	VBG	O
production	NN	O
fluids	NNS	O
to	TO	O
flow	VB	O
from	IN	O
the	DT	O
well	NN	O
bore	RB	O
;	:	O
reducing	VBG	O
the	DT	O
flow	NN	O
of	IN	O
production	NN	O
fluids	NNS	O
from	IN	O
the	DT	O
formation	NN	O
below	IN	O
expected	VBN	O
flow	NN	O
rates	NNS	O
;	:	O
formulating	VBG	O
an	DT	O
enzyme	NN	O
treatment	NN	O
by	IN	O
blending	VBG	O
together	RB	O
an	DT	O
aqueous	JJ	O
fluid	NN	O
and	CC	O
a	DT	O
polypeptide	NN	O
of	IN	O
the	DT	O
invention	NN	O
;	:	O
pumping	VBG	O
the	DT	O
enzyme	NN	O
treatment	NN	O
to	TO	O
a	DT	O
desired	VBN	O
location	NN	O
within	IN	O
the	DT	O
well	NN	O
bore	RB	O
;	:	O
allowing	VBG	O
the	DT	O
enzyme	NN	O
treatment	NN	O
to	TO	O
degrade	VB	O
the	DT	O
viscous	JJ	O
,	,	O
starch-containing	JJ	O
,	,	O
damaging	JJ	O
fluid	NN	O
,	,	O
whereby	WRB	O
the	DT	O
fluid	NN	O
can	MD	O
be	VB	O
removed	VBN	O
from	IN	O
the	DT	O
subterranean	JJ	O
formation	NN	O
to	TO	O
the	DT	O
well	NN	O
surface	NN	O
;	:	O
and	CC	O
wherein	VB	O
the	DT	O
enzyme	NN	O
treatment	NN	O
is	VBZ	O
effective	JJ	O
to	TO	O
attack	VB	O
the	DT	O
alpha	NN	O
glucosidic	JJ	O
linkages	NNS	O
in	IN	O
the	DT	O
starch-containing	JJ	O
fluid	NN	O
.	.	O
The	DT	O
present	JJ	O
invention	NN	O
exploits	VBZ	O
the	DT	O
unique	JJ	O
catalytic	JJ	O
properties	NNS	O
of	IN	O
enzymes	NNS	O
.	.	O
Whereas	IN	O
the	DT	O
use	NN	O
of	IN	O
biocatalysts	NNS	O
(	(	O
i.e.	FW	O
,	,	O
purified	VBD	O
or	CC	O
crude	JJ	O
enzymes	NNS	O
,	,	O
non-living	JJ	O
or	CC	O
living	JJ	O
cells	NNS	O
)	)	O
in	IN	O
chemical	NN	O
transformations	NNS	O
normally	RB	O
requires	VBZ	O
the	DT	O
identification	NN	O
of	IN	O
a	DT	O
particular	JJ	O
biocatalyst	NN	O
that	WDT	O
reacts	VBZ	O
with	IN	O
a	DT	O
specific	JJ	O
starting	VBG	O
compound	NN	O
,	,	O
the	DT	O
present	JJ	O
invention	NN	O
uses	VBZ	O
selected	VBN	O
biocatalysts	NNS	O
and	CC	O
reaction	NN	O
conditions	NNS	O
that	WDT	O
are	VBP	O
specific	JJ	O
for	IN	O
functional	JJ	O
groups	NNS	O
that	WDT	O
are	VBP	O
present	JJ	O
in	IN	O
many	JJ	O
starting	VBG	O
compounds	NNS	O
.	.	O
Each	DT	O
biocatalyst	NN	O
is	VBZ	O
specific	JJ	O
for	IN	O
one	CD	O
functional	JJ	O
group	NN	O
,	,	O
or	CC	O
several	JJ	O
related	JJ	O
functional	JJ	O
groups	NNS	O
,	,	O
and	CC	O
can	MD	O
react	VB	O
with	IN	O
many	JJ	O
starting	VBG	O
compounds	NNS	O
containing	VBG	O
this	DT	O
functional	JJ	O
group	NN	O
.	.	O
The	DT	O
biocatalytic	JJ	O
reactions	NNS	O
produce	VBP	O
a	DT	O
population	NN	O
of	IN	O
derivatives	NNS	O
from	IN	O
a	DT	O
single	JJ	O
starting	NN	O
compound	NN	O
.	.	O
These	DT	O
derivatives	NNS	O
can	MD	O
be	VB	O
subjected	VBN	O
to	TO	O
another	DT	O
round	NN	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
to	TO	O
produce	VB	O
a	DT	O
second	JJ	O
population	NN	O
of	IN	O
derivative	JJ	O
compounds	NNS	O
.	.	O
Thousands	NNS	O
of	IN	O
variations	NNS	O
of	IN	O
the	DT	O
original	JJ	O
compound	NN	O
can	MD	O
be	VB	O
produced	VBN	O
with	IN	O
each	DT	O
iteration	NN	O
of	IN	O
biocatalytic	JJ	O
derivatization	NN	O
.	.	O
Enzymes	NNS	O
react	VBP	O
at	IN	O
specific	JJ	O
sites	NNS	O
of	IN	O
a	DT	O
starting	VBG	O
compound	NN	O
without	IN	O
affecting	VBG	O
the	DT	O
rest	NN	O
of	IN	O
the	DT	O
molecule	NN	O
,	,	O
a	DT	O
process	NN	O
which	WDT	O
is	VBZ	O
very	RB	O
difficult	JJ	O
to	TO	O
achieve	VB	O
using	VBG	O
traditional	JJ	O
chemical	NN	O
methods	NNS	O
.	.	O
This	DT	O
high	JJ	O
degree	NN	O
of	IN	O
biocatalytic	JJ	O
specificity	NN	O
provides	VBZ	O
the	DT	O
means	NNS	O
to	TO	O
identify	VB	O
a	DT	O
single	JJ	O
active	JJ	O
compound	NN	O
within	IN	O
the	DT	O
library	NN	O
.	.	O
The	DT	O
library	NN	O
is	VBZ	O
characterized	VBN	O
by	IN	O
the	DT	O
series	NN	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
used	VBN	O
to	TO	O
produce	VB	O
it	PRP	O
,	,	O
a	DT	O
so-called	JJ	O
“	JJ	O
biosynthetic	JJ	O
history	NN	O
”	NN	O
.	.	O
Screening	VBG	O
the	DT	O
library	NN	O
for	IN	O
biological	JJ	O
activities	NNS	O
and	CC	O
tracing	VBG	O
the	DT	O
biosynthetic	JJ	O
history	NN	O
identifies	NNS	O
the	DT	O
specific	JJ	O
reaction	NN	O
sequence	NN	O
producing	VBG	O
the	DT	O
active	JJ	O
compound	NN	O
.	.	O
The	DT	O
reaction	NN	O
sequence	NN	O
is	VBZ	O
repeated	VBN	O
and	CC	O
the	DT	O
structure	NN	O
of	IN	O
the	DT	O
synthesized	VBN	O
compound	NN	O
determined	VBD	O
.	.	O
This	DT	O
mode	NN	O
of	IN	O
identification	NN	O
,	,	O
unlike	IN	O
other	JJ	O
synthesis	NN	O
and	CC	O
screening	NN	O
approaches	NNS	O
,	,	O
does	VBZ	O
not	RB	O
require	VB	O
immobilization	NN	O
technologies	NNS	O
,	,	O
and	CC	O
compounds	NNS	O
can	MD	O
be	VB	O
synthesized	VBN	O
and	CC	O
tested	VBN	O
free	JJ	O
in	IN	O
solution	NN	O
using	VBG	O
virtually	RB	O
any	DT	O
type	NN	O
of	IN	O
screening	VBG	O
assay	NN	O
.	.	O
It	PRP	O
is	VBZ	O
important	JJ	O
to	TO	O
note	VB	O
,	,	O
that	IN	O
the	DT	O
high	JJ	O
degree	NN	O
of	IN	O
specificity	NN	O
of	IN	O
enzyme	JJ	O
reactions	NNS	O
on	IN	O
functional	JJ	O
groups	NNS	O
allows	VBZ	O
for	IN	O
the	DT	O
“	NNP	O
tracking	VBG	O
”	NN	O
of	IN	O
specific	JJ	O
enzymatic	JJ	O
reactions	NNS	O
that	WDT	O
make	VBP	O
up	RP	O
the	DT	O
biocatalytically	RB	O
produced	VBN	O
library	NN	O
.	.	O
Many	JJ	O
of	IN	O
the	DT	O
procedural	JJ	O
steps	NNS	O
are	VBP	O
performed	VBN	O
using	VBG	O
robotic	JJ	O
automation	NN	O
enabling	VBG	O
the	DT	O
execution	NN	O
of	IN	O
many	JJ	O
thousands	NNS	O
of	IN	O
biocatalytic	JJ	O
reactions	NNS	O
and	CC	O
screening	VBG	O
assays	NNS	O
per	RB	O
day	NN	O
as	RB	O
well	RB	O
as	IN	O
ensuring	VBG	O
a	DT	O
high	JJ	O
level	NN	O
of	IN	O
accuracy	NN	O
and	CC	O
reproducibility	NN	O
.	.	O
As	IN	O
a	DT	O
result	NN	O
,	,	O
a	DT	O
library	NN	O
of	IN	O
derivative	JJ	O
compounds	NNS	O
can	MD	O
be	VB	O
produced	VBN	O
in	IN	O
a	DT	O
matter	NN	O
of	IN	O
weeks	NNS	O
which	WDT	O
would	MD	O
take	VB	O
years	NNS	O
to	TO	O
produce	VB	O
using	VBG	O
current	JJ	O
chemical	NN	O
methods	NNS	O
.	.	O
(	(	O
For	IN	O
further	JJ	O
teachings	NNS	O
on	IN	O
modification	NN	O
of	IN	O
molecules	NNS	O
,	,	O
including	VBG	O
small	JJ	O
molecules	NNS	O
,	,	O
see	VBP	O
,	,	O
e.g.	FW	O
,	,	O
PCT/US94/09174	NNP	O
)	)	O
.	.	O
The	DT	O
invention	NN	O
will	MD	O
be	VB	O
further	JJ	O
described	VBN	O
with	IN	O
reference	NN	O
to	TO	O
the	DT	O
following	JJ	O
examples	NNS	O
;	:	O
however	RB	O
,	,	O
it	PRP	O
is	VBZ	O
to	TO	O
be	VB	O
understood	JJ	O
that	IN	O
the	DT	O
invention	NN	O
is	VBZ	O
not	RB	O
limited	VBN	O
to	TO	O
such	JJ	O
examples	NNS	O
.	.	O
EXAMPLES	NNP	O
Example	NNP	O
1	CD	O
Identification	NNP	O
and	CC	O
Characterization	NNP	O
of	IN	O
Thermostable	NNP	O
α-Amylases	VBZ	O
The	DT	O
following	JJ	O
example	NN	O
describes	VBZ	O
an	DT	O
exemplary	JJ	O
method	NN	O
for	IN	O
determining	VBG	O
if	IN	O
a	DT	O
polypeptide	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
This	DT	O
example	NN	O
describes	VBZ	O
the	DT	O
identification	NN	O
of	IN	O
novel	JJ	O
amylases	NNS	O
.	.	O
A	DT	O
screening	JJ	O
program	NN	O
can	MD	O
be	VB	O
carried	VBN	O
out	RP	O
under	IN	O
neutral	JJ	O
and/or	NN	O
low	JJ	O
pH	NN	O
conditions	NNS	O
.	.	O
DNA	NN	O
libraries	NNS	O
generated	VBD	O
from	IN	O
low	JJ	O
pH	NN	O
samples	NNS	O
can	MD	O
be	VB	O
targeted	VBN	O
for	IN	O
discovery	NN	O
.	.	O
Biochemical	JJ	O
Studies	NNP	O
Biochemical	NNP	O
analysis	NN	O
of	IN	O
genomic	JJ	O
clones	NNS	O
can	MD	O
show	VB	O
if	IN	O
any	DT	O
have	VBP	O
pH	VBN	O
optima	NN	O
of	IN	O
less	JJR	O
than	IN	O
pH	NN	O
6	CD	O
.	.	O
Lysates	NNS	O
of	IN	O
these	DT	O
genomic	JJ	O
clones	NNS	O
can	MD	O
be	VB	O
tested	VBN	O
for	IN	O
thermal	JJ	O
tolerance	NN	O
by	IN	O
incubation	NN	O
at	IN	O
70°	CD	O
C.	NNP	O
,	,	O
80°	CD	O
C.	NNP	O
,	,	O
90°	CD	O
C.	NNP	O
or	CC	O
100°	CD	O
C.	NNP	O
for	IN	O
10	CD	O
minutes	NNS	O
and	CC	O
measurement	NN	O
of	IN	O
residual	JJ	O
activity	NN	O
at	IN	O
pH	NN	O
4.5	CD	O
.	.	O
Those	DT	O
clones	NNS	O
retaining	VBG	O
>	RB	O
50	CD	O
%	NN	O
activity	NN	O
after	IN	O
heat	NN	O
treatment	NN	O
at	IN	O
80°	CD	O
C.	NNP	O
can	MD	O
be	VB	O
chosen	VBN	O
for	IN	O
further	JJ	O
analysis	NN	O
.	.	O
These	DT	O
clones	NNS	O
can	MD	O
be	VB	O
incubated	VBN	O
at	IN	O
90°	CD	O
C.	NNP	O
for	IN	O
10	CD	O
minutes	NNS	O
at	IN	O
pH	NN	O
6.0	CD	O
and	CC	O
4.5	CD	O
and	CC	O
tested	VBD	O
for	IN	O
residual	JJ	O
activity	NN	O
at	IN	O
pH	NN	O
4.5	CD	O
.	.	O
Thermal	JJ	O
activity	NN	O
of	IN	O
the	DT	O
clones	NNS	O
with	IN	O
residual	JJ	O
activity	NN	O
after	IN	O
heat	NN	O
treatment	NN	O
at	IN	O
90°	CD	O
C.	NNP	O
at	IN	O
pH	RB	O
4.5	CD	O
can	MD	O
be	VB	O
measured	VBN	O
at	IN	O
room	NN	O
temperature	NN	O
,	,	O
70°	CD	O
C.	NNP	O
and	CC	O
90°	CD	O
C.	NNP	O
at	IN	O
pH	NN	O
4.5	CD	O
.	.	O
Example	RB	O
2	CD	O
Thermostable	JJ	O
Amylases	NNS	O
Active	VBP	O
at	IN	O
Alkaline	NNP	O
pH	VBP	O
The	DT	O
following	JJ	O
example	NN	O
describes	VBZ	O
an	DT	O
exemplary	JJ	O
method	NN	O
for	IN	O
determining	VBG	O
if	IN	O
a	DT	O
polypeptide	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
is	VBZ	O
a	DT	O
thermostable	JJ	O
amylase	NN	O
.	.	O
Biochemical	JJ	O
Studies	NNP	O
Soluble	NNP	O
,	,	O
active	JJ	O
protein	NN	O
can	MD	O
be	VB	O
successfully	RB	O
purified	VBN	O
to	TO	O
homogeneity	NN	O
and	CC	O
measured	VBN	O
at	IN	O
pH	NN	O
8	CD	O
and	CC	O
pH	VB	O
10	CD	O
(	(	O
40°	CD	O
C.	NNP	O
and	CC	O
50°	CD	O
C.	NNP	O
)	)	O
using	VBG	O
2	CD	O
%	NN	O
starch	NN	O
in	IN	O
buffer	NN	O
.	.	O
Stability	NN	O
Activity	NNP	O
can	MD	O
be	VB	O
measured	VBN	O
at	IN	O
pH	NN	O
8	CD	O
and	CC	O
50°	CD	O
C.	NNP	O
after	IN	O
a	DT	O
30	CD	O
minute	NN	O
incubation	NN	O
at	IN	O
50°	CD	O
C.	NNP	O
in	IN	O
the	DT	O
presence	NN	O
of	IN	O
various	JJ	O
components	NNS	O
of	IN	O
an	DT	O
ADW	NNP	O
formulation	NN	O
;	:	O
pH	CC	O
8	CD	O
,	,	O
pH	NN	O
10.8	CD	O
,	,	O
ADW	NNP	O
solution	NN	O
(	(	O
with	IN	O
bleach	NN	O
)	)	O
and	CC	O
ADW	NNP	O
solution	NN	O
(	(	O
without	IN	O
bleach	NN	O
)	)	O
.	.	O
The	DT	O
measured	VBN	O
activity	NN	O
after	IN	O
the	DT	O
incubation	NN	O
can	MD	O
be	VB	O
expressed	VBN	O
as	IN	O
a	DT	O
percentage	NN	O
of	IN	O
the	DT	O
original	JJ	O
activity	NN	O
.	.	O
Wash	JJ	O
Tests	NNS	O
Wash	VBP	O
tests	NNS	O
using	VBG	O
starch	NN	O
coated	VBD	O
slides	NNS	O
can	MD	O
be	VB	O
carried	VBN	O
out	IN	O
to	TO	O
gauge	VB	O
the	DT	O
performance	NN	O
of	IN	O
each	DT	O
of	IN	O
the	DT	O
purified	JJ	O
enzymes	NNS	O
as	IN	O
compared	VBN	O
to	TO	O
the	DT	O
commercial	JJ	O
amylase	NN	O
.	.	O
The	DT	O
spaghetti	NNS	O
starch	VBP	O
coated	VBN	O
slides	NNS	O
can	MD	O
be	VB	O
prepared	VBN	O
according	VBG	O
to	TO	O
manufacturer	NN	O
's	POS	O
protocol	NN	O
.	.	O
Two	CD	O
pre-weighed	JJ	O
starch	NN	O
coated	VBD	O
slides	NNS	O
can	MD	O
be	VB	O
placed	VBN	O
back	RB	O
to	TO	O
back	VB	O
in	IN	O
a	DT	O
50	CD	O
mL	NN	O
conical	JJ	O
tube	NN	O
and	CC	O
25	CD	O
mL	NN	O
of	IN	O
ADW	NNP	O
solution	NN	O
,	,	O
+/−enzyme	EX	O
were	VBD	O
added	VBN	O
per	IN	O
tube	NN	O
.	.	O
The	DT	O
tubes	NNS	O
can	MD	O
be	VB	O
incubated	VBN	O
for	IN	O
20	CD	O
minutes	NNS	O
at	IN	O
50°	CD	O
C.	NNP	O
with	IN	O
gentle	JJ	O
rotation	NN	O
on	IN	O
a	DT	O
vertical	JJ	O
carousel	NN	O
.	.	O
Following	VBG	O
the	DT	O
incubation	NN	O
period	NN	O
,	,	O
the	DT	O
slides	NNS	O
are	VBP	O
immediately	RB	O
rinsed	VBN	O
in	IN	O
water	NN	O
and	CC	O
oven	RB	O
dried	VBD	O
overnight	JJ	O
.	.	O
Trials	NNS	O
can	MD	O
be	VB	O
run	VBN	O
in	IN	O
duplicate	NN	O
and	CC	O
a	DT	O
commercial	JJ	O
enzyme	NN	O
can	MD	O
be	VB	O
run	VBN	O
as	IN	O
a	DT	O
positive	JJ	O
control	NN	O
.	.	O
Example	RB	O
3	CD	O
Amylase	NNP	O
Activity	NNP	O
Assay	NNP	O
:	:	O
BCA	NNP	O
Reducing	NNP	O
Ends	NNP	O
Assay	NNP	O
The	DT	O
following	JJ	O
example	NN	O
describes	VBZ	O
an	DT	O
exemplary	JJ	O
method	NN	O
for	IN	O
determining	VBG	O
if	IN	O
a	DT	O
polypeptide	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
for	IN	O
example	NN	O
,	,	O
by	IN	O
a	DT	O
BCA	NNP	O
reducing	VBG	O
ends	NNS	O
assay	VBP	O
.	.	O
Amylase	NNP	O
activity	NN	O
of	IN	O
clones	NNS	O
of	IN	O
interest	NN	O
was	VBD	O
determined	VBN	O
using	VBG	O
the	DT	O
following	JJ	O
methodology	NN	O
.	.	O
1	CD	O
.	.	O
Prepare	NNP	O
2	CD	O
substrate	NN	O
solutions	NNS	O
,	,	O
as	IN	O
follows	VBZ	O
:	:	O
Heat	NNP	O
both	DT	O
solutions	NNS	O
in	IN	O
a	DT	O
boiling	JJ	O
water	NN	O
bath	NN	O
,	,	O
while	IN	O
mixing	NN	O
,	,	O
for	IN	O
30-40	JJ	O
minutes	NNS	O
until	IN	O
starch	JJ	O
dissolves	NNS	O
.	.	O
2	CD	O
.	.	O
Prepare	NNP	O
Solution	NNP	O
A	NNP	O
from	IN	O
64	CD	O
mg/ml	NNS	O
sodium	JJ	O
carbonate	NN	O
monohydrate	NN	O
,	,	O
24	CD	O
mg/ml	NN	O
sodium	NN	O
bicarbonate	NN	O
and	CC	O
1.95	CD	O
mg/ml	NN	O
BCA	NNP	O
(	(	O
4,4′-dicarboxy-2,2′-biquinoline	JJ	O
disodium	NN	O
salt	NN	O
(	(	O
Sigma	NNP	O
Chemical	NNP	O
cat	NN	O
#	#	O
D-8284	NNP	O
)	)	O
.	.	O
Added	VBN	O
above	IN	O
to	TO	O
dH2O	VB	O
.	.	O
3	CD	O
.	.	O
Prepare	NNP	O
solution	NN	O
B	NNP	O
by	IN	O
combining	VBG	O
1.24	CD	O
mg/ml	JJ	O
cupric	JJ	O
sulfate	NN	O
pentahydrate	NN	O
and	CC	O
1.26	CD	O
mg/ml	JJ	O
L-serine	NNP	O
.	.	O
Add	NNP	O
mixture	NN	O
to	TO	O
dH2O	VB	O
.	.	O
4	CD	O
.	.	O
Prepare	VB	O
a	DT	O
working	JJ	O
reagent	NN	O
of	IN	O
a	DT	O
1:1	CD	O
ration	NN	O
of	IN	O
solutions	NNS	O
A	NNP	O
and	CC	O
B	NNP	O
.	.	O
5	CD	O
.	.	O
Prepare	VB	O
a	DT	O
Maltose	NNP	O
standard	JJ	O
solution	NN	O
of	IN	O
10	CD	O
mM	NNS	O
Maltose	NNP	O
in	IN	O
dH2O	NN	O
,	,	O
where	WRB	O
the	DT	O
10	CD	O
mM	NN	O
maltose	NN	O
is	VBZ	O
combined	VBN	O
in	IN	O
2	CD	O
%	NN	O
soluble	JJ	O
starch	NN	O
at	IN	O
desired	JJ	O
pH	NN	O
to	TO	O
a	DT	O
final	JJ	O
concentration	NN	O
of	IN	O
0	CD	O
,	,	O
100	CD	O
,	,	O
200	CD	O
,	,	O
300	CD	O
,	,	O
400	CD	O
,	,	O
600	CD	O
μM	NN	O
.	.	O
The	DT	O
standard	JJ	O
curve	NN	O
will	MD	O
be	VB	O
generated	VBN	O
for	IN	O
each	DT	O
set	NN	O
of	IN	O
time-points	NNS	O
.	.	O
Since	IN	O
the	DT	O
curve	NN	O
is	VBZ	O
determined	VBN	O
by	IN	O
adding	VBG	O
10	CD	O
ul	NN	O
of	IN	O
the	DT	O
standards	NNS	O
to	TO	O
the	DT	O
working	VBG	O
reagent	NN	O
it	PRP	O
works	VBZ	O
out	IN	O
to	TO	O
0	CD	O
,	,	O
1	CD	O
,	,	O
2	CD	O
,	,	O
3	CD	O
,	,	O
4	CD	O
,	,	O
6	CD	O
nmole	JJ	O
maltose	NN	O
.	.	O
See	VB	O
FIG	NNP	O
.	.	O
5	CD	O
for	IN	O
an	DT	O
example	NN	O
standard	NN	O
curve	NN	O
.	.	O
6	CD	O
.	.	O
Aliquot	$	O
1	CD	O
ml	NN	O
of	IN	O
substrate	JJ	O
solution	NN	O
into	IN	O
microcentrifuge	NN	O
tubes	NNS	O
,	,	O
equilibrate	NN	O
to	TO	O
desired	VBN	O
temperature	NN	O
(	(	O
5	CD	O
min	NN	O
)	)	O
in	IN	O
heat	NN	O
block	NN	O
or	CC	O
heated	VBN	O
water	NN	O
bath	NN	O
.	.	O
Add	$	O
50	CD	O
ul	NN	O
of	IN	O
enzyme	JJ	O
solution	NN	O
to	TO	O
the	DT	O
inside	NN	O
of	IN	O
the	DT	O
tube	NN	O
lid	NN	O
.	.	O
7	CD	O
.	.	O
While	IN	O
solution	NN	O
is	VBZ	O
equilibrating	VBG	O
mix	RB	O
5	CD	O
ml	NN	O
of	IN	O
both	DT	O
solution	NN	O
A	NNP	O
&	CC	O
B.	NNP	O
Aliquot	NNP	O
100	CD	O
ul	NN	O
to	TO	O
96	CD	O
well	RB	O
PCR	NNP	O
plate	NN	O
.	.	O
Set	NNP	O
plate	NN	O
on	IN	O
ice	NN	O
.	.	O
8	CD	O
.	.	O
After	IN	O
5	CD	O
minute	JJ	O
temperature	NN	O
equilibration	NN	O
,	,	O
close	RB	O
lid	JJ	O
on	IN	O
tubes	NNS	O
,	,	O
invert	NN	O
and	CC	O
vortex	NN	O
3	CD	O
times	NNS	O
.	.	O
Immediately	RB	O
aliquot	JJ	O
10	CD	O
ul	JJ	O
into	IN	O
plate	NN	O
as	IN	O
t=0	NN	O
(	(	O
zero	CD	O
time	NN	O
point	NN	O
)	)	O
.	.	O
Leave	NNP	O
enzyme	JJ	O
mixture	NN	O
in	IN	O
heat	NN	O
block	NN	O
and	CC	O
aliquot	NN	O
10	CD	O
ul	NN	O
at	IN	O
each	DT	O
desired	JJ	O
time	NN	O
point	NN	O
(	(	O
e.g	NN	O
.	.	O
0	CD	O
,	,	O
5	CD	O
,	,	O
10	CD	O
,	,	O
15	CD	O
,	,	O
20	CD	O
,	,	O
30	CD	O
minutes	NNS	O
)	)	O
.	.	O
9	CD	O
.	.	O
Ensure	NN	O
that	IN	O
12	CD	O
wells	NNS	O
are	VBP	O
left	VBN	O
empty	JJ	O
(	(	O
only	RB	O
working	VBG	O
reagent	NN	O
aliquotted	VBN	O
)	)	O
for	IN	O
the	DT	O
addition	NN	O
of	IN	O
10	CD	O
ul	NN	O
of	IN	O
standards	NNS	O
,	,	O
for	IN	O
the	DT	O
standard	JJ	O
curve	NN	O
.	.	O
10	CD	O
.	.	O
When	WRB	O
all	DT	O
time	NN	O
points	NNS	O
are	VBP	O
collected	VBN	O
and	CC	O
standards	NNS	O
are	VBP	O
added	VBN	O
,	,	O
cover	VB	O
plate	NN	O
and	CC	O
heated	VBD	O
to	TO	O
80°	CD	O
C.	NNP	O
for	IN	O
35	CD	O
min	NN	O
.	.	O
Cool	NNP	O
plate	NN	O
on	IN	O
ice	NN	O
for	IN	O
10	CD	O
min	NN	O
.	.	O
Add	$	O
100	CD	O
ul	JJ	O
H2O	NNP	O
to	TO	O
all	DT	O
wells	NNS	O
.	.	O
Mix	NNP	O
and	CC	O
aliquot	RB	O
100	CD	O
ul	JJ	O
into	IN	O
flat	JJ	O
bottomed	VBN	O
96-well	JJ	O
plate	NN	O
and	CC	O
read	VB	O
absorbance	NN	O
at	IN	O
560	CD	O
nm	NNS	O
.	.	O
11	CD	O
.	.	O
Zero	NNP	O
each	DT	O
sample	NN	O
's	POS	O
time	NN	O
points	NNS	O
against	IN	O
its	PRP$	O
own	JJ	O
t=0	NN	O
(	(	O
subtract	VB	O
the	DT	O
average	JJ	O
t=0	NN	O
A560	NNP	O
value	NN	O
from	IN	O
other	JJ	O
average	JJ	O
A560	NNP	O
values	NNS	O
)	)	O
.	.	O
Convert	NNP	O
the	DT	O
A560	NNP	O
(	(	O
experimental	JJ	O
)	)	O
to	TO	O
umole	JJ	O
(	(	O
Divide	NNP	O
A560	NNP	O
(	(	O
experimental	JJ	O
)	)	O
by	IN	O
the	DT	O
slope	NN	O
of	IN	O
the	DT	O
standard	JJ	O
curve	NN	O
(	(	O
A560/umole	NNP	O
)	)	O
.	.	O
Generate	VB	O
a	DT	O
slope	NN	O
of	IN	O
the	DT	O
time	NN	O
points	NNS	O
and	CC	O
the	DT	O
umole	JJ	O
(	(	O
in	IN	O
umole/min	NN	O
)	)	O
,	,	O
multiply	RB	O
by	IN	O
100	CD	O
(	(	O
as	IN	O
the	DT	O
umole	JJ	O
value	NN	O
only	RB	O
accounts	VBZ	O
for	IN	O
the	DT	O
10	CD	O
ul	NN	O
used	VBN	O
in	IN	O
the	DT	O
assay	NN	O
,	,	O
not	RB	O
the	DT	O
amount	NN	O
made	VBD	O
in	IN	O
the	DT	O
1	CD	O
ml	NNS	O
r×n	NN	O
)	)	O
.	.	O
To	TO	O
get	VB	O
the	DT	O
specific	JJ	O
activity	NN	O
divide	IN	O
the	DT	O
slope	NN	O
(	(	O
in	IN	O
umole/min	NN	O
)	)	O
by	IN	O
the	DT	O
mg	NN	O
of	IN	O
protein	NN	O
.	.	O
All	DT	O
points	NNS	O
should	MD	O
be	VB	O
done	VBN	O
at	IN	O
a	DT	O
minimum	NN	O
in	IN	O
duplicate	NN	O
with	IN	O
three	CD	O
being	VBG	O
best	JJS	O
.	.	O
Activity=0.008646	NNP	O
umole/min	JJ	O
Divide	NNP	O
protein	NN	O
concentration	NN	O
(	(	O
mg/ml	NN	O
)	)	O
by	IN	O
any	DT	O
dilution	NN	O
to	TO	O
get	VB	O
mg	NNS	O
used	VBN	O
in	IN	O
assay	NN	O
.	.	O
Divide	IN	O
the	DT	O
above	IN	O
slope	NN	O
by	IN	O
mg	NN	O
used	VBN	O
in	IN	O
assay	NN	O
to	TO	O
get	VB	O
specific	JJ	O
activity	NN	O
Specific	NNP	O
Activity=24.93	NNP	O
umole/min/mg	JJ	O
See	NNP	O
for	IN	O
example	NN	O
,	,	O
Dominic	NNP	B
W.	NNP	I
S.	NNP	I
Wong	NNP	I
,	,	I
Sarah	NNP	I
B.	NNP	I
Batt	NNP	I
,	,	I
and	CC	I
George	NNP	I
H.	NNP	I
Robertson	NNP	I
(	(	I
2000	CD	I
)	)	I
J.	NNP	I
Agric	NNP	I
.	.	I
Food	NNP	I
Chem	NNP	I
.	.	I
48:4540-4543	JJ	I
;	:	O
Jeffrey	NNP	B
D.	NNP	I
Fox	NNP	I
and	CC	I
John	NNP	I
F.	NNP	I
Robyt	NNP	I
,	,	I
(	(	I
1991	CD	I
)	)	I
Anal	NNP	I
.	.	I
Biochem	NNP	I
.	.	I
195	CD	I
,	,	I
93-96	CD	I
.	.	O
Example	RB	O
4	CD	O
Screening	VBG	O
for	IN	O
α-Amylase	JJ	O
Activity	NNP	O
The	DT	O
following	JJ	O
example	NN	O
describes	VBZ	O
an	DT	O
exemplary	JJ	O
method	NN	O
for	IN	O
determining	VBG	O
if	IN	O
a	DT	O
polypeptide	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Amylase	NNP	O
activity	NN	O
of	IN	O
clones	NNS	O
can	MD	O
be	VB	O
assessed	VBN	O
by	IN	O
a	DT	O
number	NN	O
of	IN	O
methods	NNS	O
known	VBN	O
in	IN	O
the	DT	O
art	NN	O
.	.	O
The	DT	O
following	NN	O
is	VBZ	O
the	DT	O
general	JJ	O
methodology	NN	O
that	WDT	O
was	VBD	O
used	VBN	O
in	IN	O
the	DT	O
present	JJ	O
invention	NN	O
.	.	O
The	DT	O
number	NN	O
of	IN	O
plaques	NNS	O
screened	VBN	O
,	,	O
per	IN	O
plate	NN	O
,	,	O
should	MD	O
be	VB	O
approximately	RB	O
10,000	CD	O
pfu	NN	O
's	POS	O
.	.	O
For	IN	O
each	DT	O
DNA	NN	O
library	NN	O
:	:	O
at	IN	O
least	JJS	O
50,000	CD	O
plaques	NNS	O
per	IN	O
isolated	VBN	O
library	NN	O
and	CC	O
200,000	CD	O
plaques	NNS	O
per	IN	O
non-isolated	JJ	O
library	NN	O
should	MD	O
be	VB	O
screened	VBN	O
depending	VBG	O
upon	IN	O
the	DT	O
pfu	NN	O
titer	NN	O
for	IN	O
the	DT	O
λ	NNP	O
Zap	NNP	O
Express	NNP	O
amplified	VBD	O
lysate	NN	O
.	.	O
Titer	NNP	O
Determination	NNP	O
of	IN	O
Lambda	NNP	O
Library	NNP	O
Substrate	NNP	O
Screening	NNP	O
Isolation	NNP	O
of	IN	O
Pure	NNP	O
Clones	NNP	O
Excision	NNP	O
of	IN	O
Pure	NNP	O
Clone	NNP	O
Activity	NNP	O
Verification	NNP	O
RFLP	NNP	O
Analysis	NNP	O
Example	NNP	O
5	CD	O
Assays	NNP	O
for	IN	O
Amylases	NNP	O
The	DT	O
following	JJ	O
example	NN	O
describes	VBZ	O
an	DT	O
exemplary	JJ	O
assays	NNS	O
for	IN	O
determining	VBG	O
if	IN	O
a	DT	O
polypeptide	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Preparation	NN	O
of	IN	O
Host	NNP	O
Cultures	NNP	O
Titering	NNP	O
Lambda	NNP	O
Libraries	NNP	O
Lambda	NNP	O
Microtiter	NNP	O
Screening	NNP	O
for	IN	O
Amylases	NNP	O
Preparation	NNP	O
Day	NNP	O
1	CD	O
Day	NNP	O
2	CD	O
Day	NNP	O
3	CD	O
This	DT	O
is	VBZ	O
a	DT	O
recommended	JJ	O
method	NN	O
of	IN	O
breaking	VBG	O
out	RP	O
putative	JJ	O
hits	NNS	O
.	.	O
It	PRP	O
is	VBZ	O
a	DT	O
liquid	JJ	O
phase	NN	O
assay	VBP	O
that	IN	O
relies	NNS	O
on	IN	O
confirmation	NN	O
of	IN	O
activity	NN	O
on	IN	O
BODIPY	NNP	O
starch	NN	O
.	.	O
Alternatively	RB	O
,	,	O
putative	JJ	O
hits	NNS	O
can	MD	O
be	VB	O
plated	VBN	O
directly	RB	O
onto	IN	O
solid	JJ	O
phase	NN	O
plates	NNS	O
containing	VBG	O
red	JJ	O
starch	NN	O
such	JJ	O
that	IN	O
2,000-3,000	CD	O
pfu	NNS	O
per	IN	O
hit	NN	O
are	VBP	O
examined	VBN	O
for	IN	O
clearing	VBG	O
zones	NNS	O
.	.	O
However	RB	O
,	,	O
inability	NN	O
to	TO	O
observe	VB	O
clearing	VBG	O
zones	NNS	O
on	IN	O
red	JJ	O
starch	NN	O
is	VBZ	O
not	RB	O
necessarily	RB	O
an	DT	O
indication	NN	O
that	IN	O
a	DT	O
putative	JJ	O
hit	NN	O
was	VBD	O
a	DT	O
false	JJ	O
positive	JJ	O
.	.	O
It	PRP	O
would	MD	O
then	RB	O
need	VB	O
to	TO	O
be	VB	O
assayed	VBN	O
using	VBG	O
the	DT	O
format	NN	O
in	IN	O
which	WDT	O
it	PRP	O
was	VBD	O
originally	RB	O
identified	VBN	O
(	(	O
i.e.	FW	O
,	,	O
liquid	JJ	O
phase	NN	O
using	VBG	O
BODIPY	NNP	O
starch	NN	O
as	IN	O
substrate	NN	O
)	)	O
.	.	O
In	IN	O
addition	NN	O
,	,	O
very	RB	O
weak	JJ	O
positives	NNS	O
are	VBP	O
more	RBR	O
easily	RB	O
identified	VBN	O
using	VBG	O
the	DT	O
method	NN	O
detailed	VBD	O
below	IN	O
.	.	O
Day	NNP	O
1	CD	O
Day	NNP	O
2	CD	O
Day	NNP	O
3	CD	O
Excisions	NNP	O
Day	NNP	O
1	CD	O
Day	NNP	O
2	CD	O
Growth	NNP	O
at	IN	O
30°	CD	O
C.	NNP	O
reduces	NNS	O
plasmid	VBP	O
copy	JJ	O
number	NN	O
and	CC	O
is	VBZ	O
used	VBN	O
to	TO	O
mitigate	VB	O
the	DT	O
apparent	JJ	O
toxicity	NN	O
of	IN	O
some	DT	O
amylase	NN	O
clones	NNS	O
.	.	O
Contaminants	NNS	O
that	WDT	O
Form	NNP	O
Clearing	NNP	O
Zones	NNP	O
in	IN	O
Red	NNP	O
Starch	NNP	O
When	WRB	O
using	VBG	O
red	JJ	O
starch	NN	O
on	IN	O
solid	JJ	O
medium	NN	O
to	TO	O
assay	VB	O
phage	NN	O
for	IN	O
amylase	NN	O
activity	NN	O
,	,	O
it	PRP	O
is	VBZ	O
common	JJ	O
to	TO	O
see	VB	O
contaminating	VBG	O
colony	JJ	O
forming	VBG	O
units	NNS	O
(	(	O
cfu	NN	O
)	)	O
that	WDT	O
form	VBP	O
clearing	VBG	O
zones	NNS	O
in	IN	O
the	DT	O
red	JJ	O
starch	NN	O
.	.	O
For	IN	O
pintooled	VBN	O
plates	NNS	O
,	,	O
it	PRP	O
is	VBZ	O
important	JJ	O
to	TO	O
distinguish	VB	O
amylase-positive	JJ	O
phage	NN	O
clones	NNS	O
from	IN	O
these	DT	O
contaminants	NNS	O
whenever	WRB	O
they	PRP	O
align	VBP	O
with	IN	O
a	DT	O
particular	JJ	O
well	NN	O
position	NN	O
.	.	O
The	DT	O
source	NN	O
of	IN	O
the	DT	O
contaminating	NN	O
microbes	NN	O
is	VBZ	O
presumably	RB	O
the	DT	O
2	CD	O
%	NN	O
red	JJ	O
starch	NN	O
stock	NN	O
solution	NN	O
,	,	O
which	WDT	O
can	MD	O
not	RB	O
be	VB	O
sterilized	VBN	O
by	IN	O
autoclaving	VBG	O
or	CC	O
by	IN	O
filtering	VBG	O
after	IN	O
preparation	NN	O
.	.	O
It	PRP	O
is	VBZ	O
thought	VBN	O
that	IN	O
they	PRP	O
are	VBP	O
opportunistic	JJ	O
organisms	NNS	O
that	WDT	O
survive	VBP	O
by	IN	O
metabolizing	VBG	O
the	DT	O
red	JJ	O
starch	NN	O
.	.	O
In	IN	O
order	NN	O
to	TO	O
reduce	VB	O
these	DT	O
contaminants	NNS	O
,	,	O
use	NN	O
sterile	NN	O
technique	NN	O
when	WRB	O
making	VBG	O
2	CD	O
%	NN	O
red	JJ	O
starch	NN	O
solutions	NNS	O
and	CC	O
store	VBP	O
the	DT	O
stocks	NNS	O
either	CC	O
at	IN	O
4°	CD	O
C.	NNP	O
or	CC	O
on	IN	O
ice	NN	O
.	.	O
Screening	VBG	O
of	IN	O
Primary	NNP	O
screening	NN	O
can	MD	O
be	VB	O
done	VBN	O
using	VBG	O
RBB-starch	JJ	O
and/or	JJ	O
FITC-starch	NNP	O
as	IN	O
substrates	NNS	O
.	.	O
Elevated	VBN	O
active	JJ	O
clones	NNS	O
can	MD	O
be	VB	O
screened	VBN	O
using	VBG	O
RBB-starch	NNP	O
as	IN	O
substrate	NN	O
using	VBG	O
induced	JJ	O
cultures	NNS	O
and	CC	O
by	IN	O
liquefaction	NN	O
assay	NN	O
.	.	O
Stock	NNP	O
and	CC	O
sequencing	VBG	O
new	JJ	O
elevated	VBN	O
active	JJ	O
clones	NNS	O
based	VBN	O
on	IN	O
liquefaction	NN	O
data	NNS	O
can	MD	O
be	VB	O
performed	VBN	O
.	.	O
The	DT	O
amylases	NNS	O
can	MD	O
be	VB	O
sorted	VBN	O
into	IN	O
96-well	JJ	O
plates	NNS	O
(	(	O
or	CC	O
384-well	VB	O
plates	NNS	O
)	)	O
at	IN	O
1	CD	O
cell/well	NN	O
in	IN	O
50	CD	O
Assay	NNP	O
Using	NNP	O
RBB-Starch	NNP	O
75	CD	O
Assay	NNP	O
Using	NNP	O
FITC-Starch	NNP	O
50	CD	O
Confirmation	NNP	O
of	IN	O
New	NNP	O
Active	NNP	O
Clones	NNP	O
Each	DT	O
positive	JJ	O
clone	NN	O
from	IN	O
screening	VBG	O
can	MD	O
be	VB	O
grown	VBN	O
and	CC	O
induced	VBN	O
using	VBG	O
a	DT	O
standard	JJ	O
protocol	NN	O
.	.	O
Each	DT	O
clone	NN	O
can	MD	O
be	VB	O
examined	VBN	O
for	IN	O
growth	NN	O
(	(	O
i.e.	FW	O
,	,	O
cell	VBP	O
density	NN	O
over	IN	O
time	NN	O
)	)	O
,	,	O
activity	NN	O
at	IN	O
per	NN	O
cell	NN	O
level	NN	O
(	(	O
RBB-starch	NNP	O
assay	NN	O
and	CC	O
liquefaction	NN	O
assay	NN	O
)	)	O
,	,	O
expression	NN	O
(	(	O
protein	JJ	O
gel	NN	O
)	)	O
and	CC	O
solubility	NN	O
of	IN	O
protein	NN	O
(	(	O
by	IN	O
microscope	NN	O
analysis	NN	O
)	)	O
.	.	O
The	DT	O
confirmed	JJ	O
new	JJ	O
elevated	VBN	O
clones	NNS	O
can	MD	O
be	VB	O
transferred	VBN	O
for	IN	O
fermentation	NN	O
.	.	O
One	CD	O
of	IN	O
the	DT	O
clones	NNS	O
have	VBP	O
amylase	VBN	O
activity	NN	O
greater	JJR	O
than	IN	O
that	DT	O
of	IN	O
the	DT	O
parent	NN	O
includes	VBZ	O
the	DT	O
enzyme	NN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
(	(	O
encoded	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
)	)	O
.	.	O
Example	RB	O
6	CD	O
Characterization	NNP	O
of	IN	O
Alpha	NNP	O
Amylase	NNP	O
pH	NN	O
Optimum	NNP	O
and	CC	O
Specific	NNP	O
Activity	NNP	O
Determination	NNP	O
The	DT	O
following	JJ	O
example	NN	O
describes	VBZ	O
an	DT	O
exemplary	JJ	O
method	NN	O
for	IN	O
determining	VBG	O
if	IN	O
a	DT	O
polypeptide	NN	O
is	VBZ	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
,	,	O
e.g.	NN	O
,	,	O
by	IN	O
alpha	JJ	O
amylase	NN	O
activity	NN	O
pH	VBP	O
optimum	NN	O
and	CC	O
specific	JJ	O
activity	NN	O
determination	NN	O
.	.	O
The	DT	O
pH	NN	O
optimum	NN	O
for	IN	O
the	DT	O
hydrolysis	NN	O
of	IN	O
starch	NN	O
can	MD	O
be	VB	O
determined	VBN	O
by	IN	O
reacting	VBG	O
50	CD	O
uL	NN	O
of	IN	O
the	DT	O
GP-1	NNP	O
,	,	O
0.35	CD	O
U/ml	NNP	O
,	,	O
with	IN	O
a	DT	O
100	CD	O
ml	NN	O
of	IN	O
1	CD	O
%	NN	O
soluble	JJ	O
starch	NN	O
solution	NN	O
(	(	O
0.0175	CD	O
U/g	NNP	O
of	IN	O
starch	NN	O
)	)	O
for	IN	O
30	CD	O
minutes	NNS	O
at	IN	O
95°	CD	O
C.	NNP	O
The	DT	O
reducing	VBG	O
ends	NNS	O
generated	VBN	O
in	IN	O
the	DT	O
liquefied	JJ	O
starch	NN	O
solution	NN	O
can	MD	O
be	VB	O
measured	VBN	O
by	IN	O
the	DT	O
neocupronine	JJ	O
assay	NN	O
,	,	O
described	VBN	O
herein	NN	O
.	.	O
The	DT	O
percent	NN	O
hydrolysis	NN	O
of	IN	O
cornstarch	NN	O
can	MD	O
be	VB	O
determined	VBN	O
by	IN	O
measuring	VBG	O
the	DT	O
number	NN	O
of	IN	O
sugar	NN	O
reducing	VBG	O
ends	NNS	O
produced	VBN	O
with	IN	O
the	DT	O
neocupronine	JJ	O
assay	NN	O
.	.	O
Seventy	NNP	O
grams	NNS	O
of	IN	O
buffer	NN	O
solution	NN	O
(	(	O
pH	JJ	O
4-7	NN	O
)	)	O
is	VBZ	O
weighed	VBN	O
and	CC	O
100	CD	O
ppm	NN	O
of	IN	O
calcium	NN	O
added	VBN	O
.	.	O
Thirty	NNP	O
grams	NNS	O
of	IN	O
cornstarch	NN	O
is	VBZ	O
mixed	JJ	O
into	IN	O
the	DT	O
buffer	NN	O
solution	NN	O
to	TO	O
form	VB	O
a	DT	O
starch	NN	O
slurry	NN	O
.	.	O
The	DT	O
enzyme	NN	O
can	MD	O
be	VB	O
added	VBN	O
and	CC	O
the	DT	O
vessels	NNS	O
sealed	VBN	O
and	CC	O
incubated	VBN	O
at	IN	O
95°	CD	O
C.	NNP	O
for	IN	O
30	CD	O
minutes	NNS	O
with	IN	O
an	DT	O
initial	JJ	O
heating	NN	O
rate	NN	O
of	IN	O
6°	CD	O
C.	NNP	O
per	IN	O
minute	NN	O
.	.	O
A	DT	O
1	CD	O
ml	NN	O
sample	NN	O
can	MD	O
be	VB	O
extracted	VBN	O
from	IN	O
the	DT	O
reaction	NN	O
beakers	NNS	O
and	CC	O
analyzed	VBN	O
by	IN	O
the	DT	O
neocupronine	JJ	O
assay	NN	O
.	.	O
Example	RB	O
7	CD	O
Exemplary	NNP	O
Protocol	NNP	O
for	IN	O
Liquefying	NNP	O
Starch	NNP	O
and	CC	O
Measuring	NNP	O
Results	NNP	O
The	DT	O
following	JJ	O
example	NN	O
describes	NNS	O
exemplary	JJ	O
protocols	NNS	O
for	IN	O
liquefying	VBG	O
starch	NN	O
using	VBG	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Reaction	NN	O
Conditions	NNS	O
:	:	O
100	CD	O
mM	NN	O
PO4	NNP	O
pH	NN	O
6.5	CD	O
,	,	O
1	CD	O
%	NN	O
(	(	O
w/w	NN	O
)	)	O
liquefied	VBD	O
starch	NN	O
DE	NNP	O
12	CD	O
at	IN	O
55°	CD	O
C.	NNP	O
Both	NNP	O
TLC	NNP	O
and	CC	O
HPLC	NNP	O
assays	NNS	O
were	VBD	O
done	VBN	O
to	TO	O
verify	VB	O
activity	NN	O
.	.	O
The	DT	O
data	NN	O
from	IN	O
both	DT	O
assays	NNS	O
showed	VBD	O
that	IN	O
the	DT	O
clones	NNS	O
were	VBD	O
active	JJ	O
.	.	O
pH	NN	O
profiles	NNS	O
for	IN	O
the	DT	O
amylases	NNS	O
can	MD	O
be	VB	O
run	VBN	O
using	VBG	O
phosphate	NN	O
buffer	NN	O
pHed	NN	O
from	IN	O
3.0-6.5	JJ	O
,	,	O
at	IN	O
55°	CD	O
C.	NNP	O
From	IN	O
the	DT	O
amount	NN	O
of	IN	O
observable	JJ	O
hydrolysis	NN	O
,	,	O
it	PRP	O
can	MD	O
be	VB	O
visually	RB	O
said	VBD	O
that	IN	O
the	DT	O
clones	NNS	O
were	VBD	O
more	RBR	O
active	JJ	O
at	IN	O
certain	JJ	O
pH	NN	O
values	NNS	O
than	IN	O
at	IN	O
other	JJ	O
values	NNS	O
at	IN	O
the	DT	O
above	NN	O
indicated	VBD	O
reaction	NN	O
conditions	NNS	O
:	:	O
An	DT	O
exemplary	JJ	O
protocol	NN	O
for	IN	O
the	DT	O
saccharification	NN	O
of	IN	O
liquefied	VBN	O
starch	NN	O
at	IN	O
pH	JJ	O
6.5	CD	O
:	:	O
An	DT	O
exemplary	JJ	O
DE	NNP	O
Determination	NNP	O
:	:	O
Exemplary	JJ	O
Neocuproine	NNP	O
Assay	NNP	O
:	:	O
A	DT	O
100	CD	O
ml	NN	O
sample	NN	O
can	MD	O
be	VB	O
added	VBN	O
to	TO	O
2.0	CD	O
ml	NN	O
of	IN	O
neocuproine	JJ	O
solution	NN	O
A	NNP	O
(	(	O
40	CD	O
g/L	NN	O
sodium	NN	O
carbonate	NN	O
,	,	O
16	CD	O
g/L	NN	O
glycine	NN	O
,	,	O
0.45	CD	O
g/L	NN	O
copper	NN	O
sulfate	NN	O
)	)	O
.	.	O
To	TO	O
this	DT	O
can	MD	O
be	VB	O
added	VBN	O
2.0	CD	O
ml	NN	O
of	IN	O
neocuproine	JJ	O
solution	NN	O
B	NNP	O
(	(	O
1.2	CD	O
g/L	NN	O
neocuproine	JJ	O
hydrochloride-Sigma	JJ	O
N-1626	NNP	O
)	)	O
.	.	O
The	DT	O
tubes	NNS	O
can	MD	O
be	VB	O
mixed	JJ	O
and	CC	O
heated	VBN	O
in	IN	O
a	DT	O
boiling	JJ	O
water	NN	O
bath	NN	O
for	IN	O
12	CD	O
minutes	NNS	O
;	:	O
cooled	VBN	O
,	,	O
diluted	VBN	O
to	TO	O
10	CD	O
ml	NN	O
volume	NN	O
with	IN	O
DI	NNP	O
water	NN	O
and	CC	O
the	DT	O
OD	NNP	O
read	NN	O
at	IN	O
450	CD	O
nm	NN	O
on	IN	O
the	DT	O
spectrophotometer	NN	O
.	.	O
The	DT	O
glucose	JJ	O
equivalent	NN	O
in	IN	O
the	DT	O
sample	NN	O
can	MD	O
be	VB	O
extrapolated	VBN	O
from	IN	O
the	DT	O
response	NN	O
of	IN	O
a	DT	O
0.2	CD	O
mg/ml	NN	O
glucose	JJ	O
standard	JJ	O
run	NN	O
simultaneously	RB	O
.	.	O
Exemplary	JJ	O
HPLC	NNP	O
Analysis	NN	O
:	:	O
Saccharification	NN	O
carbohydrate	NN	O
profiles	NNS	O
are	VBP	O
measured	VBN	O
by	IN	O
HPLC	NNP	O
(	(	O
Bio-Rad	NNP	O
Aminex	NNP	O
HPX-87A	NNP	O
column	NN	O
in	IN	O
silver	JJ	O
form	NN	O
,	,	O
80°	CD	O
C.	NNP	O
)	)	O
using	VBG	O
refractive	JJ	O
index	NN	O
detection	NN	O
.	.	O
Mobile	JJ	O
phase	NN	O
is	VBZ	O
filtered	VBN	O
Millipore	NNP	O
water	NN	O
used	VBN	O
at	IN	O
a	DT	O
flow	JJ	O
rate	NN	O
of	IN	O
0.7	CD	O
ml/min	NN	O
.	.	O
Saccharification	NN	O
samples	NNS	O
are	VBP	O
diluted	VBN	O
1-10	JJ	O
with	IN	O
acidified	JJ	O
DI	NNP	O
water	NN	O
(	(	O
5	CD	O
drops	NNS	O
of	IN	O
6	CD	O
M	NNP	O
HCl	NNP	O
into	IN	O
200	CD	O
mL	NNS	O
DI	NNP	O
water	NN	O
)	)	O
then	RB	O
filtered	VBD	O
through	IN	O
a	DT	O
0.45	CD	O
mm	NN	O
syringe	NN	O
filter	NN	O
.	.	O
Injection	NN	O
volume	NN	O
is	VBZ	O
20	CD	O
uL	NN	O
.	.	O
Exemplary	JJ	O
TLC	NN	O
:	:	O
Reaction	NN	O
products	NNS	O
can	MD	O
be	VB	O
w/d	VBN	O
at	IN	O
hourly	JJ	O
timepoints	NNS	O
and	CC	O
spotted	VBN	O
and	CC	O
dried	VBN	O
on	IN	O
a	DT	O
TLC	NNP	O
plate	NN	O
.	.	O
Plates	NNS	O
can	MD	O
be	VB	O
developed	VBN	O
in	IN	O
10:90	CD	O
water	NN	O
:	:	O
isopropanol	NN	O
and	CC	O
visualized	VBN	O
with	IN	O
either	CC	O
a	DT	O
vanillin	NN	O
stain	NN	O
or	CC	O
CAM	NNP	O
stain	NN	O
and	CC	O
then	RB	O
heated	VBD	O
to	TO	O
show	VB	O
reducible	JJ	O
sugars	NNS	O
.	.	O
The	DT	O
liquefied	VBN	O
starch	NN	O
can	MD	O
be	VB	O
partially	RB	O
hydrolyzed	VBN	O
to	TO	O
glucose	VB	O
in	IN	O
cases	NNS	O
where	WRB	O
activity	NN	O
is	VBZ	O
observed	VBN	O
.	.	O
Example	RB	O
8	CD	O
Starch	NNP	O
Liquefaction	NNP	O
Using	NNP	O
Amylases	NNP	O
of	IN	O
the	DT	O
Invention	NNP	O
This	DT	O
example	NN	O
describes	VBZ	O
an	DT	O
exemplary	JJ	O
method	NN	O
of	IN	O
the	DT	O
invention	NN	O
for	IN	O
liquefying	VBG	O
starch	NN	O
using	VBG	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Amylase	NNP	O
concentrate	NN	O
can	MD	O
be	VB	O
prepared	VBN	O
from	IN	O
fermentation	NN	O
broths	NNS	O
by	IN	O
heat	NN	O
treatment	NN	O
,	,	O
cell	NN	O
washing	NN	O
,	,	O
alkaline	JJ	O
extraction	NN	O
using	VBG	O
microfiltration	NN	O
and	CC	O
ultrafiltration	NN	O
(	(	O
48	CD	O
%	NN	O
overall	JJ	O
yield	NN	O
)	)	O
.	.	O
The	DT	O
UF	NNP	O
concentrate	NN	O
can	MD	O
be	VB	O
neutralized	VBN	O
with	IN	O
acetic	JJ	O
acid	NN	O
and	CC	O
formulated	VBN	O
with	IN	O
30	CD	O
%	NN	O
glycerol	NN	O
at	IN	O
pH	JJ	O
4.5	CD	O
.	.	O
The	DT	O
activity	NN	O
level	NN	O
of	IN	O
the	DT	O
slurry	JJ	O
formulation	NN	O
can	MD	O
be	VB	O
representative	JJ	O
of	IN	O
a	DT	O
commercial	JJ	O
product	NN	O
(	(	O
120	CD	O
U1/g-0.5	NNP	O
kg/ton	NNP	O
starch	NN	O
)	)	O
.	.	O
Standard	JJ	O
Amylase	NNP	O
Activity	NNP	O
Assay	NNP	O
A	NNP	O
1	CD	O
mL	NN	O
cuvette	NN	O
containing	VBG	O
950	CD	O
μL	NN	O
of	IN	O
50	CD	O
mM	NNS	O
MOPS	NNP	O
pH	VBD	O
7.0	CD	O
containing	VBG	O
5	CD	O
mM	JJ	O
pNP-α-D-hexa-	NN	O
(	(	O
1→4	CD	O
)	)	O
-glucopyranoside	NN	O
can	MD	O
be	VB	O
placed	VBN	O
in	IN	O
the	DT	O
Peltier	NNP	O
temperature	NN	O
controller	NN	O
of	IN	O
the	DT	O
Beckman	NNP	O
DU-7400	NNP	O
spectrophotometer	NN	O
preheated	VBD	O
to	TO	O
80°	CD	O
C.	NNP	O
The	DT	O
spectrophotometer	NN	O
is	VBZ	O
blanked	VBN	O
at	IN	O
405	CD	O
nm	NNS	O
and	CC	O
50	CD	O
μL	NN	O
of	IN	O
the	DT	O
enzyme	JJ	O
solution	NN	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
cuvette	NN	O
,	,	O
mixed	JJ	O
well	RB	O
and	CC	O
the	DT	O
increase	NN	O
in	IN	O
the	DT	O
OD405nm	NNP	O
was	VBD	O
monitored	VBN	O
over	IN	O
a	DT	O
one-minute	JJ	O
interval	NN	O
.	.	O
The	DT	O
ΔOD405nm/min	NN	O
rate	NN	O
is	VBZ	O
converted	VBN	O
to	TO	O
a	DT	O
standard	JJ	O
unit	NN	O
of	IN	O
μmole/minute	NN	O
from	IN	O
the	DT	O
OD405nm	NNP	O
response	NN	O
of	IN	O
50	CD	O
μL	NNS	O
of	IN	O
1	CD	O
μmole/mL	JJ	O
PNP	NNP	O
in	IN	O
950	CD	O
mL	NNS	O
50	CD	O
mM	JJ	O
MOPS	NNP	O
at	IN	O
pH	NN	O
7.0	CD	O
−80°	NNP	O
C.	NNP	O
One	NNP	O
standard	NN	O
unit	NN	O
of	IN	O
thermostable	JJ	O
alpha	JJ	O
amylase	NN	O
(	(	O
DTAA	NNP	O
)	)	O
is	VBZ	O
equal	JJ	O
to	TO	O
the	DT	O
amount	NN	O
of	IN	O
enzyme	NN	O
that	WDT	O
will	MD	O
catalyze	VB	O
the	DT	O
release	NN	O
of	IN	O
1	CD	O
μmole/mL/minute	NN	O
of	IN	O
pNP	NN	O
under	IN	O
the	DT	O
defined	JJ	O
conditions	NNS	O
of	IN	O
the	DT	O
assay	NN	O
.	.	O
Standard	JJ	O
Glucoamylase	NNP	O
Activity	NNP	O
Assay	NNP	O
A	NNP	O
1	CD	O
mL	NN	O
cuvette	NN	O
containing	VBG	O
950	CD	O
μL	NN	O
of	IN	O
50	CD	O
mM	NNS	O
MOPS	NNP	O
pH	VBD	O
7.0	CD	O
containing	VBG	O
5	CD	O
mM	JJ	O
pNP-α-D-glucopyranoside	NN	O
can	MD	O
be	VB	O
placed	VBN	O
in	IN	O
the	DT	O
Peltier	NNP	O
temperature	NN	O
controller	NN	O
of	IN	O
the	DT	O
Beckman	NNP	O
DU-7400	NNP	O
spectrophotometer	NN	O
preheated	VBD	O
to	TO	O
60°	CD	O
C.	NNP	O
The	DT	O
spectrophotometer	NN	O
can	MD	O
be	VB	O
blanked	VBN	O
at	IN	O
405	CD	O
nm	NNS	O
and	CC	O
50	CD	O
μL	NN	O
of	IN	O
the	DT	O
enzyme	JJ	O
solution	NN	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
cuvette	NN	O
,	,	O
mixed	JJ	O
well	RB	O
and	CC	O
the	DT	O
increase	NN	O
in	IN	O
the	DT	O
OD405nm	NNP	O
was	VBD	O
monitored	VBN	O
over	IN	O
a	DT	O
one-minute	JJ	O
interval	NN	O
.	.	O
The	DT	O
ΔOD405nm/min	NN	O
rate	NN	O
is	VBZ	O
converted	VBN	O
to	TO	O
a	DT	O
standard	JJ	O
unit	NN	O
of	IN	O
μmole/minute	NN	O
from	IN	O
the	DT	O
OD405nm	NNP	O
response	NN	O
of	IN	O
50	CD	O
μL	NNS	O
of	IN	O
1	CD	O
μmole/mL	JJ	O
pNP	NN	O
in	IN	O
950	CD	O
mL	NNS	O
50	CD	O
mM	JJ	O
MOPS	NNP	O
at	IN	O
pH	NN	O
7.0	CD	O
−60°	NNP	O
C.	NNP	O
One	NNP	O
standard	NN	O
unit	NN	O
of	IN	O
glucoamylase	NN	O
(	(	O
DGA	NNP	O
)	)	O
is	VBZ	O
equal	JJ	O
to	TO	O
the	DT	O
amount	NN	O
of	IN	O
enzyme	NN	O
that	WDT	O
will	MD	O
catalyze	VB	O
the	DT	O
release	NN	O
of	IN	O
1	CD	O
μmole/mL/minute	NN	O
of	IN	O
pNP	NN	O
under	IN	O
the	DT	O
defined	JJ	O
conditions	NNS	O
of	IN	O
the	DT	O
assay	NN	O
.	.	O
Dextrose	NNP	O
Equivalent	NNP	O
Determination	NNP	O
The	DT	O
neocuproine	JJ	O
method	NN	O
was	VBD	O
used	VBN	O
to	TO	O
measure	VB	O
the	DT	O
DE	NNP	O
.	.	O
Selected	VBN	O
samples	NNS	O
were	VBD	O
measured	VBN	O
by	IN	O
both	DT	O
the	DT	O
Invention	NNP	O
procedure	NN	O
and	CC	O
by	IN	O
a	DT	O
GPC	NNP	O
analyst	NN	O
using	VBG	O
the	DT	O
GPC	NNP	O
Fehlings	NNP	O
procedure	NN	O
.	.	O
Neocuproine	NNP	O
Assay	NNP	O
A	NNP	O
100	CD	O
μl	JJ	O
sample	NN	O
can	MD	O
be	VB	O
added	VBN	O
to	TO	O
2.0	CD	O
ml	NN	O
of	IN	O
neocuproine	JJ	O
solution	NN	O
A	NNP	O
(	(	O
40	CD	O
g/L	NN	O
sodium	NN	O
carbonate	NN	O
,	,	O
16	CD	O
g/L	NN	O
glycine	NN	O
,	,	O
0.45	CD	O
g/L	NN	O
copper	NN	O
sulfate	NN	O
)	)	O
.	.	O
To	TO	O
this	DT	O
is	VBZ	O
added	JJ	O
2.0	CD	O
ml	NN	O
of	IN	O
neocuproine	JJ	O
solution	NN	O
B	NNP	O
(	(	O
1.2	CD	O
g/L	NN	O
neocuproine	JJ	O
hydrochloride-Sigma	JJ	O
N-1626	NNP	O
)	)	O
.	.	O
The	DT	O
tubes	NNS	O
can	MD	O
be	VB	O
mixed	JJ	O
and	CC	O
heated	VBN	O
in	IN	O
a	DT	O
boiling	JJ	O
water	NN	O
bath	NN	O
for	IN	O
12	CD	O
minutes	NNS	O
;	:	O
cooled	VBN	O
,	,	O
diluted	VBN	O
to	TO	O
10	CD	O
ml	NN	O
volume	NN	O
with	IN	O
DI	NNP	O
water	NN	O
and	CC	O
the	DT	O
OD	NNP	O
read	NN	O
at	IN	O
450	CD	O
nm	NN	O
on	IN	O
the	DT	O
spectrophotometer	NN	O
.	.	O
The	DT	O
glucose	JJ	O
equivalent	NN	O
in	IN	O
the	DT	O
sample	NN	O
can	MD	O
be	VB	O
extrapolated	VBN	O
from	IN	O
the	DT	O
response	NN	O
of	IN	O
a	DT	O
0.2	CD	O
mg/ml	NN	O
glucose	JJ	O
standard	JJ	O
run	NN	O
simultaneously	RB	O
.	.	O
The	DT	O
starch	NN	O
sample	NN	O
is	VBZ	O
diluted	VBN	O
˜1	NNS	O
to	TO	O
16	CD	O
with	IN	O
DI	NNP	O
water	NN	O
with	IN	O
the	DT	O
exact	JJ	O
dilution	NN	O
recorded	VBN	O
.	.	O
Ten	CD	O
milliliters	NNS	O
of	IN	O
the	DT	O
diluted	JJ	O
sample	NN	O
was	VBD	O
added	VBN	O
to	TO	O
20	CD	O
mls	NN	O
of	IN	O
DI	NNP	O
water	NN	O
.	.	O
Ten	CD	O
milliliters	NNS	O
of	IN	O
Fehlings	NNP	O
solution	NN	O
A	NNP	O
and	CC	O
B	NNP	O
can	MD	O
be	VB	O
added	VBN	O
to	TO	O
the	DT	O
diluted	VBN	O
starch	NN	O
.	.	O
The	DT	O
sample	NN	O
can	MD	O
be	VB	O
boiled	VBN	O
for	IN	O
3	CD	O
minutes	NNS	O
and	CC	O
cooled	VBN	O
on	IN	O
ice	NN	O
.	.	O
Ten	CD	O
milliliters	NNS	O
of	IN	O
30	CD	O
%	NN	O
KI	NNP	O
and	CC	O
10	CD	O
ml	NN	O
of	IN	O
6N	CD	O
H2SO4	NNP	O
is	VBZ	O
added	VBN	O
.	.	O
The	DT	O
solution	NN	O
is	VBZ	O
titrated	VBN	O
against	IN	O
0.1N	CD	O
sodium	NN	O
thiosulfate	NN	O
.	.	O
The	DT	O
titrant	JJ	O
volume	NN	O
is	VBZ	O
recorded	VBN	O
and	CC	O
used	VBN	O
to	TO	O
calculate	VB	O
the	DT	O
DE	NNP	O
.	.	O
Residual	JJ	O
Starch	NNP	O
Determination	NNP	O
Post-saccharification	NNP	O
samples	NNS	O
can	MD	O
be	VB	O
checked	VBN	O
for	IN	O
residual	JJ	O
starch	NN	O
using	VBG	O
the	DT	O
Staley	NNP	O
iodine	JJ	O
procedure	NN	O
.	.	O
Twenty	NNP	O
grams	NNS	O
of	IN	O
sample	NN	O
can	MD	O
be	VB	O
weighed	VBN	O
into	IN	O
a	DT	O
large	JJ	O
weigh	JJ	O
dish	NN	O
.	.	O
45	CD	O
μL	NN	O
of	IN	O
Iodine	NNP	O
solution	NN	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
weigh	JJ	O
dish	NN	O
and	CC	O
the	DT	O
starch	NN	O
solution	NN	O
is	VBZ	O
mixed	JJ	O
well	RB	O
.	.	O
Dark	NNP	O
blue	NN	O
indicates	VBZ	O
the	DT	O
presence	NN	O
of	IN	O
starch	NN	O
,	,	O
a	DT	O
light	JJ	O
blue-green	JJ	O
indicates	NNS	O
slight	VBD	O
starch	NN	O
,	,	O
light	JJ	O
green	JJ	O
indicates	VBZ	O
a	DT	O
trace	NN	O
of	IN	O
starch	NN	O
and	CC	O
yellow-red	JJ	O
,	,	O
absence	NN	O
of	IN	O
starch	NN	O
.	.	O
Iodine	NNP	O
solution	NN	O
is	VBZ	O
prepared	VBN	O
by	IN	O
dissolving	VBG	O
21.25	CD	O
grams	NNS	O
of	IN	O
iodine	NN	O
and	CC	O
40.0	CD	O
grams	NNS	O
of	IN	O
potassium	NN	O
iodide	NN	O
in	IN	O
one	CD	O
liter	NN	O
of	IN	O
water	NN	O
.	.	O
Oligosaccharide	NNP	O
Profile	NNP	O
Liquefaction	NNP	O
and	CC	O
saccharification	NN	O
carbohydrate	NN	O
profiles	NNS	O
can	MD	O
be	VB	O
measured	VBN	O
by	IN	O
HPLC	NNP	O
(	(	O
Bio-Rad	NNP	O
Aminex	NNP	O
HPX-87C	NNP	O
column	NN	O
in	IN	O
calcium	NN	O
form	NN	O
−80°	NNP	O
C.	NNP	O
)	)	O
using	VBG	O
refractive	JJ	O
index	NN	O
detection	NN	O
.	.	O
Gel	NNP	O
Permeation	NNP	O
Chromatography	NNP	O
The	DT	O
molecular	JJ	O
weight	NN	O
distribution	NN	O
can	MD	O
be	VB	O
determined	VBN	O
by	IN	O
chromatography	NN	O
on	IN	O
a	DT	O
PL	NNP	O
Aquagel-OH	NNP	O
column	NN	O
with	IN	O
mass	NN	O
detection	NN	O
by	IN	O
refractive	JJ	O
index	NN	O
(	(	O
Waters	NNP	O
Model	NNP	O
2410	CD	O
)	)	O
.	.	O
A	DT	O
Viscotek	NNP	O
Model	NNP	O
T60	NNP	O
detector	NN	O
can	MD	O
be	VB	O
used	VBN	O
for	IN	O
continuous	JJ	O
viscosity	NN	O
and	CC	O
light	JJ	O
scattering	VBG	O
measurements	NNS	O
.	.	O
Capillary	JJ	O
Electrophoresis	NNP	O
Beckman	NNP	O
Coulter	NNP	O
P/ACE	NNP	O
MDQ	NNP	O
Glycoprotein	NNP	O
System—separation	NNP	O
of	IN	O
APTS	NNP	O
derivatized	VBD	O
oligosaccharides	NNS	O
on	IN	O
a	DT	O
fused	JJ	O
silica	NN	O
capillary-detection	NN	O
by	IN	O
laser-induced	JJ	O
fluorescence	NN	O
.	.	O
Primary	JJ	O
Liquefaction	NNP	O
Line	NNP	O
starch	VBP	O
directly	RB	O
from	IN	O
the	DT	O
GPC	NNP	O
process	NN	O
is	VBZ	O
pumped	VBN	O
into	IN	O
a	DT	O
60	CD	O
liter	NN	O
feed	NN	O
tank	NN	O
where	WRB	O
pH	NN	O
,	,	O
DS	NNP	O
(	(	O
dry	JJ	O
solids	NNS	O
)	)	O
and	CC	O
calcium	JJ	O
level	NN	O
can	MD	O
be	VB	O
adjusted	VBN	O
before	IN	O
liquefaction	NN	O
.	.	O
The	DT	O
amylase	NN	O
is	VBZ	O
added	VBN	O
to	TO	O
the	DT	O
slurry	NN	O
.	.	O
The	DT	O
32	CD	O
%	NN	O
DS	NNP	O
slurry	NN	O
is	VBZ	O
pumped	VBN	O
at	IN	O
0.7	CD	O
liter/minute	NN	O
by	IN	O
a	DT	O
positive	JJ	O
displacement	NN	O
pump	NN	O
to	TO	O
the	DT	O
jet—a	NN	O
pressurized	VBD	O
mixing	JJ	O
chamber	NN	O
where	WRB	O
the	DT	O
starch	NN	O
slurry	NN	O
is	VBZ	O
instantaneously	RB	O
heated	VBN	O
to	TO	O
greater	JJR	O
than	IN	O
100°	CD	O
C.	NNP	O
by	IN	O
steam	NN	O
injection	NN	O
.	.	O
The	DT	O
gelatinized	VBN	O
partially	RB	O
liquefied	VBN	O
starch	NN	O
is	VBZ	O
pumped	VBN	O
through	IN	O
a	DT	O
network	NN	O
of	IN	O
piping	NN	O
(	(	O
still	RB	O
under	IN	O
pressure	NN	O
)	)	O
to	TO	O
give	VB	O
the	DT	O
desired	VBN	O
dwell	NN	O
time	NN	O
(	(	O
5	CD	O
minutes	NNS	O
)	)	O
at	IN	O
temperature	NN	O
.	.	O
The	DT	O
pressure	NN	O
is	VBZ	O
released	VBN	O
into	IN	O
a	DT	O
flash	JJ	O
tank	NN	O
and	CC	O
samples	NNS	O
can	MD	O
be	VB	O
taken	VBN	O
.	.	O
Samples	NNS	O
are	VBP	O
taken	VBN	O
in	IN	O
duplicate	NN	O
.	.	O
Secondary	JJ	O
Liquefaction	NNP	O
The	DT	O
liquefied	JJ	O
starch	NN	O
can	MD	O
be	VB	O
collected	VBN	O
in	IN	O
one	CD	O
liter	NN	O
glass	NN	O
bottles	NNS	O
and	CC	O
held	VBN	O
in	IN	O
a	DT	O
water	NN	O
bath	NN	O
at	IN	O
95°	CD	O
C.	NNP	O
for	IN	O
90	CD	O
minutes	NNS	O
.	.	O
Saccharification	NNP	O
Liquefied	NNP	O
starch	NN	O
can	MD	O
be	VB	O
cooled	VBN	O
to	TO	O
60°	CD	O
C.	NNP	O
,	,	O
the	DT	O
pH	NN	O
adjusted	VBD	O
to	TO	O
4.5	CD	O
and	CC	O
the	DT	O
samples	NNS	O
treated	VBN	O
with	IN	O
glucoamylase	NN	O
.	.	O
Saccharification	NNP	O
progress	NN	O
can	MD	O
be	VB	O
monitored	VBN	O
over	IN	O
time	NN	O
by	IN	O
HPLC	NNP	O
.	.	O
Preparation	NN	O
of	IN	O
Liquefied	NNP	O
Syrups	NNP	O
for	IN	O
Analysis	NNP	O
These	DT	O
trials	NNS	O
were	VBD	O
run	VBN	O
to	TO	O
obtain	VB	O
liquefied	JJ	O
syrups	NNS	O
at	IN	O
DE	NNP	O
's	POS	O
of	IN	O
˜12	NN	O
and	CC	O
18	CD	O
for	IN	O
three	CD	O
amylases	NNS	O
;	:	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
commercial	JJ	O
B.	NNP	O
licheniformis	JJ	O
amylase	NN	O
.	.	O
The	DT	O
syrups	NNS	O
were	VBD	O
saccharified	VBN	O
with	IN	O
three	CD	O
levels	NNS	O
of	IN	O
glucoamylase	NN	O
.	.	O
The	DT	O
liquefied	JJ	O
syrups	NNS	O
were	VBD	O
also	RB	O
analyzed	VBN	O
by	IN	O
HPLC	NNP	O
and	CC	O
gel	JJ	O
permeation	NN	O
chromatography	NN	O
.	.	O
Saccharification	NN	O
The	DT	O
liquefied	JJ	O
syrups	NNS	O
produced	VBN	O
with	IN	O
each	DT	O
amylase	NN	O
can	MD	O
be	VB	O
adjusted	VBN	O
to	TO	O
approximately	RB	O
pH	VB	O
2.5	CD	O
with	IN	O
6N	CD	O
HCl	NNP	O
immediately	RB	O
after	IN	O
the	DT	O
90	CD	O
minute	NN	O
secondary	JJ	O
liquefaction	NN	O
to	TO	O
inactivate	VB	O
any	DT	O
residual	JJ	O
amylase	NN	O
.	.	O
The	DT	O
syrups	NNS	O
can	MD	O
be	VB	O
then	RB	O
adjusted	VBN	O
to	TO	O
pH	VB	O
4.5	CD	O
,	,	O
placed	VBN	O
in	IN	O
a	DT	O
60°	CD	O
C.	NNP	O
water	NN	O
bath	NN	O
and	CC	O
saccharified	VBD	O
with	IN	O
three	CD	O
levels	NNS	O
of	IN	O
glucoamylase	NN	O
.	.	O
The	DT	O
extent	NN	O
of	IN	O
saccharification	NN	O
can	MD	O
be	VB	O
monitored	VBN	O
by	IN	O
HPLC	NNP	O
at	IN	O
18	CD	O
to	TO	O
88	CD	O
hour	NN	O
time	NN	O
points	NNS	O
.	.	O
The	DT	O
liquefied	JJ	O
syrups	NNS	O
can	MD	O
be	VB	O
saccharified	VBN	O
with	IN	O
the	DT	O
standard	JJ	O
dosage—0.04	NN	O
%	NN	O
of	IN	O
a	DT	O
double-strength	JJ	O
glucoamylase—and	NN	O
two	CD	O
lower	JJR	O
dosages	NNS	O
(	(	O
50	CD	O
%	NN	O
and	CC	O
25	CD	O
%	NN	O
)	)	O
to	TO	O
monitor	VB	O
any	DT	O
differences	NNS	O
in	IN	O
the	DT	O
saccharification	NN	O
progress	NN	O
.	.	O
Saccharification	NNP	O
Progress—	NNP	O
%	NN	O
dextrose	NN	O
development	NN	O
vs	NN	O
time—0.04	NN	O
%	NN	O
glucoamylase	NN	O
.	.	O
The	DT	O
liquefied	JJ	O
syrups	NNS	O
were	VBD	O
saccharified	VBN	O
with	IN	O
the	DT	O
standard	JJ	O
dosage—0.04	NN	O
%	NN	O
of	IN	O
a	DT	O
double-strength	JJ	O
glucoamylase—and	NN	O
two	CD	O
lower	JJR	O
dosages	NNS	O
(	(	O
50	CD	O
%	NN	O
and	CC	O
25	CD	O
%	NN	O
)	)	O
to	TO	O
monitor	VB	O
any	DT	O
differences	NNS	O
in	IN	O
the	DT	O
saccharification	NN	O
progress	NN	O
.	.	O
The	DT	O
glucose	NN	O
levels	NNS	O
are	VBP	O
higher	JJR	O
at	IN	O
earlier	JJR	O
time	NN	O
points	NNS	O
with	IN	O
the	DT	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
syrups	NNS	O
.	.	O
Some	DT	O
of	IN	O
the	DT	O
difference	NN	O
is	VBZ	O
due	JJ	O
to	TO	O
a	DT	O
higher	JJR	O
starting	JJ	O
point	NN	O
but	CC	O
the	DT	O
molecular	JJ	O
weight	NN	O
profile	NN	O
difference	NN	O
is	VBZ	O
also	RB	O
a	DT	O
contributing	JJ	O
factor	NN	O
(	(	O
the	DT	O
oligosaccharides	NNS	O
in	IN	O
the	DT	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
liquefied	VBD	O
syrups—being	VBG	O
smaller	JJR	O
and	CC	O
more	RBR	O
uniform—should	JJ	O
be	VB	O
,	,	O
and	CC	O
apparently	RB	O
are	VBP	O
,	,	O
better	JJR	O
substrates	NNS	O
for	IN	O
glucoamylase	NN	O
)	)	O
.	.	O
Post-Saccharification	NN	O
Sugar	NNP	O
Profile	NNP	O
In	IN	O
these	DT	O
studies	NNS	O
and	CC	O
all	DT	O
previous	JJ	O
saccharification	NN	O
studies	NNS	O
,	,	O
the	DT	O
final	JJ	O
glucose	NN	O
level	NN	O
achieved	VBN	O
after	IN	O
saccharification	NN	O
of	IN	O
Invention	NNP	O
amylase	NN	O
and	CC	O
B.	NNP	O
licheniformis	NNP	O
liquefied	VBD	O
syrups	NNS	O
is	VBZ	O
essentially	RB	O
identical	JJ	O
.	.	O
The	DT	O
DP2	NNP	O
(	(	O
maltose	NN	O
)	)	O
level	NN	O
is	VBZ	O
also	RB	O
similar	JJ	O
.	.	O
These	DT	O
large	JJ	O
fragments	NNS	O
are	VBP	O
poor	JJ	O
substrates	NNS	O
for	IN	O
glucoamylase	NN	O
and	CC	O
tend	VB	O
to	TO	O
be	VB	O
converted	VBN	O
slowly	RB	O
,	,	O
if	IN	O
at	IN	O
all	DT	O
,	,	O
into	IN	O
smaller	JJR	O
fragments	NNS	O
and	CC	O
ultimately	RB	O
,	,	O
glucose	NN	O
)	)	O
.	.	O
Molecular	JJ	O
Weight	NNP	O
Distribution	NNP	O
The	DT	O
molecular	JJ	O
weight	NN	O
distribution	NN	O
of	IN	O
syrups	NNS	O
liquefied	VBN	O
to	TO	O
DE	NNP	O
's	POS	O
of	IN	O
12	CD	O
and	CC	O
18	CD	O
by	IN	O
the	DT	O
invention	NN	O
's	POS	O
amylase	NN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
,	,	O
and	CC	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
,	,	O
and	CC	O
commercial	JJ	O
Bacillus	NNP	O
licheniformis	NN	O
and	CC	O
commercial	JJ	O
Bacillus	NNP	O
stearothermophilus	NN	O
)	)	O
were	VBD	O
measured	VBN	O
by	IN	O
gel	JJ	O
permeation	NN	O
chromatography	NN	O
using	VBG	O
detection	NN	O
by	IN	O
refractive	JJ	O
index	NN	O
,	,	O
light	JJ	O
scattering	VBG	O
and	CC	O
viscosity	NN	O
.	.	O
Both	DT	O
the	DT	O
licheniformis	NN	O
and	CC	O
stearothermophilus	JJ	O
amylases	NNS	O
generate	VBP	O
a	DT	O
bimodal	NN	O
distribution—the	NN	O
primary	JJ	O
peak	NN	O
centered	VBN	O
at	IN	O
2000	CD	O
,	,	O
a	DT	O
secondary	JJ	O
peak	NN	O
at	IN	O
32,000	CD	O
with	IN	O
a	DT	O
shoulder	NN	O
extending	VBG	O
past	IN	O
the	DT	O
160,000	CD	O
range	NN	O
.	.	O
The	DT	O
lower	JJR	O
molecular	JJ	O
weight	NN	O
peak	NN	O
represents	VBZ	O
approximately	RB	O
60	CD	O
%	NN	O
of	IN	O
the	DT	O
total	JJ	O
mass	NN	O
of	IN	O
the	DT	O
sample	NN	O
.	.	O
The	DT	O
invention	NN	O
amylases	VBZ	O
exhibit	VBP	O
a	DT	O
single	JJ	O
peak	NN	O
at	IN	O
2000	CD	O
with	IN	O
very	RB	O
little	JJ	O
above	IN	O
30,000	CD	O
.	.	O
HPLC	NNP	O
The	DT	O
DE	NNP	O
12	CD	O
and	CC	O
18	CD	O
syrups	NNS	O
produced	VBN	O
by	IN	O
the	DT	O
Invention	NNP	O
and	CC	O
commercial	JJ	O
amylases	NNS	O
were	VBD	O
analyzed	VBN	O
by	IN	O
HPLC	NNP	O
.	.	O
Both	DT	O
techniques	NNS	O
(	(	O
chromatograms/electropherograms	NNS	O
)	)	O
produce	VBP	O
fingerprints	NNS	O
characteristic	JJ	O
of	IN	O
each	DT	O
class	NN	O
of	IN	O
amylase	NN	O
;	:	O
the	DT	O
oligosaccharide	NN	O
patterns	NNS	O
are	VBP	O
different	JJ	O
for	IN	O
licheniformis	JJ	O
vs	NN	O
stearothermophilus	NN	O
vs	IN	O
the	DT	O
invention	NN	O
's	POS	O
amylases	NNS	O
.	.	O
The	DT	O
invention	NN	O
's	POS	O
liquefied	JJ	O
syrups	NNS	O
exhibit	VBP	O
evidence	NN	O
of	IN	O
greater	JJR	O
branching	NN	O
in	IN	O
the	DT	O
oligosaccharides	NNS	O
.	.	O
HPLC	NNP	O
only	RB	O
resolve	VBZ	O
the	DT	O
oligosaccharides	NNS	O
in	IN	O
the	DT	O
<	NNP	O
DP15	NNP	O
range—larger	NN	O
fragments	NNS	O
are	VBP	O
not	RB	O
visible	JJ	O
in	IN	O
these	DT	O
techniques	NNS	O
.	.	O
Bacillus	NN	O
amylases	NNS	O
are	VBP	O
known	VBN	O
to	TO	O
liquefy	VB	O
starch	NN	O
in	IN	O
a	DT	O
manner	NN	O
such	JJ	O
that	IN	O
the	DT	O
amylopectin	JJ	O
fraction	NN	O
is	VBZ	O
hydrolyzed	VBN	O
less	RBR	O
extensively	RB	O
than	IN	O
the	DT	O
amylose	JJ	O
fraction	NN	O
.	.	O
These	DT	O
>	NNP	O
DP30	NNP	O
amylopectin	NN	O
fragments	NNS	O
are	VBP	O
contained	VBN	O
in	IN	O
the	DT	O
high	JJ	O
molecular	JJ	O
weight	NN	O
fraction	NN	O
centered	VBD	O
at	IN	O
32,000	CD	O
and	CC	O
consequently	RB	O
,	,	O
little	JJ	O
evidence	NN	O
of	IN	O
branching	NN	O
is	VBZ	O
seen	VBN	O
in	IN	O
the	DT	O
HPLC	NNP	O
analyses	NNS	O
of	IN	O
the	DT	O
Bacillus	NNP	O
liquefied	VBD	O
syrups	NNS	O
.	.	O
The	DT	O
<	NNP	O
DP15	NNP	O
oligosaccharides	IN	O
from	IN	O
Invention	NNP	O
amylases	VBZ	O
contain	VBP	O
fragments	NNS	O
from	IN	O
both	DT	O
amylose	JJ	O
and	CC	O
amylopectin	NN	O
.	.	O
This	DT	O
example	NN	O
characterizes	VBZ	O
the	DT	O
liquefaction	NN	O
oligosaccharide	IN	O
patterns	NNS	O
resulting	VBG	O
from	IN	O
the	DT	O
invention	NN	O
's	POS	O
enzyme	JJ	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
and	CC	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
versus	IN	O
commercial	JJ	O
Bacillus	NNP	O
licheniformis	NNS	O
and	CC	O
Bacillus	NNP	O
stearothermophilus	JJ	O
amylases	NNS	O
.	.	O
These	DT	O
results	NNS	O
looked	VBD	O
at	IN	O
the	DT	O
saccharification	NN	O
progress	NN	O
and	CC	O
final	JJ	O
dextrose	NN	O
levels	NNS	O
from	IN	O
syrups	NNS	O
generated	VBN	O
by	IN	O
invention	NN	O
and	CC	O
commercial	JJ	O
amylases	NNS	O
.	.	O
Three	CD	O
commercial	JJ	O
enzymes	NNS	O
,	,	O
Genencor	NNP	O
Spezyme	NNP	O
AA	NNP	O
,	,	O
and	CC	O
two	CD	O
others	NNS	O
all	DT	O
required	VBD	O
more	JJR	O
than	IN	O
double	RB	O
the	DT	O
recommended	JJ	O
dosage	NN	O
to	TO	O
achieve	VB	O
the	DT	O
target	NN	O
Dextrose	NNP	O
equivalent	NN	O
(	(	O
DE	NNP	O
)	)	O
.	.	O
Dextrose	NNP	O
equivalent	JJ	O
(	(	O
DE	NNP	O
)	)	O
is	VBZ	O
the	DT	O
industry	NN	O
standard	NN	O
for	IN	O
measuring	VBG	O
the	DT	O
concentration	NN	O
of	IN	O
total	JJ	O
reducing	VBG	O
sugars	NNS	O
,	,	O
calculated	VBD	O
as	IN	O
D-glucose	NNP	O
on	IN	O
a	DT	O
dry	JJ	O
weight	JJ	O
basis	NN	O
.	.	O
Unhydrolyzed	VBN	O
granular	JJ	O
starch	NN	O
has	VBZ	O
a	DT	O
DE	NNP	O
of	IN	O
virtually	RB	O
zero	CD	O
,	,	O
whereas	IN	O
the	DT	O
DE	NNP	O
of	IN	O
D-glucose	NNP	O
is	VBZ	O
defined	VBN	O
as	IN	O
100	CD	O
.	.	O
This	DT	O
confirms	VBZ	O
the	DT	O
“	NNP	O
double	JJ	O
dosage	NN	O
”	JJ	O
effect	NN	O
for	IN	O
all	DT	O
Bacillus	NNP	O
amylases	NNS	O
and	CC	O
gives	VBZ	O
more	JJR	O
credence	NN	O
to	TO	O
the	DT	O
proposal	NN	O
that	IN	O
the	DT	O
observed	JJ	O
dosage	NN	O
for	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
in	IN	O
the	DT	O
trials	NNS	O
is	VBZ	O
also	RB	O
twice	RB	O
the	DT	O
value	NN	O
which	WDT	O
would	MD	O
be	VB	O
required	VBN	O
under	IN	O
more	JJR	O
normal	JJ	O
conditions	NNS	O
.	.	O
The	DT	O
projected	JJ	O
“	NNP	O
normal	JJ	O
”	NNP	O
dosage	NN	O
,	,	O
60-70	JJ	O
Units/kilo	NNP	O
starch	NN	O
at	IN	O
pH	$	O
4.5	CD	O
to	TO	O
reach	VB	O
a	DT	O
19	CD	O
DE	NNP	O
,	,	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
laboratory	NN	O
liquefaction	NN	O
data	NNS	O
.	.	O
The	DT	O
oligosaccharide	JJ	O
pattern	NN	O
generated	VBN	O
by	IN	O
invention	NN	O
amylases	NNS	O
is	VBZ	O
different	JJ	O
from	IN	O
the	DT	O
Bacillus	NNP	O
profiles	NNS	O
.	.	O
The	DT	O
molecular	JJ	O
weight	NN	O
distribution	NN	O
for	IN	O
the	DT	O
Bacillus	NNP	O
amylases	NNS	O
(	(	O
gel	JJ	O
permeation	NN	O
chromatography	NN	O
with	IN	O
detection	NN	O
by	IN	O
light	JJ	O
scattering	VBG	O
and	CC	O
viscosity	NN	O
)	)	O
is	VBZ	O
bimodal	JJ	O
with	IN	O
a	DT	O
substantial	JJ	O
fraction	NN	O
at	IN	O
the	DT	O
very	RB	O
high	JJ	O
molecular	NN	O
weight	NN	O
range	NN	O
(	(	O
>	JJ	O
300,000	CD	O
)	)	O
even	RB	O
at	IN	O
an	DT	O
18DE	CD	O
.	.	O
The	DT	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
at	IN	O
18DE	CD	O
exhibits	NNS	O
a	DT	O
uniform	JJ	O
distribution	NN	O
with	IN	O
nothing	NN	O
greater	JJR	O
than	IN	O
20,000	CD	O
.	.	O
This	DT	O
is	VBZ	O
consistent	JJ	O
with	IN	O
the	DT	O
lower	JJR	O
viscosity	NN	O
for	IN	O
Invention	NNP	O
syrups	NNS	O
.	.	O
The	DT	O
DP	NNP	O
(	(	O
degrees	NNS	O
of	IN	O
polymerization	NN	O
)	)	O
profiles	VBZ	O
as	IN	O
measured	VBN	O
by	IN	O
HPLC	NNP	O
also	RB	O
reflects	VBZ	O
this	DT	O
difference	NN	O
in	IN	O
action	NN	O
pattern	NN	O
.	.	O
In	IN	O
this	DT	O
study	NN	O
,	,	O
as	RB	O
well	RB	O
as	IN	O
in	IN	O
the	DT	O
previous	JJ	O
studies	NNS	O
,	,	O
the	DT	O
final	JJ	O
glucose	NN	O
level	NN	O
after	IN	O
saccharification	NN	O
of	IN	O
Invention	NNP	O
amylase	NN	O
liquefied	VBD	O
syrups	NNS	O
vs	IN	O
the	DT	O
Bacillus	NNP	O
syrups	NNS	O
is	VBZ	O
the	DT	O
same	JJ	O
for	IN	O
both	DT	O
cases	NNS	O
.	.	O
However	RB	O
,	,	O
we	PRP	O
have	VBP	O
now	RB	O
acquired	VBN	O
sufficient	JJ	O
saccharification	NN	O
data	NNS	O
from	IN	O
internal	JJ	O
as	RB	O
well	RB	O
as	IN	O
from	IN	O
the	DT	O
GPC	NNP	O
studies	NNS	O
to	TO	O
confirm	VB	O
that	IN	O
the	DT	O
non-dextrose	JJ	O
residuals	NNS	O
for	IN	O
the	DT	O
invention	NN	O
amylases	NNS	O
are	VBP	O
different	JJ	O
from	IN	O
the	DT	O
Bacillus	NNP	O
amylase	NN	O
syrups	NN	O
.	.	O
Although	IN	O
the	DT	O
dextrose	NN	O
and	CC	O
maltose	NN	O
levels	NNS	O
are	VBP	O
essentially	RB	O
the	DT	O
same	JJ	O
for	IN	O
both	DT	O
,	,	O
the	DT	O
Invention	NNP	O
amylases	NNS	O
have	VBP	O
a	DT	O
higher	JJR	O
DP3	NNP	O
fraction	NN	O
but	CC	O
lower	JJR	O
amount	NN	O
of	IN	O
the	DT	O
“	NN	O
highers	NNS	O
”	VBP	O
vs.	IN	O
the	DT	O
Bacillus	NNP	O
enzyme	NN	O
.	.	O
Consistent	JJ	O
with	IN	O
the	DT	O
absence	NN	O
of	IN	O
high	JJ	O
molecular	JJ	O
weight	NN	O
fragments	NNS	O
after	IN	O
liquefaction	NN	O
,	,	O
the	DT	O
post	NN	O
saccharification	NN	O
Invention	NNP	O
syrups	NNS	O
have	VBP	O
a	DT	O
lower	JJR	O
content	NN	O
of	IN	O
the	DT	O
>	NNP	O
DP7	NNP	O
fraction	NN	O
.	.	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
amylase	NN	O
concentrate	NN	O
was	VBD	O
prepared	VBN	O
from	IN	O
fermentation	NN	O
broths	NNS	O
by	IN	O
heat	NN	O
treatment	NN	O
,	,	O
cell	NN	O
washing	NN	O
,	,	O
alkaline	JJ	O
extraction	NN	O
using	VBG	O
microfiltration	NN	O
and	CC	O
ultrafiltration	NN	O
(	(	O
48	CD	O
%	NN	O
overall	JJ	O
yield	NN	O
)	)	O
.	.	O
The	DT	O
UF	NNP	O
concentrate	NN	O
was	VBD	O
neutralized	VBN	O
with	IN	O
acetic	JJ	O
acid	NN	O
and	CC	O
formulated	VBN	O
with	IN	O
30	CD	O
%	NN	O
glycerol	NN	O
at	IN	O
pH	JJ	O
4.5	CD	O
.	.	O
The	DT	O
activity	NN	O
level	NN	O
of	IN	O
the	DT	O
slurry	NN	O
formulation	NN	O
was	VBD	O
representative	JJ	O
of	IN	O
a	DT	O
commercial	JJ	O
product	NN	O
(	(	O
120	CD	O
U1/g-0.5	NNP	O
kg/ton	NNP	O
starch	NN	O
)	)	O
.	.	O
Example	RB	O
9	CD	O
Starch	NNP	O
Liquefaction	NNP	O
at	IN	O
pH	NN	O
4.5	CD	O
Using	NNP	O
Amylases	NNP	O
of	IN	O
the	DT	O
Invention	NNP	O
The	DT	O
conversion	NN	O
of	IN	O
starch	NN	O
to	TO	O
glucose	VB	O
can	MD	O
be	VB	O
catalyzed	VBN	O
by	IN	O
the	DT	O
sequence	NN	O
action	NN	O
of	IN	O
two	CD	O
enzymes	NNS	O
:	:	O
alpha-amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
to	TO	O
liquefy	VB	O
the	DT	O
starch	NN	O
(	(	O
e.g.	UH	O
,	,	O
the	DT	O
hydrolysis	NN	O
of	IN	O
high	JJ	O
molecular	JJ	O
weight	NN	O
glucose	NN	O
polymers	NNS	O
to	TO	O
oligosaccharides	NNS	O
consisting	VBG	O
of	IN	O
2	CD	O
to	TO	O
20	CD	O
glycose	JJ	O
units	NNS	O
,	,	O
typically	RB	O
a	DT	O
dextrose	JJ	O
equivalent	NN	O
of	IN	O
10	CD	O
to	TO	O
12	CD	O
,	,	O
by	IN	O
an	DT	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
,	,	O
followed	VBN	O
by	IN	O
saccharification	NN	O
with	IN	O
a	DT	O
glycoamylase	NN	O
(	(	O
which	WDT	O
can	MD	O
be	VB	O
a	DT	O
glycoamylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
processing	NN	O
is	VBZ	O
in	IN	O
a	DT	O
corn	NN	O
wet	NN	O
milling	NN	O
plant	NN	O
producing	VBG	O
a	DT	O
starch	NN	O
slurry	NN	O
having	VBG	O
a	DT	O
pH	NN	O
or	CC	O
about	IN	O
4.0	CD	O
to	TO	O
4.5	CD	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
pH	NN	O
is	VBZ	O
raised	VBN	O
,	,	O
e.g.	RB	O
,	,	O
to	TO	O
5.8	CD	O
to	TO	O
6.0	CD	O
before	IN	O
liquefaction	NN	O
to	TO	O
accommodate	VB	O
an	DT	O
alpha	JJ	O
amylase	NN	O
with	IN	O
a	DT	O
low	JJ	O
pH	NN	O
activity	NN	O
and	CC	O
stability	NN	O
(	(	O
which	WDT	O
can	MD	O
be	VB	O
an	DT	O
alpha	JJ	O
amylase	NN	O
of	IN	O
the	DT	O
invention	NN	O
)	)	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
can	MD	O
liquefy	VB	O
starch	NN	O
at	IN	O
pH	$	O
4.5	CD	O
to	TO	O
dextrose	VB	O
equivalents	NNS	O
ranging	VBG	O
from	IN	O
12	CD	O
to	TO	O
18	CD	O
;	:	O
in	IN	O
one	CD	O
aspect	NN	O
,	,	O
using	VBG	O
alpha	JJ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
at	IN	O
levels	NNS	O
of	IN	O
about	RB	O
3	CD	O
to	TO	O
6	CD	O
grams	NNS	O
per	IN	O
ton	NN	O
of	IN	O
starch	NN	O
.	.	O
In	IN	O
this	DT	O
aspect	NN	O
,	,	O
use	NN	O
of	IN	O
alpha	JJ	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
enables	VBZ	O
starch	JJ	O
liquefaction	NN	O
to	TO	O
be	VB	O
conducted	VBN	O
at	IN	O
pH	NN	O
4.5	CD	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
starch	NN	O
liquefaction	NN	O
is	VBZ	O
conducted	VBN	O
at	IN	O
pH	NN	O
4.5	CD	O
for	IN	O
5	CD	O
minutes	NNS	O
at	IN	O
105°	CD	O
C.	NNP	O
to	TO	O
90	CD	O
minutes	NNS	O
at	IN	O
95°	CD	O
C.	NNP	O
using	VBG	O
amylases	NNS	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
The	DT	O
quantity	NN	O
of	IN	O
enzyme	NN	O
was	VBD	O
adjusted	VBN	O
in	IN	O
order	NN	O
to	TO	O
adjust	VB	O
a	DT	O
target	NN	O
DE	NNP	O
of	IN	O
12	CD	O
to	TO	O
15	CD	O
after	IN	O
liquefaction	NN	O
.	.	O
In	IN	O
one	CD	O
aspect	NN	O
,	,	O
the	DT	O
liquefied	VBN	O
starch	NN	O
is	VBZ	O
then	RB	O
saccharified	VBN	O
with	IN	O
a	DT	O
glucoamylase	NN	O
,	,	O
e.g.	NN	O
,	,	O
an	DT	O
Aspergillus	NNP	O
glucoamylase	NN	O
,	,	O
for	IN	O
about	IN	O
48	CD	O
hours	NNS	O
at	IN	O
about	IN	O
pH	NN	O
4.5	CD	O
and	CC	O
60°	CD	O
C.	NNP	O
If	IN	O
the	DT	O
saccharified	JJ	O
syrup	NN	O
did	VBD	O
not	RB	O
contain	VB	O
at	IN	O
least	JJS	O
95	CD	O
%	NN	O
glucose	NN	O
,	,	O
the	DT	O
target	NN	O
liquefaction	NN	O
DE	NNP	O
was	VBD	O
raised	VBN	O
and	CC	O
the	DT	O
saccharification	NN	O
repeated	VBD	O
until	IN	O
the	DT	O
liquefaction	NN	O
eventually	RB	O
did	VBD	O
produce	VB	O
a	DT	O
saccharified	JJ	O
syrup	NN	O
containing	VBG	O
more	JJR	O
than	IN	O
95	CD	O
%	NN	O
glucose	NN	O
.	.	O
The	DT	O
amylase	NN	O
protein	NN	O
required	VBN	O
to	TO	O
produce	VB	O
a	DT	O
suitable	JJ	O
liquefied	JJ	O
feedstock	NN	O
for	IN	O
saccharification	NN	O
was	VBD	O
determined	VBN	O
by	IN	O
PAGE	NNP	O
.	.	O
Example	RB	O
10	CD	O
Amylase	NNP	O
Ligation	NNP	O
Reassembly	NNP	O
Nine	NNP	O
fragments	NNS	O
(	(	O
each	DT	O
about	IN	O
150	CD	O
bp	NNS	O
)	)	O
were	VBD	O
amplified	VBN	O
from	IN	O
each	DT	O
of	IN	O
the	DT	O
parent	NN	O
clones	NNS	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:66	NNP	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:67	NNP	O
,	,	O
covering	VBG	O
the	DT	O
whole	JJ	O
open	JJ	O
reading	NN	O
frame	NN	O
.	.	O
The	DT	O
primers	NNS	O
are	VBP	O
provided	VBN	O
in	IN	O
Table	JJ	O
1	CD	O
.	.	O
Conditions	NNS	O
used	VBN	O
for	IN	O
PCR	NNP	O
were	VBD	O
as	IN	O
follows	VBZ	O
:	:	O
3	CD	O
min	NN	O
94°	CD	O
C.	NNP	O
,	,	O
(	(	O
30	CD	O
sec	RB	O
94°	CD	O
C.	NNP	O
;	:	O
30	CD	O
sec	NN	O
55°	CD	O
C.	NNP	O
,	,	O
30	CD	O
sec	NN	O
68°	CD	O
C.	NNP	O
)	)	O
×30	NN	O
cycles	NNS	O
,	,	O
followed	VBN	O
by	IN	O
10	CD	O
min	NNS	O
68°	CD	O
C.	NNP	O
PCR	NNP	O
products	NNS	O
corresponding	VBG	O
to	TO	O
homologous	JJ	O
regions	NNS	O
from	IN	O
the	DT	O
three	CD	O
parents	NNS	O
were	VBD	O
pooled	VBN	O
(	(	O
1:1:1	CD	O
)	)	O
,	,	O
cut	VBN	O
with	IN	O
the	DT	O
appropriate	JJ	O
restriction	NN	O
enzyme	NN	O
(	(	O
see	VB	O
Table	NNP	O
3	CD	O
)	)	O
,	,	O
and	CC	O
gel-purified	JJ	O
.	.	O
Equal	JJ	O
amounts	NNS	O
of	IN	O
fragment	NN	O
pools	NNS	O
were	VBD	O
combined	VBN	O
and	CC	O
ligated	VBN	O
(	(	O
16°	CD	O
C.	NNP	O
;	:	O
overnight	VBN	O
)	)	O
.	.	O
The	DT	O
resulting	VBG	O
450	CD	O
bp	JJ	O
ligation	NN	O
products	NNS	O
were	VBD	O
gel	JJ	O
purified	VBN	O
and	CC	O
ligated	VBN	O
to	TO	O
yield	VB	O
full	JJ	O
length	NN	O
amylase	NN	O
genes	NNS	O
.	.	O
The	DT	O
resulting	VBG	O
full	JJ	O
length	NN	O
products	NNS	O
were	VBD	O
gel-purified	JJ	O
and	CC	O
PCR	NNP	O
amplified	VBD	O
using	VBG	O
a	DT	O
mixture	NN	O
of	IN	O
F1	NNP	O
primers	NNS	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
.	.	O
:	:	O
6	CD	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
.	.	O
:	:	O
66	CD	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO	NNP	O
.	.	O
:	:	O
67	CD	O
and	CC	O
primer	JJR	O
SEQ	NNP	O
ID	NNP	O
NO:65	NNP	O
.	.	O
Conditions	NNS	O
used	VBN	O
for	IN	O
PCR	NNP	O
were	VBD	O
as	IN	O
follows	VBZ	O
:	:	O
3	CD	O
min	NN	O
94°	CD	O
C.	NNP	O
,	,	O
(	(	O
30	CD	O
sec	RB	O
94°	CD	O
C.	NNP	O
;	:	O
30	CD	O
sec	NN	O
50°	CD	O
C.	NNP	O
,	,	O
60	CD	O
sec	NN	O
68°	CD	O
C.	NNP	O
)	)	O
×30	NN	O
cycles	NNS	O
,	,	O
followed	VBN	O
by	IN	O
10	CD	O
min	NNS	O
68°	CD	O
C.	NNP	O
The	DT	O
resulting	VBG	O
PCR	NNP	O
products	NNS	O
(	(	O
˜1.4	NNP	O
kbp	NN	O
)	)	O
were	VBD	O
purified	VBN	O
,	,	O
cut	VBN	O
with	IN	O
SpeI	NNP	O
and	CC	O
BbvI	NNP	O
,	,	O
gel-purified	JJ	O
,	,	O
ligated	VBD	O
into	IN	O
pMYC	NN	O
(	(	O
vector	NN	O
from	IN	O
Mycogen	NNP	O
,	,	O
cut	VBD	O
with	IN	O
SpeI/XhoI	NNP	O
)	)	O
,	,	O
and	CC	O
transformed	VBD	O
into	IN	O
E.	NNP	O
coli	NNS	O
Top10	NNP	O
.	.	O
Plasmid	NNP	O
DNA	NNP	O
from	IN	O
a	DT	O
pool	NN	O
of	IN	O
˜21000	NN	O
colonies	NNS	O
was	VBD	O
isolated	VBN	O
and	CC	O
transformed	VBN	O
into	IN	O
Pseudomonas	NNP	O
.	.	O
Screening	VBG	O
of	IN	O
Reassembled	NNP	O
The	DT	O
transformed	JJ	O
Pseudomonas	NNP	O
fluorescens	NNS	O
(	(	O
MB214	NNP	O
)	)	O
containing	VBG	O
pMYC	NN	O
derived	VBN	O
from	IN	O
the	DT	O
parent	NN	O
clones	NNS	O
SEQ	NNP	O
ID	NNP	O
NO:6	NNP	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:66	NNP	O
,	,	O
SEQ	NNP	O
ID	NNP	O
NO:68	NNP	O
were	VBD	O
sorted	VBN	O
to	TO	O
96-	CD	O
or	CC	O
384-well	CD	O
plates	NNS	O
by	IN	O
FACS	NNP	O
and	CC	O
treated	VBN	O
with	IN	O
6M	CD	O
urea	NNS	O
.	.	O
Primary	JJ	O
screening	VBG	O
using	VBG	O
RBB-starch	JJ	O
and/or	JJ	O
FITC-starch	NNP	O
as	IN	O
substrates	NNS	O
was	VBD	O
carried	VBN	O
out	RP	O
as	IN	O
described	NNS	O
more	RBR	O
fully	RB	O
below	IN	O
.	.	O
Elevated	VBN	O
active	JJ	O
clones	NNS	O
were	VBD	O
screened	VBN	O
using	VBG	O
RBB-starch	NNP	O
as	IN	O
substrate	NN	O
using	VBG	O
induced	JJ	O
cultures	NNS	O
and	CC	O
by	IN	O
liquefaction	NN	O
assay	NN	O
.	.	O
Stock	NNP	O
and	CC	O
sequencing	VBG	O
new	JJ	O
elevated	VBN	O
active	JJ	O
clones	NNS	O
based	VBN	O
on	IN	O
liquefaction	NN	O
data	NNS	O
was	VBD	O
performed	VBN	O
.	.	O
The	DT	O
transformed	NN	O
reassembled	VBD	O
amylase	JJ	O
library	NN	O
(	(	O
MB214	NNP	O
(	(	O
P0	NNP	O
)	)	O
,	,	O
were	VBD	O
collected	VBN	O
and	CC	O
sorted	VBN	O
into	IN	O
96-well	JJ	O
plates	NNS	O
(	(	O
or	CC	O
384-well	VB	O
plates	NNS	O
)	)	O
at	IN	O
1	CD	O
cell/well	NN	O
in	IN	O
50	CD	O
Assay	NNP	O
Using	NNP	O
RBB-Starch	NNP	O
75	CD	O
Assay	NNP	O
Using	NNP	O
FITC-Starch	NNP	O
Added	NNP	O
50	CD	O
Confirmation	NNP	O
of	IN	O
New	NNP	O
Active	NNP	O
Clones	NNP	O
Each	DT	O
positive	JJ	O
clone	NN	O
from	IN	O
screening	VBG	O
was	VBD	O
grown	VBN	O
and	CC	O
induced	VBN	O
using	VBG	O
a	DT	O
standard	JJ	O
protocol	NN	O
.	.	O
Each	DT	O
clone	NN	O
was	VBD	O
examined	VBN	O
for	IN	O
growth	NN	O
(	(	O
i.e.	FW	O
,	,	O
cell	VBP	O
density	NN	O
over	IN	O
time	NN	O
)	)	O
,	,	O
activity	NN	O
at	IN	O
per	NN	O
cell	NN	O
level	NN	O
(	(	O
RBB-starch	NNP	O
assay	NN	O
and	CC	O
liquefaction	NN	O
assay	NN	O
)	)	O
,	,	O
expression	NN	O
(	(	O
protein	JJ	O
gel	NN	O
)	)	O
and	CC	O
solubility	NN	O
of	IN	O
protein	NN	O
(	(	O
by	IN	O
microscope	NN	O
analysis	NN	O
)	)	O
.	.	O
The	DT	O
confirmed	JJ	O
new	JJ	O
elevated	VBN	O
clones	NNS	O
were	VBD	O
transferred	VBN	O
for	IN	O
fermentation	NN	O
.	.	O
One	CD	O
of	IN	O
the	DT	O
clones	NNS	O
have	VBP	O
amylase	VBN	O
activity	NN	O
greater	JJR	O
than	IN	O
that	DT	O
of	IN	O
the	DT	O
parent	NN	O
includes	VBZ	O
the	DT	O
enzyme	NN	O
set	VBN	O
forth	NN	O
in	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2	NNP	O
(	(	O
encoded	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1	NNP	O
)	)	O
.	.	O
A	DT	O
number	NN	O
of	IN	O
embodiments	NNS	O
of	IN	O
the	DT	O
invention	NN	O
have	VBP	O
been	VBN	O
described	VBN	O
.	.	O
Nevertheless	RB	O
,	,	O
it	PRP	O
will	MD	O
be	VB	O
understood	JJ	O
that	IN	O
various	JJ	O
modifications	NNS	O
may	MD	O
be	VB	O
made	VBN	O
without	IN	O
departing	VBG	O
from	IN	O
the	DT	O
spirit	NN	O
and	CC	O
scope	NN	O
of	IN	O
the	DT	O
invention	NN	O
.	.	O
Accordingly	RB	O
,	,	O
other	JJ	O
embodiments	NNS	O
are	VBP	O
within	IN	O
the	DT	O
scope	NN	O
of	IN	O
the	DT	O
following	JJ	O
claims	NNS	O
.	.	O
Claims	NNS	O
(	(	O
21	CD	O
)	)	O
Priority	NN	O
Applications	NNP	O
(	(	O
7	CD	O
)	)	O
Applications	NNPS	O
Claiming	NNP	O
Priority	NNP	O
(	(	O
4	CD	O
)	)	O
Related	VBN	O
Parent	NN	O
Applications	NNP	O
(	(	O
3	CD	O
)	)	O
Related	VBN	O
Child	NNP	O
Applications	NNP	O
(	(	O
1	CD	O
)	)	O
Publications	NNPS	O
(	(	O
2	CD	O
)	)	O
Family	RB	O
ID=46303691	NNP	O
Family	NNP	O
Applications	NNP	O
(	(	O
5	CD	O
)	)	O
Family	NNP	O
Applications	NNP	O
Before	NNP	O
(	(	O
1	CD	O
)	)	O
Family	NNP	O
Applications	NNP	O
After	IN	O
(	(	O
3	CD	O
)	)	O
Country	NN	O
Status	NNP	O
(	(	O
1	CD	O
)	)	O
Cited	VBN	O
By	IN	O
(	(	O
5	CD	O
)	)	O
Families	NNPS	O
Citing	VBG	O
this	DT	O
family	NN	O
(	(	O
14	CD	O
)	)	O
Citations	NNPS	O
(	(	O
29	CD	O
)	)	O
Family	RB	O
Cites	VBZ	O
Families	NNS	O
(	(	O
9	CD	O
)	)	O
Patent	NN	O
Citations	NNP	O
(	(	O
33	CD	O
)	)	O
Non-Patent	JJ	O
Citations	NNP	O
(	(	O
232	CD	O
)	)	O
Cited	VBN	O
By	IN	O
(	(	O
9	CD	O
)	)	O
Also	RB	O
Published	VBN	O
As	IN	O
Similar	JJ	O
Documents	NNP	O
Legal	NNP	O
Events	NNP	O
Owner	NNP	O
name	NN	O
:	:	O
VERENIUM	NNP	O
CORPORATION	NNP	O
,	,	O
CALIFORNIA	NNP	O
Free	NNP	O
format	VBD	O
text	NN	O
:	:	O
ASSIGNMENT	NNP	O
OF	IN	O
ASSIGNORS	NNP	O
INTEREST	NNP	O
;	:	O
ASSIGNORS	NNP	O
:	:	O
CALLEN	NNP	O
,	,	O
WALTER	NNP	O
;	:	O
RICHARDSON	NNP	O
,	,	O
TOBY	NNP	O
;	:	O
FREY	NNP	O
,	,	O
GERHARD	NNP	O
;	:	O
AND	CC	O
OTHERS	NNPS	O
;	:	O
SIGNING	NNP	O
DATES	NNP	O
FROM	NNP	O
20041118	CD	O
TO	NNP	O
20070620	CD	O
;	:	O
REEL/FRAME:024297/0591	NNP	O
Owner	NNP	O
name	NN	O
:	:	O
COMERICA	NNP	O
BANK	NNP	O
,	,	O
A	NNP	O
TEXAS	NNP	O
BANKING	NNP	O
ASSOCIATION	NNP	O
,	,	O
MICHIG	NNP	O
Free	NNP	O
format	NN	O
text	NN	O
:	:	O
SECURITY	NNP	O
AGREEMENT	NNP	O
;	:	O
ASSIGNOR	NNP	O
:	:	O
VERENIUM	NNP	O
CORPORATION	NNP	O
,	,	O
A	NNP	O
DELAWARE	NNP	O
CORPORATION	NNP	O
;	:	O
REEL/FRAME:027099/0408	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20111019	CD	O
Owner	NNP	O
name	NN	O
:	:	O
VERENIUM	NNP	O
CORPORATION	NNP	O
,	,	O
CALIFORNIA	NNP	O
Free	NNP	O
format	VBD	O
text	NN	O
:	:	O
RELEASE	NN	O
BY	NNP	O
SECURED	NNP	O
PARTY	NNP	O
;	:	O
ASSIGNOR	NNP	O
:	:	O
COMERICA	NNP	O
BANK	NNP	O
;	:	O
REEL/FRAME:028300/0200	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20120401	CD	O
Owner	NNP	O
name	NN	O
:	:	O
ATHYRIUM	NNP	O
OPPORTUNITIES	NNP	O
FUND	NNP	O
(	(	O
A	NNP	O
)	)	O
LP	NNP	O
,	,	O
NEW	NNP	O
YORK	NNP	O
Free	NNP	O
format	NN	O
text	NN	O
:	:	O
NOTICE	NNP	O
OF	NNP	O
GRANT	NNP	O
OF	NNP	O
SECURITY	NNP	O
INTEREST	NNP	O
IN	NNP	O
PATENTS	NNP	O
;	:	O
ASSIGNOR	NNP	O
:	:	O
VERENIUM	NNP	O
CORPORATION	NNP	O
;	:	O
REEL/FRAME:029444/0119	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20121207	CD	O
Owner	NNP	O
name	NN	O
:	:	O
VERENIUM	NNP	O
CORPORATION	NNP	O
,	,	O
CALIFORNIA	NNP	O
Free	NNP	O
format	VBD	O
text	NN	O
:	:	O
RELEASE	NN	O
BY	NNP	O
SECURED	NNP	O
PARTY	NNP	O
;	:	O
ASSIGNOR	NNP	O
:	:	O
ATHYRIUM	NNP	O
OPPORTUNITIES	NNP	O
FUND	NNP	O
(	(	O
A	NNP	O
)	)	O
LP	NNP	O
;	:	O
REEL/FRAME:031956/0016	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20131031	CD	O
Year	NN	O
of	IN	O
fee	JJ	O
payment	NN	O
:	:	O
4	CD	O
Owner	NNP	O
name	NN	O
:	:	O
BASF	NNP	O
ENZYMES	NNP	O
LLC	NNP	O
,	,	O
CALIFORNIA	NNP	O
Free	NNP	O
format	VBD	O
text	NN	O
:	:	O
CHANGE	NN	O
OF	NNP	O
NAME	NNP	O
;	:	O
ASSIGNOR	NNP	O
:	:	O
VERENIUM	NNP	O
CORPORATION	NNP	O
;	:	O
REEL/FRAME:041656/0891	NNP	O
Effective	NNP	O
date	NN	O
:	:	O
20141101	CD	O
